The table below lists the options of the executed module.
Option | Value |
---|---|
analyze.sites | yes |
differential.report.sites | yes |
region.types | default |
differential.permutations | 0 |
differential.comparison.columns | Platform, tissue, PrEC_comparison, LNCaP_PrEC_comp |
differential.comparison.columns.all.pairwise | default |
columns.pairing | default |
differential.site.test.method | limma |
differential.variability | no |
differential.variability.method | diffVar |
covariate.adjustment.columns | default |
differential.adjustment.sva | yes |
differential.adjustment.celltype | yes |
differential.enrichment.go | yes |
differential.enrichment.lola | no |
differential.enrichment.lola.dbs | ${LOLACore} |
Differential methylation analysis was conducted on site and region level according to the sample groups specified in the analysis.
The following comparisons were made:
In the following anlyses, p-values on the site level were computed using the limma
method. I.e. hierarchical linear models from the limma package were employed and fitted using an empirical Bayes approach on derived M-values.
Differential methylation on the site level was computed based on a variety of metrics. Of particular interest for the following plots and analyses are the following quantities for each site: a) the difference in mean methylation levels of the two groups being compared, b) the quotient in mean methylation and c) a statistical test (limma or t-test depending on the settings) assessing whether the methylation values in the two groups originate from distinct distributions. Additionally each site was assigned a rank based on each of these three criteria. A combined rank is computed as the maximum (i.e. worst) rank among the three ranks. The smaller the combined rank for a site, the more evidence for differential methylation it exhibits. This section includes scatterplots of the site group means as well as volcano plots of each pairwise comparison colored according to the combined ranks or p-values of a given site.
The following rank cutfoffs have been automatically selected for the analysis of differentially methylated sites:
Rank Cutoff | |
450k vs. non.450k (based on Platform) | 25099 |
EPIC vs. non.EPIC (based on Platform) | 17301 |
WGBS vs. non.WGBS (based on Platform) | 143304 |
infant blood vs. non.infant blood (based on tissue) | 121866 |
non-malignant tissue associated fibroblasts (NAF) vs. non.non-malignant tissue associated fibroblasts (NAF) (based on tissue) | 91577 |
cancer associated fibroblasts (CAF) vs. non.cancer associated fibroblasts (CAF) (based on tissue) | 94986 |
primary prostate epithelial cells (PrEC) vs. non.primary prostate epithelial cells (PrEC) (based on tissue) | 72278 |
prostate cancer cell line (LNCaP) vs. non.prostate cancer cell line (LNCaP) (based on tissue) | 113868 |
Rep1 vs. Rep2 (based on PrEC_comparison) | 893 |
LNCaP vs. PrEC (based on LNCaP_PrEC_comp) | 137907 |
comparison | |
differential methylation measure |
Scatterplot for differential methylation (sites). If the selected criterion is not rankGradient
:
The transparency corresponds to point density. If the number of points exceeds 2e+06 then the number of points for density estimation is reduced to that number by random sampling.The1% of the points in the sparsest populated plot regions are drawn explicitly (up to a maximum of 10000 points).Additionally, the colored points represent differentially methylated sites (according to the selected criterion).
If the selected criterion is rankGradient
: median combined ranks accross hexagonal bins are shown
as a gradient according to the color legend.
comparison | |
difference metric | |
significance metric |
Volcano plot for differential methylation quantified by various metrics. Color scale according to combined ranking.
A tabular overview of measures for differential methylation on the site level for the individual comparisons are provided in this section. Below, a brief explanation of the different columns can be found:
The tables for the individual comparisons can be found here:
Differential methylation on the region level was computed based on a variety of metrics. Of particular interest for the following plots and analyses are the following quantities for each region: the mean difference in means across all sites in a region of the two groups being compared and the mean of quotients in mean methylation as well as a combined p-value calculated from all site p-values in the region [1]. Additionally each region was assigned a rank based on each of these three criteria. A combined rank is computed as the maximum (i.e. worst) value among the three ranks. The smaller the combined rank for a region, the more evidence for differential methylation it exhibits. Regions were defined based on the region types specified in the analysis. This section includes scatterplots of the region group means as well as volcano plots of each pairwise comparison colored according to the combined rank of a given region.
The following rank cutfoffs have been automatically selected for the analysis of differentially methylated regions:
tiling | genes | promoters | cpgislands | |
450k vs. non.450k (based on Platform) | 1821 | 112 | 452 | 347 |
EPIC vs. non.EPIC (based on Platform) | 2377 | 129 | 117 | 132 |
WGBS vs. non.WGBS (based on Platform) | 10884 | 1899 | 1241 | 5746 |
infant blood vs. non.infant blood (based on tissue) | 5009 | 1703 | 3391 | 2557 |
non-malignant tissue associated fibroblasts (NAF) vs. non.non-malignant tissue associated fibroblasts (NAF) (based on tissue) | 7220 | 1820 | 3154 | 789 |
cancer associated fibroblasts (CAF) vs. non.cancer associated fibroblasts (CAF) (based on tissue) | 10552 | 1663 | 2262 | 1272 |
primary prostate epithelial cells (PrEC) vs. non.primary prostate epithelial cells (PrEC) (based on tissue) | 4402 | 1305 | 1295 | 2483 |
prostate cancer cell line (LNCaP) vs. non.prostate cancer cell line (LNCaP) (based on tissue) | 7590 | 2076 | 1312 | 4330 |
Rep1 vs. Rep2 (based on PrEC_comparison) | 452 | 0 | 0 | 263 |
LNCaP vs. PrEC (based on LNCaP_PrEC_comp) | 11615 | 1987 | 3029 | 2197 |
comparison | |
regions | |
differential methylation measure |
Scatterplot for differential methylation (regions). If the selected criterion is not rankGradient
:
The transparency corresponds to point density. The 1% of the points in the sparsest populated plot regions are drawn explicitly.
Additionally, the colored points represent differentially methylated regions (according to the selected criterion).
If the selected criterion is rankGradient
: median combined ranks accross hexagonal bins are shown
as a gradient according to the color legend.
comparison | |
regions | |
difference metric | |
significance metric |
Volcano plot for differential methylation quantified by various metrics. Color scale according to combined ranking.
A tabular overview of measures for differential methylation on the region level for the individual comparisons are provided in this section.
The tables for the individual comparisons can be found here:
tiling | genes | promoters | cpgislands | |
450k vs. non.450k (based on Platform) | csv | csv | csv | csv |
EPIC vs. non.EPIC (based on Platform) | csv | csv | csv | csv |
WGBS vs. non.WGBS (based on Platform) | csv | csv | csv | csv |
infant blood vs. non.infant blood (based on tissue) | csv | csv | csv | csv |
non-malignant tissue associated fibroblasts (NAF) vs. non.non-malignant tissue associated fibroblasts (NAF) (based on tissue) | csv | csv | csv | csv |
cancer associated fibroblasts (CAF) vs. non.cancer associated fibroblasts (CAF) (based on tissue) | csv | csv | csv | csv |
primary prostate epithelial cells (PrEC) vs. non.primary prostate epithelial cells (PrEC) (based on tissue) | csv | csv | csv | csv |
prostate cancer cell line (LNCaP) vs. non.prostate cancer cell line (LNCaP) (based on tissue) | csv | csv | csv | csv |
Rep1 vs. Rep2 (based on PrEC_comparison) | csv | csv | csv | csv |
LNCaP vs. PrEC (based on LNCaP_PrEC_comp) | csv | csv | csv | csv |
GO Enrichment Analysis was conducted. The wordclouds and tables below contains significant GO terms as determined by a hypergeometric test.
comparison | |
Hypermethylation/hypomethylation | |
ontology | |
regions | |
differential methylation measure |
Wordclouds for GO enrichment terms.
comparison | |
Hypermethylation/hypomethylation | |
ontology | |
regions | |
differential methylation measure |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:1902511 | 0.0024 | Inf | 0.0024 | 1 | 1 | negative regulation of apoptotic DNA fragmentation |
GO:0032076 | 0.0048 | 427.3421 | 0.0048 | 1 | 2 | negative regulation of deoxyribonuclease activity |
GO:0050976 | 0.0048 | 427.3421 | 0.0048 | 1 | 2 | detection of mechanical stimulus involved in sensory perception of touch |
GO:0051083 | 0.0048 | 427.3421 | 0.0048 | 1 | 2 | 'de novo' cotranslational protein folding |
GO:0060133 | 0.0048 | 427.3421 | 0.0048 | 1 | 2 | somatotropin secreting cell development |
GO:0035803 | 0.0072 | 213.6579 | 0.0072 | 1 | 3 | egg coat formation |
GO:0044571 | 0.0072 | 213.6579 | 0.0072 | 1 | 3 | [2Fe-2S] cluster assembly |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0002227 | 0 | 178.3077 | 0.0442 | 5 | 18 | innate immune response in mucosa |
GO:0002251 | 0 | 105.3052 | 0.0663 | 5 | 27 | organ or tissue specific immune response |
GO:0019731 | 0 | 74.6912 | 0.0885 | 5 | 36 | antibacterial humoral response |
GO:0050830 | 0 | 41.3555 | 0.1843 | 6 | 75 | defense response to Gram-positive bacterium |
GO:0061844 | 0 | 53.8073 | 0.1179 | 5 | 48 | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO:0006334 | 0 | 22.5672 | 0.3243 | 6 | 132 | nucleosome assembly |
GO:0006333 | 0 | 16.6806 | 0.4325 | 6 | 176 | chromatin assembly or disassembly |
GO:0006323 | 0 | 15.0666 | 0.4767 | 6 | 194 | DNA packaging |
GO:0071824 | 0 | 11.2407 | 0.6315 | 6 | 257 | protein-DNA complex subunit organization |
GO:0006959 | 1e-04 | 11.5147 | 0.5013 | 5 | 204 | humoral immune response |
GO:0098542 | 5e-04 | 6.7623 | 1.0295 | 6 | 419 | defense response to other organism |
GO:0034622 | 6e-04 | 4.4195 | 2.4817 | 9 | 1010 | cellular macromolecular complex assembly |
GO:0009617 | 0.0013 | 5.6363 | 1.2261 | 6 | 499 | response to bacterium |
GO:0043207 | 0.0027 | 4.2326 | 1.9215 | 7 | 782 | response to external biotic stimulus |
GO:0045900 | 0.0048 | 427.2895 | 0.0048 | 1 | 2 | negative regulation of translational elongation |
GO:1900248 | 0.0049 | 416.359 | 0.0049 | 1 | 2 | negative regulation of cytoplasmic translational elongation |
GO:1902269 | 0.0049 | 416.359 | 0.0049 | 1 | 2 | positive regulation of polyamine transmembrane transport |
GO:1902559 | 0.0049 | 416.359 | 0.0049 | 1 | 2 | 3'-phospho-5'-adenylyl sulfate transmembrane transport |
GO:0033387 | 0.0074 | 208.1667 | 0.0074 | 1 | 3 | putrescine biosynthetic process from ornithine |
GO:0035425 | 0.0074 | 208.1667 | 0.0074 | 1 | 3 | autocrine signaling |
GO:0061760 | 0.0098 | 138.7692 | 0.0098 | 1 | 4 | antifungal innate immune response |
GO:1990966 | 0.0098 | 138.7692 | 0.0098 | 1 | 4 | ATP generation from poly-ADP-D-ribose |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0035137 | 0 | 102.2773 | 0.0386 | 3 | 37 | hindlimb morphogenesis |
GO:0048935 | 1e-04 | 196.9818 | 0.0136 | 2 | 13 | peripheral nervous system neuron development |
GO:0030326 | 3e-04 | 27.8882 | 0.1326 | 3 | 127 | embryonic limb morphogenesis |
GO:0035107 | 4e-04 | 23.9851 | 0.1535 | 3 | 147 | appendage morphogenesis |
GO:0009954 | 5e-04 | 74.6345 | 0.0324 | 2 | 31 | proximal/distal pattern formation |
GO:0035136 | 8e-04 | 56.9263 | 0.0418 | 2 | 40 | forelimb morphogenesis |
GO:0021763 | 0.001 | Inf | 0.001 | 1 | 1 | subthalamic nucleus development |
GO:0060127 | 0.001 | Inf | 0.001 | 1 | 1 | prolactin secreting cell differentiation |
GO:0060578 | 0.001 | Inf | 0.001 | 1 | 1 | superior vena cava morphogenesis |
GO:0071444 | 0.001 | Inf | 0.001 | 1 | 1 | cellular response to pheromone |
GO:0035993 | 0.0021 | 1016.3125 | 0.0021 | 1 | 2 | deltoid tuberosity development |
GO:0060460 | 0.0021 | 1016.3125 | 0.0021 | 1 | 2 | left lung morphogenesis |
GO:0060577 | 0.0021 | 1016.3125 | 0.0021 | 1 | 2 | pulmonary vein morphogenesis |
GO:0071461 | 0.0021 | 1016.3125 | 0.0021 | 1 | 2 | cellular response to redox state |
GO:0007422 | 0.0024 | 31.2908 | 0.0741 | 2 | 71 | peripheral nervous system development |
GO:0032481 | 0.0027 | 29.9815 | 0.0773 | 2 | 74 | positive regulation of type I interferon production |
GO:0008344 | 0.0029 | 28.7769 | 0.0804 | 2 | 77 | adult locomotory behavior |
GO:0003350 | 0.0031 | 508.125 | 0.0031 | 1 | 3 | pulmonary myocardium development |
GO:0061031 | 0.0031 | 508.125 | 0.0031 | 1 | 3 | endodermal digestive tract morphogenesis |
GO:0048704 | 0.0042 | 23.6938 | 0.0971 | 2 | 93 | embryonic skeletal system morphogenesis |
GO:0021855 | 0.0042 | 338.7292 | 0.0042 | 1 | 4 | hypothalamus cell migration |
GO:0061325 | 0.0042 | 338.7292 | 0.0042 | 1 | 4 | cell proliferation involved in outflow tract morphogenesis |
GO:0002074 | 0.0052 | 254.0312 | 0.0052 | 1 | 5 | extraocular skeletal muscle development |
GO:0060126 | 0.0052 | 254.0312 | 0.0052 | 1 | 5 | somatotropin secreting cell differentiation |
GO:0070221 | 0.0052 | 254.0312 | 0.0052 | 1 | 5 | sulfide oxidation, using sulfide:quinone oxidoreductase |
GO:1901164 | 0.0052 | 254.0312 | 0.0052 | 1 | 5 | negative regulation of trophoblast cell migration |
GO:0060537 | 0.0063 | 9.255 | 0.3874 | 3 | 371 | muscle tissue development |
GO:0007517 | 0.0064 | 9.1785 | 0.3906 | 3 | 374 | muscle organ development |
GO:0043900 | 0.0066 | 9.0783 | 0.3947 | 3 | 378 | regulation of multi-organism process |
GO:0003253 | 0.0073 | 169.3333 | 0.0073 | 1 | 7 | cardiac neural crest cell migration involved in outflow tract morphogenesis |
GO:0055009 | 0.0073 | 169.3333 | 0.0073 | 1 | 7 | atrial cardiac muscle tissue morphogenesis |
GO:0007389 | 0.0089 | 8.1224 | 0.4396 | 3 | 421 | pattern specification process |
GO:0048568 | 0.009 | 8.1025 | 0.4407 | 3 | 422 | embryonic organ development |
GO:0007338 | 0.0091 | 15.6934 | 0.1452 | 2 | 139 | single fertilization |
GO:0060050 | 0.0094 | 126.9844 | 0.0094 | 1 | 9 | positive regulation of protein glycosylation |
GO:2000288 | 0.0094 | 126.9844 | 0.0094 | 1 | 9 | positive regulation of myoblast proliferation |
GO:0007519 | 0.0094 | 15.4449 | 0.1485 | 2 | 151 | skeletal muscle tissue development |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0022612 | 4e-04 | 23.3957 | 0.1522 | 3 | 118 | gland morphogenesis |
GO:0060571 | 5e-04 | 71.2018 | 0.0335 | 2 | 26 | morphogenesis of an epithelial fold |
GO:0060429 | 5e-04 | 6.3715 | 1.5351 | 7 | 1190 | epithelium development |
GO:0048729 | 0.001 | 7.9353 | 0.8011 | 5 | 621 | tissue morphogenesis |
GO:0021509 | 0.0013 | Inf | 0.0013 | 1 | 1 | roof plate formation |
GO:0071444 | 0.0013 | Inf | 0.0013 | 1 | 1 | cellular response to pheromone |
GO:2001051 | 0.0013 | Inf | 0.0013 | 1 | 1 | positive regulation of tendon cell differentiation |
GO:0061138 | 0.0015 | 15.2292 | 0.2309 | 3 | 179 | morphogenesis of a branching epithelium |
GO:0021515 | 0.002 | 34.1221 | 0.0671 | 2 | 52 | cell differentiation in spinal cord |
GO:0009952 | 0.0021 | 13.4497 | 0.2606 | 3 | 202 | anterior/posterior pattern specification |
GO:0015891 | 0.0039 | 406.4 | 0.0039 | 1 | 3 | siderophore transport |
GO:0035992 | 0.0039 | 406.4 | 0.0039 | 1 | 3 | tendon formation |
GO:0048619 | 0.0039 | 406.4 | 0.0039 | 1 | 3 | embryonic hindgut morphogenesis |
GO:0045165 | 0.0039 | 10.7594 | 0.3238 | 3 | 251 | cell fate commitment |
GO:0010046 | 0.0052 | 270.9167 | 0.0052 | 1 | 4 | response to mycotoxin |
GO:0072376 | 0.0052 | 20.7651 | 0.1084 | 2 | 84 | protein activation cascade |
GO:0010628 | 0.0056 | 4.049 | 2.3143 | 7 | 1794 | positive regulation of gene expression |
GO:0060157 | 0.0064 | 203.175 | 0.0065 | 1 | 5 | urinary bladder development |
GO:0070221 | 0.0064 | 203.175 | 0.0065 | 1 | 5 | sulfide oxidation, using sulfide:quinone oxidoreductase |
GO:0015840 | 0.0077 | 162.53 | 0.0077 | 1 | 6 | urea transport |
GO:0060527 | 0.0077 | 162.53 | 0.0077 | 1 | 6 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis |
GO:0009635 | 0.009 | 135.4333 | 0.009 | 1 | 7 | response to herbicide |
GO:0060687 | 0.009 | 135.4333 | 0.009 | 1 | 7 | regulation of branching involved in prostate gland morphogenesis |
GO:0035239 | 0.0095 | 7.7332 | 0.4463 | 3 | 346 | tube morphogenesis |
GO:0048513 | 0.0098 | 3.2864 | 3.9929 | 9 | 3249 | animal organ development |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042102 | 0 | 27.4287 | 0.2205 | 5 | 97 | positive regulation of T cell proliferation |
GO:0032946 | 0 | 19.6704 | 0.3023 | 5 | 133 | positive regulation of mononuclear cell proliferation |
GO:0002274 | 0 | 30.854 | 0.1562 | 4 | 82 | myeloid leukocyte activation |
GO:0050867 | 1e-04 | 10.4628 | 0.6841 | 6 | 301 | positive regulation of cell activation |
GO:0050670 | 1e-04 | 12.7918 | 0.4568 | 5 | 201 | regulation of lymphocyte proliferation |
GO:0002263 | 1e-04 | 6.6067 | 1.4978 | 8 | 659 | cell activation involved in immune response |
GO:0070663 | 1e-04 | 12.1632 | 0.4796 | 5 | 211 | regulation of leukocyte proliferation |
GO:1903039 | 1e-04 | 12.1037 | 0.4818 | 5 | 212 | positive regulation of leukocyte cell-cell adhesion |
GO:1902715 | 1e-04 | 154.6286 | 0.0182 | 2 | 8 | positive regulation of interferon-gamma secretion |
GO:0002684 | 2e-04 | 5.2922 | 2.1342 | 9 | 939 | positive regulation of immune system process |
GO:0050900 | 2e-04 | 7.9505 | 0.891 | 6 | 392 | leukocyte migration |
GO:0006600 | 3e-04 | 103.0667 | 0.025 | 2 | 11 | creatine metabolic process |
GO:0051251 | 3e-04 | 9.8351 | 0.5887 | 5 | 259 | positive regulation of lymphocyte activation |
GO:0001787 | 3e-04 | 92.7543 | 0.0273 | 2 | 12 | natural killer cell proliferation |
GO:0045087 | 4e-04 | 5.3248 | 1.8365 | 8 | 808 | innate immune response |
GO:0002694 | 5e-04 | 6.7768 | 1.0387 | 6 | 457 | regulation of leukocyte activation |
GO:0050863 | 6e-04 | 8.3314 | 0.691 | 5 | 304 | regulation of T cell activation |
GO:0043312 | 6e-04 | 6.5093 | 1.0796 | 6 | 475 | neutrophil degranulation |
GO:0042119 | 7e-04 | 6.3556 | 1.1046 | 6 | 486 | neutrophil activation |
GO:0032940 | 8e-04 | 3.9699 | 3.1729 | 10 | 1396 | secretion by cell |
GO:0002275 | 9e-04 | 6.0582 | 1.1612 | 6 | 525 | myeloid cell activation involved in immune response |
GO:0032649 | 0.0011 | 16.5759 | 0.2023 | 3 | 89 | regulation of interferon-gamma production |
GO:0010758 | 0.0011 | 46.3486 | 0.05 | 2 | 22 | regulation of macrophage chemotaxis |
GO:0046640 | 0.0011 | 46.3486 | 0.05 | 2 | 22 | regulation of alpha-beta T cell proliferation |
GO:0002444 | 0.0012 | 5.7716 | 1.2114 | 6 | 533 | myeloid leukocyte mediated immunity |
GO:0001774 | 0.0012 | 44.1388 | 0.0523 | 2 | 23 | microglial cell activation |
GO:0042330 | 0.0015 | 5.4604 | 1.2774 | 6 | 562 | taxis |
GO:0045785 | 0.0016 | 6.6113 | 0.8637 | 5 | 380 | positive regulation of cell adhesion |
GO:0007200 | 0.0019 | 13.5605 | 0.2455 | 3 | 108 | phospholipase C-activating G-protein coupled receptor signaling pathway |
GO:0022407 | 0.0021 | 6.2042 | 0.9182 | 5 | 404 | regulation of cell-cell adhesion |
GO:0014739 | 0.0023 | Inf | 0.0023 | 1 | 1 | positive regulation of muscle hyperplasia |
GO:0071663 | 0.0023 | Inf | 0.0023 | 1 | 1 | positive regulation of granzyme B production |
GO:1903997 | 0.0023 | Inf | 0.0023 | 1 | 1 | positive regulation of non-membrane spanning protein tyrosine kinase activity |
GO:1904140 | 0.0023 | Inf | 0.0023 | 1 | 1 | negative regulation of microglial cell migration |
GO:1904151 | 0.0023 | Inf | 0.0023 | 1 | 1 | positive regulation of microglial cell mediated cytotoxicity |
GO:2001264 | 0.0023 | Inf | 0.0023 | 1 | 1 | negative regulation of C-C chemokine binding |
GO:0045937 | 0.0025 | 3.9116 | 2.4502 | 8 | 1078 | positive regulation of phosphate metabolic process |
GO:0060326 | 0.0025 | 7.8172 | 0.5728 | 4 | 252 | cell chemotaxis |
GO:0097178 | 0.0025 | 29.882 | 0.075 | 2 | 33 | ruffle assembly |
GO:0006955 | 0.0026 | 8.0993 | 0.5926 | 4 | 400 | immune response |
GO:0022610 | 0.0026 | 3.5892 | 3.0547 | 9 | 1344 | biological adhesion |
GO:0008284 | 0.0027 | 4.2676 | 1.9297 | 7 | 849 | positive regulation of cell proliferation |
GO:0006911 | 0.0032 | 26.4604 | 0.0841 | 2 | 37 | phagocytosis, engulfment |
GO:0002819 | 0.0033 | 11.0212 | 0.3 | 3 | 132 | regulation of adaptive immune response |
GO:1905517 | 0.0035 | 25.027 | 0.0886 | 2 | 39 | macrophage migration |
GO:0006954 | 0.0037 | 4.5551 | 1.5183 | 6 | 668 | inflammatory response |
GO:0050922 | 0.0037 | 24.3669 | 0.0909 | 2 | 40 | negative regulation of chemotaxis |
GO:0071675 | 0.0039 | 23.7407 | 0.0932 | 2 | 41 | regulation of mononuclear cell migration |
GO:0046960 | 0.0045 | 451.1389 | 0.0045 | 1 | 2 | sensitization |
GO:1902227 | 0.0045 | 451.1389 | 0.0045 | 1 | 2 | negative regulation of macrophage colony-stimulating factor signaling pathway |
GO:1903970 | 0.0045 | 451.1389 | 0.0045 | 1 | 2 | negative regulation of response to macrophage colony-stimulating factor |
GO:2000349 | 0.0045 | 451.1389 | 0.0045 | 1 | 2 | negative regulation of CD40 signaling pathway |
GO:2000566 | 0.0045 | 451.1389 | 0.0045 | 1 | 2 | positive regulation of CD8-positive, alpha-beta T cell proliferation |
GO:0032101 | 0.0047 | 4.3102 | 1.6001 | 6 | 704 | regulation of response to external stimulus |
GO:0002764 | 0.0051 | 5.0019 | 1.1296 | 5 | 497 | immune response-regulating signaling pathway |
GO:0045055 | 0.0056 | 4.1605 | 1.6546 | 6 | 728 | regulated exocytosis |
GO:0018149 | 0.0057 | 19.2786 | 0.1136 | 2 | 50 | peptide cross-linking |
GO:0006952 | 0.0058 | 9.1139 | 0.37 | 3 | 206 | defense response |
GO:0046635 | 0.006 | 18.884 | 0.1159 | 2 | 51 | positive regulation of alpha-beta T cell activation |
GO:0002429 | 0.0061 | 6.0311 | 0.7364 | 4 | 324 | immune response-activating cell surface receptor signaling pathway |
GO:0002440 | 0.0065 | 8.5973 | 0.3818 | 3 | 168 | production of molecular mediator of immune response |
GO:0002548 | 0.0067 | 17.7912 | 0.1227 | 2 | 54 | monocyte chemotaxis |
GO:0010324 | 0.0067 | 17.7912 | 0.1227 | 2 | 54 | membrane invagination |
GO:0002232 | 0.0068 | 225.5556 | 0.0068 | 1 | 3 | leukocyte chemotaxis involved in inflammatory response |
GO:0002277 | 0.0068 | 225.5556 | 0.0068 | 1 | 3 | myeloid dendritic cell activation involved in immune response |
GO:0002636 | 0.0068 | 225.5556 | 0.0068 | 1 | 3 | positive regulation of germinal center formation |
GO:0002669 | 0.0068 | 225.5556 | 0.0068 | 1 | 3 | positive regulation of T cell anergy |
GO:0035106 | 0.0068 | 225.5556 | 0.0068 | 1 | 3 | operant conditioning |
GO:0046005 | 0.0068 | 225.5556 | 0.0068 | 1 | 3 | positive regulation of circadian sleep/wake cycle, REM sleep |
GO:0071673 | 0.0068 | 225.5556 | 0.0068 | 1 | 3 | positive regulation of smooth muscle cell chemotaxis |
GO:0072156 | 0.0068 | 225.5556 | 0.0068 | 1 | 3 | distal tubule morphogenesis |
GO:1903972 | 0.0068 | 225.5556 | 0.0068 | 1 | 3 | regulation of cellular response to macrophage colony-stimulating factor stimulus |
GO:0002253 | 0.0071 | 4.5962 | 1.2251 | 5 | 539 | activation of immune response |
GO:0006468 | 0.0072 | 2.8708 | 4.2412 | 10 | 1866 | protein phosphorylation |
GO:0050663 | 0.0088 | 7.6583 | 0.4273 | 3 | 188 | cytokine secretion |
GO:0031296 | 0.0091 | 150.3611 | 0.0091 | 1 | 4 | B cell costimulation |
GO:0032497 | 0.0091 | 150.3611 | 0.0091 | 1 | 4 | detection of lipopolysaccharide |
GO:0038113 | 0.0091 | 150.3611 | 0.0091 | 1 | 4 | interleukin-9-mediated signaling pathway |
GO:0046959 | 0.0091 | 150.3611 | 0.0091 | 1 | 4 | habituation |
GO:0070294 | 0.0091 | 150.3611 | 0.0091 | 1 | 4 | renal sodium ion absorption |
GO:0071315 | 0.0091 | 150.3611 | 0.0091 | 1 | 4 | cellular response to morphine |
GO:1902714 | 0.0091 | 150.3611 | 0.0091 | 1 | 4 | negative regulation of interferon-gamma secretion |
GO:0002250 | 0.0092 | 7.5846 | 0.4338 | 3 | 206 | adaptive immune response |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006342 | 0 | 52.7876 | 0.1592 | 6 | 108 | chromatin silencing |
GO:0040029 | 0 | 13.4889 | 0.5868 | 6 | 398 | regulation of gene expression, epigenetic |
GO:0006968 | 0.0028 | 28.3269 | 0.0796 | 2 | 54 | cellular defense response |
GO:0070075 | 0.0029 | 706.6957 | 0.0029 | 1 | 2 | tear secretion |
GO:1903507 | 0.0057 | 4.3701 | 1.7072 | 6 | 1158 | negative regulation of nucleic acid-templated transcription |
GO:0051276 | 0.0057 | 4.366 | 1.7087 | 6 | 1159 | chromosome organization |
GO:0035021 | 0.0059 | 235.5362 | 0.0059 | 1 | 4 | negative regulation of Rac protein signal transduction |
GO:0051253 | 0.0077 | 4.0754 | 1.8208 | 6 | 1235 | negative regulation of RNA metabolic process |
GO:0051533 | 0.0088 | 141.3043 | 0.0088 | 1 | 6 | positive regulation of NFAT protein import into nucleus |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0030887 | 0.0017 | Inf | 0.0017 | 1 | 1 | positive regulation of myeloid dendritic cell activation |
GO:0038002 | 0.0017 | Inf | 0.0017 | 1 | 1 | endocrine signaling |
GO:0021897 | 0.0033 | 625.0385 | 0.0033 | 1 | 2 | forebrain astrocyte development |
GO:0050992 | 0.0033 | 625.0385 | 0.0033 | 1 | 2 | dimethylallyl diphosphate biosynthetic process |
GO:1904381 | 0.005 | 312.5 | 0.005 | 1 | 3 | Golgi apparatus mannose trimming |
GO:0006695 | 0.0055 | 19.9225 | 0.1111 | 2 | 67 | cholesterol biosynthetic process |
GO:0035022 | 0.0066 | 208.3205 | 0.0066 | 1 | 4 | positive regulation of Rac protein signal transduction |
GO:1990966 | 0.0066 | 208.3205 | 0.0066 | 1 | 4 | ATP generation from poly-ADP-D-ribose |
GO:0050810 | 0.0079 | 16.3777 | 0.1343 | 2 | 81 | regulation of steroid biosynthetic process |
GO:0009240 | 0.0083 | 156.2308 | 0.0083 | 1 | 5 | isopentenyl diphosphate biosynthetic process |
GO:0035900 | 0.0099 | 124.9769 | 0.01 | 1 | 6 | response to isolation stress |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006911 | 0 | 70.1905 | 0.0727 | 4 | 37 | phagocytosis, engulfment |
GO:0010324 | 0 | 46.2771 | 0.1061 | 4 | 54 | membrane invagination |
GO:0045055 | 1e-04 | 7.1884 | 1.431 | 8 | 728 | regulated exocytosis |
GO:0042330 | 1e-04 | 7.9167 | 1.1047 | 7 | 562 | taxis |
GO:0031529 | 1e-04 | 39.9138 | 0.0885 | 3 | 45 | ruffle organization |
GO:0002524 | 2e-04 | 135.325 | 0.0197 | 2 | 10 | hypersensitivity |
GO:0048935 | 3e-04 | 98.4 | 0.0256 | 2 | 13 | peripheral nervous system neuron development |
GO:0097529 | 3e-04 | 13.9238 | 0.3322 | 4 | 169 | myeloid leukocyte migration |
GO:0006952 | 3e-04 | 4.6597 | 2.8582 | 10 | 1454 | defense response |
GO:0002864 | 3e-04 | 90.1944 | 0.0275 | 2 | 14 | regulation of acute inflammatory response to antigenic stimulus |
GO:0050727 | 3e-04 | 9.4891 | 0.6212 | 5 | 316 | regulation of inflammatory response |
GO:0007422 | 4e-04 | 24.6131 | 0.1396 | 3 | 71 | peripheral nervous system development |
GO:0006955 | 4e-04 | 9.7146 | 0.6529 | 5 | 442 | immune response |
GO:0002275 | 5e-04 | 6.9518 | 1.0379 | 6 | 528 | myeloid cell activation involved in immune response |
GO:0002444 | 5e-04 | 6.8837 | 1.0477 | 6 | 533 | myeloid leukocyte mediated immunity |
GO:0007159 | 6e-04 | 8.4854 | 0.6919 | 5 | 352 | leukocyte cell-cell adhesion |
GO:0009952 | 6e-04 | 11.5794 | 0.3971 | 4 | 202 | anterior/posterior pattern specification |
GO:0048704 | 8e-04 | 18.5713 | 0.1828 | 3 | 93 | embryonic skeletal system morphogenesis |
GO:0007155 | 8e-04 | 4.396 | 2.6282 | 9 | 1337 | cell adhesion |
GO:0007229 | 8e-04 | 18.1653 | 0.1867 | 3 | 95 | integrin-mediated signaling pathway |
GO:0032940 | 0.0011 | 4.1923 | 2.7441 | 9 | 1396 | secretion by cell |
GO:1905521 | 0.0012 | 45.0639 | 0.0511 | 2 | 26 | regulation of macrophage migration |
GO:0002675 | 0.0013 | 43.2587 | 0.0531 | 2 | 27 | positive regulation of acute inflammatory response |
GO:0007389 | 0.0013 | 7.0473 | 0.8276 | 5 | 421 | pattern specification process |
GO:0048870 | 0.0013 | 4.1016 | 2.7992 | 9 | 1424 | cell motility |
GO:0050776 | 0.0014 | 4.9072 | 1.7377 | 7 | 884 | regulation of immune response |
GO:0002526 | 0.0014 | 15.1638 | 0.2234 | 3 | 121 | acute inflammatory response |
GO:0045165 | 0.0014 | 9.2539 | 0.4934 | 4 | 251 | cell fate commitment |
GO:0061900 | 0.0015 | 40.0494 | 0.057 | 2 | 29 | glial cell activation |
GO:0002263 | 0.0016 | 5.5109 | 1.2954 | 6 | 659 | cell activation involved in immune response |
GO:0009954 | 0.0017 | 37.2828 | 0.0609 | 2 | 31 | proximal/distal pattern formation |
GO:0016192 | 0.0018 | 3.6482 | 3.558 | 10 | 1810 | vesicle-mediated transport |
GO:0048665 | 0.0019 | 34.8731 | 0.0649 | 2 | 33 | neuron fate specification |
GO:0051250 | 0.0019 | 13.561 | 0.2477 | 3 | 126 | negative regulation of lymphocyte activation |
GO:0010920 | 0.002 | Inf | 0.002 | 1 | 1 | negative regulation of inositol phosphate biosynthetic process |
GO:0010925 | 0.002 | Inf | 0.002 | 1 | 1 | positive regulation of inositol-polyphosphate 5-phosphatase activity |
GO:0014739 | 0.002 | Inf | 0.002 | 1 | 1 | positive regulation of muscle hyperplasia |
GO:0030845 | 0.002 | Inf | 0.002 | 1 | 1 | phospholipase C-inhibiting G-protein coupled receptor signaling pathway |
GO:0045660 | 0.002 | Inf | 0.002 | 1 | 1 | positive regulation of neutrophil differentiation |
GO:0060305 | 0.002 | Inf | 0.002 | 1 | 1 | regulation of cell diameter |
GO:1903997 | 0.002 | Inf | 0.002 | 1 | 1 | positive regulation of non-membrane spanning protein tyrosine kinase activity |
GO:1904140 | 0.002 | Inf | 0.002 | 1 | 1 | negative regulation of microglial cell migration |
GO:1904151 | 0.002 | Inf | 0.002 | 1 | 1 | positive regulation of microglial cell mediated cytotoxicity |
GO:0032102 | 0.002 | 8.4217 | 0.5406 | 4 | 275 | negative regulation of response to external stimulus |
GO:0043312 | 0.0022 | 6.2163 | 0.9337 | 5 | 475 | neutrophil degranulation |
GO:0002686 | 0.0024 | 30.88 | 0.0727 | 2 | 37 | negative regulation of leukocyte migration |
GO:0035137 | 0.0024 | 30.88 | 0.0727 | 2 | 37 | hindlimb morphogenesis |
GO:0002696 | 0.0024 | 7.9725 | 0.5701 | 4 | 290 | positive regulation of leukocyte activation |
GO:0042119 | 0.0024 | 6.0699 | 0.9553 | 5 | 486 | neutrophil activation |
GO:0035136 | 0.0028 | 28.4368 | 0.0786 | 2 | 40 | forelimb morphogenesis |
GO:0050863 | 0.0028 | 7.5938 | 0.5976 | 4 | 304 | regulation of T cell activation |
GO:0030168 | 0.0029 | 11.6518 | 0.2876 | 3 | 151 | platelet activation |
GO:0002694 | 0.003 | 11.5588 | 0.2925 | 3 | 167 | regulation of leukocyte activation |
GO:0002437 | 0.0032 | 26.3512 | 0.0845 | 2 | 43 | inflammatory response to antigenic stimulus |
GO:0021517 | 0.0034 | 25.7222 | 0.0865 | 2 | 44 | ventral spinal cord development |
GO:0042060 | 0.0035 | 5.5457 | 1.0418 | 5 | 530 | wound healing |
GO:0007519 | 0.0035 | 10.8817 | 0.3067 | 3 | 156 | skeletal muscle tissue development |
GO:0043303 | 0.0035 | 25.1225 | 0.0885 | 2 | 45 | mast cell degranulation |
GO:0050766 | 0.0035 | 25.1225 | 0.0885 | 2 | 45 | positive regulation of phagocytosis |
GO:0002429 | 0.0036 | 7.1103 | 0.6369 | 4 | 324 | immune response-activating cell surface receptor signaling pathway |
GO:0002253 | 0.0038 | 5.4491 | 1.0595 | 5 | 539 | activation of immune response |
GO:0001798 | 0.0039 | 524.0645 | 0.0039 | 1 | 2 | positive regulation of type IIa hypersensitivity |
GO:0001805 | 0.0039 | 524.0645 | 0.0039 | 1 | 2 | positive regulation of type III hypersensitivity |
GO:0001808 | 0.0039 | 524.0645 | 0.0039 | 1 | 2 | negative regulation of type IV hypersensitivity |
GO:0033026 | 0.0039 | 524.0645 | 0.0039 | 1 | 2 | negative regulation of mast cell apoptotic process |
GO:0050902 | 0.0039 | 524.0645 | 0.0039 | 1 | 2 | leukocyte adhesive activation |
GO:0070560 | 0.0039 | 524.0645 | 0.0039 | 1 | 2 | protein secretion by platelet |
GO:1902227 | 0.0039 | 524.0645 | 0.0039 | 1 | 2 | negative regulation of macrophage colony-stimulating factor signaling pathway |
GO:1903970 | 0.0039 | 524.0645 | 0.0039 | 1 | 2 | negative regulation of response to macrophage colony-stimulating factor |
GO:1905461 | 0.0039 | 524.0645 | 0.0039 | 1 | 2 | positive regulation of vascular associated smooth muscle cell apoptotic process |
GO:0007599 | 0.0041 | 6.8271 | 0.6624 | 4 | 337 | hemostasis |
GO:0050817 | 0.0041 | 6.8271 | 0.6624 | 4 | 337 | coagulation |
GO:0002250 | 0.0041 | 6.8062 | 0.6644 | 4 | 338 | adaptive immune response |
GO:0050866 | 0.0042 | 10.1449 | 0.3283 | 3 | 167 | negative regulation of cell activation |
GO:0045937 | 0.0043 | 3.9676 | 2.119 | 7 | 1078 | positive regulation of phosphate metabolic process |
GO:0009792 | 0.0046 | 5.1875 | 1.1106 | 5 | 565 | embryo development ending in birth or egg hatching |
GO:0021515 | 0.0047 | 21.596 | 0.1022 | 2 | 52 | cell differentiation in spinal cord |
GO:0045576 | 0.0052 | 20.3698 | 0.1081 | 2 | 55 | mast cell activation |
GO:0060326 | 0.0054 | 20.0879 | 0.11 | 2 | 61 | cell chemotaxis |
GO:0060537 | 0.0058 | 6.1814 | 0.7293 | 4 | 371 | muscle tissue development |
GO:0001812 | 0.0059 | 262.0161 | 0.0059 | 1 | 3 | positive regulation of type I hypersensitivity |
GO:0002351 | 0.0059 | 262.0161 | 0.0059 | 1 | 3 | serotonin production involved in inflammatory response |
GO:0002554 | 0.0059 | 262.0161 | 0.0059 | 1 | 3 | serotonin secretion by platelet |
GO:0002892 | 0.0059 | 262.0161 | 0.0059 | 1 | 3 | regulation of type II hypersensitivity |
GO:0032765 | 0.0059 | 262.0161 | 0.0059 | 1 | 3 | positive regulation of mast cell cytokine production |
GO:0033023 | 0.0059 | 262.0161 | 0.0059 | 1 | 3 | mast cell homeostasis |
GO:0071673 | 0.0059 | 262.0161 | 0.0059 | 1 | 3 | positive regulation of smooth muscle cell chemotaxis |
GO:1902732 | 0.0059 | 262.0161 | 0.0059 | 1 | 3 | positive regulation of chondrocyte proliferation |
GO:1903972 | 0.0059 | 262.0161 | 0.0059 | 1 | 3 | regulation of cellular response to macrophage colony-stimulating factor stimulus |
GO:1905563 | 0.0059 | 262.0161 | 0.0059 | 1 | 3 | negative regulation of vascular endothelial cell proliferation |
GO:0030595 | 0.0061 | 8.8366 | 0.3755 | 3 | 191 | leukocyte chemotaxis |
GO:0048518 | 0.0064 | 2.5762 | 10.668 | 18 | 5427 | positive regulation of biological process |
GO:0032760 | 0.007 | 17.4032 | 0.1258 | 2 | 64 | positive regulation of tumor necrosis factor production |
GO:0042116 | 0.007 | 17.4032 | 0.1258 | 2 | 64 | macrophage activation |
GO:0043647 | 0.0076 | 16.5969 | 0.1317 | 2 | 67 | inositol phosphate metabolic process |
GO:0022407 | 0.0078 | 5.6596 | 0.7942 | 4 | 404 | regulation of cell-cell adhesion |
GO:0021913 | 0.0078 | 174.6667 | 0.0079 | 1 | 4 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification |
GO:0038165 | 0.0078 | 174.6667 | 0.0079 | 1 | 4 | oncostatin-M-mediated signaling pathway |
GO:0071315 | 0.0078 | 174.6667 | 0.0079 | 1 | 4 | cellular response to morphine |
GO:0072137 | 0.0078 | 174.6667 | 0.0079 | 1 | 4 | condensed mesenchymal cell proliferation |
GO:0097168 | 0.0078 | 174.6667 | 0.0079 | 1 | 4 | mesenchymal stem cell proliferation |
GO:0001934 | 0.008 | 3.8984 | 1.7967 | 6 | 914 | positive regulation of protein phosphorylation |
GO:0031325 | 0.0084 | 2.6778 | 5.8696 | 12 | 2986 | positive regulation of cellular metabolic process |
GO:0010572 | 0.0098 | 130.9919 | 0.0098 | 1 | 5 | positive regulation of platelet activation |
GO:0033625 | 0.0098 | 130.9919 | 0.0098 | 1 | 5 | positive regulation of integrin activation |
GO:0051534 | 0.0098 | 130.9919 | 0.0098 | 1 | 5 | negative regulation of NFAT protein import into nucleus |
GO:0071672 | 0.0098 | 130.9919 | 0.0098 | 1 | 5 | negative regulation of smooth muscle cell chemotaxis |
GO:1900028 | 0.0098 | 130.9919 | 0.0098 | 1 | 5 | negative regulation of ruffle assembly |
GO:1903980 | 0.0098 | 130.9919 | 0.0098 | 1 | 5 | positive regulation of microglial cell activation |
GO:0008285 | 0.01 | 4.2656 | 1.3387 | 5 | 681 | negative regulation of cell proliferation |
GO:0008344 | 0.01 | 14.3751 | 0.1514 | 2 | 77 | adult locomotory behavior |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0031581 | 1e-04 | 162.44 | 0.0166 | 2 | 10 | hemidesmosome assembly |
GO:1905205 | 1e-04 | 162.44 | 0.0166 | 2 | 10 | positive regulation of connective tissue replacement |
GO:1903244 | 1e-04 | 144.3822 | 0.0182 | 2 | 11 | positive regulation of cardiac muscle hypertrophy in response to stress |
GO:0014744 | 2e-04 | 108.2667 | 0.0232 | 2 | 14 | positive regulation of muscle adaptation |
GO:0010612 | 4e-04 | 81.18 | 0.0299 | 2 | 18 | regulation of cardiac muscle adaptation |
GO:0008544 | 5e-04 | 8.8928 | 0.68 | 5 | 410 | epidermis development |
GO:0070268 | 8e-04 | 19.0401 | 0.1808 | 3 | 109 | cornification |
GO:0030216 | 8e-04 | 11.0868 | 0.4229 | 4 | 255 | keratinocyte differentiation |
GO:0003299 | 0.0012 | 44.7531 | 0.0514 | 2 | 31 | muscle hypertrophy in response to stress |
GO:0014742 | 0.0016 | 38.16 | 0.0597 | 2 | 36 | positive regulation of muscle hypertrophy |
GO:0018350 | 0.0017 | Inf | 0.0017 | 1 | 1 | protein esterification |
GO:0044258 | 0.0017 | Inf | 0.0017 | 1 | 1 | intestinal lipid catabolic process |
GO:0014718 | 0.0033 | 625.0385 | 0.0033 | 1 | 2 | positive regulation of satellite cell activation involved in skeletal muscle regeneration |
GO:0034021 | 0.0033 | 625.0385 | 0.0033 | 1 | 2 | response to silicon dioxide |
GO:0048627 | 0.0033 | 625.0385 | 0.0033 | 1 | 2 | myoblast development |
GO:1905772 | 0.0033 | 625.0385 | 0.0033 | 1 | 2 | positive regulation of mesodermal cell differentiation |
GO:0014888 | 0.0033 | 25.9232 | 0.0862 | 2 | 52 | striated muscle adaptation |
GO:0010611 | 0.0043 | 22.7298 | 0.0979 | 2 | 59 | regulation of cardiac muscle hypertrophy |
GO:0030858 | 0.0043 | 22.7298 | 0.0979 | 2 | 59 | positive regulation of epithelial cell differentiation |
GO:0010482 | 0.005 | 312.5 | 0.005 | 1 | 3 | regulation of epidermal cell division |
GO:0015891 | 0.005 | 312.5 | 0.005 | 1 | 3 | siderophore transport |
GO:0097192 | 0.0061 | 18.7629 | 0.1178 | 2 | 71 | extrinsic apoptotic signaling pathway in absence of ligand |
GO:0035195 | 0.0062 | 8.9039 | 0.3782 | 3 | 228 | gene silencing by miRNA |
GO:0010046 | 0.0066 | 208.3205 | 0.0066 | 1 | 4 | response to mycotoxin |
GO:0010593 | 0.0066 | 208.3205 | 0.0066 | 1 | 4 | negative regulation of lamellipodium assembly |
GO:0045918 | 0.0066 | 208.3205 | 0.0066 | 1 | 4 | negative regulation of cytolysis |
GO:0070318 | 0.0066 | 208.3205 | 0.0066 | 1 | 4 | positive regulation of G0 to G1 transition |
GO:0016441 | 0.0067 | 8.6315 | 0.3898 | 3 | 235 | posttranscriptional gene silencing |
GO:0034103 | 0.0079 | 16.3777 | 0.1343 | 2 | 81 | regulation of tissue remodeling |
GO:0032747 | 0.0083 | 156.2308 | 0.0083 | 1 | 5 | positive regulation of interleukin-23 production |
GO:1903847 | 0.0083 | 156.2308 | 0.0083 | 1 | 5 | regulation of aorta morphogenesis |
GO:2000026 | 0.0085 | 3.2859 | 3.075 | 8 | 1854 | regulation of multicellular organismal development |
GO:0031047 | 0.0087 | 7.8417 | 0.4279 | 3 | 258 | gene silencing by RNA |
GO:0001892 | 0.0099 | 14.5285 | 0.1509 | 2 | 91 | embryonic placenta development |
GO:0014897 | 0.0099 | 14.5285 | 0.1509 | 2 | 91 | striated muscle hypertrophy |
GO:0014719 | 0.0099 | 124.9769 | 0.01 | 1 | 6 | skeletal muscle satellite cell activation |
GO:0015917 | 0.0099 | 124.9769 | 0.01 | 1 | 6 | aminophospholipid transport |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 43.1768 | 0.5612 | 14 | 261 | detection of chemical stimulus involved in sensory perception of smell |
GO:0009593 | 0 | 33.175 | 0.7181 | 14 | 334 | detection of chemical stimulus |
GO:0050906 | 0 | 31.6597 | 0.7504 | 14 | 349 | detection of stimulus involved in sensory perception |
GO:0007606 | 0 | 31.4679 | 0.7547 | 14 | 351 | sensory perception of chemical stimulus |
GO:0007186 | 0 | 11.21 | 2.4747 | 16 | 1151 | G-protein coupled receptor signaling pathway |
GO:0050877 | 0 | 9.1336 | 2.4059 | 14 | 1119 | nervous system process |
GO:0065007 | 0.0021 | 4.6506 | 24.3897 | 32 | 11344 | biological regulation |
GO:1903017 | 0.0022 | Inf | 0.0022 | 1 | 1 | positive regulation of exo-alpha-sialidase activity |
GO:0051692 | 0.0043 | 477.7353 | 0.0043 | 1 | 2 | cellular oligosaccharide catabolic process |
GO:0060763 | 0.0064 | 238.8529 | 0.0065 | 1 | 3 | mammary duct terminal end bud growth |
GO:0050794 | 0.007 | 2.9494 | 21.7516 | 29 | 10117 | regulation of cellular process |
GO:0035962 | 0.0086 | 159.2255 | 0.0086 | 1 | 4 | response to interleukin-13 |
GO:0051673 | 0.0086 | 159.2255 | 0.0086 | 1 | 4 | membrane disruption in other organism |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 24.046 | 0.2886 | 5 | 261 | detection of chemical stimulus involved in sensory perception of smell |
GO:0009593 | 0 | 18.6252 | 0.3693 | 5 | 334 | detection of chemical stimulus |
GO:0050906 | 0 | 17.7963 | 0.3859 | 5 | 349 | detection of stimulus involved in sensory perception |
GO:0007606 | 0 | 17.6912 | 0.3881 | 5 | 351 | sensory perception of chemical stimulus |
GO:0046167 | 0.0033 | 478.2059 | 0.0033 | 1 | 3 | glycerol-3-phosphate biosynthetic process |
GO:1904845 | 0.0033 | 478.2059 | 0.0033 | 1 | 3 | cellular response to L-glutamine |
GO:1904044 | 0.0044 | 318.7843 | 0.0044 | 1 | 4 | response to aldosterone |
GO:0019563 | 0.0055 | 239.0735 | 0.0055 | 1 | 5 | glycerol catabolic process |
GO:0050877 | 0.0061 | 5.2296 | 1.2373 | 5 | 1119 | nervous system process |
GO:0097411 | 0.0066 | 191.2471 | 0.0066 | 1 | 6 | hypoxia-inducible factor-1alpha signaling pathway |
GO:0007186 | 0.0069 | 5.0728 | 1.2727 | 5 | 1151 | G-protein coupled receptor signaling pathway |
GO:0052646 | 0.0088 | 136.5882 | 0.0088 | 1 | 8 | alditol phosphate metabolic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 65.3143 | 0.5131 | 16 | 261 | detection of chemical stimulus involved in sensory perception of smell |
GO:0009593 | 0 | 56.9527 | 0.6566 | 17 | 334 | detection of chemical stimulus |
GO:0050906 | 0 | 54.3283 | 0.686 | 17 | 349 | detection of stimulus involved in sensory perception |
GO:0007606 | 0 | 53.9962 | 0.69 | 17 | 351 | sensory perception of chemical stimulus |
GO:0050877 | 0 | 17.687 | 2.1996 | 18 | 1119 | nervous system process |
GO:0007186 | 0 | 17.1512 | 2.2625 | 18 | 1151 | G-protein coupled receptor signaling pathway |
GO:0023052 | 0.0033 | 2.8084 | 11.9339 | 20 | 6071 | signaling |
GO:0007154 | 0.0034 | 2.7951 | 11.9693 | 20 | 6089 | cell communication |
GO:0050789 | 0.0057 | 3.6031 | 21.1394 | 28 | 10754 | regulation of biological process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0043998 | 0.0023 | Inf | 0.0023 | 1 | 1 | H2A histone acetyltransferase activity |
GO:0060703 | 0.0023 | Inf | 0.0023 | 1 | 1 | deoxyribonuclease inhibitor activity |
GO:0050252 | 0.007 | 219.6622 | 0.007 | 1 | 3 | retinol O-fatty-acyltransferase activity |
GO:1990189 | 0.007 | 219.6622 | 0.007 | 1 | 3 | peptide-serine-N-acetyltransferase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 8e-04 | 6.2297 | 1.1217 | 6 | 481 | protein heterodimerization activity |
GO:0003948 | 0.0023 | Inf | 0.0023 | 1 | 1 | N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity |
GO:0030354 | 0.0023 | Inf | 0.0023 | 1 | 1 | melanin-concentrating hormone activity |
GO:0045182 | 0.0045 | 21.9729 | 0.1003 | 2 | 43 | translation regulator activity |
GO:0004649 | 0.0047 | 439.3514 | 0.0047 | 1 | 2 | poly(ADP-ribose) glycohydrolase activity |
GO:0046964 | 0.0047 | 439.3514 | 0.0047 | 1 | 2 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity |
GO:0042978 | 0.007 | 219.6622 | 0.007 | 1 | 3 | ornithine decarboxylase activator activity |
GO:0004869 | 0.007 | 17.313 | 0.1259 | 2 | 54 | cysteine-type endopeptidase inhibitor activity |
GO:0004945 | 0.0093 | 146.4324 | 0.0093 | 1 | 4 | angiotensin type II receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005147 | 0.0031 | Inf | 0.0031 | 1 | 1 | oncostatin-M receptor binding |
GO:0030351 | 0.0031 | Inf | 0.0031 | 1 | 1 | inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity |
GO:0034417 | 0.0031 | Inf | 0.0031 | 1 | 1 | bisphosphoglycerate 3-phosphatase activity |
GO:0052826 | 0.0031 | Inf | 0.0031 | 1 | 1 | inositol hexakisphosphate 2-phosphatase activity |
GO:0004360 | 0.0061 | 331.5102 | 0.0061 | 1 | 2 | glutamine-fructose-6-phosphate transaminase (isomerizing) activity |
GO:0017064 | 0.0061 | 331.5102 | 0.0061 | 1 | 2 | fatty acid amide hydrolase activity |
GO:0031208 | 0.0061 | 331.5102 | 0.0061 | 1 | 2 | POZ domain binding |
GO:0051717 | 0.0061 | 331.5102 | 0.0061 | 1 | 2 | inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity |
GO:0102077 | 0.0061 | 331.5102 | 0.0061 | 1 | 2 | oleamide hydrolase activity |
GO:0103073 | 0.0061 | 331.5102 | 0.0061 | 1 | 2 | anandamide amidohydrolase activity |
GO:0004534 | 0.0092 | 165.7449 | 0.0092 | 1 | 3 | 5'-3' exoribonuclease activity |
GO:0047894 | 0.0092 | 165.7449 | 0.0092 | 1 | 3 | flavonol 3-sulfotransferase activity |
GO:0101006 | 0.0092 | 165.7449 | 0.0092 | 1 | 3 | protein histidine phosphatase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 20.8581 | 0.3203 | 5 | 261 | olfactory receptor activity |
GO:0001591 | 0 | 361.5556 | 0.0086 | 2 | 7 | dopamine neurotransmitter receptor activity, coupled via Gi/Go |
GO:0035240 | 1e-04 | 180.7222 | 0.0147 | 2 | 12 | dopamine binding |
GO:0070330 | 3e-04 | 95.0643 | 0.0258 | 2 | 21 | aromatase activity |
GO:0004930 | 0.0011 | 7.7276 | 0.8322 | 5 | 678 | G-protein coupled receptor activity |
GO:0019825 | 0.0012 | 45.0972 | 0.0515 | 2 | 42 | oxygen binding |
GO:0016151 | 0.0025 | 856.5263 | 0.0025 | 1 | 2 | nickel cation binding |
GO:0015333 | 0.0049 | 285.4737 | 0.0049 | 1 | 4 | peptide:proton symporter activity |
GO:0004497 | 0.0053 | 20.6743 | 0.1092 | 2 | 89 | monooxygenase activity |
GO:0030594 | 0.0056 | 19.9815 | 0.1129 | 2 | 92 | neurotransmitter receptor activity |
GO:0005324 | 0.0061 | 214.0921 | 0.0061 | 1 | 5 | long-chain fatty acid transporter activity |
GO:0008273 | 0.0061 | 214.0921 | 0.0061 | 1 | 5 | calcium, potassium:sodium antiporter activity |
GO:0015198 | 0.0061 | 214.0921 | 0.0061 | 1 | 5 | oligopeptide transporter activity |
GO:0101020 | 0.0061 | 214.0921 | 0.0061 | 1 | 5 | estrogen 16-alpha-hydroxylase activity |
GO:0046870 | 0.0073 | 171.2632 | 0.0074 | 1 | 6 | cadmium ion binding |
GO:0020037 | 0.0097 | 14.9583 | 0.1497 | 2 | 122 | heme binding |
GO:0099600 | 0.01 | 4.5234 | 1.3771 | 5 | 1122 | transmembrane receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0003692 | 0.001 | Inf | 0.001 | 1 | 1 | left-handed Z-DNA binding |
GO:0035438 | 0.001 | Inf | 0.001 | 1 | 1 | cyclic-di-GMP binding |
GO:0050337 | 0.001 | Inf | 0.001 | 1 | 1 | thiosulfate-thiol sulfurtransferase activity |
GO:0061507 | 0.001 | Inf | 0.001 | 1 | 1 | cyclic-GMP-AMP binding |
GO:0003726 | 0.0029 | 542.5667 | 0.0029 | 1 | 3 | double-stranded RNA adenosine deaminase activity |
GO:0005094 | 0.0029 | 542.5667 | 0.0029 | 1 | 3 | Rho GDP-dissociation inhibitor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0001228 | 0.0011 | 10.5569 | 0.4722 | 4 | 405 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding |
GO:0031854 | 0.0012 | Inf | 0.0012 | 1 | 1 | orexigenic neuropeptide QRFP receptor binding |
GO:0050337 | 0.0012 | Inf | 0.0012 | 1 | 1 | thiosulfate-thiol sulfurtransferase activity |
GO:0003705 | 0.0056 | 20.0384 | 0.1131 | 2 | 97 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding |
GO:0042289 | 0.007 | 180.7889 | 0.007 | 1 | 6 | MHC class II protein binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004111 | 1e-04 | 225.7361 | 0.014 | 2 | 6 | creatine kinase activity |
GO:0038023 | 0.0013 | 3.9908 | 2.7564 | 9 | 1182 | signaling receptor activity |
GO:0001604 | 0.0023 | Inf | 0.0023 | 1 | 1 | urotensin II receptor activity |
GO:0004913 | 0.0047 | 439.3514 | 0.0047 | 1 | 2 | interleukin-4 receptor activity |
GO:0004917 | 0.0047 | 439.3514 | 0.0047 | 1 | 2 | interleukin-7 receptor activity |
GO:0004911 | 0.007 | 219.6622 | 0.007 | 1 | 3 | interleukin-2 receptor activity |
GO:0005111 | 0.007 | 219.6622 | 0.007 | 1 | 3 | type 2 fibroblast growth factor receptor binding |
GO:0005157 | 0.007 | 219.6622 | 0.007 | 1 | 3 | macrophage colony-stimulating factor receptor binding |
GO:0019976 | 0.007 | 219.6622 | 0.007 | 1 | 3 | interleukin-2 binding |
GO:0004872 | 0.0084 | 7.9052 | 0.4222 | 3 | 220 | receptor activity |
GO:0001588 | 0.0093 | 146.4324 | 0.0093 | 1 | 4 | dopamine neurotransmitter receptor activity, coupled via Gs |
GO:0004522 | 0.0093 | 146.4324 | 0.0093 | 1 | 4 | ribonuclease A activity |
GO:0004974 | 0.0093 | 146.4324 | 0.0093 | 1 | 4 | leukotriene receptor activity |
GO:0005105 | 0.0093 | 146.4324 | 0.0093 | 1 | 4 | type 1 fibroblast growth factor receptor binding |
GO:0044323 | 0.0093 | 146.4324 | 0.0093 | 1 | 4 | retinoic acid-responsive element binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042393 | 0 | 61.2935 | 0.7262 | 24 | 194 | histone binding |
GO:0046982 | 0 | 25.7616 | 1.8006 | 26 | 481 | protein heterodimerization activity |
GO:0031492 | 0 | 93.4256 | 0.1647 | 10 | 44 | nucleosomal DNA binding |
GO:0003677 | 0 | 6.0778 | 8.9469 | 31 | 2390 | DNA binding |
GO:0045296 | 0 | 11.9694 | 1.138 | 11 | 304 | cadherin binding |
GO:0019904 | 0 | 7.2478 | 2.4703 | 14 | 682 | protein domain specific binding |
GO:0003682 | 0 | 7.9355 | 1.8643 | 12 | 498 | chromatin binding |
GO:1901363 | 1e-04 | 2.6426 | 21.5699 | 36 | 5762 | heterocyclic compound binding |
GO:0097159 | 2e-04 | 2.5843 | 21.8806 | 36 | 5845 | organic cyclic compound binding |
GO:0055131 | 2e-04 | 137.5424 | 0.0225 | 2 | 6 | C3HC4-type RING finger domain binding |
GO:0003723 | 3e-04 | 3.1427 | 6.2366 | 16 | 1666 | RNA binding |
GO:0044877 | 0.0028 | 3.1581 | 3.59 | 10 | 959 | macromolecular complex binding |
GO:0008903 | 0.0037 | Inf | 0.0037 | 1 | 1 | hydroxypyruvate isomerase activity |
GO:0031249 | 0.0037 | Inf | 0.0037 | 1 | 1 | denatured protein binding |
GO:0031700 | 0.0037 | Inf | 0.0037 | 1 | 1 | adrenomedullin receptor binding |
GO:0044183 | 0.0046 | 21.9783 | 0.1011 | 2 | 27 | protein binding involved in protein folding |
GO:0001567 | 0.0075 | 270.55 | 0.0075 | 1 | 2 | cholesterol 25-hydroxylase activity |
GO:0004666 | 0.0075 | 270.55 | 0.0075 | 1 | 2 | prostaglandin-endoperoxide synthase activity |
GO:0010736 | 0.0075 | 270.55 | 0.0075 | 1 | 2 | serum response element binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 11.7377 | 0.6789 | 6 | 481 | protein heterodimerization activity |
GO:0043237 | 0.0084 | 147.8818 | 0.0085 | 1 | 6 | laminin-1 binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042393 | 0 | 48.0876 | 0.4762 | 14 | 194 | histone binding |
GO:0046982 | 0 | 22.638 | 1.1807 | 16 | 481 | protein heterodimerization activity |
GO:0019904 | 0 | 14.5147 | 1.6421 | 15 | 686 | protein domain specific binding |
GO:0003677 | 0 | 5.8586 | 5.8668 | 20 | 2390 | DNA binding |
GO:0003723 | 0 | 4.7598 | 4.0896 | 14 | 1666 | RNA binding |
GO:0017024 | 0.0025 | Inf | 0.0025 | 1 | 1 | myosin I binding |
GO:1901363 | 0.0034 | 2.4791 | 14.1442 | 23 | 5762 | heterocyclic compound binding |
GO:0097159 | 0.0042 | 2.4245 | 14.348 | 23 | 5845 | organic cyclic compound binding |
GO:0004666 | 0.0049 | 416.7692 | 0.0049 | 1 | 2 | prostaglandin-endoperoxide synthase activity |
GO:0010736 | 0.0049 | 416.7692 | 0.0049 | 1 | 2 | serum response element binding |
GO:0032090 | 0.0049 | 416.7692 | 0.0049 | 1 | 2 | Pyrin domain binding |
GO:0004771 | 0.0098 | 138.906 | 0.0098 | 1 | 4 | sterol esterase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0030354 | 0.0017 | Inf | 0.0017 | 1 | 1 | melanin-concentrating hormone activity |
GO:0004452 | 0.0033 | 625.6538 | 0.0033 | 1 | 2 | isopentenyl-diphosphate delta-isomerase activity |
GO:0004649 | 0.0033 | 625.6538 | 0.0033 | 1 | 2 | poly(ADP-ribose) glycohydrolase activity |
GO:0019002 | 0.0033 | 625.6538 | 0.0033 | 1 | 2 | GMP binding |
GO:0004719 | 0.005 | 312.8077 | 0.005 | 1 | 3 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity |
GO:0000213 | 0.0066 | 208.5256 | 0.0066 | 1 | 4 | tRNA-intron endonuclease activity |
GO:0010340 | 0.0099 | 125.1 | 0.0099 | 1 | 6 | carboxyl-O-methyltransferase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0015660 | 0.002 | Inf | 0.002 | 1 | 1 | formate efflux transmembrane transporter activity |
GO:0060703 | 0.002 | Inf | 0.002 | 1 | 1 | deoxyribonuclease inhibitor activity |
GO:0097199 | 0.0039 | 524.5806 | 0.0039 | 1 | 2 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway |
GO:0003886 | 0.0059 | 262.2742 | 0.0059 | 1 | 3 | DNA (cytosine-5-)-methyltransferase activity |
GO:0035877 | 0.0078 | 174.8387 | 0.0079 | 1 | 4 | death effector domain binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0008312 | 2e-04 | 122.5283 | 0.0236 | 2 | 7 | 7S RNA binding |
GO:0000121 | 0.0034 | Inf | 0.0034 | 1 | 1 | glycerol-1-phosphatase activity |
GO:0002135 | 0.0034 | Inf | 0.0034 | 1 | 1 | CTP binding |
GO:0004766 | 0.0034 | Inf | 0.0034 | 1 | 1 | spermidine synthase activity |
GO:0043136 | 0.0034 | Inf | 0.0034 | 1 | 1 | glycerol-3-phosphatase activity |
GO:0052927 | 0.0034 | Inf | 0.0034 | 1 | 1 | CTP:tRNA cytidylyltransferase activity |
GO:0052928 | 0.0034 | Inf | 0.0034 | 1 | 1 | CTP:3'-cytidine-tRNA cytidylyltransferase activity |
GO:0052929 | 0.0034 | Inf | 0.0034 | 1 | 1 | ATP:3'-cytidine-cytidine-tRNA adenylyltransferase activity |
GO:0102008 | 0.0034 | Inf | 0.0034 | 1 | 1 | cytosolic dipeptidase activity |
GO:0103046 | 0.0034 | Inf | 0.0034 | 1 | 1 | alanylglutamate dipeptidase activity |
GO:1990817 | 0.0034 | Inf | 0.0034 | 1 | 1 | RNA adenylyltransferase activity |
GO:0003676 | 0.0064 | 2.1066 | 13.2513 | 22 | 3926 | nucleic acid binding |
GO:0000010 | 0.0067 | 300.7222 | 0.0068 | 1 | 2 | trans-hexaprenyltranstransferase activity |
GO:0001884 | 0.0067 | 300.7222 | 0.0068 | 1 | 2 | pyrimidine nucleoside binding |
GO:0002134 | 0.0067 | 300.7222 | 0.0068 | 1 | 2 | UTP binding |
GO:0004825 | 0.0067 | 300.7222 | 0.0068 | 1 | 2 | methionine-tRNA ligase activity |
GO:0008967 | 0.0067 | 300.7222 | 0.0068 | 1 | 2 | phosphoglycolate phosphatase activity |
GO:0017098 | 0.0067 | 300.7222 | 0.0068 | 1 | 2 | sulfonylurea receptor binding |
GO:0050347 | 0.0067 | 300.7222 | 0.0068 | 1 | 2 | trans-octaprenyltranstransferase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0000823 | 0.002 | Inf | 0.002 | 1 | 1 | inositol-1,4,5-trisphosphate 6-kinase activity |
GO:0000824 | 0.002 | Inf | 0.002 | 1 | 1 | inositol tetrakisphosphate 3-kinase activity |
GO:0000825 | 0.002 | Inf | 0.002 | 1 | 1 | inositol tetrakisphosphate 6-kinase activity |
GO:0005147 | 0.002 | Inf | 0.002 | 1 | 1 | oncostatin-M receptor binding |
GO:0047326 | 0.002 | Inf | 0.002 | 1 | 1 | inositol tetrakisphosphate 5-kinase activity |
GO:0019767 | 0.0039 | 524.5806 | 0.0039 | 1 | 2 | IgE receptor activity |
GO:0004888 | 0.0042 | 3.9837 | 2.1111 | 7 | 1075 | transmembrane signaling receptor activity |
GO:0004872 | 0.0048 | 3.5555 | 2.7532 | 8 | 1402 | receptor activity |
GO:0005070 | 0.0056 | 19.6461 | 0.1119 | 2 | 57 | SH3/SH2 adaptor activity |
GO:0005157 | 0.0059 | 262.2742 | 0.0059 | 1 | 3 | macrophage colony-stimulating factor receptor binding |
GO:0004871 | 0.007 | 3.3123 | 2.9359 | 8 | 1495 | signal transducer activity |
GO:0004522 | 0.0078 | 174.8387 | 0.0079 | 1 | 4 | ribonuclease A activity |
GO:0019863 | 0.0098 | 131.121 | 0.0098 | 1 | 5 | IgE binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004713 | 3e-04 | 27.9347 | 0.1404 | 3 | 176 | protein tyrosine kinase activity |
GO:0038062 | 0.0016 | 1356.75 | 0.0016 | 1 | 2 | protein tyrosine kinase collagen receptor activity |
GO:1903231 | 0.0018 | 37.2911 | 0.0646 | 2 | 81 | mRNA binding involved in posttranscriptional gene silencing |
GO:0001875 | 0.004 | 339.125 | 0.004 | 1 | 5 | lipopolysaccharide receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:1903231 | 3e-04 | 28.3077 | 0.1243 | 3 | 81 | mRNA binding involved in posttranscriptional gene silencing |
GO:0004190 | 5e-04 | 74.3753 | 0.0322 | 2 | 21 | aspartic-type endopeptidase activity |
GO:0038062 | 0.0031 | 677.875 | 0.0031 | 1 | 2 | protein tyrosine kinase collagen receptor activity |
GO:0047275 | 0.0031 | 677.875 | 0.0031 | 1 | 2 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity |
GO:0102294 | 0.0031 | 677.875 | 0.0031 | 1 | 2 | cholesterol dehydrogenase activity |
GO:0004769 | 0.0046 | 338.9167 | 0.0046 | 1 | 3 | steroid delta-isomerase activity |
GO:0004095 | 0.0061 | 225.9306 | 0.0061 | 1 | 4 | carnitine O-palmitoyltransferase activity |
GO:0004945 | 0.0061 | 225.9306 | 0.0061 | 1 | 4 | angiotensin type II receptor activity |
GO:0001875 | 0.0076 | 169.4375 | 0.0077 | 1 | 5 | lipopolysaccharide receptor activity |
GO:0003854 | 0.0076 | 169.4375 | 0.0077 | 1 | 5 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005200 | 5e-04 | 22.05 | 0.158 | 3 | 103 | structural constituent of cytoskeleton |
GO:0005129 | 0.0015 | Inf | 0.0015 | 1 | 1 | granulocyte macrophage colony-stimulating factor receptor binding |
GO:0097110 | 0.0032 | 26.6071 | 0.0844 | 2 | 55 | scaffold protein binding |
GO:0008426 | 0.0046 | 338.9167 | 0.0046 | 1 | 3 | protein kinase C inhibitor activity |
GO:0052739 | 0.0046 | 338.9167 | 0.0046 | 1 | 3 | phosphatidylserine 1-acylhydrolase activity |
GO:0004771 | 0.0061 | 225.9306 | 0.0061 | 1 | 4 | sterol esterase activity |
GO:0102953 | 0.0061 | 225.9306 | 0.0061 | 1 | 4 | hypoglycin A gamma-glutamyl transpeptidase activity |
GO:1903231 | 0.0068 | 17.8217 | 0.1243 | 2 | 81 | mRNA binding involved in posttranscriptional gene silencing |
GO:0015247 | 0.0076 | 169.4375 | 0.0077 | 1 | 5 | aminophospholipid transporter activity |
GO:0036374 | 0.0092 | 135.5417 | 0.0092 | 1 | 6 | glutathione hydrolase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 45.3838 | 0.5446 | 14 | 261 | olfactory receptor activity |
GO:0004930 | 0 | 18.5735 | 1.4147 | 15 | 678 | G-protein coupled receptor activity |
GO:0099600 | 0 | 10.8073 | 2.3411 | 15 | 1122 | transmembrane receptor activity |
GO:0038023 | 0 | 10.2111 | 2.4663 | 15 | 1182 | signaling receptor activity |
GO:0060089 | 0 | 8.1754 | 3.0192 | 15 | 1447 | molecular transducer activity |
GO:0031721 | 0.0021 | Inf | 0.0021 | 1 | 1 | hemoglobin alpha binding |
GO:0102483 | 0.0021 | Inf | 0.0021 | 1 | 1 | scopolin beta-glucosidase activity |
GO:0017042 | 0.0042 | 492.7273 | 0.0042 | 1 | 2 | glycosylceramidase activity |
GO:0004348 | 0.0062 | 246.3485 | 0.0063 | 1 | 3 | glucosylceramidase activity |
GO:0031728 | 0.0083 | 164.2222 | 0.0083 | 1 | 4 | CCR3 chemokine receptor binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 24.07 | 0.2883 | 5 | 261 | olfactory receptor activity |
GO:0004930 | 7e-04 | 8.9176 | 0.7489 | 5 | 678 | G-protein coupled receptor activity |
GO:0004370 | 0.0033 | 478.6765 | 0.0033 | 1 | 3 | glycerol kinase activity |
GO:0008431 | 0.0033 | 478.6765 | 0.0033 | 1 | 3 | vitamin E binding |
GO:0099600 | 0.0062 | 5.22 | 1.2394 | 5 | 1122 | transmembrane receptor activity |
GO:0038023 | 0.0077 | 4.9343 | 1.3057 | 5 | 1182 | signaling receptor activity |
GO:0016175 | 0.0088 | 136.7227 | 0.0088 | 1 | 8 | superoxide-generating NADPH oxidase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 61.5299 | 0.5286 | 16 | 261 | olfactory receptor activity |
GO:0004930 | 0 | 28.3673 | 1.3731 | 18 | 678 | G-protein coupled receptor activity |
GO:0099600 | 0 | 18.6518 | 2.2722 | 19 | 1122 | transmembrane receptor activity |
GO:0038023 | 0 | 17.6195 | 2.3937 | 19 | 1182 | signaling receptor activity |
GO:0060089 | 0 | 14.0979 | 2.9304 | 19 | 1447 | molecular transducer activity |
GO:0005549 | 0.0063 | 18.3418 | 0.1195 | 2 | 59 | odorant binding |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042494 | 1e-04 | 345.2222 | 0.0121 | 2 | 4 | detection of bacterial lipoprotein |
GO:0045410 | 2e-04 | 115.0444 | 0.0241 | 2 | 8 | positive regulation of interleukin-6 biosynthetic process |
GO:0098543 | 6e-04 | 69.0089 | 0.0362 | 2 | 12 | detection of other organism |
GO:0009595 | 0.0013 | 43.1139 | 0.0543 | 2 | 18 | detection of biotic stimulus |
GO:2000482 | 0.0016 | 38.3185 | 0.0603 | 2 | 20 | regulation of interleukin-8 secretion |
GO:0031623 | 0.0017 | 13.8705 | 0.2383 | 3 | 79 | receptor internalization |
GO:0034130 | 0.003 | Inf | 0.003 | 1 | 1 | toll-like receptor 1 signaling pathway |
GO:0034150 | 0.003 | Inf | 0.003 | 1 | 1 | toll-like receptor 6 signaling pathway |
GO:0009179 | 0.0048 | 9.5622 | 0.3408 | 3 | 113 | purine ribonucleoside diphosphate metabolic process |
GO:0002755 | 0.005 | 20.8808 | 0.1056 | 2 | 35 | MyD88-dependent toll-like receptor signaling pathway |
GO:0007050 | 0.0058 | 6.0311 | 0.7238 | 4 | 240 | cell cycle arrest |
GO:0000455 | 0.006 | 337.7391 | 0.006 | 1 | 2 | enzyme-directed rRNA pseudouridine synthesis |
GO:0006196 | 0.006 | 337.7391 | 0.006 | 1 | 2 | AMP catabolic process |
GO:0021633 | 0.006 | 337.7391 | 0.006 | 1 | 2 | optic nerve structural organization |
GO:0042495 | 0.006 | 337.7391 | 0.006 | 1 | 2 | detection of triacyl bacterial lipopeptide |
GO:0042496 | 0.006 | 337.7391 | 0.006 | 1 | 2 | detection of diacyl bacterial lipopeptide |
GO:0045967 | 0.006 | 337.7391 | 0.006 | 1 | 2 | negative regulation of growth rate |
GO:0009132 | 0.0076 | 8.0184 | 0.4041 | 3 | 134 | nucleoside diphosphate metabolic process |
GO:0071221 | 0.0088 | 172.5889 | 0.0089 | 1 | 3 | cellular response to bacterial lipopeptide |
GO:0032264 | 0.009 | 168.8587 | 0.009 | 1 | 3 | IMP salvage |
GO:0034136 | 0.009 | 168.8587 | 0.009 | 1 | 3 | negative regulation of toll-like receptor 2 signaling pathway |
GO:0038123 | 0.009 | 168.8587 | 0.009 | 1 | 3 | toll-like receptor TLR1:TLR2 signaling pathway |
GO:0071727 | 0.009 | 168.8587 | 0.009 | 1 | 3 | cellular response to triacyl bacterial lipopeptide |
GO:1901068 | 0.0092 | 14.9671 | 0.1448 | 2 | 48 | guanosine-containing compound metabolic process |
GO:0010676 | 0.0096 | 14.6478 | 0.1478 | 2 | 49 | positive regulation of cellular carbohydrate metabolic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:2000502 | 0 | 758.0488 | 0.0083 | 2 | 3 | negative regulation of natural killer cell chemotaxis |
GO:2000402 | 3e-04 | 108.2509 | 0.0248 | 2 | 9 | negative regulation of lymphocyte migration |
GO:0035107 | 6e-04 | 11.7926 | 0.3808 | 4 | 138 | appendage morphogenesis |
GO:0002689 | 6e-04 | 68.8692 | 0.0359 | 2 | 13 | negative regulation of leukocyte chemotaxis |
GO:0031295 | 7e-04 | 19.3513 | 0.1738 | 3 | 63 | T cell costimulation |
GO:0060173 | 0.001 | 9.9857 | 0.447 | 4 | 162 | limb development |
GO:1901623 | 0.0011 | 47.3323 | 0.0497 | 2 | 18 | regulation of lymphocyte chemotaxis |
GO:0045954 | 0.0012 | 44.5452 | 0.0524 | 2 | 19 | positive regulation of natural killer cell mediated cytotoxicity |
GO:0032468 | 0.0028 | Inf | 0.0028 | 1 | 1 | Golgi calcium ion homeostasis |
GO:0071329 | 0.0028 | Inf | 0.0028 | 1 | 1 | cellular response to sucrose stimulus |
GO:0098751 | 0.0031 | 27.0261 | 0.0828 | 2 | 30 | bone cell development |
GO:0002715 | 0.0033 | 26.0925 | 0.0855 | 2 | 31 | regulation of natural killer cell mediated immunity |
GO:0002683 | 0.0034 | 5.4555 | 1.0237 | 5 | 371 | negative regulation of immune system process |
GO:0002220 | 0.0039 | 10.3319 | 0.3173 | 3 | 115 | innate immune response activating cell surface receptor signaling pathway |
GO:0030326 | 0.0043 | 9.9731 | 0.3283 | 3 | 119 | embryonic limb morphogenesis |
GO:0030336 | 0.0043 | 6.623 | 0.665 | 4 | 241 | negative regulation of cell migration |
GO:0032102 | 0.0051 | 6.2988 | 0.6981 | 4 | 253 | negative regulation of response to external stimulus |
GO:0045429 | 0.0054 | 19.9012 | 0.1104 | 2 | 40 | positive regulation of nitric oxide biosynthetic process |
GO:0001550 | 0.0055 | 370 | 0.0055 | 1 | 2 | ovarian cumulus expansion |
GO:0003218 | 0.0055 | 370 | 0.0055 | 1 | 2 | cardiac left ventricle formation |
GO:0032472 | 0.0055 | 370 | 0.0055 | 1 | 2 | Golgi calcium ion transport |
GO:0033277 | 0.0055 | 370 | 0.0055 | 1 | 2 | abortive mitotic cell cycle |
GO:0060672 | 0.0055 | 370 | 0.0055 | 1 | 2 | epithelial cell morphogenesis involved in placental branching |
GO:0060980 | 0.0055 | 370 | 0.0055 | 1 | 2 | cell migration involved in coronary vasculogenesis |
GO:0071461 | 0.0055 | 370 | 0.0055 | 1 | 2 | cellular response to redox state |
GO:0031343 | 0.0063 | 18.4414 | 0.1186 | 2 | 43 | positive regulation of cell killing |
GO:0034260 | 0.0063 | 18.4414 | 0.1186 | 2 | 43 | negative regulation of GTPase activity |
GO:0051271 | 0.0063 | 5.9123 | 0.7422 | 4 | 269 | negative regulation of cellular component movement |
GO:0007155 | 0.0065 | 3.0263 | 3.4739 | 9 | 1259 | cell adhesion |
GO:0040013 | 0.0074 | 5.6518 | 0.7753 | 4 | 281 | negative regulation of locomotion |
GO:0003166 | 0.0083 | 184.9881 | 0.0083 | 1 | 3 | bundle of His development |
GO:0014707 | 0.0083 | 184.9881 | 0.0083 | 1 | 3 | branchiomeric skeletal muscle development |
GO:0019805 | 0.0083 | 184.9881 | 0.0083 | 1 | 3 | quinolinate biosynthetic process |
GO:0140076 | 0.0083 | 184.9881 | 0.0083 | 1 | 3 | negative regulation of lipoprotein transport |
GO:0071222 | 0.0083 | 7.8005 | 0.4166 | 3 | 151 | cellular response to lipopolysaccharide |
GO:0001910 | 0.0084 | 15.7449 | 0.138 | 2 | 50 | regulation of leukocyte mediated cytotoxicity |
GO:0034381 | 0.0084 | 15.7449 | 0.138 | 2 | 50 | plasma lipoprotein particle clearance |
GO:0002703 | 0.0086 | 7.6955 | 0.4222 | 3 | 153 | regulation of leukocyte mediated immunity |
GO:0001501 | 0.0087 | 4.3235 | 1.2803 | 5 | 464 | skeletal system development |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0021541 | 0.0014 | Inf | 0.0014 | 1 | 1 | ammon gyrus development |
GO:0033577 | 0.0028 | 741 | 0.0028 | 1 | 2 | protein glycosylation in endoplasmic reticulum |
GO:0018312 | 0.0042 | 370.4762 | 0.0042 | 1 | 3 | peptidyl-serine ADP-ribosylation |
GO:0038026 | 0.0056 | 246.9683 | 0.0056 | 1 | 4 | reelin-mediated signaling pathway |
GO:0019230 | 0.007 | 185.2143 | 0.0071 | 1 | 5 | proprioception |
GO:0060539 | 0.007 | 185.2143 | 0.0071 | 1 | 5 | diaphragm development |
GO:1900264 | 0.0084 | 148.1619 | 0.0085 | 1 | 6 | positive regulation of DNA-directed DNA polymerase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006486 | 8e-04 | 11.2081 | 0.4235 | 4 | 264 | protein glycosylation |
GO:0070085 | 9e-04 | 10.8267 | 0.4379 | 4 | 273 | glycosylation |
GO:0048023 | 0.0016 | Inf | 0.0016 | 1 | 1 | positive regulation of melanin biosynthetic process |
GO:1902748 | 0.0016 | Inf | 0.0016 | 1 | 1 | positive regulation of lens fiber cell differentiation |
GO:0016266 | 0.0029 | 28.0996 | 0.0802 | 2 | 50 | O-glycan processing |
GO:0044242 | 0.0029 | 11.8505 | 0.2888 | 3 | 180 | cellular lipid catabolic process |
GO:0006196 | 0.0032 | 648.25 | 0.0032 | 1 | 2 | AMP catabolic process |
GO:0033306 | 0.0032 | 648.25 | 0.0032 | 1 | 2 | phytol metabolic process |
GO:0045967 | 0.0032 | 648.25 | 0.0032 | 1 | 2 | negative regulation of growth rate |
GO:0061373 | 0.0032 | 648.25 | 0.0032 | 1 | 2 | mammillary axonal complex development |
GO:0097324 | 0.0032 | 648.25 | 0.0032 | 1 | 2 | melanocyte migration |
GO:1903056 | 0.0032 | 648.25 | 0.0032 | 1 | 2 | regulation of melanosome organization |
GO:0009100 | 0.0036 | 7.2746 | 0.6433 | 4 | 401 | glycoprotein metabolic process |
GO:0032264 | 0.0048 | 324.1042 | 0.0048 | 1 | 3 | IMP salvage |
GO:1901137 | 0.0052 | 5.175 | 1.1582 | 5 | 722 | carbohydrate derivative biosynthetic process |
GO:0007264 | 0.0064 | 6.1285 | 0.7588 | 4 | 473 | small GTPase mediated signal transduction |
GO:0035021 | 0.0064 | 216.0556 | 0.0064 | 1 | 4 | negative regulation of Rac protein signal transduction |
GO:0045578 | 0.0064 | 216.0556 | 0.0064 | 1 | 4 | negative regulation of B cell differentiation |
GO:1900376 | 0.0064 | 216.0556 | 0.0064 | 1 | 4 | regulation of secondary metabolite biosynthetic process |
GO:0045638 | 0.0072 | 17.2586 | 0.1283 | 2 | 80 | negative regulation of myeloid cell differentiation |
GO:1902106 | 0.0072 | 17.2586 | 0.1283 | 2 | 80 | negative regulation of leukocyte differentiation |
GO:0018377 | 0.008 | 162.0312 | 0.008 | 1 | 5 | protein myristoylation |
GO:0021540 | 0.008 | 162.0312 | 0.008 | 1 | 5 | corpus callosum morphogenesis |
GO:0035965 | 0.008 | 162.0312 | 0.008 | 1 | 5 | cardiolipin acyl-chain remodeling |
GO:0045636 | 0.008 | 162.0312 | 0.008 | 1 | 5 | positive regulation of melanocyte differentiation |
GO:0030148 | 0.0091 | 15.2875 | 0.1444 | 2 | 90 | sphingolipid biosynthetic process |
GO:0019395 | 0.0095 | 14.9459 | 0.1476 | 2 | 92 | fatty acid oxidation |
GO:0006685 | 0.0096 | 129.6167 | 0.0096 | 1 | 6 | sphingomyelin catabolic process |
GO:0021957 | 0.0096 | 129.6167 | 0.0096 | 1 | 6 | corticospinal tract morphogenesis |
GO:0031584 | 0.0096 | 129.6167 | 0.0096 | 1 | 6 | activation of phospholipase D activity |
GO:0070345 | 0.0096 | 129.6167 | 0.0096 | 1 | 6 | negative regulation of fat cell proliferation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007229 | 0 | 22.7719 | 0.2598 | 5 | 92 | integrin-mediated signaling pathway |
GO:0007155 | 0 | 4.8108 | 3.5547 | 13 | 1259 | cell adhesion |
GO:0050900 | 0 | 9.1422 | 0.9156 | 7 | 339 | leukocyte migration |
GO:0022407 | 1e-04 | 7.63 | 1.0814 | 7 | 383 | regulation of cell-cell adhesion |
GO:0032715 | 1e-04 | 36.6066 | 0.096 | 3 | 34 | negative regulation of interleukin-6 production |
GO:0051716 | 1e-04 | 3.2998 | 18.4933 | 31 | 6550 | cellular response to stimulus |
GO:0033628 | 1e-04 | 34.3836 | 0.1016 | 3 | 36 | regulation of cell adhesion mediated by integrin |
GO:0050863 | 1e-04 | 8.5431 | 0.8131 | 6 | 288 | regulation of T cell activation |
GO:0045656 | 2e-04 | 147.9524 | 0.0198 | 2 | 7 | negative regulation of monocyte differentiation |
GO:0002429 | 2e-04 | 8.3915 | 0.8273 | 6 | 293 | immune response-activating cell surface receptor signaling pathway |
GO:0007159 | 3e-04 | 14.2073 | 0.32 | 4 | 123 | leukocyte cell-cell adhesion |
GO:0023052 | 3e-04 | 2.9558 | 16.3955 | 28 | 5807 | signaling |
GO:0072672 | 3e-04 | 92.4524 | 0.0282 | 2 | 10 | neutrophil extravasation |
GO:0007154 | 4e-04 | 2.942 | 16.4435 | 28 | 5824 | cell communication |
GO:0002275 | 4e-04 | 5.9743 | 1.3665 | 7 | 484 | myeloid cell activation involved in immune response |
GO:0002444 | 4e-04 | 5.9104 | 1.3806 | 7 | 489 | myeloid leukocyte mediated immunity |
GO:0070527 | 4e-04 | 23.1324 | 0.1468 | 3 | 52 | platelet aggregation |
GO:0045055 | 5e-04 | 5.018 | 1.8832 | 8 | 667 | regulated exocytosis |
GO:0002695 | 5e-04 | 12.1562 | 0.3698 | 4 | 134 | negative regulation of leukocyte activation |
GO:0045579 | 5e-04 | 73.9524 | 0.0339 | 2 | 12 | positive regulation of B cell differentiation |
GO:0042330 | 6e-04 | 5.4322 | 1.4964 | 7 | 530 | taxis |
GO:0032103 | 7e-04 | 8.037 | 0.703 | 5 | 249 | positive regulation of response to external stimulus |
GO:0002684 | 7e-04 | 4.336 | 2.4818 | 9 | 879 | positive regulation of immune system process |
GO:0051251 | 7e-04 | 7.9378 | 0.7115 | 5 | 252 | positive regulation of lymphocyte activation |
GO:0002694 | 8e-04 | 7.7756 | 0.7347 | 5 | 291 | regulation of leukocyte activation |
GO:0050867 | 0.0013 | 6.8136 | 0.8244 | 5 | 292 | positive regulation of cell activation |
GO:0002438 | 0.0014 | 41.0635 | 0.0565 | 2 | 20 | acute inflammatory response to antigenic stimulus |
GO:0002263 | 0.0015 | 4.6703 | 1.7279 | 7 | 612 | cell activation involved in immune response |
GO:0038093 | 0.0016 | 8.831 | 0.5026 | 4 | 178 | Fc receptor signaling pathway |
GO:0001816 | 0.0016 | 4.6305 | 1.742 | 7 | 617 | cytokine production |
GO:0002764 | 0.0017 | 5.2826 | 1.2903 | 6 | 457 | immune response-regulating signaling pathway |
GO:0045321 | 0.002 | 5.2594 | 1.348 | 6 | 619 | leukocyte activation |
GO:0050670 | 0.0021 | 8.166 | 0.5421 | 4 | 192 | regulation of lymphocyte proliferation |
GO:0031347 | 0.0021 | 4.3903 | 1.8324 | 7 | 649 | regulation of defense response |
GO:0001562 | 0.0022 | 32.1263 | 0.0706 | 2 | 25 | response to protozoan |
GO:0002460 | 0.0023 | 7.9518 | 0.5562 | 4 | 197 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
GO:0045648 | 0.0024 | 30.7857 | 0.0734 | 2 | 26 | positive regulation of erythrocyte differentiation |
GO:0090023 | 0.0024 | 30.7857 | 0.0734 | 2 | 26 | positive regulation of neutrophil chemotaxis |
GO:0002253 | 0.0024 | 4.8908 | 1.3891 | 6 | 492 | activation of immune response |
GO:0042102 | 0.0025 | 12.1534 | 0.271 | 3 | 96 | positive regulation of T cell proliferation |
GO:0048870 | 0.0025 | 3.3247 | 3.6258 | 10 | 1345 | cell motility |
GO:0070663 | 0.0025 | 7.709 | 0.5732 | 4 | 203 | regulation of leukocyte proliferation |
GO:0002675 | 0.0026 | 29.5524 | 0.0762 | 2 | 27 | positive regulation of acute inflammatory response |
GO:1903039 | 0.0028 | 7.4805 | 0.5901 | 4 | 209 | positive regulation of leukocyte cell-cell adhesion |
GO:0050869 | 0.0028 | 28.4139 | 0.0791 | 2 | 28 | negative regulation of B cell activation |
GO:0001808 | 0.0028 | Inf | 0.0028 | 1 | 1 | negative regulation of type IV hypersensitivity |
GO:0034213 | 0.0028 | Inf | 0.0028 | 1 | 1 | quinolinate catabolic process |
GO:0043378 | 0.0028 | Inf | 0.0028 | 1 | 1 | positive regulation of CD8-positive, alpha-beta T cell differentiation |
GO:0071976 | 0.0028 | Inf | 0.0028 | 1 | 1 | cell gliding |
GO:1903904 | 0.0028 | Inf | 0.0028 | 1 | 1 | negative regulation of establishment of T cell polarity |
GO:1905872 | 0.0028 | Inf | 0.0028 | 1 | 1 | negative regulation of protein localization to cell leading edge |
GO:2001107 | 0.0028 | Inf | 0.0028 | 1 | 1 | negative regulation of Rho guanyl-nucleotide exchange factor activity |
GO:0032940 | 0.0029 | 3.2408 | 3.6789 | 10 | 1303 | secretion by cell |
GO:1903131 | 0.0034 | 25.4696 | 0.0875 | 2 | 31 | mononuclear cell differentiation |
GO:0002250 | 0.0035 | 10.7394 | 0.3068 | 3 | 118 | adaptive immune response |
GO:1902622 | 0.0037 | 24.619 | 0.0903 | 2 | 32 | regulation of neutrophil migration |
GO:0097530 | 0.0038 | 10.4553 | 0.3134 | 3 | 111 | granulocyte migration |
GO:0050776 | 0.0041 | 6.7961 | 0.6582 | 4 | 275 | regulation of immune response |
GO:0042110 | 0.0041 | 10.2121 | 0.323 | 3 | 130 | T cell activation |
GO:0002686 | 0.0041 | 23.0774 | 0.096 | 2 | 34 | negative regulation of leukocyte migration |
GO:0006911 | 0.0041 | 23.0774 | 0.096 | 2 | 34 | phagocytosis, engulfment |
GO:1900015 | 0.0041 | 23.0774 | 0.096 | 2 | 34 | regulation of cytokine production involved in inflammatory response |
GO:0050777 | 0.0044 | 9.9012 | 0.3303 | 3 | 117 | negative regulation of immune response |
GO:0050794 | 0.0045 | 2.7182 | 27.4548 | 36 | 9724 | regulation of cellular process |
GO:0060326 | 0.0045 | 6.541 | 0.672 | 4 | 238 | cell chemotaxis |
GO:0014065 | 0.0048 | 9.563 | 0.3416 | 3 | 121 | phosphatidylinositol 3-kinase signaling |
GO:0007166 | 0.0049 | 2.6967 | 6.1174 | 13 | 2430 | cell surface receptor signaling pathway |
GO:0050789 | 0.0051 | 9.0034 | 0.8041 | 4 | 589 | regulation of biological process |
GO:0072678 | 0.0054 | 19.8973 | 0.1104 | 2 | 40 | T cell migration |
GO:0006897 | 0.0055 | 4.1168 | 1.6376 | 6 | 580 | endocytosis |
GO:0045659 | 0.0056 | 361.3721 | 0.0056 | 1 | 2 | negative regulation of neutrophil differentiation |
GO:0050902 | 0.0056 | 361.3721 | 0.0056 | 1 | 2 | leukocyte adhesive activation |
GO:2000255 | 0.0056 | 361.3721 | 0.0056 | 1 | 2 | negative regulation of male germ cell proliferation |
GO:0032946 | 0.0059 | 8.8802 | 0.367 | 3 | 130 | positive regulation of mononuclear cell proliferation |
GO:0043303 | 0.0062 | 18.4524 | 0.1186 | 2 | 42 | mast cell degranulation |
GO:0050853 | 0.0065 | 18.0012 | 0.1214 | 2 | 43 | B cell receptor signaling pathway |
GO:0071622 | 0.0068 | 17.5714 | 0.1242 | 2 | 44 | regulation of granulocyte chemotaxis |
GO:0006955 | 0.0074 | 5.8265 | 0.7886 | 4 | 418 | immune response |
GO:0043312 | 0.0074 | 4.4943 | 1.231 | 5 | 436 | neutrophil degranulation |
GO:0032648 | 0.0078 | 16.3968 | 0.1327 | 2 | 47 | regulation of interferon-beta production |
GO:0048017 | 0.0081 | 7.8784 | 0.4122 | 3 | 146 | inositol lipid-mediated signaling |
GO:0032480 | 0.0081 | 16.0393 | 0.1355 | 2 | 48 | negative regulation of type I interferon production |
GO:0042119 | 0.0081 | 4.3895 | 1.2592 | 5 | 446 | neutrophil activation |
GO:0030886 | 0.0084 | 180.6744 | 0.0085 | 1 | 3 | negative regulation of myeloid dendritic cell activation |
GO:0038165 | 0.0084 | 180.6744 | 0.0085 | 1 | 3 | oncostatin-M-mediated signaling pathway |
GO:0045588 | 0.0084 | 180.6744 | 0.0085 | 1 | 3 | positive regulation of gamma-delta T cell differentiation |
GO:0070358 | 0.0084 | 180.6744 | 0.0085 | 1 | 3 | actin polymerization-dependent cell motility |
GO:1904475 | 0.0084 | 180.6744 | 0.0085 | 1 | 3 | regulation of Ras GTPase binding |
GO:1905936 | 0.0084 | 180.6744 | 0.0085 | 1 | 3 | regulation of germ cell proliferation |
GO:2000405 | 0.0084 | 180.6744 | 0.0085 | 1 | 3 | negative regulation of T cell migration |
GO:0045576 | 0.0088 | 15.369 | 0.1412 | 2 | 50 | mast cell activation |
GO:2000242 | 0.0088 | 15.369 | 0.1412 | 2 | 50 | negative regulation of reproductive process |
GO:0002443 | 0.0091 | 7.5918 | 0.4314 | 3 | 176 | leukocyte mediated immunity |
GO:0010324 | 0.0091 | 15.0544 | 0.144 | 2 | 51 | membrane invagination |
GO:0050852 | 0.0092 | 7.5073 | 0.432 | 3 | 153 | T cell receptor signaling pathway |
GO:0002532 | 0.0094 | 14.7524 | 0.1468 | 2 | 52 | production of molecular mediator involved in inflammatory response |
GO:0008285 | 0.0098 | 3.617 | 1.8522 | 6 | 656 | negative regulation of cell proliferation |
GO:0030098 | 0.01 | 5.15 | 0.847 | 4 | 300 | lymphocyte differentiation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0008544 | 0 | 16.5725 | 1.0461 | 12 | 418 | epidermis development |
GO:0070268 | 0 | 34.4799 | 0.2628 | 7 | 105 | cornification |
GO:0030216 | 0 | 17.7058 | 0.6707 | 9 | 268 | keratinocyte differentiation |
GO:0030855 | 0 | 8.7084 | 1.7068 | 11 | 682 | epithelial cell differentiation |
GO:0031581 | 0 | 161.8438 | 0.0275 | 3 | 11 | hemidesmosome assembly |
GO:0032287 | 1e-04 | 168 | 0.0175 | 2 | 7 | peripheral nervous system myelin maintenance |
GO:0033157 | 2e-04 | 7.8023 | 0.9009 | 6 | 360 | regulation of intracellular protein transport |
GO:0043124 | 3e-04 | 25.825 | 0.1326 | 3 | 53 | negative regulation of I-kappaB kinase/NF-kappaB signaling |
GO:0060707 | 4e-04 | 83.973 | 0.03 | 2 | 12 | trophoblast giant cell differentiation |
GO:0042308 | 5e-04 | 21.5069 | 0.1577 | 3 | 63 | negative regulation of protein import into nucleus |
GO:0001892 | 0.0013 | 15.3383 | 0.2177 | 3 | 87 | embryonic placenta development |
GO:0034329 | 0.0014 | 9.2361 | 0.4855 | 4 | 194 | cell junction assembly |
GO:0032292 | 0.0014 | 41.9595 | 0.0551 | 2 | 22 | peripheral nervous system axon ensheathment |
GO:0042994 | 0.0014 | 41.9595 | 0.0551 | 2 | 22 | cytoplasmic sequestering of transcription factor |
GO:0046822 | 0.0017 | 8.7244 | 0.513 | 4 | 205 | regulation of nucleocytoplasmic transport |
GO:0014044 | 0.0018 | 36.4794 | 0.0626 | 2 | 25 | Schwann cell development |
GO:0010837 | 0.0021 | 33.5568 | 0.0676 | 2 | 27 | regulation of keratinocyte proliferation |
GO:0015692 | 0.0025 | Inf | 0.0025 | 1 | 1 | lead ion transport |
GO:0085032 | 0.0025 | Inf | 0.0025 | 1 | 1 | modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade |
GO:0048869 | 0.0032 | 2.5858 | 9.73 | 18 | 3888 | cellular developmental process |
GO:0032387 | 0.0033 | 10.9886 | 0.3003 | 3 | 120 | negative regulation of intracellular transport |
GO:0052250 | 0.005 | 409.0526 | 0.005 | 1 | 2 | modulation of signal transduction in other organism involved in symbiotic interaction |
GO:1903828 | 0.0053 | 9.2362 | 0.3554 | 3 | 142 | negative regulation of cellular protein localization |
GO:0008219 | 0.0074 | 2.7182 | 4.9401 | 11 | 1974 | cell death |
GO:0018149 | 0.0075 | 16.7514 | 0.1301 | 2 | 52 | peptide cross-linking |
GO:0003383 | 0.0075 | 204.5132 | 0.0075 | 1 | 3 | apical constriction |
GO:0010482 | 0.0075 | 204.5132 | 0.0075 | 1 | 3 | regulation of epidermal cell division |
GO:0010593 | 0.0075 | 204.5132 | 0.0075 | 1 | 3 | negative regulation of lamellipodium assembly |
GO:0043163 | 0.0075 | 204.5132 | 0.0075 | 1 | 3 | cell envelope organization |
GO:0070574 | 0.0075 | 204.5132 | 0.0075 | 1 | 3 | cadmium ion transmembrane transport |
GO:0031032 | 0.0078 | 8.013 | 0.4079 | 3 | 163 | actomyosin structure organization |
GO:1904589 | 0.0081 | 7.9131 | 0.4129 | 3 | 165 | regulation of protein import |
GO:0008588 | 0.01 | 136.3333 | 0.01 | 1 | 4 | release of cytoplasmic sequestered NF-kappaB |
GO:0060708 | 0.01 | 136.3333 | 0.01 | 1 | 4 | spongiotrophoblast differentiation |
GO:0071421 | 0.01 | 136.3333 | 0.01 | 1 | 4 | manganese ion transmembrane transport |
GO:1903847 | 0.01 | 136.3333 | 0.01 | 1 | 4 | regulation of aorta morphogenesis |
GO:1905867 | 0.01 | 136.3333 | 0.01 | 1 | 4 | epididymis development |
GO:0048731 | 0.01 | 2.256 | 10.756 | 18 | 4298 | system development |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 27.5492 | 0.734 | 13 | 301 | detection of chemical stimulus involved in sensory perception of smell |
GO:0009593 | 0 | 21.9353 | 0.9095 | 13 | 373 | detection of chemical stimulus |
GO:0050906 | 0 | 21.1527 | 0.9412 | 13 | 386 | detection of stimulus involved in sensory perception |
GO:0007606 | 0 | 20.8096 | 0.9559 | 13 | 392 | sensory perception of chemical stimulus |
GO:0050877 | 0 | 7.6309 | 2.7261 | 14 | 1118 | nervous system process |
GO:0007186 | 0 | 7.4277 | 2.7944 | 14 | 1146 | G-protein coupled receptor signaling pathway |
GO:0007402 | 0.0049 | 420.1351 | 0.0049 | 1 | 2 | ganglion mother cell fate determination |
GO:0045950 | 0.0073 | 210.0541 | 0.0073 | 1 | 3 | negative regulation of mitotic recombination |
GO:2000503 | 0.0097 | 140.027 | 0.0098 | 1 | 4 | positive regulation of natural killer cell chemotaxis |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0035663 | 0 | 691.2 | 0.009 | 2 | 3 | Toll-like receptor 2 binding |
GO:0071723 | 4e-04 | 86.3611 | 0.0301 | 2 | 10 | lipopeptide binding |
GO:0050290 | 0.003 | Inf | 0.003 | 1 | 1 | sphingomyelin phosphodiesterase D activity |
GO:0019239 | 0.0034 | 25.5572 | 0.0874 | 2 | 29 | deaminase activity |
GO:0003876 | 0.006 | 338.087 | 0.006 | 1 | 2 | AMP deaminase activity |
GO:0005093 | 0.006 | 338.087 | 0.006 | 1 | 2 | Rab GDP-dissociation inhibitor activity |
GO:0005153 | 0.006 | 338.087 | 0.006 | 1 | 2 | interleukin-8 receptor binding |
GO:0016509 | 0.006 | 338.087 | 0.006 | 1 | 2 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity |
GO:0031716 | 0.006 | 338.087 | 0.006 | 1 | 2 | calcitonin receptor binding |
GO:0038049 | 0.006 | 338.087 | 0.006 | 1 | 2 | transcription factor activity, ligand-activated RNA polymerase II transcription factor binding |
GO:0004948 | 0.009 | 169.0326 | 0.009 | 1 | 3 | calcitonin receptor activity |
GO:0097643 | 0.009 | 169.0326 | 0.009 | 1 | 3 | amylin receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005309 | 0.0021 | Inf | 0.0021 | 1 | 1 | creatine:sodium symporter activity |
GO:0045130 | 0.0021 | Inf | 0.0021 | 1 | 1 | keratan sulfotransferase activity |
GO:0031492 | 0.0037 | 24.6444 | 0.0903 | 2 | 44 | nucleosomal DNA binding |
GO:0004530 | 0.0041 | 502.1613 | 0.0041 | 1 | 2 | deoxyribonuclease I activity |
GO:0047710 | 0.0041 | 502.1613 | 0.0041 | 1 | 2 | bis(5'-adenosyl)-triphosphatase activity |
GO:0000979 | 0.0061 | 18.8036 | 0.1169 | 2 | 57 | RNA polymerase II core promoter sequence-specific DNA binding |
GO:0000404 | 0.0061 | 251.0645 | 0.0062 | 1 | 3 | heteroduplex DNA loop binding |
GO:0042393 | 0.0066 | 8.6019 | 0.3856 | 3 | 188 | histone binding |
GO:0004525 | 0.0082 | 167.3656 | 0.0082 | 1 | 4 | ribonuclease III activity |
GO:0030160 | 0.0082 | 167.3656 | 0.0082 | 1 | 4 | GKAP/Homer scaffold activity |
GO:0000980 | 0.0083 | 15.9005 | 0.1374 | 2 | 67 | RNA polymerase II distal enhancer sequence-specific DNA binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005229 | 0.0011 | 48.6803 | 0.05 | 2 | 13 | intracellular calcium activated chloride channel activity |
GO:0005254 | 0.0027 | 11.8009 | 0.2769 | 3 | 72 | chloride channel activity |
GO:0033897 | 0.0038 | Inf | 0.0038 | 1 | 1 | ribonuclease T2 activity |
GO:0004776 | 0.0077 | 263.3729 | 0.0077 | 1 | 2 | succinate-CoA ligase (GDP-forming) activity |
GO:0051500 | 0.0077 | 263.3729 | 0.0077 | 1 | 2 | D-tyrosyl-tRNA(Tyr) deacylase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005550 | 0.0022 | Inf | 0.0022 | 1 | 1 | pheromone binding |
GO:0047704 | 0.0022 | Inf | 0.0022 | 1 | 1 | bile-salt sulfotransferase activity |
GO:0004930 | 0.0036 | 4.6059 | 1.5213 | 6 | 698 | G-protein coupled receptor activity |
GO:0004984 | 0.004 | 6.8548 | 0.656 | 4 | 301 | olfactory receptor activity |
GO:0004304 | 0.0044 | 471.6667 | 0.0044 | 1 | 2 | estrone sulfotransferase activity |
GO:0004825 | 0.0044 | 471.6667 | 0.0044 | 1 | 2 | methionine-tRNA ligase activity |
GO:0003896 | 0.0065 | 235.8182 | 0.0065 | 1 | 3 | DNA primase activity |
GO:0050294 | 0.0087 | 157.202 | 0.0087 | 1 | 4 | steroid sulfotransferase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0032394 | 0 | Inf | 0.0055 | 2 | 2 | MHC class Ib receptor activity |
GO:0042288 | 0.0012 | 44.5911 | 0.0524 | 2 | 19 | MHC class I protein binding |
GO:0001605 | 0.0028 | Inf | 0.0028 | 1 | 1 | adrenomedullin receptor activity |
GO:0003692 | 0.0028 | Inf | 0.0028 | 1 | 1 | left-handed Z-DNA binding |
GO:0004502 | 0.0028 | Inf | 0.0028 | 1 | 1 | kynurenine 3-monooxygenase activity |
GO:0008887 | 0.0028 | Inf | 0.0028 | 1 | 1 | glycerate kinase activity |
GO:0050337 | 0.0028 | Inf | 0.0028 | 1 | 1 | thiosulfate-thiol sulfurtransferase activity |
GO:0005310 | 0.0033 | 26.1194 | 0.0854 | 2 | 31 | dicarboxylic acid transmembrane transporter activity |
GO:0001635 | 0.0055 | 370.381 | 0.0055 | 1 | 2 | calcitonin gene-related peptide receptor activity |
GO:0001791 | 0.0055 | 370.381 | 0.0055 | 1 | 2 | IgM binding |
GO:1990698 | 0.0055 | 370.381 | 0.0055 | 1 | 2 | palmitoleoyltransferase activity |
GO:0003726 | 0.0082 | 185.1786 | 0.0083 | 1 | 3 | double-stranded RNA adenosine deaminase activity |
GO:0004948 | 0.0082 | 185.1786 | 0.0083 | 1 | 3 | calcitonin receptor activity |
GO:0005094 | 0.0082 | 185.1786 | 0.0083 | 1 | 3 | Rho GDP-dissociation inhibitor activity |
GO:0015501 | 0.0082 | 185.1786 | 0.0083 | 1 | 3 | glutamate:sodium symporter activity |
GO:0017137 | 0.0095 | 7.4043 | 0.4383 | 3 | 159 | Rab GTPase binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042169 | 0.0025 | 30.2788 | 0.0744 | 2 | 29 | SH2 domain binding |
GO:0003692 | 0.0026 | Inf | 0.0026 | 1 | 1 | left-handed Z-DNA binding |
GO:0008859 | 0.0026 | Inf | 0.0026 | 1 | 1 | exoribonuclease II activity |
GO:0030107 | 0.0026 | Inf | 0.0026 | 1 | 1 | HLA-A specific inhibitory MHC class I receptor activity |
GO:0030109 | 0.0026 | Inf | 0.0026 | 1 | 1 | HLA-B specific inhibitory MHC class I receptor activity |
GO:0050337 | 0.0026 | Inf | 0.0026 | 1 | 1 | thiosulfate-thiol sulfurtransferase activity |
GO:0001791 | 0.0051 | 398.9487 | 0.0051 | 1 | 2 | IgM binding |
GO:0005298 | 0.0051 | 398.9487 | 0.0051 | 1 | 2 | proline:sodium symporter activity |
GO:0097199 | 0.0051 | 398.9487 | 0.0051 | 1 | 2 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway |
GO:1990698 | 0.0051 | 398.9487 | 0.0051 | 1 | 2 | palmitoleoyltransferase activity |
GO:0003726 | 0.0077 | 199.4615 | 0.0077 | 1 | 3 | double-stranded RNA adenosine deaminase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042393 | 0 | 41.3169 | 0.9882 | 25 | 188 | histone binding |
GO:0046982 | 0 | 20.8785 | 2.4705 | 31 | 470 | protein heterodimerization activity |
GO:0031492 | 0 | 63.2516 | 0.2313 | 10 | 44 | nucleosomal DNA binding |
GO:0019904 | 0 | 6.9393 | 3.2884 | 18 | 641 | protein domain specific binding |
GO:0045296 | 0 | 9.3294 | 1.5349 | 12 | 292 | cadherin binding |
GO:0003677 | 0 | 3.7102 | 12.1686 | 32 | 2315 | DNA binding |
GO:0031711 | 0 | Inf | 0.0105 | 2 | 2 | bradykinin receptor binding |
GO:0003682 | 0 | 4.9604 | 2.5283 | 11 | 481 | chromatin binding |
GO:1901363 | 1e-04 | 2.2994 | 29.3781 | 46 | 5589 | heterocyclic compound binding |
GO:0097159 | 2e-04 | 2.2511 | 29.7776 | 46 | 5665 | organic cyclic compound binding |
GO:0045503 | 2e-04 | 29.4266 | 0.1209 | 3 | 23 | dynein light chain binding |
GO:0055131 | 4e-04 | 96.9625 | 0.0315 | 2 | 6 | C3HC4-type RING finger domain binding |
GO:0003723 | 9e-04 | 2.5279 | 8.794 | 19 | 1673 | RNA binding |
GO:0044877 | 0.0031 | 2.7519 | 4.8464 | 12 | 922 | macromolecular complex binding |
GO:0008569 | 0.0035 | 25.8383 | 0.0894 | 2 | 17 | ATP-dependent microtubule motor activity, minus-end-directed |
GO:0000334 | 0.0053 | Inf | 0.0053 | 1 | 1 | 3-hydroxyanthranilate 3,4-dioxygenase activity |
GO:0001596 | 0.0053 | Inf | 0.0053 | 1 | 1 | angiotensin type I receptor activity |
GO:0008903 | 0.0053 | Inf | 0.0053 | 1 | 1 | hydroxypyruvate isomerase activity |
GO:0031249 | 0.0053 | Inf | 0.0053 | 1 | 1 | denatured protein binding |
GO:0045505 | 0.0082 | 16.1396 | 0.1367 | 2 | 26 | dynein intermediate chain binding |
GO:0003777 | 0.0086 | 7.6152 | 0.4205 | 3 | 80 | microtubule motor activity |
GO:0044183 | 0.0088 | 15.493 | 0.1419 | 2 | 27 | protein binding involved in protein folding |
GO:0051959 | 0.0094 | 14.8962 | 0.1472 | 2 | 28 | dynein light intermediate chain binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042923 | 0.0016 | 38.358 | 0.0603 | 2 | 20 | neuropeptide binding |
GO:0045503 | 0.0022 | 32.872 | 0.0693 | 2 | 23 | dynein light chain binding |
GO:0001596 | 0.003 | Inf | 0.003 | 1 | 1 | angiotensin type I receptor activity |
GO:0008903 | 0.003 | Inf | 0.003 | 1 | 1 | hydroxypyruvate isomerase activity |
GO:0000981 | 0.0055 | 3.6317 | 2.1753 | 7 | 722 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
GO:0001653 | 0.0058 | 8.9185 | 0.3646 | 3 | 121 | peptide receptor activity |
GO:0005019 | 0.006 | 338.087 | 0.006 | 1 | 2 | platelet-derived growth factor beta-receptor activity |
GO:0031711 | 0.006 | 338.087 | 0.006 | 1 | 2 | bradykinin receptor binding |
GO:0008188 | 0.0078 | 16.4138 | 0.1326 | 2 | 44 | neuropeptide receptor activity |
GO:1990939 | 0.0081 | 16.031 | 0.1356 | 2 | 45 | ATP-dependent microtubule motor activity |
GO:0004945 | 0.009 | 169.0326 | 0.009 | 1 | 3 | angiotensin type II receptor activity |
GO:0004992 | 0.009 | 169.0326 | 0.009 | 1 | 3 | platelet activating factor receptor activity |
GO:0070573 | 0.009 | 169.0326 | 0.009 | 1 | 3 | metallodipeptidase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0045130 | 0.0013 | Inf | 0.0013 | 1 | 1 | keratan sulfotransferase activity |
GO:0004530 | 0.0027 | 778.9 | 0.0027 | 1 | 2 | deoxyribonuclease I activity |
GO:0034647 | 0.0027 | 778.9 | 0.0027 | 1 | 2 | histone demethylase activity (H3-trimethyl-K4 specific) |
GO:0035718 | 0.0027 | 778.9 | 0.0027 | 1 | 2 | macrophage migration inhibitory factor binding |
GO:0051033 | 0.004 | 389.425 | 0.004 | 1 | 3 | RNA transmembrane transporter activity |
GO:0004525 | 0.0054 | 259.6 | 0.0054 | 1 | 4 | ribonuclease III activity |
GO:0004971 | 0.0054 | 259.6 | 0.0054 | 1 | 4 | AMPA glutamate receptor activity |
GO:0034648 | 0.0054 | 259.6 | 0.0054 | 1 | 4 | histone demethylase activity (H3-dimethyl-K4 specific) |
GO:0070883 | 0.0067 | 194.6875 | 0.0067 | 1 | 5 | pre-miRNA binding |
GO:0070915 | 0.0067 | 194.6875 | 0.0067 | 1 | 5 | lysophosphatidic acid receptor activity |
GO:0001517 | 0.0094 | 129.775 | 0.0094 | 1 | 7 | N-acetylglucosamine 6-O-sulfotransferase activity |
GO:0019784 | 0.0094 | 129.775 | 0.0094 | 1 | 7 | NEDD8-specific protease activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0001106 | 0.0037 | 24.6302 | 0.0914 | 2 | 23 | RNA polymerase II transcription corepressor activity |
GO:0005199 | 0.004 | Inf | 0.004 | 1 | 1 | structural constituent of cell wall |
GO:0005309 | 0.004 | Inf | 0.004 | 1 | 1 | creatine:sodium symporter activity |
GO:0047315 | 0.004 | Inf | 0.004 | 1 | 1 | kynurenine-glyoxylate transaminase activity |
GO:0004693 | 0.0048 | 21.5472 | 0.1033 | 2 | 26 | cyclin-dependent protein serine/threonine kinase activity |
GO:0098632 | 0.0059 | 19.1494 | 0.1153 | 2 | 29 | cell-cell adhesion mediator activity |
GO:0045296 | 0.006 | 4.6613 | 1.1605 | 5 | 292 | cadherin binding |
GO:0005515 | 0.0066 | 2.2574 | 41.7347 | 51 | 10501 | protein binding |
GO:0016316 | 0.0079 | 254.7049 | 0.0079 | 1 | 2 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity |
GO:0017161 | 0.0079 | 254.7049 | 0.0079 | 1 | 2 | inositol-1,3,4-trisphosphate 4-phosphatase activity |
GO:0047804 | 0.0079 | 254.7049 | 0.0079 | 1 | 2 | cysteine-S-conjugate beta-lyase activity |
GO:0052828 | 0.0079 | 254.7049 | 0.0079 | 1 | 2 | inositol-3,4-bisphosphate 4-phosphatase activity |
GO:0016409 | 0.01 | 14.3537 | 0.151 | 2 | 38 | palmitoyltransferase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0035591 | 0.0012 | 15.9082 | 0.2095 | 3 | 76 | signaling adaptor activity |
GO:0043548 | 0.0027 | 29.1388 | 0.0772 | 2 | 28 | phosphatidylinositol 3-kinase binding |
GO:0005147 | 0.0028 | Inf | 0.0028 | 1 | 1 | oncostatin-M receptor binding |
GO:0005096 | 0.0049 | 6.3836 | 0.6891 | 4 | 250 | GTPase activator activity |
GO:0004667 | 0.0055 | 370.381 | 0.0055 | 1 | 2 | prostaglandin-D synthase activity |
GO:0004514 | 0.0082 | 185.1786 | 0.0083 | 1 | 3 | nicotinate-nucleotide diphosphorylase (carboxylating) activity |
GO:0016314 | 0.0082 | 185.1786 | 0.0083 | 1 | 3 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity |
GO:1990430 | 0.0082 | 185.1786 | 0.0083 | 1 | 3 | extracellular matrix protein binding |
GO:0030674 | 0.0095 | 7.4043 | 0.4383 | 3 | 159 | protein binding, bridging |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0000980 | 3e-04 | 27.9573 | 0.1246 | 3 | 67 | RNA polymerase II distal enhancer sequence-specific DNA binding |
GO:0035326 | 8e-04 | 18.4068 | 0.1859 | 3 | 100 | enhancer binding |
GO:0015130 | 0.0019 | Inf | 0.0019 | 1 | 1 | mevalonate transmembrane transporter activity |
GO:0038062 | 0.0019 | Inf | 0.0019 | 1 | 1 | protein tyrosine kinase collagen receptor activity |
GO:0038182 | 0.0019 | Inf | 0.0019 | 1 | 1 | G-protein coupled bile acid receptor activity |
GO:0031492 | 0.003 | 27.388 | 0.0818 | 2 | 44 | nucleosomal DNA binding |
GO:0098640 | 0.0037 | 556.0714 | 0.0037 | 1 | 2 | integrin binding involved in cell-matrix adhesion |
GO:0017171 | 0.0046 | 9.866 | 0.3402 | 3 | 183 | serine hydrolase activity |
GO:0000979 | 0.005 | 20.897 | 0.106 | 2 | 57 | RNA polymerase II core promoter sequence-specific DNA binding |
GO:0005518 | 0.0052 | 20.5225 | 0.1078 | 2 | 58 | collagen binding |
GO:0003896 | 0.0056 | 278.0179 | 0.0056 | 1 | 3 | DNA primase activity |
GO:0035241 | 0.0056 | 278.0179 | 0.0056 | 1 | 3 | protein-arginine omega-N monomethyltransferase activity |
GO:0001758 | 0.0074 | 185.3333 | 0.0074 | 1 | 4 | retinal dehydrogenase activity |
GO:0030023 | 0.0074 | 185.3333 | 0.0074 | 1 | 4 | extracellular matrix constituent conferring elasticity |
GO:0004028 | 0.0093 | 138.9911 | 0.0093 | 1 | 5 | 3-chloroallyl aldehyde dehydrogenase activity |
GO:0015129 | 0.0093 | 138.9911 | 0.0093 | 1 | 5 | lactate transmembrane transporter activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0003830 | 0.0021 | Inf | 0.0021 | 1 | 1 | beta-1,4-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity |
GO:0015130 | 0.0021 | Inf | 0.0021 | 1 | 1 | mevalonate transmembrane transporter activity |
GO:0038062 | 0.0021 | Inf | 0.0021 | 1 | 1 | protein tyrosine kinase collagen receptor activity |
GO:0038182 | 0.0021 | Inf | 0.0021 | 1 | 1 | G-protein coupled bile acid receptor activity |
GO:1903231 | 0.0028 | 11.8261 | 0.2831 | 3 | 138 | mRNA binding involved in posttranscriptional gene silencing |
GO:0098640 | 0.0041 | 502.1613 | 0.0041 | 1 | 2 | integrin binding involved in cell-matrix adhesion |
GO:0004735 | 0.0061 | 251.0645 | 0.0062 | 1 | 3 | pyrroline-5-carboxylate reductase activity |
GO:0035241 | 0.0061 | 251.0645 | 0.0062 | 1 | 3 | protein-arginine omega-N monomethyltransferase activity |
GO:0030023 | 0.0082 | 167.3656 | 0.0082 | 1 | 4 | extracellular matrix constituent conferring elasticity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005200 | 1e-04 | 20.0013 | 0.2314 | 4 | 95 | structural constituent of cytoskeleton |
GO:0097110 | 3e-04 | 27.7036 | 0.1242 | 3 | 51 | scaffold protein binding |
GO:0005198 | 0.0011 | 5.9478 | 1.1929 | 6 | 544 | structural molecule activity |
GO:0015086 | 0.0024 | Inf | 0.0024 | 1 | 1 | cadmium ion transmembrane transporter activity |
GO:0015087 | 0.0024 | Inf | 0.0024 | 1 | 1 | cobalt ion transmembrane transporter activity |
GO:0015094 | 0.0024 | Inf | 0.0024 | 1 | 1 | lead ion transmembrane transporter activity |
GO:0008426 | 0.0073 | 210.2703 | 0.0073 | 1 | 3 | protein kinase C inhibitor activity |
GO:0015093 | 0.0073 | 210.2703 | 0.0073 | 1 | 3 | ferrous iron transmembrane transporter activity |
GO:0005384 | 0.0097 | 140.1712 | 0.0097 | 1 | 4 | manganese ion transmembrane transporter activity |
GO:0061665 | 0.0097 | 140.1712 | 0.0097 | 1 | 4 | SUMO ligase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 28.729 | 0.7139 | 13 | 301 | olfactory receptor activity |
GO:0004930 | 0 | 11.7648 | 1.6555 | 13 | 698 | G-protein coupled receptor activity |
GO:0099600 | 0 | 7.171 | 2.6232 | 13 | 1106 | transmembrane receptor activity |
GO:0038023 | 0 | 6.776 | 2.7631 | 13 | 1165 | signaling receptor activity |
GO:0060089 | 0 | 5.5274 | 3.3253 | 13 | 1402 | molecular transducer activity |
GO:1903231 | 0.0042 | 10.0837 | 0.3273 | 3 | 138 | mRNA binding involved in posttranscriptional gene silencing |
GO:0031726 | 0.0071 | 216.125 | 0.0071 | 1 | 3 | CCR1 chemokine receptor binding |
GO:0031727 | 0.0071 | 216.125 | 0.0071 | 1 | 3 | CCR2 chemokine receptor binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005309 | 0.0013 | Inf | 0.0013 | 1 | 1 | creatine:sodium symporter activity |
GO:0017099 | 0.0027 | 778.9 | 0.0027 | 1 | 2 | very-long-chain-acyl-CoA dehydrogenase activity |
GO:0030197 | 0.0054 | 259.6 | 0.0054 | 1 | 4 | extracellular matrix constituent, lubricant activity |
GO:0005132 | 0.0067 | 194.6875 | 0.0067 | 1 | 5 | type I interferon receptor binding |
GO:0050815 | 0.0067 | 194.6875 | 0.0067 | 1 | 5 | phosphoserine residue binding |
GO:0008479 | 0.0081 | 155.74 | 0.0081 | 1 | 6 | queuine tRNA-ribosyltransferase activity |
GO:0060228 | 0.0081 | 155.74 | 0.0081 | 1 | 6 | phosphatidylcholine-sterol O-acyltransferase activator activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 32.8396 | 0.656 | 13 | 301 | olfactory receptor activity |
GO:0004930 | 0 | 13.4482 | 1.5213 | 13 | 698 | G-protein coupled receptor activity |
GO:0099600 | 0 | 10.4745 | 2.4105 | 15 | 1106 | transmembrane receptor activity |
GO:0038023 | 0 | 9.8966 | 2.5391 | 15 | 1165 | signaling receptor activity |
GO:0060089 | 0 | 8.0706 | 3.0556 | 15 | 1402 | molecular transducer activity |
GO:0032396 | 0.0044 | 471.6667 | 0.0044 | 1 | 2 | inhibitory MHC class I receptor activity |
GO:0004252 | 0.0045 | 9.8793 | 0.3356 | 3 | 154 | serine-type endopeptidase activity |
GO:0017171 | 0.0073 | 8.272 | 0.3988 | 3 | 183 | serine hydrolase activity |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0034641 | 0 | 1.6324 | 120.6388 | 157 | 6397 | cellular nitrogen compound metabolic process |
GO:0048634 | 0 | 4.828 | 2.5082 | 11 | 133 | regulation of muscle organ development |
GO:0019219 | 1e-04 | 1.6271 | 77.3771 | 108 | 4103 | regulation of nucleobase-containing compound metabolic process |
GO:0060255 | 1e-04 | 1.5705 | 111.1529 | 144 | 5894 | regulation of macromolecule metabolic process |
GO:0006355 | 1e-04 | 1.6471 | 66.2127 | 95 | 3511 | regulation of transcription, DNA-templated |
GO:0046483 | 1e-04 | 1.5581 | 109.8516 | 142 | 5825 | heterocycle metabolic process |
GO:2001141 | 1e-04 | 1.6295 | 66.7596 | 95 | 3540 | regulation of RNA biosynthetic process |
GO:0006725 | 1e-04 | 1.5421 | 110.5683 | 142 | 5863 | cellular aromatic compound metabolic process |
GO:0034654 | 2e-04 | 1.5728 | 78.4709 | 107 | 4161 | nucleobase-containing compound biosynthetic process |
GO:0045944 | 2e-04 | 1.9994 | 20.5936 | 38 | 1092 | positive regulation of transcription from RNA polymerase II promoter |
GO:0009889 | 2e-04 | 1.5545 | 82.5255 | 111 | 4376 | regulation of biosynthetic process |
GO:1901360 | 2e-04 | 1.5178 | 114.472 | 145 | 6070 | organic cyclic compound metabolic process |
GO:0061061 | 3e-04 | 2.3032 | 11.6358 | 25 | 617 | muscle structure development |
GO:1903508 | 3e-04 | 1.8513 | 26.421 | 45 | 1401 | positive regulation of nucleic acid-templated transcription |
GO:0060021 | 3e-04 | 5.122 | 1.7161 | 8 | 91 | palate development |
GO:0006268 | 3e-04 | 31.5138 | 0.1509 | 3 | 8 | DNA unwinding involved in DNA replication |
GO:0018003 | 4e-04 | Inf | 0.0377 | 2 | 2 | peptidyl-lysine N6-acetylation |
GO:0021623 | 4e-04 | Inf | 0.0377 | 2 | 2 | oculomotor nerve formation |
GO:0048704 | 4e-04 | 5.0008 | 1.7539 | 8 | 93 | embryonic skeletal system morphogenesis |
GO:0048641 | 4e-04 | 7.0551 | 0.9618 | 6 | 51 | regulation of skeletal muscle tissue development |
GO:0043009 | 4e-04 | 2.3278 | 10.5608 | 23 | 560 | chordate embryonic development |
GO:0010557 | 4e-04 | 1.7635 | 30.8716 | 50 | 1637 | positive regulation of macromolecule biosynthetic process |
GO:0034645 | 5e-04 | 1.5768 | 63.1395 | 87 | 3532 | cellular macromolecule biosynthetic process |
GO:0043587 | 5e-04 | 26.2599 | 0.1697 | 3 | 9 | tongue morphogenesis |
GO:0072048 | 5e-04 | 26.2599 | 0.1697 | 3 | 9 | renal system pattern specification |
GO:0010467 | 6e-04 | 1.5752 | 61.0303 | 84 | 3467 | gene expression |
GO:0051254 | 8e-04 | 1.7507 | 27.7599 | 45 | 1472 | positive regulation of RNA metabolic process |
GO:0031328 | 8e-04 | 1.6875 | 33.4552 | 52 | 1774 | positive regulation of cellular biosynthetic process |
GO:0000079 | 9e-04 | 4.9457 | 1.5464 | 7 | 82 | regulation of cyclin-dependent protein serine/threonine kinase activity |
GO:0045445 | 0.001 | 4.8804 | 1.5653 | 7 | 83 | myoblast differentiation |
GO:0010628 | 0.0011 | 1.6658 | 33.8324 | 52 | 1794 | positive regulation of gene expression |
GO:0001942 | 0.0013 | 4.6352 | 1.6407 | 7 | 87 | hair follicle development |
GO:1901576 | 0.0013 | 1.4289 | 116.8482 | 143 | 6196 | organic substance biosynthetic process |
GO:0022404 | 0.0015 | 4.5215 | 1.6784 | 7 | 89 | molting cycle process |
GO:0048538 | 0.0015 | 6.5944 | 0.8486 | 5 | 45 | thymus development |
GO:1904030 | 0.0015 | 9.1543 | 0.5092 | 4 | 27 | negative regulation of cyclin-dependent protein kinase activity |
GO:0008219 | 0.0016 | 1.5926 | 39.5277 | 58 | 2096 | cell death |
GO:0043066 | 0.002 | 1.9058 | 15.5961 | 28 | 827 | negative regulation of apoptotic process |
GO:0021557 | 0.0021 | 52.3607 | 0.0754 | 2 | 4 | oculomotor nerve development |
GO:0051754 | 0.0021 | 52.3607 | 0.0754 | 2 | 4 | meiotic sister chromatid cohesion, centromeric |
GO:0061056 | 0.0021 | 52.3607 | 0.0754 | 2 | 4 | sclerotome development |
GO:0072086 | 0.0021 | 52.3607 | 0.0754 | 2 | 4 | specification of loop of Henle identity |
GO:0072268 | 0.0021 | 52.3607 | 0.0754 | 2 | 4 | pattern specification involved in metanephros development |
GO:0045844 | 0.0022 | 4.8782 | 1.339 | 6 | 71 | positive regulation of striated muscle tissue development |
GO:1901862 | 0.0022 | 5.9934 | 0.9241 | 5 | 49 | negative regulation of muscle tissue development |
GO:1901215 | 0.0026 | 3.057 | 3.47 | 10 | 184 | negative regulation of neuron death |
GO:0051306 | 0.0027 | 5.7321 | 0.9618 | 5 | 51 | mitotic sister chromatid separation |
GO:0072088 | 0.0029 | 4.5943 | 1.4144 | 6 | 75 | nephron epithelium morphogenesis |
GO:0035115 | 0.0029 | 7.5172 | 0.6035 | 4 | 32 | embryonic forelimb morphogenesis |
GO:0051147 | 0.003 | 3.0046 | 3.5266 | 10 | 187 | regulation of muscle cell differentiation |
GO:0035295 | 0.0031 | 2.0435 | 10.8437 | 21 | 575 | tube development |
GO:0048532 | 0.0031 | 12.1146 | 0.3017 | 3 | 16 | anatomical structure arrangement |
GO:0071901 | 0.0033 | 3.4761 | 2.4516 | 8 | 130 | negative regulation of protein serine/threonine kinase activity |
GO:0061333 | 0.0033 | 4.4643 | 1.4521 | 6 | 77 | renal tubule morphogenesis |
GO:0060916 | 0.0034 | 34.9049 | 0.0943 | 2 | 5 | mesenchymal cell proliferation involved in lung development |
GO:0072047 | 0.0034 | 34.9049 | 0.0943 | 2 | 5 | proximal/distal pattern formation involved in nephron development |
GO:0090074 | 0.0034 | 34.9049 | 0.0943 | 2 | 5 | negative regulation of protein homodimerization activity |
GO:0098528 | 0.0034 | 34.9049 | 0.0943 | 2 | 5 | skeletal muscle fiber differentiation |
GO:1901861 | 0.004 | 4.2846 | 1.5072 | 6 | 81 | regulation of muscle tissue development |
GO:2000113 | 0.0041 | 1.6204 | 27.6279 | 42 | 1465 | negative regulation of cellular macromolecule biosynthetic process |
GO:0048598 | 0.0041 | 2.026 | 10.3951 | 20 | 556 | embryonic morphogenesis |
GO:0003002 | 0.0043 | 2.3521 | 6.2611 | 14 | 332 | regionalization |
GO:0042633 | 0.0044 | 3.6666 | 2.0367 | 7 | 108 | hair cycle |
GO:0048486 | 0.0044 | 10.498 | 0.3395 | 3 | 18 | parasympathetic nervous system development |
GO:0071542 | 0.005 | 6.3762 | 0.6978 | 4 | 37 | dopaminergic neuron differentiation |
GO:0006620 | 0.0051 | 26.177 | 0.1132 | 2 | 6 | posttranslational protein targeting to endoplasmic reticulum membrane |
GO:0019236 | 0.0051 | 26.177 | 0.1132 | 2 | 6 | response to pheromone |
GO:0061196 | 0.0051 | 26.177 | 0.1132 | 2 | 6 | fungiform papilla development |
GO:0042474 | 0.0051 | 9.8413 | 0.3583 | 3 | 19 | middle ear morphogenesis |
GO:0072074 | 0.0051 | 9.8413 | 0.3583 | 3 | 19 | kidney mesenchyme development |
GO:0072079 | 0.0051 | 9.8413 | 0.3583 | 3 | 19 | nephron tubule formation |
GO:0060173 | 0.0052 | 2.9474 | 3.2248 | 9 | 171 | limb development |
GO:0048513 | 0.0055 | 1.421 | 61.3661 | 80 | 3254 | animal organ development |
GO:0044238 | 0.0056 | 1.3758 | 191.4342 | 213 | 10151 | primary metabolic process |
GO:0009966 | 0.0057 | 1.4306 | 56.9343 | 75 | 3019 | regulation of signal transduction |
GO:0097659 | 0.0057 | 1.5076 | 40.3063 | 56 | 2289 | nucleic acid-templated transcription |
GO:0060429 | 0.0059 | 1.6507 | 22.4418 | 35 | 1190 | epithelium development |
GO:0016070 | 0.0062 | 1.4482 | 53.8225 | 71 | 3042 | RNA metabolic process |
GO:0030901 | 0.0064 | 3.8627 | 1.6596 | 6 | 88 | midbrain development |
GO:0014855 | 0.0066 | 4.5427 | 1.1881 | 5 | 63 | striated muscle cell proliferation |
GO:0039702 | 0.0069 | 8.7467 | 0.396 | 3 | 21 | viral budding via host ESCRT complex |
GO:0043369 | 0.0069 | 8.7467 | 0.396 | 3 | 21 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment |
GO:0006678 | 0.007 | 20.9403 | 0.132 | 2 | 7 | glucosylceramide metabolic process |
GO:0048478 | 0.007 | 20.9403 | 0.132 | 2 | 7 | replication fork protection |
GO:0060017 | 0.007 | 20.9403 | 0.132 | 2 | 7 | parathyroid gland development |
GO:0072080 | 0.0075 | 3.7257 | 1.7161 | 6 | 91 | nephron tubule development |
GO:0043067 | 0.0076 | 1.5626 | 27.8165 | 41 | 1475 | regulation of programmed cell death |
GO:0045995 | 0.0077 | 3.2747 | 2.263 | 7 | 120 | regulation of embryonic development |
GO:2000027 | 0.0078 | 2.4568 | 4.6958 | 11 | 249 | regulation of organ morphogenesis |
GO:0046632 | 0.0079 | 3.6821 | 1.735 | 6 | 92 | alpha-beta T cell differentiation |
GO:0060993 | 0.0079 | 3.6821 | 1.735 | 6 | 92 | kidney morphogenesis |
GO:0007080 | 0.0079 | 5.5355 | 0.7921 | 4 | 42 | mitotic metaphase plate congression |
GO:0060043 | 0.0079 | 5.5355 | 0.7921 | 4 | 42 | regulation of cardiac muscle cell proliferation |
GO:0051155 | 0.0081 | 4.3185 | 1.2447 | 5 | 66 | positive regulation of striated muscle cell differentiation |
GO:0007049 | 0.0083 | 1.5061 | 33.9079 | 48 | 1798 | cell cycle |
GO:0045165 | 0.0083 | 2.436 | 4.7335 | 11 | 251 | cell fate commitment |
GO:0061024 | 0.0092 | 1.723 | 15.8413 | 26 | 840 | membrane organization |
GO:0006681 | 0.0092 | 17.4492 | 0.1509 | 2 | 8 | galactosylceramide metabolic process |
GO:0045144 | 0.0092 | 17.4492 | 0.1509 | 2 | 8 | meiotic sister chromatid segregation |
GO:0021517 | 0.0093 | 5.2581 | 0.8298 | 4 | 44 | ventral spinal cord development |
GO:0008064 | 0.0096 | 2.8607 | 2.9419 | 8 | 156 | regulation of actin polymerization or depolymerization |
GO:0098813 | 0.0097 | 2.2797 | 5.5067 | 12 | 292 | nuclear chromosome segregation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 215.5695 | 0.4855 | 24 | 32 | DNA replication-dependent nucleosome assembly |
GO:0000183 | 0 | 123.1365 | 0.5766 | 24 | 38 | chromatin silencing at rDNA |
GO:0051290 | 0 | 94.9087 | 0.6676 | 25 | 44 | protein heterotetramerization |
GO:0006323 | 0 | 15.2012 | 2.9435 | 33 | 194 | DNA packaging |
GO:0045815 | 0 | 30.7034 | 1.2138 | 24 | 80 | positive regulation of gene expression, epigenetic |
GO:0045814 | 0 | 20.1614 | 1.8814 | 27 | 124 | negative regulation of gene expression, epigenetic |
GO:0060964 | 0 | 22.1763 | 1.6083 | 25 | 106 | regulation of gene silencing by miRNA |
GO:0045653 | 0 | 240.7639 | 0.2731 | 14 | 18 | negative regulation of megakaryocyte differentiation |
GO:0071824 | 0 | 11.3162 | 3.8994 | 34 | 257 | protein-DNA complex subunit organization |
GO:1902036 | 0 | 21.7331 | 1.5628 | 24 | 103 | regulation of hematopoietic stem cell differentiation |
GO:0048863 | 0 | 11.2538 | 3.6611 | 32 | 244 | stem cell differentiation |
GO:0060968 | 0 | 17.0817 | 1.9725 | 25 | 130 | regulation of gene silencing |
GO:0002244 | 0 | 12.0791 | 2.7401 | 26 | 182 | hematopoietic progenitor cell differentiation |
GO:0009893 | 0 | 8.3854 | 4.7112 | 31 | 347 | positive regulation of metabolic process |
GO:0032200 | 0 | 12.0432 | 2.5187 | 24 | 166 | telomere organization |
GO:1902679 | 0 | 4.2559 | 17.6006 | 59 | 1160 | negative regulation of RNA biosynthetic process |
GO:0030099 | 0 | 7.0695 | 5.8871 | 34 | 388 | myeloid cell differentiation |
GO:0035194 | 0 | 9.3824 | 3.5505 | 27 | 234 | posttranscriptional gene silencing by RNA |
GO:0006333 | 0 | 14.6276 | 1.752 | 20 | 122 | chromatin assembly or disassembly |
GO:0034080 | 0 | 34.3433 | 0.6373 | 14 | 42 | CENP-A containing nucleosome assembly |
GO:0045934 | 0 | 3.7911 | 21.1055 | 63 | 1391 | negative regulation of nucleobase-containing compound metabolic process |
GO:1904837 | 0 | 32.0498 | 0.6676 | 14 | 44 | beta-catenin-TCF complex assembly |
GO:0034654 | 0 | 2.7578 | 63.1345 | 119 | 4161 | nucleobase-containing compound biosynthetic process |
GO:0045892 | 0 | 7.215 | 4.6981 | 28 | 337 | negative regulation of transcription, DNA-templated |
GO:0034724 | 0 | 24.0223 | 0.8193 | 14 | 54 | DNA replication-independent nucleosome organization |
GO:0016233 | 0 | 23.4349 | 0.8345 | 14 | 55 | telomere capping |
GO:0009890 | 0 | 3.3085 | 24.6863 | 65 | 1627 | negative regulation of biosynthetic process |
GO:0017148 | 0 | 6.547 | 4.8857 | 27 | 322 | negative regulation of translation |
GO:1903707 | 0 | 11.2684 | 1.9572 | 18 | 130 | negative regulation of hemopoiesis |
GO:0006303 | 0 | 15.7317 | 1.138 | 14 | 75 | double-strand break repair via nonhomologous end joining |
GO:0043044 | 0 | 14.9914 | 1.1835 | 14 | 78 | ATP-dependent chromatin remodeling |
GO:0051259 | 0 | 4.761 | 7.8596 | 32 | 518 | protein oligomerization |
GO:0048534 | 0 | 3.8501 | 12.2525 | 40 | 819 | hematopoietic or lymphoid organ development |
GO:0010628 | 0 | 3.0397 | 23.5954 | 58 | 1714 | positive regulation of gene expression |
GO:0045944 | 0 | 3.3703 | 16.5688 | 47 | 1092 | positive regulation of transcription from RNA polymerase II promoter |
GO:0038111 | 0 | 24.1169 | 0.5766 | 10 | 38 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 23.2839 | 0.5917 | 10 | 39 | response to interleukin-7 |
GO:0034645 | 0 | 2.2403 | 75.6674 | 122 | 4987 | cellular macromolecule biosynthetic process |
GO:0051254 | 0 | 2.8836 | 22.3345 | 54 | 1472 | positive regulation of RNA metabolic process |
GO:0032502 | 0 | 2.3221 | 69.0527 | 112 | 4881 | developmental process |
GO:1903508 | 0 | 2.9025 | 21.2573 | 52 | 1401 | positive regulation of nucleic acid-templated transcription |
GO:0097659 | 0 | 2.6711 | 29.999 | 63 | 2289 | nucleic acid-templated transcription |
GO:0045652 | 0 | 15.2476 | 0.8167 | 10 | 57 | regulation of megakaryocyte differentiation |
GO:0034248 | 0 | 3.8678 | 8.2086 | 28 | 541 | regulation of cellular amide metabolic process |
GO:0007389 | 0 | 4.3766 | 6.2041 | 24 | 412 | pattern specification process |
GO:1901576 | 0 | 2.0162 | 94.0114 | 136 | 6196 | organic substance biosynthetic process |
GO:0031328 | 0 | 2.4428 | 26.9168 | 56 | 1774 | positive regulation of cellular biosynthetic process |
GO:0010608 | 0 | 3.4156 | 9.5589 | 29 | 630 | posttranscriptional regulation of gene expression |
GO:0009790 | 0 | 2.9211 | 14.3991 | 37 | 949 | embryo development |
GO:0002251 | 0 | 23.3508 | 0.4097 | 7 | 27 | organ or tissue specific immune response |
GO:0002227 | 0 | 33.2365 | 0.2731 | 6 | 18 | innate immune response in mucosa |
GO:0010557 | 0 | 2.4306 | 24.8381 | 52 | 1637 | positive regulation of macromolecule biosynthetic process |
GO:0034622 | 0 | 2.8171 | 15.3247 | 38 | 1010 | cellular macromolecular complex assembly |
GO:0045596 | 0 | 4.4162 | 5.0707 | 20 | 345 | negative regulation of cell differentiation |
GO:0007275 | 0 | 2.1254 | 52.6881 | 86 | 3967 | multicellular organism development |
GO:0006725 | 0 | 1.9313 | 88.9588 | 128 | 5863 | cellular aromatic compound metabolic process |
GO:1901360 | 0 | 1.9192 | 92.0996 | 131 | 6070 | organic cyclic compound metabolic process |
GO:0006352 | 0 | 4.9327 | 3.6112 | 16 | 238 | DNA-templated transcription, initiation |
GO:2001141 | 0 | 2.3014 | 29.5945 | 56 | 2380 | regulation of RNA biosynthetic process |
GO:0006355 | 0 | 2.2978 | 29.632 | 56 | 2389 | regulation of transcription, DNA-templated |
GO:0051239 | 0 | 2.0575 | 41.7124 | 72 | 2779 | regulation of multicellular organismal process |
GO:0000122 | 0 | 2.9081 | 11.9107 | 31 | 785 | negative regulation of transcription from RNA polymerase II promoter |
GO:0046483 | 0 | 1.8572 | 88.3823 | 125 | 5825 | heterocycle metabolic process |
GO:0009953 | 0 | 7.9161 | 1.4414 | 10 | 95 | dorsal/ventral pattern formation |
GO:0009952 | 0 | 5.0638 | 3.0649 | 14 | 202 | anterior/posterior pattern specification |
GO:0002376 | 0 | 1.9617 | 40.4965 | 68 | 2669 | immune system process |
GO:0009889 | 0 | 2.1006 | 34.1467 | 59 | 2749 | regulation of biosynthetic process |
GO:0061844 | 0 | 11.3757 | 0.7283 | 7 | 48 | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO:0043043 | 0 | 2.7106 | 11.8197 | 29 | 779 | peptide biosynthetic process |
GO:0048665 | 0 | 14.758 | 0.5007 | 6 | 33 | neuron fate specification |
GO:0034641 | 0 | 1.7313 | 97.0612 | 130 | 6397 | cellular nitrogen compound metabolic process |
GO:0019731 | 0 | 13.2797 | 0.5462 | 6 | 36 | antibacterial humoral response |
GO:0051248 | 0 | 2.2664 | 19.1786 | 39 | 1264 | negative regulation of protein metabolic process |
GO:0019219 | 0 | 2.0368 | 33.5175 | 57 | 2712 | regulation of nucleobase-containing compound metabolic process |
GO:0016070 | 1e-04 | 1.8929 | 39.6479 | 63 | 3042 | RNA metabolic process |
GO:0006334 | 1e-04 | 6.4437 | 1.3726 | 8 | 100 | nucleosome assembly |
GO:0009954 | 1e-04 | 12.7193 | 0.4704 | 5 | 31 | proximal/distal pattern formation |
GO:1903706 | 1e-04 | 3.5541 | 4.2607 | 14 | 303 | regulation of hemopoiesis |
GO:0007498 | 1e-04 | 5.2802 | 1.8663 | 9 | 123 | mesoderm development |
GO:0003357 | 1e-04 | 49.2664 | 0.1062 | 3 | 7 | noradrenergic neuron differentiation |
GO:0070271 | 2e-04 | 2.0179 | 21.2724 | 39 | 1402 | protein complex biogenesis |
GO:0001501 | 2e-04 | 2.7836 | 7.3589 | 19 | 485 | skeletal system development |
GO:0048565 | 2e-04 | 4.9725 | 1.9725 | 9 | 130 | digestive tract development |
GO:0043009 | 2e-04 | 2.6864 | 8.0313 | 20 | 535 | chordate embryonic development |
GO:0048485 | 3e-04 | 15.5071 | 0.3186 | 4 | 21 | sympathetic nervous system development |
GO:0042538 | 3e-04 | 32.8402 | 0.1366 | 3 | 9 | hyperosmotic salinity response |
GO:0048664 | 3e-04 | 32.8402 | 0.1366 | 3 | 9 | neuron fate determination |
GO:0003211 | 4e-04 | 28.147 | 0.1517 | 3 | 10 | cardiac ventricle formation |
GO:0042756 | 4e-04 | 28.147 | 0.1517 | 3 | 10 | drinking behavior |
GO:0051173 | 4e-04 | 1.6812 | 43.607 | 65 | 2874 | positive regulation of nitrogen compound metabolic process |
GO:0048523 | 5e-04 | 1.6463 | 53.0903 | 75 | 3863 | negative regulation of cellular process |
GO:0048484 | 5e-04 | 24.627 | 0.1669 | 3 | 11 | enteric nervous system development |
GO:0090084 | 5e-04 | 24.627 | 0.1669 | 3 | 11 | negative regulation of inclusion body assembly |
GO:0043010 | 6e-04 | 3.1141 | 4.4608 | 13 | 294 | camera-type eye development |
GO:0060249 | 6e-04 | 2.8307 | 5.6595 | 15 | 373 | anatomical structure homeostasis |
GO:0007631 | 7e-04 | 5.1717 | 1.4698 | 7 | 98 | feeding behavior |
GO:0001546 | 7e-04 | 130.8653 | 0.0455 | 2 | 3 | preantral ovarian follicle growth |
GO:0002125 | 7e-04 | 130.8653 | 0.0455 | 2 | 3 | maternal aggressive behavior |
GO:0055014 | 7e-04 | 130.8653 | 0.0455 | 2 | 3 | atrial cardiac muscle cell development |
GO:0070370 | 7e-04 | 130.8653 | 0.0455 | 2 | 3 | cellular heat acclimation |
GO:0070434 | 7e-04 | 130.8653 | 0.0455 | 2 | 3 | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway |
GO:0060272 | 7e-04 | 21.8893 | 0.1821 | 3 | 12 | embryonic skeletal joint morphogenesis |
GO:0007218 | 9e-04 | 4.9453 | 1.5325 | 7 | 101 | neuropeptide signaling pathway |
GO:0021978 | 9e-04 | 19.6992 | 0.1972 | 3 | 13 | telencephalon regionalization |
GO:0050830 | 0.001 | 5.7597 | 1.138 | 6 | 75 | defense response to Gram-positive bacterium |
GO:0007423 | 0.001 | 2.4417 | 7.8596 | 18 | 518 | sensory organ development |
GO:0060485 | 0.001 | 3.2745 | 3.5808 | 11 | 236 | mesenchyme development |
GO:0060255 | 0.001 | 1.6765 | 42.5049 | 61 | 3282 | regulation of macromolecule metabolic process |
GO:0014706 | 0.0011 | 2.7731 | 5.3712 | 14 | 354 | striated muscle tissue development |
GO:0060322 | 0.0011 | 2.1974 | 10.6969 | 22 | 705 | head development |
GO:0002065 | 0.0012 | 4.6941 | 1.6083 | 7 | 106 | columnar/cuboidal epithelial cell differentiation |
GO:0002317 | 0.0013 | 65.4286 | 0.0607 | 2 | 4 | plasma cell differentiation |
GO:0021764 | 0.0013 | 65.4286 | 0.0607 | 2 | 4 | amygdala development |
GO:0090063 | 0.0013 | 65.4286 | 0.0607 | 2 | 4 | positive regulation of microtubule nucleation |
GO:0030902 | 0.0015 | 3.9713 | 2.1546 | 8 | 142 | hindbrain development |
GO:0035108 | 0.0018 | 3.8272 | 2.2304 | 8 | 147 | limb morphogenesis |
GO:0044238 | 0.0019 | 1.5052 | 154.0203 | 176 | 10151 | primary metabolic process |
GO:2000738 | 0.002 | 14.0673 | 0.2579 | 3 | 17 | positive regulation of stem cell differentiation |
GO:0048536 | 0.0021 | 8.2305 | 0.5462 | 4 | 36 | spleen development |
GO:0048562 | 0.0021 | 3.4085 | 2.8055 | 9 | 190 | embryonic organ morphogenesis |
GO:0045595 | 0.0021 | 1.9639 | 14.238 | 26 | 1036 | regulation of cell differentiation |
GO:0048645 | 0.0021 | 6.0019 | 0.9104 | 5 | 60 | animal organ formation |
GO:0048880 | 0.0022 | 43.6163 | 0.0759 | 2 | 5 | sensory system development |
GO:0060023 | 0.0022 | 43.6163 | 0.0759 | 2 | 5 | soft palate development |
GO:0061743 | 0.0022 | 43.6163 | 0.0759 | 2 | 5 | motor learning |
GO:2000609 | 0.0022 | 43.6163 | 0.0759 | 2 | 5 | regulation of thyroid hormone generation |
GO:2000851 | 0.0022 | 43.6163 | 0.0759 | 2 | 5 | positive regulation of glucocorticoid secretion |
GO:0014032 | 0.0023 | 5.8943 | 0.9255 | 5 | 61 | neural crest cell development |
GO:0032094 | 0.0023 | 7.9805 | 0.5614 | 4 | 37 | response to food |
GO:0071392 | 0.0023 | 7.9805 | 0.5614 | 4 | 37 | cellular response to estradiol stimulus |
GO:0071542 | 0.0023 | 7.9805 | 0.5614 | 4 | 37 | dopaminergic neuron differentiation |
GO:0014003 | 0.0025 | 7.7453 | 0.5766 | 4 | 38 | oligodendrocyte development |
GO:2000648 | 0.0025 | 7.7453 | 0.5766 | 4 | 38 | positive regulation of stem cell proliferation |
GO:0051961 | 0.0026 | 2.8724 | 4.0512 | 11 | 267 | negative regulation of nervous system development |
GO:0045665 | 0.0028 | 3.257 | 2.9284 | 9 | 193 | negative regulation of neuron differentiation |
GO:0001759 | 0.0028 | 12.3074 | 0.2883 | 3 | 19 | organ induction |
GO:0003215 | 0.0028 | 12.3074 | 0.2883 | 3 | 19 | cardiac right ventricle morphogenesis |
GO:0065007 | 0.0028 | 1.5276 | 172.1216 | 192 | 11344 | biological regulation |
GO:0061061 | 0.0028 | 2.1508 | 9.3617 | 19 | 617 | muscle structure development |
GO:0071345 | 0.0032 | 1.9464 | 13.1094 | 24 | 864 | cellular response to cytokine stimulus |
GO:0071822 | 0.0032 | 1.6866 | 24.9291 | 39 | 1643 | protein complex subunit organization |
GO:0002089 | 0.0033 | 11.5827 | 0.3035 | 3 | 20 | lens morphogenesis in camera-type eye |
GO:0042403 | 0.0033 | 11.5827 | 0.3035 | 3 | 20 | thyroid hormone metabolic process |
GO:0060065 | 0.0033 | 11.5827 | 0.3035 | 3 | 20 | uterus development |
GO:0022605 | 0.0033 | 32.7102 | 0.091 | 2 | 6 | oogenesis stage |
GO:0060022 | 0.0033 | 32.7102 | 0.091 | 2 | 6 | hard palate development |
GO:0072049 | 0.0033 | 32.7102 | 0.091 | 2 | 6 | comma-shaped body morphogenesis |
GO:1901533 | 0.0033 | 32.7102 | 0.091 | 2 | 6 | negative regulation of hematopoietic progenitor cell differentiation |
GO:0010605 | 0.0034 | 1.794 | 18.6736 | 31 | 1348 | negative regulation of macromolecule metabolic process |
GO:0071772 | 0.0037 | 3.3846 | 2.5035 | 8 | 165 | response to BMP |
GO:0007617 | 0.0037 | 10.9385 | 0.3186 | 3 | 21 | mating behavior |
GO:0035809 | 0.0037 | 10.9385 | 0.3186 | 3 | 21 | regulation of urine volume |
GO:2000678 | 0.0037 | 10.9385 | 0.3186 | 3 | 21 | negative regulation of transcription regulatory region DNA binding |
GO:0030900 | 0.0038 | 2.482 | 5.5229 | 13 | 364 | forebrain development |
GO:0021954 | 0.0039 | 5.155 | 1.0469 | 5 | 69 | central nervous system neuron development |
GO:0048522 | 0.004 | 1.4408 | 73.2549 | 93 | 4828 | positive regulation of cellular process |
GO:0048513 | 0.0041 | 1.7258 | 22.2334 | 35 | 1824 | animal organ development |
GO:0006950 | 0.0041 | 1.4783 | 54.8805 | 73 | 3617 | response to stress |
GO:0035813 | 0.0043 | 10.3622 | 0.3338 | 3 | 22 | regulation of renal sodium excretion |
GO:0044458 | 0.0043 | 10.3622 | 0.3338 | 3 | 22 | motile cilium assembly |
GO:0021517 | 0.0044 | 6.5811 | 0.6676 | 4 | 44 | ventral spinal cord development |
GO:0055078 | 0.0044 | 6.5811 | 0.6676 | 4 | 44 | sodium ion homeostasis |
GO:0044703 | 0.0044 | 1.867 | 14.217 | 25 | 937 | multi-organism reproductive process |
GO:0010721 | 0.0045 | 2.6608 | 4.3546 | 11 | 287 | negative regulation of cell development |
GO:0060017 | 0.0046 | 26.1665 | 0.1062 | 2 | 7 | parathyroid gland development |
GO:2001237 | 0.0046 | 4.1328 | 1.5476 | 6 | 102 | negative regulation of extrinsic apoptotic signaling pathway |
GO:0042127 | 0.0046 | 1.6664 | 23.8215 | 37 | 1570 | regulation of cell proliferation |
GO:0048736 | 0.0046 | 3.2588 | 2.5946 | 8 | 171 | appendage development |
GO:0008217 | 0.0048 | 3.2387 | 2.6097 | 8 | 172 | regulation of blood pressure |
GO:0032504 | 0.0048 | 1.9328 | 12.0473 | 22 | 794 | multicellular organism reproduction |
GO:0022607 | 0.0049 | 1.5166 | 41.8166 | 58 | 2756 | cellular component assembly |
GO:0043576 | 0.0049 | 9.8434 | 0.349 | 3 | 23 | regulation of respiratory gaseous exchange |
GO:0060429 | 0.0049 | 1.7872 | 16.6799 | 28 | 1117 | epithelium development |
GO:0035050 | 0.005 | 4.8505 | 1.1076 | 5 | 73 | embryonic heart tube development |
GO:0042026 | 0.0055 | 9.3741 | 0.3642 | 3 | 24 | protein refolding |
GO:0001764 | 0.0055 | 3.4866 | 2.1242 | 7 | 140 | neuron migration |
GO:0030154 | 0.0056 | 1.902 | 13.1009 | 23 | 1113 | cell differentiation |
GO:0048699 | 0.0057 | 1.7327 | 18.4547 | 30 | 1241 | generation of neurons |
GO:0006281 | 0.0058 | 2.1428 | 7.8596 | 16 | 518 | DNA repair |
GO:0055010 | 0.006 | 5.9813 | 0.7283 | 4 | 48 | ventricular cardiac muscle tissue morphogenesis |
GO:0007217 | 0.006 | 21.8041 | 0.1214 | 2 | 8 | tachykinin receptor signaling pathway |
GO:0045924 | 0.006 | 21.8041 | 0.1214 | 2 | 8 | regulation of female receptivity |
GO:0070474 | 0.006 | 21.8041 | 0.1214 | 2 | 8 | positive regulation of uterine smooth muscle contraction |
GO:0072050 | 0.006 | 21.8041 | 0.1214 | 2 | 8 | S-shaped body morphogenesis |
GO:1903265 | 0.006 | 21.8041 | 0.1214 | 2 | 8 | positive regulation of tumor necrosis factor-mediated signaling pathway |
GO:0003309 | 0.0062 | 8.9475 | 0.3793 | 3 | 25 | type B pancreatic cell differentiation |
GO:0060037 | 0.0062 | 8.9475 | 0.3793 | 3 | 25 | pharyngeal system development |
GO:0021953 | 0.0064 | 4.5638 | 1.1713 | 5 | 79 | central nervous system neuron differentiation |
GO:0001708 | 0.0064 | 5.8554 | 0.7417 | 4 | 50 | cell fate specification |
GO:0021545 | 0.0064 | 5.848 | 0.7435 | 4 | 49 | cranial nerve development |
GO:0048592 | 0.0064 | 3.384 | 2.1849 | 7 | 144 | eye morphogenesis |
GO:0021987 | 0.0066 | 3.813 | 1.669 | 6 | 110 | cerebral cortex development |
GO:0051101 | 0.0072 | 3.7405 | 1.6994 | 6 | 112 | regulation of DNA binding |
GO:0070542 | 0.0074 | 4.3959 | 1.2138 | 5 | 80 | response to fatty acid |
GO:0048704 | 0.0074 | 4.3897 | 1.215 | 5 | 81 | embryonic skeletal system morphogenesis |
GO:0016331 | 0.0075 | 3.2871 | 2.2456 | 7 | 148 | morphogenesis of embryonic epithelium |
GO:0007276 | 0.0075 | 1.9872 | 9.5286 | 18 | 628 | gamete generation |
GO:0048468 | 0.0076 | 1.6113 | 24.6006 | 37 | 1667 | cell development |
GO:0003139 | 0.0077 | 18.688 | 0.1366 | 2 | 9 | secondary heart field specification |
GO:0006348 | 0.0077 | 18.688 | 0.1366 | 2 | 9 | chromatin silencing at telomere |
GO:0014049 | 0.0077 | 18.688 | 0.1366 | 2 | 9 | positive regulation of glutamate secretion |
GO:0014807 | 0.0077 | 18.688 | 0.1366 | 2 | 9 | regulation of somitogenesis |
GO:0043084 | 0.0077 | 18.688 | 0.1366 | 2 | 9 | penile erection |
GO:0061004 | 0.0077 | 18.688 | 0.1366 | 2 | 9 | pattern specification involved in kidney development |
GO:0070424 | 0.0077 | 18.688 | 0.1366 | 2 | 9 | regulation of nucleotide-binding oligomerization domain containing signaling pathway |
GO:2000833 | 0.0077 | 18.688 | 0.1366 | 2 | 9 | positive regulation of steroid hormone secretion |
GO:0060562 | 0.0077 | 2.461 | 4.6884 | 11 | 309 | epithelial tube morphogenesis |
GO:0021515 | 0.0079 | 5.4815 | 0.789 | 4 | 52 | cell differentiation in spinal cord |
GO:0035176 | 0.0079 | 5.4815 | 0.789 | 4 | 52 | social behavior |
GO:0015837 | 0.0082 | 4.2812 | 1.2442 | 5 | 82 | amine transport |
GO:1902692 | 0.0085 | 7.8723 | 0.4248 | 3 | 28 | regulation of neuroblast proliferation |
GO:0042475 | 0.0086 | 4.226 | 1.2594 | 5 | 83 | odontogenesis of dentin-containing tooth |
GO:0048644 | 0.0086 | 4.226 | 1.2594 | 5 | 83 | muscle organ morphogenesis |
GO:0048663 | 0.0087 | 7.8105 | 0.4268 | 3 | 29 | neuron fate commitment |
GO:0030509 | 0.0089 | 3.1736 | 2.3215 | 7 | 153 | BMP signaling pathway |
GO:0021879 | 0.009 | 5.2616 | 0.8193 | 4 | 54 | forebrain neuron differentiation |
GO:0003231 | 0.0092 | 3.5388 | 1.7904 | 6 | 118 | cardiac ventricle development |
GO:0001825 | 0.0094 | 7.569 | 0.44 | 3 | 29 | blastocyst formation |
GO:0045778 | 0.0095 | 4.1198 | 1.2897 | 5 | 85 | positive regulation of ossification |
GO:0007417 | 0.0095 | 1.901 | 10.5187 | 19 | 721 | central nervous system development |
GO:1902093 | 0.0095 | 16.351 | 0.1517 | 2 | 10 | positive regulation of flagellated sperm motility |
GO:1990403 | 0.0095 | 16.351 | 0.1517 | 2 | 10 | embryonic brain development |
GO:0035270 | 0.0096 | 3.5043 | 1.8068 | 6 | 120 | endocrine system development |
GO:0033993 | 0.0098 | 1.8316 | 12.0709 | 21 | 808 | response to lipid |
GO:0048646 | 0.0099 | 1.7808 | 13.6247 | 23 | 923 | anatomical structure formation involved in morphogenesis |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:1901750 | 0 | 85.0899 | 0.0948 | 4 | 8 | leukotriene D4 biosynthetic process |
GO:0006751 | 0 | 68.0677 | 0.1067 | 4 | 9 | glutathione catabolic process |
GO:0018003 | 1e-04 | Inf | 0.0237 | 2 | 2 | peptidyl-lysine N6-acetylation |
GO:0031204 | 1e-04 | Inf | 0.0237 | 2 | 2 | posttranslational protein targeting to membrane, translocation |
GO:0006342 | 3e-04 | 5.9563 | 1.2804 | 7 | 108 | chromatin silencing |
GO:0006691 | 4e-04 | 13.0729 | 0.3557 | 4 | 30 | leukotriene metabolic process |
GO:0006518 | 6e-04 | 2.2882 | 10.9192 | 23 | 921 | peptide metabolic process |
GO:0040029 | 6e-04 | 4.6056 | 1.8694 | 8 | 163 | regulation of gene expression, epigenetic |
GO:0035195 | 0.0016 | 3.5439 | 2.7031 | 9 | 228 | gene silencing by miRNA |
GO:0016441 | 0.002 | 3.4326 | 2.7861 | 9 | 235 | posttranscriptional gene silencing |
GO:0046456 | 0.0021 | 8.0847 | 0.5454 | 4 | 46 | icosanoid biosynthetic process |
GO:2000767 | 0.0028 | 33.6775 | 0.083 | 2 | 7 | positive regulation of cytoplasmic translation |
GO:0005980 | 0.0031 | 11.5292 | 0.2964 | 3 | 25 | glycogen catabolic process |
GO:0031047 | 0.0037 | 3.111 | 3.0588 | 9 | 258 | gene silencing by RNA |
GO:0006575 | 0.0038 | 3.7374 | 1.9842 | 7 | 169 | cellular modified amino acid metabolic process |
GO:0000272 | 0.0043 | 10.1438 | 0.332 | 3 | 28 | polysaccharide catabolic process |
GO:0043604 | 0.0065 | 1.9869 | 10.1604 | 19 | 857 | amide biosynthetic process |
GO:0006600 | 0.0072 | 18.7051 | 0.1304 | 2 | 11 | creatine metabolic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 252.1885 | 0.4226 | 24 | 32 | DNA replication-dependent nucleosome assembly |
GO:0000183 | 0 | 144.0539 | 0.5019 | 24 | 38 | chromatin silencing at rDNA |
GO:0051290 | 0 | 111.115 | 0.5811 | 25 | 44 | protein heterotetramerization |
GO:0045815 | 0 | 38.299 | 1.0566 | 25 | 80 | positive regulation of gene expression, epigenetic |
GO:0045653 | 0 | 279.6517 | 0.2377 | 14 | 18 | negative regulation of megakaryocyte differentiation |
GO:1902036 | 0 | 25.4251 | 1.3603 | 24 | 103 | regulation of hematopoietic stem cell differentiation |
GO:0060964 | 0 | 24.4904 | 1.4 | 24 | 106 | regulation of gene silencing by miRNA |
GO:0045814 | 0 | 21.2188 | 1.6377 | 25 | 124 | negative regulation of gene expression, epigenetic |
GO:0031497 | 0 | 17.5413 | 1.9943 | 26 | 151 | chromatin assembly |
GO:0048863 | 0 | 12.8863 | 3.0346 | 30 | 236 | stem cell differentiation |
GO:0060968 | 0 | 18.9169 | 1.7169 | 24 | 130 | regulation of gene silencing |
GO:0002244 | 0 | 13.4698 | 2.3822 | 25 | 182 | hematopoietic progenitor cell differentiation |
GO:0032200 | 0 | 14.0892 | 2.1924 | 24 | 166 | telomere organization |
GO:0065004 | 0 | 11.4497 | 2.9848 | 27 | 226 | protein-DNA complex assembly |
GO:0035194 | 0 | 11.0016 | 3.0905 | 27 | 234 | posttranscriptional gene silencing by RNA |
GO:0034080 | 0 | 39.8905 | 0.5547 | 14 | 42 | CENP-A containing nucleosome assembly |
GO:1904837 | 0 | 37.2265 | 0.5811 | 14 | 44 | beta-catenin-TCF complex assembly |
GO:0030099 | 0 | 7.4126 | 5.1244 | 31 | 388 | myeloid cell differentiation |
GO:0071103 | 0 | 8.7732 | 3.6188 | 26 | 274 | DNA conformation change |
GO:0034724 | 0 | 27.9025 | 0.7132 | 14 | 54 | DNA replication-independent nucleosome organization |
GO:0016233 | 0 | 27.2202 | 0.7264 | 14 | 55 | telomere capping |
GO:0017148 | 0 | 7.6769 | 4.2527 | 27 | 322 | negative regulation of translation |
GO:1902679 | 0 | 4.0824 | 15.3204 | 50 | 1160 | negative regulation of RNA biosynthetic process |
GO:0045892 | 0 | 7.5498 | 4.1761 | 26 | 337 | negative regulation of transcription, DNA-templated |
GO:0045934 | 0 | 3.6945 | 18.3712 | 54 | 1391 | negative regulation of nucleobase-containing compound metabolic process |
GO:0006303 | 0 | 18.2727 | 0.9905 | 14 | 75 | double-strand break repair via nonhomologous end joining |
GO:1903707 | 0 | 12.2403 | 1.7016 | 17 | 130 | negative regulation of hemopoiesis |
GO:0043044 | 0 | 17.4129 | 1.0302 | 14 | 78 | ATP-dependent chromatin remodeling |
GO:0051259 | 0 | 5.3889 | 6.8413 | 31 | 518 | protein oligomerization |
GO:0048534 | 0 | 4.2767 | 11.2922 | 40 | 855 | hematopoietic or lymphoid organ development |
GO:0009890 | 0 | 3.3305 | 21.4881 | 57 | 1627 | negative regulation of biosynthetic process |
GO:0034654 | 0 | 2.5702 | 54.9552 | 100 | 4161 | nucleobase-containing compound biosynthetic process |
GO:0038111 | 0 | 27.9373 | 0.5019 | 10 | 38 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 26.9722 | 0.5151 | 10 | 39 | response to interleukin-7 |
GO:0034248 | 0 | 4.7359 | 7.1451 | 29 | 541 | regulation of cellular amide metabolic process |
GO:0009893 | 0 | 2.5386 | 42.5404 | 82 | 3221 | positive regulation of metabolic process |
GO:0006352 | 0 | 7.0137 | 3.1433 | 19 | 238 | DNA-templated transcription, initiation |
GO:0097659 | 0 | 2.8693 | 27.6914 | 61 | 2289 | nucleic acid-templated transcription |
GO:0045596 | 0 | 5.7865 | 4.4018 | 22 | 345 | negative regulation of cell differentiation |
GO:0010608 | 0 | 4.1795 | 8.3205 | 30 | 630 | posttranscriptional regulation of gene expression |
GO:0045652 | 0 | 17.8378 | 0.7046 | 10 | 57 | regulation of megakaryocyte differentiation |
GO:0034728 | 0 | 10.6459 | 1.3255 | 12 | 107 | nucleosome organization |
GO:0034645 | 0 | 2.1863 | 65.8643 | 105 | 4987 | cellular macromolecule biosynthetic process |
GO:0048869 | 0 | 2.2426 | 47.6792 | 82 | 3802 | cellular developmental process |
GO:0051248 | 0 | 2.7712 | 16.6939 | 40 | 1264 | negative regulation of protein metabolic process |
GO:0043043 | 0 | 3.1836 | 10.2884 | 29 | 779 | peptide biosynthetic process |
GO:0010628 | 0 | 2.5099 | 20.1037 | 43 | 1714 | positive regulation of gene expression |
GO:1901576 | 0 | 1.9241 | 81.8318 | 116 | 6196 | organic substance biosynthetic process |
GO:0016070 | 0 | 2.1426 | 36.5665 | 63 | 3042 | RNA metabolic process |
GO:0048665 | 0 | 17.0516 | 0.4358 | 6 | 33 | neuron fate specification |
GO:0046483 | 0 | 1.8616 | 76.9319 | 109 | 5825 | heterocycle metabolic process |
GO:1901360 | 0 | 1.8444 | 80.1677 | 112 | 6070 | organic cyclic compound metabolic process |
GO:0070271 | 0 | 2.39 | 18.5165 | 39 | 1402 | protein complex biogenesis |
GO:0006725 | 0 | 1.8081 | 77.4338 | 108 | 5863 | cellular aromatic compound metabolic process |
GO:0007389 | 0 | 3.5508 | 5.5602 | 18 | 421 | pattern specification process |
GO:0034641 | 0 | 1.7907 | 84.4865 | 115 | 6397 | cellular nitrogen compound metabolic process |
GO:0045944 | 0 | 2.4751 | 14.4223 | 32 | 1092 | positive regulation of transcription from RNA polymerase II promoter |
GO:2001141 | 0 | 2.1547 | 25.9739 | 47 | 2380 | regulation of RNA biosynthetic process |
GO:0006355 | 0 | 2.1331 | 26.1644 | 47 | 2389 | regulation of transcription, DNA-templated |
GO:0060249 | 0 | 3.5375 | 4.9263 | 16 | 373 | anatomical structure homeostasis |
GO:0003278 | 0 | 75.7594 | 0.0792 | 3 | 6 | apoptotic process involved in heart morphogenesis |
GO:0002376 | 1e-04 | 1.9034 | 35.25 | 58 | 2669 | immune system process |
GO:0009889 | 1e-04 | 2.0232 | 29.6439 | 50 | 2749 | regulation of biosynthetic process |
GO:0003357 | 1e-04 | 56.816 | 0.0925 | 3 | 7 | noradrenergic neuron differentiation |
GO:1903706 | 1e-04 | 3.8353 | 3.6789 | 13 | 303 | regulation of hemopoiesis |
GO:0045823 | 1e-04 | 12.7254 | 0.4623 | 5 | 35 | positive regulation of heart contraction |
GO:0051254 | 1e-04 | 2.1191 | 19.441 | 37 | 1472 | positive regulation of RNA metabolic process |
GO:0071822 | 1e-04 | 2.062 | 21.6994 | 40 | 1643 | protein complex subunit organization |
GO:0014036 | 2e-04 | Inf | 0.0264 | 2 | 2 | neural crest cell fate specification |
GO:1903508 | 2e-04 | 2.0922 | 18.5033 | 35 | 1401 | positive regulation of nucleic acid-templated transcription |
GO:0007530 | 2e-04 | 16.8994 | 0.2906 | 4 | 22 | sex determination |
GO:0048664 | 2e-04 | 37.8726 | 0.1189 | 3 | 9 | neuron fate determination |
GO:0065003 | 2e-04 | 1.9689 | 23.2183 | 41 | 1758 | macromolecular complex assembly |
GO:0019219 | 2e-04 | 1.9235 | 29.3278 | 48 | 2712 | regulation of nucleobase-containing compound metabolic process |
GO:0009953 | 3e-04 | 6.1097 | 1.2547 | 7 | 95 | dorsal/ventral pattern formation |
GO:0000122 | 3e-04 | 2.4056 | 10.3677 | 23 | 785 | negative regulation of transcription from RNA polymerase II promoter |
GO:0048484 | 3e-04 | 28.4009 | 0.1453 | 3 | 11 | enteric nervous system development |
GO:0090084 | 3e-04 | 28.4009 | 0.1453 | 3 | 11 | negative regulation of inclusion body assembly |
GO:0009888 | 4e-04 | 1.9714 | 20.8016 | 37 | 1620 | tissue development |
GO:0032268 | 4e-04 | 1.7801 | 33.6387 | 53 | 2547 | regulation of cellular protein metabolic process |
GO:0048562 | 4e-04 | 3.4449 | 3.7376 | 12 | 283 | embryonic organ morphogenesis |
GO:2000738 | 4e-04 | 25.4794 | 0.1571 | 3 | 12 | positive regulation of stem cell differentiation |
GO:0003207 | 5e-04 | 25.2437 | 0.1585 | 3 | 12 | cardiac chamber formation |
GO:0071345 | 5e-04 | 2.2773 | 11.411 | 24 | 864 | cellular response to cytokine stimulus |
GO:0031328 | 5e-04 | 1.8889 | 23.4296 | 40 | 1774 | positive regulation of cellular biosynthetic process |
GO:0001546 | 5e-04 | 150.8263 | 0.0396 | 2 | 3 | preantral ovarian follicle growth |
GO:0055014 | 5e-04 | 150.8263 | 0.0396 | 2 | 3 | atrial cardiac muscle cell development |
GO:0070370 | 5e-04 | 150.8263 | 0.0396 | 2 | 3 | cellular heat acclimation |
GO:0070434 | 5e-04 | 150.8263 | 0.0396 | 2 | 3 | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway |
GO:0045137 | 6e-04 | 3.7924 | 2.8263 | 10 | 214 | development of primary sexual characteristics |
GO:0021781 | 6e-04 | 22.7179 | 0.1717 | 3 | 13 | glial cell fate commitment |
GO:0009954 | 7e-04 | 11.26 | 0.4094 | 4 | 31 | proximal/distal pattern formation |
GO:0007417 | 7e-04 | 2.1998 | 11.7808 | 24 | 892 | central nervous system development |
GO:0048608 | 8e-04 | 2.8764 | 5.2025 | 14 | 399 | reproductive structure development |
GO:0050878 | 8e-04 | 2.6502 | 6.4583 | 16 | 489 | regulation of body fluid levels |
GO:0045165 | 9e-04 | 3.563 | 2.9978 | 10 | 231 | cell fate commitment |
GO:0001501 | 9e-04 | 3.3034 | 3.5552 | 11 | 276 | skeletal system development |
GO:0002317 | 0.001 | 75.4085 | 0.0528 | 2 | 4 | plasma cell differentiation |
GO:0003219 | 0.001 | 75.4085 | 0.0528 | 2 | 4 | cardiac right ventricle formation |
GO:0021764 | 0.001 | 75.4085 | 0.0528 | 2 | 4 | amygdala development |
GO:0090063 | 0.001 | 75.4085 | 0.0528 | 2 | 4 | positive regulation of microtubule nucleation |
GO:0045665 | 0.0011 | 3.7706 | 2.549 | 9 | 193 | negative regulation of neuron differentiation |
GO:0065007 | 0.0012 | 1.6532 | 149.8225 | 170 | 11344 | biological regulation |
GO:0048598 | 0.0013 | 3.1627 | 3.7057 | 11 | 292 | embryonic morphogenesis |
GO:0048513 | 0.0013 | 1.8201 | 24.1126 | 39 | 2198 | animal organ development |
GO:0071542 | 0.0014 | 9.2092 | 0.4887 | 4 | 37 | dopaminergic neuron differentiation |
GO:0006281 | 0.0015 | 2.4925 | 6.8413 | 16 | 518 | DNA repair |
GO:0010557 | 0.0015 | 1.8168 | 21.6202 | 36 | 1637 | positive regulation of macromolecule biosynthetic process |
GO:0048880 | 0.0017 | 50.2692 | 0.066 | 2 | 5 | sensory system development |
GO:0051891 | 0.0017 | 50.2692 | 0.066 | 2 | 5 | positive regulation of cardioblast differentiation |
GO:0061743 | 0.0017 | 50.2692 | 0.066 | 2 | 5 | motor learning |
GO:2000026 | 0.0017 | 1.939 | 16.3475 | 29 | 1415 | regulation of multicellular organismal development |
GO:0048565 | 0.0017 | 4.3616 | 1.7169 | 7 | 130 | digestive tract development |
GO:0007276 | 0.0017 | 2.3148 | 8.2941 | 18 | 628 | gamete generation |
GO:0008285 | 0.0018 | 2.2554 | 8.9941 | 19 | 681 | negative regulation of cell proliferation |
GO:0043009 | 0.0018 | 2.4416 | 6.978 | 16 | 535 | chordate embryonic development |
GO:0007631 | 0.0018 | 5.0296 | 1.2831 | 6 | 98 | feeding behavior |
GO:0007283 | 0.0019 | 2.5104 | 6.3527 | 15 | 481 | spermatogenesis |
GO:0051705 | 0.0019 | 6.1452 | 0.8849 | 5 | 67 | multi-organism behavior |
GO:0045595 | 0.0021 | 2.0633 | 12.0527 | 23 | 1036 | regulation of cell differentiation |
GO:0032691 | 0.0022 | 13.3577 | 0.2641 | 3 | 20 | negative regulation of interleukin-1 beta production |
GO:0060065 | 0.0022 | 13.3577 | 0.2641 | 3 | 20 | uterus development |
GO:0007218 | 0.0022 | 4.8257 | 1.3339 | 6 | 101 | neuropeptide signaling pathway |
GO:0022605 | 0.0025 | 37.6995 | 0.0792 | 2 | 6 | oogenesis stage |
GO:1901533 | 0.0025 | 37.6995 | 0.0792 | 2 | 6 | negative regulation of hematopoietic progenitor cell differentiation |
GO:0048485 | 0.0025 | 12.6148 | 0.2774 | 3 | 21 | sympathetic nervous system development |
GO:0044238 | 0.0025 | 1.5321 | 134.0663 | 154 | 10151 | primary metabolic process |
GO:0035050 | 0.0028 | 5.6008 | 0.9641 | 5 | 73 | embryonic heart tube development |
GO:0032757 | 0.0029 | 7.4086 | 0.5943 | 4 | 45 | positive regulation of interleukin-8 production |
GO:0060255 | 0.003 | 1.6569 | 35.7809 | 51 | 3282 | regulation of macromolecule metabolic process |
GO:0043576 | 0.0033 | 11.3519 | 0.3038 | 3 | 23 | regulation of respiratory gaseous exchange |
GO:0035107 | 0.0034 | 3.8279 | 1.9415 | 7 | 147 | appendage morphogenesis |
GO:0061061 | 0.0035 | 2.2129 | 8.1488 | 17 | 617 | muscle structure development |
GO:1904995 | 0.0035 | 30.1577 | 0.0925 | 2 | 7 | negative regulation of leukocyte adhesion to vascular endothelial cell |
GO:0055010 | 0.0037 | 6.9022 | 0.6339 | 4 | 48 | ventricular cardiac muscle tissue morphogenesis |
GO:0042026 | 0.0037 | 10.8106 | 0.317 | 3 | 24 | protein refolding |
GO:0048103 | 0.0037 | 10.8106 | 0.317 | 3 | 24 | somatic stem cell division |
GO:0045682 | 0.0039 | 5.1448 | 1.0434 | 5 | 79 | regulation of epidermis development |
GO:0048519 | 0.0039 | 1.5697 | 43.9474 | 60 | 3885 | negative regulation of biological process |
GO:0021545 | 0.0039 | 6.7484 | 0.6472 | 4 | 49 | cranial nerve development |
GO:0060485 | 0.0042 | 3.0481 | 3.1169 | 9 | 236 | mesenchyme development |
GO:0060037 | 0.0042 | 10.3186 | 0.3302 | 3 | 25 | pharyngeal system development |
GO:0072282 | 0.0046 | 25.1299 | 0.1057 | 2 | 8 | metanephric nephron tubule morphogenesis |
GO:1903265 | 0.0046 | 25.1299 | 0.1057 | 2 | 8 | positive regulation of tumor necrosis factor-mediated signaling pathway |
GO:0009611 | 0.0047 | 2.1423 | 8.3998 | 17 | 636 | response to wounding |
GO:0007596 | 0.0047 | 2.6445 | 4.3848 | 11 | 332 | blood coagulation |
GO:0042475 | 0.0048 | 4.8797 | 1.0962 | 5 | 83 | odontogenesis of dentin-containing tooth |
GO:0048644 | 0.0048 | 4.8797 | 1.0962 | 5 | 83 | muscle organ morphogenesis |
GO:0010721 | 0.0049 | 2.7801 | 3.7905 | 10 | 287 | negative regulation of cell development |
GO:0046661 | 0.0051 | 3.5466 | 2.0867 | 7 | 158 | male sex differentiation |
GO:0021879 | 0.0056 | 6.0717 | 0.7132 | 4 | 54 | forebrain neuron differentiation |
GO:0048646 | 0.0057 | 1.8801 | 13.0195 | 23 | 999 | anatomical structure formation involved in morphogenesis |
GO:0060322 | 0.0058 | 2.0451 | 9.3111 | 18 | 705 | head development |
GO:0048865 | 0.0059 | 21.5386 | 0.1189 | 2 | 9 | stem cell fate commitment |
GO:0070424 | 0.0059 | 21.5386 | 0.1189 | 2 | 9 | regulation of nucleotide-binding oligomerization domain containing signaling pathway |
GO:0010812 | 0.0064 | 5.8374 | 0.7396 | 4 | 56 | negative regulation of cell-substrate adhesion |
GO:0071773 | 0.0064 | 3.388 | 2.1792 | 7 | 165 | cellular response to BMP stimulus |
GO:0044703 | 0.0064 | 1.8872 | 12.3751 | 22 | 937 | multi-organism reproductive process |
GO:0048705 | 0.0067 | 3.0501 | 2.7603 | 8 | 209 | skeletal system morphogenesis |
GO:0070887 | 0.0068 | 1.5208 | 38.2613 | 53 | 2897 | cellular response to chemical stimulus |
GO:0030326 | 0.0068 | 3.7826 | 1.6773 | 6 | 127 | embryonic limb morphogenesis |
GO:0032355 | 0.0068 | 3.7826 | 1.6773 | 6 | 127 | response to estradiol |
GO:0071396 | 0.007 | 2.1561 | 7.33 | 15 | 555 | cellular response to lipid |
GO:0090322 | 0.0071 | 8.4051 | 0.3962 | 3 | 30 | regulation of superoxide metabolic process |
GO:0001892 | 0.0071 | 4.4236 | 1.2019 | 5 | 91 | embryonic placenta development |
GO:0051241 | 0.0072 | 2.0997 | 8.0705 | 16 | 682 | negative regulation of multicellular organismal process |
GO:0001947 | 0.0072 | 5.6205 | 0.766 | 4 | 58 | heart looping |
GO:0010605 | 0.0073 | 1.7843 | 15.711 | 26 | 1348 | negative regulation of macromolecule metabolic process |
GO:0042756 | 0.0073 | 18.8451 | 0.1321 | 2 | 10 | drinking behavior |
GO:0014706 | 0.0076 | 2.4714 | 4.6753 | 11 | 354 | striated muscle tissue development |
GO:0060173 | 0.0077 | 3.2628 | 2.2584 | 7 | 171 | limb development |
GO:0097191 | 0.0081 | 2.9461 | 2.8528 | 8 | 216 | extrinsic apoptotic signaling pathway |
GO:0031110 | 0.0081 | 5.4191 | 0.7924 | 4 | 60 | regulation of microtubule polymerization or depolymerization |
GO:0060562 | 0.0081 | 2.572 | 4.081 | 10 | 309 | epithelial tube morphogenesis |
GO:0006641 | 0.0081 | 4.2737 | 1.2415 | 5 | 94 | triglyceride metabolic process |
GO:0033554 | 0.0083 | 1.6049 | 24.8163 | 37 | 1879 | cellular response to stress |
GO:0042127 | 0.0084 | 1.9004 | 11.1709 | 20 | 889 | regulation of cell proliferation |
GO:0021522 | 0.0085 | 7.8245 | 0.4226 | 3 | 32 | spinal cord motor neuron differentiation |
GO:1902742 | 0.0085 | 7.8245 | 0.4226 | 3 | 32 | apoptotic process involved in development |
GO:0014032 | 0.0086 | 5.3237 | 0.8056 | 4 | 61 | neural crest cell development |
GO:0007512 | 0.0088 | 16.7501 | 0.1453 | 2 | 11 | adult heart development |
GO:0031274 | 0.0088 | 16.7501 | 0.1453 | 2 | 11 | positive regulation of pseudopodium assembly |
GO:0044848 | 0.0088 | 16.7501 | 0.1453 | 2 | 11 | biological phase |
GO:0008584 | 0.0091 | 3.5462 | 1.783 | 6 | 135 | male gonad development |
GO:0032504 | 0.0091 | 1.9124 | 10.4865 | 19 | 794 | multicellular organism reproduction |
GO:0030900 | 0.0092 | 2.3999 | 4.8074 | 11 | 364 | forebrain development |
GO:0051961 | 0.0092 | 2.6766 | 3.5263 | 9 | 267 | negative regulation of nervous system development |
GO:0006308 | 0.0093 | 7.5632 | 0.4358 | 3 | 33 | DNA catabolic process |
GO:0008585 | 0.0093 | 4.1335 | 1.2811 | 5 | 97 | female gonad development |
GO:0072359 | 0.0099 | 1.8074 | 12.877 | 22 | 975 | circulatory system development |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0072599 | 0 | 9.9135 | 1.9674 | 16 | 102 | establishment of protein localization to endoplasmic reticulum |
GO:0006614 | 0 | 10.8203 | 1.5913 | 14 | 83 | SRP-dependent cotranslational protein targeting to membrane |
GO:0000184 | 0 | 8.4333 | 2.2568 | 16 | 117 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay |
GO:0006612 | 0 | 6.9237 | 3.0283 | 18 | 157 | protein targeting to membrane |
GO:0006413 | 0 | 6.2828 | 3.4912 | 19 | 181 | translational initiation |
GO:0006402 | 0 | 4.0046 | 6.4038 | 23 | 332 | mRNA catabolic process |
GO:0006364 | 0 | 4.3869 | 4.8222 | 19 | 250 | rRNA processing |
GO:0019083 | 0 | 4.9556 | 3.3755 | 15 | 175 | viral transcription |
GO:0006396 | 0 | 2.4576 | 17.5527 | 39 | 910 | RNA processing |
GO:0043043 | 0 | 2.4807 | 15.0259 | 34 | 779 | peptide biosynthetic process |
GO:0044265 | 0 | 2.2523 | 20.0409 | 41 | 1039 | cellular macromolecule catabolic process |
GO:0034655 | 0 | 2.8708 | 9.49 | 25 | 492 | nucleobase-containing compound catabolic process |
GO:0034660 | 0 | 2.7185 | 10.8209 | 27 | 561 | ncRNA metabolic process |
GO:0002227 | 0 | 19.8556 | 0.3472 | 5 | 18 | innate immune response in mucosa |
GO:0072657 | 0 | 2.7493 | 9.8758 | 25 | 512 | protein localization to membrane |
GO:0022613 | 1e-04 | 3.4858 | 4.6592 | 15 | 248 | ribonucleoprotein complex biogenesis |
GO:0043603 | 1e-04 | 2.0269 | 20.8896 | 39 | 1083 | cellular amide metabolic process |
GO:0002251 | 1e-04 | 11.7262 | 0.5208 | 5 | 27 | organ or tissue specific immune response |
GO:0006886 | 2e-04 | 1.9982 | 20.5967 | 38 | 1079 | intracellular protein transport |
GO:0070647 | 3e-04 | 1.934 | 21.1982 | 38 | 1099 | protein modification by small protein conjugation or removal |
GO:1902559 | 4e-04 | Inf | 0.0386 | 2 | 2 | 3'-phospho-5'-adenylyl sulfate transmembrane transport |
GO:0016567 | 4e-04 | 2.0602 | 16.1446 | 31 | 837 | protein ubiquitination |
GO:0019731 | 6e-04 | 8.3172 | 0.6944 | 5 | 36 | antibacterial humoral response |
GO:0046483 | 7e-04 | 1.4549 | 112.3564 | 140 | 5825 | heterocycle metabolic process |
GO:0009987 | 7e-04 | 2.368 | 287.2852 | 302 | 14894 | cellular process |
GO:0075522 | 8e-04 | 21.9908 | 0.1929 | 3 | 10 | IRES-dependent viral translational initiation |
GO:0033365 | 9e-04 | 1.9267 | 17.7456 | 32 | 920 | protein localization to organelle |
GO:0006334 | 0.0011 | 3.8006 | 2.5461 | 9 | 132 | nucleosome assembly |
GO:0044238 | 0.0011 | 1.4669 | 195.7991 | 222 | 10151 | primary metabolic process |
GO:0044403 | 0.0013 | 1.9468 | 15.8553 | 29 | 822 | symbiosis, encompassing mutualism through parasitism |
GO:0044271 | 0.0015 | 1.4361 | 94.1286 | 119 | 4880 | cellular nitrogen compound biosynthetic process |
GO:0015833 | 0.0018 | 1.5953 | 37.9601 | 56 | 1968 | peptide transport |
GO:0090304 | 0.0019 | 1.4199 | 96.6554 | 121 | 5011 | nucleic acid metabolic process |
GO:0019080 | 0.002 | 14.5522 | 0.2599 | 3 | 14 | viral gene expression |
GO:0006725 | 0.0021 | 1.4025 | 113.0894 | 138 | 5863 | cellular aromatic compound metabolic process |
GO:0061844 | 0.0022 | 5.9916 | 0.9259 | 5 | 48 | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO:0034622 | 0.0027 | 1.8898 | 15.1423 | 27 | 806 | cellular macromolecular complex assembly |
GO:0051649 | 0.003 | 1.536 | 41.4513 | 59 | 2149 | establishment of localization in cell |
GO:0070727 | 0.0031 | 1.5851 | 33.8323 | 50 | 1754 | cellular macromolecule localization |
GO:1901360 | 0.0031 | 1.3796 | 117.0821 | 141 | 6070 | organic cyclic compound metabolic process |
GO:0045184 | 0.0034 | 1.5402 | 39.1174 | 56 | 2028 | establishment of protein localization |
GO:0042780 | 0.0036 | 34.1068 | 0.0964 | 2 | 5 | tRNA 3'-end processing |
GO:0036158 | 0.004 | 10.9906 | 0.3279 | 3 | 17 | outer dynein arm assembly |
GO:0044267 | 0.0042 | 1.3777 | 96.829 | 119 | 5020 | cellular protein metabolic process |
GO:1901575 | 0.0045 | 1.5274 | 37.9022 | 54 | 1965 | organic substance catabolic process |
GO:0022618 | 0.0046 | 2.808 | 3.7583 | 10 | 196 | ribonucleoprotein complex assembly |
GO:0051302 | 0.0051 | 3.2094 | 2.6425 | 8 | 137 | regulation of cell division |
GO:0006616 | 0.0053 | 25.5785 | 0.1157 | 2 | 6 | SRP-dependent cotranslational protein targeting to membrane, translocation |
GO:0050428 | 0.0053 | 25.5785 | 0.1157 | 2 | 6 | 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process |
GO:0051096 | 0.0053 | 25.5785 | 0.1157 | 2 | 6 | positive regulation of helicase activity |
GO:0060770 | 0.0053 | 25.5785 | 0.1157 | 2 | 6 | negative regulation of epithelial cell proliferation involved in prostate gland development |
GO:0097428 | 0.0053 | 25.5785 | 0.1157 | 2 | 6 | protein maturation by iron-sulfur cluster transfer |
GO:1904776 | 0.0053 | 25.5785 | 0.1157 | 2 | 6 | regulation of protein localization to cell cortex |
GO:0071705 | 0.0063 | 1.4702 | 43.7852 | 60 | 2270 | nitrogen compound transport |
GO:0032527 | 0.0066 | 5.8728 | 0.7523 | 4 | 39 | protein exit from endoplasmic reticulum |
GO:0043933 | 0.0066 | 1.4887 | 39.5032 | 55 | 2048 | macromolecular complex subunit organization |
GO:1901564 | 0.007 | 1.3332 | 127.228 | 149 | 6596 | organonitrogen compound metabolic process |
GO:0006333 | 0.0072 | 2.7914 | 3.3948 | 9 | 176 | chromatin assembly or disassembly |
GO:0071806 | 0.0073 | 4.4378 | 1.2152 | 5 | 63 | protein transmembrane transport |
GO:0071840 | 0.0081 | 1.3284 | 117.9115 | 139 | 6113 | cellular component organization or biogenesis |
GO:0006807 | 0.0091 | 1.4847 | 52.2793 | 67 | 3068 | nitrogen compound metabolic process |
GO:0071157 | 0.0095 | 7.6905 | 0.4436 | 3 | 23 | negative regulation of cell cycle arrest |
GO:0001731 | 0.0096 | 17.0502 | 0.1543 | 2 | 8 | formation of translation preinitiation complex |
GO:0048280 | 0.0096 | 17.0502 | 0.1543 | 2 | 8 | vesicle fusion with Golgi apparatus |
GO:1900118 | 0.0096 | 17.0502 | 0.1543 | 2 | 8 | negative regulation of execution phase of apoptosis |
GO:2001236 | 0.0097 | 2.8524 | 2.9512 | 8 | 153 | regulation of extrinsic apoptotic signaling pathway |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0045653 | 0 | 255.1977 | 0.2587 | 14 | 18 | negative regulation of megakaryocyte differentiation |
GO:0006335 | 0 | 56.6611 | 0.46 | 14 | 32 | DNA replication-dependent nucleosome assembly |
GO:0000183 | 0 | 42.4799 | 0.5462 | 14 | 38 | chromatin silencing at rDNA |
GO:0034080 | 0 | 36.4023 | 0.6037 | 14 | 42 | CENP-A containing nucleosome assembly |
GO:0051290 | 0 | 33.9712 | 0.6325 | 14 | 44 | protein heterotetramerization |
GO:1904837 | 0 | 33.9712 | 0.6325 | 14 | 44 | beta-catenin-TCF complex assembly |
GO:0002682 | 0 | 9.1501 | 3.2168 | 24 | 250 | regulation of immune system process |
GO:0034724 | 0 | 25.4625 | 0.7762 | 14 | 54 | DNA replication-independent nucleosome organization |
GO:0016233 | 0 | 24.8399 | 0.7906 | 14 | 55 | telomere capping |
GO:0006303 | 0 | 16.6748 | 1.0781 | 14 | 75 | double-strand break repair via nonhomologous end joining |
GO:0043044 | 0 | 15.8902 | 1.1212 | 14 | 78 | ATP-dependent chromatin remodeling |
GO:0045815 | 0 | 15.4067 | 1.1499 | 14 | 80 | positive regulation of gene expression, epigenetic |
GO:0002520 | 0 | 3.7695 | 12.8938 | 41 | 897 | immune system development |
GO:1903707 | 0 | 9.7401 | 1.9549 | 16 | 136 | negative regulation of hemopoiesis |
GO:1902036 | 0 | 11.4088 | 1.4806 | 14 | 103 | regulation of hematopoietic stem cell differentiation |
GO:0060964 | 0 | 11.0347 | 1.5237 | 14 | 106 | regulation of gene silencing by miRNA |
GO:0048863 | 0 | 6.1287 | 3.7517 | 20 | 261 | stem cell differentiation |
GO:0045814 | 0 | 9.2186 | 1.7824 | 14 | 124 | negative regulation of gene expression, epigenetic |
GO:0045321 | 0 | 3.7974 | 9.7775 | 32 | 729 | leukocyte activation |
GO:0045637 | 0 | 9.0024 | 1.8191 | 14 | 129 | regulation of myeloid cell differentiation |
GO:0060968 | 0 | 8.7385 | 1.8687 | 14 | 130 | regulation of gene silencing |
GO:0051716 | 0 | 2.1489 | 98.4499 | 142 | 6849 | cellular response to stimulus |
GO:0035194 | 0 | 6.1069 | 3.3636 | 18 | 234 | posttranscriptional gene silencing by RNA |
GO:0002244 | 0 | 6.7732 | 2.7024 | 16 | 188 | hematopoietic progenitor cell differentiation |
GO:0031497 | 0 | 7.3893 | 2.1705 | 14 | 151 | chromatin assembly |
GO:0032200 | 0 | 6.6538 | 2.3861 | 14 | 166 | telomere organization |
GO:0060249 | 0 | 4.1545 | 5.3616 | 20 | 373 | anatomical structure homeostasis |
GO:0002275 | 0 | 3.524 | 7.5897 | 24 | 528 | myeloid cell activation involved in immune response |
GO:0045055 | 0 | 3.1057 | 10.4645 | 29 | 728 | regulated exocytosis |
GO:0002444 | 0 | 3.4883 | 7.6615 | 24 | 533 | myeloid leukocyte mediated immunity |
GO:0051674 | 0 | 2.4609 | 20.4691 | 44 | 1424 | localization of cell |
GO:0017148 | 0 | 4.315 | 4.6285 | 18 | 322 | negative regulation of translation |
GO:0006950 | 0 | 1.9832 | 51.992 | 84 | 3617 | response to stress |
GO:0040011 | 0 | 3.0034 | 10.8778 | 29 | 791 | locomotion |
GO:0032940 | 0 | 2.4447 | 20.0666 | 43 | 1396 | secretion by cell |
GO:0009952 | 0 | 5.3675 | 2.9036 | 14 | 202 | anterior/posterior pattern specification |
GO:0043312 | 0 | 3.5718 | 6.8278 | 22 | 475 | neutrophil degranulation |
GO:0045596 | 0 | 3.1683 | 9.1277 | 26 | 635 | negative regulation of cell differentiation |
GO:0051259 | 0 | 3.4243 | 7.4459 | 23 | 518 | protein oligomerization |
GO:0006352 | 0 | 4.8596 | 3.4211 | 15 | 238 | DNA-templated transcription, initiation |
GO:0007389 | 0 | 3.7654 | 5.8749 | 20 | 412 | pattern specification process |
GO:0042119 | 0 | 3.4847 | 6.9859 | 22 | 486 | neutrophil activation |
GO:0009893 | 0 | 4.2606 | 4.4783 | 17 | 347 | positive regulation of metabolic process |
GO:0002263 | 0 | 3.0434 | 9.4727 | 26 | 659 | cell activation involved in immune response |
GO:0002253 | 0 | 3.2805 | 7.7478 | 23 | 539 | activation of immune response |
GO:0048513 | 0 | 2.091 | 34.7421 | 61 | 2582 | animal organ development |
GO:0065004 | 0 | 4.7526 | 3.2486 | 14 | 226 | protein-DNA complex assembly |
GO:0042474 | 0 | 25.0016 | 0.2731 | 5 | 19 | middle ear morphogenesis |
GO:0001501 | 0 | 4.1085 | 4.2816 | 16 | 305 | skeletal system development |
GO:0060173 | 0 | 5.4006 | 2.458 | 12 | 171 | limb development |
GO:0006955 | 0 | 5.8087 | 2.1055 | 11 | 172 | immune response |
GO:0035107 | 0 | 5.7702 | 2.113 | 11 | 147 | appendage morphogenesis |
GO:0002695 | 0 | 5.7277 | 2.1274 | 11 | 148 | negative regulation of leukocyte activation |
GO:0071103 | 0 | 4.1746 | 3.9386 | 15 | 274 | DNA conformation change |
GO:0045576 | 0 | 10.2771 | 0.7906 | 7 | 55 | mast cell activation |
GO:0006911 | 0 | 13.5942 | 0.5319 | 6 | 37 | phagocytosis, engulfment |
GO:0032943 | 0 | 4.2628 | 3.5936 | 14 | 250 | mononuclear cell proliferation |
GO:0002429 | 0 | 3.75 | 4.6573 | 16 | 324 | immune response-activating cell surface receptor signaling pathway |
GO:0030097 | 0 | 3.1286 | 7.0004 | 20 | 518 | hemopoiesis |
GO:0030155 | 0 | 2.7918 | 9.4152 | 24 | 655 | regulation of cell adhesion |
GO:0007599 | 0 | 3.5952 | 4.8442 | 16 | 337 | hemostasis |
GO:0050817 | 0 | 3.5952 | 4.8442 | 16 | 337 | coagulation |
GO:0002250 | 0 | 3.5838 | 4.8585 | 16 | 338 | adaptive immune response |
GO:0034248 | 0 | 2.9435 | 7.7765 | 21 | 541 | regulation of cellular amide metabolic process |
GO:0045944 | 0 | 2.3233 | 15.6968 | 33 | 1092 | positive regulation of transcription from RNA polymerase II promoter |
GO:0048568 | 0 | 3.2263 | 6.066 | 18 | 422 | embryonic organ development |
GO:0048704 | 1e-04 | 10.2261 | 0.6771 | 6 | 48 | embryonic skeletal system morphogenesis |
GO:1903037 | 1e-04 | 3.5112 | 4.6285 | 15 | 322 | regulation of leukocyte cell-cell adhesion |
GO:0050865 | 1e-04 | 4.5263 | 2.6453 | 11 | 193 | regulation of cell activation |
GO:0009954 | 1e-04 | 13.4523 | 0.4456 | 5 | 31 | proximal/distal pattern formation |
GO:0007154 | 1e-04 | 1.7345 | 65.1137 | 91 | 4812 | cell communication |
GO:0007166 | 1e-04 | 2.0633 | 22.3853 | 41 | 1651 | cell surface receptor signaling pathway |
GO:0015844 | 1e-04 | 7.3539 | 1.0637 | 7 | 74 | monoamine transport |
GO:0002697 | 1e-04 | 3.3983 | 4.7723 | 15 | 332 | regulation of immune effector process |
GO:0002764 | 1e-04 | 2.878 | 7.1441 | 19 | 497 | immune response-regulating signaling pathway |
GO:0009617 | 1e-04 | 2.8656 | 7.1728 | 19 | 499 | response to bacterium |
GO:0010608 | 1e-04 | 2.6348 | 9.0558 | 22 | 630 | posttranscriptional regulation of gene expression |
GO:0010324 | 1e-04 | 8.7703 | 0.7762 | 6 | 54 | membrane invagination |
GO:0045892 | 2e-04 | 2.1735 | 16.128 | 32 | 1122 | negative regulation of transcription, DNA-templated |
GO:0043207 | 2e-04 | 2.4157 | 11.2407 | 25 | 782 | response to external biotic stimulus |
GO:0050852 | 2e-04 | 4.4604 | 2.4293 | 10 | 169 | T cell receptor signaling pathway |
GO:0031347 | 2e-04 | 2.4898 | 10.0045 | 23 | 696 | regulation of defense response |
GO:0048598 | 2e-04 | 2.7432 | 7.4786 | 19 | 535 | embryonic morphogenesis |
GO:0043583 | 2e-04 | 4.0094 | 2.9611 | 11 | 206 | ear development |
GO:0072376 | 2e-04 | 6.3949 | 1.2074 | 7 | 84 | protein activation cascade |
GO:0044663 | 2e-04 | Inf | 0.0287 | 2 | 2 | establishment or maintenance of cell type involved in phenotypic switching |
GO:1903508 | 2e-04 | 2.0215 | 20.1385 | 37 | 1401 | positive regulation of nucleic acid-templated transcription |
GO:0010628 | 2e-04 | 1.9586 | 23.278 | 41 | 1714 | positive regulation of gene expression |
GO:0072172 | 2e-04 | 34.7165 | 0.1294 | 3 | 9 | mesonephric tubule formation |
GO:0048869 | 2e-04 | 1.6877 | 52.6606 | 76 | 3802 | cellular developmental process |
GO:1902679 | 3e-04 | 2.0949 | 16.6742 | 32 | 1160 | negative regulation of RNA biosynthetic process |
GO:0045165 | 3e-04 | 3.5748 | 3.608 | 12 | 251 | cell fate commitment |
GO:0002696 | 3e-04 | 3.3485 | 4.1686 | 13 | 290 | positive regulation of leukocyte activation |
GO:0072537 | 3e-04 | 29.7551 | 0.1437 | 3 | 10 | fibroblast activation |
GO:2000026 | 4e-04 | 1.8976 | 23.8688 | 41 | 1695 | regulation of multicellular organismal development |
GO:0023052 | 4e-04 | 1.6426 | 64.8333 | 88 | 4790 | signaling |
GO:0031328 | 4e-04 | 1.8617 | 25.5001 | 43 | 1774 | positive regulation of cellular biosynthetic process |
GO:0001975 | 4e-04 | 13.2704 | 0.3594 | 4 | 25 | response to amphetamine |
GO:0006928 | 4e-04 | 2.1514 | 14.1975 | 28 | 1032 | movement of cell or subcellular component |
GO:0090009 | 4e-04 | 26.0341 | 0.1581 | 3 | 11 | primitive streak formation |
GO:0048701 | 4e-04 | 8.7364 | 0.6468 | 5 | 45 | embryonic cranial skeleton morphogenesis |
GO:0030595 | 5e-04 | 3.9128 | 2.7455 | 10 | 191 | leukocyte chemotaxis |
GO:2000146 | 5e-04 | 3.3605 | 3.8236 | 12 | 266 | negative regulation of cell motility |
GO:0060571 | 5e-04 | 12.6664 | 0.3737 | 4 | 26 | morphogenesis of an epithelial fold |
GO:0009890 | 5e-04 | 1.8784 | 23.3871 | 40 | 1627 | negative regulation of biosynthetic process |
GO:0032101 | 5e-04 | 2.3376 | 10.1195 | 22 | 704 | regulation of response to external stimulus |
GO:0048662 | 6e-04 | 8.3193 | 0.6756 | 5 | 47 | negative regulation of smooth muscle cell proliferation |
GO:0012501 | 6e-04 | 1.7979 | 28.2887 | 46 | 1968 | programmed cell death |
GO:0051254 | 6e-04 | 1.9122 | 21.159 | 37 | 1472 | positive regulation of RNA metabolic process |
GO:0010557 | 6e-04 | 1.8654 | 23.5308 | 40 | 1637 | positive regulation of macromolecule biosynthetic process |
GO:0030168 | 6e-04 | 5.3096 | 1.4318 | 7 | 101 | platelet activation |
GO:0032496 | 6e-04 | 3.1084 | 4.4704 | 13 | 311 | response to lipopolysaccharide |
GO:0090100 | 6e-04 | 5.2894 | 1.4374 | 7 | 100 | positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
GO:0010463 | 6e-04 | 8.1253 | 0.69 | 5 | 48 | mesenchymal cell proliferation |
GO:0002351 | 6e-04 | 138.3103 | 0.0431 | 2 | 3 | serotonin production involved in inflammatory response |
GO:0002554 | 6e-04 | 138.3103 | 0.0431 | 2 | 3 | serotonin secretion by platelet |
GO:0014738 | 6e-04 | 138.3103 | 0.0431 | 2 | 3 | regulation of muscle hyperplasia |
GO:0045658 | 6e-04 | 138.3103 | 0.0431 | 2 | 3 | regulation of neutrophil differentiation |
GO:0072078 | 6e-04 | 6.2757 | 1.0493 | 6 | 73 | nephron tubule morphogenesis |
GO:0010941 | 6e-04 | 1.869 | 22.8552 | 39 | 1590 | regulation of cell death |
GO:0042060 | 7e-04 | 2.5282 | 7.6184 | 18 | 530 | wound healing |
GO:0002684 | 7e-04 | 2.3949 | 8.9705 | 20 | 649 | positive regulation of immune system process |
GO:0035116 | 7e-04 | 11.1443 | 0.4169 | 4 | 29 | embryonic hindlimb morphogenesis |
GO:0048935 | 8e-04 | 20.8247 | 0.1869 | 3 | 13 | peripheral nervous system neuron development |
GO:0042110 | 8e-04 | 4.423 | 1.9454 | 8 | 142 | T cell activation |
GO:0051173 | 8e-04 | 1.6586 | 41.3119 | 61 | 2874 | positive regulation of nitrogen compound metabolic process |
GO:0008344 | 8e-04 | 5.9207 | 1.1068 | 6 | 77 | adult locomotory behavior |
GO:0072028 | 8e-04 | 5.9207 | 1.1068 | 6 | 77 | nephron morphogenesis |
GO:0006957 | 9e-04 | 18.9303 | 0.2012 | 3 | 14 | complement activation, alternative pathway |
GO:0048853 | 9e-04 | 18.9303 | 0.2012 | 3 | 14 | forebrain morphogenesis |
GO:0050869 | 0.001 | 10.3176 | 0.4456 | 4 | 31 | negative regulation of B cell activation |
GO:0051954 | 0.001 | 10.3176 | 0.4456 | 4 | 31 | positive regulation of amine transport |
GO:0042098 | 0.001 | 3.8263 | 2.5155 | 9 | 175 | T cell proliferation |
GO:0030326 | 0.001 | 5.7144 | 1.1427 | 6 | 81 | embryonic limb morphogenesis |
GO:0032268 | 0.001 | 1.6711 | 36.6115 | 55 | 2547 | regulation of cellular protein metabolic process |
GO:0042981 | 0.001 | 1.8902 | 19.5474 | 34 | 1383 | regulation of apoptotic process |
GO:1902532 | 0.0011 | 2.4869 | 7.2878 | 17 | 507 | negative regulation of intracellular signal transduction |
GO:0035115 | 0.0011 | 9.9484 | 0.46 | 4 | 32 | embryonic forelimb morphogenesis |
GO:0048585 | 0.0011 | 1.8992 | 18.8565 | 33 | 1336 | negative regulation of response to stimulus |
GO:0035148 | 0.0011 | 4.1408 | 2.0699 | 8 | 144 | tube formation |
GO:0072107 | 0.0012 | 69.1509 | 0.0575 | 2 | 4 | positive regulation of ureteric bud formation |
GO:0072268 | 0.0012 | 69.1509 | 0.0575 | 2 | 4 | pattern specification involved in metanephros development |
GO:2001274 | 0.0012 | 69.1509 | 0.0575 | 2 | 4 | negative regulation of glucose import in response to insulin stimulus |
GO:0051248 | 0.0012 | 1.9047 | 18.1692 | 32 | 1264 | negative regulation of protein metabolic process |
GO:0048665 | 0.0012 | 9.6048 | 0.4744 | 4 | 33 | neuron fate specification |
GO:0006935 | 0.0013 | 2.4503 | 7.3933 | 17 | 522 | chemotaxis |
GO:0022408 | 0.0013 | 4.0507 | 2.113 | 8 | 147 | negative regulation of cell-cell adhesion |
GO:0065007 | 0.0014 | 1.7524 | 72.6066 | 90 | 5933 | biological regulation |
GO:2000249 | 0.0014 | 9.2841 | 0.4887 | 4 | 34 | regulation of actin cytoskeleton reorganization |
GO:0032695 | 0.0014 | 16.016 | 0.23 | 3 | 16 | negative regulation of interleukin-12 production |
GO:0045934 | 0.0015 | 1.8401 | 19.9947 | 34 | 1391 | negative regulation of nucleobase-containing compound metabolic process |
GO:0070372 | 0.0016 | 3.0666 | 3.8092 | 11 | 265 | regulation of ERK1 and ERK2 cascade |
GO:0051241 | 0.0016 | 2.0645 | 12.4878 | 24 | 933 | negative regulation of multicellular organismal process |
GO:2000112 | 0.0016 | 1.5388 | 57.6843 | 78 | 4013 | regulation of cellular macromolecule biosynthetic process |
GO:0048645 | 0.0017 | 6.3478 | 0.8625 | 5 | 60 | animal organ formation |
GO:0006897 | 0.0017 | 2.2592 | 8.9552 | 19 | 623 | endocytosis |
GO:0048536 | 0.0017 | 8.7027 | 0.5175 | 4 | 36 | spleen development |
GO:0015696 | 0.0018 | 5.0609 | 1.2793 | 6 | 89 | ammonium transport |
GO:0009967 | 0.0018 | 1.8399 | 19.4042 | 33 | 1383 | positive regulation of signal transduction |
GO:0002706 | 0.0018 | 4.3093 | 1.7393 | 7 | 121 | regulation of lymphocyte mediated immunity |
GO:0001838 | 0.0019 | 4.2716 | 1.7537 | 7 | 122 | embryonic epithelial tube formation |
GO:0050859 | 0.002 | 46.0977 | 0.0719 | 2 | 5 | negative regulation of B cell receptor signaling pathway |
GO:0060414 | 0.002 | 46.0977 | 0.0719 | 2 | 5 | aorta smooth muscle tissue morphogenesis |
GO:0072081 | 0.002 | 46.0977 | 0.0719 | 2 | 5 | specification of nephron tubule identity |
GO:1901164 | 0.002 | 46.0977 | 0.0719 | 2 | 5 | negative regulation of trophoblast cell migration |
GO:0042127 | 0.002 | 1.8427 | 18.7763 | 32 | 1359 | regulation of cell proliferation |
GO:0010818 | 0.002 | 13.8788 | 0.2587 | 3 | 18 | T cell chemotaxis |
GO:0033622 | 0.002 | 13.8788 | 0.2587 | 3 | 18 | integrin activation |
GO:1905276 | 0.002 | 13.8788 | 0.2587 | 3 | 18 | regulation of epithelial tube formation |
GO:0000165 | 0.0021 | 2.0179 | 12.7069 | 24 | 884 | MAPK cascade |
GO:0061326 | 0.0022 | 4.827 | 1.3368 | 6 | 93 | renal tubule development |
GO:0060485 | 0.0022 | 3.1248 | 3.3923 | 10 | 236 | mesenchyme development |
GO:0050776 | 0.0023 | 2.9296 | 3.9834 | 11 | 292 | regulation of immune response |
GO:0050868 | 0.0024 | 4.7718 | 1.3512 | 6 | 94 | negative regulation of T cell activation |
GO:0001710 | 0.0024 | 13.0106 | 0.2731 | 3 | 19 | mesodermal cell fate commitment |
GO:1901741 | 0.0024 | 13.0106 | 0.2731 | 3 | 19 | positive regulation of myoblast fusion |
GO:0042326 | 0.0025 | 2.4292 | 6.5403 | 15 | 455 | negative regulation of phosphorylation |
GO:0050922 | 0.0025 | 7.7338 | 0.575 | 4 | 40 | negative regulation of chemotaxis |
GO:0050672 | 0.0026 | 5.7212 | 0.9487 | 5 | 66 | negative regulation of lymphocyte proliferation |
GO:0072087 | 0.0028 | 12.2445 | 0.2875 | 3 | 20 | renal vesicle development |
GO:2000406 | 0.0028 | 12.2445 | 0.2875 | 3 | 20 | positive regulation of T cell migration |
GO:0010648 | 0.0028 | 1.8138 | 18.356 | 31 | 1277 | negative regulation of cell communication |
GO:0006959 | 0.0028 | 3.2513 | 2.9324 | 9 | 204 | humoral immune response |
GO:0060537 | 0.0028 | 2.5776 | 5.3329 | 13 | 371 | muscle tissue development |
GO:0023057 | 0.0029 | 1.8075 | 18.4135 | 31 | 1281 | negative regulation of signaling |
GO:0022409 | 0.0029 | 3.0034 | 3.5217 | 10 | 245 | positive regulation of cell-cell adhesion |
GO:0065008 | 0.003 | 1.5241 | 49.8359 | 68 | 3467 | regulation of biological quality |
GO:2000504 | 0.003 | 34.5711 | 0.0862 | 2 | 6 | positive regulation of blood vessel remodeling |
GO:0072210 | 0.003 | 7.3259 | 0.6037 | 4 | 42 | metanephric nephron development |
GO:2000401 | 0.003 | 7.3259 | 0.6037 | 4 | 42 | regulation of lymphocyte migration |
GO:0098542 | 0.003 | 2.4575 | 6.0229 | 14 | 419 | defense response to other organism |
GO:0050670 | 0.0031 | 3.906 | 1.9068 | 7 | 135 | regulation of lymphocyte proliferation |
GO:0043009 | 0.0031 | 2.2365 | 8.0496 | 17 | 560 | chordate embryonic development |
GO:0048522 | 0.0032 | 1.4935 | 62.0486 | 81 | 4527 | positive regulation of cellular process |
GO:0001934 | 0.0032 | 1.9461 | 13.1382 | 24 | 914 | positive regulation of protein phosphorylation |
GO:0050679 | 0.0032 | 3.4706 | 2.4436 | 8 | 170 | positive regulation of epithelial cell proliferation |
GO:0090596 | 0.0033 | 2.9524 | 3.5792 | 10 | 249 | sensory organ morphogenesis |
GO:0070271 | 0.0033 | 1.76 | 20.1528 | 33 | 1402 | protein complex biogenesis |
GO:0070664 | 0.0033 | 5.3678 | 1.0062 | 5 | 70 | negative regulation of leukocyte proliferation |
GO:0045937 | 0.0035 | 1.8608 | 15.4955 | 27 | 1078 | positive regulation of phosphate metabolic process |
GO:0050853 | 0.0035 | 7.0184 | 0.6273 | 4 | 44 | B cell receptor signaling pathway |
GO:0007422 | 0.0035 | 5.2862 | 1.0206 | 5 | 71 | peripheral nervous system development |
GO:0065009 | 0.0036 | 1.5236 | 46.616 | 64 | 3243 | regulation of molecular function |
GO:0002704 | 0.0036 | 6.9587 | 0.6325 | 4 | 44 | negative regulation of leukocyte mediated immunity |
GO:0002438 | 0.0037 | 10.9542 | 0.3162 | 3 | 22 | acute inflammatory response to antigenic stimulus |
GO:0001707 | 0.0038 | 5.2069 | 1.035 | 5 | 72 | mesoderm formation |
GO:0002702 | 0.0038 | 5.2069 | 1.035 | 5 | 72 | positive regulation of production of molecular mediator of immune response |
GO:0048729 | 0.0038 | 2.1341 | 8.9265 | 18 | 621 | tissue morphogenesis |
GO:0050900 | 0.0039 | 3.364 | 2.5167 | 8 | 183 | leukocyte migration |
GO:0030183 | 0.0039 | 4.2822 | 1.4949 | 6 | 104 | B cell differentiation |
GO:0032720 | 0.0039 | 6.7885 | 0.6468 | 4 | 45 | negative regulation of tumor necrosis factor production |
GO:0043303 | 0.0039 | 6.7885 | 0.6468 | 4 | 45 | mast cell degranulation |
GO:0070663 | 0.0039 | 3.7287 | 1.992 | 7 | 141 | regulation of leukocyte proliferation |
GO:0032226 | 0.0041 | 27.6552 | 0.1006 | 2 | 7 | positive regulation of synaptic transmission, dopaminergic |
GO:0045656 | 0.0041 | 27.6552 | 0.1006 | 2 | 7 | negative regulation of monocyte differentiation |
GO:1900165 | 0.0041 | 27.6552 | 0.1006 | 2 | 7 | negative regulation of interleukin-6 secretion |
GO:1900239 | 0.0041 | 27.6552 | 0.1006 | 2 | 7 | regulation of phenotypic switching |
GO:0006954 | 0.0042 | 2.3686 | 6.2439 | 14 | 456 | inflammatory response |
GO:0002861 | 0.0042 | 10.4058 | 0.3306 | 3 | 23 | regulation of inflammatory response to antigenic stimulus |
GO:0090189 | 0.0042 | 10.4058 | 0.3306 | 3 | 23 | regulation of branching involved in ureteric bud morphogenesis |
GO:0032675 | 0.0043 | 4.1961 | 1.5237 | 6 | 106 | regulation of interleukin-6 production |
GO:0043043 | 0.0043 | 1.9883 | 11.1976 | 21 | 779 | peptide biosynthetic process |
GO:0051216 | 0.0046 | 3.2667 | 2.5874 | 8 | 180 | cartilage development |
GO:0034654 | 0.0046 | 1.4649 | 59.8117 | 78 | 4161 | nucleobase-containing compound biosynthetic process |
GO:0010563 | 0.0046 | 2.1425 | 8.3802 | 17 | 583 | negative regulation of phosphorus metabolic process |
GO:0042089 | 0.0047 | 4.1133 | 1.5524 | 6 | 108 | cytokine biosynthetic process |
GO:0080090 | 0.0047 | 1.4269 | 84.3487 | 104 | 5868 | regulation of primary metabolic process |
GO:0090103 | 0.0047 | 9.9097 | 0.345 | 3 | 24 | cochlea morphogenesis |
GO:2000482 | 0.0047 | 9.9097 | 0.345 | 3 | 24 | regulation of interleukin-8 secretion |
GO:0097190 | 0.0048 | 2.1347 | 8.409 | 17 | 585 | apoptotic signaling pathway |
GO:0007155 | 0.005 | 2.0825 | 9.1667 | 18 | 682 | cell adhesion |
GO:2000106 | 0.005 | 4.8438 | 1.1068 | 5 | 77 | regulation of leukocyte apoptotic process |
GO:0035137 | 0.0053 | 23.4123 | 0.1132 | 2 | 8 | hindlimb morphogenesis |
GO:0051240 | 0.0053 | 1.6868 | 21.6046 | 34 | 1503 | positive regulation of multicellular organismal process |
GO:0072202 | 0.0053 | 9.4587 | 0.3594 | 3 | 25 | cell differentiation involved in metanephros development |
GO:0002761 | 0.0053 | 3.995 | 1.5956 | 6 | 111 | regulation of myeloid leukocyte differentiation |
GO:0030334 | 0.0054 | 1.9806 | 10.6801 | 20 | 743 | regulation of cell migration |
GO:0051897 | 0.0054 | 3.5033 | 2.113 | 7 | 147 | positive regulation of protein kinase B signaling |
GO:0001816 | 0.0054 | 2.161 | 7.811 | 16 | 554 | cytokine production |
GO:0051249 | 0.0054 | 3.1667 | 2.6649 | 8 | 193 | regulation of lymphocyte activation |
GO:0030854 | 0.0054 | 23.0445 | 0.115 | 2 | 8 | positive regulation of granulocyte differentiation |
GO:0048743 | 0.0054 | 23.0445 | 0.115 | 2 | 8 | positive regulation of skeletal muscle fiber development |
GO:0051584 | 0.0054 | 23.0445 | 0.115 | 2 | 8 | regulation of dopamine uptake involved in synaptic transmission |
GO:0072161 | 0.0054 | 23.0445 | 0.115 | 2 | 8 | mesenchymal cell differentiation involved in kidney development |
GO:1905522 | 0.0054 | 23.0445 | 0.115 | 2 | 8 | negative regulation of macrophage migration |
GO:2000270 | 0.0054 | 23.0445 | 0.115 | 2 | 8 | negative regulation of fibroblast apoptotic process |
GO:0060255 | 0.0055 | 1.4169 | 84.7224 | 104 | 5894 | regulation of macromolecule metabolic process |
GO:0071310 | 0.0055 | 1.5552 | 34.2684 | 49 | 2384 | cellular response to organic substance |
GO:0050728 | 0.0058 | 3.9198 | 1.6243 | 6 | 113 | negative regulation of inflammatory response |
GO:1903555 | 0.0058 | 3.9198 | 1.6243 | 6 | 113 | regulation of tumor necrosis factor superfamily cytokine production |
GO:0045730 | 0.006 | 9.0469 | 0.3737 | 3 | 26 | respiratory burst |
GO:0045822 | 0.006 | 9.0469 | 0.3737 | 3 | 26 | negative regulation of heart contraction |
GO:0034103 | 0.0062 | 4.5877 | 1.1643 | 5 | 81 | regulation of tissue remodeling |
GO:0021515 | 0.0066 | 5.796 | 0.7475 | 4 | 52 | cell differentiation in spinal cord |
GO:0050729 | 0.0066 | 4.5221 | 1.1797 | 5 | 83 | positive regulation of inflammatory response |
GO:0016192 | 0.0066 | 1.7681 | 16.3008 | 27 | 1187 | vesicle-mediated transport |
GO:0097530 | 0.0066 | 3.8122 | 1.6674 | 6 | 116 | granulocyte migration |
GO:0002675 | 0.0066 | 8.6694 | 0.3881 | 3 | 27 | positive regulation of acute inflammatory response |
GO:0036065 | 0.0066 | 8.6694 | 0.3881 | 3 | 27 | fucosylation |
GO:0060142 | 0.0066 | 8.6694 | 0.3881 | 3 | 27 | regulation of syncytium formation by plasma membrane fusion |
GO:0040012 | 0.0067 | 1.8761 | 12.4051 | 22 | 863 | regulation of locomotion |
GO:0030509 | 0.0067 | 3.3581 | 2.1993 | 7 | 153 | BMP signaling pathway |
GO:0071822 | 0.0068 | 1.6335 | 23.6171 | 36 | 1643 | protein complex subunit organization |
GO:0048644 | 0.0069 | 4.4695 | 1.1931 | 5 | 83 | muscle organ morphogenesis |
GO:0002883 | 0.0069 | 19.7512 | 0.1294 | 2 | 9 | regulation of hypersensitivity |
GO:0045988 | 0.0069 | 19.7512 | 0.1294 | 2 | 9 | negative regulation of striated muscle contraction |
GO:0072048 | 0.0069 | 19.7512 | 0.1294 | 2 | 9 | renal system pattern specification |
GO:2000035 | 0.0069 | 19.7512 | 0.1294 | 2 | 9 | regulation of stem cell division |
GO:0090183 | 0.007 | 5.6774 | 0.7618 | 4 | 53 | regulation of kidney development |
GO:0007275 | 0.0072 | 1.5459 | 36.927 | 51 | 2985 | multicellular organism development |
GO:0010922 | 0.0074 | 8.3221 | 0.4025 | 3 | 28 | positive regulation of phosphatase activity |
GO:0002252 | 0.0074 | 2.9979 | 2.8099 | 8 | 219 | immune effector process |
GO:0050854 | 0.0075 | 5.5635 | 0.7762 | 4 | 54 | regulation of antigen receptor-mediated signaling pathway |
GO:0051270 | 0.0076 | 1.8528 | 12.5488 | 22 | 873 | regulation of cellular component movement |
GO:0007167 | 0.0077 | 1.7998 | 14.1156 | 24 | 982 | enzyme linked receptor protein signaling pathway |
GO:0045995 | 0.0078 | 3.6775 | 1.7249 | 6 | 120 | regulation of embryonic development |
GO:0007159 | 0.0079 | 8.0818 | 0.4117 | 3 | 30 | leukocyte cell-cell adhesion |
GO:0002686 | 0.008 | 8.0684 | 0.4135 | 3 | 29 | negative regulation of leukocyte migration |
GO:0090630 | 0.008 | 4.3032 | 1.2362 | 5 | 86 | activation of GTPase activity |
GO:0070527 | 0.008 | 5.454 | 0.7906 | 4 | 55 | platelet aggregation |
GO:0002822 | 0.0081 | 3.6453 | 1.7393 | 6 | 121 | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
GO:0061900 | 0.0081 | 8.0015 | 0.4169 | 3 | 29 | glial cell activation |
GO:0009966 | 0.0082 | 1.6807 | 19.8688 | 31 | 1513 | regulation of signal transduction |
GO:0016477 | 0.0084 | 2.4365 | 4.7474 | 11 | 359 | cell migration |
GO:0045453 | 0.0085 | 5.3488 | 0.805 | 4 | 56 | bone resorption |
GO:0042447 | 0.0086 | 17.2812 | 0.1437 | 2 | 10 | hormone catabolic process |
GO:0007498 | 0.0087 | 3.5825 | 1.768 | 6 | 123 | mesoderm development |
GO:0001568 | 0.0088 | 1.9959 | 8.9552 | 17 | 623 | blood vessel development |
GO:0050870 | 0.0089 | 2.8923 | 2.9036 | 8 | 202 | positive regulation of T cell activation |
GO:0040020 | 0.0089 | 7.7047 | 0.4312 | 3 | 30 | regulation of meiotic nuclear division |
GO:0030098 | 0.0089 | 2.8924 | 2.9037 | 8 | 206 | lymphocyte differentiation |
GO:0014065 | 0.0091 | 3.552 | 1.7824 | 6 | 124 | phosphatidylinositol 3-kinase signaling |
GO:0050777 | 0.0094 | 3.5219 | 1.7968 | 6 | 125 | negative regulation of immune response |
GO:0045087 | 0.0095 | 1.8688 | 11.2766 | 20 | 794 | innate immune response |
GO:0050867 | 0.0096 | 15.9909 | 0.152 | 2 | 11 | positive regulation of cell activation |
GO:0051048 | 0.0097 | 2.8477 | 2.9467 | 8 | 205 | negative regulation of secretion |
GO:0035587 | 0.0098 | 7.429 | 0.4456 | 3 | 31 | purinergic receptor signaling pathway |
GO:1901701 | 0.0099 | 1.7588 | 14.4175 | 24 | 1003 | cellular response to oxygen-containing compound |
GO:0071772 | 0.0099 | 3.1007 | 2.3718 | 7 | 165 | response to BMP |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0070268 | 0 | 15.7683 | 1.1851 | 15 | 109 | cornification |
GO:0008544 | 0 | 6.3867 | 4.4579 | 24 | 410 | epidermis development |
GO:0030855 | 0 | 4.8951 | 6.7941 | 28 | 637 | epithelial cell differentiation |
GO:0030216 | 0 | 7.5782 | 2.7726 | 18 | 255 | keratinocyte differentiation |
GO:0008219 | 0 | 3.0205 | 12.0211 | 31 | 1176 | cell death |
GO:2000514 | 0 | 13.4169 | 0.5219 | 6 | 48 | regulation of CD4-positive, alpha-beta T cell activation |
GO:0045622 | 0 | 16.6881 | 0.3588 | 5 | 33 | regulation of T-helper cell differentiation |
GO:0002294 | 0 | 11.4952 | 0.598 | 6 | 55 | CD4-positive, alpha-beta T cell differentiation involved in immune response |
GO:0002287 | 0 | 11.2646 | 0.6089 | 6 | 56 | alpha-beta T cell activation involved in immune response |
GO:0046637 | 0 | 11.2646 | 0.6089 | 6 | 56 | regulation of alpha-beta T cell differentiation |
GO:1905331 | 0 | 24.7969 | 0.2066 | 4 | 19 | negative regulation of morphogenesis of an epithelium |
GO:0002292 | 1e-04 | 10.2373 | 0.6632 | 6 | 61 | T cell differentiation involved in immune response |
GO:0048627 | 1e-04 | Inf | 0.0217 | 2 | 2 | myoblast development |
GO:0045582 | 1e-04 | 8.3975 | 0.7937 | 6 | 73 | positive regulation of T cell differentiation |
GO:0009636 | 1e-04 | 4.5535 | 2.3812 | 10 | 219 | response to toxic substance |
GO:0043372 | 2e-04 | 16.1639 | 0.2936 | 4 | 27 | positive regulation of CD4-positive, alpha-beta T cell differentiation |
GO:0070555 | 2e-04 | 6.3959 | 1.196 | 7 | 110 | response to interleukin-1 |
GO:0048608 | 2e-04 | 3.3289 | 4.5557 | 14 | 419 | reproductive structure development |
GO:0022610 | 3e-04 | 2.2034 | 14.6132 | 29 | 1344 | biological adhesion |
GO:0097284 | 3e-04 | 27.7448 | 0.1413 | 3 | 13 | hepatocyte apoptotic process |
GO:2000145 | 4e-04 | 2.5159 | 8.6548 | 20 | 796 | regulation of cell motility |
GO:0045581 | 5e-04 | 12.3869 | 0.3697 | 4 | 34 | negative regulation of T cell differentiation |
GO:0022414 | 6e-04 | 2.1114 | 14.6132 | 28 | 1344 | reproductive process |
GO:0043371 | 6e-04 | 21.3382 | 0.174 | 3 | 16 | negative regulation of CD4-positive, alpha-beta T cell differentiation |
GO:0048513 | 7e-04 | 1.7583 | 34.8687 | 53 | 3241 | animal organ development |
GO:0008584 | 7e-04 | 5.1387 | 1.4678 | 7 | 135 | male gonad development |
GO:0045629 | 7e-04 | 92 | 0.0435 | 2 | 4 | negative regulation of T-helper 2 cell differentiation |
GO:0072164 | 7e-04 | 6.106 | 1.0655 | 6 | 98 | mesonephric tubule development |
GO:2000738 | 8e-04 | 19.8128 | 0.1848 | 3 | 17 | positive regulation of stem cell differentiation |
GO:1903038 | 9e-04 | 5.8501 | 1.109 | 6 | 102 | negative regulation of leukocyte cell-cell adhesion |
GO:0048869 | 9e-04 | 1.6776 | 44.0679 | 63 | 4053 | cellular developmental process |
GO:0045785 | 9e-04 | 3.1095 | 4.1317 | 12 | 380 | positive regulation of cell adhesion |
GO:0002285 | 0.001 | 4.7984 | 1.5657 | 7 | 144 | lymphocyte activation involved in immune response |
GO:0045103 | 0.0011 | 9.7743 | 0.4567 | 4 | 42 | intermediate filament-based process |
GO:1901031 | 0.0011 | 9.7743 | 0.4567 | 4 | 42 | regulation of response to reactive oxygen species |
GO:1901509 | 0.0012 | 61.3295 | 0.0544 | 2 | 5 | regulation of endothelial tube morphogenesis |
GO:1901668 | 0.0012 | 61.3295 | 0.0544 | 2 | 5 | regulation of superoxide dismutase activity |
GO:0045109 | 0.0013 | 16.3134 | 0.2175 | 3 | 20 | intermediate filament organization |
GO:0061436 | 0.0013 | 16.3134 | 0.2175 | 3 | 20 | establishment of skin barrier |
GO:0045619 | 0.0013 | 4.5954 | 1.6309 | 7 | 150 | regulation of lymphocyte differentiation |
GO:0010632 | 0.0014 | 4.0071 | 2.1311 | 8 | 196 | regulation of epithelial cell migration |
GO:0002825 | 0.0015 | 15.4061 | 0.2283 | 3 | 21 | regulation of T-helper 1 type immune response |
GO:0051497 | 0.0015 | 15.4061 | 0.2283 | 3 | 21 | negative regulation of stress fiber assembly |
GO:0070498 | 0.0015 | 15.4061 | 0.2283 | 3 | 21 | interleukin-1-mediated signaling pathway |
GO:0048646 | 0.0015 | 2.1689 | 10.9925 | 22 | 1011 | anatomical structure formation involved in morphogenesis |
GO:0072028 | 0.0015 | 6.4721 | 0.8372 | 5 | 77 | nephron morphogenesis |
GO:0046456 | 0.0015 | 8.8412 | 0.5002 | 4 | 46 | icosanoid biosynthetic process |
GO:0010595 | 0.0016 | 6.383 | 0.8481 | 5 | 78 | positive regulation of endothelial cell migration |
GO:1902904 | 0.0017 | 5.1011 | 1.2613 | 6 | 116 | negative regulation of supramolecular fiber organization |
GO:0045627 | 0.0017 | 45.9943 | 0.0652 | 2 | 6 | positive regulation of T-helper 1 cell differentiation |
GO:0061218 | 0.0017 | 45.9943 | 0.0652 | 2 | 6 | negative regulation of mesonephros development |
GO:1901723 | 0.0017 | 45.9943 | 0.0652 | 2 | 6 | negative regulation of cell proliferation involved in kidney development |
GO:0051346 | 0.0017 | 2.8845 | 4.4361 | 12 | 408 | negative regulation of hydrolase activity |
GO:0046661 | 0.0017 | 4.3497 | 1.7179 | 7 | 158 | male sex differentiation |
GO:0006959 | 0.0018 | 3.8416 | 2.2181 | 8 | 204 | humoral immune response |
GO:1900407 | 0.0019 | 6.1299 | 0.8807 | 5 | 81 | regulation of cellular response to oxidative stress |
GO:0001516 | 0.0019 | 13.8638 | 0.2501 | 3 | 23 | prostaglandin biosynthetic process |
GO:0019430 | 0.0019 | 13.8638 | 0.2501 | 3 | 23 | removal of superoxide radicals |
GO:0042347 | 0.0019 | 13.8638 | 0.2501 | 3 | 23 | negative regulation of NF-kappaB import into nucleus |
GO:0090132 | 0.0019 | 3.453 | 2.7726 | 9 | 255 | epithelium migration |
GO:0045995 | 0.002 | 4.9209 | 1.3047 | 6 | 120 | regulation of embryonic development |
GO:0040017 | 0.0021 | 2.6775 | 5.1755 | 13 | 476 | positive regulation of locomotion |
GO:0001655 | 0.0022 | 3.1328 | 3.3923 | 10 | 312 | urogenital system development |
GO:1903039 | 0.0023 | 3.6891 | 2.3051 | 8 | 212 | positive regulation of leukocyte cell-cell adhesion |
GO:0046635 | 0.0023 | 7.8982 | 0.5545 | 4 | 51 | positive regulation of alpha-beta T cell activation |
GO:0060017 | 0.0024 | 36.7931 | 0.0761 | 2 | 7 | parathyroid gland development |
GO:0022603 | 0.0024 | 2.1139 | 10.7098 | 21 | 985 | regulation of anatomical structure morphogenesis |
GO:0009310 | 0.0024 | 12.6019 | 0.2718 | 3 | 25 | amine catabolic process |
GO:0061037 | 0.0024 | 12.6019 | 0.2718 | 3 | 25 | negative regulation of cartilage development |
GO:0071450 | 0.0024 | 12.6019 | 0.2718 | 3 | 25 | cellular response to oxygen radical |
GO:0060548 | 0.0025 | 2.1492 | 10.0139 | 20 | 921 | negative regulation of cell death |
GO:0090183 | 0.0026 | 7.5748 | 0.5763 | 4 | 53 | regulation of kidney development |
GO:0006915 | 0.0026 | 1.8107 | 20.0279 | 33 | 1842 | apoptotic process |
GO:0002828 | 0.0027 | 12.0532 | 0.2827 | 3 | 26 | regulation of type 2 immune response |
GO:1903427 | 0.0027 | 12.0532 | 0.2827 | 3 | 26 | negative regulation of reactive oxygen species biosynthetic process |
GO:1902107 | 0.0031 | 4.4848 | 1.4244 | 6 | 131 | positive regulation of leukocyte differentiation |
GO:0051674 | 0.0031 | 1.8947 | 15.483 | 27 | 1424 | localization of cell |
GO:0003056 | 0.0032 | 30.659 | 0.087 | 2 | 8 | regulation of vascular smooth muscle contraction |
GO:0072497 | 0.0032 | 30.659 | 0.087 | 2 | 8 | mesenchymal stem cell differentiation |
GO:0090594 | 0.0032 | 30.659 | 0.087 | 2 | 8 | inflammatory response to wounding |
GO:1901299 | 0.0032 | 30.659 | 0.087 | 2 | 8 | negative regulation of hydrogen peroxide-mediated programmed cell death |
GO:1904685 | 0.0032 | 30.659 | 0.087 | 2 | 8 | positive regulation of metalloendopeptidase activity |
GO:0048729 | 0.0033 | 2.3677 | 6.7521 | 15 | 621 | tissue morphogenesis |
GO:0000303 | 0.0034 | 11.0876 | 0.3044 | 3 | 28 | response to superoxide |
GO:0046636 | 0.0034 | 11.0876 | 0.3044 | 3 | 28 | negative regulation of alpha-beta T cell activation |
GO:0060512 | 0.0034 | 11.0876 | 0.3044 | 3 | 28 | prostate gland morphogenesis |
GO:0035195 | 0.0035 | 3.4173 | 2.479 | 8 | 228 | gene silencing by miRNA |
GO:0032689 | 0.0038 | 10.6605 | 0.3153 | 3 | 29 | negative regulation of interferon-gamma production |
GO:0072073 | 0.0039 | 4.2778 | 1.4896 | 6 | 137 | kidney epithelium development |
GO:0030858 | 0.0039 | 6.746 | 0.6415 | 4 | 59 | positive regulation of epithelial cell differentiation |
GO:0090322 | 0.0041 | 10.265 | 0.3262 | 3 | 30 | regulation of superoxide metabolic process |
GO:0016441 | 0.0042 | 3.3105 | 2.5551 | 8 | 235 | posttranscriptional gene silencing |
GO:1990748 | 0.0043 | 5.0041 | 1.0655 | 5 | 98 | cellular detoxification |
GO:0051272 | 0.0044 | 2.553 | 4.9798 | 12 | 458 | positive regulation of cellular component movement |
GO:0007162 | 0.0044 | 3.2812 | 2.5769 | 8 | 237 | negative regulation of cell adhesion |
GO:0001667 | 0.0046 | 2.8183 | 3.7512 | 10 | 345 | ameboidal-type cell migration |
GO:0035239 | 0.0046 | 2.8097 | 3.762 | 10 | 346 | tube morphogenesis |
GO:0022407 | 0.0047 | 2.6487 | 4.3927 | 11 | 404 | regulation of cell-cell adhesion |
GO:0050891 | 0.0049 | 6.2871 | 0.685 | 4 | 63 | multicellular organismal water homeostasis |
GO:0010951 | 0.0049 | 3.224 | 2.6204 | 8 | 241 | negative regulation of endopeptidase activity |
GO:0045923 | 0.005 | 9.5559 | 0.3479 | 3 | 32 | positive regulation of fatty acid metabolic process |
GO:0070232 | 0.005 | 9.5559 | 0.3479 | 3 | 32 | regulation of T cell apoptotic process |
GO:0002934 | 0.005 | 22.9914 | 0.1087 | 2 | 10 | desmosome organization |
GO:0031581 | 0.005 | 22.9914 | 0.1087 | 2 | 10 | hemidesmosome assembly |
GO:1905205 | 0.005 | 22.9914 | 0.1087 | 2 | 10 | positive regulation of connective tissue replacement |
GO:2001054 | 0.005 | 22.9914 | 0.1087 | 2 | 10 | negative regulation of mesenchymal cell apoptotic process |
GO:0042308 | 0.0052 | 6.1819 | 0.6959 | 4 | 64 | negative regulation of protein import into nucleus |
GO:0060675 | 0.0052 | 6.1819 | 0.6959 | 4 | 64 | ureteric bud morphogenesis |
GO:0008284 | 0.0052 | 2.0804 | 9.2311 | 18 | 849 | positive regulation of cell proliferation |
GO:0006692 | 0.0054 | 9.2368 | 0.3588 | 3 | 33 | prostanoid metabolic process |
GO:0052547 | 0.0056 | 2.588 | 4.4905 | 11 | 413 | regulation of peptidase activity |
GO:0002526 | 0.0056 | 3.9437 | 1.6092 | 6 | 148 | acute inflammatory response |
GO:0002695 | 0.0056 | 3.9437 | 1.6092 | 6 | 148 | negative regulation of leukocyte activation |
GO:0044092 | 0.0057 | 1.9189 | 12.2973 | 22 | 1131 | negative regulation of molecular function |
GO:0050867 | 0.0057 | 2.9006 | 3.2727 | 9 | 301 | positive regulation of cell activation |
GO:2001240 | 0.0059 | 8.9383 | 0.3697 | 3 | 34 | negative regulation of extrinsic apoptotic signaling pathway in absence of ligand |
GO:0019852 | 0.0061 | 20.4356 | 0.1196 | 2 | 11 | L-ascorbic acid metabolic process |
GO:0060433 | 0.0061 | 20.4356 | 0.1196 | 2 | 11 | bronchus development |
GO:1903244 | 0.0061 | 20.4356 | 0.1196 | 2 | 11 | positive regulation of cardiac muscle hypertrophy in response to stress |
GO:1904753 | 0.0061 | 20.4356 | 0.1196 | 2 | 11 | negative regulation of vascular associated smooth muscle cell migration |
GO:0080134 | 0.0062 | 1.8298 | 14.711 | 25 | 1353 | regulation of response to stress |
GO:0071345 | 0.0062 | 2.0415 | 9.3942 | 18 | 864 | cellular response to cytokine stimulus |
GO:0006979 | 0.0063 | 2.5425 | 4.5666 | 11 | 420 | response to oxidative stress |
GO:0070227 | 0.0064 | 5.7941 | 0.7394 | 4 | 68 | lymphocyte apoptotic process |
GO:1901700 | 0.0067 | 1.777 | 16.3963 | 27 | 1508 | response to oxygen-containing compound |
GO:1901568 | 0.0068 | 3.7824 | 1.6744 | 6 | 154 | fatty acid derivative metabolic process |
GO:0014742 | 0.0069 | 8.3955 | 0.3914 | 3 | 36 | positive regulation of muscle hypertrophy |
GO:0019731 | 0.0069 | 8.3955 | 0.3914 | 3 | 36 | antibacterial humoral response |
GO:0051896 | 0.0072 | 3.3074 | 2.2289 | 7 | 205 | regulation of protein kinase B signaling |
GO:0001660 | 0.0072 | 18.3909 | 0.1305 | 2 | 12 | fever generation |
GO:0031047 | 0.0073 | 3.0016 | 2.8052 | 8 | 258 | gene silencing by RNA |
GO:0030335 | 0.0074 | 2.4864 | 4.6645 | 11 | 429 | positive regulation of cell migration |
GO:0038034 | 0.0075 | 5.5336 | 0.772 | 4 | 71 | signal transduction in absence of ligand |
GO:0042149 | 0.0075 | 8.1481 | 0.4023 | 3 | 37 | cellular response to glucose starvation |
GO:0051251 | 0.0075 | 2.9894 | 2.8161 | 8 | 259 | positive regulation of lymphocyte activation |
GO:0042127 | 0.0076 | 2.149 | 7.4296 | 15 | 721 | regulation of cell proliferation |
GO:0050727 | 0.0078 | 2.7562 | 3.4358 | 9 | 316 | regulation of inflammatory response |
GO:1901343 | 0.0078 | 4.305 | 1.2286 | 5 | 113 | negative regulation of vasculature development |
GO:0006952 | 0.0079 | 1.7694 | 15.8092 | 26 | 1454 | defense response |
GO:0006636 | 0.0081 | 7.9148 | 0.4132 | 3 | 38 | unsaturated fatty acid biosynthetic process |
GO:0001568 | 0.0082 | 2.185 | 6.7738 | 14 | 623 | blood vessel development |
GO:0072078 | 0.0082 | 5.3725 | 0.7937 | 4 | 73 | nephron tubule morphogenesis |
GO:0003158 | 0.0084 | 4.2262 | 1.2504 | 5 | 115 | endothelium development |
GO:0072189 | 0.0085 | 16.7179 | 0.1413 | 2 | 13 | ureter development |
GO:0090343 | 0.0085 | 16.7179 | 0.1413 | 2 | 13 | positive regulation of cell aging |
GO:0010035 | 0.0085 | 2.3319 | 5.4256 | 12 | 499 | response to inorganic substance |
GO:0001659 | 0.0087 | 7.6944 | 0.424 | 3 | 39 | temperature homeostasis |
GO:0032941 | 0.0087 | 7.6944 | 0.424 | 3 | 39 | secretion by tissue |
GO:0048771 | 0.0089 | 3.5635 | 1.7723 | 6 | 163 | tissue remodeling |
GO:0045137 | 0.009 | 3.1618 | 2.3268 | 7 | 214 | development of primary sexual characteristics |
GO:0033673 | 0.0091 | 2.8843 | 2.9139 | 8 | 268 | negative regulation of kinase activity |
GO:0097191 | 0.0094 | 3.1312 | 2.3485 | 7 | 216 | extrinsic apoptotic signaling pathway |
GO:0014744 | 0.0098 | 15.3238 | 0.1522 | 2 | 14 | positive regulation of muscle adaptation |
GO:0060009 | 0.0098 | 15.3238 | 0.1522 | 2 | 14 | Sertoli cell development |
GO:1900037 | 0.0098 | 15.3238 | 0.1522 | 2 | 14 | regulation of cellular response to hypoxia |
GO:2000106 | 0.0099 | 5.0769 | 0.8372 | 4 | 77 | regulation of leukocyte apoptotic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 38.7279 | 3.2226 | 65 | 261 | detection of chemical stimulus involved in sensory perception of smell |
GO:0050906 | 0 | 29.493 | 4.3092 | 69 | 349 | detection of stimulus involved in sensory perception |
GO:0009593 | 0 | 30.3922 | 4.124 | 68 | 334 | detection of chemical stimulus |
GO:0007606 | 0 | 29.2801 | 4.3339 | 69 | 351 | sensory perception of chemical stimulus |
GO:0050877 | 0 | 8.9605 | 13.8165 | 77 | 1119 | nervous system process |
GO:0007186 | 0 | 8.9176 | 13.7262 | 76 | 1133 | G-protein coupled receptor signaling pathway |
GO:0007154 | 0 | 2.509 | 75.1821 | 120 | 6089 | cell communication |
GO:0023052 | 0 | 2.4689 | 74.9598 | 119 | 6071 | signaling |
GO:0032501 | 0 | 2.3736 | 85.9241 | 128 | 6959 | multicellular organismal process |
GO:0051716 | 0 | 2.0158 | 84.5659 | 119 | 6849 | cellular response to stimulus |
GO:0098664 | 1e-04 | 23.298 | 0.2222 | 4 | 18 | G-protein coupled serotonin receptor signaling pathway |
GO:0033141 | 1e-04 | 60.8864 | 0.0864 | 3 | 7 | positive regulation of peptidyl-serine phosphorylation of STAT protein |
GO:0050794 | 1e-04 | 1.8033 | 124.9166 | 150 | 10117 | regulation of cellular process |
GO:0065007 | 2e-04 | 1.8787 | 140.0666 | 163 | 11344 | biological regulation |
GO:0019228 | 9e-04 | 10.5106 | 0.4322 | 4 | 35 | neuronal action potential |
GO:0032747 | 0.0015 | 53.8526 | 0.0617 | 2 | 5 | positive regulation of interleukin-23 production |
GO:0050704 | 0.0017 | 8.5707 | 0.5186 | 4 | 42 | regulation of interleukin-1 secretion |
GO:0070098 | 0.0023 | 5.8338 | 0.926 | 5 | 75 | chemokine-mediated signaling pathway |
GO:0097530 | 0.0032 | 4.4666 | 1.4323 | 6 | 116 | granulocyte migration |
GO:0002250 | 0.0033 | 2.7887 | 4.1734 | 11 | 338 | adaptive immune response |
GO:0002286 | 0.0033 | 5.3712 | 1.0001 | 5 | 81 | T cell activation involved in immune response |
GO:0097264 | 0.004 | 26.9213 | 0.0988 | 2 | 8 | self proteolysis |
GO:0002548 | 0.0044 | 6.5088 | 0.6667 | 4 | 54 | monocyte chemotaxis |
GO:0032651 | 0.0064 | 5.8093 | 0.7408 | 4 | 60 | regulation of interleukin-1 beta production |
GO:0045591 | 0.0078 | 17.9442 | 0.1358 | 2 | 11 | positive regulation of regulatory T cell differentiation |
GO:0048245 | 0.0078 | 17.9442 | 0.1358 | 2 | 11 | eosinophil chemotaxis |
GO:0050713 | 0.0078 | 17.9442 | 0.1358 | 2 | 11 | negative regulation of interleukin-1 beta secretion |
GO:0050663 | 0.0089 | 3.1691 | 2.3213 | 7 | 188 | cytokine secretion |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 11.7387 | 2.5813 | 24 | 261 | detection of chemical stimulus involved in sensory perception of smell |
GO:0009593 | 0 | 9.4047 | 3.3033 | 25 | 334 | detection of chemical stimulus |
GO:0050906 | 0 | 8.5128 | 3.4516 | 24 | 349 | detection of stimulus involved in sensory perception |
GO:0007606 | 0 | 8.4597 | 3.4714 | 24 | 351 | sensory perception of chemical stimulus |
GO:0007186 | 0 | 3.5954 | 11.3834 | 34 | 1151 | G-protein coupled receptor signaling pathway |
GO:0050877 | 0 | 3.029 | 11.067 | 29 | 1119 | nervous system process |
GO:0009913 | 1e-04 | 4.365 | 3.0066 | 12 | 304 | epidermal cell differentiation |
GO:0031640 | 1e-04 | 11.1984 | 0.5044 | 5 | 51 | killing of cells of other organism |
GO:0043588 | 3e-04 | 3.5864 | 3.6198 | 12 | 366 | skin development |
GO:0031424 | 5e-04 | 4.7635 | 1.8099 | 8 | 183 | keratinization |
GO:1990523 | 6e-04 | 101.3585 | 0.0396 | 2 | 4 | bone regeneration |
GO:0019373 | 0.001 | 17.9832 | 0.1978 | 3 | 20 | epoxygenase P450 pathway |
GO:0030728 | 0.0013 | 16.0883 | 0.2176 | 3 | 22 | ovulation |
GO:0034058 | 0.0042 | 25.3302 | 0.0989 | 2 | 10 | endosomal vesicle fusion |
GO:0072348 | 0.0049 | 9.5447 | 0.3462 | 3 | 35 | sulfur compound transport |
GO:0042738 | 0.005 | 22.5143 | 0.1088 | 2 | 11 | exogenous drug catabolic process |
GO:0070098 | 0.0065 | 5.7583 | 0.7418 | 4 | 75 | chemokine-mediated signaling pathway |
GO:0045616 | 0.0067 | 8.4821 | 0.3857 | 3 | 39 | regulation of keratinocyte differentiation |
GO:1902358 | 0.0071 | 18.4185 | 0.1286 | 2 | 13 | sulfate transmembrane transport |
GO:0071361 | 0.0082 | 16.8826 | 0.1385 | 2 | 14 | cellular response to ethanol |
GO:0001680 | 0.0099 | Inf | 0.0099 | 1 | 1 | tRNA 3'-terminal CCA addition |
GO:0003311 | 0.0099 | Inf | 0.0099 | 1 | 1 | pancreatic D cell differentiation |
GO:0019290 | 0.0099 | Inf | 0.0099 | 1 | 1 | siderophore biosynthetic process |
GO:0044278 | 0.0099 | Inf | 0.0099 | 1 | 1 | cell wall disruption in other organism |
GO:0071307 | 0.0099 | Inf | 0.0099 | 1 | 1 | cellular response to vitamin K |
GO:0090104 | 0.0099 | Inf | 0.0099 | 1 | 1 | pancreatic epsilon cell differentiation |
GO:1902038 | 0.0099 | Inf | 0.0099 | 1 | 1 | positive regulation of hematopoietic stem cell differentiation |
GO:1990180 | 0.0099 | Inf | 0.0099 | 1 | 1 | mitochondrial tRNA 3'-end processing |
GO:1990786 | 0.0099 | Inf | 0.0099 | 1 | 1 | cellular response to dsDNA |
GO:0044764 | 0.0099 | 7.2676 | 0.4451 | 3 | 45 | multi-organism cellular process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 29.697 | 3.2387 | 56 | 261 | detection of chemical stimulus involved in sensory perception of smell |
GO:0009593 | 0 | 23.708 | 4.1445 | 59 | 334 | detection of chemical stimulus |
GO:0050906 | 0 | 21.8497 | 4.3306 | 58 | 349 | detection of stimulus involved in sensory perception |
GO:0007606 | 0 | 21.6978 | 4.3554 | 58 | 351 | sensory perception of chemical stimulus |
GO:0007186 | 0 | 7.3565 | 14.2823 | 70 | 1151 | G-protein coupled receptor signaling pathway |
GO:0050877 | 0 | 6.293 | 13.8853 | 62 | 1119 | nervous system process |
GO:0018149 | 0 | 18.2388 | 0.6204 | 9 | 50 | peptide cross-linking |
GO:0050896 | 0 | 3.161 | 13.4224 | 32 | 1361 | response to stimulus |
GO:0009913 | 0 | 4.7159 | 3.7722 | 16 | 304 | epidermal cell differentiation |
GO:0043588 | 0 | 4.1412 | 4.5416 | 17 | 366 | skin development |
GO:0023052 | 0 | 1.9099 | 75.3328 | 107 | 6071 | signaling |
GO:0007154 | 0 | 1.9007 | 75.5561 | 107 | 6089 | cell communication |
GO:0006959 | 0 | 5.2253 | 2.5314 | 12 | 204 | humoral immune response |
GO:0061844 | 0 | 11.6873 | 0.5956 | 6 | 48 | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO:0031424 | 0 | 8.8406 | 0.8924 | 7 | 74 | keratinization |
GO:0032501 | 1e-04 | 1.7904 | 79.1431 | 106 | 6776 | multicellular organismal process |
GO:0051716 | 4e-04 | 1.6236 | 84.9867 | 109 | 6849 | cellular response to stimulus |
GO:0070268 | 4e-04 | 5.6222 | 1.3525 | 7 | 109 | cornification |
GO:0050776 | 6e-04 | 2.2708 | 10.9692 | 23 | 884 | regulation of immune response |
GO:0019228 | 9e-04 | 10.4568 | 0.4343 | 4 | 35 | neuronal action potential |
GO:0002250 | 0.0011 | 3.0515 | 4.1941 | 12 | 338 | adaptive immune response |
GO:0042742 | 0.0013 | 3.6648 | 2.6182 | 9 | 211 | defense response to bacterium |
GO:0002361 | 0.0015 | 53.58 | 0.062 | 2 | 5 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation |
GO:0032747 | 0.0015 | 53.58 | 0.062 | 2 | 5 | positive regulation of interleukin-23 production |
GO:0035821 | 0.0017 | 4.3696 | 1.7124 | 7 | 138 | modification of morphology or physiology of other organism |
GO:0007338 | 0.0018 | 4.3362 | 1.7248 | 7 | 139 | single fertilization |
GO:0050704 | 0.0018 | 8.5268 | 0.5212 | 4 | 42 | regulation of interleukin-1 secretion |
GO:0002376 | 0.0025 | 1.6449 | 33.1186 | 49 | 2669 | immune system process |
GO:0045087 | 0.0026 | 2.1321 | 10.0262 | 20 | 808 | innate immune response |
GO:0032612 | 0.0032 | 5.4152 | 0.9927 | 5 | 80 | interleukin-1 production |
GO:0051715 | 0.0052 | 22.9571 | 0.1117 | 2 | 9 | cytolysis in other organism |
GO:0050482 | 0.0054 | 9.3067 | 0.3599 | 3 | 29 | arachidonic acid secretion |
GO:0080154 | 0.0054 | 9.3067 | 0.3599 | 3 | 29 | regulation of fertilization |
GO:0032651 | 0.0065 | 5.7796 | 0.7445 | 4 | 60 | regulation of interleukin-1 beta production |
GO:0031640 | 0.0075 | 8.1796 | 0.4038 | 3 | 33 | killing of cells of other organism |
GO:0045670 | 0.0077 | 5.4847 | 0.7817 | 4 | 63 | regulation of osteoclast differentiation |
GO:0045591 | 0.0078 | 17.8533 | 0.1365 | 2 | 11 | positive regulation of regulatory T cell differentiation |
GO:0050713 | 0.0078 | 17.8533 | 0.1365 | 2 | 11 | negative regulation of interleukin-1 beta secretion |
GO:2000344 | 0.0078 | 17.8533 | 0.1365 | 2 | 11 | positive regulation of acrosome reaction |
GO:0050832 | 0.0085 | 7.8032 | 0.4219 | 3 | 34 | defense response to fungus |
GO:0050663 | 0.0091 | 3.1526 | 2.3328 | 7 | 188 | cytokine secretion |
GO:0006954 | 0.0092 | 2.0351 | 8.289 | 16 | 668 | inflammatory response |
GO:0051712 | 0.0093 | 16.067 | 0.1489 | 2 | 12 | positive regulation of killing of cells of other organism |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0030197 | 0.0013 | 67.7384 | 0.0587 | 2 | 4 | extracellular matrix constituent, lubricant activity |
GO:0034987 | 0.0043 | 27.0903 | 0.1027 | 2 | 7 | immunoglobulin receptor binding |
GO:0016884 | 0.0089 | 16.9283 | 0.1467 | 2 | 10 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor |
GO:0004896 | 0.0095 | 4.1121 | 1.2907 | 5 | 88 | cytokine receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0043023 | 1e-04 | 54.526 | 0.0962 | 3 | 7 | ribosomal large subunit binding |
GO:1903231 | 9e-04 | 5.8701 | 1.1135 | 6 | 81 | mRNA binding involved in posttranscriptional gene silencing |
GO:0004024 | 0.0018 | 48.2523 | 0.0687 | 2 | 5 | alcohol dehydrogenase activity, zinc-dependent |
GO:0048027 | 0.0033 | 11.4684 | 0.3024 | 3 | 22 | mRNA 5'-UTR binding |
GO:0008318 | 0.0038 | 28.9477 | 0.0962 | 2 | 7 | protein prenyltransferase activity |
GO:0003723 | 0.0041 | 1.6965 | 22.9017 | 36 | 1666 | RNA binding |
GO:0008234 | 0.0098 | 3.1097 | 2.3644 | 7 | 172 | cysteine-type peptidase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 15.1722 | 2.4666 | 28 | 261 | olfactory receptor activity |
GO:0004930 | 0 | 6.0355 | 6.4076 | 31 | 678 | G-protein coupled receptor activity |
GO:0038023 | 0 | 3.8448 | 11.1708 | 35 | 1182 | signaling receptor activity |
GO:0099600 | 0 | 3.9201 | 10.6037 | 34 | 1122 | transmembrane receptor activity |
GO:0060089 | 0 | 3.068 | 13.6752 | 35 | 1447 | molecular transducer activity |
GO:0070330 | 0 | 33.8192 | 0.1985 | 5 | 21 | aromatase activity |
GO:0005549 | 0 | 14.7335 | 0.5576 | 7 | 59 | odorant binding |
GO:0019825 | 0 | 14.6055 | 0.3969 | 5 | 42 | oxygen binding |
GO:0016705 | 1e-04 | 6.3081 | 1.3893 | 8 | 147 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen |
GO:0020037 | 2e-04 | 6.636 | 1.153 | 7 | 122 | heme binding |
GO:0048020 | 2e-04 | 16.5282 | 0.2835 | 4 | 30 | CCR chemokine receptor binding |
GO:0008392 | 4e-04 | 24.648 | 0.1512 | 3 | 16 | arachidonic acid epoxygenase activity |
GO:0034875 | 5e-04 | 106.1776 | 0.0378 | 2 | 4 | caffeine oxidase activity |
GO:0005506 | 6e-04 | 5.2532 | 1.4365 | 7 | 152 | iron ion binding |
GO:0008009 | 6e-04 | 11.3004 | 0.3969 | 4 | 42 | chemokine activity |
GO:0004190 | 0.001 | 17.7958 | 0.1985 | 3 | 21 | aspartic-type endopeptidase activity |
GO:0030545 | 0.0011 | 3.073 | 4.1961 | 12 | 444 | receptor regulator activity |
GO:0008131 | 0.0013 | 53.0822 | 0.0567 | 2 | 6 | primary amine oxidase activity |
GO:0001591 | 0.0018 | 42.4632 | 0.0662 | 2 | 7 | dopamine neurotransmitter receptor activity, coupled via Gi/Go |
GO:0042056 | 0.0023 | 12.8074 | 0.2646 | 3 | 28 | chemoattractant activity |
GO:0008395 | 0.0027 | 11.9363 | 0.2817 | 3 | 30 | steroid hydroxylase activity |
GO:0016725 | 0.0031 | 30.3271 | 0.0851 | 2 | 9 | oxidoreductase activity, acting on CH or CH2 groups |
GO:0035240 | 0.0055 | 21.225 | 0.1134 | 2 | 12 | dopamine binding |
GO:0030414 | 0.0062 | 3.8545 | 1.6444 | 6 | 174 | peptidase inhibitor activity |
GO:0030246 | 0.0088 | 3.1819 | 2.3154 | 7 | 245 | carbohydrate binding |
GO:0005133 | 0.0095 | Inf | 0.0095 | 1 | 1 | interferon-gamma receptor binding |
GO:0008123 | 0.0095 | Inf | 0.0095 | 1 | 1 | cholesterol 7-alpha-monooxygenase activity |
GO:0036458 | 0.0095 | Inf | 0.0095 | 1 | 1 | hepatocyte growth factor binding |
GO:0038164 | 0.0095 | Inf | 0.0095 | 1 | 1 | thrombopoietin receptor activity |
GO:1902122 | 0.0095 | Inf | 0.0095 | 1 | 1 | chenodeoxycholic acid binding |
GO:0005537 | 0.0098 | 15.157 | 0.1512 | 2 | 16 | mannose binding |
GO:0022821 | 0.0098 | 15.157 | 0.1512 | 2 | 16 | potassium ion antiporter activity |
GO:0033038 | 0.0098 | 15.157 | 0.1512 | 2 | 16 | bitter taste receptor activity |
GO:0001664 | 0.0099 | 3.1025 | 2.3721 | 7 | 251 | G-protein coupled receptor binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005509 | 4e-04 | 2.6068 | 7.8944 | 19 | 670 | calcium ion binding |
GO:0035662 | 4e-04 | 169.4947 | 0.0353 | 2 | 3 | Toll-like receptor 4 binding |
GO:0001228 | 5e-04 | 3.1975 | 4.3689 | 13 | 376 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding |
GO:0050544 | 0.0013 | 56.4912 | 0.0589 | 2 | 5 | arachidonic acid binding |
GO:0005125 | 0.0023 | 3.6806 | 2.3094 | 8 | 196 | cytokine activity |
GO:0001205 | 0.0047 | 9.815 | 0.3417 | 3 | 29 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding |
GO:0050786 | 0.0058 | 21.1776 | 0.1178 | 2 | 10 | RAGE receptor binding |
GO:0036041 | 0.0071 | 18.8234 | 0.1296 | 2 | 11 | long-chain fatty acid binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004872 | 0 | 3.761 | 17.1217 | 51 | 1402 | receptor activity |
GO:0004871 | 0 | 2.9515 | 18.2574 | 45 | 1495 | signal transducer activity |
GO:0004930 | 0 | 3.2382 | 8.28 | 24 | 678 | G-protein coupled receptor activity |
GO:0004984 | 0 | 4.8558 | 3.1874 | 14 | 261 | olfactory receptor activity |
GO:0005549 | 1e-04 | 9.4103 | 0.7205 | 6 | 59 | odorant binding |
GO:0004867 | 1e-04 | 6.7872 | 1.1357 | 7 | 93 | serine-type endopeptidase inhibitor activity |
GO:0102294 | 1e-04 | Inf | 0.0244 | 2 | 2 | cholesterol dehydrogenase activity |
GO:0004888 | 2e-04 | 3.419 | 4.4487 | 14 | 397 | transmembrane signaling receptor activity |
GO:0061135 | 3e-04 | 4.6017 | 2.1127 | 9 | 173 | endopeptidase regulator activity |
GO:0030414 | 3e-04 | 4.5735 | 2.1249 | 9 | 174 | peptidase inhibitor activity |
GO:0004769 | 4e-04 | 163.401 | 0.0366 | 2 | 3 | steroid delta-isomerase activity |
GO:0001588 | 9e-04 | 81.6954 | 0.0488 | 2 | 4 | dopamine neurotransmitter receptor activity, coupled via Gs |
GO:0030246 | 9e-04 | 3.5711 | 2.992 | 10 | 245 | carbohydrate binding |
GO:0001875 | 0.0014 | 54.4602 | 0.0611 | 2 | 5 | lipopolysaccharide receptor activity |
GO:0003854 | 0.0014 | 54.4602 | 0.0611 | 2 | 5 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity |
GO:0004111 | 0.0022 | 40.8426 | 0.0733 | 2 | 6 | creatine kinase activity |
GO:0016229 | 0.0042 | 10.25 | 0.3297 | 3 | 27 | steroid dehydrogenase activity |
GO:0019864 | 0.005 | 23.3343 | 0.1099 | 2 | 9 | IgG binding |
GO:0016709 | 0.0081 | 7.932 | 0.4152 | 3 | 34 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen |
GO:0001784 | 0.0088 | 7.6837 | 0.4274 | 3 | 35 | phosphotyrosine residue binding |
GO:0008329 | 0.0089 | 16.4954 | 0.1451 | 2 | 12 | signaling pattern recognition receptor activity |
GO:0005126 | 0.0099 | 2.8392 | 2.9554 | 8 | 242 | cytokine receptor binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004689 | 0 | 127.1053 | 0.0592 | 3 | 5 | phosphorylase kinase activity |
GO:0036374 | 0 | 84.7316 | 0.0711 | 3 | 6 | glutathione hydrolase activity |
GO:0031720 | 4e-04 | 168.5969 | 0.0355 | 2 | 3 | haptoglobin binding |
GO:0004111 | 0.002 | 42.1414 | 0.0711 | 2 | 6 | creatine kinase activity |
GO:0004468 | 0.002 | 42.1414 | 0.0711 | 2 | 6 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor |
GO:1903231 | 0.0027 | 5.6082 | 0.9594 | 5 | 81 | mRNA binding involved in posttranscriptional gene silencing |
GO:0140104 | 0.0028 | 34.0444 | 0.0821 | 2 | 7 | molecular carrier activity |
GO:0003723 | 0.0041 | 1.7599 | 19.7323 | 32 | 1666 | RNA binding |
GO:0050321 | 0.0085 | 16.8503 | 0.1421 | 2 | 12 | tau-protein kinase activity |
GO:0005344 | 0.01 | 15.3175 | 0.154 | 2 | 13 | oxygen carrier activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:1903231 | 0 | 8.004 | 1.1284 | 8 | 81 | mRNA binding involved in posttranscriptional gene silencing |
GO:0004111 | 0.0028 | 35.6978 | 0.0836 | 2 | 6 | creatine kinase activity |
GO:0002151 | 0.0039 | 28.5564 | 0.0975 | 2 | 7 | G-quadruplex RNA binding |
GO:0003747 | 0.0039 | 28.5564 | 0.0975 | 2 | 7 | translation release factor activity |
GO:0017091 | 0.0049 | 9.7683 | 0.3483 | 3 | 25 | AU-rich element binding |
GO:0000990 | 0.0051 | 23.7956 | 0.1114 | 2 | 8 | transcription factor activity, core RNA polymerase binding |
GO:0016861 | 0.0051 | 23.7956 | 0.1114 | 2 | 8 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses |
GO:0003723 | 0.0084 | 1.6323 | 22.3051 | 34 | 1634 | RNA binding |
GO:0070410 | 0.0098 | 15.8607 | 0.1532 | 2 | 11 | co-SMAD binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0019864 | 1e-04 | 43.2796 | 0.1044 | 3 | 9 | IgG binding |
GO:0031720 | 4e-04 | 172.246 | 0.0348 | 2 | 3 | haptoglobin binding |
GO:0004468 | 0.0019 | 43.0535 | 0.0696 | 2 | 6 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor |
GO:0005344 | 0.0096 | 15.649 | 0.1508 | 2 | 13 | oxygen carrier activity |
GO:0048019 | 0.0096 | 15.649 | 0.1508 | 2 | 13 | receptor antagonist activity |
GO:0005179 | 0.0098 | 4.0631 | 1.299 | 5 | 112 | hormone activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0003735 | 0 | 5.863 | 3.1093 | 16 | 154 | structural constituent of ribosome |
GO:0046964 | 4e-04 | Inf | 0.0404 | 2 | 2 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity |
GO:0003743 | 0.0025 | 5.851 | 0.9489 | 5 | 47 | translation initiation factor activity |
GO:0005488 | 0.0058 | 1.6113 | 283.5316 | 299 | 14043 | binding |
GO:0003723 | 0.0061 | 1.5325 | 33.3063 | 48 | 1659 | RNA binding |
GO:0008312 | 0.008 | 19.5242 | 0.1413 | 2 | 7 | 7S RNA binding |
GO:0008318 | 0.008 | 19.5242 | 0.1413 | 2 | 7 | protein prenyltransferase activity |
GO:0000149 | 0.0096 | 3.1336 | 2.3623 | 7 | 117 | SNARE binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042393 | 0 | 5.7199 | 2.7383 | 14 | 194 | histone binding |
GO:0046982 | 0 | 3.2236 | 6.7892 | 20 | 481 | protein heterodimerization activity |
GO:0043565 | 1e-04 | 2.3266 | 14.1571 | 30 | 1003 | sequence-specific DNA binding |
GO:0001228 | 1e-04 | 5.3502 | 1.8397 | 9 | 134 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding |
GO:0019904 | 1e-04 | 2.7708 | 7.8259 | 20 | 565 | protein domain specific binding |
GO:0005102 | 1e-04 | 2.0716 | 20.3111 | 38 | 1439 | receptor binding |
GO:0004872 | 5e-04 | 4.1986 | 2.3097 | 9 | 174 | receptor activity |
GO:0001012 | 0.001 | 2.3702 | 8.5677 | 19 | 607 | RNA polymerase II regulatory region DNA binding |
GO:0005070 | 0.0012 | 6.8432 | 0.8045 | 5 | 57 | SH3/SH2 adaptor activity |
GO:0038023 | 0.0013 | 1.9418 | 16.6836 | 30 | 1182 | signaling receptor activity |
GO:0003700 | 0.0016 | 1.9096 | 16.9377 | 30 | 1200 | DNA binding transcription factor activity |
GO:0030545 | 0.0016 | 2.5429 | 6.267 | 15 | 444 | receptor regulator activity |
GO:0000976 | 0.0017 | 2.2125 | 9.6404 | 20 | 683 | transcription regulatory region sequence-specific DNA binding |
GO:0001159 | 0.0026 | 2.6061 | 5.2789 | 13 | 374 | core promoter proximal region DNA binding |
GO:0000975 | 0.0038 | 1.9791 | 11.8141 | 22 | 837 | regulatory region DNA binding |
GO:0005031 | 0.004 | 10.6024 | 0.3246 | 3 | 23 | tumor necrosis factor-activated receptor activity |
GO:0035586 | 0.0045 | 10.0969 | 0.3388 | 3 | 24 | purinergic receptor activity |
GO:0099600 | 0.0046 | 1.8183 | 15.8368 | 27 | 1122 | transmembrane receptor activity |
GO:0005160 | 0.005 | 6.3009 | 0.6916 | 4 | 49 | transforming growth factor beta receptor binding |
GO:0000978 | 0.005 | 2.5008 | 5.0531 | 12 | 358 | RNA polymerase II core promoter proximal region sequence-specific DNA binding |
GO:0001077 | 0.0053 | 2.7524 | 3.8251 | 10 | 271 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding |
GO:0019864 | 0.0067 | 20.1228 | 0.127 | 2 | 9 | IgG binding |
GO:0008083 | 0.0067 | 3.3531 | 2.2019 | 7 | 156 | growth factor activity |
GO:0005125 | 0.0068 | 3.0433 | 2.7665 | 8 | 196 | cytokine activity |
GO:0017124 | 0.008 | 3.6511 | 1.7361 | 6 | 123 | SH3 domain binding |
GO:0003690 | 0.0097 | 1.8638 | 11.3059 | 20 | 801 | double-stranded DNA binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0031492 | 0 | 33.1304 | 0.4131 | 10 | 44 | nucleosomal DNA binding |
GO:0044877 | 0 | 3.3372 | 9.0044 | 26 | 959 | macromolecular complex binding |
GO:0042393 | 0 | 6.7555 | 1.8215 | 11 | 194 | histone binding |
GO:0005518 | 0 | 13.5298 | 0.6009 | 7 | 64 | collagen binding |
GO:0046982 | 0 | 3.6565 | 4.5163 | 15 | 481 | protein heterodimerization activity |
GO:0050840 | 1e-04 | 11.8214 | 0.4789 | 5 | 51 | extracellular matrix binding |
GO:0003682 | 3e-04 | 3.2584 | 4.6759 | 14 | 498 | chromatin binding |
GO:0005178 | 6e-04 | 6.2943 | 1.0328 | 6 | 110 | integrin binding |
GO:0045296 | 6e-04 | 3.7696 | 2.8544 | 10 | 304 | cadherin binding |
GO:0030023 | 9e-04 | 71.2539 | 0.0469 | 2 | 5 | extracellular matrix constituent conferring elasticity |
GO:0004190 | 0.001 | 17.9156 | 0.1972 | 3 | 21 | aspartic-type endopeptidase activity |
GO:1903231 | 0.001 | 7.1417 | 0.7605 | 5 | 81 | mRNA binding involved in posttranscriptional gene silencing |
GO:0001968 | 0.002 | 13.4317 | 0.2535 | 3 | 27 | fibronectin binding |
GO:0016229 | 0.002 | 13.4317 | 0.2535 | 3 | 27 | steroid dehydrogenase activity |
GO:0008201 | 0.0037 | 4.3225 | 1.4741 | 6 | 157 | heparin binding |
GO:0048407 | 0.0046 | 23.7425 | 0.1033 | 2 | 11 | platelet-derived growth factor binding |
GO:0061135 | 0.0059 | 3.9044 | 1.6244 | 6 | 173 | endopeptidase regulator activity |
GO:0030414 | 0.006 | 3.881 | 1.6338 | 6 | 174 | peptidase inhibitor activity |
GO:0048019 | 0.0064 | 19.4232 | 0.1221 | 2 | 13 | receptor antagonist activity |
GO:0002020 | 0.0074 | 4.3641 | 1.2112 | 5 | 129 | protease binding |
GO:0008191 | 0.0085 | 16.433 | 0.1408 | 2 | 15 | metalloendopeptidase inhibitor activity |
GO:0003868 | 0.0094 | Inf | 0.0094 | 1 | 1 | 4-hydroxyphenylpyruvate dioxygenase activity |
GO:0004341 | 0.0094 | Inf | 0.0094 | 1 | 1 | gluconolactonase activity |
GO:0008112 | 0.0094 | Inf | 0.0094 | 1 | 1 | nicotinamide N-methyltransferase activity |
GO:0019807 | 0.0094 | Inf | 0.0094 | 1 | 1 | aspartoacylase activity |
GO:0030760 | 0.0094 | Inf | 0.0094 | 1 | 1 | pyridine N-methyltransferase activity |
GO:0031962 | 0.0094 | Inf | 0.0094 | 1 | 1 | mineralocorticoid receptor binding |
GO:0035410 | 0.0094 | Inf | 0.0094 | 1 | 1 | dihydrotestosterone 17-beta-dehydrogenase activity |
GO:0036130 | 0.0094 | Inf | 0.0094 | 1 | 1 | prostaglandin H2 endoperoxidase reductase activity |
GO:0036131 | 0.0094 | Inf | 0.0094 | 1 | 1 | prostaglandin D2 11-ketoreductase activity |
GO:0045703 | 0.0094 | Inf | 0.0094 | 1 | 1 | ketoreductase activity |
GO:0047020 | 0.0094 | Inf | 0.0094 | 1 | 1 | 15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity |
GO:0050683 | 0.0094 | Inf | 0.0094 | 1 | 1 | AF-1 domain binding |
GO:0061627 | 0.0094 | Inf | 0.0094 | 1 | 1 | S-methylmethionine-homocysteine S-methyltransferase activity |
GO:0070524 | 0.0094 | Inf | 0.0094 | 1 | 1 | 11-beta-hydroxysteroid dehydrogenase (NADP+) activity |
GO:1902118 | 0.0094 | Inf | 0.0094 | 1 | 1 | calcidiol binding |
GO:1902122 | 0.0094 | Inf | 0.0094 | 1 | 1 | chenodeoxycholic acid binding |
GO:0048038 | 0.0096 | 15.2583 | 0.1502 | 2 | 16 | quinone binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004252 | 6e-04 | 4.5519 | 1.8889 | 8 | 171 | serine-type endopeptidase activity |
GO:0098641 | 0.001 | 18.1921 | 0.1988 | 3 | 18 | cadherin binding involved in cell-cell adhesion |
GO:0005198 | 0.0014 | 2.4461 | 7.4673 | 17 | 676 | structural molecule activity |
GO:0008201 | 0.0018 | 4.3066 | 1.7343 | 7 | 157 | heparin binding |
GO:0017171 | 0.0019 | 3.7973 | 2.2424 | 8 | 203 | serine hydrolase activity |
GO:1903231 | 0.002 | 6.0297 | 0.8948 | 5 | 81 | mRNA binding involved in posttranscriptional gene silencing |
GO:0004866 | 0.0026 | 4.0349 | 1.8447 | 7 | 167 | endopeptidase inhibitor activity |
GO:0097110 | 0.0032 | 7.1586 | 0.6075 | 4 | 55 | scaffold protein binding |
GO:0070851 | 0.0032 | 4.4469 | 1.436 | 6 | 130 | growth factor receptor binding |
GO:0045294 | 0.0052 | 22.6222 | 0.1105 | 2 | 10 | alpha-catenin binding |
GO:0070513 | 0.0052 | 22.6222 | 0.1105 | 2 | 10 | death domain binding |
GO:0005126 | 0.0055 | 3.1566 | 2.6732 | 8 | 242 | cytokine receptor binding |
GO:0005088 | 0.0058 | 3.1295 | 2.6953 | 8 | 244 | Ras guanyl-nucleotide exchange factor activity |
GO:0098631 | 0.0084 | 7.7869 | 0.4198 | 3 | 38 | cell adhesion mediator activity |
GO:0061134 | 0.0086 | 3.1875 | 2.3087 | 7 | 209 | peptidase regulator activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 41.2105 | 3.0913 | 65 | 261 | olfactory receptor activity |
GO:0004930 | 0 | 17.1206 | 8.0303 | 77 | 678 | G-protein coupled receptor activity |
GO:0099600 | 0 | 10.2322 | 13.2891 | 80 | 1122 | transmembrane receptor activity |
GO:0038023 | 0 | 9.6365 | 13.9998 | 80 | 1182 | signaling receptor activity |
GO:0060089 | 0 | 8.1529 | 17.1384 | 83 | 1447 | molecular transducer activity |
GO:0005549 | 0 | 22.6472 | 0.6988 | 12 | 59 | odorant binding |
GO:0004993 | 1e-04 | 24.3205 | 0.2132 | 4 | 18 | G-protein coupled serotonin receptor activity |
GO:0005132 | 4e-04 | 168.5969 | 0.0355 | 2 | 3 | type I interferon receptor binding |
GO:0005248 | 0.0024 | 12.6963 | 0.2724 | 3 | 23 | voltage-gated sodium channel activity |
GO:1903231 | 0.0027 | 5.6082 | 0.9594 | 5 | 81 | mRNA binding involved in posttranscriptional gene silencing |
GO:0089720 | 0.0059 | 21.0654 | 0.1184 | 2 | 10 | caspase binding |
GO:0005125 | 0.0089 | 3.1687 | 2.3214 | 7 | 196 | cytokine activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 32.6593 | 3.0272 | 56 | 261 | olfactory receptor activity |
GO:0004930 | 0 | 16.3404 | 6.2134 | 62 | 552 | G-protein coupled receptor activity |
GO:0099600 | 0 | 8.619 | 13.0137 | 71 | 1122 | transmembrane receptor activity |
GO:0038023 | 0 | 8.3138 | 13.7096 | 72 | 1182 | signaling receptor activity |
GO:0060089 | 0 | 7.0652 | 16.7832 | 75 | 1447 | molecular transducer activity |
GO:0005549 | 0 | 28.5529 | 0.6843 | 14 | 59 | odorant binding |
GO:1903231 | 0 | 8.3326 | 0.9395 | 7 | 81 | mRNA binding involved in posttranscriptional gene silencing |
GO:0042834 | 4e-04 | 25.9613 | 0.1508 | 3 | 13 | peptidoglycan binding |
GO:0008528 | 7e-04 | 5.1671 | 1.4614 | 7 | 126 | G-protein coupled peptide receptor activity |
GO:0015926 | 0.0082 | 17.215 | 0.1392 | 2 | 12 | glucosidase activity |
GO:0005344 | 0.0096 | 15.649 | 0.1508 | 2 | 13 | oxygen carrier activity |
GO:0030280 | 0.0096 | 15.649 | 0.1508 | 2 | 13 | structural constituent of epidermis |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0001816 | 0 | 3.5031 | 8.7102 | 27 | 617 | cytokine production |
GO:2000402 | 0 | 56.8852 | 0.1271 | 4 | 9 | negative regulation of lymphocyte migration |
GO:0002764 | 0 | 3.2993 | 6.3113 | 19 | 451 | immune response-regulating signaling pathway |
GO:0002253 | 0 | 3.1551 | 6.9456 | 20 | 492 | activation of immune response |
GO:0050900 | 0 | 5.7149 | 1.933 | 10 | 142 | leukocyte migration |
GO:0045321 | 0 | 2.7556 | 9.1734 | 23 | 674 | leukocyte activation |
GO:0002429 | 1e-04 | 3.6745 | 4.1363 | 14 | 293 | immune response-activating cell surface receptor signaling pathway |
GO:1903037 | 1e-04 | 3.4836 | 4.348 | 14 | 308 | regulation of leukocyte cell-cell adhesion |
GO:0045670 | 1e-04 | 8.4184 | 0.8047 | 6 | 57 | regulation of osteoclast differentiation |
GO:0002263 | 2e-04 | 2.6378 | 8.6396 | 21 | 612 | cell activation involved in immune response |
GO:0045087 | 2e-04 | 2.4547 | 10.6443 | 24 | 754 | innate immune response |
GO:0044663 | 2e-04 | Inf | 0.0282 | 2 | 2 | establishment or maintenance of cell type involved in phenotypic switching |
GO:0070488 | 2e-04 | Inf | 0.0282 | 2 | 2 | neutrophil aggregation |
GO:0065007 | 2e-04 | 1.7964 | 153.4946 | 177 | 10873 | biological regulation |
GO:0048583 | 3e-04 | 2.4828 | 9.7884 | 22 | 754 | regulation of response to stimulus |
GO:0038166 | 4e-04 | 26.5369 | 0.1553 | 3 | 11 | angiotensin-activated signaling pathway |
GO:0030155 | 5e-04 | 2.4822 | 8.682 | 20 | 615 | regulation of cell adhesion |
GO:0002774 | 6e-04 | 140.945 | 0.0424 | 2 | 3 | Fc receptor mediated inhibitory signaling pathway |
GO:1905772 | 6e-04 | 140.945 | 0.0424 | 2 | 3 | positive regulation of mesodermal cell differentiation |
GO:2000502 | 6e-04 | 140.945 | 0.0424 | 2 | 3 | negative regulation of natural killer cell chemotaxis |
GO:0007154 | 6e-04 | 1.5686 | 82.2177 | 106 | 5824 | cell communication |
GO:0006919 | 7e-04 | 6.215 | 1.0588 | 6 | 75 | activation of cysteine-type endopeptidase activity involved in apoptotic process |
GO:0098751 | 8e-04 | 10.9245 | 0.4235 | 4 | 30 | bone cell development |
GO:0070527 | 8e-04 | 7.5789 | 0.7341 | 5 | 52 | platelet aggregation |
GO:0023052 | 9e-04 | 1.5471 | 81.9777 | 105 | 5807 | signaling |
GO:0002715 | 9e-04 | 10.5192 | 0.4376 | 4 | 31 | regulation of natural killer cell mediated immunity |
GO:0030593 | 9e-04 | 5.7931 | 1.1294 | 6 | 80 | neutrophil chemotaxis |
GO:0007159 | 0.001 | 18.6262 | 0.2014 | 3 | 15 | leukocyte cell-cell adhesion |
GO:0051336 | 0.001 | 2.0274 | 14.9499 | 28 | 1059 | regulation of hydrolase activity |
GO:0002573 | 0.0011 | 4.186 | 2.0505 | 8 | 147 | myeloid leukocyte differentiation |
GO:0007166 | 0.0012 | 1.6965 | 33.567 | 51 | 2430 | cell surface receptor signaling pathway |
GO:0016554 | 0.0012 | 70.4679 | 0.0565 | 2 | 4 | cytidine to uridine editing |
GO:2001188 | 0.0012 | 70.4679 | 0.0565 | 2 | 4 | regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell |
GO:2001205 | 0.0012 | 70.4679 | 0.0565 | 2 | 4 | negative regulation of osteoclast development |
GO:0006955 | 0.0012 | 3.0263 | 4.2524 | 12 | 346 | immune response |
GO:0002275 | 0.0014 | 2.4964 | 6.8326 | 16 | 484 | myeloid cell activation involved in immune response |
GO:0030097 | 0.0017 | 2.1321 | 11.0536 | 22 | 783 | hemopoiesis |
GO:0010952 | 0.0018 | 3.8274 | 2.2305 | 8 | 158 | positive regulation of peptidase activity |
GO:0007229 | 0.0019 | 4.9809 | 1.2988 | 6 | 92 | integrin-mediated signaling pathway |
GO:0031349 | 0.0019 | 2.5957 | 5.7315 | 14 | 406 | positive regulation of defense response |
GO:0036446 | 0.0019 | 46.9755 | 0.0706 | 2 | 5 | myofibroblast differentiation |
GO:0045409 | 0.0019 | 46.9755 | 0.0706 | 2 | 5 | negative regulation of interleukin-6 biosynthetic process |
GO:0060414 | 0.0019 | 46.9755 | 0.0706 | 2 | 5 | aorta smooth muscle tissue morphogenesis |
GO:1903010 | 0.0019 | 14.1465 | 0.2541 | 3 | 18 | regulation of bone development |
GO:0002460 | 0.002 | 3.4432 | 2.7811 | 9 | 197 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
GO:0050870 | 0.002 | 3.4247 | 2.7952 | 9 | 198 | positive regulation of T cell activation |
GO:0043647 | 0.0021 | 6.0327 | 0.9035 | 5 | 64 | inositol phosphate metabolic process |
GO:0050688 | 0.0021 | 6.0327 | 0.9035 | 5 | 64 | regulation of defense response to virus |
GO:0022409 | 0.0021 | 3.1472 | 3.374 | 10 | 239 | positive regulation of cell-cell adhesion |
GO:0042113 | 0.0023 | 3.3706 | 2.8375 | 9 | 201 | B cell activation |
GO:0045954 | 0.0023 | 13.2615 | 0.2682 | 3 | 19 | positive regulation of natural killer cell mediated cytotoxicity |
GO:0048646 | 0.0023 | 1.9785 | 13.5524 | 25 | 960 | anatomical structure formation involved in morphogenesis |
GO:0002699 | 0.0023 | 3.6788 | 2.3152 | 8 | 164 | positive regulation of immune effector process |
GO:0051249 | 0.0025 | 2.6249 | 5.2515 | 13 | 372 | regulation of lymphocyte activation |
GO:0030856 | 0.0025 | 4.0722 | 1.8352 | 7 | 130 | regulation of epithelial cell differentiation |
GO:0048870 | 0.0025 | 1.8155 | 19.0439 | 32 | 1349 | cell motility |
GO:0002520 | 0.0025 | 2.0212 | 12.1689 | 23 | 862 | immune system development |
GO:0007155 | 0.0025 | 2.2344 | 8.6044 | 18 | 644 | cell adhesion |
GO:0002335 | 0.0026 | 12.4806 | 0.2823 | 3 | 20 | mature B cell differentiation |
GO:0002740 | 0.0029 | 35.2294 | 0.0847 | 2 | 6 | negative regulation of cytokine secretion involved in immune response |
GO:0002765 | 0.0029 | 35.2294 | 0.0847 | 2 | 6 | immune response-inhibiting signal transduction |
GO:0032074 | 0.0029 | 35.2294 | 0.0847 | 2 | 6 | negative regulation of nuclease activity |
GO:0045345 | 0.0029 | 35.2294 | 0.0847 | 2 | 6 | positive regulation of MHC class I biosynthetic process |
GO:0051240 | 0.0029 | 1.7826 | 20.0039 | 33 | 1417 | positive regulation of multicellular organismal process |
GO:0032675 | 0.0031 | 4.5063 | 1.4258 | 6 | 101 | regulation of interleukin-6 production |
GO:0050853 | 0.0031 | 7.2768 | 0.607 | 4 | 43 | B cell receptor signaling pathway |
GO:0072678 | 0.0031 | 7.2768 | 0.607 | 4 | 43 | T cell migration |
GO:0002684 | 0.0031 | 2.3037 | 7.3808 | 16 | 541 | positive regulation of immune system process |
GO:0048522 | 0.0031 | 1.5272 | 53.9697 | 72 | 3981 | positive regulation of cellular process |
GO:0002695 | 0.0033 | 3.8511 | 1.934 | 7 | 137 | negative regulation of leukocyte activation |
GO:0045682 | 0.0035 | 5.3096 | 1.0164 | 5 | 72 | regulation of epidermis development |
GO:0060143 | 0.0035 | 11.1654 | 0.3106 | 3 | 22 | positive regulation of syncytium formation by plasma membrane fusion |
GO:1990776 | 0.0035 | 11.1654 | 0.3106 | 3 | 22 | response to angiotensin |
GO:0030098 | 0.0036 | 2.7454 | 4.2351 | 11 | 300 | lymphocyte differentiation |
GO:0022408 | 0.0037 | 3.7635 | 1.9764 | 7 | 140 | negative regulation of cell-cell adhesion |
GO:0010668 | 0.004 | 28.1817 | 0.0988 | 2 | 7 | ectodermal cell differentiation |
GO:0045656 | 0.004 | 28.1817 | 0.0988 | 2 | 7 | negative regulation of monocyte differentiation |
GO:2000343 | 0.004 | 28.1817 | 0.0988 | 2 | 7 | positive regulation of chemokine (C-X-C motif) ligand 2 production |
GO:2000382 | 0.004 | 28.1817 | 0.0988 | 2 | 7 | positive regulation of mesoderm development |
GO:0042832 | 0.004 | 10.6065 | 0.3247 | 3 | 23 | defense response to protozoan |
GO:0030595 | 0.0041 | 3.333 | 2.5411 | 8 | 180 | leukocyte chemotaxis |
GO:0002444 | 0.0041 | 2.2985 | 6.9032 | 15 | 489 | myeloid leukocyte mediated immunity |
GO:0002708 | 0.0044 | 5.0092 | 1.0729 | 5 | 76 | positive regulation of lymphocyte mediated immunity |
GO:0052548 | 0.0045 | 2.5417 | 4.9833 | 12 | 353 | regulation of endopeptidase activity |
GO:0042119 | 0.0045 | 2.3491 | 6.2962 | 14 | 446 | neutrophil activation |
GO:0034113 | 0.0046 | 6.4478 | 0.6776 | 4 | 48 | heterotypic cell-cell adhesion |
GO:0008283 | 0.0048 | 1.6394 | 26.4553 | 40 | 1874 | cell proliferation |
GO:0097530 | 0.0049 | 4.0745 | 1.567 | 6 | 111 | granulocyte migration |
GO:0032608 | 0.005 | 6.3041 | 0.6917 | 4 | 49 | interferon-beta production |
GO:0055069 | 0.0051 | 9.641 | 0.3529 | 3 | 25 | zinc ion homeostasis |
GO:0060706 | 0.0051 | 9.641 | 0.3529 | 3 | 25 | cell differentiation involved in embryonic placenta development |
GO:0050728 | 0.0051 | 4.0358 | 1.5811 | 6 | 112 | negative regulation of inflammatory response |
GO:0070887 | 0.0052 | 1.5382 | 38.6242 | 54 | 2736 | cellular response to chemical stimulus |
GO:0045617 | 0.0053 | 23.4832 | 0.1129 | 2 | 8 | negative regulation of keratinocyte differentiation |
GO:0071550 | 0.0053 | 23.4832 | 0.1129 | 2 | 8 | death-inducing signaling complex assembly |
GO:1904685 | 0.0053 | 23.4832 | 0.1129 | 2 | 8 | positive regulation of metalloendopeptidase activity |
GO:2001198 | 0.0053 | 23.4832 | 0.1129 | 2 | 8 | regulation of dendritic cell differentiation |
GO:0045637 | 0.0053 | 2.9361 | 3.2328 | 9 | 229 | regulation of myeloid cell differentiation |
GO:0001910 | 0.0054 | 6.1667 | 0.7059 | 4 | 50 | regulation of leukocyte mediated cytotoxicity |
GO:0007599 | 0.0054 | 2.5986 | 4.461 | 11 | 316 | hemostasis |
GO:0050817 | 0.0055 | 2.59 | 4.4751 | 11 | 317 | coagulation |
GO:0071222 | 0.0056 | 3.4735 | 2.1317 | 7 | 151 | cellular response to lipopolysaccharide |
GO:0002250 | 0.0057 | 3.9366 | 1.6181 | 6 | 118 | adaptive immune response |
GO:0010942 | 0.006 | 2.086 | 8.6114 | 17 | 610 | positive regulation of cell death |
GO:0002685 | 0.0061 | 3.4255 | 2.1599 | 7 | 153 | regulation of leukocyte migration |
GO:0002703 | 0.0061 | 3.4255 | 2.1599 | 7 | 153 | regulation of leukocyte mediated immunity |
GO:0050865 | 0.0061 | 2.2627 | 6.5221 | 14 | 462 | regulation of cell activation |
GO:0002449 | 0.0063 | 3.8565 | 1.6498 | 6 | 119 | lymphocyte mediated immunity |
GO:0050777 | 0.0063 | 3.8527 | 1.6517 | 6 | 117 | negative regulation of immune response |
GO:2001056 | 0.0063 | 3.8527 | 1.6517 | 6 | 117 | positive regulation of cysteine-type endopeptidase activity |
GO:0002675 | 0.0063 | 8.8364 | 0.3812 | 3 | 27 | positive regulation of acute inflammatory response |
GO:0030851 | 0.0063 | 8.8364 | 0.3812 | 3 | 27 | granulocyte differentiation |
GO:0045055 | 0.0065 | 2.0204 | 9.4161 | 18 | 667 | regulated exocytosis |
GO:0002696 | 0.0066 | 2.6621 | 3.9528 | 10 | 280 | positive regulation of leukocyte activation |
GO:0002315 | 0.0067 | 20.1271 | 0.1271 | 2 | 9 | marginal zone B cell differentiation |
GO:0002923 | 0.0067 | 20.1271 | 0.1271 | 2 | 9 | regulation of humoral immune response mediated by circulating immunoglobulin |
GO:0036462 | 0.0067 | 20.1271 | 0.1271 | 2 | 9 | TRAIL-activated apoptotic signaling pathway |
GO:1900239 | 0.0067 | 20.1271 | 0.1271 | 2 | 9 | regulation of phenotypic switching |
GO:2000543 | 0.0067 | 20.1271 | 0.1271 | 2 | 9 | positive regulation of gastrulation |
GO:0001773 | 0.007 | 8.4824 | 0.3953 | 3 | 28 | myeloid dendritic cell activation |
GO:1901222 | 0.007 | 5.6719 | 0.7623 | 4 | 54 | regulation of NIK/NF-kappaB signaling |
GO:0048856 | 0.0071 | 1.4197 | 74.1992 | 92 | 5256 | anatomical structure development |
GO:0030336 | 0.0073 | 2.7821 | 3.4022 | 9 | 241 | negative regulation of cell migration |
GO:0098869 | 0.0074 | 4.3879 | 1.2141 | 5 | 86 | cellular oxidant detoxification |
GO:0032943 | 0.0075 | 2.7699 | 3.4163 | 9 | 242 | mononuclear cell proliferation |
GO:0061756 | 0.0077 | 8.1556 | 0.4094 | 3 | 29 | leukocyte adhesion to vascular endothelial cell |
GO:0051707 | 0.0081 | 1.9367 | 10.3619 | 19 | 734 | response to other organism |
GO:0070663 | 0.0083 | 2.9355 | 2.8658 | 8 | 203 | regulation of leukocyte proliferation |
GO:0033623 | 0.0083 | 17.6101 | 0.1412 | 2 | 10 | regulation of integrin activation |
GO:0045346 | 0.0083 | 17.6101 | 0.1412 | 2 | 10 | regulation of MHC class II biosynthetic process |
GO:0072672 | 0.0083 | 17.6101 | 0.1412 | 2 | 10 | neutrophil extravasation |
GO:1905902 | 0.0083 | 17.6101 | 0.1412 | 2 | 10 | regulation of mesoderm formation |
GO:0048869 | 0.0083 | 1.4415 | 54.8871 | 71 | 3888 | cellular developmental process |
GO:0031347 | 0.0083 | 2.9346 | 2.8685 | 8 | 213 | regulation of defense response |
GO:0061515 | 0.0085 | 5.3498 | 0.8047 | 4 | 57 | myeloid cell development |
GO:1902041 | 0.0085 | 5.3498 | 0.8047 | 4 | 57 | regulation of extrinsic apoptotic signaling pathway via death domain receptors |
GO:0050868 | 0.0085 | 4.2303 | 1.2564 | 5 | 89 | negative regulation of T cell activation |
GO:2001235 | 0.0087 | 3.1832 | 2.3152 | 7 | 164 | positive regulation of apoptotic signaling pathway |
GO:1902107 | 0.009 | 3.5617 | 1.7787 | 6 | 126 | positive regulation of leukocyte differentiation |
GO:0032103 | 0.009 | 2.6879 | 3.5151 | 9 | 249 | positive regulation of response to external stimulus |
GO:0009966 | 0.0091 | 1.4834 | 40.5724 | 55 | 2874 | regulation of signal transduction |
GO:0043312 | 0.0092 | 2.2183 | 6.155 | 13 | 436 | neutrophil degranulation |
GO:0030168 | 0.0094 | 4.1204 | 1.2873 | 5 | 93 | platelet activation |
GO:0032940 | 0.0096 | 1.6792 | 18.3945 | 29 | 1303 | secretion by cell |
GO:0032729 | 0.0096 | 5.1545 | 0.8329 | 4 | 59 | positive regulation of interferon-gamma production |
GO:0042098 | 0.0099 | 3.1033 | 2.3717 | 7 | 168 | T cell proliferation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0022610 | 0 | 3.3013 | 19.8717 | 54 | 1264 | biological adhesion |
GO:0002252 | 0 | 3.2869 | 12.6257 | 36 | 832 | immune effector process |
GO:0042119 | 0 | 4.0267 | 7.0117 | 25 | 446 | neutrophil activation |
GO:0050865 | 0 | 3.8751 | 7.2632 | 25 | 462 | regulation of cell activation |
GO:0043312 | 0 | 3.9345 | 6.8545 | 24 | 436 | neutrophil degranulation |
GO:0045055 | 0 | 3.2205 | 10.4861 | 30 | 667 | regulated exocytosis |
GO:0002695 | 0 | 6.8755 | 2.1538 | 13 | 137 | negative regulation of leukocyte activation |
GO:0006955 | 0 | 3.1471 | 10.8698 | 30 | 786 | immune response |
GO:1903037 | 0 | 4.3781 | 4.8421 | 19 | 308 | regulation of leukocyte cell-cell adhesion |
GO:0050900 | 0 | 4.9148 | 3.6332 | 16 | 242 | leukocyte migration |
GO:0002275 | 0 | 3.5758 | 6.8254 | 22 | 442 | myeloid cell activation involved in immune response |
GO:0051249 | 0 | 3.7846 | 5.8483 | 20 | 372 | regulation of lymphocyte activation |
GO:0030155 | 0 | 3.0822 | 8.9747 | 25 | 579 | regulation of cell adhesion |
GO:0002520 | 0 | 2.6262 | 13.5517 | 32 | 862 | immune system development |
GO:0002444 | 0 | 3.3643 | 6.8726 | 21 | 445 | myeloid leukocyte mediated immunity |
GO:0032940 | 0 | 2.3098 | 20.4848 | 42 | 1303 | secretion by cell |
GO:0022408 | 0 | 5.5426 | 2.201 | 11 | 140 | negative regulation of cell-cell adhesion |
GO:0050776 | 0 | 4.7617 | 2.7711 | 12 | 191 | regulation of immune response |
GO:0022409 | 0 | 4.0711 | 3.7574 | 14 | 239 | positive regulation of cell-cell adhesion |
GO:0002253 | 0 | 2.9594 | 7.7349 | 21 | 492 | activation of immune response |
GO:0002696 | 0 | 3.7098 | 4.402 | 15 | 280 | positive regulation of leukocyte activation |
GO:0048870 | 0 | 2.7735 | 9.0886 | 23 | 602 | cell motility |
GO:0032944 | 1e-04 | 4.3131 | 3.0342 | 12 | 193 | regulation of mononuclear cell proliferation |
GO:0002699 | 1e-04 | 4.6658 | 2.5783 | 11 | 164 | positive regulation of immune effector process |
GO:0023052 | 1e-04 | 1.6566 | 91.2933 | 121 | 5807 | signaling |
GO:0007154 | 1e-04 | 1.6488 | 91.5606 | 121 | 5824 | cell communication |
GO:0070664 | 1e-04 | 7.6171 | 1.0376 | 7 | 66 | negative regulation of leukocyte proliferation |
GO:0030098 | 1e-04 | 3.4449 | 4.7164 | 15 | 300 | lymphocyte differentiation |
GO:0002764 | 1e-04 | 2.9261 | 7.0351 | 19 | 451 | immune response-regulating signaling pathway |
GO:0030168 | 1e-04 | 6.1963 | 1.431 | 8 | 93 | platelet activation |
GO:0050777 | 1e-04 | 5.3782 | 1.8394 | 9 | 117 | negative regulation of immune response |
GO:0007599 | 1e-04 | 3.2583 | 4.9679 | 15 | 316 | hemostasis |
GO:0050817 | 2e-04 | 3.2473 | 4.9836 | 15 | 317 | coagulation |
GO:0006952 | 2e-04 | 2.5226 | 9.9317 | 23 | 679 | defense response |
GO:0070527 | 2e-04 | 8.3462 | 0.8175 | 6 | 52 | platelet aggregation |
GO:0051345 | 2e-04 | 3.3692 | 4.487 | 14 | 297 | positive regulation of hydrolase activity |
GO:0044093 | 2e-04 | 1.913 | 25.4527 | 44 | 1619 | positive regulation of molecular function |
GO:0072676 | 3e-04 | 5.9859 | 1.2891 | 7 | 82 | lymphocyte migration |
GO:0042733 | 3e-04 | 7.106 | 0.9433 | 6 | 60 | embryonic digit morphogenesis |
GO:0097530 | 4e-04 | 4.9932 | 1.7451 | 8 | 111 | granulocyte migration |
GO:0002460 | 4e-04 | 7.0297 | 0.9511 | 6 | 62 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
GO:0007159 | 4e-04 | 13.5405 | 0.3551 | 4 | 24 | leukocyte cell-cell adhesion |
GO:0042110 | 4e-04 | 4.8526 | 1.7899 | 8 | 120 | T cell activation |
GO:0002279 | 5e-04 | 8.616 | 0.6603 | 5 | 42 | mast cell activation involved in immune response |
GO:0016192 | 5e-04 | 1.8285 | 26.4746 | 44 | 1684 | vesicle-mediated transport |
GO:0050732 | 5e-04 | 8.3887 | 0.676 | 5 | 43 | negative regulation of peptidyl-tyrosine phosphorylation |
GO:0032103 | 6e-04 | 3.2818 | 3.9146 | 12 | 249 | positive regulation of response to external stimulus |
GO:0043547 | 6e-04 | 2.8344 | 5.6597 | 15 | 360 | positive regulation of GTPase activity |
GO:0002448 | 6e-04 | 8.1731 | 0.6917 | 5 | 44 | mast cell mediated immunity |
GO:0007229 | 6e-04 | 5.2782 | 1.4464 | 7 | 92 | integrin-mediated signaling pathway |
GO:0010942 | 7e-04 | 2.3477 | 9.59 | 21 | 610 | positive regulation of cell death |
GO:0090023 | 7e-04 | 11.5556 | 0.4088 | 4 | 26 | positive regulation of neutrophil chemotaxis |
GO:0002774 | 7e-04 | 126.2387 | 0.0472 | 2 | 3 | Fc receptor mediated inhibitory signaling pathway |
GO:0045658 | 7e-04 | 126.2387 | 0.0472 | 2 | 3 | regulation of neutrophil differentiation |
GO:0045060 | 8e-04 | 21.1157 | 0.1887 | 3 | 12 | negative thymic T cell selection |
GO:0051798 | 8e-04 | 21.1157 | 0.1887 | 3 | 12 | positive regulation of hair follicle development |
GO:0002675 | 8e-04 | 11.0525 | 0.4245 | 4 | 27 | positive regulation of acute inflammatory response |
GO:0016339 | 8e-04 | 11.0525 | 0.4245 | 4 | 27 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules |
GO:0030851 | 8e-04 | 11.0525 | 0.4245 | 4 | 27 | granulocyte differentiation |
GO:0002763 | 8e-04 | 7.5878 | 0.7389 | 5 | 47 | positive regulation of myeloid leukocyte differentiation |
GO:0050672 | 9e-04 | 19.2655 | 0.2017 | 3 | 13 | negative regulation of lymphocyte proliferation |
GO:0002237 | 0.001 | 2.9284 | 4.7321 | 13 | 301 | response to molecule of bacterial origin |
GO:2000404 | 0.001 | 10.167 | 0.4559 | 4 | 29 | regulation of T cell migration |
GO:2000242 | 0.0011 | 7.0806 | 0.7861 | 5 | 50 | negative regulation of reproductive process |
GO:0006919 | 0.0012 | 5.5558 | 1.1791 | 6 | 75 | activation of cysteine-type endopeptidase activity involved in apoptotic process |
GO:0050856 | 0.0013 | 9.4126 | 0.4874 | 4 | 31 | regulation of T cell receptor signaling pathway |
GO:0060326 | 0.0014 | 3.1295 | 3.7417 | 11 | 238 | cell chemotaxis |
GO:0043065 | 0.0014 | 2.2996 | 8.8039 | 19 | 560 | positive regulation of apoptotic process |
GO:0006909 | 0.0014 | 3.3394 | 3.1914 | 10 | 203 | phagocytosis |
GO:0046874 | 0.0014 | 63.1152 | 0.0629 | 2 | 4 | quinolinate metabolic process |
GO:2001188 | 0.0014 | 63.1152 | 0.0629 | 2 | 4 | regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell |
GO:2001205 | 0.0014 | 63.1152 | 0.0629 | 2 | 4 | negative regulation of osteoclast development |
GO:0002690 | 0.0015 | 5.25 | 1.242 | 6 | 79 | positive regulation of leukocyte chemotaxis |
GO:1902622 | 0.0015 | 9.0759 | 0.5031 | 4 | 32 | regulation of neutrophil migration |
GO:0030335 | 0.0016 | 2.5536 | 6.2413 | 15 | 397 | positive regulation of cell migration |
GO:1902106 | 0.0016 | 5.1787 | 1.2577 | 6 | 80 | negative regulation of leukocyte differentiation |
GO:0098609 | 0.0016 | 2.7601 | 5.0119 | 13 | 346 | cell-cell adhesion |
GO:0040017 | 0.0017 | 2.4578 | 6.9174 | 16 | 440 | positive regulation of locomotion |
GO:0042092 | 0.0017 | 8.7623 | 0.5188 | 4 | 33 | type 2 immune response |
GO:0010950 | 0.0018 | 3.8593 | 2.2167 | 8 | 141 | positive regulation of endopeptidase activity |
GO:0002577 | 0.0018 | 14.6147 | 0.2515 | 3 | 16 | regulation of antigen processing and presentation |
GO:0051446 | 0.0018 | 14.6147 | 0.2515 | 3 | 16 | positive regulation of meiotic cell cycle |
GO:0003158 | 0.0018 | 4.3085 | 1.7451 | 7 | 111 | endothelium development |
GO:0002686 | 0.0019 | 8.4697 | 0.5345 | 4 | 34 | negative regulation of leukocyte migration |
GO:0045670 | 0.002 | 6.1246 | 0.8961 | 5 | 57 | regulation of osteoclast differentiation |
GO:0002449 | 0.0021 | 6.0492 | 0.9052 | 5 | 59 | lymphocyte mediated immunity |
GO:0071216 | 0.0022 | 3.3827 | 2.8298 | 9 | 180 | cellular response to biotic stimulus |
GO:0042249 | 0.0022 | 13.57 | 0.2673 | 3 | 17 | establishment of planar polarity of embryonic epithelium |
GO:0098542 | 0.0023 | 2.5371 | 5.8474 | 14 | 376 | defense response to other organism |
GO:0033628 | 0.0024 | 7.9393 | 0.566 | 4 | 36 | regulation of cell adhesion mediated by integrin |
GO:1902042 | 0.0024 | 7.9393 | 0.566 | 4 | 36 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors |
GO:0050859 | 0.0024 | 42.0741 | 0.0786 | 2 | 5 | negative regulation of B cell receptor signaling pathway |
GO:0060157 | 0.0024 | 42.0741 | 0.0786 | 2 | 5 | urinary bladder development |
GO:1902262 | 0.0024 | 42.0741 | 0.0786 | 2 | 5 | apoptotic process involved in blood vessel morphogenesis |
GO:0050790 | 0.0024 | 1.6307 | 32.826 | 49 | 2088 | regulation of catalytic activity |
GO:0042060 | 0.0026 | 2.2787 | 7.9078 | 17 | 503 | wound healing |
GO:0030855 | 0.0026 | 2.0818 | 10.7219 | 21 | 682 | epithelial cell differentiation |
GO:0098657 | 0.0026 | 2.1209 | 10.0144 | 20 | 637 | import into cell |
GO:0010818 | 0.0026 | 12.6645 | 0.283 | 3 | 18 | T cell chemotaxis |
GO:0033622 | 0.0026 | 12.6645 | 0.283 | 3 | 18 | integrin activation |
GO:0045088 | 0.0026 | 2.5004 | 5.9269 | 14 | 377 | regulation of innate immune response |
GO:0071222 | 0.0027 | 3.587 | 2.3739 | 8 | 151 | cellular response to lipopolysaccharide |
GO:0001501 | 0.0028 | 2.3224 | 7.2947 | 16 | 464 | skeletal system development |
GO:0032418 | 0.0029 | 5.5855 | 0.9747 | 5 | 62 | lysosome localization |
GO:0002704 | 0.0029 | 7.4713 | 0.5974 | 4 | 38 | negative regulation of leukocyte mediated immunity |
GO:0051272 | 0.003 | 2.3807 | 6.6658 | 15 | 424 | positive regulation of cellular component movement |
GO:0048565 | 0.003 | 3.928 | 1.9023 | 7 | 121 | digestive tract development |
GO:0050851 | 0.0031 | 3.2117 | 2.9713 | 9 | 189 | antigen receptor-mediated signaling pathway |
GO:0043549 | 0.0031 | 1.9819 | 12.3412 | 23 | 785 | regulation of kinase activity |
GO:0031295 | 0.0031 | 5.4889 | 0.9904 | 5 | 63 | T cell costimulation |
GO:0016064 | 0.0031 | 4.5052 | 1.4306 | 6 | 91 | immunoglobulin mediated immune response |
GO:0030097 | 0.0034 | 2.3505 | 6.7569 | 15 | 450 | hemopoiesis |
GO:0045637 | 0.0034 | 2.9379 | 3.6002 | 10 | 229 | regulation of myeloid cell differentiation |
GO:0071675 | 0.0035 | 7.0553 | 0.6289 | 4 | 40 | regulation of mononuclear cell migration |
GO:0002740 | 0.0035 | 31.5535 | 0.0943 | 2 | 6 | negative regulation of cytokine secretion involved in immune response |
GO:0002765 | 0.0035 | 31.5535 | 0.0943 | 2 | 6 | immune response-inhibiting signal transduction |
GO:0003402 | 0.0035 | 31.5535 | 0.0943 | 2 | 6 | planar cell polarity pathway involved in axis elongation |
GO:0043067 | 0.0036 | 1.7214 | 21.8368 | 35 | 1389 | regulation of programmed cell death |
GO:0002438 | 0.0036 | 11.1731 | 0.3144 | 3 | 20 | acute inflammatory response to antigenic stimulus |
GO:1904385 | 0.0036 | 11.1731 | 0.3144 | 3 | 20 | cellular response to angiotensin |
GO:0050727 | 0.0036 | 2.7477 | 4.2295 | 11 | 272 | regulation of inflammatory response |
GO:0009952 | 0.0038 | 3.1068 | 3.0656 | 9 | 195 | anterior/posterior pattern specification |
GO:0048869 | 0.0038 | 1.4682 | 61.1242 | 80 | 3888 | cellular developmental process |
GO:1903708 | 0.0038 | 3.3726 | 2.5154 | 8 | 160 | positive regulation of hemopoiesis |
GO:0050868 | 0.0039 | 10.7761 | 0.3235 | 3 | 21 | negative regulation of T cell activation |
GO:0002544 | 0.0041 | 10.5517 | 0.3301 | 3 | 21 | chronic inflammatory response |
GO:0002861 | 0.0041 | 10.5517 | 0.3301 | 3 | 21 | regulation of inflammatory response to antigenic stimulus |
GO:0001816 | 0.0042 | 3.3205 | 2.5529 | 8 | 171 | cytokine production |
GO:0009615 | 0.0044 | 2.674 | 4.3391 | 11 | 276 | response to virus |
GO:0002684 | 0.0044 | 2.2777 | 6.9637 | 15 | 474 | positive regulation of immune system process |
GO:0045123 | 0.0046 | 10.1072 | 0.3422 | 3 | 22 | cellular extravasation |
GO:0045321 | 0.0049 | 3.2301 | 2.6211 | 8 | 194 | leukocyte activation |
GO:2001233 | 0.0049 | 2.4068 | 5.6911 | 13 | 362 | regulation of apoptotic signaling pathway |
GO:0002606 | 0.0049 | 25.2412 | 0.11 | 2 | 7 | positive regulation of dendritic cell antigen processing and presentation |
GO:0002883 | 0.0049 | 25.2412 | 0.11 | 2 | 7 | regulation of hypersensitivity |
GO:0045656 | 0.0049 | 25.2412 | 0.11 | 2 | 7 | negative regulation of monocyte differentiation |
GO:0060028 | 0.0049 | 25.2412 | 0.11 | 2 | 7 | convergent extension involved in axis elongation |
GO:0060907 | 0.0049 | 25.2412 | 0.11 | 2 | 7 | positive regulation of macrophage cytokine production |
GO:2000343 | 0.0049 | 25.2412 | 0.11 | 2 | 7 | positive regulation of chemokine (C-X-C motif) ligand 2 production |
GO:0009607 | 0.0049 | 2.0805 | 9.1465 | 18 | 597 | response to biotic stimulus |
GO:0046677 | 0.0049 | 6.3481 | 0.6917 | 4 | 44 | response to antibiotic |
GO:0071622 | 0.0049 | 6.3481 | 0.6917 | 4 | 44 | regulation of granulocyte chemotaxis |
GO:0050870 | 0.005 | 3.5566 | 2.0875 | 7 | 135 | positive regulation of T cell activation |
GO:0031349 | 0.0051 | 2.3109 | 6.3828 | 14 | 406 | positive regulation of defense response |
GO:0019221 | 0.0051 | 2.0697 | 9.1812 | 18 | 584 | cytokine-mediated signaling pathway |
GO:0080134 | 0.0052 | 1.7142 | 19.9345 | 32 | 1268 | regulation of response to stress |
GO:0002429 | 0.0053 | 4.0091 | 1.5943 | 6 | 104 | immune response-activating cell surface receptor signaling pathway |
GO:0035306 | 0.0054 | 6.1929 | 0.7075 | 4 | 45 | positive regulation of dephosphorylation |
GO:0045058 | 0.0054 | 6.1929 | 0.7075 | 4 | 45 | T cell selection |
GO:0001819 | 0.0054 | 2.3788 | 5.754 | 13 | 366 | positive regulation of cytokine production |
GO:0042832 | 0.0054 | 9.4952 | 0.3616 | 3 | 23 | defense response to protozoan |
GO:0045682 | 0.0055 | 4.7488 | 1.1319 | 5 | 72 | regulation of epidermis development |
GO:0043407 | 0.0058 | 4.6786 | 1.1477 | 5 | 73 | negative regulation of MAP kinase activity |
GO:2000106 | 0.0058 | 4.6786 | 1.1477 | 5 | 73 | regulation of leukocyte apoptotic process |
GO:0070665 | 0.006 | 3.441 | 2.1538 | 7 | 137 | positive regulation of leukocyte proliferation |
GO:0042089 | 0.006 | 3.9043 | 1.635 | 6 | 104 | cytokine biosynthetic process |
GO:0002691 | 0.0061 | 9.0425 | 0.3773 | 3 | 24 | regulation of cellular extravasation |
GO:0060142 | 0.0061 | 9.0425 | 0.3773 | 3 | 24 | regulation of syncytium formation by plasma membrane fusion |
GO:0002456 | 0.0062 | 4.6105 | 1.1634 | 5 | 74 | T cell mediated immunity |
GO:0035108 | 0.0062 | 3.4145 | 2.1695 | 7 | 138 | limb morphogenesis |
GO:0042127 | 0.0063 | 1.989 | 10.117 | 19 | 682 | regulation of cell proliferation |
GO:0032071 | 0.0065 | 21.0329 | 0.1258 | 2 | 8 | regulation of endodeoxyribonuclease activity |
GO:0045617 | 0.0065 | 21.0329 | 0.1258 | 2 | 8 | negative regulation of keratinocyte differentiation |
GO:0071316 | 0.0065 | 21.0329 | 0.1258 | 2 | 8 | cellular response to nicotine |
GO:0071550 | 0.0065 | 21.0329 | 0.1258 | 2 | 8 | death-inducing signaling complex assembly |
GO:0072610 | 0.0065 | 21.0329 | 0.1258 | 2 | 8 | interleukin-12 secretion |
GO:2000035 | 0.0065 | 21.0329 | 0.1258 | 2 | 8 | regulation of stem cell division |
GO:2000304 | 0.0065 | 21.0329 | 0.1258 | 2 | 8 | positive regulation of ceramide biosynthetic process |
GO:2001198 | 0.0065 | 21.0329 | 0.1258 | 2 | 8 | regulation of dendritic cell differentiation |
GO:0032069 | 0.0068 | 8.6309 | 0.393 | 3 | 25 | regulation of nuclease activity |
GO:0055069 | 0.0068 | 8.6309 | 0.393 | 3 | 25 | zinc ion homeostasis |
GO:0060706 | 0.0068 | 8.6309 | 0.393 | 3 | 25 | cell differentiation involved in embryonic placenta development |
GO:0051100 | 0.0069 | 3.3374 | 2.2167 | 7 | 141 | negative regulation of binding |
GO:0042130 | 0.0073 | 5.6409 | 0.7703 | 4 | 49 | negative regulation of T cell proliferation |
GO:0042267 | 0.0073 | 5.6409 | 0.7703 | 4 | 49 | natural killer cell mediated cytotoxicity |
GO:2000145 | 0.0073 | 1.887 | 11.7438 | 21 | 747 | regulation of cell motility |
GO:0007275 | 0.0074 | 1.3988 | 75.745 | 94 | 4818 | multicellular organism development |
GO:0002682 | 0.0075 | 2.7765 | 3.4157 | 9 | 251 | regulation of immune system process |
GO:0009435 | 0.0076 | 8.2551 | 0.4088 | 3 | 26 | NAD biosynthetic process |
GO:0042634 | 0.0076 | 8.2551 | 0.4088 | 3 | 26 | regulation of hair cycle |
GO:0045992 | 0.0076 | 8.2551 | 0.4088 | 3 | 26 | negative regulation of embryonic development |
GO:0002367 | 0.0077 | 4.3567 | 1.2263 | 5 | 78 | cytokine production involved in immune response |
GO:0001885 | 0.0078 | 5.518 | 0.7861 | 4 | 50 | endothelial cell development |
GO:0050994 | 0.0078 | 5.518 | 0.7861 | 4 | 50 | regulation of lipid catabolic process |
GO:0045944 | 0.0078 | 1.7369 | 16.4759 | 27 | 1048 | positive regulation of transcription from RNA polymerase II promoter |
GO:0032635 | 0.0078 | 3.6776 | 1.7293 | 6 | 110 | interleukin-6 production |
GO:0001768 | 0.0082 | 18.027 | 0.1415 | 2 | 9 | establishment of T cell polarity |
GO:0002315 | 0.0082 | 18.027 | 0.1415 | 2 | 9 | marginal zone B cell differentiation |
GO:0002923 | 0.0082 | 18.027 | 0.1415 | 2 | 9 | regulation of humoral immune response mediated by circulating immunoglobulin |
GO:0003344 | 0.0082 | 18.027 | 0.1415 | 2 | 9 | pericardium morphogenesis |
GO:0036462 | 0.0082 | 18.027 | 0.1415 | 2 | 9 | TRAIL-activated apoptotic signaling pathway |
GO:0045080 | 0.0082 | 18.027 | 0.1415 | 2 | 9 | positive regulation of chemokine biosynthetic process |
GO:0090009 | 0.0082 | 18.027 | 0.1415 | 2 | 9 | primitive streak formation |
GO:1905770 | 0.0082 | 18.027 | 0.1415 | 2 | 9 | regulation of mesodermal cell differentiation |
GO:0007166 | 0.0083 | 1.5781 | 27.3451 | 40 | 1854 | cell surface receptor signaling pathway |
GO:0036065 | 0.0085 | 7.9106 | 0.4245 | 3 | 27 | fucosylation |
GO:0043304 | 0.0085 | 7.9106 | 0.4245 | 3 | 27 | regulation of mast cell degranulation |
GO:0002822 | 0.0085 | 3.6077 | 1.7608 | 6 | 112 | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
GO:0002286 | 0.0085 | 4.24 | 1.2577 | 5 | 80 | T cell activation involved in immune response |
GO:0048856 | 0.0086 | 2.2587 | 6.1432 | 13 | 438 | anatomical structure development |
GO:0006959 | 0.0087 | 2.9081 | 2.8927 | 8 | 184 | humoral immune response |
GO:2001244 | 0.0089 | 5.2873 | 0.8175 | 4 | 52 | positive regulation of intrinsic apoptotic signaling pathway |
GO:0032649 | 0.009 | 4.1839 | 1.2734 | 5 | 81 | regulation of interferon-gamma production |
GO:0002244 | 0.009 | 2.8915 | 2.9084 | 8 | 185 | hematopoietic progenitor cell differentiation |
GO:0002366 | 0.0092 | 3.5411 | 1.7902 | 6 | 124 | leukocyte activation involved in immune response |
GO:0002706 | 0.0092 | 3.5404 | 1.7922 | 6 | 114 | regulation of lymphocyte mediated immunity |
GO:0043900 | 0.0094 | 2.2927 | 5.4867 | 12 | 349 | regulation of multi-organism process |
GO:0001773 | 0.0094 | 7.5937 | 0.4402 | 3 | 28 | myeloid dendritic cell activation |
GO:0019433 | 0.0094 | 7.5937 | 0.4402 | 3 | 28 | triglyceride catabolic process |
GO:0046636 | 0.0094 | 7.5937 | 0.4402 | 3 | 28 | negative regulation of alpha-beta T cell activation |
GO:0050869 | 0.0094 | 7.5937 | 0.4402 | 3 | 28 | negative regulation of B cell activation |
GO:0008284 | 0.0097 | 1.8975 | 10.5387 | 19 | 684 | positive regulation of cell proliferation |
GO:0042330 | 0.0098 | 2.0152 | 8.3323 | 16 | 530 | taxis |
GO:0034097 | 0.0098 | 1.7589 | 14.4007 | 24 | 916 | response to cytokine |
GO:0045860 | 0.0099 | 2.0632 | 7.6248 | 15 | 485 | positive regulation of protein kinase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 200.1003 | 0.5689 | 24 | 31 | DNA replication-dependent nucleosome assembly |
GO:0000183 | 0 | 107.7041 | 0.679 | 24 | 37 | chromatin silencing at rDNA |
GO:0051290 | 0 | 73.6633 | 0.7891 | 24 | 43 | protein heterotetramerization |
GO:0045815 | 0 | 25.8592 | 1.4315 | 24 | 78 | positive regulation of gene expression, epigenetic |
GO:0045653 | 0 | 262.4142 | 0.312 | 14 | 17 | negative regulation of megakaryocyte differentiation |
GO:0060964 | 0 | 18.593 | 1.8169 | 24 | 99 | regulation of gene silencing by miRNA |
GO:0031497 | 0 | 13.3894 | 2.7712 | 28 | 151 | chromatin assembly |
GO:1902036 | 0 | 17.8743 | 1.8719 | 24 | 102 | regulation of hematopoietic stem cell differentiation |
GO:0045814 | 0 | 14.8565 | 2.2573 | 25 | 123 | negative regulation of gene expression, epigenetic |
GO:0060968 | 0 | 14.3552 | 2.2206 | 24 | 121 | regulation of gene silencing |
GO:0048863 | 0 | 8.0688 | 4.5697 | 30 | 249 | stem cell differentiation |
GO:0002244 | 0 | 9.5214 | 3.3951 | 26 | 185 | hematopoietic progenitor cell differentiation |
GO:0065004 | 0 | 8.3621 | 4.1109 | 28 | 224 | protein-DNA complex assembly |
GO:0032200 | 0 | 10.2124 | 2.9363 | 24 | 160 | telomere organization |
GO:0034080 | 0 | 28.0699 | 0.7708 | 14 | 42 | CENP-A containing nucleosome assembly |
GO:1904837 | 0 | 28.0699 | 0.7708 | 14 | 42 | beta-catenin-TCF complex assembly |
GO:0071103 | 0 | 6.752 | 4.9551 | 28 | 270 | DNA conformation change |
GO:0016233 | 0 | 21.8207 | 0.9176 | 14 | 50 | telomere capping |
GO:0034724 | 0 | 20.1382 | 0.9727 | 14 | 53 | DNA replication-independent nucleosome organization |
GO:1903707 | 0 | 9.8254 | 2.3674 | 19 | 129 | negative regulation of hemopoiesis |
GO:0006303 | 0 | 14.2648 | 1.2663 | 14 | 69 | double-strand break repair via nonhomologous end joining |
GO:0030099 | 0 | 4.9944 | 6.7352 | 29 | 367 | myeloid cell differentiation |
GO:0043044 | 0 | 12.6485 | 1.3948 | 14 | 76 | ATP-dependent chromatin remodeling |
GO:0035194 | 0 | 5.4758 | 5.2854 | 25 | 288 | posttranscriptional gene silencing by RNA |
GO:0051259 | 0 | 4.0277 | 9.1027 | 32 | 496 | protein oligomerization |
GO:0038111 | 0 | 20.4925 | 0.679 | 10 | 37 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 19.7593 | 0.6974 | 10 | 38 | response to interleukin-7 |
GO:0017148 | 0 | 4.5049 | 6.8454 | 27 | 373 | negative regulation of translation |
GO:0045652 | 0 | 12.9347 | 0.961 | 10 | 55 | regulation of megakaryocyte differentiation |
GO:0048534 | 0 | 2.9191 | 15.1222 | 39 | 824 | hematopoietic or lymphoid organ development |
GO:0034728 | 0 | 8.0119 | 1.8914 | 13 | 108 | nucleosome organization |
GO:0048869 | 0 | 1.9138 | 67.6705 | 105 | 3781 | cellular developmental process |
GO:0034248 | 0 | 2.9697 | 10.8094 | 29 | 589 | regulation of cellular amide metabolic process |
GO:0010608 | 0 | 2.7618 | 12.4061 | 31 | 676 | posttranscriptional regulation of gene expression |
GO:0045596 | 0 | 2.8279 | 11.3049 | 29 | 616 | negative regulation of cell differentiation |
GO:0051239 | 0 | 1.8848 | 48.725 | 79 | 2655 | regulation of multicellular organismal process |
GO:0051248 | 0 | 2.2216 | 23.1421 | 46 | 1261 | negative regulation of protein metabolic process |
GO:0045892 | 0 | 2.2361 | 19.7653 | 40 | 1077 | negative regulation of transcription, DNA-templated |
GO:0006352 | 0 | 3.8648 | 4.2393 | 15 | 231 | DNA-templated transcription, initiation |
GO:1902679 | 0 | 2.147 | 20.4994 | 40 | 1117 | negative regulation of RNA biosynthetic process |
GO:0045934 | 1e-04 | 2.0225 | 24.5552 | 45 | 1338 | negative regulation of nucleobase-containing compound metabolic process |
GO:0070271 | 1e-04 | 2.019 | 24.5919 | 45 | 1340 | protein complex biogenesis |
GO:0048731 | 1e-04 | 1.6619 | 71.7657 | 101 | 4005 | system development |
GO:0009611 | 1e-04 | 2.4438 | 11.048 | 25 | 602 | response to wounding |
GO:0048856 | 2e-04 | 2.3409 | 13.4314 | 28 | 886 | anatomical structure development |
GO:0065003 | 2e-04 | 1.8111 | 30.9784 | 51 | 1688 | macromolecular complex assembly |
GO:0014855 | 2e-04 | 6.2671 | 1.2479 | 7 | 68 | striated muscle cell proliferation |
GO:0060249 | 3e-04 | 2.8314 | 6.4416 | 17 | 351 | anatomical structure homeostasis |
GO:0050878 | 3e-04 | 2.569 | 8.3502 | 20 | 455 | regulation of body fluid levels |
GO:0021879 | 4e-04 | 6.9533 | 0.9727 | 6 | 53 | forebrain neuron differentiation |
GO:0071822 | 5e-04 | 1.7761 | 28.8496 | 47 | 1572 | protein complex subunit organization |
GO:0001764 | 8e-04 | 3.976 | 2.4408 | 9 | 133 | neuron migration |
GO:0045595 | 8e-04 | 1.978 | 16.9124 | 31 | 985 | regulation of cell differentiation |
GO:0002019 | 0.001 | 107.7254 | 0.0551 | 2 | 3 | regulation of renal output by angiotensin |
GO:0007412 | 0.001 | 107.7254 | 0.0551 | 2 | 3 | axon target recognition |
GO:0055014 | 0.001 | 107.7254 | 0.0551 | 2 | 3 | atrial cardiac muscle cell development |
GO:0070370 | 0.001 | 107.7254 | 0.0551 | 2 | 3 | cellular heat acclimation |
GO:0070434 | 0.001 | 107.7254 | 0.0551 | 2 | 3 | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway |
GO:0043043 | 0.0012 | 1.9851 | 15.0671 | 28 | 821 | peptide biosynthetic process |
GO:0071345 | 0.0013 | 1.9746 | 15.1405 | 28 | 825 | cellular response to cytokine stimulus |
GO:0061061 | 0.0016 | 2.1299 | 10.9746 | 22 | 598 | muscle structure development |
GO:0010823 | 0.0016 | 6.4633 | 0.8626 | 5 | 47 | negative regulation of mitochondrion organization |
GO:0060043 | 0.0018 | 6.3126 | 0.8809 | 5 | 48 | regulation of cardiac muscle cell proliferation |
GO:0006935 | 0.0019 | 2.1802 | 9.7266 | 20 | 530 | chemotaxis |
GO:0055003 | 0.0019 | 14.7321 | 0.2569 | 3 | 14 | cardiac myofibril assembly |
GO:0060192 | 0.0019 | 14.7321 | 0.2569 | 3 | 14 | negative regulation of lipase activity |
GO:0061343 | 0.002 | 53.8592 | 0.0734 | 2 | 4 | cell adhesion involved in heart morphogenesis |
GO:0090063 | 0.002 | 53.8592 | 0.0734 | 2 | 4 | positive regulation of microtubule nucleation |
GO:0007411 | 0.0022 | 2.945 | 3.9641 | 11 | 216 | axon guidance |
GO:1903506 | 0.0023 | 1.4785 | 62.3423 | 83 | 3397 | regulation of nucleic acid-templated transcription |
GO:0034654 | 0.0023 | 1.4536 | 73.3169 | 95 | 3995 | nucleobase-containing compound biosynthetic process |
GO:0048519 | 0.0028 | 1.4233 | 87.6866 | 110 | 4778 | negative regulation of biological process |
GO:0006590 | 0.0029 | 12.464 | 0.2936 | 3 | 16 | thyroid hormone generation |
GO:0048598 | 0.003 | 2.091 | 10.112 | 20 | 551 | embryonic morphogenesis |
GO:0051252 | 0.0031 | 1.4522 | 65.7191 | 86 | 3581 | regulation of RNA metabolic process |
GO:0010936 | 0.0032 | 35.9038 | 0.0918 | 2 | 5 | negative regulation of macrophage cytokine production |
GO:0033864 | 0.0032 | 35.9038 | 0.0918 | 2 | 5 | positive regulation of NAD(P)H oxidase activity |
GO:0051891 | 0.0032 | 35.9038 | 0.0918 | 2 | 5 | positive regulation of cardioblast differentiation |
GO:0045823 | 0.0033 | 7.2189 | 0.624 | 4 | 34 | positive regulation of heart contraction |
GO:0009890 | 0.0034 | 1.6166 | 29.8957 | 45 | 1629 | negative regulation of biosynthetic process |
GO:0061564 | 0.0035 | 2.2009 | 8.1484 | 17 | 444 | axon development |
GO:0034599 | 0.0037 | 2.6044 | 4.8633 | 12 | 265 | cellular response to oxidative stress |
GO:0001708 | 0.0037 | 4.3494 | 1.4865 | 6 | 81 | cell fate specification |
GO:0060065 | 0.0041 | 10.8007 | 0.3303 | 3 | 18 | uterus development |
GO:1904994 | 0.0041 | 10.8007 | 0.3303 | 3 | 18 | regulation of leukocyte adhesion to vascular endothelial cell |
GO:0000302 | 0.0042 | 2.8506 | 3.7071 | 10 | 202 | response to reactive oxygen species |
GO:0018958 | 0.0047 | 4.1281 | 1.5599 | 6 | 85 | phenol-containing compound metabolic process |
GO:0003278 | 0.0048 | 26.9261 | 0.1101 | 2 | 6 | apoptotic process involved in heart morphogenesis |
GO:0072049 | 0.0048 | 26.9261 | 0.1101 | 2 | 6 | comma-shaped body morphogenesis |
GO:0007596 | 0.005 | 2.3969 | 5.7075 | 13 | 311 | blood coagulation |
GO:0072091 | 0.0052 | 4.843 | 1.1195 | 5 | 61 | regulation of stem cell proliferation |
GO:2000379 | 0.0053 | 4.0257 | 1.5966 | 6 | 87 | positive regulation of reactive oxygen species metabolic process |
GO:0001822 | 0.0054 | 2.5976 | 4.4596 | 11 | 243 | kidney development |
GO:0032268 | 0.0054 | 1.4816 | 45.3298 | 62 | 2470 | regulation of cellular protein metabolic process |
GO:1903706 | 0.0055 | 2.4696 | 5.1137 | 12 | 296 | regulation of hemopoiesis |
GO:0001709 | 0.0055 | 6.1856 | 0.7157 | 4 | 39 | cell fate determination |
GO:0007595 | 0.0055 | 6.1856 | 0.7157 | 4 | 39 | lactation |
GO:0002052 | 0.0055 | 9.5288 | 0.367 | 3 | 20 | positive regulation of neuroblast proliferation |
GO:0055017 | 0.0056 | 3.9763 | 1.615 | 6 | 88 | cardiac muscle tissue growth |
GO:0048518 | 0.0061 | 1.3716 | 94.4769 | 115 | 5148 | positive regulation of biological process |
GO:0043010 | 0.0062 | 2.4285 | 5.1937 | 12 | 283 | camera-type eye development |
GO:0022008 | 0.0063 | 1.6039 | 25.8765 | 39 | 1410 | neurogenesis |
GO:0002376 | 0.0066 | 1.465 | 45.7519 | 62 | 2493 | immune system process |
GO:0021796 | 0.0066 | 21.5394 | 0.1285 | 2 | 7 | cerebral cortex regionalization |
GO:0032429 | 0.0066 | 21.5394 | 0.1285 | 2 | 7 | regulation of phospholipase A2 activity |
GO:0046439 | 0.0066 | 21.5394 | 0.1285 | 2 | 7 | L-cysteine metabolic process |
GO:1903265 | 0.0066 | 21.5394 | 0.1285 | 2 | 7 | positive regulation of tumor necrosis factor-mediated signaling pathway |
GO:0003081 | 0.0073 | 8.5246 | 0.4037 | 3 | 22 | regulation of systemic arterial blood pressure by renin-angiotensin |
GO:0010604 | 0.0074 | 1.4331 | 52.2486 | 69 | 2847 | positive regulation of macromolecule metabolic process |
GO:0060420 | 0.0077 | 4.3726 | 1.2296 | 5 | 67 | regulation of heart growth |
GO:0006928 | 0.008 | 1.5185 | 33.0522 | 47 | 1801 | movement of cell or subcellular component |
GO:0001655 | 0.0081 | 2.3405 | 5.3772 | 12 | 293 | urogenital system development |
GO:0048663 | 0.0082 | 4.3029 | 1.2479 | 5 | 68 | neuron fate commitment |
GO:0048568 | 0.0082 | 2.1103 | 7.451 | 15 | 406 | embryonic organ development |
GO:0060343 | 0.0083 | 8.0979 | 0.4221 | 3 | 23 | trabecula formation |
GO:0003006 | 0.0085 | 1.8843 | 11.1398 | 20 | 607 | developmental process involved in reproduction |
GO:0072050 | 0.0087 | 17.9484 | 0.1468 | 2 | 8 | S-shaped body morphogenesis |
GO:0016043 | 0.009 | 1.3424 | 103.2859 | 123 | 5628 | cellular component organization |
GO:0040008 | 0.0091 | 1.871 | 11.2132 | 20 | 611 | regulation of growth |
GO:0042026 | 0.0093 | 7.7118 | 0.4405 | 3 | 24 | protein refolding |
GO:0050482 | 0.0093 | 7.7118 | 0.4405 | 3 | 24 | arachidonic acid secretion |
GO:0055001 | 0.0095 | 2.8675 | 2.9363 | 8 | 160 | muscle cell development |
GO:0032526 | 0.0098 | 3.5035 | 1.8169 | 6 | 99 | response to retinoic acid |
GO:0048666 | 0.0098 | 1.6805 | 17.5447 | 28 | 956 | neuron development |
GO:0046426 | 0.0099 | 5.1523 | 0.8442 | 4 | 46 | negative regulation of JAK-STAT cascade |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050792 | 5e-04 | 4.7509 | 1.8172 | 8 | 177 | regulation of viral process |
GO:0018103 | 0.0015 | 48.7975 | 0.0616 | 2 | 6 | protein C-linked glycosylation |
GO:0018211 | 0.0015 | 48.7975 | 0.0616 | 2 | 6 | peptidyl-tryptophan modification |
GO:0018406 | 0.0015 | 48.7975 | 0.0616 | 2 | 6 | protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan |
GO:0044829 | 0.0021 | 39.0354 | 0.0719 | 2 | 7 | positive regulation by host of viral genome replication |
GO:0008285 | 0.0031 | 2.3858 | 6.7351 | 15 | 656 | negative regulation of cell proliferation |
GO:0014049 | 0.0036 | 27.8788 | 0.0924 | 2 | 9 | positive regulation of glutamate secretion |
GO:0097502 | 0.0042 | 10.1439 | 0.3285 | 3 | 32 | mannosylation |
GO:1900076 | 0.0045 | 6.4578 | 0.6674 | 4 | 65 | regulation of cellular response to insulin stimulus |
GO:0006069 | 0.0045 | 24.3924 | 0.1027 | 2 | 10 | ethanol oxidation |
GO:0008217 | 0.0064 | 3.838 | 1.653 | 6 | 161 | regulation of blood pressure |
GO:0001937 | 0.0069 | 8.4016 | 0.3901 | 3 | 38 | negative regulation of endothelial cell proliferation |
GO:0050434 | 0.0091 | 7.538 | 0.4312 | 3 | 42 | positive regulation of viral transcription |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 202.4578 | 0.5629 | 24 | 31 | DNA replication-dependent nucleosome assembly |
GO:0000183 | 0 | 108.973 | 0.6719 | 24 | 37 | chromatin silencing at rDNA |
GO:0051290 | 0 | 74.5312 | 0.7809 | 24 | 43 | protein heterotetramerization |
GO:0045815 | 0 | 26.1639 | 1.4165 | 24 | 78 | positive regulation of gene expression, epigenetic |
GO:0045653 | 0 | 265.3928 | 0.3087 | 14 | 17 | negative regulation of megakaryocyte differentiation |
GO:0060964 | 0 | 18.812 | 1.7978 | 24 | 99 | regulation of gene silencing by miRNA |
GO:1902036 | 0 | 18.0849 | 1.8523 | 24 | 102 | regulation of hematopoietic stem cell differentiation |
GO:0045814 | 0 | 15.0322 | 2.2336 | 25 | 123 | negative regulation of gene expression, epigenetic |
GO:0060968 | 0 | 14.5244 | 2.1973 | 24 | 121 | regulation of gene silencing |
GO:0031497 | 0 | 11.0715 | 2.7421 | 24 | 151 | chromatin assembly |
GO:0002244 | 0 | 9.6344 | 3.3595 | 26 | 185 | hematopoietic progenitor cell differentiation |
GO:0032200 | 0 | 10.3327 | 2.9055 | 24 | 160 | telomere organization |
GO:0034080 | 0 | 28.3885 | 0.7627 | 14 | 42 | CENP-A containing nucleosome assembly |
GO:1904837 | 0 | 28.3885 | 0.7627 | 14 | 42 | beta-catenin-TCF complex assembly |
GO:0048863 | 0 | 7.4925 | 4.5218 | 28 | 249 | stem cell differentiation |
GO:0016233 | 0 | 22.0684 | 0.908 | 14 | 50 | telomere capping |
GO:0034724 | 0 | 20.3668 | 0.9625 | 14 | 53 | DNA replication-independent nucleosome organization |
GO:0065004 | 0 | 6.9966 | 4.0678 | 24 | 224 | protein-DNA complex assembly |
GO:0030099 | 0 | 5.2652 | 6.6646 | 30 | 367 | myeloid cell differentiation |
GO:1903707 | 0 | 9.2953 | 2.3426 | 18 | 129 | negative regulation of hemopoiesis |
GO:0006303 | 0 | 14.4268 | 1.253 | 14 | 69 | double-strand break repair via nonhomologous end joining |
GO:0043044 | 0 | 12.7921 | 1.3801 | 14 | 76 | ATP-dependent chromatin remodeling |
GO:0035194 | 0 | 5.5406 | 5.23 | 25 | 288 | posttranscriptional gene silencing by RNA |
GO:0002520 | 0 | 3.352 | 15.6536 | 45 | 862 | immune system development |
GO:0071103 | 0 | 5.671 | 4.9031 | 24 | 270 | DNA conformation change |
GO:0051259 | 0 | 4.0767 | 9.0072 | 32 | 496 | protein oligomerization |
GO:0038111 | 0 | 20.7217 | 0.6719 | 10 | 37 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 19.9804 | 0.6901 | 10 | 38 | response to interleukin-7 |
GO:0017148 | 0 | 4.3598 | 6.7735 | 26 | 373 | negative regulation of translation |
GO:0045652 | 0 | 13.0871 | 0.9504 | 10 | 55 | regulation of megakaryocyte differentiation |
GO:0051239 | 0 | 1.9827 | 48.2139 | 81 | 2655 | regulation of multicellular organismal process |
GO:0032502 | 0 | 1.8408 | 81.1292 | 117 | 4671 | developmental process |
GO:0034248 | 0 | 2.885 | 10.696 | 28 | 589 | regulation of cellular amide metabolic process |
GO:0051248 | 0 | 2.2502 | 22.8993 | 46 | 1261 | negative regulation of protein metabolic process |
GO:0045892 | 0 | 2.2642 | 19.5579 | 40 | 1077 | negative regulation of transcription, DNA-templated |
GO:0010608 | 0 | 2.5859 | 12.2759 | 29 | 676 | posttranscriptional regulation of gene expression |
GO:0034728 | 0 | 5.9743 | 1.8706 | 10 | 108 | nucleosome organization |
GO:0070271 | 0 | 2.101 | 24.3339 | 46 | 1340 | protein complex biogenesis |
GO:0060249 | 0 | 3.2449 | 6.374 | 19 | 351 | anatomical structure homeostasis |
GO:1902679 | 0 | 2.174 | 20.2843 | 40 | 1117 | negative regulation of RNA biosynthetic process |
GO:0007275 | 0 | 1.6845 | 74.9382 | 105 | 4290 | multicellular organism development |
GO:0071822 | 1e-04 | 1.9428 | 28.547 | 50 | 1572 | protein complex subunit organization |
GO:0045596 | 1e-04 | 2.5225 | 11.1863 | 26 | 616 | negative regulation of cell differentiation |
GO:0045934 | 1e-04 | 1.9928 | 24.2976 | 44 | 1338 | negative regulation of nucleobase-containing compound metabolic process |
GO:0006352 | 1e-04 | 3.6177 | 4.1949 | 14 | 231 | DNA-templated transcription, initiation |
GO:0048513 | 3e-04 | 1.6922 | 43.9293 | 66 | 2544 | animal organ development |
GO:0001655 | 3e-04 | 3.0246 | 5.3208 | 15 | 293 | urogenital system development |
GO:0042060 | 4e-04 | 2.4643 | 9.1343 | 21 | 503 | wound healing |
GO:0032268 | 4e-04 | 1.6649 | 44.8543 | 67 | 2470 | regulation of cellular protein metabolic process |
GO:0021879 | 4e-04 | 7.03 | 0.9625 | 6 | 53 | forebrain neuron differentiation |
GO:0001709 | 7e-04 | 8.0761 | 0.7082 | 5 | 39 | cell fate determination |
GO:0045595 | 8e-04 | 1.978 | 16.9124 | 31 | 985 | regulation of cell differentiation |
GO:0002019 | 0.001 | 108.8968 | 0.0545 | 2 | 3 | regulation of renal output by angiotensin |
GO:0060978 | 0.001 | 108.8968 | 0.0545 | 2 | 3 | angiogenesis involved in coronary vascular morphogenesis |
GO:0070370 | 0.001 | 108.8968 | 0.0545 | 2 | 3 | cellular heat acclimation |
GO:0070434 | 0.001 | 108.8968 | 0.0545 | 2 | 3 | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway |
GO:0043043 | 0.001 | 2.0089 | 14.9091 | 28 | 821 | peptide biosynthetic process |
GO:0071345 | 0.0011 | 1.9982 | 14.9817 | 28 | 825 | cellular response to cytokine stimulus |
GO:0048598 | 0.0011 | 2.2338 | 10.006 | 21 | 551 | embryonic morphogenesis |
GO:0035930 | 0.0012 | 18.2048 | 0.2179 | 3 | 12 | corticosteroid hormone secretion |
GO:0048519 | 0.0012 | 1.4705 | 86.7668 | 111 | 4778 | negative regulation of biological process |
GO:0048704 | 0.0013 | 4.6502 | 1.6344 | 7 | 90 | embryonic skeletal system morphogenesis |
GO:0051716 | 0.0015 | 1.4385 | 118.9457 | 144 | 6550 | cellular response to stimulus |
GO:0010604 | 0.0015 | 1.5403 | 51.7005 | 72 | 2847 | positive regulation of macromolecule metabolic process |
GO:0010823 | 0.0016 | 6.5343 | 0.8535 | 5 | 47 | negative regulation of mitochondrion organization |
GO:0001822 | 0.0017 | 2.8888 | 4.4128 | 12 | 243 | kidney development |
GO:0006935 | 0.0017 | 2.2055 | 9.6246 | 20 | 530 | chemotaxis |
GO:1903706 | 0.0018 | 2.7174 | 5.0754 | 13 | 296 | regulation of hemopoiesis |
GO:0060192 | 0.0019 | 14.8929 | 0.2542 | 3 | 14 | negative regulation of lipase activity |
GO:0065003 | 0.0019 | 1.6578 | 30.6535 | 47 | 1688 | macromolecular complex assembly |
GO:0048518 | 0.0019 | 1.4388 | 93.4859 | 117 | 5148 | positive regulation of biological process |
GO:0090063 | 0.0019 | 54.4448 | 0.0726 | 2 | 4 | positive regulation of microtubule nucleation |
GO:0010951 | 0.0021 | 2.9634 | 3.9406 | 11 | 217 | negative regulation of endopeptidase activity |
GO:0001501 | 0.0021 | 2.2624 | 8.4261 | 18 | 464 | skeletal system development |
GO:2000831 | 0.0023 | 13.6509 | 0.2724 | 3 | 15 | regulation of steroid hormone secretion |
GO:0008584 | 0.0025 | 3.6496 | 2.3426 | 8 | 129 | male gonad development |
GO:1903506 | 0.0026 | 1.4751 | 61.6883 | 82 | 3397 | regulation of nucleic acid-templated transcription |
GO:0009890 | 0.0028 | 1.6373 | 29.5821 | 45 | 1629 | negative regulation of biosynthetic process |
GO:0048665 | 0.0029 | 7.5501 | 0.5993 | 4 | 33 | neuron fate specification |
GO:0009952 | 0.003 | 2.993 | 3.5411 | 10 | 195 | anterior/posterior pattern specification |
GO:0010936 | 0.0032 | 36.2942 | 0.0908 | 2 | 5 | negative regulation of macrophage cytokine production |
GO:0033864 | 0.0032 | 36.2942 | 0.0908 | 2 | 5 | positive regulation of NAD(P)H oxidase activity |
GO:0048818 | 0.0032 | 36.2942 | 0.0908 | 2 | 5 | positive regulation of hair follicle maturation |
GO:1905007 | 0.0032 | 36.2942 | 0.0908 | 2 | 5 | positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation |
GO:0065008 | 0.0032 | 1.5057 | 49.7151 | 68 | 2817 | regulation of biological quality |
GO:0007409 | 0.0034 | 2.2732 | 7.4273 | 16 | 409 | axonogenesis |
GO:0034599 | 0.0034 | 2.6337 | 4.8123 | 12 | 265 | cellular response to oxidative stress |
GO:0060065 | 0.004 | 10.9186 | 0.3269 | 3 | 18 | uterus development |
GO:1904994 | 0.004 | 10.9186 | 0.3269 | 3 | 18 | regulation of leukocyte adhesion to vascular endothelial cell |
GO:0006950 | 0.0044 | 1.441 | 61.9607 | 81 | 3412 | response to stress |
GO:0018958 | 0.0045 | 4.1737 | 1.5436 | 6 | 85 | phenol-containing compound metabolic process |
GO:0061339 | 0.0046 | 10.2355 | 0.345 | 3 | 19 | establishment or maintenance of monopolar cell polarity |
GO:2000178 | 0.0046 | 10.2355 | 0.345 | 3 | 19 | negative regulation of neural precursor cell proliferation |
GO:0072049 | 0.0047 | 27.2189 | 0.109 | 2 | 6 | comma-shaped body morphogenesis |
GO:0045777 | 0.0048 | 6.4377 | 0.6901 | 4 | 38 | positive regulation of blood pressure |
GO:0072091 | 0.0049 | 4.8963 | 1.1077 | 5 | 61 | regulation of stem cell proliferation |
GO:0048646 | 0.0049 | 1.7623 | 17.4333 | 29 | 960 | anatomical structure formation involved in morphogenesis |
GO:0002052 | 0.0054 | 9.6328 | 0.3632 | 3 | 20 | positive regulation of neuroblast proliferation |
GO:0006497 | 0.0054 | 3.1732 | 2.6695 | 8 | 147 | protein lipidation |
GO:0051346 | 0.0055 | 2.2867 | 6.438 | 14 | 358 | negative regulation of hydrolase activity |
GO:0030326 | 0.006 | 3.4395 | 2.161 | 7 | 119 | embryonic limb morphogenesis |
GO:0046661 | 0.0061 | 3.1056 | 2.7239 | 8 | 150 | male sex differentiation |
GO:0061082 | 0.0062 | 9.097 | 0.3814 | 3 | 21 | myeloid leukocyte cytokine production |
GO:0021796 | 0.0065 | 21.7737 | 0.1271 | 2 | 7 | cerebral cortex regionalization |
GO:0021891 | 0.0065 | 21.7737 | 0.1271 | 2 | 7 | olfactory bulb interneuron development |
GO:0032429 | 0.0065 | 21.7737 | 0.1271 | 2 | 7 | regulation of phospholipase A2 activity |
GO:0044851 | 0.0065 | 21.7737 | 0.1271 | 2 | 7 | hair cycle phase |
GO:0046439 | 0.0065 | 21.7737 | 0.1271 | 2 | 7 | L-cysteine metabolic process |
GO:0060017 | 0.0065 | 21.7737 | 0.1271 | 2 | 7 | parathyroid gland development |
GO:1903265 | 0.0065 | 21.7737 | 0.1271 | 2 | 7 | positive regulation of tumor necrosis factor-mediated signaling pathway |
GO:0040011 | 0.0065 | 1.5754 | 28.438 | 42 | 1566 | locomotion |
GO:0006518 | 0.0068 | 3.3561 | 2.2109 | 7 | 128 | peptide metabolic process |
GO:0003081 | 0.0071 | 8.6177 | 0.3995 | 3 | 22 | regulation of systemic arterial blood pressure by renin-angiotensin |
GO:0033002 | 0.0072 | 2.7907 | 3.3959 | 9 | 187 | muscle cell proliferation |
GO:0006259 | 0.0073 | 1.7244 | 17.1427 | 28 | 944 | DNA metabolic process |
GO:0051252 | 0.0074 | 1.4003 | 65.0297 | 83 | 3581 | regulation of RNA metabolic process |
GO:0048568 | 0.0075 | 2.1343 | 7.3728 | 15 | 406 | embryonic organ development |
GO:0007389 | 0.0078 | 2.1232 | 7.4091 | 15 | 408 | pattern specification process |
GO:0008589 | 0.0078 | 4.3502 | 1.2349 | 5 | 68 | regulation of smoothened signaling pathway |
GO:1903409 | 0.0081 | 3.6609 | 1.7433 | 6 | 96 | reactive oxygen species biosynthetic process |
GO:0030097 | 0.0085 | 2.9239 | 2.8816 | 8 | 174 | hemopoiesis |
GO:0072050 | 0.0086 | 18.1435 | 0.1453 | 2 | 8 | S-shaped body morphogenesis |
GO:2000849 | 0.0086 | 18.1435 | 0.1453 | 2 | 8 | regulation of glucocorticoid secretion |
GO:0120039 | 0.0088 | 1.9122 | 10.4236 | 19 | 574 | plasma membrane bounded cell projection morphogenesis |
GO:0090288 | 0.0089 | 3.1818 | 2.3244 | 7 | 128 | negative regulation of cellular response to growth factor stimulus |
GO:0042026 | 0.009 | 7.7959 | 0.4358 | 3 | 24 | protein refolding |
GO:0050482 | 0.009 | 7.7959 | 0.4358 | 3 | 24 | arachidonic acid secretion |
GO:0050878 | 0.0092 | 2.0287 | 8.2626 | 16 | 455 | regulation of body fluid levels |
GO:0001101 | 0.0094 | 2.292 | 5.4842 | 12 | 302 | response to acid chemical |
GO:0030154 | 0.0096 | 1.5345 | 31.022 | 44 | 1936 | cell differentiation |
GO:2000377 | 0.0099 | 2.8427 | 2.96 | 8 | 163 | regulation of reactive oxygen species metabolic process |
GO:0045682 | 0.0099 | 4.0894 | 1.3075 | 5 | 72 | regulation of epidermis development |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0010721 | 1e-04 | 4.3537 | 3.0131 | 12 | 273 | negative regulation of cell development |
GO:1902340 | 1e-04 | Inf | 0.0221 | 2 | 2 | negative regulation of chromosome condensation |
GO:0051961 | 1e-04 | 4.2472 | 2.8144 | 11 | 255 | negative regulation of nervous system development |
GO:0031054 | 3e-04 | 27.3408 | 0.1435 | 3 | 13 | pre-miRNA processing |
GO:0031509 | 4e-04 | 181.3059 | 0.0331 | 2 | 3 | telomeric heterochromatin assembly |
GO:0031508 | 7e-04 | 90.6471 | 0.0441 | 2 | 4 | pericentric heterochromatin assembly |
GO:0031050 | 0.0011 | 9.8938 | 0.4525 | 4 | 41 | dsRNA fragmentation |
GO:0060231 | 0.0011 | 17.0814 | 0.2097 | 3 | 19 | mesenchymal to epithelial transition |
GO:0010626 | 0.0012 | 60.4275 | 0.0552 | 2 | 5 | negative regulation of Schwann cell proliferation |
GO:0030325 | 0.0013 | 16.0755 | 0.2207 | 3 | 20 | adrenal gland development |
GO:0002028 | 0.0014 | 6.562 | 0.8278 | 5 | 75 | regulation of sodium ion transport |
GO:0010586 | 0.0017 | 14.3815 | 0.2428 | 3 | 22 | miRNA metabolic process |
GO:0090230 | 0.0018 | 45.3176 | 0.0662 | 2 | 6 | regulation of centromere complex assembly |
GO:1905940 | 0.0018 | 45.3176 | 0.0662 | 2 | 6 | negative regulation of gonad development |
GO:0048519 | 0.0019 | 1.5987 | 52.7346 | 71 | 4778 | negative regulation of biological process |
GO:0061005 | 0.0024 | 7.7837 | 0.5629 | 4 | 51 | cell differentiation involved in kidney development |
GO:2000018 | 0.0025 | 36.2518 | 0.0773 | 2 | 7 | regulation of male gonad development |
GO:0036336 | 0.0025 | 12.418 | 0.2759 | 3 | 25 | dendritic cell migration |
GO:0072273 | 0.0029 | 11.8773 | 0.287 | 3 | 26 | metanephric nephron morphogenesis |
GO:0010033 | 0.0029 | 1.6706 | 31.0139 | 46 | 2810 | response to organic substance |
GO:0030422 | 0.0032 | 30.2078 | 0.0883 | 2 | 8 | production of siRNA involved in RNA interference |
GO:0072033 | 0.0032 | 30.2078 | 0.0883 | 2 | 8 | renal vesicle formation |
GO:0035195 | 0.0041 | 3.0619 | 3.1124 | 9 | 282 | gene silencing by miRNA |
GO:0042473 | 0.0041 | 25.8908 | 0.0993 | 2 | 9 | outer ear morphogenesis |
GO:0045665 | 0.0044 | 3.6516 | 2.0308 | 7 | 184 | negative regulation of neuron differentiation |
GO:0007346 | 0.005 | 2.2529 | 7.0857 | 15 | 642 | regulation of mitotic cell cycle |
GO:0060147 | 0.0054 | 4.7271 | 1.1258 | 5 | 102 | regulation of posttranscriptional gene silencing |
GO:0060966 | 0.0054 | 4.7271 | 1.1258 | 5 | 102 | regulation of gene silencing by RNA |
GO:0045687 | 0.0057 | 9.1018 | 0.3642 | 3 | 33 | positive regulation of glial cell differentiation |
GO:0031327 | 0.0057 | 1.7704 | 17.8026 | 29 | 1613 | negative regulation of cellular biosynthetic process |
GO:0008285 | 0.0061 | 2.2016 | 7.2402 | 15 | 656 | negative regulation of cell proliferation |
GO:1900449 | 0.0062 | 8.8076 | 0.3753 | 3 | 34 | regulation of glutamate receptor signaling pathway |
GO:0016322 | 0.0062 | 20.1346 | 0.1214 | 2 | 11 | neuron remodeling |
GO:0050767 | 0.0067 | 2.1768 | 7.3175 | 15 | 663 | regulation of neurogenesis |
GO:1903798 | 0.0074 | 18.12 | 0.1324 | 2 | 12 | regulation of production of miRNAs involved in gene silencing by miRNA |
GO:0090184 | 0.0078 | 8.0289 | 0.4084 | 3 | 37 | positive regulation of kidney development |
GO:0099601 | 0.0078 | 8.0289 | 0.4084 | 3 | 37 | regulation of neurotransmitter receptor activity |
GO:0014014 | 0.0084 | 7.799 | 0.4194 | 3 | 38 | negative regulation of gliogenesis |
GO:1900025 | 0.0087 | 16.4717 | 0.1435 | 2 | 13 | negative regulation of substrate adhesion-dependent cell spreading |
GO:1901722 | 0.0087 | 16.4717 | 0.1435 | 2 | 13 | regulation of cell proliferation involved in kidney development |
GO:2000651 | 0.0087 | 16.4717 | 0.1435 | 2 | 13 | positive regulation of sodium ion transmembrane transporter activity |
GO:0045595 | 0.0094 | 1.7107 | 17.6702 | 28 | 1601 | regulation of cell differentiation |
GO:0008344 | 0.0095 | 5.1445 | 0.8278 | 4 | 75 | adult locomotory behavior |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0001895 | 1e-04 | 9.7564 | 0.6986 | 6 | 57 | retina homeostasis |
GO:0018003 | 1e-04 | Inf | 0.0245 | 2 | 2 | peptidyl-lysine N6-acetylation |
GO:0002252 | 5e-04 | 2.4067 | 9.4914 | 21 | 798 | immune effector process |
GO:0016192 | 6e-04 | 1.9371 | 20.6394 | 36 | 1684 | vesicle-mediated transport |
GO:1902746 | 9e-04 | 81.4339 | 0.049 | 2 | 4 | regulation of lens fiber cell differentiation |
GO:0001775 | 0.0014 | 2.0163 | 14.5726 | 27 | 1189 | cell activation |
GO:0006955 | 0.0018 | 2.317 | 8.3818 | 18 | 725 | immune response |
GO:0060444 | 0.002 | 13.6303 | 0.2574 | 3 | 21 | branching involved in mammary gland duct morphogenesis |
GO:0060992 | 0.0022 | 40.7116 | 0.0735 | 2 | 6 | response to fungicide |
GO:0071378 | 0.0024 | 12.9121 | 0.2696 | 3 | 22 | cellular response to growth hormone stimulus |
GO:0002757 | 0.0025 | 2.6294 | 5.2579 | 13 | 429 | immune response-activating signal transduction |
GO:0006678 | 0.003 | 32.5672 | 0.0858 | 2 | 7 | glucosylceramide metabolic process |
GO:0039536 | 0.003 | 32.5672 | 0.0858 | 2 | 7 | negative regulation of RIG-I signaling pathway |
GO:2000328 | 0.003 | 32.5672 | 0.0858 | 2 | 7 | regulation of T-helper 17 cell lineage commitment |
GO:0051607 | 0.0031 | 3.498 | 2.4267 | 8 | 198 | defense response to virus |
GO:0007165 | 0.0031 | 1.5154 | 65.4111 | 84 | 5337 | signal transduction |
GO:0002366 | 0.0034 | 2.2859 | 7.4517 | 16 | 608 | leukocyte activation involved in immune response |
GO:0051707 | 0.004 | 2.1328 | 8.996 | 18 | 734 | response to other organism |
GO:0045087 | 0.0053 | 2.072 | 9.2411 | 18 | 754 | innate immune response |
GO:0008544 | 0.0055 | 2.4747 | 5.1231 | 12 | 418 | epidermis development |
GO:0007264 | 0.0056 | 2.3709 | 5.7972 | 13 | 473 | small GTPase mediated signal transduction |
GO:0043368 | 0.0058 | 9.0816 | 0.3677 | 3 | 30 | positive T cell selection |
GO:0002768 | 0.0066 | 2.6618 | 3.9587 | 10 | 323 | immune response-regulating cell surface receptor signaling pathway |
GO:0007339 | 0.0069 | 8.4541 | 0.3922 | 3 | 32 | binding of sperm to zona pellucida |
GO:0009607 | 0.0072 | 2.0061 | 9.523 | 18 | 777 | response to biotic stimulus |
GO:0002444 | 0.0073 | 2.2887 | 5.9933 | 13 | 489 | myeloid leukocyte mediated immunity |
GO:0014031 | 0.0074 | 5.5593 | 0.7721 | 4 | 63 | mesenchymal cell development |
GO:0030279 | 0.0074 | 5.5593 | 0.7721 | 4 | 63 | negative regulation of ossification |
GO:0048864 | 0.0074 | 5.5593 | 0.7721 | 4 | 63 | stem cell development |
GO:0015804 | 0.0075 | 8.1718 | 0.4045 | 3 | 33 | neutral amino acid transport |
GO:0043312 | 0.0076 | 2.3668 | 5.3437 | 12 | 436 | neutrophil degranulation |
GO:0034244 | 0.0076 | 18.0882 | 0.1348 | 2 | 11 | negative regulation of transcription elongation from RNA polymerase II promoter |
GO:0014033 | 0.0087 | 5.2893 | 0.8089 | 4 | 66 | neural crest cell differentiation |
GO:0042119 | 0.009 | 2.3107 | 5.4662 | 12 | 446 | neutrophil activation |
GO:0015671 | 0.0091 | 16.2783 | 0.1471 | 2 | 12 | oxygen transport |
GO:0048583 | 0.0092 | 1.4808 | 44.4653 | 59 | 3628 | regulation of response to stimulus |
GO:0001755 | 0.0096 | 7.4275 | 0.4412 | 3 | 36 | neural crest cell migration |
GO:0050778 | 0.0099 | 2.0725 | 7.6356 | 15 | 623 | positive regulation of immune response |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0045653 | 0 | 207.1293 | 0.3894 | 14 | 17 | negative regulation of megakaryocyte differentiation |
GO:0006335 | 0 | 36.5186 | 0.7102 | 14 | 31 | DNA replication-dependent nucleosome assembly |
GO:0034080 | 0 | 24.6914 | 0.9621 | 15 | 42 | CENP-A containing nucleosome assembly |
GO:1904837 | 0 | 24.6914 | 0.9621 | 15 | 42 | beta-catenin-TCF complex assembly |
GO:0034724 | 0 | 19.2629 | 1.2141 | 16 | 53 | DNA replication-independent nucleosome organization |
GO:0000183 | 0 | 26.9814 | 0.8476 | 14 | 37 | chromatin silencing at rDNA |
GO:0016233 | 0 | 19.0376 | 1.1454 | 15 | 50 | telomere capping |
GO:0051290 | 0 | 21.3906 | 0.985 | 14 | 43 | protein heterotetramerization |
GO:0006303 | 0 | 13.4335 | 1.5807 | 16 | 69 | double-strand break repair via nonhomologous end joining |
GO:0065004 | 0 | 5.6866 | 5.1314 | 25 | 224 | protein-DNA complex assembly |
GO:0043044 | 0 | 10.9045 | 1.741 | 15 | 76 | ATP-dependent chromatin remodeling |
GO:1902036 | 0 | 8.2608 | 2.3366 | 16 | 102 | regulation of hematopoietic stem cell differentiation |
GO:0045815 | 0 | 9.6703 | 1.7868 | 14 | 78 | positive regulation of gene expression, epigenetic |
GO:0006352 | 0 | 4.9723 | 5.2918 | 23 | 231 | DNA-templated transcription, initiation |
GO:0060964 | 0 | 7.9067 | 2.2679 | 15 | 99 | regulation of gene silencing by miRNA |
GO:0060968 | 0 | 6.7575 | 2.7719 | 16 | 121 | regulation of gene silencing |
GO:0045814 | 0 | 6.6303 | 2.8177 | 16 | 123 | negative regulation of gene expression, epigenetic |
GO:1903707 | 0 | 6.2758 | 2.9551 | 16 | 129 | negative regulation of hemopoiesis |
GO:0002244 | 0 | 5.1001 | 4.238 | 19 | 185 | hematopoietic progenitor cell differentiation |
GO:0016070 | 0 | 1.8281 | 97.7577 | 144 | 4318 | RNA metabolic process |
GO:0031497 | 0 | 5.6317 | 3.4591 | 17 | 151 | chromatin assembly |
GO:0032200 | 0 | 5.2741 | 3.6653 | 17 | 160 | telomere organization |
GO:0071103 | 0 | 3.9665 | 6.1852 | 22 | 270 | DNA conformation change |
GO:0065003 | 0 | 2.0515 | 38.6689 | 70 | 1688 | macromolecular complex assembly |
GO:0045637 | 0 | 4.0198 | 5.246 | 19 | 229 | regulation of myeloid cell differentiation |
GO:0048863 | 0 | 3.6653 | 5.7041 | 19 | 249 | stem cell differentiation |
GO:0060249 | 0 | 3.128 | 8.0407 | 23 | 351 | anatomical structure homeostasis |
GO:2001141 | 0 | 1.658 | 77.9563 | 112 | 3403 | regulation of RNA biosynthetic process |
GO:0006325 | 0 | 2.3361 | 16.3106 | 35 | 712 | chromatin organization |
GO:0019219 | 0 | 1.6145 | 90.1434 | 125 | 3935 | regulation of nucleobase-containing compound metabolic process |
GO:0097659 | 0 | 1.6332 | 81.2551 | 115 | 3547 | nucleic acid-templated transcription |
GO:0034470 | 0 | 2.8519 | 8.7509 | 23 | 382 | ncRNA processing |
GO:0051259 | 0 | 2.5746 | 11.3624 | 27 | 496 | protein oligomerization |
GO:0010608 | 0 | 2.3101 | 15.4859 | 33 | 676 | posttranscriptional regulation of gene expression |
GO:0043604 | 0 | 2.1211 | 20.5028 | 40 | 895 | amide biosynthetic process |
GO:0006139 | 0 | 2.1182 | 22.4128 | 42 | 1133 | nucleobase-containing compound metabolic process |
GO:0090063 | 0 | 129.0339 | 0.0916 | 3 | 4 | positive regulation of microtubule nucleation |
GO:0034654 | 1e-04 | 1.5612 | 91.5179 | 124 | 3995 | nucleobase-containing compound biosynthetic process |
GO:0044237 | 1e-04 | 1.5579 | 225.3929 | 259 | 9839 | cellular metabolic process |
GO:0006281 | 1e-04 | 2.4448 | 11.4541 | 26 | 500 | DNA repair |
GO:0070271 | 1e-04 | 1.8451 | 30.6969 | 52 | 1340 | protein complex biogenesis |
GO:0035194 | 1e-04 | 2.9414 | 6.5975 | 18 | 288 | posttranscriptional gene silencing by RNA |
GO:0017148 | 1e-04 | 2.6412 | 8.5447 | 21 | 373 | negative regulation of translation |
GO:0009889 | 2e-04 | 1.5182 | 97.6573 | 129 | 4263 | regulation of biosynthetic process |
GO:0006400 | 2e-04 | 5.6068 | 1.6036 | 8 | 70 | tRNA modification |
GO:0034248 | 2e-04 | 2.2249 | 13.4929 | 28 | 589 | regulation of cellular amide metabolic process |
GO:0006355 | 2e-04 | 1.6466 | 50.7121 | 75 | 2299 | regulation of transcription, DNA-templated |
GO:0006518 | 3e-04 | 1.9295 | 21.7398 | 39 | 949 | peptide metabolic process |
GO:0019058 | 3e-04 | 2.7909 | 6.5288 | 17 | 285 | viral life cycle |
GO:1903265 | 4e-04 | 32.2521 | 0.1604 | 3 | 7 | positive regulation of tumor necrosis factor-mediated signaling pathway |
GO:0006893 | 4e-04 | 7.0178 | 0.985 | 6 | 43 | Golgi to plasma membrane transport |
GO:0042998 | 5e-04 | Inf | 0.0458 | 2 | 2 | positive regulation of Golgi to plasma membrane protein transport |
GO:1905366 | 5e-04 | Inf | 0.0458 | 2 | 2 | negative regulation of intralumenal vesicle formation |
GO:0044403 | 5e-04 | 1.9715 | 17.8912 | 33 | 781 | symbiosis, encompassing mutualism through parasitism |
GO:0022613 | 5e-04 | 2.3266 | 10.0796 | 22 | 440 | ribonucleoprotein complex biogenesis |
GO:1901673 | 6e-04 | 12.3132 | 0.4123 | 4 | 18 | regulation of mitotic spindle assembly |
GO:0090140 | 8e-04 | 11.4916 | 0.4353 | 4 | 19 | regulation of mitochondrial fission |
GO:0006807 | 8e-04 | 1.432 | 212.0146 | 241 | 9255 | nitrogen compound metabolic process |
GO:0051649 | 9e-04 | 1.5742 | 46.9158 | 68 | 2048 | establishment of localization in cell |
GO:0000959 | 0.0013 | 6.963 | 0.8247 | 5 | 36 | mitochondrial RNA metabolic process |
GO:0006996 | 0.0014 | 1.4468 | 79.5599 | 104 | 3473 | organelle organization |
GO:0090224 | 0.0015 | 6.7449 | 0.8476 | 5 | 37 | regulation of spindle organization |
GO:0070370 | 0.0015 | 85.7803 | 0.0687 | 2 | 3 | cellular heat acclimation |
GO:0070434 | 0.0015 | 85.7803 | 0.0687 | 2 | 3 | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway |
GO:1903542 | 0.0015 | 85.7803 | 0.0687 | 2 | 3 | negative regulation of exosomal secretion |
GO:0072599 | 0.0018 | 3.8553 | 2.245 | 8 | 98 | establishment of protein localization to endoplasmic reticulum |
GO:0006612 | 0.0027 | 3.0615 | 3.482 | 10 | 152 | protein targeting to membrane |
GO:1901576 | 0.0029 | 1.3547 | 137.2654 | 163 | 5992 | organic substance biosynthetic process |
GO:1905477 | 0.003 | 3.5387 | 2.4283 | 8 | 106 | positive regulation of protein localization to membrane |
GO:0044878 | 0.003 | 42.8873 | 0.0916 | 2 | 4 | mitotic cytokinesis checkpoint |
GO:1901843 | 0.003 | 42.8873 | 0.0916 | 2 | 4 | positive regulation of high voltage-gated calcium channel activity |
GO:1904978 | 0.003 | 42.8873 | 0.0916 | 2 | 4 | regulation of endosome organization |
GO:0006614 | 0.0036 | 3.8349 | 1.9701 | 7 | 86 | SRP-dependent cotranslational protein targeting to membrane |
GO:0007034 | 0.0036 | 3.4329 | 2.497 | 8 | 109 | vacuolar transport |
GO:0010467 | 0.0036 | 1.9959 | 11.8247 | 22 | 622 | gene expression |
GO:0051123 | 0.0041 | 6.8904 | 0.6643 | 4 | 29 | RNA polymerase II transcriptional preinitiation complex assembly |
GO:0045596 | 0.0042 | 1.8648 | 14.1114 | 25 | 616 | negative regulation of cell differentiation |
GO:0071822 | 0.0043 | 1.5375 | 36.0116 | 52 | 1572 | protein complex subunit organization |
GO:0010468 | 0.0045 | 2.0612 | 9.8058 | 19 | 491 | regulation of gene expression |
GO:0006397 | 0.0046 | 2.0038 | 10.4919 | 20 | 458 | mRNA processing |
GO:0048534 | 0.0047 | 1.7308 | 18.8763 | 31 | 824 | hematopoietic or lymphoid organ development |
GO:0071681 | 0.005 | 28.5897 | 0.1145 | 2 | 5 | cellular response to indole-3-methanol |
GO:0008380 | 0.005 | 2.069 | 9.1403 | 18 | 399 | RNA splicing |
GO:0016072 | 0.0052 | 2.3045 | 6.3914 | 14 | 279 | rRNA metabolic process |
GO:0034645 | 0.0053 | 1.3726 | 87.9692 | 109 | 4065 | cellular macromolecule biosynthetic process |
GO:0019083 | 0.0054 | 2.7485 | 3.8486 | 10 | 168 | viral transcription |
GO:0030260 | 0.0058 | 3.1502 | 2.7032 | 8 | 118 | entry into host cell |
GO:0051828 | 0.0058 | 3.1502 | 2.7032 | 8 | 118 | entry into other organism involved in symbiotic interaction |
GO:2001259 | 0.0061 | 4.6878 | 1.1683 | 5 | 51 | positive regulation of cation channel activity |
GO:0042147 | 0.0061 | 3.9267 | 1.6494 | 6 | 72 | retrograde transport, endosome to Golgi |
GO:0051865 | 0.0066 | 4.5878 | 1.1912 | 5 | 52 | protein autoubiquitination |
GO:0015833 | 0.0068 | 1.463 | 42.9298 | 59 | 1874 | peptide transport |
GO:1903533 | 0.007 | 3.0389 | 2.7948 | 8 | 122 | regulation of protein targeting |
GO:0000245 | 0.0072 | 4.4919 | 1.2141 | 5 | 53 | spliceosomal complex assembly |
GO:0007040 | 0.0072 | 4.4919 | 1.2141 | 5 | 53 | lysosome organization |
GO:0000154 | 0.0073 | 5.7401 | 0.7789 | 4 | 34 | rRNA modification |
GO:0009838 | 0.0074 | 21.4408 | 0.1374 | 2 | 6 | abscission |
GO:0044539 | 0.0074 | 21.4408 | 0.1374 | 2 | 6 | long-chain fatty acid import |
GO:0061724 | 0.0074 | 21.4408 | 0.1374 | 2 | 6 | lipophagy |
GO:1904951 | 0.0074 | 1.9095 | 10.973 | 20 | 479 | positive regulation of establishment of protein localization |
GO:0006886 | 0.0076 | 1.5954 | 24.42 | 37 | 1066 | intracellular protein transport |
GO:0006399 | 0.008 | 2.5832 | 4.0776 | 10 | 178 | tRNA metabolic process |
GO:0070423 | 0.0081 | 5.5546 | 0.8018 | 4 | 35 | nucleotide-binding oligomerization domain containing signaling pathway |
GO:0006368 | 0.0081 | 3.2546 | 2.2908 | 7 | 100 | transcription elongation from RNA polymerase II promoter |
GO:0050708 | 0.0081 | 2.0077 | 8.8654 | 17 | 387 | regulation of protein secretion |
GO:0045892 | 0.0088 | 1.5773 | 24.672 | 37 | 1077 | negative regulation of transcription, DNA-templated |
GO:0006457 | 0.0089 | 2.4131 | 4.7878 | 11 | 209 | protein folding |
GO:1902803 | 0.0089 | 5.3807 | 0.8247 | 4 | 36 | regulation of synaptic vesicle transport |
GO:0071826 | 0.0092 | 2.4008 | 4.8107 | 11 | 210 | ribonucleoprotein complex subunit organization |
GO:0044085 | 0.0095 | 1.5967 | 23.2252 | 35 | 1131 | cellular component biogenesis |
GO:0006412 | 0.0098 | 1.9238 | 9.7884 | 18 | 441 | translation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0002694 | 0 | 5.9598 | 7.3054 | 36 | 428 | regulation of leukocyte activation |
GO:0007229 | 0 | 14.0498 | 1.4574 | 16 | 86 | integrin-mediated signaling pathway |
GO:0045321 | 0 | 4.3922 | 9.424 | 35 | 621 | leukocyte activation |
GO:0002263 | 0 | 4.1427 | 10.4461 | 37 | 612 | cell activation involved in immune response |
GO:0050866 | 0 | 8.1629 | 2.6115 | 18 | 153 | negative regulation of cell activation |
GO:0007154 | 0 | 2.3089 | 74.2846 | 120 | 4597 | cell communication |
GO:0051716 | 0 | 2.4302 | 59.668 | 101 | 3814 | cellular response to stimulus |
GO:0023052 | 0 | 2.2436 | 73.9659 | 118 | 4576 | signaling |
GO:0065007 | 0 | 2.5543 | 185.5889 | 227 | 10873 | biological regulation |
GO:0050867 | 0 | 5.163 | 4.8635 | 22 | 287 | positive regulation of cell activation |
GO:0002275 | 0 | 3.9971 | 8.2613 | 29 | 484 | myeloid cell activation involved in immune response |
GO:0048534 | 0 | 3.1807 | 14.0647 | 39 | 824 | hematopoietic or lymphoid organ development |
GO:0002521 | 0 | 6.0222 | 3.4221 | 18 | 206 | leukocyte differentiation |
GO:0045055 | 0 | 3.3999 | 11.3849 | 34 | 667 | regulated exocytosis |
GO:0007166 | 0 | 2.3178 | 37.8735 | 72 | 2400 | cell surface receptor signaling pathway |
GO:0002253 | 0 | 3.7662 | 8.3978 | 28 | 492 | activation of immune response |
GO:0002429 | 0 | 5.5456 | 3.6853 | 18 | 219 | immune response-activating cell surface receptor signaling pathway |
GO:0050868 | 0 | 9.3513 | 1.5191 | 12 | 89 | negative regulation of T cell activation |
GO:0050900 | 0 | 7.3734 | 2.1905 | 14 | 135 | leukocyte migration |
GO:0042119 | 0 | 3.8427 | 7.6127 | 26 | 446 | neutrophil activation |
GO:0002764 | 0 | 3.7419 | 7.8004 | 26 | 457 | immune response-regulating signaling pathway |
GO:0002444 | 0 | 3.6327 | 8.3466 | 27 | 489 | myeloid leukocyte mediated immunity |
GO:0007159 | 0 | 7.5196 | 1.992 | 13 | 123 | leukocyte cell-cell adhesion |
GO:1903039 | 0 | 5.3786 | 3.5674 | 17 | 209 | positive regulation of leukocyte cell-cell adhesion |
GO:0002684 | 0 | 3.3197 | 10.1924 | 30 | 625 | positive regulation of immune system process |
GO:0048870 | 0 | 2.4349 | 23.0258 | 49 | 1349 | cell motility |
GO:0045785 | 0 | 3.9365 | 6.2301 | 22 | 365 | positive regulation of cell adhesion |
GO:0070663 | 0 | 5.1785 | 3.465 | 16 | 203 | regulation of leukocyte proliferation |
GO:0050853 | 0 | 13.5398 | 0.734 | 8 | 43 | B cell receptor signaling pathway |
GO:0022408 | 0 | 6.1462 | 2.3896 | 13 | 140 | negative regulation of cell-cell adhesion |
GO:0048584 | 0 | 3.6594 | 6.7234 | 22 | 426 | positive regulation of response to stimulus |
GO:0043312 | 0 | 3.5127 | 7.2542 | 23 | 428 | neutrophil degranulation |
GO:0006911 | 0 | 15.3063 | 0.5803 | 7 | 34 | phagocytosis, engulfment |
GO:0032940 | 0 | 2.4586 | 18.8018 | 41 | 1132 | secretion by cell |
GO:0007599 | 0 | 3.8904 | 5.3937 | 19 | 316 | hemostasis |
GO:0050817 | 0 | 3.8771 | 5.4108 | 19 | 317 | coagulation |
GO:0051251 | 0 | 5.0894 | 3.0619 | 14 | 182 | positive regulation of lymphocyte activation |
GO:0070527 | 0 | 10.7639 | 0.8876 | 8 | 52 | platelet aggregation |
GO:0022407 | 0 | 4.4503 | 3.9808 | 16 | 243 | regulation of cell-cell adhesion |
GO:0098657 | 0 | 2.8415 | 10.8728 | 28 | 637 | import into cell |
GO:0006955 | 0 | 5.5683 | 2.4041 | 12 | 179 | immune response |
GO:0031347 | 0 | 2.7843 | 11.0776 | 28 | 649 | regulation of defense response |
GO:0016192 | 0 | 2.0881 | 28.7438 | 53 | 1684 | vesicle-mediated transport |
GO:1903555 | 0 | 6.6094 | 1.7069 | 10 | 100 | regulation of tumor necrosis factor superfamily cytokine production |
GO:0050776 | 0 | 4.5119 | 3.1671 | 13 | 208 | regulation of immune response |
GO:0030168 | 0 | 6.6956 | 1.5118 | 9 | 91 | platelet activation |
GO:0097529 | 0 | 4.8097 | 2.7481 | 12 | 161 | myeloid leukocyte migration |
GO:0051707 | 0 | 2.5363 | 12.5285 | 29 | 734 | response to other organism |
GO:0010324 | 0 | 9.3821 | 0.8705 | 7 | 51 | membrane invagination |
GO:0050710 | 0 | 8.973 | 0.9046 | 7 | 53 | negative regulation of cytokine secretion |
GO:0042102 | 0 | 6.1308 | 1.6386 | 9 | 96 | positive regulation of T cell proliferation |
GO:0050863 | 0 | 4.8053 | 2.5118 | 11 | 154 | regulation of T cell activation |
GO:0045409 | 0 | 87.3536 | 0.0853 | 3 | 5 | negative regulation of interleukin-6 biosynthetic process |
GO:0042060 | 1e-04 | 2.7812 | 8.5856 | 22 | 503 | wound healing |
GO:0030183 | 1e-04 | 5.7957 | 1.7239 | 9 | 101 | B cell differentiation |
GO:0002437 | 1e-04 | 10.0767 | 0.6998 | 6 | 41 | inflammatory response to antigenic stimulus |
GO:0009607 | 1e-04 | 2.3835 | 13.2624 | 29 | 777 | response to biotic stimulus |
GO:0001816 | 1e-04 | 3.687 | 4.1237 | 14 | 250 | cytokine production |
GO:0032695 | 1e-04 | 23.371 | 0.239 | 4 | 14 | negative regulation of interleukin-12 production |
GO:0032946 | 1e-04 | 4.9473 | 2.2189 | 10 | 130 | positive regulation of mononuclear cell proliferation |
GO:0052547 | 1e-04 | 3.0243 | 6.4349 | 18 | 377 | regulation of peptidase activity |
GO:0050794 | 1e-04 | 1.7569 | 117.4518 | 144 | 7686 | regulation of cellular process |
GO:0002460 | 1e-04 | 4.8054 | 2.2779 | 10 | 136 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
GO:0032715 | 1e-04 | 12.3482 | 0.4896 | 5 | 29 | negative regulation of interleukin-6 production |
GO:0050728 | 1e-04 | 5.173 | 1.9117 | 9 | 112 | negative regulation of inflammatory response |
GO:0045087 | 1e-04 | 2.8298 | 7.2543 | 19 | 436 | innate immune response |
GO:0006954 | 1e-04 | 2.7308 | 7.9108 | 20 | 481 | inflammatory response |
GO:0002683 | 2e-04 | 4.9921 | 1.9727 | 9 | 121 | negative regulation of immune system process |
GO:0042742 | 2e-04 | 3.8021 | 3.4138 | 12 | 200 | defense response to bacterium |
GO:0002819 | 2e-04 | 4.7121 | 2.0824 | 9 | 122 | regulation of adaptive immune response |
GO:0032720 | 3e-04 | 10.1751 | 0.5762 | 5 | 34 | negative regulation of tumor necrosis factor production |
GO:0042113 | 3e-04 | 9.8838 | 0.5884 | 5 | 36 | B cell activation |
GO:0002731 | 3e-04 | Inf | 0.0341 | 2 | 2 | negative regulation of dendritic cell cytokine production |
GO:0003366 | 3e-04 | Inf | 0.0341 | 2 | 2 | cell-matrix adhesion involved in ameboidal cell migration |
GO:0044663 | 3e-04 | Inf | 0.0341 | 2 | 2 | establishment or maintenance of cell type involved in phenotypic switching |
GO:0070560 | 3e-04 | Inf | 0.0341 | 2 | 2 | protein secretion by platelet |
GO:0006952 | 3e-04 | 4.5734 | 2.1377 | 9 | 147 | defense response |
GO:0050777 | 3e-04 | 5.077 | 1.723 | 8 | 102 | negative regulation of immune response |
GO:0040008 | 3e-04 | 2.3711 | 10.429 | 23 | 611 | regulation of growth |
GO:0032103 | 4e-04 | 3.2837 | 4.2501 | 13 | 249 | positive regulation of response to external stimulus |
GO:0001776 | 4e-04 | 5.804 | 1.3314 | 7 | 78 | leukocyte homeostasis |
GO:0072678 | 4e-04 | 13.8833 | 0.3549 | 4 | 21 | T cell migration |
GO:0051250 | 4e-04 | 13.5253 | 0.3608 | 4 | 22 | negative regulation of lymphocyte activation |
GO:0010941 | 4e-04 | 1.8442 | 25.4837 | 43 | 1493 | regulation of cell death |
GO:0002703 | 5e-04 | 8.7871 | 0.6529 | 5 | 39 | regulation of leukocyte mediated immunity |
GO:0050670 | 5e-04 | 4.2922 | 2.2684 | 9 | 136 | regulation of lymphocyte proliferation |
GO:0051241 | 5e-04 | 2.0941 | 14.9484 | 29 | 892 | negative regulation of multicellular organismal process |
GO:0002718 | 5e-04 | 6.6466 | 1.0071 | 6 | 59 | regulation of cytokine production involved in immune response |
GO:0007155 | 5e-04 | 2.7619 | 6.2236 | 16 | 419 | cell adhesion |
GO:0032692 | 6e-04 | 12.2933 | 0.3926 | 4 | 23 | negative regulation of interleukin-1 production |
GO:0042832 | 6e-04 | 12.2933 | 0.3926 | 4 | 23 | defense response to protozoan |
GO:0051234 | 6e-04 | 1.5295 | 79.9502 | 105 | 4684 | establishment of localization |
GO:0002687 | 6e-04 | 4.5804 | 1.8946 | 8 | 111 | positive regulation of leukocyte migration |
GO:0032945 | 6e-04 | 6.2893 | 1.0583 | 6 | 62 | negative regulation of mononuclear cell proliferation |
GO:0044092 | 7e-04 | 1.9565 | 18.2124 | 33 | 1067 | negative regulation of molecular function |
GO:0030217 | 7e-04 | 5.2056 | 1.468 | 7 | 89 | T cell differentiation |
GO:0031295 | 7e-04 | 6.1785 | 1.0753 | 6 | 63 | T cell costimulation |
GO:1903531 | 7e-04 | 3.6775 | 2.9188 | 10 | 171 | negative regulation of secretion by cell |
GO:0045861 | 8e-04 | 2.8688 | 5.206 | 14 | 305 | negative regulation of proteolysis |
GO:0036336 | 8e-04 | 11.121 | 0.4267 | 4 | 25 | dendritic cell migration |
GO:0008284 | 9e-04 | 2.0665 | 14.0135 | 27 | 821 | positive regulation of cell proliferation |
GO:0002351 | 9e-04 | 116.0379 | 0.0512 | 2 | 3 | serotonin production involved in inflammatory response |
GO:0002554 | 9e-04 | 116.0379 | 0.0512 | 2 | 3 | serotonin secretion by platelet |
GO:0030886 | 9e-04 | 116.0379 | 0.0512 | 2 | 3 | negative regulation of myeloid dendritic cell activation |
GO:0043901 | 9e-04 | 3.8805 | 2.492 | 9 | 146 | negative regulation of multi-organism process |
GO:0002864 | 0.001 | 19.403 | 0.2048 | 3 | 12 | regulation of acute inflammatory response to antigenic stimulus |
GO:0050862 | 0.001 | 19.403 | 0.2048 | 3 | 12 | positive regulation of T cell receptor signaling pathway |
GO:0030595 | 0.0011 | 3.4807 | 3.0724 | 10 | 180 | leukocyte chemotaxis |
GO:0002675 | 0.0011 | 10.1527 | 0.4609 | 4 | 27 | positive regulation of acute inflammatory response |
GO:0002701 | 0.0011 | 10.1527 | 0.4609 | 4 | 27 | negative regulation of production of molecular mediator of immune response |
GO:0050854 | 0.0011 | 7.1381 | 0.7852 | 5 | 46 | regulation of antigen receptor-mediated signaling pathway |
GO:0042110 | 0.0012 | 6.8781 | 0.8064 | 5 | 52 | T cell activation |
GO:0035589 | 0.0012 | 17.4616 | 0.2219 | 3 | 13 | G-protein coupled purinergic nucleotide receptor signaling pathway |
GO:0010951 | 0.0013 | 3.1645 | 3.7039 | 11 | 217 | negative regulation of endopeptidase activity |
GO:0009605 | 0.0014 | 1.7244 | 27.7995 | 44 | 1685 | response to external stimulus |
GO:0007160 | 0.0015 | 3.3297 | 3.2022 | 10 | 189 | cell-matrix adhesion |
GO:0051346 | 0.0015 | 2.568 | 6.2026 | 15 | 366 | negative regulation of hydrolase activity |
GO:0006915 | 0.0016 | 1.6895 | 29.5802 | 46 | 1733 | apoptotic process |
GO:0045576 | 0.0016 | 6.5019 | 0.8534 | 5 | 50 | mast cell activation |
GO:0035587 | 0.0016 | 8.9794 | 0.5121 | 4 | 30 | purinergic receptor signaling pathway |
GO:0045347 | 0.0017 | 58.0152 | 0.0683 | 2 | 4 | negative regulation of MHC class II biosynthetic process |
GO:0070212 | 0.0017 | 58.0152 | 0.0683 | 2 | 4 | protein poly-ADP-ribosylation |
GO:0071611 | 0.0017 | 58.0152 | 0.0683 | 2 | 4 | granulocyte colony-stimulating factor production |
GO:2001274 | 0.0017 | 58.0152 | 0.0683 | 2 | 4 | negative regulation of glucose import in response to insulin stimulus |
GO:0046634 | 0.0018 | 5.1 | 1.2802 | 6 | 75 | regulation of alpha-beta T cell activation |
GO:0030889 | 0.0019 | 14.5494 | 0.256 | 3 | 15 | negative regulation of B cell proliferation |
GO:0045623 | 0.0019 | 14.5494 | 0.256 | 3 | 15 | negative regulation of T-helper cell differentiation |
GO:0071345 | 0.0019 | 1.9686 | 14.0818 | 26 | 825 | cellular response to cytokine stimulus |
GO:0002823 | 0.002 | 8.337 | 0.5462 | 4 | 32 | negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
GO:0006909 | 0.0021 | 3.4045 | 2.8149 | 9 | 169 | phagocytosis |
GO:0042107 | 0.0023 | 4.1548 | 1.8093 | 7 | 106 | cytokine metabolic process |
GO:1902105 | 0.0023 | 2.92 | 3.9941 | 11 | 234 | regulation of leukocyte differentiation |
GO:0007597 | 0.0023 | 13.4294 | 0.2731 | 3 | 16 | blood coagulation, intrinsic pathway |
GO:0002449 | 0.0024 | 4.7861 | 1.3561 | 6 | 81 | lymphocyte mediated immunity |
GO:2000026 | 0.0024 | 1.6487 | 30.2118 | 46 | 1770 | regulation of multicellular organismal development |
GO:0051224 | 0.0024 | 3.0937 | 3.4308 | 10 | 201 | negative regulation of protein transport |
GO:0002686 | 0.0026 | 7.7802 | 0.5803 | 4 | 34 | negative regulation of leukocyte migration |
GO:0032649 | 0.0026 | 4.6902 | 1.3826 | 6 | 81 | regulation of interferon-gamma production |
GO:0070887 | 0.0027 | 1.5312 | 46.7002 | 65 | 2736 | cellular response to chemical stimulus |
GO:0045019 | 0.0028 | 12.4693 | 0.2902 | 3 | 17 | negative regulation of nitric oxide biosynthetic process |
GO:0070242 | 0.0028 | 12.4693 | 0.2902 | 3 | 17 | thymocyte apoptotic process |
GO:0010572 | 0.0028 | 38.6742 | 0.0853 | 2 | 5 | positive regulation of platelet activation |
GO:0033625 | 0.0028 | 38.6742 | 0.0853 | 2 | 5 | positive regulation of integrin activation |
GO:0060414 | 0.0028 | 38.6742 | 0.0853 | 2 | 5 | aorta smooth muscle tissue morphogenesis |
GO:0009966 | 0.003 | 1.7224 | 23.2752 | 37 | 1445 | regulation of signal transduction |
GO:0042116 | 0.0031 | 5.5176 | 0.99 | 5 | 58 | macrophage activation |
GO:0033628 | 0.0032 | 7.2929 | 0.6145 | 4 | 36 | regulation of cell adhesion mediated by integrin |
GO:0035137 | 0.0032 | 7.2929 | 0.6145 | 4 | 36 | hindlimb morphogenesis |
GO:0002706 | 0.0034 | 3.8421 | 1.9458 | 7 | 114 | regulation of lymphocyte mediated immunity |
GO:0010648 | 0.0034 | 1.7352 | 20.9434 | 34 | 1227 | negative regulation of cell communication |
GO:0010470 | 0.0035 | 7.0715 | 0.6315 | 4 | 37 | regulation of gastrulation |
GO:0031638 | 0.0035 | 7.0715 | 0.6315 | 4 | 37 | zymogen activation |
GO:0042088 | 0.0035 | 7.0715 | 0.6315 | 4 | 37 | T-helper 1 type immune response |
GO:0043029 | 0.0035 | 7.0715 | 0.6315 | 4 | 37 | T cell homeostasis |
GO:0002292 | 0.0035 | 5.3163 | 1.0241 | 5 | 60 | T cell differentiation involved in immune response |
GO:0042733 | 0.0035 | 5.3163 | 1.0241 | 5 | 60 | embryonic digit morphogenesis |
GO:0002252 | 0.0036 | 2.6209 | 4.8444 | 12 | 321 | immune effector process |
GO:0023057 | 0.0036 | 1.7289 | 21.0117 | 34 | 1231 | negative regulation of signaling |
GO:1902532 | 0.0037 | 2.1905 | 8.193 | 17 | 480 | negative regulation of intracellular signal transduction |
GO:0043367 | 0.0038 | 6.9321 | 0.6424 | 4 | 38 | CD4-positive, alpha-beta T cell differentiation |
GO:0046639 | 0.0039 | 10.9092 | 0.3243 | 3 | 19 | negative regulation of alpha-beta T cell differentiation |
GO:0050901 | 0.0039 | 10.9092 | 0.3243 | 3 | 19 | leukocyte tethering or rolling |
GO:1901739 | 0.0039 | 10.9092 | 0.3243 | 3 | 19 | regulation of myoblast fusion |
GO:0043068 | 0.0039 | 2.0811 | 9.6439 | 19 | 565 | positive regulation of programmed cell death |
GO:0032496 | 0.0039 | 2.5843 | 4.8987 | 12 | 287 | response to lipopolysaccharide |
GO:0002792 | 0.0039 | 3.7366 | 1.997 | 7 | 117 | negative regulation of peptide secretion |
GO:0002312 | 0.0041 | 5.1291 | 1.0583 | 5 | 62 | B cell activation involved in immune response |
GO:0002885 | 0.0042 | 29.0038 | 0.1024 | 2 | 6 | positive regulation of hypersensitivity |
GO:0010757 | 0.0042 | 29.0038 | 0.1024 | 2 | 6 | negative regulation of plasminogen activation |
GO:0032074 | 0.0042 | 29.0038 | 0.1024 | 2 | 6 | negative regulation of nuclease activity |
GO:0032687 | 0.0042 | 29.0038 | 0.1024 | 2 | 6 | negative regulation of interferon-alpha production |
GO:0042536 | 0.0042 | 29.0038 | 0.1024 | 2 | 6 | negative regulation of tumor necrosis factor biosynthetic process |
GO:2000510 | 0.0042 | 29.0038 | 0.1024 | 2 | 6 | positive regulation of dendritic cell chemotaxis |
GO:2001046 | 0.0042 | 29.0038 | 0.1024 | 2 | 6 | positive regulation of integrin-mediated signaling pathway |
GO:1990266 | 0.0042 | 4.2359 | 1.5191 | 6 | 89 | neutrophil migration |
GO:0001819 | 0.0042 | 2.3621 | 6.2472 | 14 | 366 | positive regulation of cytokine production |
GO:0030308 | 0.0042 | 3.3139 | 2.5603 | 8 | 150 | negative regulation of cell growth |
GO:0030334 | 0.0043 | 1.9529 | 11.914 | 22 | 698 | regulation of cell migration |
GO:0032653 | 0.0043 | 6.6665 | 0.6657 | 4 | 39 | regulation of interleukin-10 production |
GO:0035113 | 0.0043 | 3.6694 | 2.0312 | 7 | 119 | embryonic appendage morphogenesis |
GO:0070227 | 0.0044 | 5.0403 | 1.0753 | 5 | 63 | lymphocyte apoptotic process |
GO:0051345 | 0.0044 | 1.9787 | 11.2142 | 21 | 657 | positive regulation of hydrolase activity |
GO:2000515 | 0.0045 | 10.2668 | 0.3414 | 3 | 20 | negative regulation of CD4-positive, alpha-beta T cell activation |
GO:0016064 | 0.0046 | 4.1357 | 1.5533 | 6 | 91 | immunoglobulin mediated immune response |
GO:0030888 | 0.0049 | 6.3734 | 0.6926 | 4 | 41 | regulation of B cell proliferation |
GO:1903034 | 0.005 | 3.2223 | 2.6286 | 8 | 154 | regulation of response to wounding |
GO:2000401 | 0.0051 | 6.3053 | 0.6998 | 4 | 41 | regulation of lymphocyte migration |
GO:0042035 | 0.0052 | 4.0401 | 1.5874 | 6 | 93 | regulation of cytokine biosynthetic process |
GO:0060396 | 0.0052 | 9.6958 | 0.3584 | 3 | 21 | growth hormone receptor signaling pathway |
GO:0043069 | 0.0052 | 1.861 | 13.638 | 24 | 799 | negative regulation of programmed cell death |
GO:0043281 | 0.0052 | 2.9451 | 3.226 | 9 | 189 | regulation of cysteine-type endopeptidase activity involved in apoptotic process |
GO:0051248 | 0.0052 | 1.683 | 21.5237 | 34 | 1261 | negative regulation of protein metabolic process |
GO:0043303 | 0.0056 | 6.139 | 0.7169 | 4 | 42 | mast cell degranulation |
GO:0045620 | 0.0056 | 6.139 | 0.7169 | 4 | 42 | negative regulation of lymphocyte differentiation |
GO:0051489 | 0.0056 | 6.139 | 0.7169 | 4 | 42 | regulation of filopodium assembly |
GO:0032088 | 0.0057 | 4.7139 | 1.1436 | 5 | 67 | negative regulation of NF-kappaB transcription factor activity |
GO:0010668 | 0.0058 | 23.2015 | 0.1195 | 2 | 7 | ectodermal cell differentiation |
GO:0032661 | 0.0058 | 23.2015 | 0.1195 | 2 | 7 | regulation of interleukin-18 production |
GO:0045656 | 0.0058 | 23.2015 | 0.1195 | 2 | 7 | negative regulation of monocyte differentiation |
GO:0070669 | 0.0058 | 23.2015 | 0.1195 | 2 | 7 | response to interleukin-2 |
GO:1902715 | 0.0058 | 23.2015 | 0.1195 | 2 | 7 | positive regulation of interferon-gamma secretion |
GO:2000406 | 0.006 | 9.1849 | 0.3755 | 3 | 22 | positive regulation of T cell migration |
GO:0002262 | 0.0061 | 3.423 | 2.1677 | 7 | 127 | myeloid cell homeostasis |
GO:0098609 | 0.0062 | 2.4316 | 5.1952 | 12 | 337 | cell-cell adhesion |
GO:0048585 | 0.0063 | 1.6749 | 20.9876 | 33 | 1273 | negative regulation of response to stimulus |
GO:0030198 | 0.0063 | 2.4227 | 5.206 | 12 | 305 | extracellular matrix organization |
GO:0006968 | 0.0066 | 5.8313 | 0.751 | 4 | 44 | cellular defense response |
GO:0048662 | 0.0066 | 5.8313 | 0.751 | 4 | 44 | negative regulation of smooth muscle cell proliferation |
GO:0071622 | 0.0066 | 5.8313 | 0.751 | 4 | 44 | regulation of granulocyte chemotaxis |
GO:1903707 | 0.0067 | 3.3664 | 2.2019 | 7 | 129 | negative regulation of hemopoiesis |
GO:0060173 | 0.0067 | 3.0533 | 2.7651 | 8 | 162 | limb development |
GO:0051270 | 0.0067 | 1.8189 | 13.9281 | 24 | 816 | regulation of cellular component movement |
GO:0050871 | 0.0069 | 4.4954 | 1.1948 | 5 | 70 | positive regulation of B cell activation |
GO:0043113 | 0.0071 | 5.6887 | 0.7681 | 4 | 45 | receptor clustering |
GO:0045058 | 0.0071 | 5.6887 | 0.7681 | 4 | 45 | T cell selection |
GO:0002699 | 0.0072 | 3.0137 | 2.7993 | 8 | 164 | positive regulation of immune effector process |
GO:0007264 | 0.0074 | 2.0812 | 8.0735 | 16 | 473 | small GTPase mediated signal transduction |
GO:0043313 | 0.0076 | 19.3333 | 0.1366 | 2 | 8 | regulation of neutrophil degranulation |
GO:1900044 | 0.0076 | 19.3333 | 0.1366 | 2 | 8 | regulation of protein K63-linked ubiquitination |
GO:2000035 | 0.0076 | 19.3333 | 0.1366 | 2 | 8 | regulation of stem cell division |
GO:2000270 | 0.0076 | 19.3333 | 0.1366 | 2 | 8 | negative regulation of fibroblast apoptotic process |
GO:1905521 | 0.0076 | 8.3091 | 0.4097 | 3 | 24 | regulation of macrophage migration |
GO:0010033 | 0.0077 | 1.4505 | 47.9633 | 64 | 2810 | response to organic substance |
GO:0045582 | 0.0077 | 4.3607 | 1.229 | 5 | 72 | positive regulation of T cell differentiation |
GO:0008285 | 0.0079 | 1.9363 | 10.3181 | 19 | 612 | negative regulation of cell proliferation |
GO:0009967 | 0.008 | 1.6096 | 23.7936 | 36 | 1404 | positive regulation of signal transduction |
GO:0038094 | 0.0082 | 4.2963 | 1.246 | 5 | 73 | Fc-gamma receptor signaling pathway |
GO:2000106 | 0.0082 | 4.2963 | 1.246 | 5 | 73 | regulation of leukocyte apoptotic process |
GO:0043525 | 0.0083 | 5.4234 | 0.8022 | 4 | 47 | positive regulation of neuron apoptotic process |
GO:0001773 | 0.0084 | 7.9911 | 0.4236 | 3 | 25 | myeloid dendritic cell activation |
GO:0002250 | 0.0086 | 3.6021 | 1.7649 | 6 | 109 | adaptive immune response |
GO:0002431 | 0.0086 | 4.2337 | 1.2631 | 5 | 74 | Fc receptor mediated stimulatory signaling pathway |
GO:0045089 | 0.0087 | 2.3177 | 5.4279 | 12 | 318 | positive regulation of innate immune response |
GO:0038083 | 0.009 | 5.2998 | 0.8193 | 4 | 48 | peptidyl-tyrosine autophosphorylation |
GO:0002285 | 0.0091 | 4.1786 | 1.2779 | 5 | 76 | lymphocyte activation involved in immune response |
GO:0040013 | 0.0091 | 2.4042 | 4.7963 | 11 | 281 | negative regulation of locomotion |
GO:0006919 | 0.0091 | 4.173 | 1.2802 | 5 | 75 | activation of cysteine-type endopeptidase activity involved in apoptotic process |
GO:0030193 | 0.0091 | 4.173 | 1.2802 | 5 | 75 | regulation of blood coagulation |
GO:0031324 | 0.0095 | 1.454 | 43.0646 | 58 | 2523 | negative regulation of cellular metabolic process |
GO:0035556 | 0.0095 | 1.5761 | 25.8233 | 38 | 1615 | intracellular signal transduction |
GO:0001782 | 0.0096 | 7.5856 | 0.4438 | 3 | 26 | B cell homeostasis |
GO:0034142 | 0.0096 | 7.5856 | 0.4438 | 3 | 26 | toll-like receptor 4 signaling pathway |
GO:0043372 | 0.0096 | 7.5856 | 0.4438 | 3 | 26 | positive regulation of CD4-positive, alpha-beta T cell differentiation |
GO:0090023 | 0.0096 | 7.5856 | 0.4438 | 3 | 26 | positive regulation of neutrophil chemotaxis |
GO:0001938 | 0.0096 | 4.1139 | 1.2972 | 5 | 76 | positive regulation of endothelial cell proliferation |
GO:0001768 | 0.0097 | 16.5703 | 0.1536 | 2 | 9 | establishment of T cell polarity |
GO:0002315 | 0.0097 | 16.5703 | 0.1536 | 2 | 9 | marginal zone B cell differentiation |
GO:0045625 | 0.0097 | 16.5703 | 0.1536 | 2 | 9 | regulation of T-helper 1 cell differentiation |
GO:1900239 | 0.0097 | 16.5703 | 0.1536 | 2 | 9 | regulation of phenotypic switching |
GO:1905562 | 0.0097 | 16.5703 | 0.1536 | 2 | 9 | regulation of vascular endothelial cell proliferation |
GO:1905770 | 0.0097 | 16.5703 | 0.1536 | 2 | 9 | regulation of mesodermal cell differentiation |
GO:0006935 | 0.0097 | 1.9703 | 9.0465 | 17 | 530 | chemotaxis |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0030198 | 1e-04 | 4.4187 | 2.709 | 11 | 221 | extracellular matrix organization |
GO:0007155 | 1e-04 | 2.2519 | 15.8344 | 32 | 1259 | cell adhesion |
GO:0061766 | 2e-04 | Inf | 0.0252 | 2 | 2 | positive regulation of lung blood pressure |
GO:1902340 | 2e-04 | Inf | 0.0252 | 2 | 2 | negative regulation of chromosome condensation |
GO:0031509 | 5e-04 | 158.6289 | 0.0377 | 2 | 3 | telomeric heterochromatin assembly |
GO:0035879 | 5e-04 | 158.6289 | 0.0377 | 2 | 3 | plasma membrane lactate transport |
GO:1905180 | 5e-04 | 158.6289 | 0.0377 | 2 | 3 | positive regulation of cardiac muscle tissue regeneration |
GO:0030334 | 5e-04 | 2.4655 | 8.7787 | 20 | 698 | regulation of cell migration |
GO:0022617 | 7e-04 | 6.1984 | 1.0565 | 6 | 84 | extracellular matrix disassembly |
GO:0044259 | 7e-04 | 5.0974 | 1.4841 | 7 | 118 | multicellular organismal macromolecule metabolic process |
GO:0031508 | 9e-04 | 79.3093 | 0.0503 | 2 | 4 | pericentric heterochromatin assembly |
GO:0090280 | 0.001 | 18.3838 | 0.2012 | 3 | 16 | positive regulation of calcium ion import |
GO:0000320 | 0.0015 | 52.8694 | 0.0629 | 2 | 5 | re-entry into mitotic cell cycle |
GO:0015727 | 0.0023 | 39.6495 | 0.0755 | 2 | 6 | lactate transport |
GO:0019800 | 0.0023 | 39.6495 | 0.0755 | 2 | 6 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan |
GO:0034638 | 0.0023 | 39.6495 | 0.0755 | 2 | 6 | phosphatidylcholine catabolic process |
GO:0090230 | 0.0023 | 39.6495 | 0.0755 | 2 | 6 | regulation of centromere complex assembly |
GO:0006936 | 0.0027 | 2.8637 | 4.0749 | 11 | 324 | muscle contraction |
GO:0071526 | 0.0029 | 11.944 | 0.2893 | 3 | 23 | semaphorin-plexin signaling pathway |
GO:0040012 | 0.003 | 2.1054 | 10.1622 | 20 | 808 | regulation of locomotion |
GO:0031666 | 0.0032 | 31.7175 | 0.088 | 2 | 7 | positive regulation of lipopolysaccharide-mediated signaling pathway |
GO:1900747 | 0.0032 | 31.7175 | 0.088 | 2 | 7 | negative regulation of vascular endothelial growth factor signaling pathway |
GO:0051058 | 0.0033 | 7.1032 | 0.6163 | 4 | 49 | negative regulation of small GTPase mediated signal transduction |
GO:0051270 | 0.0033 | 2.0831 | 10.2628 | 20 | 816 | regulation of cellular component movement |
GO:0061052 | 0.0042 | 26.4296 | 0.1006 | 2 | 8 | negative regulation of cell growth involved in cardiac muscle cell development |
GO:0032490 | 0.0053 | 22.6524 | 0.1132 | 2 | 9 | detection of molecule of bacterial origin |
GO:0042246 | 0.0057 | 6.0279 | 0.7169 | 4 | 57 | tissue regeneration |
GO:0010594 | 0.006 | 3.8873 | 1.635 | 6 | 130 | regulation of endothelial cell migration |
GO:0061041 | 0.0065 | 3.8251 | 1.6602 | 6 | 132 | regulation of wound healing |
GO:0003301 | 0.0068 | 8.527 | 0.3899 | 3 | 31 | physiological cardiac muscle hypertrophy |
GO:0008015 | 0.0074 | 2.2849 | 5.9992 | 13 | 477 | blood circulation |
GO:0001867 | 0.008 | 17.6163 | 0.1383 | 2 | 11 | complement activation, lectin pathway |
GO:0046415 | 0.008 | 17.6163 | 0.1383 | 2 | 11 | urate metabolic process |
GO:1903244 | 0.008 | 17.6163 | 0.1383 | 2 | 11 | positive regulation of cardiac muscle hypertrophy in response to stress |
GO:0030574 | 0.0081 | 5.4128 | 0.7924 | 4 | 63 | collagen catabolic process |
GO:0010959 | 0.0087 | 2.5478 | 4.1253 | 10 | 328 | regulation of metal ion transport |
GO:0006959 | 0.0087 | 3.1829 | 2.3142 | 7 | 184 | humoral immune response |
GO:1901342 | 0.0089 | 2.6948 | 3.509 | 9 | 279 | regulation of vasculature development |
GO:0009611 | 0.0092 | 2.0896 | 7.5714 | 15 | 602 | response to wounding |
GO:0016525 | 0.0093 | 4.1267 | 1.2829 | 5 | 102 | negative regulation of angiogenesis |
GO:0030207 | 0.0096 | 15.8536 | 0.1509 | 2 | 12 | chondroitin sulfate catabolic process |
GO:0030208 | 0.0096 | 15.8536 | 0.1509 | 2 | 12 | dermatan sulfate biosynthetic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0008544 | 0 | 5.7603 | 5.5209 | 27 | 385 | epidermis development |
GO:0070268 | 0 | 12.0024 | 1.5295 | 15 | 105 | cornification |
GO:0030216 | 0 | 6.2362 | 3.9037 | 21 | 268 | keratinocyte differentiation |
GO:0030855 | 0 | 3.1307 | 7.751 | 22 | 552 | epithelial cell differentiation |
GO:0048869 | 0 | 1.8186 | 56.6335 | 85 | 3888 | cellular developmental process |
GO:0008219 | 1e-04 | 1.9723 | 28.7537 | 50 | 1974 | cell death |
GO:0019755 | 2e-04 | 34.2656 | 0.1311 | 3 | 9 | one-carbon compound transport |
GO:0060706 | 4e-04 | 13.0993 | 0.3642 | 4 | 25 | cell differentiation involved in embryonic placenta development |
GO:0031581 | 5e-04 | 25.6959 | 0.1602 | 3 | 11 | hemidesmosome assembly |
GO:0008542 | 5e-04 | 8.4135 | 0.67 | 5 | 46 | visual learning |
GO:0034329 | 6e-04 | 3.8001 | 2.8258 | 10 | 194 | cell junction assembly |
GO:0071918 | 6e-04 | 136.4978 | 0.0437 | 2 | 3 | urea transmembrane transport |
GO:0031032 | 6e-04 | 4.0756 | 2.3743 | 9 | 163 | actomyosin structure organization |
GO:0045604 | 9e-04 | 7.3366 | 0.7574 | 5 | 52 | regulation of epidermal cell differentiation |
GO:0042636 | 0.0012 | 68.2444 | 0.0583 | 2 | 4 | negative regulation of hair cycle |
GO:0045684 | 0.0013 | 9.4807 | 0.4807 | 4 | 33 | positive regulation of epidermis development |
GO:0050891 | 0.0013 | 6.7594 | 0.8157 | 5 | 56 | multicellular organismal water homeostasis |
GO:0048518 | 0.0013 | 1.5224 | 74.9869 | 97 | 5148 | positive regulation of biological process |
GO:0006833 | 0.0018 | 14.6776 | 0.2476 | 3 | 17 | water transport |
GO:0061045 | 0.0019 | 6.1539 | 0.8885 | 5 | 61 | negative regulation of wound healing |
GO:0042127 | 0.002 | 1.7846 | 21.893 | 36 | 1503 | regulation of cell proliferation |
GO:0051797 | 0.0021 | 13.6982 | 0.2622 | 3 | 18 | regulation of hair follicle development |
GO:0042308 | 0.0022 | 5.9409 | 0.9177 | 5 | 63 | negative regulation of protein import into nucleus |
GO:0045103 | 0.0024 | 7.8524 | 0.5681 | 4 | 39 | intermediate filament-based process |
GO:0045603 | 0.0025 | 12.8412 | 0.2768 | 3 | 19 | positive regulation of endothelial cell differentiation |
GO:1902373 | 0.0027 | 7.6338 | 0.5826 | 4 | 40 | negative regulation of mRNA catabolic process |
GO:0048731 | 0.0029 | 1.4944 | 62.6056 | 82 | 4298 | system development |
GO:0045109 | 0.0029 | 12.0851 | 0.2913 | 3 | 20 | intermediate filament organization |
GO:0090132 | 0.0029 | 3.0043 | 3.525 | 10 | 242 | epithelium migration |
GO:0015793 | 0.003 | 34.1178 | 0.0874 | 2 | 6 | glycerol transport |
GO:0001667 | 0.0031 | 2.6652 | 4.7632 | 12 | 327 | ameboidal-type cell migration |
GO:0007266 | 0.0031 | 3.4917 | 2.4326 | 8 | 167 | Rho protein signal transduction |
GO:0007010 | 0.0038 | 1.829 | 16.387 | 28 | 1125 | cytoskeleton organization |
GO:0032287 | 0.0042 | 27.2924 | 0.102 | 2 | 7 | peripheral nervous system myelin maintenance |
GO:0042303 | 0.0043 | 4.1843 | 1.5295 | 6 | 105 | molting cycle |
GO:0007155 | 0.0051 | 1.7506 | 18.3389 | 30 | 1259 | cell adhesion |
GO:0009653 | 0.0051 | 1.7422 | 19.1978 | 31 | 1383 | anatomical structure morphogenesis |
GO:0030856 | 0.0052 | 4.8094 | 1.1149 | 5 | 78 | regulation of epithelial cell differentiation |
GO:0006776 | 0.0056 | 22.7422 | 0.1165 | 2 | 8 | vitamin A metabolic process |
GO:0015886 | 0.0056 | 22.7422 | 0.1165 | 2 | 8 | heme transport |
GO:0090594 | 0.0056 | 22.7422 | 0.1165 | 2 | 8 | inflammatory response to wounding |
GO:1904685 | 0.0056 | 22.7422 | 0.1165 | 2 | 8 | positive regulation of metalloendopeptidase activity |
GO:0010634 | 0.0057 | 3.9436 | 1.6169 | 6 | 111 | positive regulation of epithelial cell migration |
GO:0030029 | 0.0058 | 2.0437 | 9.3078 | 18 | 639 | actin filament-based process |
GO:0048646 | 0.0069 | 1.8215 | 13.9836 | 24 | 960 | anatomical structure formation involved in morphogenesis |
GO:0010838 | 0.0071 | 19.4921 | 0.1311 | 2 | 9 | positive regulation of keratinocyte proliferation |
GO:0042574 | 0.0071 | 19.4921 | 0.1311 | 2 | 9 | retinal metabolic process |
GO:0090331 | 0.0071 | 19.4921 | 0.1311 | 2 | 9 | negative regulation of platelet aggregation |
GO:0043124 | 0.0073 | 5.6037 | 0.772 | 4 | 53 | negative regulation of I-kappaB kinase/NF-kappaB signaling |
GO:1903034 | 0.0074 | 3.2922 | 2.2432 | 7 | 154 | regulation of response to wounding |
GO:0043616 | 0.0075 | 8.2838 | 0.4045 | 3 | 28 | keratinocyte proliferation |
GO:0010469 | 0.0083 | 2.1111 | 7.4725 | 15 | 513 | regulation of receptor activity |
GO:0045600 | 0.0084 | 5.3833 | 0.8011 | 4 | 55 | positive regulation of fat cell differentiation |
GO:0003382 | 0.0084 | 7.8971 | 0.4224 | 3 | 29 | epithelial cell morphogenesis |
GO:0033623 | 0.0088 | 17.0544 | 0.1457 | 2 | 10 | regulation of integrin activation |
GO:0051017 | 0.0089 | 3.5671 | 1.7771 | 6 | 122 | actin filament bundle assembly |
GO:0007015 | 0.009 | 2.4084 | 4.7923 | 11 | 329 | actin filament organization |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 37.7055 | 3.9595 | 74 | 301 | detection of chemical stimulus involved in sensory perception of smell |
GO:0007606 | 0 | 28.0833 | 5.1566 | 76 | 392 | sensory perception of chemical stimulus |
GO:0050906 | 0 | 27.952 | 5.0776 | 75 | 386 | detection of stimulus involved in sensory perception |
GO:0009593 | 0 | 28.4899 | 4.9066 | 74 | 373 | detection of chemical stimulus |
GO:0050877 | 0 | 8.8422 | 14.7068 | 80 | 1118 | nervous system process |
GO:0007186 | 0 | 8.7815 | 14.614 | 79 | 1126 | G-protein coupled receptor signaling pathway |
GO:0032501 | 0 | 2.3906 | 82.6075 | 124 | 6483 | multicellular organismal process |
GO:0007154 | 0 | 1.9585 | 76.6119 | 110 | 5824 | cell communication |
GO:0023052 | 0 | 1.9291 | 76.3883 | 109 | 5807 | signaling |
GO:0016441 | 0 | 4.0258 | 3.8017 | 14 | 289 | posttranscriptional gene silencing |
GO:0031047 | 1e-04 | 3.7222 | 4.0911 | 14 | 311 | gene silencing by RNA |
GO:0050704 | 1e-04 | 13.7063 | 0.4341 | 5 | 33 | regulation of interleukin-1 secretion |
GO:0035278 | 1e-04 | 9.63 | 0.7103 | 6 | 54 | miRNA mediated inhibition of translation |
GO:0045974 | 1e-04 | 9.63 | 0.7103 | 6 | 54 | regulation of translation, ncRNA-mediated |
GO:0070269 | 1e-04 | 57.0854 | 0.0921 | 3 | 7 | pyroptosis |
GO:0050713 | 3e-04 | 32.6139 | 0.1315 | 3 | 10 | negative regulation of interleukin-1 beta secretion |
GO:0097340 | 3e-04 | 28.5353 | 0.1447 | 3 | 11 | inhibition of cysteine-type endopeptidase activity |
GO:0032651 | 5e-04 | 8.5189 | 0.6577 | 5 | 50 | regulation of interleukin-1 beta production |
GO:0034249 | 6e-04 | 2.9488 | 5.0908 | 14 | 387 | negative regulation of cellular amide metabolic process |
GO:0051716 | 8e-04 | 1.5756 | 86.1621 | 109 | 6550 | cellular response to stimulus |
GO:0031424 | 0.0014 | 3.613 | 2.6572 | 9 | 202 | keratinization |
GO:0098664 | 0.0022 | 13.4205 | 0.2631 | 3 | 20 | G-protein coupled serotonin receptor signaling pathway |
GO:0019236 | 0.0025 | 37.8695 | 0.0789 | 2 | 6 | response to pheromone |
GO:0065007 | 0.003 | 1.5942 | 143.0291 | 161 | 10873 | biological regulation |
GO:0050794 | 0.003 | 1.5355 | 127.9145 | 147 | 9724 | regulation of cellular process |
GO:0032692 | 0.0033 | 11.4052 | 0.3026 | 3 | 23 | negative regulation of interleukin-1 production |
GO:0048245 | 0.0046 | 25.243 | 0.1052 | 2 | 8 | eosinophil chemotaxis |
GO:0033141 | 0.0058 | 21.6355 | 0.1184 | 2 | 9 | positive regulation of peptidyl-serine phosphorylation of STAT protein |
GO:2000010 | 0.0088 | 16.8254 | 0.1447 | 2 | 11 | positive regulation of protein localization to cell surface |
GO:0035195 | 0.0092 | 2.8769 | 2.9216 | 8 | 228 | gene silencing by miRNA |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 26.3706 | 3.8436 | 59 | 301 | detection of chemical stimulus involved in sensory perception of smell |
GO:0050906 | 0 | 20.4829 | 4.929 | 61 | 386 | detection of stimulus involved in sensory perception |
GO:0009593 | 0 | 20.7856 | 4.763 | 60 | 373 | detection of chemical stimulus |
GO:0007606 | 0 | 19.5714 | 5.0056 | 60 | 392 | sensory perception of chemical stimulus |
GO:0050877 | 0 | 6.761 | 14.2763 | 66 | 1118 | nervous system process |
GO:0007186 | 0 | 6.5729 | 14.6339 | 66 | 1146 | G-protein coupled receptor signaling pathway |
GO:0009913 | 0 | 6.8022 | 3.9969 | 23 | 313 | epidermal cell differentiation |
GO:0031424 | 0 | 13.3711 | 1.1844 | 13 | 97 | keratinization |
GO:0043588 | 0 | 5.5488 | 4.8141 | 23 | 377 | skin development |
GO:0032501 | 0 | 2.3675 | 74.1781 | 111 | 6483 | multicellular organismal process |
GO:0070268 | 0 | 8.5157 | 1.3408 | 10 | 105 | cornification |
GO:0018149 | 1e-04 | 10.3665 | 0.664 | 6 | 52 | peptide cross-linking |
GO:0035278 | 1e-04 | 9.9333 | 0.6896 | 6 | 54 | miRNA mediated inhibition of translation |
GO:0045974 | 1e-04 | 9.9333 | 0.6896 | 6 | 54 | regulation of translation, ncRNA-mediated |
GO:0035194 | 1e-04 | 3.8403 | 3.6776 | 13 | 288 | posttranscriptional gene silencing by RNA |
GO:0050713 | 2e-04 | 33.6254 | 0.1277 | 3 | 10 | negative regulation of interleukin-1 beta secretion |
GO:0060429 | 4e-04 | 2.1499 | 14.8126 | 29 | 1160 | epithelium development |
GO:0002774 | 5e-04 | 156.1827 | 0.0383 | 2 | 3 | Fc receptor mediated inhibitory signaling pathway |
GO:0007154 | 6e-04 | 1.6037 | 74.3696 | 97 | 5824 | cell communication |
GO:0051926 | 7e-04 | 7.7491 | 0.7151 | 5 | 56 | negative regulation of calcium ion transport |
GO:0050704 | 8e-04 | 10.8619 | 0.4214 | 4 | 33 | regulation of interleukin-1 secretion |
GO:0007338 | 9e-04 | 4.8838 | 1.5451 | 7 | 121 | single fertilization |
GO:0023052 | 9e-04 | 1.5788 | 74.1525 | 96 | 5807 | signaling |
GO:0017148 | 0.001 | 2.917 | 4.763 | 13 | 373 | negative regulation of translation |
GO:0060467 | 0.0016 | 52.0541 | 0.0638 | 2 | 5 | negative regulation of fertilization |
GO:0016458 | 0.0017 | 2.745 | 5.044 | 13 | 395 | gene silencing |
GO:0002765 | 0.0024 | 39.0381 | 0.0766 | 2 | 6 | immune response-inhibiting signal transduction |
GO:0032692 | 0.003 | 11.7589 | 0.2937 | 3 | 23 | negative regulation of interleukin-1 production |
GO:0060046 | 0.0032 | 31.5323 | 0.0885 | 2 | 7 | regulation of acrosome reaction |
GO:0032661 | 0.0033 | 31.2284 | 0.0894 | 2 | 7 | regulation of interleukin-18 production |
GO:0070269 | 0.0033 | 31.2284 | 0.0894 | 2 | 7 | pyroptosis |
GO:0071222 | 0.0033 | 3.8588 | 1.9282 | 7 | 151 | cellular response to lipopolysaccharide |
GO:0032651 | 0.0038 | 6.8401 | 0.6385 | 4 | 50 | regulation of interleukin-1 beta production |
GO:0050896 | 0.0038 | 1.4846 | 99.8448 | 119 | 7819 | response to stimulus |
GO:2001198 | 0.0043 | 26.022 | 0.1022 | 2 | 8 | regulation of dendritic cell differentiation |
GO:0050710 | 0.0046 | 6.4201 | 0.6768 | 4 | 53 | negative regulation of cytokine secretion |
GO:0040029 | 0.0052 | 2.3907 | 5.7463 | 13 | 450 | regulation of gene expression, epigenetic |
GO:0031665 | 0.0055 | 22.3031 | 0.1149 | 2 | 9 | negative regulation of lipopolysaccharide-mediated signaling pathway |
GO:2000818 | 0.0055 | 22.3031 | 0.1149 | 2 | 9 | negative regulation of myoblast proliferation |
GO:0009617 | 0.0067 | 2.3144 | 5.9251 | 13 | 464 | response to bacterium |
GO:1900004 | 0.0068 | 19.514 | 0.1277 | 2 | 10 | negative regulation of serine-type endopeptidase activity |
GO:2000344 | 0.0068 | 19.514 | 0.1277 | 2 | 10 | positive regulation of acrosome reaction |
GO:2001256 | 0.0068 | 19.514 | 0.1277 | 2 | 10 | regulation of store-operated calcium entry |
GO:0071216 | 0.0084 | 3.2058 | 2.2985 | 7 | 180 | cellular response to biotic stimulus |
GO:0015671 | 0.0098 | 15.6091 | 0.1532 | 2 | 12 | oxygen transport |
GO:1902571 | 0.0098 | 15.6091 | 0.1532 | 2 | 12 | regulation of serine-type peptidase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004937 | 8e-04 | 124.2915 | 0.0479 | 2 | 3 | alpha1-adrenergic receptor activity |
GO:0035663 | 8e-04 | 124.2915 | 0.0479 | 2 | 3 | Toll-like receptor 2 binding |
GO:0019864 | 0.0036 | 31.0668 | 0.0958 | 2 | 6 | IgG binding |
GO:0005509 | 0.0062 | 1.9861 | 10.0877 | 19 | 632 | calcium ion binding |
GO:0003857 | 0.0067 | 20.7085 | 0.1277 | 2 | 8 | 3-hydroxyacyl-CoA dehydrogenase activity |
GO:0004300 | 0.0067 | 20.7085 | 0.1277 | 2 | 8 | enoyl-CoA hydratase activity |
GO:0039706 | 0.0085 | 17.749 | 0.1437 | 2 | 9 | co-receptor binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042393 | 0 | 12.8203 | 2.7236 | 27 | 188 | histone binding |
GO:0019904 | 0 | 3.3709 | 9.3732 | 28 | 647 | protein domain specific binding |
GO:0046982 | 0 | 3.593 | 6.809 | 22 | 470 | protein heterodimerization activity |
GO:0031492 | 4e-04 | 8.896 | 0.6374 | 5 | 44 | nucleosomal DNA binding |
GO:0003714 | 8e-04 | 3.6416 | 2.9409 | 10 | 203 | transcription corepressor activity |
GO:0003677 | 0.0012 | 1.6876 | 33.5378 | 51 | 2315 | DNA binding |
GO:0003723 | 0.0033 | 1.6985 | 24.2371 | 38 | 1673 | RNA binding |
GO:1901363 | 0.0035 | 1.4555 | 80.9688 | 101 | 5589 | heterocyclic compound binding |
GO:0097159 | 0.0037 | 1.4507 | 82.0699 | 102 | 5665 | organic cyclic compound binding |
GO:0015405 | 0.0051 | 4.0435 | 1.5791 | 6 | 109 | P-P-bond-hydrolysis-driven transmembrane transporter activity |
GO:0019706 | 0.0068 | 8.6043 | 0.3912 | 3 | 27 | protein-cysteine S-palmitoyltransferase activity |
GO:0061578 | 0.007 | 19.6008 | 0.1304 | 2 | 9 | Lys63-specific deubiquitinase activity |
GO:0089720 | 0.0087 | 17.1496 | 0.1449 | 2 | 10 | caspase binding |
GO:0015085 | 0.0094 | 3.526 | 1.7964 | 6 | 124 | calcium ion transmembrane transporter activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 9.9107 | 3.8397 | 30 | 301 | olfactory receptor activity |
GO:0004930 | 0 | 5.4528 | 8.904 | 39 | 698 | G-protein coupled receptor activity |
GO:0099600 | 0 | 3.8328 | 14.1086 | 44 | 1106 | transmembrane receptor activity |
GO:0060089 | 0 | 3.487 | 17.8845 | 50 | 1402 | molecular transducer activity |
GO:0038023 | 0 | 3.6978 | 13.4578 | 41 | 1076 | signaling receptor activity |
GO:0005549 | 0 | 10.1973 | 0.9057 | 8 | 71 | odorant binding |
GO:0001591 | 0 | 78.5612 | 0.0765 | 3 | 6 | dopamine neurotransmitter receptor activity, coupled via Gi/Go |
GO:0036374 | 0 | 78.5612 | 0.0765 | 3 | 6 | glutathione hydrolase activity |
GO:0035240 | 3e-04 | 29.4509 | 0.1403 | 3 | 11 | dopamine binding |
GO:0070492 | 0.0033 | 31.2609 | 0.0893 | 2 | 7 | oligosaccharide binding |
GO:0015643 | 0.0043 | 26.0491 | 0.1021 | 2 | 8 | toxic substance binding |
GO:0032052 | 0.0043 | 26.0491 | 0.1021 | 2 | 8 | bile acid binding |
GO:0030594 | 0.0056 | 4.6996 | 1.1353 | 5 | 89 | neurotransmitter receptor activity |
GO:0008201 | 0.0088 | 3.5688 | 1.7731 | 6 | 139 | heparin binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050544 | 0 | 108.3239 | 0.0692 | 3 | 5 | arachidonic acid binding |
GO:0042288 | 1e-04 | 19.3321 | 0.2631 | 4 | 19 | MHC class I protein binding |
GO:0031720 | 2e-04 | Inf | 0.0277 | 2 | 2 | haptoglobin binding |
GO:0032394 | 2e-04 | Inf | 0.0277 | 2 | 2 | MHC class Ib receptor activity |
GO:0032396 | 2e-04 | Inf | 0.0277 | 2 | 2 | inhibitory MHC class I receptor activity |
GO:0036041 | 3e-04 | 30.9396 | 0.1385 | 3 | 10 | long-chain fatty acid binding |
GO:0035662 | 6e-04 | 143.7664 | 0.0415 | 2 | 3 | Toll-like receptor 4 binding |
GO:1901567 | 0.0038 | 10.8197 | 0.3185 | 3 | 23 | fatty acid derivative binding |
GO:0004435 | 0.0054 | 9.4066 | 0.36 | 3 | 26 | phosphatidylinositol phospholipase C activity |
GO:0050786 | 0.0064 | 20.53 | 0.1246 | 2 | 9 | RAGE receptor binding |
GO:0033293 | 0.007 | 5.6726 | 0.7615 | 4 | 55 | monocarboxylic acid binding |
GO:0000978 | 0.0077 | 2.4631 | 4.6938 | 11 | 339 | RNA polymerase II core promoter proximal region sequence-specific DNA binding |
GO:0001228 | 0.0078 | 2.3544 | 5.3585 | 12 | 387 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding |
GO:0042043 | 0.008 | 17.9626 | 0.1385 | 2 | 10 | neurexin family protein binding |
GO:0005310 | 0.0088 | 7.7243 | 0.4292 | 3 | 31 | dicarboxylic acid transmembrane transporter activity |
GO:0005085 | 0.0095 | 2.509 | 4.1815 | 10 | 302 | guanyl-nucleotide exchange factor activity |
GO:0005344 | 0.0097 | 15.9657 | 0.1523 | 2 | 11 | oxygen carrier activity |
GO:0046030 | 0.0097 | 15.9657 | 0.1523 | 2 | 11 | inositol trisphosphate phosphatase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0032396 | 2e-04 | Inf | 0.0308 | 2 | 2 | inhibitory MHC class I receptor activity |
GO:0097199 | 2e-04 | Inf | 0.0308 | 2 | 2 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway |
GO:0030492 | 0.0014 | 64.5294 | 0.0615 | 2 | 4 | hemoglobin binding |
GO:0035877 | 0.0014 | 64.5294 | 0.0615 | 2 | 4 | death effector domain binding |
GO:0001784 | 0.0014 | 9.2809 | 0.4923 | 4 | 32 | phosphotyrosine residue binding |
GO:0050544 | 0.0023 | 43.0168 | 0.0769 | 2 | 5 | arachidonic acid binding |
GO:0004465 | 0.0034 | 32.2605 | 0.0923 | 2 | 6 | lipoprotein lipase activity |
GO:0042289 | 0.0034 | 32.2605 | 0.0923 | 2 | 6 | MHC class II protein binding |
GO:0005102 | 0.0045 | 1.7218 | 20.5514 | 33 | 1357 | receptor binding |
GO:0042609 | 0.0047 | 25.8067 | 0.1077 | 2 | 7 | CD4 receptor binding |
GO:0004715 | 0.0063 | 5.8998 | 0.7385 | 4 | 48 | non-membrane spanning protein tyrosine kinase activity |
GO:0097200 | 0.0079 | 18.431 | 0.1385 | 2 | 9 | cysteine-type endopeptidase activity involved in execution phase of apoptosis |
GO:0001205 | 0.008 | 8.0886 | 0.4154 | 3 | 27 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding |
GO:0043548 | 0.0089 | 7.7646 | 0.4308 | 3 | 28 | phosphatidylinositol 3-kinase binding |
GO:0005125 | 0.0093 | 2.8757 | 2.9231 | 8 | 190 | cytokine activity |
GO:0036041 | 0.0098 | 16.1261 | 0.1538 | 2 | 10 | long-chain fatty acid binding |
GO:0042043 | 0.0098 | 16.1261 | 0.1538 | 2 | 10 | neurexin family protein binding |
GO:0042169 | 0.0098 | 7.4654 | 0.4462 | 3 | 29 | SH2 domain binding |
GO:0032403 | 0.0099 | 1.8593 | 11.3231 | 20 | 736 | protein complex binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004872 | 0 | 2.8846 | 20.1533 | 49 | 1361 | receptor activity |
GO:0005070 | 2e-04 | 8.1701 | 0.8292 | 6 | 56 | SH3/SH2 adaptor activity |
GO:0032396 | 2e-04 | Inf | 0.0296 | 2 | 2 | inhibitory MHC class I receptor activity |
GO:0004871 | 4e-04 | 1.9266 | 21.6637 | 38 | 1463 | signal transducer activity |
GO:0004888 | 5e-04 | 2.0692 | 15.7554 | 30 | 1064 | transmembrane signaling receptor activity |
GO:0008329 | 0.0013 | 16.8388 | 0.2221 | 3 | 15 | signaling pattern recognition receptor activity |
GO:0061134 | 0.0016 | 3.5403 | 2.7098 | 9 | 183 | peptidase regulator activity |
GO:0030246 | 0.0024 | 3.1015 | 3.4206 | 10 | 231 | carbohydrate binding |
GO:0042288 | 0.0026 | 12.6258 | 0.2813 | 3 | 19 | MHC class I protein binding |
GO:0001530 | 0.003 | 11.8824 | 0.2962 | 3 | 20 | lipopolysaccharide binding |
GO:0004465 | 0.0031 | 33.548 | 0.0888 | 2 | 6 | lipoprotein lipase activity |
GO:0004468 | 0.0031 | 33.548 | 0.0888 | 2 | 6 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor |
GO:0034987 | 0.0031 | 33.548 | 0.0888 | 2 | 6 | immunoglobulin receptor binding |
GO:0003823 | 0.0034 | 7.1092 | 0.6219 | 4 | 42 | antigen binding |
GO:0004950 | 0.0058 | 9.1788 | 0.3702 | 3 | 25 | chemokine receptor activity |
GO:0004866 | 0.0061 | 3.424 | 2.1619 | 7 | 146 | endopeptidase inhibitor activity |
GO:0005539 | 0.0062 | 3.0968 | 2.7246 | 8 | 184 | glycosaminoglycan binding |
GO:0052659 | 0.0073 | 19.1666 | 0.1333 | 2 | 9 | inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity |
GO:0004252 | 0.0081 | 3.236 | 2.2804 | 7 | 154 | serine-type endopeptidase activity |
GO:0046906 | 0.0086 | 3.6002 | 1.7621 | 6 | 119 | tetrapyrrole binding |
GO:0016709 | 0.0088 | 7.7647 | 0.4294 | 3 | 29 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen |
GO:0042169 | 0.0088 | 7.7647 | 0.4294 | 3 | 29 | SH2 domain binding |
GO:0016813 | 0.0091 | 16.7697 | 0.1481 | 2 | 10 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042393 | 0 | 9.2268 | 3.3382 | 25 | 188 | histone binding |
GO:0046982 | 0 | 5.4806 | 8.3455 | 38 | 470 | protein heterodimerization activity |
GO:0031492 | 0 | 16.8418 | 0.7813 | 10 | 44 | nucleosomal DNA binding |
GO:0003677 | 1e-04 | 2.0717 | 22.57 | 42 | 1342 | DNA binding |
GO:0019904 | 2e-04 | 2.3869 | 11.304 | 25 | 641 | protein domain specific binding |
GO:0031711 | 3e-04 | Inf | 0.0355 | 2 | 2 | bradykinin receptor binding |
GO:0017077 | 9e-04 | 111.4327 | 0.0533 | 2 | 3 | oxidative phosphorylation uncoupler activity |
GO:0070573 | 9e-04 | 111.4327 | 0.0533 | 2 | 3 | metallodipeptidase activity |
GO:0003682 | 0.001 | 2.3689 | 8.5408 | 19 | 481 | chromatin binding |
GO:0043565 | 0.0011 | 1.9238 | 17.277 | 31 | 973 | sequence-specific DNA binding |
GO:0045296 | 0.0022 | 2.6552 | 5.1849 | 13 | 292 | cadherin binding |
GO:0055131 | 0.0045 | 27.8527 | 0.1065 | 2 | 6 | C3HC4-type RING finger domain binding |
GO:0008198 | 0.0066 | 8.8191 | 0.3906 | 3 | 22 | ferrous iron binding |
GO:0045503 | 0.0075 | 8.3776 | 0.4084 | 3 | 23 | dynein light chain binding |
GO:1901612 | 0.0082 | 18.5661 | 0.1421 | 2 | 8 | cardiolipin binding |
GO:0000981 | 0.0098 | 1.8023 | 12.8201 | 22 | 722 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0000030 | 0.0017 | 14.5453 | 0.2388 | 3 | 23 | mannosyltransferase activity |
GO:0000981 | 0.0035 | 2.2868 | 7.4977 | 16 | 722 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
GO:0016405 | 0.0055 | 21.4292 | 0.1142 | 2 | 11 | CoA-ligase activity |
GO:0005247 | 0.0066 | 19.285 | 0.1246 | 2 | 12 | voltage-gated chloride channel activity |
GO:0070008 | 0.0066 | 19.285 | 0.1246 | 2 | 12 | serine-type exopeptidase activity |
GO:0004697 | 0.0078 | 17.5307 | 0.135 | 2 | 13 | protein kinase C activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042393 | 0 | 9.2642 | 3.3262 | 25 | 188 | histone binding |
GO:0046982 | 0 | 4.9708 | 8.3154 | 35 | 470 | protein heterodimerization activity |
GO:0031492 | 0 | 16.9062 | 0.7785 | 10 | 44 | nucleosomal DNA binding |
GO:0019904 | 0 | 2.6181 | 11.2629 | 27 | 641 | protein domain specific binding |
GO:0031711 | 3e-04 | Inf | 0.0354 | 2 | 2 | bradykinin receptor binding |
GO:0045296 | 7e-04 | 2.892 | 5.1662 | 14 | 292 | cadherin binding |
GO:0070573 | 9e-04 | 111.8467 | 0.0531 | 2 | 3 | metallodipeptidase activity |
GO:0003682 | 0.001 | 2.3782 | 8.51 | 19 | 481 | chromatin binding |
GO:0003677 | 0.002 | 1.7653 | 22.6618 | 37 | 1342 | DNA binding |
GO:0043565 | 0.0041 | 1.7885 | 17.2146 | 29 | 973 | sequence-specific DNA binding |
GO:0004957 | 0.0045 | 27.9562 | 0.1062 | 2 | 6 | prostaglandin E receptor activity |
GO:0005114 | 0.0045 | 27.9562 | 0.1062 | 2 | 6 | type II transforming growth factor beta receptor binding |
GO:0055131 | 0.0045 | 27.9562 | 0.1062 | 2 | 6 | C3HC4-type RING finger domain binding |
GO:0004866 | 0.0045 | 3.2849 | 2.5831 | 8 | 146 | endopeptidase inhibitor activity |
GO:0019838 | 0.0057 | 3.4719 | 2.1408 | 7 | 121 | growth factor binding |
GO:0005044 | 0.0058 | 6.0759 | 0.7254 | 4 | 41 | scavenger receptor activity |
GO:0008198 | 0.0066 | 8.8519 | 0.3892 | 3 | 22 | ferrous iron binding |
GO:0031995 | 0.0081 | 18.635 | 0.1415 | 2 | 8 | insulin-like growth factor II binding |
GO:1901612 | 0.0081 | 18.635 | 0.1415 | 2 | 8 | cardiolipin binding |
GO:0004857 | 0.0091 | 2.2184 | 6.1392 | 13 | 347 | enzyme inhibitor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0003714 | 1e-04 | 5.0621 | 2.1601 | 10 | 203 | transcription corepressor activity |
GO:0070883 | 0.0011 | 62.7276 | 0.0532 | 2 | 5 | pre-miRNA binding |
GO:0001671 | 0.0014 | 15.7628 | 0.2235 | 3 | 21 | ATPase activator activity |
GO:0140110 | 0.0021 | 1.9376 | 15.8658 | 28 | 1491 | transcription regulator activity |
GO:0000989 | 0.0031 | 2.4693 | 6.0547 | 14 | 569 | transcription factor activity, transcription factor binding |
GO:0051117 | 0.0069 | 5.6632 | 0.7555 | 4 | 71 | ATPase binding |
GO:0015036 | 0.0076 | 8.0976 | 0.4044 | 3 | 38 | disulfide oxidoreductase activity |
GO:0016671 | 0.0081 | 17.0987 | 0.1383 | 2 | 13 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor |
GO:0003690 | 0.0085 | 2.0652 | 8.2362 | 16 | 774 | double-stranded DNA binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0019894 | 0.001 | 10.0609 | 0.45 | 4 | 36 | kinesin binding |
GO:0004468 | 0.0023 | 39.899 | 0.075 | 2 | 6 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor |
GO:0030274 | 0.0031 | 31.9171 | 0.0875 | 2 | 7 | LIM domain binding |
GO:0031681 | 0.0041 | 26.5959 | 0.1 | 2 | 8 | G-protein beta-subunit binding |
GO:0015175 | 0.0055 | 9.2422 | 0.3625 | 3 | 29 | neutral amino acid transmembrane transporter activity |
GO:0098772 | 0.0058 | 1.713 | 20.2 | 32 | 1616 | molecular function regulator |
GO:0030957 | 0.0065 | 19.9443 | 0.125 | 2 | 10 | Tat protein binding |
GO:0048487 | 0.0073 | 8.2845 | 0.4 | 3 | 32 | beta-tubulin binding |
GO:0005344 | 0.0079 | 17.7271 | 0.1375 | 2 | 11 | oxygen carrier activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042393 | 0 | 5.9105 | 4.3385 | 22 | 188 | histone binding |
GO:0003723 | 0 | 2.2892 | 36.9092 | 73 | 1616 | RNA binding |
GO:1901363 | 0 | 1.549 | 128.9769 | 166 | 5589 | heterocyclic compound binding |
GO:0097159 | 1e-04 | 1.5157 | 130.7308 | 166 | 5665 | organic cyclic compound binding |
GO:0019904 | 2e-04 | 2.1893 | 14.7158 | 30 | 641 | protein domain specific binding |
GO:0046982 | 2e-04 | 2.3693 | 10.8462 | 24 | 470 | protein heterodimerization activity |
GO:0005515 | 4e-04 | 1.5741 | 160.7212 | 187 | 7935 | protein binding |
GO:0001104 | 0.0012 | 4.1503 | 2.1 | 8 | 91 | RNA polymerase II transcription cofactor activity |
GO:0019899 | 0.0021 | 1.5237 | 46.6846 | 66 | 2023 | enzyme binding |
GO:0001042 | 0.0051 | 28.3743 | 0.1154 | 2 | 5 | RNA polymerase I core binding |
GO:0003713 | 0.0074 | 2.2019 | 6.6692 | 14 | 289 | transcription coactivator activity |
GO:0035174 | 0.0075 | 21.2793 | 0.1385 | 2 | 6 | histone serine kinase activity |
GO:0055131 | 0.0075 | 21.2793 | 0.1385 | 2 | 6 | C3HC4-type RING finger domain binding |
GO:0019843 | 0.01 | 4.1138 | 1.3154 | 5 | 57 | rRNA binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005070 | 0 | 8.7751 | 0.919 | 7 | 56 | SH3/SH2 adaptor activity |
GO:0030246 | 1e-04 | 3.712 | 3.7908 | 13 | 231 | carbohydrate binding |
GO:0004872 | 1e-04 | 4.5851 | 2.3798 | 10 | 155 | receptor activity |
GO:0016502 | 2e-04 | 16.2212 | 0.3118 | 4 | 19 | nucleotide receptor activity |
GO:0038023 | 4e-04 | 1.9921 | 19.1179 | 35 | 1165 | signaling receptor activity |
GO:0035586 | 5e-04 | 12.8028 | 0.3774 | 4 | 23 | purinergic receptor activity |
GO:0003823 | 6e-04 | 8.2411 | 0.6892 | 5 | 42 | antigen binding |
GO:0001968 | 7e-04 | 11.582 | 0.4103 | 4 | 25 | fibronectin binding |
GO:0030414 | 9e-04 | 3.8733 | 2.4944 | 9 | 152 | peptidase inhibitor activity |
GO:0061135 | 9e-04 | 3.8733 | 2.4944 | 9 | 152 | endopeptidase regulator activity |
GO:0004715 | 0.0011 | 7.0884 | 0.7877 | 5 | 48 | non-membrane spanning protein tyrosine kinase activity |
GO:0045028 | 0.0011 | 18.1826 | 0.2133 | 3 | 13 | G-protein coupled purinergic nucleotide receptor activity |
GO:0099600 | 0.0012 | 1.8981 | 18.1497 | 32 | 1106 | transmembrane receptor activity |
GO:0008191 | 0.0014 | 16.5286 | 0.2297 | 3 | 14 | metalloendopeptidase inhibitor activity |
GO:0030492 | 0.0016 | 60.4016 | 0.0656 | 2 | 4 | hemoglobin binding |
GO:0004896 | 0.0024 | 4.7585 | 1.3621 | 6 | 83 | cytokine receptor activity |
GO:0019864 | 0.0039 | 30.1969 | 0.0985 | 2 | 6 | IgG binding |
GO:0042289 | 0.0039 | 30.1969 | 0.0985 | 2 | 6 | MHC class II protein binding |
GO:0005044 | 0.0045 | 6.5667 | 0.6728 | 4 | 41 | scavenger receptor activity |
GO:0043325 | 0.0053 | 9.5642 | 0.361 | 3 | 22 | phosphatidylinositol-3,4-bisphosphate binding |
GO:0004871 | 0.0063 | 2.5418 | 4.5624 | 11 | 298 | signal transducer activity |
GO:0030234 | 0.0081 | 1.7682 | 14.9333 | 25 | 910 | enzyme regulator activity |
GO:0060090 | 0.0081 | 2.9495 | 2.8554 | 8 | 174 | molecular adaptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0036374 | 0 | 80.644 | 0.0746 | 3 | 6 | glutathione hydrolase activity |
GO:0008201 | 1e-04 | 5.7166 | 1.7286 | 9 | 139 | heparin binding |
GO:0005518 | 1e-04 | 9.4235 | 0.7213 | 6 | 58 | collagen binding |
GO:0005201 | 2e-04 | 7.6506 | 0.8705 | 6 | 70 | extracellular matrix structural constituent |
GO:0046332 | 3e-04 | 7.5324 | 0.8829 | 6 | 71 | SMAD binding |
GO:0008083 | 6e-04 | 4.5907 | 1.8778 | 8 | 151 | growth factor activity |
GO:0000979 | 7e-04 | 7.8114 | 0.7088 | 5 | 57 | RNA polymerase II core promoter sequence-specific DNA binding |
GO:1901618 | 0.0031 | 11.6213 | 0.2956 | 3 | 24 | organic hydroxy compound transmembrane transporter activity |
GO:0042056 | 0.004 | 10.5051 | 0.3233 | 3 | 26 | chemoattractant activity |
GO:0004930 | 0.0064 | 2.0767 | 8.6803 | 17 | 698 | G-protein coupled receptor activity |
GO:0005501 | 0.0066 | 8.6264 | 0.3855 | 3 | 31 | retinoid binding |
GO:0015125 | 0.0094 | 16.0375 | 0.1492 | 2 | 12 | bile acid transmembrane transporter activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005518 | 0 | 11.4563 | 0.7101 | 7 | 58 | collagen binding |
GO:0005201 | 2e-04 | 7.7762 | 0.8571 | 6 | 70 | extracellular matrix structural constituent |
GO:0008028 | 0.0012 | 9.6729 | 0.4653 | 4 | 38 | monocarboxylic acid transmembrane transporter activity |
GO:0005539 | 0.002 | 8.2118 | 0.5385 | 4 | 45 | glycosaminoglycan binding |
GO:0016298 | 0.0027 | 4.6381 | 1.3835 | 6 | 113 | lipase activity |
GO:0043236 | 0.0047 | 9.8196 | 0.3428 | 3 | 28 | laminin binding |
GO:0004623 | 0.0052 | 9.4413 | 0.3551 | 3 | 29 | phospholipase A2 activity |
GO:0008201 | 0.0073 | 3.7251 | 1.7019 | 6 | 139 | heparin binding |
GO:0017171 | 0.0074 | 3.2927 | 2.2406 | 7 | 183 | serine hydrolase activity |
GO:1901618 | 0.0096 | 7.4352 | 0.4408 | 3 | 36 | organic hydroxy compound transmembrane transporter activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005200 | 1e-04 | 6.4183 | 1.3824 | 8 | 95 | structural constituent of cytoskeleton |
GO:0015265 | 6e-04 | 136.64 | 0.0437 | 2 | 3 | urea channel activity |
GO:0097110 | 9e-04 | 7.5044 | 0.7421 | 5 | 51 | scaffold protein binding |
GO:0015254 | 0.0012 | 68.3156 | 0.0582 | 2 | 4 | glycerol channel activity |
GO:0050294 | 0.0012 | 68.3156 | 0.0582 | 2 | 4 | steroid sulfotransferase activity |
GO:0050839 | 0.002 | 2.4886 | 6.4026 | 15 | 440 | cell adhesion molecule binding |
GO:0016702 | 0.0038 | 10.8228 | 0.3201 | 3 | 22 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen |
GO:0032395 | 0.0042 | 27.3209 | 0.1019 | 2 | 7 | MHC class II receptor activity |
GO:0005104 | 0.0055 | 9.3452 | 0.3638 | 3 | 25 | fibroblast growth factor receptor binding |
GO:0003810 | 0.0056 | 22.7659 | 0.1164 | 2 | 8 | protein-glutamine gamma-glutamyltransferase activity |
GO:0015232 | 0.0056 | 22.7659 | 0.1164 | 2 | 8 | heme transporter activity |
GO:0015166 | 0.0071 | 19.5124 | 0.131 | 2 | 9 | polyol transmembrane transporter activity |
GO:0015250 | 0.0088 | 17.0722 | 0.1455 | 2 | 10 | water channel activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 41.5844 | 3.7239 | 74 | 301 | olfactory receptor activity |
GO:0004930 | 0 | 16.1624 | 8.5109 | 77 | 695 | G-protein coupled receptor activity |
GO:0099600 | 0 | 10.8471 | 13.6832 | 84 | 1106 | transmembrane receptor activity |
GO:0038023 | 0 | 10.4406 | 14.4131 | 85 | 1165 | signaling receptor activity |
GO:0060089 | 0 | 8.7955 | 17.3453 | 87 | 1402 | molecular transducer activity |
GO:1903231 | 0 | 9.6397 | 1.7073 | 14 | 138 | mRNA binding involved in posttranscriptional gene silencing |
GO:0005549 | 0 | 13.7472 | 0.8784 | 10 | 71 | odorant binding |
GO:0089720 | 2e-04 | 34.7368 | 0.1237 | 3 | 10 | caspase binding |
GO:0050700 | 4e-04 | 27.014 | 0.1485 | 3 | 12 | CARD domain binding |
GO:0016503 | 5e-04 | 161.3194 | 0.0371 | 2 | 3 | pheromone receptor activity |
GO:0097153 | 6e-04 | 22.0995 | 0.1732 | 3 | 14 | cysteine-type endopeptidase activity involved in apoptotic process |
GO:0005132 | 0.0015 | 53.7661 | 0.0619 | 2 | 5 | type I interferon receptor binding |
GO:0004993 | 0.0018 | 14.2941 | 0.2474 | 3 | 20 | G-protein coupled serotonin receptor activity |
GO:0004869 | 0.0031 | 7.2249 | 0.6062 | 4 | 49 | cysteine-type endopeptidase inhibitor activity |
GO:0005344 | 0.0078 | 17.9151 | 0.1361 | 2 | 11 | oxygen carrier activity |
GO:0061134 | 0.0078 | 3.2569 | 2.264 | 7 | 183 | peptidase regulator activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 9.5062 | 2.9907 | 23 | 301 | olfactory receptor activity |
GO:0004930 | 0 | 4.015 | 6.9353 | 24 | 698 | G-protein coupled receptor activity |
GO:0005549 | 0 | 11.3669 | 0.7054 | 7 | 71 | odorant binding |
GO:0099600 | 0 | 2.8085 | 10.9891 | 27 | 1106 | transmembrane receptor activity |
GO:0038023 | 0 | 2.6519 | 11.5753 | 27 | 1165 | signaling receptor activity |
GO:0060089 | 0 | 2.4617 | 13.9301 | 30 | 1402 | molecular transducer activity |
GO:0047196 | 1e-04 | Inf | 0.0199 | 2 | 2 | long-chain-alcohol O-fatty-acyltransferase activity |
GO:0102966 | 1e-04 | Inf | 0.0199 | 2 | 2 | arachidoyl-CoA:1-dodecanol O-acyltransferase activity |
GO:0103095 | 1e-04 | Inf | 0.0199 | 2 | 2 | wax ester synthase activity |
GO:0005132 | 0.001 | 67.2854 | 0.0497 | 2 | 5 | type I interferon receptor binding |
GO:0004693 | 0.0021 | 13.234 | 0.2583 | 3 | 26 | cyclin-dependent protein serine/threonine kinase activity |
GO:0004508 | 0.0099 | Inf | 0.0099 | 1 | 1 | steroid 17-alpha-monooxygenase activity |
GO:0004979 | 0.0099 | Inf | 0.0099 | 1 | 1 | beta-endorphin receptor activity |
GO:0005309 | 0.0099 | Inf | 0.0099 | 1 | 1 | creatine:sodium symporter activity |
GO:0008747 | 0.0099 | Inf | 0.0099 | 1 | 1 | N-acetylneuraminate lyase activity |
GO:0036328 | 0.0099 | Inf | 0.0099 | 1 | 1 | VEGF-C-activated receptor activity |
GO:0038047 | 0.0099 | Inf | 0.0099 | 1 | 1 | morphine receptor activity |
GO:0047442 | 0.0099 | Inf | 0.0099 | 1 | 1 | 17-alpha-hydroxyprogesterone aldolase activity |
GO:0050333 | 0.0099 | Inf | 0.0099 | 1 | 1 | thiamin-triphosphatase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 28.8962 | 3.6081 | 59 | 301 | olfactory receptor activity |
GO:0004930 | 0 | 11.8239 | 8.3671 | 63 | 698 | G-protein coupled receptor activity |
GO:0038023 | 0 | 7.8231 | 13.9651 | 70 | 1165 | signaling receptor activity |
GO:0099600 | 0 | 7.9136 | 13.2578 | 68 | 1106 | transmembrane receptor activity |
GO:0060089 | 0 | 6.4757 | 16.806 | 71 | 1402 | molecular transducer activity |
GO:0005549 | 0 | 19.7795 | 0.8511 | 13 | 71 | odorant binding |
GO:1903231 | 0 | 9.1377 | 1.6542 | 13 | 138 | mRNA binding involved in posttranscriptional gene silencing |
GO:0032396 | 1e-04 | Inf | 0.024 | 2 | 2 | inhibitory MHC class I receptor activity |
GO:0030492 | 8e-04 | 83.3027 | 0.0479 | 2 | 4 | hemoglobin binding |
GO:0089720 | 0.006 | 20.8176 | 0.1199 | 2 | 10 | caspase binding |
GO:0061134 | 0.0066 | 3.3668 | 2.1937 | 7 | 183 | peptidase regulator activity |
GO:0005344 | 0.0073 | 18.5033 | 0.1319 | 2 | 11 | oxygen carrier activity |
GO:0004866 | 0.0083 | 3.6163 | 1.7501 | 6 | 146 | endopeptidase inhibitor activity |
GO:0050700 | 0.0087 | 16.6519 | 0.1438 | 2 | 12 | CARD domain binding |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0045944 | 0 | 1.8401 | 41.2544 | 70 | 1092 | positive regulation of transcription from RNA polymerase II promoter |
GO:0006355 | 0 | 1.4821 | 132.6411 | 176 | 3511 | regulation of transcription, DNA-templated |
GO:1903508 | 0 | 1.6982 | 52.928 | 83 | 1401 | positive regulation of nucleic acid-templated transcription |
GO:2001141 | 0 | 1.4659 | 133.7367 | 176 | 3540 | regulation of RNA biosynthetic process |
GO:0034654 | 0 | 1.4349 | 157.1973 | 201 | 4161 | nucleobase-containing compound biosynthetic process |
GO:0060255 | 0 | 1.3971 | 222.6679 | 270 | 5894 | regulation of macromolecule metabolic process |
GO:0031328 | 0 | 1.6023 | 67.0195 | 99 | 1774 | positive regulation of cellular biosynthetic process |
GO:0019219 | 0 | 1.4298 | 155.0061 | 198 | 4103 | regulation of nucleobase-containing compound metabolic process |
GO:0045995 | 0 | 3.7045 | 4.5334 | 15 | 120 | regulation of embryonic development |
GO:0042474 | 1e-04 | 11.8613 | 0.7178 | 6 | 19 | middle ear morphogenesis |
GO:0034641 | 1e-04 | 1.3682 | 241.6706 | 287 | 6397 | cellular nitrogen compound metabolic process |
GO:0010557 | 1e-04 | 1.5859 | 61.8438 | 91 | 1637 | positive regulation of macromolecule biosynthetic process |
GO:0051254 | 1e-04 | 1.6034 | 55.6103 | 83 | 1472 | positive regulation of RNA metabolic process |
GO:0060021 | 2e-04 | 3.9259 | 3.4379 | 12 | 91 | palate development |
GO:0043009 | 2e-04 | 1.968 | 21.1561 | 39 | 560 | chordate embryonic development |
GO:0090304 | 2e-04 | 1.3599 | 189.3092 | 230 | 5011 | nucleic acid metabolic process |
GO:0010628 | 3e-04 | 1.5214 | 67.775 | 96 | 1794 | positive regulation of gene expression |
GO:0045736 | 3e-04 | 8.1125 | 0.9445 | 6 | 25 | negative regulation of cyclin-dependent protein serine/threonine kinase activity |
GO:0050793 | 3e-04 | 1.4565 | 89.7623 | 121 | 2376 | regulation of developmental process |
GO:1904029 | 4e-04 | 3.7854 | 3.249 | 11 | 86 | regulation of cyclin-dependent protein kinase activity |
GO:0001501 | 4e-04 | 1.974 | 18.3227 | 34 | 485 | skeletal system development |
GO:1905276 | 4e-04 | 9.8682 | 0.68 | 5 | 18 | regulation of epithelial tube formation |
GO:0043066 | 7e-04 | 1.6955 | 31.243 | 50 | 827 | negative regulation of apoptotic process |
GO:0043067 | 9e-04 | 1.5064 | 55.7236 | 79 | 1475 | regulation of programmed cell death |
GO:0046483 | 0.001 | 1.3017 | 220.0611 | 257 | 5825 | heterocycle metabolic process |
GO:0009889 | 0.001 | 1.3972 | 99.4383 | 128 | 2749 | regulation of biosynthetic process |
GO:0035115 | 0.0011 | 5.9257 | 1.2089 | 6 | 32 | embryonic forelimb morphogenesis |
GO:0001708 | 0.0011 | 3.5302 | 3.1356 | 10 | 83 | cell fate specification |
GO:2000113 | 0.0012 | 1.4951 | 55.3458 | 78 | 1465 | negative regulation of cellular macromolecule biosynthetic process |
GO:0009890 | 0.0012 | 1.4688 | 61.466 | 85 | 1627 | negative regulation of biosynthetic process |
GO:0034645 | 0.0014 | 1.3484 | 127.9468 | 158 | 3532 | cellular macromolecule biosynthetic process |
GO:0016539 | 0.0014 | Inf | 0.0756 | 2 | 2 | intein-mediated protein splicing |
GO:0018003 | 0.0014 | Inf | 0.0756 | 2 | 2 | peptidyl-lysine N6-acetylation |
GO:0021623 | 0.0014 | Inf | 0.0756 | 2 | 2 | oculomotor nerve formation |
GO:0032764 | 0.0014 | Inf | 0.0756 | 2 | 2 | negative regulation of mast cell cytokine production |
GO:0033624 | 0.0014 | Inf | 0.0756 | 2 | 2 | negative regulation of integrin activation |
GO:0043376 | 0.0014 | Inf | 0.0756 | 2 | 2 | regulation of CD8-positive, alpha-beta T cell differentiation |
GO:0044338 | 0.0014 | Inf | 0.0756 | 2 | 2 | canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation |
GO:1901301 | 0.0014 | Inf | 0.0756 | 2 | 2 | regulation of cargo loading into COPII-coated vesicle |
GO:0016331 | 0.0015 | 2.6997 | 5.5913 | 14 | 148 | morphogenesis of embryonic epithelium |
GO:0006725 | 0.0015 | 1.288 | 221.4967 | 257 | 5863 | cellular aromatic compound metabolic process |
GO:1903707 | 0.0019 | 2.7285 | 5.1379 | 13 | 136 | negative regulation of hemopoiesis |
GO:0036037 | 0.002 | 9.3159 | 0.5667 | 4 | 15 | CD8-positive, alpha-beta T cell activation |
GO:0060173 | 0.0021 | 2.4853 | 6.4602 | 15 | 171 | limb development |
GO:0048522 | 0.0021 | 1.3148 | 144.8925 | 175 | 3940 | positive regulation of cellular process |
GO:0051173 | 0.0023 | 1.3404 | 108.5761 | 136 | 2874 | positive regulation of nitrogen compound metabolic process |
GO:0071542 | 0.0024 | 4.9684 | 1.3978 | 6 | 37 | dopaminergic neuron differentiation |
GO:0060548 | 0.0024 | 1.5725 | 34.7942 | 52 | 921 | negative regulation of cell death |
GO:1901360 | 0.0026 | 1.2683 | 229.3169 | 263 | 6070 | organic cyclic compound metabolic process |
GO:0006268 | 0.0026 | 15.352 | 0.3022 | 3 | 8 | DNA unwinding involved in DNA replication |
GO:0033083 | 0.0026 | 15.352 | 0.3022 | 3 | 8 | regulation of immature T cell proliferation |
GO:0051683 | 0.0026 | 15.352 | 0.3022 | 3 | 8 | establishment of Golgi localization |
GO:0048568 | 0.0029 | 1.8487 | 15.9426 | 28 | 422 | embryonic organ development |
GO:0051053 | 0.0029 | 2.7145 | 4.7601 | 12 | 126 | negative regulation of DNA metabolic process |
GO:0051348 | 0.003 | 1.9155 | 13.7515 | 25 | 364 | negative regulation of transferase activity |
GO:0035270 | 0.0031 | 2.6907 | 4.7979 | 12 | 127 | endocrine system development |
GO:1901576 | 0.0032 | 1.2598 | 234.077 | 267 | 6196 | organic substance biosynthetic process |
GO:0035148 | 0.0032 | 2.5605 | 5.4401 | 13 | 144 | tube formation |
GO:0006469 | 0.0032 | 2.1205 | 9.4825 | 19 | 251 | negative regulation of protein kinase activity |
GO:0051172 | 0.0033 | 1.35 | 91.3112 | 116 | 2417 | negative regulation of nitrogen compound metabolic process |
GO:0043367 | 0.0033 | 3.5462 | 2.4934 | 8 | 66 | CD4-positive, alpha-beta T cell differentiation |
GO:0090092 | 0.0034 | 2.2205 | 8.1224 | 17 | 215 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
GO:0034377 | 0.0036 | 5.5741 | 1.0578 | 5 | 28 | plasma lipoprotein particle assembly |
GO:0007369 | 0.0037 | 2.334 | 6.838 | 15 | 181 | gastrulation |
GO:0031324 | 0.0037 | 1.3353 | 97.1291 | 122 | 2571 | negative regulation of cellular metabolic process |
GO:0032392 | 0.0037 | 3.1719 | 3.0979 | 9 | 82 | DNA geometric change |
GO:0006991 | 0.0038 | 12.7925 | 0.34 | 3 | 9 | response to sterol depletion |
GO:0043587 | 0.0038 | 12.7925 | 0.34 | 3 | 9 | tongue morphogenesis |
GO:0072048 | 0.0038 | 12.7925 | 0.34 | 3 | 9 | renal system pattern specification |
GO:0048486 | 0.004 | 7.3182 | 0.68 | 4 | 18 | parasympathetic nervous system development |
GO:0036079 | 0.0042 | 51.1028 | 0.1133 | 2 | 3 | purine nucleotide-sugar transport |
GO:0051684 | 0.0042 | 51.1028 | 0.1133 | 2 | 3 | maintenance of Golgi location |
GO:0060061 | 0.0042 | 51.1028 | 0.1133 | 2 | 3 | Spemann organizer formation |
GO:2000502 | 0.0042 | 51.1028 | 0.1133 | 2 | 3 | negative regulation of natural killer cell chemotaxis |
GO:0090596 | 0.0043 | 2.107 | 9.0277 | 18 | 240 | sensory organ morphogenesis |
GO:0045620 | 0.0047 | 4.277 | 1.5867 | 6 | 42 | negative regulation of lymphocyte differentiation |
GO:0021772 | 0.0049 | 5.1275 | 1.1334 | 5 | 30 | olfactory bulb development |
GO:0046639 | 0.005 | 6.8299 | 0.7178 | 4 | 19 | negative regulation of alpha-beta T cell differentiation |
GO:0072079 | 0.005 | 6.8299 | 0.7178 | 4 | 19 | nephron tubule formation |
GO:0045597 | 0.005 | 1.5297 | 33.5475 | 49 | 888 | positive regulation of cell differentiation |
GO:0002890 | 0.0053 | 10.9643 | 0.3778 | 3 | 10 | negative regulation of immunoglobulin mediated immune response |
GO:0001942 | 0.0055 | 2.9676 | 3.2867 | 9 | 87 | hair follicle development |
GO:0051174 | 0.0056 | 1.3799 | 64.035 | 84 | 1695 | regulation of phosphorus metabolic process |
GO:0060349 | 0.0059 | 2.9299 | 3.3245 | 9 | 88 | bone morphogenesis |
GO:0009790 | 0.0063 | 1.7352 | 16.8968 | 28 | 460 | embryo development |
GO:0022404 | 0.0064 | 2.8931 | 3.3623 | 9 | 89 | molting cycle process |
GO:0031668 | 0.0065 | 2.119 | 7.9713 | 16 | 211 | cellular response to extracellular stimulus |
GO:0009966 | 0.0065 | 1.3017 | 104.382 | 128 | 2804 | regulation of signal transduction |
GO:0021522 | 0.0065 | 4.7471 | 1.2089 | 5 | 32 | spinal cord motor neuron differentiation |
GO:2000027 | 0.0066 | 2.0144 | 9.4069 | 18 | 249 | regulation of organ morphogenesis |
GO:0044764 | 0.0066 | 3.9472 | 1.7 | 6 | 45 | multi-organism cellular process |
GO:0042325 | 0.0071 | 1.3941 | 54.8925 | 73 | 1453 | regulation of phosphorylation |
GO:0072088 | 0.0072 | 3.0681 | 2.8334 | 8 | 75 | nephron epithelium morphogenesis |
GO:0065007 | 0.0074 | 1.258 | 428.562 | 456 | 11344 | biological regulation |
GO:0042339 | 0.0075 | 4.5773 | 1.2467 | 5 | 33 | keratan sulfate metabolic process |
GO:1903507 | 0.0077 | 1.4342 | 43.7478 | 60 | 1158 | negative regulation of nucleic acid-templated transcription |
GO:0003002 | 0.008 | 2.0149 | 8.8743 | 17 | 237 | regionalization |
GO:0021557 | 0.0081 | 25.5498 | 0.1511 | 2 | 4 | oculomotor nerve development |
GO:0033088 | 0.0081 | 25.5498 | 0.1511 | 2 | 4 | negative regulation of immature T cell proliferation in thymus |
GO:0034287 | 0.0081 | 25.5498 | 0.1511 | 2 | 4 | detection of monosaccharide stimulus |
GO:0051594 | 0.0081 | 25.5498 | 0.1511 | 2 | 4 | detection of glucose |
GO:0051754 | 0.0081 | 25.5498 | 0.1511 | 2 | 4 | meiotic sister chromatid cohesion, centromeric |
GO:0061056 | 0.0081 | 25.5498 | 0.1511 | 2 | 4 | sclerotome development |
GO:0070212 | 0.0081 | 25.5498 | 0.1511 | 2 | 4 | protein poly-ADP-ribosylation |
GO:0070213 | 0.0081 | 25.5498 | 0.1511 | 2 | 4 | protein auto-ADP-ribosylation |
GO:0072086 | 0.0081 | 25.5498 | 0.1511 | 2 | 4 | specification of loop of Henle identity |
GO:0072107 | 0.0081 | 25.5498 | 0.1511 | 2 | 4 | positive regulation of ureteric bud formation |
GO:0072268 | 0.0081 | 25.5498 | 0.1511 | 2 | 4 | pattern specification involved in metanephros development |
GO:2000491 | 0.0081 | 25.5498 | 0.1511 | 2 | 4 | positive regulation of hepatic stellate cell activation |
GO:0007399 | 0.0082 | 1.3175 | 83.9443 | 105 | 2222 | nervous system development |
GO:0044248 | 0.0083 | 1.3294 | 76.7286 | 97 | 2031 | cellular catabolic process |
GO:0061333 | 0.0084 | 2.9788 | 2.909 | 8 | 77 | renal tubule morphogenesis |
GO:0048704 | 0.0085 | 2.7546 | 3.5134 | 9 | 93 | embryonic skeletal system morphogenesis |
GO:1904886 | 0.0086 | 5.6905 | 0.8311 | 4 | 22 | beta-catenin destruction complex disassembly |
GO:0060429 | 0.009 | 1.4176 | 44.9567 | 61 | 1190 | epithelium development |
GO:0071107 | 0.0091 | 8.5267 | 0.4533 | 3 | 12 | response to parathyroid hormone |
GO:2001053 | 0.0091 | 8.5267 | 0.4533 | 3 | 12 | regulation of mesenchymal cell apoptotic process |
GO:0016202 | 0.0092 | 2.42 | 4.8357 | 11 | 128 | regulation of striated muscle tissue development |
GO:0000122 | 0.0094 | 1.5118 | 29.6563 | 43 | 785 | negative regulation of transcription from RNA polymerase II promoter |
GO:2001021 | 0.0094 | 3.2089 | 2.3801 | 7 | 63 | negative regulation of response to DNA damage stimulus |
GO:0048469 | 0.0094 | 2.2185 | 6.1957 | 13 | 164 | cell maturation |
GO:0032008 | 0.0096 | 4.2716 | 1.3223 | 5 | 35 | positive regulation of TOR signaling |
GO:0009953 | 0.0097 | 2.6902 | 3.589 | 9 | 95 | dorsal/ventral pattern formation |
GO:0042472 | 0.0097 | 2.6902 | 3.589 | 9 | 95 | inner ear morphogenesis |
GO:0010171 | 0.01 | 3.5791 | 1.8512 | 6 | 49 | body morphogenesis |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 14.7388 | 5.4512 | 55 | 261 | detection of chemical stimulus involved in sensory perception of smell |
GO:0051606 | 0 | 8.2065 | 10.4847 | 64 | 502 | detection of stimulus |
GO:0007600 | 0 | 5.8139 | 16.2074 | 72 | 776 | sensory perception |
GO:0007186 | 0 | 3.8866 | 23.8016 | 74 | 1146 | G-protein coupled receptor signaling pathway |
GO:0003008 | 0 | 3.1239 | 38.7432 | 95 | 1855 | system process |
GO:0031424 | 0 | 5.001 | 3.8221 | 17 | 183 | keratinization |
GO:0050907 | 0 | 12.3547 | 0.6939 | 7 | 39 | detection of chemical stimulus involved in sensory perception |
GO:0043588 | 0 | 3.1363 | 7.6442 | 22 | 366 | skin development |
GO:0019730 | 0 | 5.8599 | 1.9215 | 10 | 92 | antimicrobial humoral response |
GO:0006952 | 0 | 1.9608 | 30.368 | 54 | 1454 | defense response |
GO:0009913 | 0 | 3.2511 | 6.3493 | 19 | 304 | epidermal cell differentiation |
GO:0001580 | 0 | 11.4352 | 0.6475 | 6 | 31 | detection of chemical stimulus involved in sensory perception of bitter taste |
GO:0017144 | 0 | 10.9947 | 0.6683 | 6 | 32 | drug metabolic process |
GO:0042742 | 0 | 4.3792 | 3.0075 | 12 | 146 | defense response to bacterium |
GO:0009820 | 3e-04 | 35.4636 | 0.1462 | 3 | 7 | alkaloid metabolic process |
GO:0019441 | 3e-04 | 35.4636 | 0.1462 | 3 | 7 | tryptophan catabolic process to kynurenine |
GO:0048007 | 3e-04 | 35.4636 | 0.1462 | 3 | 7 | antigen processing and presentation, exogenous lipid antigen via MHC class Ib |
GO:0042221 | 3e-04 | 1.5106 | 85.7153 | 114 | 4104 | response to chemical |
GO:0019442 | 4e-04 | Inf | 0.0418 | 2 | 2 | tryptophan catabolic process to acetyl-CoA |
GO:0010951 | 6e-04 | 2.9725 | 5.0335 | 14 | 241 | negative regulation of endopeptidase activity |
GO:0001991 | 6e-04 | 12.6381 | 0.3968 | 4 | 19 | regulation of systemic arterial blood pressure by circulatory renin-angiotensin |
GO:0048147 | 6e-04 | 8.4813 | 0.6892 | 5 | 33 | negative regulation of fibroblast proliferation |
GO:0018149 | 6e-04 | 6.4895 | 1.0443 | 6 | 50 | peptide cross-linking |
GO:0009074 | 7e-04 | 11.8475 | 0.4177 | 4 | 20 | aromatic amino acid family catabolic process |
GO:0019373 | 7e-04 | 11.8475 | 0.4177 | 4 | 20 | epoxygenase P450 pathway |
GO:0042537 | 8e-04 | 11.1499 | 0.4386 | 4 | 21 | benzene-containing compound metabolic process |
GO:0002475 | 0.001 | 20.2611 | 0.2089 | 3 | 10 | antigen processing and presentation via MHC class Ib |
GO:0010838 | 0.001 | 20.2611 | 0.2089 | 3 | 10 | positive regulation of keratinocyte proliferation |
GO:0046218 | 0.001 | 20.2611 | 0.2089 | 3 | 10 | indolalkylamine catabolic process |
GO:0001990 | 0.0011 | 7.194 | 0.7937 | 5 | 38 | regulation of systemic arterial blood pressure by hormone |
GO:0015747 | 0.0013 | 17.7274 | 0.2297 | 3 | 11 | urate transport |
GO:0042738 | 0.0013 | 17.7274 | 0.2297 | 3 | 11 | exogenous drug catabolic process |
GO:0009310 | 0.0017 | 9.0238 | 0.5221 | 4 | 25 | amine catabolic process |
GO:0006568 | 0.0017 | 15.7567 | 0.2506 | 3 | 12 | tryptophan metabolic process |
GO:0070989 | 0.0017 | 15.7567 | 0.2506 | 3 | 12 | oxidative demethylation |
GO:0006775 | 0.0017 | 6.4147 | 0.8772 | 5 | 42 | fat-soluble vitamin metabolic process |
GO:0045861 | 0.0019 | 2.4181 | 6.9967 | 16 | 335 | negative regulation of proteolysis |
GO:0050829 | 0.0023 | 4.8351 | 1.3576 | 6 | 65 | defense response to Gram-negative bacterium |
GO:0051346 | 0.0024 | 2.2287 | 8.5214 | 18 | 408 | negative regulation of hydrolase activity |
GO:0052547 | 0.0028 | 2.1998 | 8.6258 | 18 | 413 | regulation of peptidase activity |
GO:0001675 | 0.0028 | 12.8902 | 0.2924 | 3 | 14 | acrosome assembly |
GO:0050909 | 0.0037 | 5.302 | 1.0385 | 5 | 50 | sensory perception of taste |
GO:0043207 | 0.0039 | 1.8074 | 16.3327 | 28 | 782 | response to external biotic stimulus |
GO:0031640 | 0.0041 | 5.1567 | 1.0652 | 5 | 51 | killing of cells of other organism |
GO:0042699 | 0.0042 | 31.432 | 0.1044 | 2 | 5 | follicle-stimulating hormone signaling pathway |
GO:0070098 | 0.0048 | 4.1317 | 1.5664 | 6 | 75 | chemokine-mediated signaling pathway |
GO:0050832 | 0.0053 | 6.3131 | 0.7101 | 4 | 34 | defense response to fungus |
GO:0034308 | 0.0057 | 4.743 | 1.1487 | 5 | 55 | primary alcohol metabolic process |
GO:0000820 | 0.0062 | 23.5725 | 0.1253 | 2 | 6 | regulation of glutamine family amino acid metabolic process |
GO:0016098 | 0.0062 | 23.5725 | 0.1253 | 2 | 6 | monoterpenoid metabolic process |
GO:0050917 | 0.0062 | 23.5725 | 0.1253 | 2 | 6 | sensory perception of umami taste |
GO:0060501 | 0.0062 | 23.5725 | 0.1253 | 2 | 6 | positive regulation of epithelial cell proliferation involved in lung morphogenesis |
GO:0071346 | 0.0063 | 3.0984 | 2.736 | 8 | 131 | cellular response to interferon-gamma |
GO:0010592 | 0.0068 | 8.8592 | 0.3968 | 3 | 19 | positive regulation of lamellipodium assembly |
GO:0006814 | 0.0076 | 2.4685 | 4.6784 | 11 | 224 | sodium ion transport |
GO:0001502 | 0.0079 | 8.3376 | 0.4177 | 3 | 20 | cartilage condensation |
GO:0030593 | 0.0082 | 3.6529 | 1.7544 | 6 | 84 | neutrophil chemotaxis |
GO:0050706 | 0.0086 | 5.4095 | 0.8145 | 4 | 39 | regulation of interleukin-1 beta secretion |
GO:1901616 | 0.0088 | 4.2332 | 1.274 | 5 | 61 | organic hydroxy compound catabolic process |
GO:0051341 | 0.0097 | 3.517 | 1.8171 | 6 | 87 | regulation of oxidoreductase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0009913 | 0 | 6.4913 | 7.974 | 42 | 304 | epidermal cell differentiation |
GO:0050911 | 0 | 6.8464 | 6.8461 | 38 | 261 | detection of chemical stimulus involved in sensory perception of smell |
GO:0009593 | 0 | 5.6404 | 8.7609 | 41 | 334 | detection of chemical stimulus |
GO:0018149 | 0 | 21.7573 | 1.3115 | 18 | 50 | peptide cross-linking |
GO:0007606 | 0 | 5.3253 | 9.2068 | 41 | 351 | sensory perception of chemical stimulus |
GO:0043588 | 0 | 5.0746 | 9.6002 | 41 | 366 | skin development |
GO:0050906 | 0 | 5.1991 | 9.1543 | 40 | 349 | detection of stimulus involved in sensory perception |
GO:0007186 | 0 | 2.9753 | 28.8956 | 73 | 1112 | G-protein coupled receptor signaling pathway |
GO:0031424 | 0 | 12.9786 | 1.8626 | 18 | 74 | keratinization |
GO:0070268 | 0 | 8.7033 | 2.8591 | 20 | 109 | cornification |
GO:0006954 | 0 | 4.6296 | 7.4678 | 30 | 294 | inflammatory response |
GO:0045087 | 0 | 3.1451 | 12.0384 | 34 | 468 | innate immune response |
GO:0060326 | 0 | 4.081 | 6.61 | 24 | 252 | cell chemotaxis |
GO:0002263 | 0 | 2.6937 | 17.2856 | 42 | 659 | cell activation involved in immune response |
GO:0042119 | 0 | 2.9476 | 12.7478 | 34 | 486 | neutrophil activation |
GO:0050900 | 0 | 3.7163 | 6.8758 | 23 | 267 | leukocyte migration |
GO:0050877 | 0 | 2.1912 | 29.3515 | 58 | 1119 | nervous system process |
GO:0002275 | 0 | 2.7816 | 13.8495 | 35 | 528 | myeloid cell activation involved in immune response |
GO:0070098 | 0 | 7.2468 | 1.9673 | 12 | 75 | chemokine-mediated signaling pathway |
GO:0006959 | 0 | 4.8745 | 3.7121 | 16 | 143 | humoral immune response |
GO:0043312 | 0 | 2.8179 | 12.4593 | 32 | 475 | neutrophil degranulation |
GO:0002250 | 0 | 3.3959 | 7.7951 | 24 | 300 | adaptive immune response |
GO:0006968 | 0 | 8.6157 | 1.4164 | 10 | 54 | cellular defense response |
GO:0002444 | 0 | 2.5717 | 13.9806 | 33 | 533 | myeloid leukocyte mediated immunity |
GO:0050776 | 0 | 3.8059 | 5.2237 | 18 | 209 | regulation of immune response |
GO:0042102 | 0 | 5.3637 | 2.5443 | 12 | 97 | positive regulation of T cell proliferation |
GO:0050867 | 0 | 3.1031 | 7.7301 | 22 | 296 | positive regulation of cell activation |
GO:0070663 | 0 | 3.5707 | 5.5346 | 18 | 211 | regulation of leukocyte proliferation |
GO:0060429 | 0 | 1.9591 | 31.2138 | 56 | 1190 | epithelium development |
GO:0042330 | 0 | 2.4261 | 14.7413 | 33 | 562 | taxis |
GO:0002274 | 0 | 7.1387 | 1.4763 | 9 | 60 | myeloid leukocyte activation |
GO:0051251 | 0 | 3.2101 | 6.7936 | 20 | 259 | positive regulation of lymphocyte activation |
GO:0045055 | 0 | 2.2121 | 19.0955 | 39 | 728 | regulated exocytosis |
GO:0043207 | 0 | 2.1048 | 20.5119 | 40 | 782 | response to external biotic stimulus |
GO:1903039 | 0 | 3.3292 | 5.5608 | 17 | 212 | positive regulation of leukocyte cell-cell adhesion |
GO:0032946 | 0 | 4.1167 | 3.4886 | 13 | 133 | positive regulation of mononuclear cell proliferation |
GO:0031295 | 1e-04 | 5.8631 | 1.7574 | 9 | 67 | T cell costimulation |
GO:0002548 | 1e-04 | 6.5605 | 1.4164 | 8 | 54 | monocyte chemotaxis |
GO:0032940 | 1e-04 | 1.7763 | 36.6172 | 60 | 1396 | secretion by cell |
GO:1901623 | 1e-04 | 13.4039 | 0.4984 | 5 | 19 | regulation of lymphocyte chemotaxis |
GO:0002757 | 1e-04 | 2.3533 | 12.3019 | 27 | 469 | immune response-activating signal transduction |
GO:0006955 | 1e-04 | 3.7052 | 3.8227 | 13 | 172 | immune response |
GO:0032501 | 1e-04 | 1.4869 | 140.2607 | 174 | 6116 | multicellular organismal process |
GO:0048870 | 2e-04 | 1.7365 | 37.3517 | 60 | 1424 | cell motility |
GO:2000503 | 2e-04 | 56.0731 | 0.1312 | 3 | 5 | positive regulation of natural killer cell chemotaxis |
GO:0022407 | 2e-04 | 2.4248 | 10.597 | 24 | 404 | regulation of cell-cell adhesion |
GO:0045086 | 2e-04 | 18.7281 | 0.3148 | 4 | 12 | positive regulation of interleukin-2 biosynthetic process |
GO:0050670 | 2e-04 | 3.7376 | 3.5055 | 12 | 135 | regulation of lymphocyte proliferation |
GO:0032753 | 2e-04 | 11.0364 | 0.5771 | 5 | 22 | positive regulation of interleukin-4 production |
GO:0061844 | 2e-04 | 6.4272 | 1.259 | 7 | 48 | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO:0003071 | 3e-04 | 10.4226 | 0.6033 | 5 | 23 | renal system process involved in regulation of systemic arterial blood pressure |
GO:0002933 | 3e-04 | 37.3797 | 0.1574 | 3 | 6 | lipid hydroxylation |
GO:0032663 | 3e-04 | 5.9879 | 1.3377 | 7 | 51 | regulation of interleukin-2 production |
GO:0030593 | 3e-04 | 4.5293 | 2.2033 | 9 | 84 | neutrophil chemotaxis |
GO:0007154 | 4e-04 | 1.4063 | 159.7152 | 194 | 6089 | cell communication |
GO:0023052 | 4e-04 | 1.3995 | 159.243 | 193 | 6071 | signaling |
GO:0050778 | 4e-04 | 2.4768 | 8.6172 | 20 | 335 | positive regulation of immune response |
GO:0050921 | 5e-04 | 3.587 | 3.3312 | 11 | 127 | positive regulation of chemotaxis |
GO:0045104 | 6e-04 | 6.4406 | 1.0754 | 6 | 41 | intermediate filament cytoskeleton organization |
GO:0046960 | 7e-04 | Inf | 0.0525 | 2 | 2 | sensitization |
GO:0061766 | 7e-04 | Inf | 0.0525 | 2 | 2 | positive regulation of lung blood pressure |
GO:1905180 | 7e-04 | Inf | 0.0525 | 2 | 2 | positive regulation of cardiac muscle tissue regeneration |
GO:0050710 | 7e-04 | 5.2673 | 1.4951 | 7 | 57 | negative regulation of cytokine secretion |
GO:0001816 | 7e-04 | 1.9673 | 16.7275 | 31 | 643 | cytokine production |
GO:0032101 | 8e-04 | 2.8544 | 5.2465 | 14 | 207 | regulation of response to external stimulus |
GO:0031343 | 8e-04 | 6.0917 | 1.1279 | 6 | 43 | positive regulation of cell killing |
GO:0032733 | 9e-04 | 7.814 | 0.7607 | 5 | 29 | positive regulation of interleukin-10 production |
GO:0010820 | 9e-04 | 22.425 | 0.2098 | 3 | 8 | positive regulation of T cell chemotaxis |
GO:1902715 | 9e-04 | 22.425 | 0.2098 | 3 | 8 | positive regulation of interferon-gamma secretion |
GO:0002695 | 9e-04 | 3.3225 | 3.5707 | 11 | 137 | negative regulation of leukocyte activation |
GO:0097530 | 0.001 | 3.5623 | 3.0427 | 10 | 116 | granulocyte migration |
GO:0032102 | 0.001 | 2.5061 | 7.2133 | 17 | 275 | negative regulation of response to external stimulus |
GO:0042035 | 0.001 | 3.857 | 2.5443 | 9 | 97 | regulation of cytokine biosynthetic process |
GO:0002687 | 0.0011 | 3.4959 | 3.0952 | 10 | 118 | positive regulation of leukocyte migration |
GO:0050865 | 0.0013 | 2.8509 | 4.8679 | 13 | 193 | regulation of cell activation |
GO:0097267 | 0.0013 | 18.6863 | 0.2361 | 3 | 9 | omega-hydroxylase P450 pathway |
GO:0042742 | 0.0015 | 3.1196 | 3.7819 | 11 | 146 | defense response to bacterium |
GO:0009620 | 0.0015 | 5.3648 | 1.259 | 6 | 48 | response to fungus |
GO:0050829 | 0.0015 | 4.5385 | 1.705 | 7 | 65 | defense response to Gram-negative bacterium |
GO:0051716 | 0.0016 | 1.3429 | 179.65 | 210 | 6849 | cellular response to stimulus |
GO:0002698 | 0.0016 | 3.5712 | 2.7279 | 9 | 104 | negative regulation of immune effector process |
GO:0010951 | 0.0018 | 2.5173 | 6.3215 | 15 | 241 | negative regulation of endopeptidase activity |
GO:0002707 | 0.0018 | 6.4647 | 0.8918 | 5 | 34 | negative regulation of lymphocyte mediated immunity |
GO:1905205 | 0.0019 | 16.0158 | 0.2623 | 3 | 10 | positive regulation of connective tissue replacement |
GO:0009595 | 0.002 | 8.8082 | 0.5508 | 4 | 21 | detection of biotic stimulus |
GO:0003095 | 0.002 | 74.5929 | 0.0787 | 2 | 3 | pressure natriuresis |
GO:0032304 | 0.002 | 74.5929 | 0.0787 | 2 | 3 | negative regulation of icosanoid secretion |
GO:0051714 | 0.002 | 74.5929 | 0.0787 | 2 | 3 | positive regulation of cytolysis in other organism |
GO:0031347 | 0.0021 | 2.1586 | 9.7839 | 20 | 380 | regulation of defense response |
GO:0032649 | 0.0023 | 3.7175 | 2.3345 | 8 | 89 | regulation of interferon-gamma production |
GO:0032715 | 0.0023 | 6.0469 | 0.9443 | 5 | 36 | negative regulation of interleukin-6 production |
GO:0006874 | 0.0024 | 2.0891 | 10.597 | 21 | 404 | cellular calcium ion homeostasis |
GO:0042107 | 0.0024 | 3.3578 | 2.8853 | 9 | 110 | cytokine metabolic process |
GO:0050863 | 0.0025 | 2.5205 | 5.8845 | 14 | 227 | regulation of T cell activation |
GO:0002221 | 0.0025 | 2.7491 | 4.6427 | 12 | 177 | pattern recognition receptor signaling pathway |
GO:0006600 | 0.0025 | 14.013 | 0.2885 | 3 | 11 | creatine metabolic process |
GO:0033004 | 0.0025 | 14.013 | 0.2885 | 3 | 11 | negative regulation of mast cell activation |
GO:0002521 | 0.0025 | 2.0035 | 12.0921 | 23 | 461 | leukocyte differentiation |
GO:0007204 | 0.0027 | 2.3255 | 7.2657 | 16 | 277 | positive regulation of cytosolic calcium ion concentration |
GO:0002407 | 0.0028 | 7.8801 | 0.6033 | 4 | 23 | dendritic cell chemotaxis |
GO:0002820 | 0.003 | 5.6797 | 0.9967 | 5 | 38 | negative regulation of adaptive immune response |
GO:0046209 | 0.003 | 3.9864 | 1.9148 | 7 | 73 | nitric oxide metabolic process |
GO:0070527 | 0.0031 | 4.5963 | 1.4427 | 6 | 55 | platelet aggregation |
GO:0001773 | 0.0032 | 7.5197 | 0.6268 | 4 | 24 | myeloid dendritic cell activation |
GO:0001787 | 0.0033 | 12.4552 | 0.3148 | 3 | 12 | natural killer cell proliferation |
GO:0045060 | 0.0033 | 12.4552 | 0.3148 | 3 | 12 | negative thymic T cell selection |
GO:0035150 | 0.0035 | 2.9459 | 3.6198 | 10 | 138 | regulation of tube size |
GO:0035821 | 0.0035 | 2.9459 | 3.6198 | 10 | 138 | modification of morphology or physiology of other organism |
GO:0002703 | 0.0035 | 2.768 | 4.223 | 11 | 161 | regulation of leukocyte mediated immunity |
GO:0072507 | 0.0037 | 1.9718 | 11.7249 | 22 | 447 | divalent inorganic cation homeostasis |
GO:0050918 | 0.0037 | 4.4155 | 1.4951 | 6 | 57 | positive chemotaxis |
GO:0010614 | 0.0038 | 7.1287 | 0.6558 | 4 | 25 | negative regulation of cardiac muscle hypertrophy |
GO:0000320 | 0.004 | 37.2941 | 0.1049 | 2 | 4 | re-entry into mitotic cell cycle |
GO:0032497 | 0.004 | 37.2941 | 0.1049 | 2 | 4 | detection of lipopolysaccharide |
GO:0036101 | 0.004 | 37.2941 | 0.1049 | 2 | 4 | leukotriene B4 catabolic process |
GO:0071611 | 0.004 | 37.2941 | 0.1049 | 2 | 4 | granulocyte colony-stimulating factor production |
GO:0046634 | 0.004 | 3.7576 | 2.0197 | 7 | 77 | regulation of alpha-beta T cell activation |
GO:0045744 | 0.0042 | 5.2054 | 1.0754 | 5 | 41 | negative regulation of G-protein coupled receptor protein signaling pathway |
GO:0006703 | 0.0042 | 11.209 | 0.341 | 3 | 13 | estrogen biosynthetic process |
GO:0016973 | 0.0042 | 11.209 | 0.341 | 3 | 13 | poly(A)+ mRNA export from nucleus |
GO:0070234 | 0.0042 | 11.209 | 0.341 | 3 | 13 | positive regulation of T cell apoptotic process |
GO:0098543 | 0.0042 | 11.209 | 0.341 | 3 | 13 | detection of other organism |
GO:1905521 | 0.0044 | 6.8042 | 0.682 | 4 | 26 | regulation of macrophage migration |
GO:0070374 | 0.0044 | 2.5462 | 4.9837 | 12 | 190 | positive regulation of ERK1 and ERK2 cascade |
GO:0006950 | 0.0045 | 1.3482 | 94.8743 | 118 | 3617 | response to stress |
GO:0002822 | 0.0046 | 3.0259 | 3.1738 | 9 | 121 | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
GO:0051249 | 0.0047 | 10.6124 | 0.3531 | 3 | 14 | regulation of lymphocyte activation |
GO:0022610 | 0.0048 | 1.5273 | 35.2533 | 51 | 1344 | biological adhesion |
GO:0002831 | 0.0049 | 2.9989 | 3.2001 | 9 | 122 | regulation of response to biotic stimulus |
GO:2000404 | 0.0051 | 6.508 | 0.7082 | 4 | 27 | regulation of T cell migration |
GO:0006909 | 0.0051 | 2.3967 | 5.7182 | 13 | 218 | phagocytosis |
GO:0046903 | 0.0052 | 2.9661 | 3.2303 | 9 | 131 | secretion |
GO:0006956 | 0.0052 | 4.0934 | 1.6 | 6 | 61 | complement activation |
GO:0002523 | 0.0053 | 10.1893 | 0.3672 | 3 | 14 | leukocyte migration involved in inflammatory response |
GO:0014744 | 0.0053 | 10.1893 | 0.3672 | 3 | 14 | positive regulation of muscle adaptation |
GO:0048853 | 0.0053 | 10.1893 | 0.3672 | 3 | 14 | forebrain morphogenesis |
GO:0045785 | 0.0057 | 1.9983 | 9.9674 | 19 | 380 | positive regulation of cell adhesion |
GO:0055078 | 0.0057 | 4.804 | 1.1541 | 5 | 44 | sodium ion homeostasis |
GO:0002526 | 0.0057 | 2.7307 | 3.8821 | 10 | 148 | acute inflammatory response |
GO:0050708 | 0.0057 | 1.9585 | 10.7019 | 20 | 408 | regulation of protein secretion |
GO:0019724 | 0.0057 | 3.1668 | 2.7017 | 8 | 103 | B cell mediated immunity |
GO:0050891 | 0.0061 | 3.9492 | 1.6525 | 6 | 63 | multicellular organismal water homeostasis |
GO:0045619 | 0.0062 | 2.6913 | 3.9345 | 10 | 150 | regulation of lymphocyte differentiation |
GO:0045776 | 0.0063 | 4.6836 | 1.1804 | 5 | 45 | negative regulation of blood pressure |
GO:0042268 | 0.0064 | 9.3396 | 0.3935 | 3 | 15 | regulation of cytolysis |
GO:2000484 | 0.0064 | 9.3396 | 0.3935 | 3 | 15 | positive regulation of interleukin-8 secretion |
GO:0001909 | 0.0065 | 3.4145 | 2.2033 | 7 | 84 | leukocyte mediated cytotoxicity |
GO:0001992 | 0.0065 | 24.8612 | 0.1312 | 2 | 5 | regulation of systemic arterial blood pressure by vasopressin |
GO:0010536 | 0.0065 | 24.8612 | 0.1312 | 2 | 5 | positive regulation of activation of Janus kinase activity |
GO:0010572 | 0.0065 | 24.8612 | 0.1312 | 2 | 5 | positive regulation of platelet activation |
GO:0030885 | 0.0065 | 24.8612 | 0.1312 | 2 | 5 | regulation of myeloid dendritic cell activation |
GO:0038145 | 0.0065 | 24.8612 | 0.1312 | 2 | 5 | macrophage colony-stimulating factor signaling pathway |
GO:0042640 | 0.0065 | 24.8612 | 0.1312 | 2 | 5 | anagen |
GO:0044245 | 0.0065 | 24.8612 | 0.1312 | 2 | 5 | polysaccharide digestion |
GO:0071672 | 0.0065 | 24.8612 | 0.1312 | 2 | 5 | negative regulation of smooth muscle cell chemotaxis |
GO:1901523 | 0.0065 | 24.8612 | 0.1312 | 2 | 5 | icosanoid catabolic process |
GO:0042060 | 0.0069 | 1.8061 | 13.902 | 24 | 530 | wound healing |
GO:0030193 | 0.0069 | 3.3705 | 2.2296 | 7 | 85 | regulation of blood coagulation |
GO:0071347 | 0.0069 | 3.3705 | 2.2296 | 7 | 85 | cellular response to interleukin-1 |
GO:0097746 | 0.007 | 2.8227 | 3.3837 | 9 | 129 | regulation of blood vessel diameter |
GO:0002688 | 0.007 | 3.3647 | 2.232 | 7 | 86 | regulation of leukocyte chemotaxis |
GO:0032496 | 0.007 | 2.0916 | 8.0169 | 16 | 307 | response to lipopolysaccharide |
GO:0009617 | 0.0071 | 2.1456 | 7.3308 | 15 | 288 | response to bacterium |
GO:0048247 | 0.0072 | 5.8197 | 0.7786 | 4 | 30 | lymphocyte chemotaxis |
GO:2000516 | 0.0075 | 5.756 | 0.7869 | 4 | 30 | positive regulation of CD4-positive, alpha-beta T cell activation |
GO:0045058 | 0.0075 | 4.4601 | 1.2328 | 5 | 47 | T cell selection |
GO:0050672 | 0.0076 | 3.7511 | 1.7312 | 6 | 66 | negative regulation of lymphocyte proliferation |
GO:0051155 | 0.0076 | 3.7511 | 1.7312 | 6 | 66 | positive regulation of striated muscle cell differentiation |
GO:0071346 | 0.0077 | 2.7761 | 3.4361 | 9 | 131 | cellular response to interferon-gamma |
GO:0006704 | 0.0078 | 8.6206 | 0.4197 | 3 | 16 | glucocorticoid biosynthetic process |
GO:0045019 | 0.0078 | 8.6206 | 0.4197 | 3 | 16 | negative regulation of nitric oxide biosynthetic process |
GO:0052695 | 0.0078 | 8.6206 | 0.4197 | 3 | 16 | cellular glucuronidation |
GO:0050869 | 0.0084 | 5.5424 | 0.8131 | 4 | 31 | negative regulation of B cell activation |
GO:0045089 | 0.0086 | 1.9935 | 8.9182 | 17 | 340 | positive regulation of innate immune response |
GO:0002700 | 0.0088 | 2.9194 | 2.9115 | 8 | 111 | regulation of production of molecular mediator of immune response |
GO:0050715 | 0.009 | 3.1937 | 2.3415 | 7 | 90 | positive regulation of cytokine secretion |
GO:0032604 | 0.0093 | 8.0044 | 0.4459 | 3 | 17 | granulocyte macrophage colony-stimulating factor production |
GO:0003018 | 0.0093 | 2.5273 | 4.1706 | 10 | 159 | vascular process in circulatory system |
GO:0034122 | 0.0094 | 5.3441 | 0.8394 | 4 | 32 | negative regulation of toll-like receptor signaling pathway |
GO:0050727 | 0.0095 | 2.0181 | 8.2887 | 16 | 316 | regulation of inflammatory response |
GO:0002249 | 0.0096 | 18.6447 | 0.1574 | 2 | 6 | lymphocyte anergy |
GO:0002667 | 0.0096 | 18.6447 | 0.1574 | 2 | 6 | regulation of T cell anergy |
GO:0002924 | 0.0096 | 18.6447 | 0.1574 | 2 | 6 | negative regulation of humoral immune response mediated by circulating immunoglobulin |
GO:0003105 | 0.0096 | 18.6447 | 0.1574 | 2 | 6 | negative regulation of glomerular filtration |
GO:0010760 | 0.0096 | 18.6447 | 0.1574 | 2 | 6 | negative regulation of macrophage chemotaxis |
GO:0043152 | 0.0096 | 18.6447 | 0.1574 | 2 | 6 | induction of bacterial agglutination |
GO:0032655 | 0.0098 | 4.1619 | 1.3115 | 5 | 50 | regulation of interleukin-12 production |
GO:1903555 | 0.0098 | 2.8634 | 2.964 | 8 | 113 | regulation of tumor necrosis factor superfamily cytokine production |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 96.8791 | 1.0065 | 24 | 32 | DNA replication-dependent nucleosome assembly |
GO:0000183 | 0 | 55.3384 | 1.1952 | 24 | 38 | chromatin silencing at rDNA |
GO:0051290 | 0 | 42.5484 | 1.3839 | 25 | 44 | protein heterotetramerization |
GO:0006323 | 0 | 7.7448 | 6.1016 | 37 | 194 | DNA packaging |
GO:0045653 | 0 | 110.7841 | 0.5661 | 14 | 18 | negative regulation of megakaryocyte differentiation |
GO:0045815 | 0 | 13.7977 | 2.5161 | 24 | 80 | positive regulation of gene expression, epigenetic |
GO:0048863 | 0 | 6.3211 | 7.6072 | 39 | 244 | stem cell differentiation |
GO:1902036 | 0 | 10.3255 | 3.2395 | 25 | 103 | regulation of hematopoietic stem cell differentiation |
GO:0045814 | 0 | 8.9933 | 3.9 | 27 | 124 | negative regulation of gene expression, epigenetic |
GO:0071824 | 0 | 5.6916 | 8.0831 | 38 | 257 | protein-DNA complex subunit organization |
GO:0060964 | 0 | 9.9412 | 3.3339 | 25 | 106 | regulation of gene silencing by miRNA |
GO:1903707 | 0 | 18.7061 | 1.5252 | 18 | 49 | negative regulation of hemopoiesis |
GO:0007389 | 0 | 5.2219 | 8.9311 | 39 | 289 | pattern specification process |
GO:0032502 | 0 | 2.0759 | 144.8188 | 221 | 4881 | developmental process |
GO:0006333 | 0 | 8.5166 | 3.7446 | 25 | 122 | chromatin assembly or disassembly |
GO:1902679 | 0 | 2.7618 | 36.4838 | 86 | 1160 | negative regulation of RNA biosynthetic process |
GO:0034654 | 0 | 2.0106 | 130.87 | 206 | 4161 | nucleobase-containing compound biosynthetic process |
GO:0060968 | 0 | 7.6572 | 4.0887 | 25 | 130 | regulation of gene silencing |
GO:0045944 | 0 | 2.7 | 34.3451 | 80 | 1092 | positive regulation of transcription from RNA polymerase II promoter |
GO:1904837 | 0 | 16.379 | 1.3839 | 15 | 44 | beta-catenin-TCF complex assembly |
GO:0045934 | 0 | 2.4397 | 43.7491 | 92 | 1391 | negative regulation of nucleobase-containing compound metabolic process |
GO:0034080 | 0 | 15.8022 | 1.321 | 14 | 42 | CENP-A containing nucleosome assembly |
GO:0010628 | 0 | 2.281 | 51.6348 | 101 | 1714 | positive regulation of gene expression |
GO:1903508 | 0 | 2.3517 | 44.0636 | 90 | 1401 | positive regulation of nucleic acid-templated transcription |
GO:0051254 | 0 | 2.3158 | 46.2967 | 93 | 1472 | positive regulation of RNA metabolic process |
GO:0009893 | 0 | 4.0851 | 9.9402 | 35 | 347 | positive regulation of metabolic process |
GO:0009890 | 0 | 2.2043 | 51.1717 | 98 | 1627 | negative regulation of biosynthetic process |
GO:2000026 | 0 | 2.21 | 49.4998 | 95 | 1610 | regulation of multicellular organismal development |
GO:0009952 | 0 | 5.8013 | 4.7083 | 23 | 151 | anterior/posterior pattern specification |
GO:0032200 | 0 | 5.4116 | 5.221 | 24 | 166 | telomere organization |
GO:0002520 | 0 | 2.5611 | 28.2121 | 64 | 897 | immune system development |
GO:0034724 | 0 | 11.0531 | 1.6984 | 14 | 54 | DNA replication-independent nucleosome organization |
GO:0031328 | 0 | 2.0972 | 55.7951 | 102 | 1774 | positive regulation of cellular biosynthetic process |
GO:0001501 | 0 | 3.1789 | 15.254 | 43 | 485 | skeletal system development |
GO:0016233 | 0 | 10.7828 | 1.7298 | 14 | 55 | telomere capping |
GO:0045892 | 0 | 3.7447 | 10.0052 | 33 | 337 | negative regulation of transcription, DNA-templated |
GO:0010557 | 0 | 2.073 | 51.4862 | 94 | 1637 | positive regulation of macromolecule biosynthetic process |
GO:0035194 | 0 | 4.1847 | 7.3597 | 27 | 234 | posttranscriptional gene silencing by RNA |
GO:0007423 | 0 | 2.9517 | 16.2919 | 43 | 518 | sensory organ development |
GO:0034645 | 0 | 1.6819 | 156.8489 | 216 | 4987 | cellular macromolecule biosynthetic process |
GO:0048513 | 0 | 2.1076 | 42.862 | 79 | 1572 | animal organ development |
GO:1901576 | 0 | 1.6147 | 194.8739 | 253 | 6196 | organic substance biosynthetic process |
GO:0006303 | 0 | 7.2383 | 2.3589 | 14 | 75 | double-strand break repair via nonhomologous end joining |
GO:0043044 | 0 | 6.8977 | 2.4532 | 14 | 78 | ATP-dependent chromatin remodeling |
GO:2001141 | 0 | 1.8567 | 67.06 | 108 | 2380 | regulation of RNA biosynthetic process |
GO:0038111 | 0 | 11.1974 | 1.1952 | 10 | 38 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 10.8106 | 1.2266 | 10 | 39 | response to interleukin-7 |
GO:0000122 | 0 | 2.3185 | 24.6895 | 52 | 785 | negative regulation of transcription from RNA polymerase II promoter |
GO:0097659 | 0 | 1.8368 | 64.9209 | 104 | 2289 | nucleic acid-templated transcription |
GO:0002682 | 0 | 1.9748 | 43.2144 | 77 | 1374 | regulation of immune system process |
GO:0051259 | 0 | 2.6316 | 16.2919 | 39 | 518 | protein oligomerization |
GO:0030154 | 0 | 1.757 | 79.6788 | 121 | 2860 | cell differentiation |
GO:0021515 | 0 | 8.4215 | 1.6355 | 11 | 52 | cell differentiation in spinal cord |
GO:0043010 | 0 | 3.2701 | 9.1491 | 27 | 292 | camera-type eye development |
GO:0002227 | 0 | 19.8545 | 0.5661 | 7 | 18 | innate immune response in mucosa |
GO:0021953 | 0 | 5.0493 | 3.6488 | 16 | 117 | central nervous system neuron differentiation |
GO:0021517 | 0 | 9.2178 | 1.3839 | 10 | 44 | ventral spinal cord development |
GO:0035107 | 0 | 4.4171 | 4.6234 | 18 | 147 | appendage morphogenesis |
GO:0045596 | 0 | 3.3396 | 8.2926 | 25 | 271 | negative regulation of cell differentiation |
GO:0002251 | 0 | 13.1562 | 0.8492 | 8 | 27 | organ or tissue specific immune response |
GO:0009889 | 0 | 1.7438 | 76.035 | 115 | 2710 | regulation of biosynthetic process |
GO:0017148 | 0 | 3.0447 | 10.1274 | 28 | 322 | negative regulation of translation |
GO:0006355 | 0 | 1.8138 | 58.7386 | 94 | 2123 | regulation of transcription, DNA-templated |
GO:0060173 | 0 | 3.9592 | 5.3782 | 19 | 171 | limb development |
GO:0009953 | 0 | 6.2221 | 2.2811 | 12 | 73 | dorsal/ventral pattern formation |
GO:0090304 | 0 | 1.5358 | 157.6038 | 206 | 5011 | nucleic acid metabolic process |
GO:0019219 | 0 | 1.7021 | 76.5073 | 114 | 2712 | regulation of nucleobase-containing compound metabolic process |
GO:0006352 | 0 | 3.2324 | 7.4855 | 22 | 238 | DNA-templated transcription, initiation |
GO:0045652 | 0 | 6.8521 | 1.7456 | 10 | 57 | regulation of megakaryocyte differentiation |
GO:0006725 | 0 | 1.4793 | 184.4005 | 231 | 5863 | cellular aromatic compound metabolic process |
GO:0060322 | 0 | 2.1486 | 22.1734 | 44 | 705 | head development |
GO:0051173 | 0 | 1.5806 | 90.3918 | 128 | 2874 | positive regulation of nitrogen compound metabolic process |
GO:0008284 | 0 | 2.0274 | 26.7024 | 50 | 849 | positive regulation of cell proliferation |
GO:0035270 | 0 | 4.5688 | 3.2189 | 13 | 103 | endocrine system development |
GO:0003207 | 0 | 22.2034 | 0.3774 | 5 | 12 | cardiac chamber formation |
GO:1901360 | 0 | 1.4559 | 190.911 | 236 | 6070 | organic cyclic compound metabolic process |
GO:0048665 | 0 | 13.4688 | 0.6234 | 6 | 20 | neuron fate specification |
GO:0031016 | 0 | 5.2232 | 2.4218 | 11 | 77 | pancreas development |
GO:0061458 | 0 | 2.4412 | 13.2726 | 30 | 422 | reproductive system development |
GO:0002125 | 0 | Inf | 0.0944 | 3 | 3 | maternal aggressive behavior |
GO:0003357 | 0 | 41.3753 | 0.2202 | 4 | 7 | noradrenergic neuron differentiation |
GO:0021520 | 0 | 19.4268 | 0.4089 | 5 | 13 | spinal cord motor neuron cell fate specification |
GO:0021978 | 0 | 19.4268 | 0.4089 | 5 | 13 | telencephalon regionalization |
GO:0048935 | 0 | 19.4268 | 0.4089 | 5 | 13 | peripheral nervous system neuron development |
GO:0048545 | 0 | 2.5043 | 12.0774 | 28 | 384 | response to steroid hormone |
GO:0048704 | 0 | 4.9606 | 2.5295 | 11 | 81 | embryonic skeletal system morphogenesis |
GO:0072210 | 0 | 7.345 | 1.321 | 8 | 42 | metanephric nephron development |
GO:0006334 | 0 | 4.4894 | 3.0036 | 12 | 100 | nucleosome assembly |
GO:0046483 | 0 | 1.4351 | 183.2054 | 226 | 5825 | heterocycle metabolic process |
GO:0060249 | 1e-04 | 2.4812 | 11.7314 | 27 | 373 | anatomical structure homeostasis |
GO:0007275 | 1e-04 | 1.5997 | 75.1943 | 106 | 2927 | multicellular organism development |
GO:0048048 | 1e-04 | 8.0807 | 1.0694 | 7 | 34 | embryonic eye morphogenesis |
GO:0045823 | 1e-04 | 7.7916 | 1.1008 | 7 | 35 | positive regulation of heart contraction |
GO:0048645 | 1e-04 | 5.5137 | 1.8871 | 9 | 60 | animal organ formation |
GO:0034248 | 1e-04 | 2.1409 | 17.0153 | 34 | 541 | regulation of cellular amide metabolic process |
GO:0008217 | 1e-04 | 3.2281 | 5.4097 | 16 | 172 | regulation of blood pressure |
GO:0019731 | 1e-04 | 7.5224 | 1.1323 | 7 | 36 | antibacterial humoral response |
GO:0061844 | 1e-04 | 6.2409 | 1.5097 | 8 | 48 | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO:0002317 | 1e-04 | 92.9234 | 0.1258 | 3 | 4 | plasma cell differentiation |
GO:0031394 | 1e-04 | 92.9234 | 0.1258 | 3 | 4 | positive regulation of prostaglandin biosynthetic process |
GO:0072193 | 1e-04 | 92.9234 | 0.1258 | 3 | 4 | ureter smooth muscle cell differentiation |
GO:0048699 | 1e-04 | 2.0135 | 20.778 | 39 | 683 | generation of neurons |
GO:0009954 | 1e-04 | 9.3714 | 0.8148 | 6 | 26 | proximal/distal pattern formation |
GO:0060562 | 1e-04 | 2.546 | 9.7185 | 23 | 309 | epithelial tube morphogenesis |
GO:0071542 | 1e-04 | 7.2712 | 1.1637 | 7 | 37 | dopaminergic neuron differentiation |
GO:0072009 | 1e-04 | 3.9592 | 3.3653 | 12 | 107 | nephron epithelium development |
GO:0043651 | 1e-04 | 12.9479 | 0.5347 | 5 | 17 | linoleic acid metabolic process |
GO:0001655 | 1e-04 | 2.519 | 9.8129 | 23 | 312 | urogenital system development |
GO:0046887 | 1e-04 | 8.9868 | 0.8406 | 6 | 27 | positive regulation of hormone secretion |
GO:0061326 | 2e-04 | 4.1998 | 2.925 | 11 | 93 | renal tubule development |
GO:0042756 | 2e-04 | 20.6837 | 0.3145 | 4 | 10 | drinking behavior |
GO:0043009 | 2e-04 | 2.3316 | 11.9421 | 26 | 387 | chordate embryonic development |
GO:0060021 | 2e-04 | 4.3668 | 2.5653 | 10 | 82 | palate development |
GO:0034641 | 2e-04 | 1.3772 | 201.1957 | 240 | 6397 | cellular nitrogen compound metabolic process |
GO:0071310 | 3e-04 | 1.5078 | 74.9805 | 104 | 2384 | cellular response to organic substance |
GO:0090084 | 3e-04 | 17.7278 | 0.346 | 4 | 11 | negative regulation of inclusion body assembly |
GO:0048562 | 3e-04 | 4.7433 | 2.1388 | 9 | 71 | embryonic organ morphogenesis |
GO:0032892 | 3e-04 | 7.7782 | 0.9435 | 6 | 30 | positive regulation of organic acid transport |
GO:0010040 | 3e-04 | 46.4587 | 0.1573 | 3 | 5 | response to iron(II) ion |
GO:0051248 | 3e-04 | 1.6695 | 39.7548 | 62 | 1264 | negative regulation of protein metabolic process |
GO:0060065 | 3e-04 | 10.3563 | 0.629 | 5 | 20 | uterus development |
GO:0060216 | 3e-04 | 10.3563 | 0.629 | 5 | 20 | definitive hemopoiesis |
GO:0007218 | 3e-04 | 3.8245 | 3.1766 | 11 | 101 | neuropeptide signaling pathway |
GO:1903793 | 4e-04 | 6.057 | 1.3524 | 7 | 43 | positive regulation of anion transport |
GO:0051954 | 4e-04 | 7.4666 | 0.975 | 6 | 31 | positive regulation of amine transport |
GO:0014706 | 4e-04 | 2.3006 | 11.1339 | 24 | 354 | striated muscle tissue development |
GO:0060272 | 4e-04 | 15.5108 | 0.3774 | 4 | 12 | embryonic skeletal joint morphogenesis |
GO:0021854 | 4e-04 | 9.7085 | 0.6605 | 5 | 21 | hypothalamus development |
GO:0048485 | 4e-04 | 9.7085 | 0.6605 | 5 | 21 | sympathetic nervous system development |
GO:0060255 | 4e-04 | 1.4698 | 93.8949 | 123 | 3282 | regulation of macromolecule metabolic process |
GO:0060349 | 4e-04 | 4.0068 | 2.7677 | 10 | 88 | bone morphogenesis |
GO:0001947 | 4e-04 | 4.9895 | 1.8242 | 8 | 58 | heart looping |
GO:0035050 | 5e-04 | 4.3901 | 2.296 | 9 | 73 | embryonic heart tube development |
GO:0090092 | 5e-04 | 2.7005 | 6.7621 | 17 | 215 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
GO:0007530 | 5e-04 | 9.1368 | 0.6919 | 5 | 22 | sex determination |
GO:0051047 | 5e-04 | 2.2371 | 11.4217 | 24 | 365 | positive regulation of secretion |
GO:0030900 | 5e-04 | 2.2315 | 11.4484 | 24 | 364 | forebrain development |
GO:0034622 | 6e-04 | 1.7082 | 31.7661 | 51 | 1010 | cellular macromolecular complex assembly |
GO:0009887 | 6e-04 | 2.0021 | 16.4571 | 31 | 560 | animal organ morphogenesis |
GO:0003278 | 6e-04 | 30.9705 | 0.1887 | 3 | 6 | apoptotic process involved in heart morphogenesis |
GO:0038001 | 6e-04 | 30.9705 | 0.1887 | 3 | 6 | paracrine signaling |
GO:0060022 | 6e-04 | 30.9705 | 0.1887 | 3 | 6 | hard palate development |
GO:0072284 | 6e-04 | 30.9705 | 0.1887 | 3 | 6 | metanephric S-shaped body morphogenesis |
GO:2001279 | 6e-04 | 30.9705 | 0.1887 | 3 | 6 | regulation of unsaturated fatty acid biosynthetic process |
GO:0098801 | 6e-04 | 6.6653 | 1.0694 | 6 | 34 | regulation of renal system process |
GO:0014032 | 6e-04 | 4.7062 | 1.9185 | 8 | 61 | neural crest cell development |
GO:0048592 | 6e-04 | 3.518 | 3.4195 | 11 | 110 | eye morphogenesis |
GO:0048522 | 7e-04 | 1.3993 | 119.0935 | 150 | 3977 | positive regulation of cellular process |
GO:0009719 | 7e-04 | 1.5803 | 45.9507 | 68 | 1461 | response to endogenous stimulus |
GO:0050767 | 7e-04 | 1.835 | 21.9532 | 38 | 698 | regulation of neurogenesis |
GO:0060548 | 7e-04 | 1.7223 | 28.9669 | 47 | 921 | negative regulation of cell death |
GO:2000177 | 7e-04 | 4.0707 | 2.4532 | 9 | 78 | regulation of neural precursor cell proliferation |
GO:0021545 | 8e-04 | 5.1898 | 1.5411 | 7 | 49 | cranial nerve development |
GO:0035282 | 8e-04 | 3.6752 | 2.9879 | 10 | 95 | segmentation |
GO:0007517 | 8e-04 | 2.3514 | 9.0556 | 20 | 291 | muscle organ development |
GO:0072091 | 9e-04 | 4.4532 | 2.0129 | 8 | 64 | regulation of stem cell proliferation |
GO:0048609 | 9e-04 | 1.7958 | 23 | 39 | 738 | multicellular organismal reproductive process |
GO:0002930 | 0.001 | Inf | 0.0629 | 2 | 2 | trabecular meshwork development |
GO:0014036 | 0.001 | Inf | 0.0629 | 2 | 2 | neural crest cell fate specification |
GO:0060465 | 0.001 | Inf | 0.0629 | 2 | 2 | pharynx development |
GO:0060516 | 0.001 | Inf | 0.0629 | 2 | 2 | primary prostatic bud elongation |
GO:0061032 | 0.001 | Inf | 0.0629 | 2 | 2 | visceral serous pericardium development |
GO:2000824 | 0.001 | Inf | 0.0629 | 2 | 2 | negative regulation of androgen receptor activity |
GO:2001111 | 0.001 | Inf | 0.0629 | 2 | 2 | positive regulation of lens epithelial cell proliferation |
GO:0042221 | 0.001 | 1.3626 | 129.0772 | 160 | 4104 | response to chemical |
GO:0051090 | 0.0011 | 2.1168 | 12.0145 | 24 | 382 | regulation of DNA binding transcription factor activity |
GO:0007618 | 0.0011 | 5.8307 | 1.1952 | 6 | 38 | mating |
GO:0051241 | 0.0012 | 1.8324 | 20.2192 | 35 | 682 | negative regulation of multicellular organismal process |
GO:0048729 | 0.0013 | 1.8394 | 19.5314 | 34 | 621 | tissue morphogenesis |
GO:0002089 | 0.0013 | 10.3775 | 0.5014 | 4 | 16 | lens morphogenesis in camera-type eye |
GO:1903530 | 0.0014 | 1.8078 | 20.4435 | 35 | 650 | regulation of secretion by cell |
GO:0010720 | 0.0014 | 1.9469 | 15.1911 | 28 | 483 | positive regulation of cell development |
GO:0021915 | 0.0015 | 2.8068 | 4.9693 | 13 | 158 | neural tube development |
GO:0007548 | 0.0015 | 2.3376 | 8.1774 | 18 | 260 | sex differentiation |
GO:0043066 | 0.0015 | 1.7055 | 26.0104 | 42 | 827 | negative regulation of apoptotic process |
GO:0001838 | 0.0016 | 3.0968 | 3.8371 | 11 | 122 | embryonic epithelial tube formation |
GO:0051955 | 0.0016 | 6.7507 | 0.8806 | 5 | 28 | regulation of amino acid transport |
GO:0007498 | 0.0017 | 3.069 | 3.8685 | 11 | 123 | mesoderm development |
GO:0048523 | 0.0018 | 1.4034 | 88.744 | 114 | 3100 | negative regulation of cellular process |
GO:0007610 | 0.0018 | 1.8708 | 16.9114 | 30 | 542 | behavior |
GO:0009266 | 0.0018 | 2.4367 | 6.9822 | 16 | 222 | response to temperature stimulus |
GO:0009914 | 0.0018 | 2.1848 | 9.6871 | 20 | 308 | hormone transport |
GO:0009799 | 0.0018 | 3.0416 | 3.9 | 11 | 124 | specification of symmetry |
GO:0003208 | 0.0019 | 3.8946 | 2.2645 | 8 | 72 | cardiac ventricle morphogenesis |
GO:0010721 | 0.0019 | 2.2288 | 9.0266 | 19 | 287 | negative regulation of cell development |
GO:0035116 | 0.0019 | 6.469 | 0.9121 | 5 | 29 | embryonic hindlimb morphogenesis |
GO:0010605 | 0.002 | 1.5541 | 40.3996 | 59 | 1348 | negative regulation of macromolecule metabolic process |
GO:0045165 | 0.002 | 2.7051 | 5.1346 | 13 | 168 | cell fate commitment |
GO:0035148 | 0.002 | 2.8427 | 4.529 | 12 | 144 | tube formation |
GO:0051384 | 0.002 | 2.8427 | 4.529 | 12 | 144 | response to glucocorticoid |
GO:0072078 | 0.002 | 3.8344 | 2.296 | 8 | 73 | nephron tubule morphogenesis |
GO:0051961 | 0.002 | 2.2708 | 8.3976 | 18 | 267 | negative regulation of nervous system development |
GO:0048598 | 0.0021 | 2.3288 | 7.7362 | 17 | 260 | embryonic morphogenesis |
GO:0032095 | 0.0021 | 8.86 | 0.5661 | 4 | 18 | regulation of response to food |
GO:0051962 | 0.0022 | 1.9124 | 14.8766 | 27 | 473 | positive regulation of nervous system development |
GO:0032355 | 0.0022 | 2.9624 | 3.9943 | 11 | 127 | response to estradiol |
GO:0019098 | 0.0022 | 6.2099 | 0.9435 | 5 | 30 | reproductive behavior |
GO:0003149 | 0.0023 | 15.4823 | 0.2831 | 3 | 9 | membranous septum morphogenesis |
GO:0014049 | 0.0023 | 15.4823 | 0.2831 | 3 | 9 | positive regulation of glutamate secretion |
GO:0042538 | 0.0023 | 15.4823 | 0.2831 | 3 | 9 | hyperosmotic salinity response |
GO:0043084 | 0.0023 | 15.4823 | 0.2831 | 3 | 9 | penile erection |
GO:0048664 | 0.0023 | 15.4823 | 0.2831 | 3 | 9 | neuron fate determination |
GO:0060180 | 0.0023 | 15.4823 | 0.2831 | 3 | 9 | female mating behavior |
GO:0072048 | 0.0023 | 15.4823 | 0.2831 | 3 | 9 | renal system pattern specification |
GO:0048565 | 0.0023 | 2.9486 | 4.0106 | 11 | 128 | digestive tract development |
GO:0042743 | 0.0024 | 4.9082 | 1.3839 | 6 | 44 | hydrogen peroxide metabolic process |
GO:0050830 | 0.0024 | 3.7195 | 2.3589 | 8 | 75 | defense response to Gram-positive bacterium |
GO:0003407 | 0.0024 | 4.1891 | 1.8556 | 7 | 59 | neural retina development |
GO:0001759 | 0.0026 | 8.2688 | 0.5976 | 4 | 19 | organ induction |
GO:0002320 | 0.0026 | 8.2688 | 0.5976 | 4 | 19 | lymphoid progenitor cell differentiation |
GO:0060438 | 0.0026 | 8.2688 | 0.5976 | 4 | 19 | trachea development |
GO:0009743 | 0.0027 | 2.4102 | 6.6048 | 15 | 210 | response to carbohydrate |
GO:0007283 | 0.0027 | 1.8777 | 15.1282 | 27 | 481 | spermatogenesis |
GO:1901532 | 0.0028 | 13.8861 | 0.3011 | 3 | 10 | regulation of hematopoietic progenitor cell differentiation |
GO:0072028 | 0.0028 | 3.6112 | 2.4218 | 8 | 77 | nephron morphogenesis |
GO:0001546 | 0.0029 | 61.8275 | 0.0944 | 2 | 3 | preantral ovarian follicle growth |
GO:0032227 | 0.0029 | 61.8275 | 0.0944 | 2 | 3 | negative regulation of synaptic transmission, dopaminergic |
GO:0055014 | 0.0029 | 61.8275 | 0.0944 | 2 | 3 | atrial cardiac muscle cell development |
GO:0060278 | 0.0029 | 61.8275 | 0.0944 | 2 | 3 | regulation of ovulation |
GO:0070370 | 0.0029 | 61.8275 | 0.0944 | 2 | 3 | cellular heat acclimation |
GO:0070434 | 0.0029 | 61.8275 | 0.0944 | 2 | 3 | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway |
GO:0072190 | 0.0029 | 61.8275 | 0.0944 | 2 | 3 | ureter urothelium development |
GO:0072197 | 0.0029 | 61.8275 | 0.0944 | 2 | 3 | ureter morphogenesis |
GO:0072199 | 0.0029 | 61.8275 | 0.0944 | 2 | 3 | regulation of mesenchymal cell proliferation involved in ureter development |
GO:0010608 | 0.003 | 1.7506 | 19.8145 | 33 | 630 | posttranscriptional regulation of gene expression |
GO:0035115 | 0.003 | 5.7491 | 1.0065 | 5 | 32 | embryonic forelimb morphogenesis |
GO:0042423 | 0.0031 | 7.7515 | 0.629 | 4 | 20 | catecholamine biosynthetic process |
GO:0060174 | 0.0031 | 13.2697 | 0.3145 | 3 | 10 | limb bud formation |
GO:0060502 | 0.0031 | 13.2697 | 0.3145 | 3 | 10 | epithelial cell proliferation involved in lung morphogenesis |
GO:2001214 | 0.0031 | 13.2697 | 0.3145 | 3 | 10 | positive regulation of vasculogenesis |
GO:0007368 | 0.0032 | 3.0001 | 3.5855 | 10 | 114 | determination of left/right symmetry |
GO:0045665 | 0.0032 | 2.4481 | 6.0702 | 14 | 193 | negative regulation of neuron differentiation |
GO:0006950 | 0.0032 | 1.3302 | 113.7603 | 140 | 3617 | response to stress |
GO:0019953 | 0.0033 | 1.6844 | 23.0864 | 37 | 741 | sexual reproduction |
GO:0070848 | 0.0033 | 1.7233 | 20.7266 | 34 | 659 | response to growth factor |
GO:1903426 | 0.0033 | 3.5091 | 2.4847 | 8 | 79 | regulation of reactive oxygen species biosynthetic process |
GO:2000677 | 0.0034 | 4.5482 | 1.4782 | 6 | 47 | regulation of transcription regulatory region DNA binding |
GO:0050878 | 0.0034 | 1.8682 | 14.6232 | 26 | 468 | regulation of body fluid levels |
GO:0003338 | 0.0035 | 5.5435 | 1.0379 | 5 | 33 | metanephros morphogenesis |
GO:0045907 | 0.0035 | 5.5435 | 1.0379 | 5 | 33 | positive regulation of vasoconstriction |
GO:0098751 | 0.0035 | 5.5435 | 1.0379 | 5 | 33 | bone cell development |
GO:0007281 | 0.0035 | 2.2692 | 7.454 | 16 | 237 | germ cell development |
GO:0014855 | 0.0035 | 3.8889 | 1.9814 | 7 | 63 | striated muscle cell proliferation |
GO:0042733 | 0.0035 | 3.8889 | 1.9814 | 7 | 63 | embryonic digit morphogenesis |
GO:0010469 | 0.0036 | 1.7962 | 16.9524 | 29 | 539 | regulation of receptor activity |
GO:0003205 | 0.0037 | 2.6222 | 4.875 | 12 | 155 | cardiac chamber development |
GO:0030326 | 0.0037 | 5.4309 | 1.0545 | 5 | 34 | embryonic limb morphogenesis |
GO:0045933 | 0.0038 | 4.4396 | 1.5097 | 6 | 48 | positive regulation of muscle contraction |
GO:0002052 | 0.0038 | 7.295 | 0.6605 | 4 | 21 | positive regulation of neuroblast proliferation |
GO:0035809 | 0.0038 | 7.295 | 0.6605 | 4 | 21 | regulation of urine volume |
GO:0045666 | 0.0038 | 2.0403 | 10.3161 | 20 | 328 | positive regulation of neuron differentiation |
GO:0001708 | 0.0042 | 4.3253 | 1.5419 | 6 | 50 | cell fate specification |
GO:1904888 | 0.0042 | 3.7543 | 2.0444 | 7 | 65 | cranial skeletal system development |
GO:0048484 | 0.0042 | 11.6103 | 0.346 | 3 | 11 | enteric nervous system development |
GO:0060433 | 0.0042 | 11.6103 | 0.346 | 3 | 11 | bronchus development |
GO:0030856 | 0.0042 | 2.7039 | 4.3403 | 11 | 138 | regulation of epithelial cell differentiation |
GO:0045637 | 0.0043 | 2.5643 | 4.9691 | 12 | 165 | regulation of myeloid cell differentiation |
GO:0007417 | 0.0044 | 1.6744 | 21.9326 | 35 | 721 | central nervous system development |
GO:2000826 | 0.0045 | 5.1732 | 1.1008 | 5 | 35 | regulation of heart morphogenesis |
GO:0021513 | 0.0045 | 6.8893 | 0.6919 | 4 | 22 | spinal cord dorsal/ventral patterning |
GO:0048644 | 0.0045 | 3.3211 | 2.6105 | 8 | 83 | muscle organ morphogenesis |
GO:0097756 | 0.0045 | 3.3211 | 2.6105 | 8 | 83 | negative regulation of blood vessel diameter |
GO:0001568 | 0.0046 | 1.7119 | 19.5943 | 32 | 623 | blood vessel development |
GO:0045995 | 0.0046 | 2.8354 | 3.7742 | 10 | 120 | regulation of embryonic development |
GO:0009712 | 0.0046 | 4.2372 | 1.5726 | 6 | 50 | catechol-containing compound metabolic process |
GO:0060485 | 0.0047 | 5.098 | 1.1128 | 5 | 36 | mesenchyme development |
GO:0048839 | 0.0048 | 2.419 | 5.6927 | 13 | 181 | inner ear development |
GO:0009948 | 0.0051 | 4.1428 | 1.604 | 6 | 51 | anterior/posterior axis specification |
GO:0032526 | 0.0051 | 2.9833 | 3.2395 | 9 | 103 | response to retinoic acid |
GO:0045778 | 0.0052 | 3.2344 | 2.6734 | 8 | 85 | positive regulation of ossification |
GO:0030902 | 0.0053 | 2.6207 | 4.4661 | 11 | 142 | hindbrain development |
GO:0071773 | 0.0053 | 10.4525 | 0.3728 | 3 | 12 | cellular response to BMP stimulus |
GO:0043576 | 0.0053 | 6.5263 | 0.7234 | 4 | 23 | regulation of respiratory gaseous exchange |
GO:0046457 | 0.0053 | 6.5263 | 0.7234 | 4 | 23 | prostanoid biosynthetic process |
GO:2000738 | 0.0054 | 10.3583 | 0.3761 | 3 | 12 | positive regulation of stem cell differentiation |
GO:0003084 | 0.0055 | 10.3196 | 0.3774 | 3 | 12 | positive regulation of systemic arterial blood pressure |
GO:0003184 | 0.0055 | 10.3196 | 0.3774 | 3 | 12 | pulmonary valve morphogenesis |
GO:0032099 | 0.0055 | 10.3196 | 0.3774 | 3 | 12 | negative regulation of appetite |
GO:0002791 | 0.0055 | 1.8421 | 13.65 | 24 | 434 | regulation of peptide secretion |
GO:0035176 | 0.0056 | 4.0525 | 1.6355 | 6 | 52 | social behavior |
GO:0048568 | 0.0056 | 2.7417 | 3.8838 | 10 | 131 | embryonic organ development |
GO:0001705 | 0.0057 | 30.9118 | 0.1258 | 2 | 4 | ectoderm formation |
GO:0003219 | 0.0057 | 30.9118 | 0.1258 | 2 | 4 | cardiac right ventricle formation |
GO:0003415 | 0.0057 | 30.9118 | 0.1258 | 2 | 4 | chondrocyte hypertrophy |
GO:0007621 | 0.0057 | 30.9118 | 0.1258 | 2 | 4 | negative regulation of female receptivity |
GO:0018916 | 0.0057 | 30.9118 | 0.1258 | 2 | 4 | nitrobenzene metabolic process |
GO:0021764 | 0.0057 | 30.9118 | 0.1258 | 2 | 4 | amygdala development |
GO:0032849 | 0.0057 | 30.9118 | 0.1258 | 2 | 4 | positive regulation of cellular pH reduction |
GO:0034287 | 0.0057 | 30.9118 | 0.1258 | 2 | 4 | detection of monosaccharide stimulus |
GO:0051594 | 0.0057 | 30.9118 | 0.1258 | 2 | 4 | detection of glucose |
GO:0051673 | 0.0057 | 30.9118 | 0.1258 | 2 | 4 | membrane disruption in other organism |
GO:0060018 | 0.0057 | 30.9118 | 0.1258 | 2 | 4 | astrocyte fate commitment |
GO:0060235 | 0.0057 | 30.9118 | 0.1258 | 2 | 4 | lens induction in camera-type eye |
GO:0061047 | 0.0057 | 30.9118 | 0.1258 | 2 | 4 | positive regulation of branching involved in lung morphogenesis |
GO:0061056 | 0.0057 | 30.9118 | 0.1258 | 2 | 4 | sclerotome development |
GO:0061325 | 0.0057 | 30.9118 | 0.1258 | 2 | 4 | cell proliferation involved in outflow tract morphogenesis |
GO:0070384 | 0.0057 | 30.9118 | 0.1258 | 2 | 4 | Harderian gland development |
GO:0072086 | 0.0057 | 30.9118 | 0.1258 | 2 | 4 | specification of loop of Henle identity |
GO:0072125 | 0.0057 | 30.9118 | 0.1258 | 2 | 4 | negative regulation of glomerular mesangial cell proliferation |
GO:0072278 | 0.0057 | 30.9118 | 0.1258 | 2 | 4 | metanephric comma-shaped body morphogenesis |
GO:0090063 | 0.0057 | 30.9118 | 0.1258 | 2 | 4 | positive regulation of microtubule nucleation |
GO:0097476 | 0.0057 | 30.9118 | 0.1258 | 2 | 4 | spinal cord motor neuron migration |
GO:1902106 | 0.006 | 3.1521 | 2.7363 | 8 | 87 | negative regulation of leukocyte differentiation |
GO:0061005 | 0.0062 | 3.966 | 1.6669 | 6 | 53 | cell differentiation involved in kidney development |
GO:0002065 | 0.0062 | 2.8905 | 3.3339 | 9 | 106 | columnar/cuboidal epithelial cell differentiation |
GO:0043279 | 0.0062 | 2.8905 | 3.3339 | 9 | 106 | response to alkaloid |
GO:0008406 | 0.0062 | 2.2567 | 6.5419 | 14 | 208 | gonad development |
GO:0002068 | 0.0062 | 6.1996 | 0.7548 | 4 | 24 | glandular epithelial cell development |
GO:0030878 | 0.0062 | 6.1996 | 0.7548 | 4 | 24 | thyroid gland development |
GO:0032104 | 0.0062 | 6.1996 | 0.7548 | 4 | 24 | regulation of response to extracellular stimulus |
GO:0042026 | 0.0062 | 6.1996 | 0.7548 | 4 | 24 | protein refolding |
GO:0048103 | 0.0062 | 6.1996 | 0.7548 | 4 | 24 | somatic stem cell division |
GO:0048646 | 0.0063 | 1.5994 | 24.8812 | 38 | 815 | anatomical structure formation involved in morphogenesis |
GO:0048762 | 0.0063 | 2.3347 | 5.8814 | 13 | 187 | mesenchymal cell differentiation |
GO:0014003 | 0.0064 | 4.7021 | 1.1952 | 5 | 38 | oligodendrocyte development |
GO:0031113 | 0.0064 | 4.7021 | 1.1952 | 5 | 38 | regulation of microtubule polymerization |
GO:0030316 | 0.0064 | 3.1125 | 2.7677 | 8 | 88 | osteoclast differentiation |
GO:0030901 | 0.0064 | 3.1125 | 2.7677 | 8 | 88 | midbrain development |
GO:0060419 | 0.0064 | 3.1125 | 2.7677 | 8 | 88 | heart growth |
GO:0021879 | 0.0068 | 3.8832 | 1.6984 | 6 | 54 | forebrain neuron differentiation |
GO:0001967 | 0.007 | 9.287 | 0.4089 | 3 | 13 | suckling behavior |
GO:0002087 | 0.007 | 9.287 | 0.4089 | 3 | 13 | regulation of respiratory gaseous exchange by neurological system process |
GO:0007320 | 0.007 | 9.287 | 0.4089 | 3 | 13 | insemination |
GO:0035815 | 0.007 | 9.287 | 0.4089 | 3 | 13 | positive regulation of renal sodium excretion |
GO:0072044 | 0.007 | 9.287 | 0.4089 | 3 | 13 | collecting duct development |
GO:0071695 | 0.0071 | 2.5049 | 4.6548 | 11 | 148 | anatomical structure maturation |
GO:0003197 | 0.0072 | 4.5635 | 1.2266 | 5 | 39 | endocardial cushion development |
GO:0090184 | 0.0072 | 4.5635 | 1.2266 | 5 | 39 | positive regulation of kidney development |
GO:0003148 | 0.0072 | 5.904 | 0.7863 | 4 | 25 | outflow tract septum morphogenesis |
GO:0003309 | 0.0072 | 5.904 | 0.7863 | 4 | 25 | type B pancreatic cell differentiation |
GO:0031112 | 0.0072 | 5.904 | 0.7863 | 4 | 25 | positive regulation of microtubule polymerization or depolymerization |
GO:0042481 | 0.0072 | 5.904 | 0.7863 | 4 | 25 | regulation of odontogenesis |
GO:0044062 | 0.0072 | 5.904 | 0.7863 | 4 | 25 | regulation of excretion |
GO:0060037 | 0.0072 | 5.904 | 0.7863 | 4 | 25 | pharyngeal system development |
GO:0090277 | 0.0074 | 3.0362 | 2.8306 | 8 | 90 | positive regulation of peptide hormone secretion |
GO:0060429 | 0.0074 | 1.5545 | 27.6147 | 41 | 915 | epithelium development |
GO:0035296 | 0.0076 | 2.6194 | 4.0573 | 10 | 129 | regulation of tube diameter |
GO:0009791 | 0.0079 | 2.9994 | 2.8621 | 8 | 91 | post-embryonic development |
GO:2000379 | 0.0079 | 2.9994 | 2.8621 | 8 | 91 | positive regulation of reactive oxygen species metabolic process |
GO:0035019 | 0.008 | 3.2975 | 2.296 | 7 | 73 | somatic stem cell population maintenance |
GO:0014014 | 0.008 | 4.4328 | 1.2581 | 5 | 40 | negative regulation of gliogenesis |
GO:0045453 | 0.0081 | 3.7274 | 1.7613 | 6 | 56 | bone resorption |
GO:0061217 | 0.0083 | 5.6353 | 0.8177 | 4 | 26 | regulation of mesonephros development |
GO:0072207 | 0.0083 | 5.6353 | 0.8177 | 4 | 26 | metanephric epithelium development |
GO:0032108 | 0.0087 | 8.4422 | 0.4403 | 3 | 14 | negative regulation of response to nutrient levels |
GO:0042711 | 0.0087 | 8.4422 | 0.4403 | 3 | 14 | maternal behavior |
GO:0060712 | 0.0087 | 8.4422 | 0.4403 | 3 | 14 | spongiotrophoblast layer development |
GO:0040011 | 0.0089 | 1.3936 | 52.0209 | 69 | 1654 | locomotion |
GO:0030097 | 0.0091 | 1.6381 | 19.757 | 31 | 661 | hemopoiesis |
GO:0030509 | 0.0091 | 2.4159 | 4.8121 | 11 | 153 | BMP signaling pathway |
GO:0048585 | 0.0092 | 1.415 | 45.9507 | 62 | 1461 | negative regulation of response to stimulus |
GO:0007356 | 0.0093 | 20.6065 | 0.1573 | 2 | 5 | thorax and anterior abdomen determination |
GO:0033591 | 0.0093 | 20.6065 | 0.1573 | 2 | 5 | response to L-ascorbic acid |
GO:0048880 | 0.0093 | 20.6065 | 0.1573 | 2 | 5 | sensory system development |
GO:0051891 | 0.0093 | 20.6065 | 0.1573 | 2 | 5 | positive regulation of cardioblast differentiation |
GO:0051970 | 0.0093 | 20.6065 | 0.1573 | 2 | 5 | negative regulation of transmission of nerve impulse |
GO:0060023 | 0.0093 | 20.6065 | 0.1573 | 2 | 5 | soft palate development |
GO:0060455 | 0.0093 | 20.6065 | 0.1573 | 2 | 5 | negative regulation of gastric acid secretion |
GO:0061743 | 0.0093 | 20.6065 | 0.1573 | 2 | 5 | motor learning |
GO:0072047 | 0.0093 | 20.6065 | 0.1573 | 2 | 5 | proximal/distal pattern formation involved in nephron development |
GO:0072223 | 0.0093 | 20.6065 | 0.1573 | 2 | 5 | metanephric glomerular mesangium development |
GO:2000195 | 0.0093 | 20.6065 | 0.1573 | 2 | 5 | negative regulation of female gonad development |
GO:2000609 | 0.0093 | 20.6065 | 0.1573 | 2 | 5 | regulation of thyroid hormone generation |
GO:2000851 | 0.0093 | 20.6065 | 0.1573 | 2 | 5 | positive regulation of glucocorticoid secretion |
GO:2000987 | 0.0093 | 20.6065 | 0.1573 | 2 | 5 | positive regulation of behavioral fear response |
GO:0051240 | 0.0094 | 1.5472 | 26.362 | 39 | 882 | positive regulation of multicellular organismal process |
GO:1990830 | 0.0095 | 2.8942 | 2.9564 | 8 | 94 | cellular response to leukemia inhibitory factor |
GO:0051385 | 0.0096 | 5.3899 | 0.8492 | 4 | 27 | response to mineralocorticoid |
GO:0044057 | 0.0098 | 1.7261 | 15.1087 | 25 | 485 | regulation of system process |
GO:0060043 | 0.0098 | 4.1927 | 1.321 | 5 | 42 | regulation of cardiac muscle cell proliferation |
GO:0042471 | 0.0098 | 2.6689 | 3.5855 | 9 | 114 | ear morphogenesis |
GO:0055024 | 0.0099 | 3.1536 | 2.3903 | 7 | 76 | regulation of cardiac muscle tissue development |
GO:0072358 | 0.0099 | 1.6125 | 20.6951 | 32 | 658 | cardiovascular system development |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0045653 | 0 | 131.0473 | 0.4832 | 14 | 18 | negative regulation of megakaryocyte differentiation |
GO:0000183 | 0 | 24.4472 | 1.0201 | 15 | 38 | chromatin silencing at rDNA |
GO:0006335 | 0 | 29.0959 | 0.859 | 14 | 32 | DNA replication-dependent nucleosome assembly |
GO:0016233 | 0 | 16.8338 | 1.4764 | 17 | 55 | telomere capping |
GO:0034080 | 0 | 20.8202 | 1.1275 | 15 | 42 | CENP-A containing nucleosome assembly |
GO:0016441 | 0 | 5.8531 | 6.3084 | 31 | 235 | posttranscriptional gene silencing |
GO:0051290 | 0 | 19.3818 | 1.1812 | 15 | 44 | protein heterotetramerization |
GO:0031047 | 0 | 5.4595 | 6.9259 | 32 | 258 | gene silencing by RNA |
GO:1904837 | 0 | 17.4443 | 1.1812 | 14 | 44 | beta-catenin-TCF complex assembly |
GO:0034724 | 0 | 14.403 | 1.4496 | 15 | 54 | DNA replication-independent nucleosome organization |
GO:0006303 | 0 | 11.0151 | 2.0133 | 17 | 75 | double-strand break repair via nonhomologous end joining |
GO:0034249 | 0 | 4.189 | 9.0197 | 33 | 336 | negative regulation of cellular amide metabolic process |
GO:0060964 | 0 | 7.6907 | 2.8455 | 18 | 106 | regulation of gene silencing by miRNA |
GO:0060968 | 0 | 6.4419 | 3.4898 | 19 | 130 | regulation of gene silencing |
GO:0043044 | 0 | 8.9026 | 2.0939 | 15 | 78 | ATP-dependent chromatin remodeling |
GO:0045815 | 0 | 8.6276 | 2.1476 | 15 | 80 | positive regulation of gene expression, epigenetic |
GO:0006518 | 0 | 2.6003 | 24.7237 | 57 | 921 | peptide metabolic process |
GO:0006412 | 0 | 2.5799 | 20.2407 | 47 | 754 | translation |
GO:1902036 | 0 | 6.3634 | 2.765 | 15 | 103 | regulation of hematopoietic stem cell differentiation |
GO:0043604 | 0 | 2.4071 | 23.0057 | 50 | 857 | amide biosynthetic process |
GO:0032200 | 0 | 4.5554 | 4.4562 | 18 | 166 | telomere organization |
GO:0031497 | 0 | 4.4218 | 4.0535 | 16 | 151 | chromatin assembly |
GO:0035195 | 0 | 4.5959 | 3.1607 | 13 | 122 | gene silencing by miRNA |
GO:0071103 | 0 | 3.1105 | 7.3554 | 21 | 274 | DNA conformation change |
GO:1903707 | 0 | 4.2646 | 3.6508 | 14 | 136 | negative regulation of hemopoiesis |
GO:0006281 | 0 | 2.4074 | 13.9054 | 31 | 518 | DNA repair |
GO:0051259 | 0 | 2.4074 | 13.9054 | 31 | 518 | protein oligomerization |
GO:1901750 | 0 | 36.5774 | 0.2148 | 4 | 8 | leukotriene D4 biosynthetic process |
GO:0002244 | 0 | 3.4624 | 5.0467 | 16 | 188 | hematopoietic progenitor cell differentiation |
GO:0006751 | 1e-04 | 29.26 | 0.2416 | 4 | 9 | glutathione catabolic process |
GO:0065004 | 1e-04 | 3.0276 | 6.0668 | 17 | 226 | protein-DNA complex assembly |
GO:0010629 | 7e-04 | 1.5712 | 48.6421 | 71 | 1812 | negative regulation of gene expression |
GO:1901566 | 7e-04 | 1.5427 | 53.8499 | 77 | 2006 | organonitrogen compound biosynthetic process |
GO:0048863 | 7e-04 | 2.5875 | 7.0064 | 17 | 261 | stem cell differentiation |
GO:0018003 | 7e-04 | Inf | 0.0537 | 2 | 2 | peptidyl-lysine N6-acetylation |
GO:0031204 | 7e-04 | Inf | 0.0537 | 2 | 2 | posttranslational protein targeting to membrane, translocation |
GO:2000113 | 0.001 | 1.6026 | 39.327 | 59 | 1465 | negative regulation of cellular macromolecule biosynthetic process |
GO:0006691 | 0.0011 | 7.3227 | 0.8053 | 5 | 30 | leukotriene metabolic process |
GO:0060249 | 0.0012 | 2.2214 | 10.013 | 21 | 373 | anatomical structure homeostasis |
GO:0034641 | 0.0017 | 1.3385 | 171.7236 | 202 | 6397 | cellular nitrogen compound metabolic process |
GO:0006352 | 0.002 | 2.4896 | 6.389 | 15 | 238 | DNA-templated transcription, initiation |
GO:0009890 | 0.0045 | 1.479 | 43.6758 | 61 | 1627 | negative regulation of biosynthetic process |
GO:0044249 | 0.0052 | 1.2927 | 163.7508 | 190 | 6100 | cellular biosynthetic process |
GO:0045637 | 0.0055 | 2.2869 | 6.4427 | 14 | 240 | regulation of myeloid cell differentiation |
GO:0030071 | 0.0069 | 4.5723 | 1.208 | 5 | 45 | regulation of mitotic metaphase/anaphase transition |
GO:0046456 | 0.0076 | 4.4605 | 1.2348 | 5 | 46 | icosanoid biosynthetic process |
GO:1903830 | 0.0083 | 8.4167 | 0.4295 | 3 | 16 | magnesium ion transmembrane transport |
GO:0009059 | 0.0088 | 1.2791 | 137.5239 | 161 | 5123 | macromolecule biosynthetic process |
GO:0044784 | 0.009 | 4.2525 | 1.2885 | 5 | 48 | metaphase/anaphase transition of cell cycle |
GO:0006575 | 0.0095 | 2.3947 | 4.832 | 11 | 180 | cellular modified amino acid metabolic process |
GO:0006342 | 0.0096 | 3.5506 | 1.8189 | 6 | 70 | chromatin silencing |
GO:0040029 | 0.0098 | 2.8626 | 2.9619 | 8 | 117 | regulation of gene expression, epigenetic |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 107.0248 | 0.918 | 24 | 32 | DNA replication-dependent nucleosome assembly |
GO:0000183 | 0 | 61.1338 | 1.0901 | 24 | 38 | chromatin silencing at rDNA |
GO:0051290 | 0 | 47.0142 | 1.2622 | 25 | 44 | protein heterotetramerization |
GO:0045815 | 0 | 16.2042 | 2.295 | 25 | 80 | positive regulation of gene expression, epigenetic |
GO:0045653 | 0 | 122.1369 | 0.5164 | 14 | 18 | negative regulation of megakaryocyte differentiation |
GO:1902036 | 0 | 11.4094 | 2.9548 | 25 | 103 | regulation of hematopoietic stem cell differentiation |
GO:0045814 | 0 | 9.9415 | 3.5572 | 27 | 124 | negative regulation of gene expression, epigenetic |
GO:0006323 | 0 | 7.3916 | 5.5653 | 33 | 194 | DNA packaging |
GO:0060964 | 0 | 10.9847 | 3.0409 | 25 | 106 | regulation of gene silencing by miRNA |
GO:0048863 | 0 | 5.9116 | 6.917 | 34 | 244 | stem cell differentiation |
GO:0071824 | 0 | 5.6895 | 7.3726 | 35 | 257 | protein-DNA complex subunit organization |
GO:0034654 | 0 | 2.1025 | 119.3677 | 193 | 4161 | nucleobase-containing compound biosynthetic process |
GO:0060968 | 0 | 8.461 | 3.7293 | 25 | 130 | regulation of gene silencing |
GO:1902679 | 0 | 2.8653 | 33.2772 | 81 | 1160 | negative regulation of RNA biosynthetic process |
GO:0009893 | 0 | 4.8967 | 9.2654 | 38 | 343 | positive regulation of metabolic process |
GO:2000026 | 0 | 2.5029 | 49.1473 | 103 | 1734 | regulation of multicellular organismal development |
GO:0007389 | 0 | 4.1408 | 12.0773 | 43 | 421 | pattern specification process |
GO:1903707 | 0 | 7.5943 | 3.9015 | 24 | 136 | negative regulation of hemopoiesis |
GO:0045934 | 0 | 2.5855 | 39.904 | 88 | 1391 | negative regulation of nucleobase-containing compound metabolic process |
GO:0035194 | 0 | 5.4671 | 6.7128 | 31 | 234 | posttranscriptional gene silencing by RNA |
GO:0034080 | 0 | 17.4216 | 1.2049 | 14 | 42 | CENP-A containing nucleosome assembly |
GO:1904837 | 0 | 16.2581 | 1.2622 | 14 | 44 | beta-catenin-TCF complex assembly |
GO:0032200 | 0 | 5.9784 | 4.7621 | 24 | 166 | telomere organization |
GO:0034645 | 0 | 1.854 | 143.0634 | 208 | 4987 | cellular macromolecule biosynthetic process |
GO:0002520 | 0 | 2.7458 | 25.7325 | 62 | 897 | immune system development |
GO:0009890 | 0 | 2.2818 | 46.6742 | 92 | 1627 | negative regulation of biosynthetic process |
GO:0006333 | 0 | 7.096 | 3.4062 | 20 | 122 | chromatin assembly or disassembly |
GO:0097659 | 0 | 2.1613 | 59.998 | 108 | 2289 | nucleic acid-templated transcription |
GO:0034724 | 0 | 12.1859 | 1.5491 | 14 | 54 | DNA replication-independent nucleosome organization |
GO:0016233 | 0 | 11.8879 | 1.5778 | 14 | 55 | telomere capping |
GO:0045892 | 0 | 4.0042 | 9.1134 | 32 | 337 | negative regulation of transcription, DNA-templated |
GO:0010628 | 0 | 2.1926 | 46.7676 | 89 | 1714 | positive regulation of gene expression |
GO:0045944 | 0 | 2.4164 | 31.3265 | 67 | 1092 | positive regulation of transcription from RNA polymerase II promoter |
GO:0048513 | 0 | 2.1805 | 46.6331 | 87 | 1833 | animal organ development |
GO:0017148 | 0 | 3.7923 | 9.2373 | 31 | 322 | negative regulation of translation |
GO:1901576 | 0 | 1.7189 | 177.7463 | 238 | 6196 | organic substance biosynthetic process |
GO:0009790 | 0 | 2.5743 | 23.4966 | 54 | 829 | embryo development |
GO:0002682 | 0 | 2.1734 | 39.4163 | 76 | 1374 | regulation of immune system process |
GO:2001141 | 0 | 1.991 | 60.7633 | 103 | 2380 | regulation of RNA biosynthetic process |
GO:1903508 | 0 | 2.1605 | 40.1909 | 77 | 1401 | positive regulation of nucleic acid-templated transcription |
GO:0006303 | 0 | 7.9801 | 2.1515 | 14 | 75 | double-strand break repair via nonhomologous end joining |
GO:0045165 | 0 | 4.2612 | 6.3815 | 24 | 224 | cell fate commitment |
GO:0051254 | 0 | 2.1076 | 42.2277 | 79 | 1472 | positive regulation of RNA metabolic process |
GO:0048665 | 0 | 23.137 | 0.5693 | 8 | 20 | neuron fate specification |
GO:0043044 | 0 | 7.6046 | 2.2376 | 14 | 78 | ATP-dependent chromatin remodeling |
GO:0045596 | 0 | 3.4449 | 9.7271 | 30 | 348 | negative regulation of cell differentiation |
GO:0038111 | 0 | 12.3351 | 1.0901 | 10 | 38 | interleukin-7-mediated signaling pathway |
GO:0006352 | 0 | 3.9488 | 6.8276 | 24 | 238 | DNA-templated transcription, initiation |
GO:0098760 | 0 | 11.909 | 1.1188 | 10 | 39 | response to interleukin-7 |
GO:0051259 | 0 | 2.8293 | 14.86 | 38 | 518 | protein oligomerization |
GO:0009889 | 0 | 1.862 | 68.8024 | 109 | 2710 | regulation of biosynthetic process |
GO:0006355 | 0 | 1.946 | 53.3209 | 90 | 2123 | regulation of transcription, DNA-templated |
GO:0009953 | 0 | 6.0021 | 2.7253 | 14 | 95 | dorsal/ventral pattern formation |
GO:0000122 | 0 | 2.3432 | 22.5195 | 48 | 785 | negative regulation of transcription from RNA polymerase II promoter |
GO:0048704 | 0 | 9.1605 | 1.366 | 10 | 48 | embryonic skeletal system morphogenesis |
GO:0031328 | 0 | 1.8652 | 50.1575 | 84 | 1758 | positive regulation of cellular biosynthetic process |
GO:0009952 | 0 | 3.8425 | 5.7948 | 20 | 202 | anterior/posterior pattern specification |
GO:0009888 | 0 | 2.2902 | 22.093 | 46 | 811 | tissue development |
GO:0045652 | 0 | 7.5698 | 1.5879 | 10 | 57 | regulation of megakaryocyte differentiation |
GO:0021517 | 0 | 8.858 | 1.2622 | 9 | 44 | ventral spinal cord development |
GO:0019219 | 0 | 1.7257 | 69.0387 | 104 | 2712 | regulation of nucleobase-containing compound metabolic process |
GO:0051248 | 0 | 1.9338 | 36.2607 | 64 | 1264 | negative regulation of protein metabolic process |
GO:0060322 | 0 | 2.258 | 20.2245 | 42 | 705 | head development |
GO:0048545 | 0 | 2.7691 | 11.0159 | 28 | 384 | response to steroid hormone |
GO:0034248 | 0 | 2.4507 | 15.5198 | 35 | 541 | regulation of cellular amide metabolic process |
GO:0002227 | 0 | 17.1367 | 0.5164 | 6 | 18 | innate immune response in mucosa |
GO:0010557 | 0 | 1.819 | 45.9953 | 76 | 1615 | positive regulation of macromolecule biosynthetic process |
GO:0002251 | 0 | 12.0157 | 0.7746 | 7 | 27 | organ or tissue specific immune response |
GO:0021515 | 0 | 9.2228 | 1.084 | 8 | 38 | cell differentiation in spinal cord |
GO:0060022 | 0 | 68.2937 | 0.1721 | 4 | 6 | hard palate development |
GO:0043009 | 0 | 2.4304 | 15.1738 | 34 | 535 | chordate embryonic development |
GO:0046483 | 0 | 1.4972 | 167.1033 | 211 | 5825 | heterocycle metabolic process |
GO:0006725 | 0 | 1.5008 | 163.6247 | 207 | 5770 | cellular aromatic compound metabolic process |
GO:0070887 | 0 | 1.6044 | 83.107 | 119 | 2897 | cellular response to chemical stimulus |
GO:0030900 | 0 | 2.6991 | 10.4422 | 26 | 364 | forebrain development |
GO:0021978 | 0 | 21.3799 | 0.3729 | 5 | 13 | telencephalon regionalization |
GO:0034641 | 0 | 1.4781 | 183.5124 | 227 | 6397 | cellular nitrogen compound metabolic process |
GO:0003357 | 0 | 45.5263 | 0.2008 | 4 | 7 | noradrenergic neuron differentiation |
GO:0071773 | 0 | 3.7293 | 4.7334 | 16 | 165 | cellular response to BMP stimulus |
GO:1901360 | 0 | 1.4832 | 169.4948 | 212 | 5977 | organic cyclic compound metabolic process |
GO:0051094 | 0 | 1.8574 | 35.0814 | 60 | 1228 | positive regulation of developmental process |
GO:0032502 | 0 | 1.648 | 72.3641 | 103 | 3060 | developmental process |
GO:0021953 | 0 | 4.4933 | 2.9877 | 12 | 106 | central nervous system neuron differentiation |
GO:0034622 | 1e-04 | 1.8988 | 28.9741 | 51 | 1010 | cellular macromolecular complex assembly |
GO:0060037 | 1e-04 | 10.8184 | 0.7172 | 6 | 25 | pharyngeal system development |
GO:0010608 | 1e-04 | 2.1399 | 18.073 | 36 | 630 | posttranscriptional regulation of gene expression |
GO:0003149 | 1e-04 | 27.3123 | 0.2582 | 4 | 9 | membranous septum morphogenesis |
GO:0016070 | 1e-04 | 1.5708 | 79.7066 | 111 | 3042 | RNA metabolic process |
GO:0071345 | 1e-04 | 1.9521 | 24.7858 | 45 | 864 | cellular response to cytokine stimulus |
GO:0048562 | 1e-04 | 3.2817 | 5.3058 | 16 | 190 | embryonic organ morphogenesis |
GO:0060562 | 1e-04 | 2.6743 | 8.8644 | 22 | 309 | epithelial tube morphogenesis |
GO:0061458 | 1e-04 | 2.395 | 12.106 | 27 | 422 | reproductive system development |
GO:0072193 | 1e-04 | 102.2263 | 0.1147 | 3 | 4 | ureter smooth muscle cell differentiation |
GO:0090191 | 1e-04 | 102.2263 | 0.1147 | 3 | 4 | negative regulation of branching involved in ureteric bud morphogenesis |
GO:0048484 | 2e-04 | 19.5063 | 0.3156 | 4 | 11 | enteric nervous system development |
GO:0090084 | 2e-04 | 19.5063 | 0.3156 | 4 | 11 | negative regulation of inclusion body assembly |
GO:0060249 | 2e-04 | 2.4004 | 10.7004 | 24 | 373 | anatomical structure homeostasis |
GO:0007423 | 2e-04 | 2.1557 | 14.86 | 30 | 518 | sensory organ development |
GO:0010721 | 2e-04 | 2.605 | 8.2332 | 20 | 287 | negative regulation of cell development |
GO:0035148 | 3e-04 | 3.4276 | 4.131 | 13 | 144 | tube formation |
GO:0048485 | 3e-04 | 10.6845 | 0.6024 | 5 | 21 | sympathetic nervous system development |
GO:2000738 | 3e-04 | 17.1377 | 0.3429 | 4 | 12 | positive regulation of stem cell differentiation |
GO:0003207 | 3e-04 | 17.067 | 0.3442 | 4 | 12 | cardiac chamber formation |
GO:0061326 | 3e-04 | 4.1467 | 2.6679 | 10 | 93 | renal tubule development |
GO:0007530 | 3e-04 | 10.0554 | 0.6311 | 5 | 22 | sex determination |
GO:0031016 | 3e-04 | 4.5497 | 2.2089 | 9 | 77 | pancreas development |
GO:0048565 | 4e-04 | 3.5077 | 3.7293 | 12 | 130 | digestive tract development |
GO:0021520 | 4e-04 | 15.1697 | 0.3729 | 4 | 13 | spinal cord motor neuron cell fate specification |
GO:0048935 | 4e-04 | 15.1697 | 0.3729 | 4 | 13 | peripheral nervous system neuron development |
GO:0045823 | 4e-04 | 9.5528 | 0.6561 | 5 | 23 | positive regulation of heart contraction |
GO:0061844 | 4e-04 | 5.8535 | 1.377 | 7 | 48 | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO:0003278 | 4e-04 | 34.0711 | 0.1721 | 3 | 6 | apoptotic process involved in heart morphogenesis |
GO:0072284 | 4e-04 | 34.0711 | 0.1721 | 3 | 6 | metanephric S-shaped body morphogenesis |
GO:0035270 | 5e-04 | 3.9652 | 2.7742 | 10 | 98 | endocrine system development |
GO:0061061 | 5e-04 | 1.9827 | 17.7 | 33 | 617 | muscle structure development |
GO:0021545 | 5e-04 | 5.7138 | 1.4057 | 7 | 49 | cranial nerve development |
GO:0060485 | 5e-04 | 2.6898 | 6.7702 | 17 | 236 | mesenchyme development |
GO:0008284 | 5e-04 | 1.8613 | 22.2965 | 39 | 786 | positive regulation of cell proliferation |
GO:0019731 | 5e-04 | 6.8469 | 1.0327 | 6 | 36 | antibacterial humoral response |
GO:0030878 | 5e-04 | 8.9958 | 0.6885 | 5 | 24 | thyroid gland development |
GO:0051241 | 5e-04 | 1.9679 | 17.8526 | 33 | 670 | negative regulation of multicellular organismal process |
GO:0019953 | 5e-04 | 1.8559 | 22.3474 | 39 | 779 | sexual reproduction |
GO:0046887 | 5e-04 | 3.5743 | 3.3564 | 11 | 117 | positive regulation of hormone secretion |
GO:0048609 | 6e-04 | 1.8507 | 22.4048 | 39 | 781 | multicellular organismal reproductive process |
GO:0071542 | 6e-04 | 6.6256 | 1.0614 | 6 | 37 | dopaminergic neuron differentiation |
GO:0014706 | 6e-04 | 2.3051 | 10.1553 | 22 | 354 | striated muscle tissue development |
GO:0007568 | 7e-04 | 2.4505 | 8.2619 | 19 | 288 | aging |
GO:0050873 | 7e-04 | 6.4181 | 1.0901 | 6 | 38 | brown fat cell differentiation |
GO:0014048 | 7e-04 | 12.41 | 0.4303 | 4 | 15 | regulation of glutamate secretion |
GO:0060579 | 7e-04 | 12.41 | 0.4303 | 4 | 15 | ventral spinal cord interneuron fate commitment |
GO:0001655 | 7e-04 | 2.3781 | 8.9504 | 20 | 312 | urogenital system development |
GO:0051961 | 7e-04 | 2.5056 | 7.6595 | 18 | 267 | negative regulation of nervous system development |
GO:0060017 | 8e-04 | 25.5517 | 0.2008 | 3 | 7 | parathyroid gland development |
GO:0030902 | 8e-04 | 3.1815 | 4.0736 | 12 | 142 | hindbrain development |
GO:0009887 | 8e-04 | 2.0313 | 14.6294 | 28 | 544 | animal organ morphogenesis |
GO:0014036 | 8e-04 | Inf | 0.0574 | 2 | 2 | neural crest cell fate specification |
GO:0061032 | 8e-04 | Inf | 0.0574 | 2 | 2 | visceral serous pericardium development |
GO:2001111 | 8e-04 | Inf | 0.0574 | 2 | 2 | positive regulation of lens epithelial cell proliferation |
GO:0051385 | 9e-04 | 7.7676 | 0.7746 | 5 | 27 | response to mineralocorticoid |
GO:0048592 | 9e-04 | 3.1329 | 4.131 | 12 | 144 | eye morphogenesis |
GO:0048870 | 0.001 | 1.5927 | 40.8507 | 61 | 1424 | cell motility |
GO:0072009 | 0.001 | 3.5451 | 3.0695 | 10 | 107 | nephron epithelium development |
GO:0048523 | 0.001 | 1.4837 | 68.8784 | 93 | 2677 | negative regulation of cellular process |
GO:0043043 | 0.001 | 1.8016 | 22.3474 | 38 | 779 | peptide biosynthetic process |
GO:0045744 | 0.001 | 5.8669 | 1.1762 | 6 | 41 | negative regulation of G-protein coupled receptor protein signaling pathway |
GO:0003208 | 0.001 | 4.2887 | 2.0655 | 8 | 72 | cardiac ventricle morphogenesis |
GO:0030097 | 0.0011 | 1.8787 | 18.6058 | 33 | 678 | hemopoiesis |
GO:0035108 | 0.0011 | 3.0627 | 4.217 | 12 | 147 | limb morphogenesis |
GO:0010605 | 0.0011 | 1.628 | 36.1801 | 55 | 1348 | negative regulation of macromolecule metabolic process |
GO:0070271 | 0.0011 | 1.5895 | 40.2195 | 60 | 1402 | protein complex biogenesis |
GO:0009719 | 0.0011 | 1.5772 | 41.9121 | 62 | 1461 | response to endogenous stimulus |
GO:0048646 | 0.0012 | 1.7611 | 24.0756 | 40 | 859 | anatomical structure formation involved in morphogenesis |
GO:0072210 | 0.0012 | 5.7035 | 1.2049 | 6 | 42 | metanephric nephron development |
GO:0043651 | 0.0012 | 10.4994 | 0.4877 | 4 | 17 | linoleic acid metabolic process |
GO:2000136 | 0.0012 | 10.4994 | 0.4877 | 4 | 17 | regulation of cell proliferation involved in heart morphogenesis |
GO:0051240 | 0.0012 | 1.5954 | 38.7365 | 58 | 1385 | positive regulation of multicellular organismal process |
GO:0030855 | 0.0012 | 1.9697 | 15.0363 | 28 | 535 | epithelial cell differentiation |
GO:0048736 | 0.0013 | 2.837 | 4.9055 | 13 | 171 | appendage development |
GO:0045665 | 0.0014 | 2.6991 | 5.5366 | 14 | 193 | negative regulation of neuron differentiation |
GO:0090185 | 0.0015 | 9.7488 | 0.5164 | 4 | 18 | negative regulation of kidney development |
GO:0090322 | 0.0015 | 6.8342 | 0.8606 | 5 | 30 | regulation of superoxide metabolic process |
GO:0060255 | 0.0015 | 1.4383 | 83.5689 | 108 | 3282 | regulation of macromolecule metabolic process |
GO:0051090 | 0.0016 | 2.122 | 10.9585 | 22 | 382 | regulation of DNA binding transcription factor activity |
GO:0007417 | 0.0017 | 1.8033 | 19.9184 | 34 | 721 | central nervous system development |
GO:0048664 | 0.0017 | 17.0323 | 0.2582 | 3 | 9 | neuron fate determination |
GO:1903426 | 0.0019 | 3.8641 | 2.2663 | 8 | 79 | regulation of reactive oxygen species biosynthetic process |
GO:0040012 | 0.0019 | 1.7061 | 24.7571 | 40 | 863 | regulation of locomotion |
GO:0030154 | 0.002 | 1.6826 | 27.4063 | 43 | 1161 | cell differentiation |
GO:1901532 | 0.0021 | 15.3534 | 0.2732 | 3 | 10 | regulation of hematopoietic progenitor cell differentiation |
GO:2000677 | 0.0021 | 5.0064 | 1.3483 | 6 | 47 | regulation of transcription regulatory region DNA binding |
GO:0001838 | 0.0021 | 8.647 | 0.5662 | 4 | 20 | embryonic epithelial tube formation |
GO:0034103 | 0.0022 | 3.7578 | 2.3237 | 8 | 81 | regulation of tissue remodeling |
GO:0002089 | 0.0022 | 8.5292 | 0.5737 | 4 | 20 | lens morphogenesis in camera-type eye |
GO:0042423 | 0.0022 | 8.5292 | 0.5737 | 4 | 20 | catecholamine biosynthetic process |
GO:0060065 | 0.0022 | 8.5292 | 0.5737 | 4 | 20 | uterus development |
GO:0003281 | 0.0023 | 4.2061 | 1.836 | 7 | 64 | ventricular septum development |
GO:0003338 | 0.0023 | 6.1008 | 0.9467 | 5 | 33 | metanephros morphogenesis |
GO:0006308 | 0.0023 | 6.1008 | 0.9467 | 5 | 33 | DNA catabolic process |
GO:0051270 | 0.0024 | 1.6845 | 25.044 | 40 | 873 | regulation of cellular component movement |
GO:0009409 | 0.0024 | 4.8869 | 1.377 | 6 | 48 | response to cold |
GO:2000179 | 0.0024 | 4.8869 | 1.377 | 6 | 48 | positive regulation of neural precursor cell proliferation |
GO:0015837 | 0.0024 | 3.7068 | 2.3524 | 8 | 82 | amine transport |
GO:0001546 | 0.0024 | 68.0043 | 0.0861 | 2 | 3 | preantral ovarian follicle growth |
GO:0010159 | 0.0024 | 68.0043 | 0.0861 | 2 | 3 | specification of animal organ position |
GO:0032227 | 0.0024 | 68.0043 | 0.0861 | 2 | 3 | negative regulation of synaptic transmission, dopaminergic |
GO:0035990 | 0.0024 | 68.0043 | 0.0861 | 2 | 3 | tendon cell differentiation |
GO:0055014 | 0.0024 | 68.0043 | 0.0861 | 2 | 3 | atrial cardiac muscle cell development |
GO:0070370 | 0.0024 | 68.0043 | 0.0861 | 2 | 3 | cellular heat acclimation |
GO:0070434 | 0.0024 | 68.0043 | 0.0861 | 2 | 3 | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway |
GO:0072190 | 0.0024 | 68.0043 | 0.0861 | 2 | 3 | ureter urothelium development |
GO:0072197 | 0.0024 | 68.0043 | 0.0861 | 2 | 3 | ureter morphogenesis |
GO:0072199 | 0.0024 | 68.0043 | 0.0861 | 2 | 3 | regulation of mesenchymal cell proliferation involved in ureter development |
GO:0042756 | 0.0024 | 14.5982 | 0.2869 | 3 | 10 | drinking behavior |
GO:1905205 | 0.0024 | 14.5982 | 0.2869 | 3 | 10 | positive regulation of connective tissue replacement |
GO:0065007 | 0.0025 | 1.3582 | 325.4283 | 353 | 11344 | biological regulation |
GO:0007218 | 0.0025 | 3.3577 | 2.8974 | 9 | 101 | neuropeptide signaling pathway |
GO:0048644 | 0.0026 | 3.6571 | 2.381 | 8 | 83 | muscle organ morphogenesis |
GO:0001841 | 0.0026 | 3.3214 | 2.9261 | 9 | 102 | neural tube formation |
GO:0003156 | 0.0027 | 5.8901 | 0.9754 | 5 | 34 | regulation of animal organ formation |
GO:0021854 | 0.0027 | 8.0269 | 0.6024 | 4 | 21 | hypothalamus development |
GO:0060538 | 0.0028 | 2.7172 | 4.7047 | 12 | 164 | skeletal muscle organ development |
GO:0051384 | 0.0029 | 2.8438 | 4.131 | 11 | 144 | response to glucocorticoid |
GO:0035914 | 0.003 | 3.9951 | 1.922 | 7 | 67 | skeletal muscle cell differentiation |
GO:0045778 | 0.003 | 3.5617 | 2.4384 | 8 | 85 | positive regulation of ossification |
GO:0051047 | 0.0031 | 2.0384 | 10.8438 | 21 | 378 | positive regulation of secretion |
GO:0032967 | 0.0032 | 7.5805 | 0.6311 | 4 | 22 | positive regulation of collagen biosynthetic process |
GO:0048745 | 0.0032 | 7.5805 | 0.6311 | 4 | 22 | smooth muscle tissue development |
GO:0061213 | 0.0032 | 7.5805 | 0.6311 | 4 | 22 | positive regulation of mesonephros development |
GO:0060573 | 0.0033 | 12.7726 | 0.3156 | 3 | 11 | cell fate specification involved in pattern specification |
GO:1903244 | 0.0033 | 12.7726 | 0.3156 | 3 | 11 | positive regulation of cardiac muscle hypertrophy in response to stress |
GO:0072359 | 0.0033 | 1.6192 | 27.9701 | 43 | 975 | circulatory system development |
GO:0002065 | 0.0034 | 3.1836 | 3.0409 | 9 | 106 | columnar/cuboidal epithelial cell differentiation |
GO:0043279 | 0.0034 | 3.1836 | 3.0409 | 9 | 106 | response to alkaloid |
GO:0030510 | 0.0035 | 3.4711 | 2.4958 | 8 | 87 | regulation of BMP signaling pathway |
GO:0060548 | 0.0035 | 1.6331 | 26.421 | 41 | 921 | negative regulation of cell death |
GO:0006950 | 0.0035 | 1.3466 | 101.3683 | 126 | 3569 | response to stress |
GO:0051704 | 0.0037 | 1.4069 | 65.9807 | 87 | 2300 | multi-organism process |
GO:0030901 | 0.0037 | 3.4275 | 2.5245 | 8 | 88 | midbrain development |
GO:0008544 | 0.0038 | 1.9653 | 11.7618 | 22 | 410 | epidermis development |
GO:0043576 | 0.0038 | 7.1811 | 0.6598 | 4 | 23 | regulation of respiratory gaseous exchange |
GO:0044253 | 0.0038 | 7.1811 | 0.6598 | 4 | 23 | positive regulation of multicellular organismal metabolic process |
GO:0048729 | 0.0039 | 1.7681 | 17.8148 | 30 | 621 | tissue morphogenesis |
GO:0071392 | 0.0039 | 5.3369 | 1.0614 | 5 | 37 | cellular response to estradiol stimulus |
GO:0051173 | 0.0041 | 1.3663 | 82.4472 | 105 | 2874 | positive regulation of nitrogen compound metabolic process |
GO:0010033 | 0.0042 | 1.4071 | 64.5988 | 85 | 2309 | response to organic substance |
GO:0003184 | 0.0043 | 11.3527 | 0.3442 | 3 | 12 | pulmonary valve morphogenesis |
GO:0032099 | 0.0043 | 11.3527 | 0.3442 | 3 | 12 | negative regulation of appetite |
GO:0060452 | 0.0043 | 11.3527 | 0.3442 | 3 | 12 | positive regulation of cardiac muscle contraction |
GO:0008285 | 0.0044 | 1.7187 | 19.536 | 32 | 681 | negative regulation of cell proliferation |
GO:0006636 | 0.0044 | 5.1748 | 1.0901 | 5 | 38 | unsaturated fatty acid biosynthetic process |
GO:0031113 | 0.0044 | 5.1748 | 1.0901 | 5 | 38 | regulation of microtubule polymerization |
GO:2000648 | 0.0044 | 5.1748 | 1.0901 | 5 | 38 | positive regulation of stem cell proliferation |
GO:0002068 | 0.0045 | 6.8216 | 0.6885 | 4 | 24 | glandular epithelial cell development |
GO:0021511 | 0.0045 | 6.8216 | 0.6885 | 4 | 24 | spinal cord patterning |
GO:0035412 | 0.0045 | 6.8216 | 0.6885 | 4 | 24 | regulation of catenin import into nucleus |
GO:0042026 | 0.0045 | 6.8216 | 0.6885 | 4 | 24 | protein refolding |
GO:0007166 | 0.0046 | 1.3716 | 76.3942 | 98 | 2663 | cell surface receptor signaling pathway |
GO:2000379 | 0.0046 | 3.3029 | 2.6105 | 8 | 91 | positive regulation of reactive oxygen species metabolic process |
GO:0061217 | 0.0047 | 34.256 | 0.1139 | 2 | 4 | regulation of mesonephros development |
GO:0001705 | 0.0047 | 34 | 0.1147 | 2 | 4 | ectoderm formation |
GO:0002317 | 0.0047 | 34 | 0.1147 | 2 | 4 | plasma cell differentiation |
GO:0003219 | 0.0047 | 34 | 0.1147 | 2 | 4 | cardiac right ventricle formation |
GO:0003415 | 0.0047 | 34 | 0.1147 | 2 | 4 | chondrocyte hypertrophy |
GO:0007621 | 0.0047 | 34 | 0.1147 | 2 | 4 | negative regulation of female receptivity |
GO:0018916 | 0.0047 | 34 | 0.1147 | 2 | 4 | nitrobenzene metabolic process |
GO:0021615 | 0.0047 | 34 | 0.1147 | 2 | 4 | glossopharyngeal nerve morphogenesis |
GO:0021764 | 0.0047 | 34 | 0.1147 | 2 | 4 | amygdala development |
GO:0021913 | 0.0047 | 34 | 0.1147 | 2 | 4 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification |
GO:0031394 | 0.0047 | 34 | 0.1147 | 2 | 4 | positive regulation of prostaglandin biosynthetic process |
GO:0034287 | 0.0047 | 34 | 0.1147 | 2 | 4 | detection of monosaccharide stimulus |
GO:0045110 | 0.0047 | 34 | 0.1147 | 2 | 4 | intermediate filament bundle assembly |
GO:0051594 | 0.0047 | 34 | 0.1147 | 2 | 4 | detection of glucose |
GO:0061325 | 0.0047 | 34 | 0.1147 | 2 | 4 | cell proliferation involved in outflow tract morphogenesis |
GO:0070318 | 0.0047 | 34 | 0.1147 | 2 | 4 | positive regulation of G0 to G1 transition |
GO:0070384 | 0.0047 | 34 | 0.1147 | 2 | 4 | Harderian gland development |
GO:0072095 | 0.0047 | 34 | 0.1147 | 2 | 4 | regulation of branch elongation involved in ureteric bud branching |
GO:0072125 | 0.0047 | 34 | 0.1147 | 2 | 4 | negative regulation of glomerular mesangial cell proliferation |
GO:0072278 | 0.0047 | 34 | 0.1147 | 2 | 4 | metanephric comma-shaped body morphogenesis |
GO:0090063 | 0.0047 | 34 | 0.1147 | 2 | 4 | positive regulation of microtubule nucleation |
GO:0097476 | 0.0047 | 34 | 0.1147 | 2 | 4 | spinal cord motor neuron migration |
GO:0098707 | 0.0047 | 34 | 0.1147 | 2 | 4 | ferrous iron import across plasma membrane |
GO:1901896 | 0.0047 | 34 | 0.1147 | 2 | 4 | positive regulation of calcium-transporting ATPase activity |
GO:0035050 | 0.0049 | 3.6305 | 2.0942 | 7 | 73 | embryonic heart tube development |
GO:0072078 | 0.0049 | 3.6305 | 2.0942 | 7 | 73 | nephron tubule morphogenesis |
GO:0007178 | 0.0049 | 2.0729 | 9.1226 | 18 | 318 | transmembrane receptor protein serine/threonine kinase signaling pathway |
GO:0030334 | 0.005 | 1.6727 | 21.3146 | 34 | 743 | regulation of cell migration |
GO:0001101 | 0.0051 | 2.0659 | 9.1512 | 18 | 319 | response to acid chemical |
GO:0021879 | 0.0051 | 6.5426 | 0.7123 | 4 | 25 | forebrain neuron differentiation |
GO:0003205 | 0.0051 | 2.6247 | 4.4465 | 11 | 155 | cardiac chamber development |
GO:0048705 | 0.0052 | 2.9671 | 3.2393 | 9 | 116 | skeletal system morphogenesis |
GO:0018958 | 0.0052 | 3.2248 | 2.6679 | 8 | 93 | phenol-containing compound metabolic process |
GO:0003148 | 0.0052 | 6.4963 | 0.7172 | 4 | 25 | outflow tract septum morphogenesis |
GO:0003309 | 0.0052 | 6.4963 | 0.7172 | 4 | 25 | type B pancreatic cell differentiation |
GO:0031112 | 0.0052 | 6.4963 | 0.7172 | 4 | 25 | positive regulation of microtubule polymerization or depolymerization |
GO:0001967 | 0.0054 | 10.2168 | 0.3729 | 3 | 13 | suckling behavior |
GO:0002087 | 0.0054 | 10.2168 | 0.3729 | 3 | 13 | regulation of respiratory gaseous exchange by neurological system process |
GO:0021781 | 0.0054 | 10.2168 | 0.3729 | 3 | 13 | glial cell fate commitment |
GO:0032780 | 0.0054 | 10.2168 | 0.3729 | 3 | 13 | negative regulation of ATPase activity |
GO:0061548 | 0.0054 | 10.2168 | 0.3729 | 3 | 13 | ganglion development |
GO:0014014 | 0.0055 | 4.8785 | 1.1475 | 5 | 40 | negative regulation of gliogenesis |
GO:0098869 | 0.0056 | 3.1871 | 2.6966 | 8 | 94 | cellular oxidant detoxification |
GO:0032501 | 0.0056 | 1.3501 | 107.9607 | 130 | 4636 | multicellular organismal process |
GO:0050767 | 0.0056 | 1.7012 | 19.0887 | 31 | 670 | regulation of neurogenesis |
GO:0045637 | 0.0057 | 2.5805 | 4.5109 | 11 | 165 | regulation of myeloid cell differentiation |
GO:0043524 | 0.0058 | 2.7241 | 3.9015 | 10 | 136 | negative regulation of neuron apoptotic process |
GO:0060411 | 0.0059 | 4.7777 | 1.1679 | 5 | 41 | cardiac septum morphogenesis |
GO:0006334 | 0.006 | 3.1408 | 2.7267 | 8 | 100 | nucleosome assembly |
GO:0072207 | 0.0061 | 6.2007 | 0.7459 | 4 | 26 | metanephric epithelium development |
GO:0003006 | 0.0061 | 1.9446 | 10.7783 | 20 | 383 | developmental process involved in reproduction |
GO:0060041 | 0.0062 | 2.7025 | 3.9302 | 10 | 137 | retina development in camera-type eye |
GO:0001947 | 0.0062 | 3.9446 | 1.6639 | 6 | 58 | heart looping |
GO:0045604 | 0.0062 | 3.9446 | 1.6639 | 6 | 58 | regulation of epidermal cell differentiation |
GO:0060348 | 0.0064 | 2.4267 | 5.2211 | 12 | 182 | bone development |
GO:0090257 | 0.0065 | 2.242 | 6.5694 | 14 | 229 | regulation of muscle system process |
GO:0072028 | 0.0065 | 3.4222 | 2.2089 | 7 | 77 | nephron morphogenesis |
GO:0045807 | 0.0065 | 2.8574 | 3.3564 | 9 | 117 | positive regulation of endocytosis |
GO:0030858 | 0.0067 | 3.8699 | 1.6925 | 6 | 59 | positive regulation of epithelial cell differentiation |
GO:0014744 | 0.0067 | 9.2874 | 0.4016 | 3 | 14 | positive regulation of muscle adaptation |
GO:0021527 | 0.0067 | 9.2874 | 0.4016 | 3 | 14 | spinal cord association neuron differentiation |
GO:0032108 | 0.0067 | 9.2874 | 0.4016 | 3 | 14 | negative regulation of response to nutrient levels |
GO:0045986 | 0.0067 | 9.2874 | 0.4016 | 3 | 14 | negative regulation of smooth muscle contraction |
GO:1990845 | 0.0067 | 9.2874 | 0.4016 | 3 | 14 | adaptive thermogenesis |
GO:0042493 | 0.0068 | 1.8917 | 11.6183 | 21 | 405 | response to drug |
GO:0048585 | 0.0069 | 1.4564 | 41.9121 | 58 | 1461 | negative regulation of response to stimulus |
GO:0001764 | 0.0071 | 2.6396 | 4.0162 | 10 | 140 | neuron migration |
GO:0001568 | 0.0074 | 1.6963 | 17.8722 | 29 | 623 | blood vessel development |
GO:0048699 | 0.0075 | 1.7129 | 17.113 | 28 | 622 | generation of neurons |
GO:0009605 | 0.0075 | 1.3857 | 58.7802 | 77 | 2049 | response to external stimulus |
GO:0045995 | 0.0077 | 2.7796 | 3.4425 | 9 | 120 | regulation of embryonic development |
GO:0003150 | 0.0078 | 22.6652 | 0.1434 | 2 | 5 | muscular septum morphogenesis |
GO:0010040 | 0.0078 | 22.6652 | 0.1434 | 2 | 5 | response to iron(II) ion |
GO:0035989 | 0.0078 | 22.6652 | 0.1434 | 2 | 5 | tendon development |
GO:0048880 | 0.0078 | 22.6652 | 0.1434 | 2 | 5 | sensory system development |
GO:0051891 | 0.0078 | 22.6652 | 0.1434 | 2 | 5 | positive regulation of cardioblast differentiation |
GO:0060023 | 0.0078 | 22.6652 | 0.1434 | 2 | 5 | soft palate development |
GO:0061743 | 0.0078 | 22.6652 | 0.1434 | 2 | 5 | motor learning |
GO:1900028 | 0.0078 | 22.6652 | 0.1434 | 2 | 5 | negative regulation of ruffle assembly |
GO:1905007 | 0.0078 | 22.6652 | 0.1434 | 2 | 5 | positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation |
GO:2000195 | 0.0078 | 22.6652 | 0.1434 | 2 | 5 | negative regulation of female gonad development |
GO:2000609 | 0.0078 | 22.6652 | 0.1434 | 2 | 5 | regulation of thyroid hormone generation |
GO:2000851 | 0.0078 | 22.6652 | 0.1434 | 2 | 5 | positive regulation of glucocorticoid secretion |
GO:0014032 | 0.0079 | 3.7287 | 1.7499 | 6 | 61 | neural crest cell development |
GO:0042104 | 0.0079 | 5.6832 | 0.8032 | 4 | 28 | positive regulation of activated T cell proliferation |
GO:1902692 | 0.0079 | 5.6832 | 0.8032 | 4 | 28 | regulation of neuroblast proliferation |
GO:0048468 | 0.008 | 1.461 | 39.6507 | 55 | 1444 | cell development |
GO:0042743 | 0.0082 | 4.377 | 1.2622 | 5 | 44 | hydrogen peroxide metabolic process |
GO:2000272 | 0.0082 | 4.377 | 1.2622 | 5 | 44 | negative regulation of receptor activity |
GO:0051957 | 0.0083 | 8.5129 | 0.4303 | 3 | 15 | positive regulation of amino acid transport |
GO:1901317 | 0.0083 | 8.5129 | 0.4303 | 3 | 15 | regulation of flagellated sperm motility |
GO:1904994 | 0.0083 | 8.5129 | 0.4303 | 3 | 15 | regulation of leukocyte adhesion to vascular endothelial cell |
GO:0002573 | 0.0085 | 2.3297 | 5.4219 | 12 | 189 | myeloid leukocyte differentiation |
GO:0007281 | 0.0087 | 2.1604 | 6.7989 | 14 | 237 | germ cell development |
GO:0070848 | 0.0087 | 1.6571 | 18.9049 | 30 | 659 | response to growth factor |
GO:0051093 | 0.0088 | 2.3161 | 5.4465 | 12 | 205 | negative regulation of developmental process |
GO:0003203 | 0.009 | 5.4556 | 0.8319 | 4 | 29 | endocardial cushion morphogenesis |
GO:0021884 | 0.009 | 5.4556 | 0.8319 | 4 | 29 | forebrain neuron development |
GO:0098754 | 0.009 | 2.9144 | 2.9261 | 8 | 102 | detoxification |
GO:0048538 | 0.009 | 4.2673 | 1.2909 | 5 | 45 | thymus development |
GO:0048701 | 0.009 | 4.2673 | 1.2909 | 5 | 45 | embryonic cranial skeleton morphogenesis |
GO:0045670 | 0.0092 | 3.5974 | 1.8073 | 6 | 63 | regulation of osteoclast differentiation |
GO:0048844 | 0.0092 | 3.5974 | 1.8073 | 6 | 63 | artery morphogenesis |
GO:0048232 | 0.0095 | 1.7531 | 14.2863 | 24 | 498 | male gamete generation |
GO:0003151 | 0.0096 | 4.2024 | 1.3077 | 5 | 46 | outflow tract morphogenesis |
GO:0009617 | 0.0097 | 1.7493 | 14.3149 | 24 | 499 | response to bacterium |
GO:0048589 | 0.0097 | 1.69 | 16.6673 | 27 | 581 | developmental growth |
GO:0001890 | 0.0099 | 2.5036 | 4.217 | 10 | 147 | placenta development |
GO:0060675 | 0.0099 | 3.5352 | 1.836 | 6 | 64 | ureteric bud morphogenesis |
GO:0000097 | 0.0099 | 7.8576 | 0.459 | 3 | 16 | sulfur amino acid biosynthetic process |
GO:0003222 | 0.0099 | 7.8576 | 0.459 | 3 | 16 | ventricular trabecula myocardium morphogenesis |
GO:0045723 | 0.0099 | 7.8576 | 0.459 | 3 | 16 | positive regulation of fatty acid biosynthetic process |
GO:0072148 | 0.0099 | 7.8576 | 0.459 | 3 | 16 | epithelial cell fate commitment |
GO:1905314 | 0.0099 | 7.8576 | 0.459 | 3 | 16 | semi-lunar valve development |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006954 | 4e-04 | 1.9709 | 18.9169 | 35 | 668 | inflammatory response |
GO:0007588 | 6e-04 | 4.717 | 1.8974 | 8 | 67 | excretion |
GO:0045359 | 7e-04 | 25.8963 | 0.1982 | 3 | 7 | positive regulation of interferon-beta biosynthetic process |
GO:0006968 | 8e-04 | 5.1737 | 1.5292 | 7 | 54 | cellular defense response |
GO:0018003 | 8e-04 | Inf | 0.0566 | 2 | 2 | peptidyl-lysine N6-acetylation |
GO:0002604 | 0.0011 | 20.7157 | 0.2265 | 3 | 8 | regulation of dendritic cell antigen processing and presentation |
GO:0042355 | 0.0017 | 17.262 | 0.2549 | 3 | 9 | L-fucose catabolic process |
GO:0061314 | 0.0017 | 17.262 | 0.2549 | 3 | 9 | Notch signaling involved in heart development |
GO:0035584 | 0.0021 | 8.6444 | 0.5664 | 4 | 20 | calcium-mediated signaling using intracellular calcium source |
GO:0042116 | 0.0022 | 4.2634 | 1.8124 | 7 | 64 | macrophage activation |
GO:0050896 | 0.0023 | 1.3156 | 232.4965 | 263 | 8210 | response to stimulus |
GO:0045080 | 0.0023 | 14.7951 | 0.2832 | 3 | 10 | positive regulation of chemokine biosynthetic process |
GO:0010730 | 0.0024 | 68.9194 | 0.085 | 2 | 3 | negative regulation of hydrogen peroxide biosynthetic process |
GO:0060620 | 0.0024 | 68.9194 | 0.085 | 2 | 3 | regulation of cholesterol import |
GO:1903038 | 0.0024 | 3.3668 | 2.8885 | 9 | 102 | negative regulation of leukocyte cell-cell adhesion |
GO:0042744 | 0.0031 | 7.683 | 0.623 | 4 | 22 | hydrogen peroxide catabolic process |
GO:0060315 | 0.0031 | 12.9449 | 0.3115 | 3 | 11 | negative regulation of ryanodine-sensitive calcium-release channel activity |
GO:0045351 | 0.0041 | 11.5058 | 0.3398 | 3 | 12 | type I interferon biosynthetic process |
GO:0051924 | 0.0043 | 2.362 | 6.2584 | 14 | 221 | regulation of calcium ion transport |
GO:0007165 | 0.0046 | 1.2943 | 158.0749 | 185 | 5582 | signal transduction |
GO:0006121 | 0.0046 | 34.4575 | 0.1133 | 2 | 4 | mitochondrial electron transport, succinate to ubiquinone |
GO:0043091 | 0.0046 | 34.4575 | 0.1133 | 2 | 4 | L-arginine import |
GO:0045356 | 0.0046 | 34.4575 | 0.1133 | 2 | 4 | positive regulation of interferon-alpha biosynthetic process |
GO:0060800 | 0.0046 | 34.4575 | 0.1133 | 2 | 4 | regulation of cell differentiation involved in embryonic placenta development |
GO:0009437 | 0.0052 | 10.3546 | 0.3681 | 3 | 13 | carnitine metabolic process |
GO:0043123 | 0.0053 | 2.4897 | 5.0974 | 12 | 180 | positive regulation of I-kappaB kinase/NF-kappaB signaling |
GO:0046717 | 0.0057 | 2.9236 | 3.285 | 9 | 116 | acid secretion |
GO:1903170 | 0.0058 | 4.8069 | 1.1611 | 5 | 41 | negative regulation of calcium ion transmembrane transport |
GO:0010469 | 0.006 | 1.7832 | 15.2638 | 26 | 539 | regulation of receptor activity |
GO:1903409 | 0.007 | 3.0521 | 2.8036 | 8 | 99 | reactive oxygen species biosynthetic process |
GO:0007212 | 0.0071 | 4.5533 | 1.2177 | 5 | 43 | dopamine receptor signaling pathway |
GO:0055001 | 0.0074 | 2.4863 | 4.6726 | 11 | 165 | muscle cell development |
GO:0006032 | 0.0076 | 22.9702 | 0.1416 | 2 | 5 | chitin catabolic process |
GO:0010536 | 0.0076 | 22.9702 | 0.1416 | 2 | 5 | positive regulation of activation of Janus kinase activity |
GO:0035811 | 0.0076 | 22.9702 | 0.1416 | 2 | 5 | negative regulation of urine volume |
GO:0002757 | 0.0078 | 1.8099 | 13.2815 | 23 | 469 | immune response-activating signal transduction |
GO:0007252 | 0.008 | 8.6277 | 0.4248 | 3 | 15 | I-kappaB phosphorylation |
GO:0050755 | 0.008 | 8.6277 | 0.4248 | 3 | 15 | chemokine metabolic process |
GO:0050482 | 0.0086 | 5.5293 | 0.8212 | 4 | 29 | arachidonic acid secretion |
GO:0061900 | 0.0086 | 5.5293 | 0.8212 | 4 | 29 | glial cell activation |
GO:2001257 | 0.0087 | 2.5567 | 4.1345 | 10 | 146 | regulation of cation channel activity |
GO:0030817 | 0.0092 | 2.6953 | 3.5398 | 9 | 125 | regulation of cAMP biosynthetic process |
GO:0006909 | 0.0094 | 2.21 | 6.1735 | 13 | 218 | phagocytosis |
GO:0006004 | 0.0096 | 7.9636 | 0.4531 | 3 | 16 | fucose metabolic process |
GO:0014061 | 0.0096 | 7.9636 | 0.4531 | 3 | 16 | regulation of norepinephrine secretion |
GO:0031000 | 0.0096 | 7.9636 | 0.4531 | 3 | 16 | response to caffeine |
GO:0051284 | 0.0096 | 7.9636 | 0.4531 | 3 | 16 | positive regulation of sequestering of calcium ion |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0045653 | 0 | 108.9773 | 0.575 | 14 | 18 | negative regulation of megakaryocyte differentiation |
GO:0006335 | 0 | 24.1957 | 1.0222 | 14 | 32 | DNA replication-dependent nucleosome assembly |
GO:0045944 | 0 | 2.6495 | 34.8817 | 80 | 1092 | positive regulation of transcription from RNA polymerase II promoter |
GO:0009790 | 0 | 2.7746 | 30.3139 | 73 | 949 | embryo development |
GO:0048863 | 0 | 4.7868 | 8.3371 | 34 | 261 | stem cell differentiation |
GO:0000183 | 0 | 18.1398 | 1.2138 | 14 | 38 | chromatin silencing at rDNA |
GO:0002263 | 0 | 3.0996 | 21.0504 | 57 | 659 | cell activation involved in immune response |
GO:0042119 | 0 | 3.4676 | 15.5243 | 47 | 486 | neutrophil activation |
GO:0034080 | 0 | 15.5445 | 1.3416 | 14 | 42 | CENP-A containing nucleosome assembly |
GO:0002444 | 0 | 3.2833 | 17.0256 | 49 | 533 | myeloid leukocyte mediated immunity |
GO:0010628 | 0 | 2.2341 | 53.5394 | 103 | 1714 | positive regulation of gene expression |
GO:0051290 | 0 | 14.5063 | 1.4055 | 14 | 44 | protein heterotetramerization |
GO:1904837 | 0 | 14.5063 | 1.4055 | 14 | 44 | beta-catenin-TCF complex assembly |
GO:0002275 | 0 | 3.2371 | 16.8659 | 48 | 528 | myeloid cell activation involved in immune response |
GO:0050865 | 0 | 3.3167 | 15.7798 | 46 | 494 | regulation of cell activation |
GO:0002682 | 0 | 3.9904 | 10.3721 | 36 | 359 | regulation of immune system process |
GO:1903508 | 0 | 2.3066 | 44.7521 | 90 | 1401 | positive regulation of nucleic acid-templated transcription |
GO:0031328 | 0 | 2.163 | 56.6669 | 106 | 1774 | positive regulation of cellular biosynthetic process |
GO:0010557 | 0 | 2.2031 | 52.2907 | 100 | 1637 | positive regulation of macromolecule biosynthetic process |
GO:0002520 | 0 | 2.66 | 27.7426 | 65 | 874 | immune system development |
GO:0043312 | 0 | 3.2874 | 15.1729 | 44 | 475 | neutrophil degranulation |
GO:0032940 | 0 | 2.7873 | 23.1976 | 57 | 746 | secretion by cell |
GO:0009952 | 0 | 4.8771 | 6.4525 | 27 | 202 | anterior/posterior pattern specification |
GO:0051674 | 0 | 2.2311 | 45.4868 | 89 | 1424 | localization of cell |
GO:0001501 | 0 | 3.9557 | 9.5295 | 33 | 305 | skeletal system development |
GO:0035113 | 0 | 6.2146 | 4.0568 | 21 | 127 | embryonic appendage morphogenesis |
GO:0045055 | 0 | 2.7096 | 23.2545 | 56 | 728 | regulated exocytosis |
GO:0034724 | 0 | 10.8728 | 1.7249 | 14 | 54 | DNA replication-independent nucleosome organization |
GO:0051254 | 0 | 2.1774 | 47.0201 | 90 | 1472 | positive regulation of RNA metabolic process |
GO:0016233 | 0 | 10.607 | 1.7569 | 14 | 55 | telomere capping |
GO:0035115 | 0 | 16.1959 | 1.0222 | 11 | 32 | embryonic forelimb morphogenesis |
GO:0048736 | 0 | 4.8814 | 5.4623 | 23 | 171 | appendage development |
GO:0048513 | 0 | 1.8351 | 88.5961 | 139 | 2882 | animal organ development |
GO:0051173 | 0 | 1.8095 | 91.8042 | 143 | 2874 | positive regulation of nitrogen compound metabolic process |
GO:1902679 | 0 | 2.2043 | 37.0539 | 73 | 1160 | negative regulation of RNA biosynthetic process |
GO:0048704 | 0 | 10.5007 | 1.5079 | 12 | 48 | embryonic skeletal system morphogenesis |
GO:0043044 | 0 | 7.4003 | 2.4916 | 15 | 78 | ATP-dependent chromatin remodeling |
GO:0050778 | 0 | 2.576 | 21.5615 | 50 | 675 | positive regulation of immune response |
GO:0045596 | 0 | 2.6285 | 20.2838 | 48 | 635 | negative regulation of cell differentiation |
GO:0043207 | 0 | 2.4456 | 24.9794 | 55 | 782 | response to external biotic stimulus |
GO:0043009 | 0 | 2.7307 | 17.8881 | 44 | 560 | chordate embryonic development |
GO:0045165 | 0 | 3.7982 | 8.0177 | 27 | 251 | cell fate commitment |
GO:0051241 | 0 | 2.3117 | 28.8491 | 60 | 933 | negative regulation of multicellular organismal process |
GO:0006303 | 0 | 7.1202 | 2.3957 | 14 | 75 | double-strand break repair via nonhomologous end joining |
GO:1902036 | 0 | 5.7187 | 3.2901 | 16 | 103 | regulation of hematopoietic stem cell differentiation |
GO:0070887 | 0 | 1.7198 | 92.5389 | 139 | 2897 | cellular response to chemical stimulus |
GO:0040011 | 0 | 2.1043 | 36.4514 | 69 | 1178 | locomotion |
GO:0045815 | 0 | 6.5787 | 2.5554 | 14 | 80 | positive regulation of gene expression, epigenetic |
GO:0009890 | 0 | 1.9094 | 51.9713 | 89 | 1627 | negative regulation of biosynthetic process |
GO:1903707 | 0 | 4.7528 | 4.3442 | 18 | 136 | negative regulation of hemopoiesis |
GO:0002757 | 0 | 2.7179 | 14.9813 | 37 | 469 | immune response-activating signal transduction |
GO:2000026 | 0 | 1.9599 | 44.8472 | 79 | 1450 | regulation of multicellular organismal development |
GO:0007166 | 0 | 1.772 | 70.1001 | 110 | 2284 | cell surface receptor signaling pathway |
GO:0045934 | 0 | 1.9416 | 44.4327 | 78 | 1391 | negative regulation of nucleobase-containing compound metabolic process |
GO:0045637 | 0 | 4.7863 | 4.0691 | 17 | 129 | regulation of myeloid cell differentiation |
GO:0002244 | 0 | 3.9292 | 6.0053 | 21 | 188 | hematopoietic progenitor cell differentiation |
GO:0060021 | 0 | 5.6349 | 2.9068 | 14 | 91 | palate development |
GO:0032720 | 0 | 8.809 | 1.4374 | 10 | 45 | negative regulation of tumor necrosis factor production |
GO:0048701 | 0 | 8.809 | 1.4374 | 10 | 45 | embryonic cranial skeleton morphogenesis |
GO:1903039 | 0 | 3.6199 | 6.7719 | 22 | 212 | positive regulation of leukocyte cell-cell adhesion |
GO:0060964 | 0 | 5.1141 | 3.386 | 15 | 106 | regulation of gene silencing by miRNA |
GO:0030097 | 0 | 2.5148 | 16.0751 | 37 | 518 | hemopoiesis |
GO:0035116 | 0 | 11.7098 | 0.9263 | 8 | 29 | embryonic hindlimb morphogenesis |
GO:0032496 | 0 | 2.9842 | 9.9343 | 27 | 311 | response to lipopolysaccharide |
GO:2000112 | 0 | 1.5615 | 128.1872 | 174 | 4013 | regulation of cellular macromolecule biosynthetic process |
GO:0051240 | 0 | 1.8466 | 46.4261 | 78 | 1464 | positive regulation of multicellular organismal process |
GO:0080090 | 0 | 1.5063 | 187.4415 | 237 | 5868 | regulation of primary metabolic process |
GO:0072048 | 0 | 38.2403 | 0.2875 | 5 | 9 | renal system pattern specification |
GO:0022407 | 0 | 3.2289 | 7.845 | 23 | 250 | regulation of cell-cell adhesion |
GO:0048869 | 0 | 1.5732 | 115.9762 | 159 | 3791 | cellular developmental process |
GO:0048646 | 0 | 2.0417 | 29.3424 | 55 | 934 | anatomical structure formation involved in morphogenesis |
GO:0045892 | 0 | 2.8662 | 10.3097 | 27 | 337 | negative regulation of transcription, DNA-templated |
GO:0006955 | 0 | 4.0071 | 4.7284 | 17 | 172 | immune response |
GO:0031497 | 0 | 3.9409 | 4.8234 | 17 | 151 | chromatin assembly |
GO:0002695 | 0 | 4.1253 | 4.3539 | 16 | 137 | negative regulation of leukocyte activation |
GO:0034654 | 0 | 1.5252 | 132.9148 | 177 | 4161 | nucleobase-containing compound biosynthetic process |
GO:0030098 | 0 | 2.8679 | 9.9023 | 26 | 310 | lymphocyte differentiation |
GO:0010646 | 0 | 1.5601 | 105.4119 | 146 | 3300 | regulation of cell communication |
GO:0043583 | 0 | 3.349 | 6.5803 | 20 | 206 | ear development |
GO:0051094 | 0 | 1.8562 | 39.2899 | 67 | 1230 | positive regulation of developmental process |
GO:0001816 | 0 | 2.6179 | 12.0361 | 29 | 386 | cytokine production |
GO:0006952 | 0 | 3.9294 | 4.5297 | 16 | 156 | defense response |
GO:0042102 | 0 | 4.7848 | 3.0985 | 13 | 97 | positive regulation of T cell proliferation |
GO:0009617 | 0 | 2.8977 | 9.0336 | 24 | 288 | response to bacterium |
GO:0045785 | 0 | 2.5927 | 12.1383 | 29 | 380 | positive regulation of cell adhesion |
GO:0060968 | 0 | 4.0406 | 4.1526 | 15 | 130 | regulation of gene silencing |
GO:0097530 | 0 | 4.247 | 3.7054 | 14 | 116 | granulocyte migration |
GO:0023051 | 0 | 1.5303 | 106.9771 | 146 | 3349 | regulation of signaling |
GO:0048522 | 0 | 1.5417 | 110.52 | 149 | 3717 | positive regulation of cellular process |
GO:0065007 | 0 | 1.5915 | 238.0088 | 276 | 8101 | biological regulation |
GO:0043066 | 0 | 2.0033 | 26.4169 | 49 | 827 | negative regulation of apoptotic process |
GO:0072088 | 0 | 5.2998 | 2.3957 | 11 | 75 | nephron epithelium morphogenesis |
GO:0002768 | 0 | 2.6008 | 11.2439 | 27 | 352 | immune response-regulating cell surface receptor signaling pathway |
GO:0006352 | 0 | 3.0142 | 7.6024 | 21 | 238 | DNA-templated transcription, initiation |
GO:0012501 | 0 | 1.7852 | 42.0905 | 69 | 1360 | programmed cell death |
GO:0031347 | 0 | 2.0854 | 22.2323 | 43 | 696 | regulation of defense response |
GO:0051607 | 0 | 3.1926 | 6.5164 | 19 | 204 | defense response to virus |
GO:0061333 | 0 | 5.1385 | 2.4596 | 11 | 77 | renal tubule morphogenesis |
GO:0072080 | 0 | 4.6885 | 2.9068 | 12 | 91 | nephron tubule development |
GO:0042116 | 0 | 5.7026 | 2.0444 | 10 | 64 | macrophage activation |
GO:0021953 | 0 | 3.4247 | 5.4623 | 17 | 171 | central nervous system neuron differentiation |
GO:0006954 | 0 | 2.355 | 14.1906 | 31 | 456 | inflammatory response |
GO:0045814 | 0 | 3.9361 | 3.9609 | 14 | 124 | negative regulation of gene expression, epigenetic |
GO:0035295 | 0 | 2.1673 | 18.3672 | 37 | 575 | tube development |
GO:0007155 | 1e-04 | 1.8982 | 29.5545 | 52 | 957 | cell adhesion |
GO:0090596 | 1e-04 | 2.8667 | 7.9538 | 21 | 249 | sensory organ morphogenesis |
GO:0000122 | 1e-04 | 1.9724 | 25.0753 | 46 | 785 | negative regulation of transcription from RNA polymerase II promoter |
GO:0042110 | 1e-04 | 3.8137 | 4.0654 | 14 | 132 | T cell activation |
GO:0006928 | 1e-04 | 1.724 | 44.6919 | 71 | 1443 | movement of cell or subcellular component |
GO:0042035 | 1e-04 | 4.3559 | 3.0985 | 12 | 97 | regulation of cytokine biosynthetic process |
GO:0035194 | 1e-04 | 2.9056 | 7.4747 | 20 | 234 | posttranscriptional gene silencing by RNA |
GO:0002407 | 1e-04 | 10.8093 | 0.7347 | 6 | 23 | dendritic cell chemotaxis |
GO:0042113 | 1e-04 | 3.2208 | 5.7687 | 17 | 182 | B cell activation |
GO:0051716 | 1e-04 | 1.5183 | 112.5177 | 147 | 3952 | cellular response to stimulus |
GO:0002690 | 1e-04 | 4.5807 | 2.7152 | 11 | 85 | positive regulation of leukocyte chemotaxis |
GO:0002250 | 1e-04 | 2.6073 | 9.513 | 23 | 300 | adaptive immune response |
GO:0032946 | 1e-04 | 3.6364 | 4.2484 | 14 | 133 | positive regulation of mononuclear cell proliferation |
GO:0051251 | 1e-04 | 2.7445 | 8.2732 | 21 | 259 | positive regulation of lymphocyte activation |
GO:0032879 | 1e-04 | 1.5262 | 82.6365 | 115 | 2587 | regulation of localization |
GO:0016192 | 1e-04 | 1.6132 | 57.8168 | 86 | 1810 | vesicle-mediated transport |
GO:1903555 | 1e-04 | 6.3614 | 1.4871 | 8 | 47 | regulation of tumor necrosis factor superfamily cytokine production |
GO:0042325 | 1e-04 | 1.6732 | 46.4132 | 72 | 1453 | regulation of phosphorylation |
GO:0007159 | 1e-04 | 3.5452 | 4.3393 | 14 | 140 | leukocyte cell-cell adhesion |
GO:0032715 | 1e-04 | 7.4014 | 1.1499 | 7 | 36 | negative regulation of interleukin-6 production |
GO:0045087 | 1e-04 | 1.9092 | 25.2381 | 45 | 794 | innate immune response |
GO:0072086 | 1e-04 | 91.4391 | 0.1278 | 3 | 4 | specification of loop of Henle identity |
GO:0007389 | 1e-04 | 4.6624 | 2.4139 | 10 | 81 | pattern specification process |
GO:0031076 | 1e-04 | 7.1542 | 1.1819 | 7 | 37 | embryonic camera-type eye development |
GO:0040017 | 1e-04 | 2.1816 | 15.2049 | 31 | 476 | positive regulation of locomotion |
GO:2000145 | 2e-04 | 2.1209 | 16.6483 | 33 | 530 | regulation of cell motility |
GO:0070663 | 2e-04 | 3.4394 | 4.4625 | 14 | 141 | regulation of leukocyte proliferation |
GO:0046632 | 2e-04 | 4.1829 | 2.9388 | 11 | 92 | alpha-beta T cell differentiation |
GO:0060993 | 2e-04 | 4.1829 | 2.9388 | 11 | 92 | kidney morphogenesis |
GO:0051272 | 2e-04 | 2.1931 | 14.6299 | 30 | 458 | positive regulation of cellular component movement |
GO:0060548 | 2e-04 | 1.8184 | 29.4195 | 50 | 921 | negative regulation of cell death |
GO:0060249 | 2e-04 | 2.3376 | 11.9147 | 26 | 373 | anatomical structure homeostasis |
GO:0072537 | 2e-04 | 20.3527 | 0.3194 | 4 | 10 | fibroblast activation |
GO:0010941 | 2e-04 | 1.9875 | 20.4734 | 38 | 669 | regulation of cell death |
GO:0014706 | 2e-04 | 2.3687 | 11.3078 | 25 | 354 | striated muscle tissue development |
GO:0090092 | 2e-04 | 2.8325 | 6.8677 | 18 | 215 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
GO:0060485 | 2e-04 | 2.8235 | 6.8863 | 18 | 217 | mesenchyme development |
GO:0050729 | 2e-04 | 3.7749 | 3.5137 | 12 | 110 | positive regulation of inflammatory response |
GO:0045321 | 2e-04 | 2.9159 | 6.2958 | 17 | 222 | leukocyte activation |
GO:0051047 | 2e-04 | 2.3037 | 12.0745 | 26 | 378 | positive regulation of secretion |
GO:0030595 | 2e-04 | 4.0208 | 3.0386 | 11 | 97 | leukocyte chemotaxis |
GO:0000165 | 2e-04 | 1.8153 | 28.2376 | 48 | 884 | MAPK cascade |
GO:0002274 | 3e-04 | 7.9888 | 0.9142 | 6 | 31 | myeloid leukocyte activation |
GO:0071345 | 3e-04 | 1.8173 | 27.5987 | 47 | 864 | cellular response to cytokine stimulus |
GO:0042474 | 3e-04 | 10.9189 | 0.6069 | 5 | 19 | middle ear morphogenesis |
GO:0061900 | 3e-04 | 7.9865 | 0.9263 | 6 | 29 | glial cell activation |
GO:0090009 | 3e-04 | 17.4441 | 0.3514 | 4 | 11 | primitive streak formation |
GO:0006968 | 3e-04 | 5.3373 | 1.7249 | 8 | 54 | cellular defense response |
GO:0050854 | 3e-04 | 5.3373 | 1.7249 | 8 | 54 | regulation of antigen receptor-mediated signaling pathway |
GO:0050859 | 3e-04 | 45.7166 | 0.1597 | 3 | 5 | negative regulation of B cell receptor signaling pathway |
GO:1901164 | 3e-04 | 45.7166 | 0.1597 | 3 | 5 | negative regulation of trophoblast cell migration |
GO:0051048 | 3e-04 | 2.7992 | 6.5483 | 17 | 205 | negative regulation of secretion |
GO:0048665 | 3e-04 | 10.2435 | 0.6357 | 5 | 20 | neuron fate specification |
GO:0009893 | 3e-04 | 2.4222 | 9.759 | 22 | 347 | positive regulation of metabolic process |
GO:2000406 | 3e-04 | 10.1903 | 0.6389 | 5 | 20 | positive regulation of T cell migration |
GO:0003002 | 3e-04 | 3.8034 | 3.1856 | 11 | 105 | regionalization |
GO:0002697 | 4e-04 | 3.5229 | 3.7331 | 12 | 119 | regulation of immune effector process |
GO:0045444 | 4e-04 | 2.7694 | 6.6122 | 17 | 207 | fat cell differentiation |
GO:0051174 | 4e-04 | 1.5678 | 54.1434 | 79 | 1695 | regulation of phosphorus metabolic process |
GO:0021988 | 4e-04 | 7.3466 | 0.9902 | 6 | 31 | olfactory lobe development |
GO:0007154 | 4e-04 | 1.5029 | 80.3672 | 108 | 2789 | cell communication |
GO:0050853 | 4e-04 | 5.8315 | 1.3978 | 7 | 44 | B cell receptor signaling pathway |
GO:0042981 | 4e-04 | 2.063 | 15.4959 | 30 | 512 | regulation of apoptotic process |
GO:0010033 | 5e-04 | 1.492 | 71.9899 | 99 | 2309 | response to organic substance |
GO:0030168 | 5e-04 | 3.0429 | 4.9831 | 14 | 156 | platelet activation |
GO:0015844 | 6e-04 | 4.2525 | 2.3638 | 9 | 74 | monoamine transport |
GO:0035710 | 6e-04 | 4.2525 | 2.3638 | 9 | 74 | CD4-positive, alpha-beta T cell activation |
GO:0048935 | 6e-04 | 13.5659 | 0.4153 | 4 | 13 | peripheral nervous system neuron development |
GO:0001878 | 6e-04 | 30.4758 | 0.1917 | 3 | 6 | response to yeast |
GO:0048645 | 6e-04 | 4.7197 | 1.9166 | 8 | 60 | animal organ formation |
GO:0048048 | 6e-04 | 6.5582 | 1.0861 | 6 | 34 | embryonic eye morphogenesis |
GO:0048585 | 7e-04 | 2.3992 | 8.9035 | 20 | 288 | negative regulation of response to stimulus |
GO:0002703 | 7e-04 | 2.9385 | 5.1428 | 14 | 161 | regulation of leukocyte mediated immunity |
GO:0035108 | 7e-04 | 3.4882 | 3.4472 | 11 | 110 | limb morphogenesis |
GO:0045937 | 7e-04 | 1.6675 | 34.4345 | 54 | 1078 | positive regulation of phosphate metabolic process |
GO:0050670 | 7e-04 | 3.7615 | 2.9273 | 10 | 93 | regulation of lymphocyte proliferation |
GO:0002292 | 7e-04 | 4.6303 | 1.9485 | 8 | 61 | T cell differentiation involved in immune response |
GO:0017148 | 7e-04 | 2.2764 | 10.2856 | 22 | 322 | negative regulation of translation |
GO:0046634 | 8e-04 | 4.0641 | 2.4596 | 9 | 77 | regulation of alpha-beta T cell activation |
GO:2000826 | 8e-04 | 6.3317 | 1.118 | 6 | 35 | regulation of heart morphogenesis |
GO:0072210 | 8e-04 | 12.3349 | 0.4428 | 4 | 14 | metanephric nephron development |
GO:0051248 | 8e-04 | 1.608 | 40.3759 | 61 | 1264 | negative regulation of protein metabolic process |
GO:0010463 | 8e-04 | 5.2311 | 1.5333 | 7 | 48 | mesenchymal cell proliferation |
GO:0010862 | 8e-04 | 5.2311 | 1.5333 | 7 | 48 | positive regulation of pathway-restricted SMAD protein phosphorylation |
GO:0060538 | 8e-04 | 2.8791 | 5.2387 | 14 | 164 | skeletal muscle organ development |
GO:0001906 | 8e-04 | 3.1855 | 4.0887 | 12 | 128 | cell killing |
GO:0050868 | 8e-04 | 3.659 | 3.0026 | 10 | 94 | negative regulation of T cell activation |
GO:2000482 | 8e-04 | 8.0429 | 0.7666 | 5 | 24 | regulation of interleukin-8 secretion |
GO:0048844 | 8e-04 | 4.4614 | 2.0124 | 8 | 63 | artery morphogenesis |
GO:0032200 | 9e-04 | 2.8409 | 5.3025 | 14 | 166 | telomere organization |
GO:0042472 | 9e-04 | 3.6157 | 3.0346 | 10 | 95 | inner ear morphogenesis |
GO:0009888 | 9e-04 | 1.9892 | 15.4805 | 29 | 508 | tissue development |
GO:0021872 | 9e-04 | 4.3814 | 2.0444 | 8 | 64 | forebrain generation of neurons |
GO:0051216 | 0.001 | 2.8187 | 5.3394 | 14 | 168 | cartilage development |
GO:0065004 | 0.001 | 2.5146 | 7.2191 | 17 | 226 | protein-DNA complex assembly |
GO:0033002 | 0.001 | 2.6917 | 5.9733 | 15 | 187 | muscle cell proliferation |
GO:0051704 | 0.001 | 1.4485 | 73.4689 | 99 | 2300 | multi-organism process |
GO:0072268 | 0.001 | Inf | 0.0636 | 2 | 2 | pattern specification involved in metanephros development |
GO:0003218 | 0.001 | Inf | 0.0639 | 2 | 2 | cardiac left ventricle formation |
GO:0003404 | 0.001 | Inf | 0.0639 | 2 | 2 | optic vesicle morphogenesis |
GO:0018003 | 0.001 | Inf | 0.0639 | 2 | 2 | peptidyl-lysine N6-acetylation |
GO:0043376 | 0.001 | Inf | 0.0639 | 2 | 2 | regulation of CD8-positive, alpha-beta T cell differentiation |
GO:0044663 | 0.001 | Inf | 0.0639 | 2 | 2 | establishment or maintenance of cell type involved in phenotypic switching |
GO:0060460 | 0.001 | Inf | 0.0639 | 2 | 2 | left lung morphogenesis |
GO:0060809 | 0.001 | Inf | 0.0639 | 2 | 2 | mesodermal to mesenchymal transition involved in gastrulation |
GO:0072272 | 0.001 | Inf | 0.0639 | 2 | 2 | proximal/distal pattern formation involved in metanephric nephron development |
GO:2000417 | 0.001 | Inf | 0.0639 | 2 | 2 | negative regulation of eosinophil migration |
GO:2001055 | 0.001 | Inf | 0.0639 | 2 | 2 | positive regulation of mesenchymal cell apoptotic process |
GO:0042481 | 0.001 | 7.6403 | 0.7986 | 5 | 25 | regulation of odontogenesis |
GO:0003253 | 0.001 | 22.8554 | 0.2236 | 3 | 7 | cardiac neural crest cell migration involved in outflow tract morphogenesis |
GO:0021796 | 0.001 | 22.8554 | 0.2236 | 3 | 7 | cerebral cortex regionalization |
GO:0001829 | 0.0011 | 11.098 | 0.4791 | 4 | 15 | trophectodermal cell differentiation |
GO:0036037 | 0.0011 | 11.098 | 0.4791 | 4 | 15 | CD8-positive, alpha-beta T cell activation |
GO:0050755 | 0.0011 | 11.098 | 0.4791 | 4 | 15 | chemokine metabolic process |
GO:0045936 | 0.0011 | 1.8773 | 18.5908 | 33 | 582 | negative regulation of phosphate metabolic process |
GO:0006935 | 0.0011 | 2.1487 | 11.3481 | 23 | 365 | chemotaxis |
GO:1901342 | 0.0011 | 2.2861 | 9.2954 | 20 | 291 | regulation of vasculature development |
GO:0031399 | 0.0011 | 1.5056 | 54.5586 | 77 | 1708 | regulation of protein modification process |
GO:0009967 | 0.0012 | 2.0344 | 13.546 | 26 | 442 | positive regulation of signal transduction |
GO:0033628 | 0.0012 | 5.737 | 1.2138 | 6 | 38 | regulation of cell adhesion mediated by integrin |
GO:0072507 | 0.0012 | 2.0002 | 14.2785 | 27 | 447 | divalent inorganic cation homeostasis |
GO:0050709 | 0.0012 | 3.2219 | 3.7054 | 11 | 116 | negative regulation of protein secretion |
GO:0042742 | 0.0013 | 2.5338 | 6.74 | 16 | 211 | defense response to bacterium |
GO:0051259 | 0.0013 | 1.9159 | 16.5465 | 30 | 518 | protein oligomerization |
GO:0071103 | 0.0013 | 2.3058 | 8.7524 | 19 | 274 | DNA conformation change |
GO:0050920 | 0.0014 | 2.9833 | 4.3364 | 12 | 137 | regulation of chemotaxis |
GO:0022603 | 0.0014 | 1.6475 | 31.4638 | 49 | 985 | regulation of anatomical structure morphogenesis |
GO:0007379 | 0.0014 | 10.1725 | 0.5111 | 4 | 16 | segment specification |
GO:0030335 | 0.0014 | 2.0055 | 13.7035 | 26 | 429 | positive regulation of cell migration |
GO:2001235 | 0.0014 | 2.6975 | 5.5581 | 14 | 174 | positive regulation of apoptotic signaling pathway |
GO:0048562 | 0.0014 | 2.8143 | 4.9528 | 13 | 162 | embryonic organ morphogenesis |
GO:0061061 | 0.0015 | 1.8211 | 19.7088 | 34 | 617 | muscle structure development |
GO:0031323 | 0.0015 | 1.3623 | 129.9958 | 159 | 4299 | regulation of cellular metabolic process |
GO:0036065 | 0.0015 | 6.9448 | 0.8625 | 5 | 27 | fucosylation |
GO:0061311 | 0.0015 | 6.9448 | 0.8625 | 5 | 27 | cell surface receptor signaling pathway involved in heart development |
GO:0048583 | 0.0015 | 1.5261 | 49.4043 | 70 | 1748 | regulation of response to stimulus |
GO:0023052 | 0.0015 | 1.4393 | 78.8479 | 103 | 2727 | signaling |
GO:0035137 | 0.0015 | 18.5458 | 0.2521 | 3 | 8 | hindlimb morphogenesis |
GO:0010324 | 0.0016 | 4.5616 | 1.7249 | 7 | 54 | membrane invagination |
GO:0050922 | 0.0016 | 5.3988 | 1.2777 | 6 | 40 | negative regulation of chemotaxis |
GO:0002072 | 0.0016 | 18.2832 | 0.2555 | 3 | 8 | optic cup morphogenesis involved in camera-type eye development |
GO:0048743 | 0.0016 | 18.2832 | 0.2555 | 3 | 8 | positive regulation of skeletal muscle fiber development |
GO:0050776 | 0.0017 | 2.5388 | 6.2952 | 15 | 209 | regulation of immune response |
GO:0001568 | 0.0017 | 1.8018 | 19.9005 | 34 | 623 | blood vessel development |
GO:0008284 | 0.0018 | 1.8167 | 19.1648 | 33 | 615 | positive regulation of cell proliferation |
GO:0003198 | 0.0018 | 9.3894 | 0.543 | 4 | 17 | epithelial to mesenchymal transition involved in endocardial cushion formation |
GO:0043370 | 0.0018 | 5.2442 | 1.3097 | 6 | 41 | regulation of CD4-positive, alpha-beta T cell differentiation |
GO:0002698 | 0.0018 | 3.2676 | 3.3221 | 10 | 104 | negative regulation of immune effector process |
GO:0043068 | 0.0018 | 1.8123 | 19.1977 | 33 | 601 | positive regulation of programmed cell death |
GO:0050863 | 0.0019 | 2.7274 | 5.1007 | 13 | 163 | regulation of T cell activation |
GO:0010605 | 0.0019 | 1.5491 | 41.2076 | 60 | 1348 | negative regulation of macromolecule metabolic process |
GO:0002287 | 0.0019 | 4.3748 | 1.7888 | 7 | 56 | alpha-beta T cell activation involved in immune response |
GO:0002673 | 0.002 | 3.4958 | 2.811 | 9 | 88 | regulation of acute inflammatory response |
GO:0060349 | 0.002 | 3.4958 | 2.811 | 9 | 88 | bone morphogenesis |
GO:0060415 | 0.002 | 3.8461 | 2.2918 | 8 | 72 | muscle tissue morphogenesis |
GO:0045766 | 0.002 | 2.8399 | 4.5359 | 12 | 142 | positive regulation of angiogenesis |
GO:2000401 | 0.002 | 5.0982 | 1.3416 | 6 | 42 | regulation of lymphocyte migration |
GO:0001707 | 0.002 | 3.8318 | 2.2999 | 8 | 72 | mesoderm formation |
GO:0003203 | 0.0021 | 6.3653 | 0.9263 | 5 | 29 | endocardial cushion morphogenesis |
GO:0016477 | 0.0021 | 1.8126 | 18.6254 | 32 | 620 | cell migration |
GO:0010818 | 0.0022 | 8.7182 | 0.575 | 4 | 18 | T cell chemotaxis |
GO:0033622 | 0.0022 | 8.7182 | 0.575 | 4 | 18 | integrin activation |
GO:0050860 | 0.0022 | 8.7182 | 0.575 | 4 | 18 | negative regulation of T cell receptor signaling pathway |
GO:0072358 | 0.0023 | 1.7533 | 21.0185 | 35 | 658 | cardiovascular system development |
GO:0031532 | 0.0023 | 3.409 | 2.8749 | 9 | 90 | actin cytoskeleton reorganization |
GO:0021983 | 0.0023 | 4.9601 | 1.3735 | 6 | 43 | pituitary gland development |
GO:0042355 | 0.0024 | 15.235 | 0.2875 | 3 | 9 | L-fucose catabolic process |
GO:0042473 | 0.0024 | 15.235 | 0.2875 | 3 | 9 | outer ear morphogenesis |
GO:0072172 | 0.0024 | 15.235 | 0.2875 | 3 | 9 | mesonephric tubule formation |
GO:0043281 | 0.0024 | 2.447 | 6.5164 | 15 | 204 | regulation of cysteine-type endopeptidase activity involved in apoptotic process |
GO:0040020 | 0.0024 | 6.1103 | 0.9583 | 5 | 30 | regulation of meiotic nuclear division |
GO:0051952 | 0.0024 | 3.7152 | 2.3638 | 8 | 74 | regulation of amine transport |
GO:0071773 | 0.0025 | 2.6328 | 5.2706 | 13 | 165 | cellular response to BMP stimulus |
GO:0002696 | 0.0025 | 6.032 | 0.9656 | 5 | 31 | positive regulation of leukocyte activation |
GO:0045576 | 0.0025 | 4.8552 | 1.3983 | 6 | 44 | mast cell activation |
GO:0048518 | 0.0026 | 2.5179 | 5.9416 | 14 | 237 | positive regulation of biological process |
GO:0090287 | 0.0026 | 2.2719 | 7.9219 | 17 | 248 | regulation of cellular response to growth factor stimulus |
GO:0022408 | 0.0027 | 2.7339 | 4.6956 | 12 | 147 | negative regulation of cell-cell adhesion |
GO:0048754 | 0.0027 | 2.7339 | 4.6956 | 12 | 147 | branching morphogenesis of an epithelial tube |
GO:0072074 | 0.0027 | 8.1364 | 0.6069 | 4 | 19 | kidney mesenchyme development |
GO:0065009 | 0.0027 | 1.371 | 89.4456 | 114 | 2861 | regulation of molecular function |
GO:0050714 | 0.0028 | 2.3281 | 7.283 | 16 | 228 | positive regulation of protein secretion |
GO:0050869 | 0.0028 | 5.8749 | 0.9902 | 5 | 31 | negative regulation of B cell activation |
GO:0051090 | 0.0028 | 1.9852 | 12.2022 | 23 | 382 | regulation of DNA binding transcription factor activity |
GO:0007599 | 0.0028 | 2.0567 | 10.7648 | 21 | 337 | hemostasis |
GO:0050817 | 0.0028 | 2.0567 | 10.7648 | 21 | 337 | coagulation |
GO:0042733 | 0.0029 | 4.0592 | 1.9096 | 7 | 60 | embryonic digit morphogenesis |
GO:0045595 | 0.0029 | 1.6759 | 24.5419 | 39 | 829 | regulation of cell differentiation |
GO:0030888 | 0.0029 | 4.0436 | 1.9166 | 7 | 60 | regulation of B cell proliferation |
GO:0050663 | 0.0029 | 2.4782 | 6.0053 | 14 | 188 | cytokine secretion |
GO:0032757 | 0.0029 | 4.7052 | 1.4374 | 6 | 45 | positive regulation of interleukin-8 production |
GO:0043303 | 0.0029 | 4.7052 | 1.4374 | 6 | 45 | mast cell degranulation |
GO:0050766 | 0.0029 | 4.7052 | 1.4374 | 6 | 45 | positive regulation of phagocytosis |
GO:0002761 | 0.0029 | 3.0398 | 3.5457 | 10 | 111 | regulation of myeloid leukocyte differentiation |
GO:0072047 | 0.003 | 61.0775 | 0.0955 | 2 | 3 | proximal/distal pattern formation involved in nephron development |
GO:0002351 | 0.003 | 60.8417 | 0.0958 | 2 | 3 | serotonin production involved in inflammatory response |
GO:0002378 | 0.003 | 60.8417 | 0.0958 | 2 | 3 | immunoglobulin biosynthetic process |
GO:0002554 | 0.003 | 60.8417 | 0.0958 | 2 | 3 | serotonin secretion by platelet |
GO:0009946 | 0.003 | 60.8417 | 0.0958 | 2 | 3 | proximal/distal axis specification |
GO:0014738 | 0.003 | 60.8417 | 0.0958 | 2 | 3 | regulation of muscle hyperplasia |
GO:0032765 | 0.003 | 60.8417 | 0.0958 | 2 | 3 | positive regulation of mast cell cytokine production |
GO:0035880 | 0.003 | 60.8417 | 0.0958 | 2 | 3 | embryonic nail plate morphogenesis |
GO:0042631 | 0.003 | 60.8417 | 0.0958 | 2 | 3 | cellular response to water deprivation |
GO:0045658 | 0.003 | 60.8417 | 0.0958 | 2 | 3 | regulation of neutrophil differentiation |
GO:0060166 | 0.003 | 60.8417 | 0.0958 | 2 | 3 | olfactory pit development |
GO:0090427 | 0.003 | 60.8417 | 0.0958 | 2 | 3 | activation of meiosis |
GO:1903238 | 0.003 | 60.8417 | 0.0958 | 2 | 3 | positive regulation of leukocyte tethering or rolling |
GO:2001183 | 0.003 | 60.8417 | 0.0958 | 2 | 3 | negative regulation of interleukin-12 secretion |
GO:0072175 | 0.003 | 2.8403 | 4.1526 | 11 | 130 | epithelial tube formation |
GO:0008344 | 0.0031 | 3.553 | 2.4596 | 8 | 77 | adult locomotory behavior |
GO:0048661 | 0.0031 | 3.553 | 2.4596 | 8 | 77 | positive regulation of smooth muscle cell proliferation |
GO:0050852 | 0.0032 | 2.6732 | 4.7916 | 12 | 151 | T cell receptor signaling pathway |
GO:0042107 | 0.0032 | 3.2328 | 3.014 | 9 | 95 | cytokine metabolic process |
GO:0002224 | 0.0032 | 2.8165 | 4.1845 | 11 | 131 | toll-like receptor signaling pathway |
GO:1902107 | 0.0032 | 2.8165 | 4.1845 | 11 | 131 | positive regulation of leukocyte differentiation |
GO:0090022 | 0.0032 | 5.657 | 1.0222 | 5 | 32 | regulation of neutrophil chemotaxis |
GO:1904951 | 0.0032 | 1.8312 | 16.0673 | 28 | 503 | positive regulation of establishment of protein localization |
GO:0072079 | 0.0032 | 13.129 | 0.3178 | 3 | 10 | nephron tubule formation |
GO:0001654 | 0.0033 | 2.0304 | 10.8926 | 21 | 341 | eye development |
GO:0021877 | 0.0033 | 13.0578 | 0.3194 | 3 | 10 | forebrain neuron fate commitment |
GO:0045080 | 0.0033 | 13.0578 | 0.3194 | 3 | 10 | positive regulation of chemokine biosynthetic process |
GO:0071639 | 0.0033 | 13.0578 | 0.3194 | 3 | 10 | positive regulation of monocyte chemotactic protein-1 production |
GO:0072087 | 0.0033 | 7.6274 | 0.6389 | 4 | 20 | renal vesicle development |
GO:0050728 | 0.0033 | 2.9804 | 3.6096 | 10 | 113 | negative regulation of inflammatory response |
GO:1902533 | 0.0034 | 1.591 | 30.4097 | 46 | 952 | positive regulation of intracellular signal transduction |
GO:1903530 | 0.0034 | 1.7198 | 20.7629 | 34 | 650 | regulation of secretion by cell |
GO:0002791 | 0.0034 | 1.8955 | 13.8633 | 25 | 434 | regulation of peptide secretion |
GO:0042060 | 0.0035 | 1.7988 | 16.9298 | 29 | 530 | wound healing |
GO:0001763 | 0.0035 | 2.4219 | 6.1331 | 14 | 192 | morphogenesis of a branching structure |
GO:0099565 | 0.0035 | 2.9515 | 3.6415 | 10 | 114 | chemical synaptic transmission, postsynaptic |
GO:0007204 | 0.0036 | 2.1459 | 8.8482 | 18 | 277 | positive regulation of cytosolic calcium ion concentration |
GO:0071887 | 0.0036 | 3.1727 | 3.0665 | 9 | 96 | leukocyte apoptotic process |
GO:0060429 | 0.0036 | 1.524 | 38.0122 | 55 | 1190 | epithelium development |
GO:0035094 | 0.0036 | 4.4751 | 1.5013 | 6 | 47 | response to nicotine |
GO:0030513 | 0.0037 | 5.4546 | 1.0541 | 5 | 33 | positive regulation of BMP signaling pathway |
GO:0009653 | 0.0038 | 1.6719 | 23.3339 | 37 | 783 | anatomical structure morphogenesis |
GO:0003279 | 0.0038 | 3.1364 | 3.0985 | 9 | 97 | cardiac septum development |
GO:0001934 | 0.0039 | 1.6118 | 27.371 | 42 | 866 | positive regulation of protein phosphorylation |
GO:0061082 | 0.004 | 7.1783 | 0.6708 | 4 | 21 | myeloid leukocyte cytokine production |
GO:2000678 | 0.004 | 7.1783 | 0.6708 | 4 | 21 | negative regulation of transcription regulatory region DNA binding |
GO:0009889 | 0.0041 | 1.3737 | 80.864 | 103 | 2749 | regulation of biosynthetic process |
GO:0002707 | 0.0042 | 5.2662 | 1.0861 | 5 | 34 | negative regulation of lymphocyte mediated immunity |
GO:0001933 | 0.0042 | 1.887 | 13.3522 | 24 | 418 | negative regulation of protein phosphorylation |
GO:0032609 | 0.0044 | 3.0663 | 3.1624 | 9 | 99 | interferon-gamma production |
GO:0003264 | 0.0044 | 11.4248 | 0.3514 | 3 | 11 | regulation of cardioblast proliferation |
GO:0033004 | 0.0044 | 11.4248 | 0.3514 | 3 | 11 | negative regulation of mast cell activation |
GO:0042535 | 0.0044 | 11.4248 | 0.3514 | 3 | 11 | positive regulation of tumor necrosis factor biosynthetic process |
GO:0060099 | 0.0044 | 11.4248 | 0.3514 | 3 | 11 | regulation of phagocytosis, engulfment |
GO:0061308 | 0.0044 | 11.4248 | 0.3514 | 3 | 11 | cardiac neural crest cell development involved in heart development |
GO:2000047 | 0.0044 | 11.4248 | 0.3514 | 3 | 11 | regulation of cell-cell adhesion mediated by cadherin |
GO:0032103 | 0.0045 | 2.5533 | 4.9955 | 12 | 159 | positive regulation of response to external stimulus |
GO:0021545 | 0.0045 | 4.2664 | 1.5652 | 6 | 49 | cranial nerve development |
GO:0003231 | 0.0045 | 2.8415 | 3.7693 | 10 | 118 | cardiac ventricle development |
GO:0002686 | 0.0047 | 5.1101 | 1.1138 | 5 | 35 | negative regulation of leukocyte migration |
GO:0030856 | 0.0048 | 2.66 | 4.4081 | 11 | 138 | regulation of epithelial cell differentiation |
GO:0002438 | 0.0048 | 6.7791 | 0.7027 | 4 | 22 | acute inflammatory response to antigenic stimulus |
GO:0048566 | 0.0048 | 5.0903 | 1.118 | 5 | 35 | embryonic digestive tract development |
GO:0009798 | 0.0048 | 3.2861 | 2.6369 | 8 | 83 | axis specification |
GO:2001141 | 0.005 | 1.3828 | 70.3658 | 91 | 2380 | regulation of RNA biosynthetic process |
GO:0007566 | 0.005 | 4.1692 | 1.5971 | 6 | 50 | embryo implantation |
GO:0050672 | 0.005 | 3.631 | 2.1082 | 7 | 66 | negative regulation of lymphocyte proliferation |
GO:1903557 | 0.005 | 3.631 | 2.1082 | 7 | 66 | positive regulation of tumor necrosis factor superfamily cytokine production |
GO:0048729 | 0.005 | 1.7678 | 16.5968 | 28 | 531 | tissue morphogenesis |
GO:0016331 | 0.0051 | 2.6331 | 4.4484 | 11 | 140 | morphogenesis of embryonic epithelium |
GO:0070372 | 0.0052 | 2.1138 | 8.4649 | 17 | 265 | regulation of ERK1 and ERK2 cascade |
GO:0072376 | 0.0053 | 3.2243 | 2.6832 | 8 | 84 | protein activation cascade |
GO:2000146 | 0.0054 | 2.1052 | 8.4968 | 17 | 266 | negative regulation of cell motility |
GO:0009954 | 0.0054 | 6.4966 | 0.7266 | 4 | 23 | proximal/distal pattern formation |
GO:0030500 | 0.0054 | 3.5703 | 2.1402 | 7 | 67 | regulation of bone mineralization |
GO:0031295 | 0.0054 | 3.5703 | 2.1402 | 7 | 67 | T cell costimulation |
GO:0035914 | 0.0054 | 3.5703 | 2.1402 | 7 | 67 | skeletal muscle cell differentiation |
GO:0048536 | 0.0054 | 4.9258 | 1.1499 | 5 | 36 | spleen development |
GO:0048641 | 0.0055 | 4.0763 | 1.6291 | 6 | 51 | regulation of skeletal muscle tissue development |
GO:0050851 | 0.0056 | 31.2671 | 0.1244 | 2 | 4 | antigen receptor-mediated signaling pathway |
GO:0006874 | 0.0056 | 1.8679 | 12.905 | 23 | 404 | cellular calcium ion homeostasis |
GO:0001655 | 0.0056 | 2.0018 | 9.9662 | 19 | 312 | urogenital system development |
GO:0050900 | 0.0056 | 2.5939 | 4.5041 | 11 | 148 | leukocyte migration |
GO:0002507 | 0.0056 | 6.4219 | 0.7347 | 4 | 23 | tolerance induction |
GO:0002691 | 0.0056 | 6.4219 | 0.7347 | 4 | 23 | regulation of cellular extravasation |
GO:0042402 | 0.0056 | 6.4219 | 0.7347 | 4 | 23 | cellular biogenic amine catabolic process |
GO:0045686 | 0.0056 | 6.4219 | 0.7347 | 4 | 23 | negative regulation of glial cell differentiation |
GO:1900745 | 0.0056 | 6.4219 | 0.7347 | 4 | 23 | positive regulation of p38MAPK cascade |
GO:2000778 | 0.0056 | 6.4219 | 0.7347 | 4 | 23 | positive regulation of interleukin-6 secretion |
GO:0003207 | 0.0057 | 10.1547 | 0.3833 | 3 | 12 | cardiac chamber formation |
GO:0021889 | 0.0057 | 10.1547 | 0.3833 | 3 | 12 | olfactory bulb interneuron differentiation |
GO:0033605 | 0.0057 | 10.1547 | 0.3833 | 3 | 12 | positive regulation of catecholamine secretion |
GO:0033631 | 0.0057 | 10.1547 | 0.3833 | 3 | 12 | cell-cell adhesion mediated by integrin |
GO:0045086 | 0.0057 | 10.1547 | 0.3833 | 3 | 12 | positive regulation of interleukin-2 biosynthetic process |
GO:0060536 | 0.0057 | 10.1547 | 0.3833 | 3 | 12 | cartilage morphogenesis |
GO:0030593 | 0.0058 | 4.0196 | 1.6483 | 6 | 52 | neutrophil chemotaxis |
GO:0003199 | 0.0059 | 30.4189 | 0.1278 | 2 | 4 | endocardial cushion to mesenchymal transition involved in heart valve formation |
GO:0003219 | 0.0059 | 30.4189 | 0.1278 | 2 | 4 | cardiac right ventricle formation |
GO:0021764 | 0.0059 | 30.4189 | 0.1278 | 2 | 4 | amygdala development |
GO:0021913 | 0.0059 | 30.4189 | 0.1278 | 2 | 4 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification |
GO:0045415 | 0.0059 | 30.4189 | 0.1278 | 2 | 4 | negative regulation of interleukin-8 biosynthetic process |
GO:0048852 | 0.0059 | 30.4189 | 0.1278 | 2 | 4 | diencephalon morphogenesis |
GO:0061055 | 0.0059 | 30.4189 | 0.1278 | 2 | 4 | myotome development |
GO:0061325 | 0.0059 | 30.4189 | 0.1278 | 2 | 4 | cell proliferation involved in outflow tract morphogenesis |
GO:0065001 | 0.0059 | 30.4189 | 0.1278 | 2 | 4 | specification of axis polarity |
GO:0072107 | 0.0059 | 30.4189 | 0.1278 | 2 | 4 | positive regulation of ureteric bud formation |
GO:0072513 | 0.0059 | 30.4189 | 0.1278 | 2 | 4 | positive regulation of secondary heart field cardioblast proliferation |
GO:0097168 | 0.0059 | 30.4189 | 0.1278 | 2 | 4 | mesenchymal stem cell proliferation |
GO:2000491 | 0.0059 | 30.4189 | 0.1278 | 2 | 4 | positive regulation of hepatic stellate cell activation |
GO:2001274 | 0.0059 | 30.4189 | 0.1278 | 2 | 4 | negative regulation of glucose import in response to insulin stimulus |
GO:1901576 | 0.0059 | 1.2604 | 197.9188 | 226 | 6196 | organic substance biosynthetic process |
GO:0021515 | 0.006 | 3.9874 | 1.661 | 6 | 52 | cell differentiation in spinal cord |
GO:0007498 | 0.0061 | 2.7149 | 3.929 | 10 | 123 | mesoderm development |
GO:0060412 | 0.0061 | 4.7715 | 1.1819 | 5 | 37 | ventricular septum morphogenesis |
GO:0071542 | 0.0061 | 4.7715 | 1.1819 | 5 | 37 | dopaminergic neuron differentiation |
GO:0055123 | 0.0062 | 2.5584 | 4.5678 | 11 | 143 | digestive system development |
GO:0032611 | 0.0064 | 3.4547 | 2.2041 | 7 | 69 | interleukin-1 beta production |
GO:0032675 | 0.0065 | 3.4403 | 2.2108 | 7 | 70 | regulation of interleukin-6 production |
GO:0002285 | 0.0065 | 2.539 | 4.5998 | 11 | 144 | lymphocyte activation involved in immune response |
GO:0009968 | 0.0066 | 1.4834 | 37.4691 | 53 | 1173 | negative regulation of signal transduction |
GO:0003171 | 0.0066 | 6.1004 | 0.7666 | 4 | 24 | atrioventricular valve development |
GO:0021871 | 0.0066 | 6.1004 | 0.7666 | 4 | 24 | forebrain regionalization |
GO:0006351 | 0.0066 | 1.3652 | 71.1217 | 91 | 2398 | transcription, DNA-templated |
GO:0071396 | 0.0066 | 1.7105 | 17.7284 | 29 | 555 | cellular response to lipid |
GO:0070228 | 0.0066 | 3.9023 | 1.693 | 6 | 53 | regulation of lymphocyte apoptotic process |
GO:0051050 | 0.0067 | 1.7105 | 17.7394 | 29 | 571 | positive regulation of transport |
GO:0002820 | 0.0069 | 4.6267 | 1.2138 | 5 | 38 | negative regulation of adaptive immune response |
GO:0032924 | 0.0069 | 4.6267 | 1.2138 | 5 | 38 | activin receptor signaling pathway |
GO:0032642 | 0.0069 | 3.3996 | 2.236 | 7 | 70 | regulation of chemokine production |
GO:0070664 | 0.0069 | 3.3996 | 2.236 | 7 | 70 | negative regulation of leukocyte proliferation |
GO:0048872 | 0.0072 | 2.1475 | 7.3469 | 15 | 230 | homeostasis of number of cells |
GO:0032695 | 0.0072 | 9.1736 | 0.4137 | 3 | 13 | negative regulation of interleukin-12 production |
GO:0001910 | 0.0073 | 3.8208 | 1.7249 | 6 | 54 | regulation of leukocyte mediated cytotoxicity |
GO:0003337 | 0.0073 | 9.1387 | 0.4153 | 3 | 13 | mesenchymal to epithelial transition involved in metanephros morphogenesis |
GO:0010623 | 0.0073 | 9.1387 | 0.4153 | 3 | 13 | programmed cell death involved in cell development |
GO:0021520 | 0.0073 | 9.1387 | 0.4153 | 3 | 13 | spinal cord motor neuron cell fate specification |
GO:0035723 | 0.0073 | 9.1387 | 0.4153 | 3 | 13 | interleukin-15-mediated signaling pathway |
GO:0045605 | 0.0073 | 9.1387 | 0.4153 | 3 | 13 | negative regulation of epidermal cell differentiation |
GO:0070234 | 0.0073 | 9.1387 | 0.4153 | 3 | 13 | positive regulation of T cell apoptotic process |
GO:0098657 | 0.0073 | 1.6262 | 21.849 | 34 | 684 | import into cell |
GO:0070848 | 0.0073 | 1.6381 | 21.0504 | 33 | 659 | response to growth factor |
GO:0032270 | 0.0073 | 1.425 | 47.1798 | 64 | 1477 | positive regulation of cellular protein metabolic process |
GO:0032637 | 0.0074 | 5.8633 | 0.7915 | 4 | 25 | interleukin-8 production |
GO:0015696 | 0.0075 | 3.0243 | 2.8429 | 8 | 89 | ammonium transport |
GO:0002685 | 0.0076 | 3.3256 | 2.2776 | 7 | 73 | regulation of leukocyte migration |
GO:0001975 | 0.0076 | 5.8095 | 0.7986 | 4 | 25 | response to amphetamine |
GO:0034105 | 0.0077 | 4.4903 | 1.2458 | 5 | 39 | positive regulation of tissue remodeling |
GO:0060255 | 0.0078 | 1.3244 | 95.8161 | 117 | 3282 | regulation of macromolecule metabolic process |
GO:0002294 | 0.008 | 3.7426 | 1.7569 | 6 | 55 | CD4-positive, alpha-beta T cell differentiation involved in immune response |
GO:0002702 | 0.008 | 3.2946 | 2.2999 | 7 | 72 | positive regulation of production of molecular mediator of immune response |
GO:0001837 | 0.0082 | 2.5872 | 4.1053 | 10 | 129 | epithelial to mesenchymal transition |
GO:0051100 | 0.0084 | 2.4463 | 4.7595 | 11 | 149 | negative regulation of binding |
GO:0050679 | 0.0085 | 2.3325 | 5.4303 | 12 | 170 | positive regulation of epithelial cell proliferation |
GO:0043029 | 0.0085 | 4.3617 | 1.2777 | 5 | 40 | T cell homeostasis |
GO:0035019 | 0.0086 | 3.2445 | 2.3318 | 7 | 73 | somatic stem cell population maintenance |
GO:0009719 | 0.0086 | 1.4161 | 46.6687 | 63 | 1461 | response to endogenous stimulus |
GO:0006911 | 0.0086 | 5.5747 | 0.8263 | 4 | 26 | phagocytosis, engulfment |
GO:0003014 | 0.0087 | 2.7305 | 3.5137 | 9 | 110 | renal system process |
GO:0045730 | 0.0088 | 5.5451 | 0.8305 | 4 | 26 | respiratory burst |
GO:0045822 | 0.0088 | 5.5451 | 0.8305 | 4 | 26 | negative regulation of heart contraction |
GO:0060571 | 0.0088 | 5.5451 | 0.8305 | 4 | 26 | morphogenesis of an epithelial fold |
GO:0072273 | 0.0088 | 5.5451 | 0.8305 | 4 | 26 | metanephric nephron morphogenesis |
GO:1905521 | 0.0088 | 5.5451 | 0.8305 | 4 | 26 | regulation of macrophage migration |
GO:0006957 | 0.0091 | 8.3074 | 0.4472 | 3 | 14 | complement activation, alternative pathway |
GO:0070672 | 0.0091 | 8.3074 | 0.4472 | 3 | 14 | response to interleukin-15 |
GO:0006959 | 0.0091 | 2.7051 | 3.5426 | 9 | 112 | humoral immune response |
GO:0019730 | 0.0092 | 2.9157 | 2.9388 | 8 | 92 | antimicrobial humoral response |
GO:0042476 | 0.0093 | 2.906 | 2.9467 | 8 | 93 | odontogenesis |
GO:0050918 | 0.0094 | 3.5953 | 1.8208 | 6 | 57 | positive chemotaxis |
GO:0060395 | 0.0094 | 3.5953 | 1.8208 | 6 | 57 | SMAD protein signal transduction |
GO:0046006 | 0.0095 | 4.2403 | 1.3097 | 5 | 41 | regulation of activated T cell proliferation |
GO:0002361 | 0.0096 | 20.278 | 0.1597 | 2 | 5 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation |
GO:0038110 | 0.0096 | 20.278 | 0.1597 | 2 | 5 | interleukin-2-mediated signaling pathway |
GO:0046874 | 0.0096 | 20.278 | 0.1597 | 2 | 5 | quinolinate metabolic process |
GO:0048818 | 0.0096 | 20.278 | 0.1597 | 2 | 5 | positive regulation of hair follicle maturation |
GO:0048859 | 0.0096 | 20.278 | 0.1597 | 2 | 5 | formation of anatomical boundary |
GO:0060414 | 0.0096 | 20.278 | 0.1597 | 2 | 5 | aorta smooth muscle tissue morphogenesis |
GO:0061743 | 0.0096 | 20.278 | 0.1597 | 2 | 5 | motor learning |
GO:0070487 | 0.0096 | 20.278 | 0.1597 | 2 | 5 | monocyte aggregation |
GO:0071376 | 0.0096 | 20.278 | 0.1597 | 2 | 5 | cellular response to corticotropin-releasing hormone stimulus |
GO:1903980 | 0.0096 | 20.278 | 0.1597 | 2 | 5 | positive regulation of microglial cell activation |
GO:0043523 | 0.0096 | 2.2068 | 6.1969 | 13 | 194 | regulation of neuron apoptotic process |
GO:0070098 | 0.01 | 3.1486 | 2.3957 | 7 | 75 | chemokine-mediated signaling pathway |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 19.7231 | 0.7391 | 10 | 32 | DNA replication-dependent nucleosome assembly |
GO:0000183 | 0 | 15.4908 | 0.8777 | 10 | 38 | chromatin silencing at rDNA |
GO:0038111 | 0 | 15.4908 | 0.8777 | 10 | 38 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 14.9557 | 0.9008 | 10 | 39 | response to interleukin-7 |
GO:0051290 | 0 | 12.7523 | 1.0163 | 10 | 44 | protein heterotetramerization |
GO:0045652 | 0 | 6.6574 | 1.7323 | 10 | 75 | regulation of megakaryocyte differentiation |
GO:0016441 | 0 | 3.6345 | 5.4279 | 18 | 235 | posttranscriptional gene silencing |
GO:0045815 | 0 | 6.1799 | 1.8478 | 10 | 80 | positive regulation of gene expression, epigenetic |
GO:2000026 | 0 | 1.8669 | 35.3894 | 60 | 1563 | regulation of multicellular organismal development |
GO:0031047 | 0 | 3.2814 | 5.9591 | 18 | 258 | gene silencing by RNA |
GO:0030198 | 1e-04 | 2.908 | 7.4235 | 20 | 323 | extracellular matrix organization |
GO:0050878 | 1e-04 | 2.4773 | 11.2946 | 26 | 489 | regulation of body fluid levels |
GO:0042135 | 1e-04 | 24.4178 | 0.2541 | 4 | 11 | neurotransmitter catabolic process |
GO:1902036 | 1e-04 | 4.6448 | 2.379 | 10 | 103 | regulation of hematopoietic stem cell differentiation |
GO:0045814 | 1e-04 | 4.2112 | 2.8641 | 11 | 124 | negative regulation of gene expression, epigenetic |
GO:0044259 | 2e-04 | 4.1374 | 2.9103 | 11 | 126 | multicellular organismal macromolecule metabolic process |
GO:0060964 | 2e-04 | 4.4988 | 2.4483 | 10 | 106 | regulation of gene silencing by miRNA |
GO:0009611 | 2e-04 | 2.1887 | 14.6898 | 30 | 636 | response to wounding |
GO:0031497 | 2e-04 | 3.7388 | 3.4877 | 12 | 151 | chromatin assembly |
GO:0001675 | 2e-04 | 17.0892 | 0.3234 | 4 | 14 | acrosome assembly |
GO:0007596 | 3e-04 | 2.6509 | 7.6683 | 19 | 332 | blood coagulation |
GO:0001568 | 3e-04 | 2.1539 | 14.3896 | 29 | 623 | blood vessel development |
GO:0072358 | 3e-04 | 2.109 | 15.198 | 30 | 658 | cardiovascular system development |
GO:0034728 | 4e-04 | 3.4857 | 3.7187 | 12 | 161 | nucleosome organization |
GO:0060485 | 4e-04 | 2.9484 | 5.4509 | 15 | 236 | mesenchyme development |
GO:0061766 | 5e-04 | Inf | 0.0462 | 2 | 2 | positive regulation of lung blood pressure |
GO:1905180 | 5e-04 | Inf | 0.0462 | 2 | 2 | positive regulation of cardiac muscle tissue regeneration |
GO:0031214 | 8e-04 | 3.655 | 2.9564 | 10 | 128 | biomineral tissue development |
GO:0034249 | 9e-04 | 2.4642 | 7.7607 | 18 | 336 | negative regulation of cellular amide metabolic process |
GO:0060968 | 9e-04 | 3.5936 | 3.0026 | 10 | 130 | regulation of gene silencing |
GO:0030500 | 9e-04 | 5.0091 | 1.5475 | 7 | 67 | regulation of bone mineralization |
GO:0048863 | 0.0011 | 2.6446 | 6.0284 | 15 | 261 | stem cell differentiation |
GO:0032501 | 0.0011 | 1.41 | 131.2078 | 159 | 5885 | multicellular organismal process |
GO:0060021 | 0.0012 | 4.1435 | 2.1018 | 8 | 91 | palate development |
GO:0014888 | 0.0012 | 5.59 | 1.2011 | 6 | 52 | striated muscle adaptation |
GO:0035904 | 0.0012 | 5.59 | 1.2011 | 6 | 52 | aorta development |
GO:1905205 | 0.0013 | 18.2643 | 0.231 | 3 | 10 | positive regulation of connective tissue replacement |
GO:0002244 | 0.0014 | 2.9459 | 4.3423 | 12 | 188 | hematopoietic progenitor cell differentiation |
GO:0032967 | 0.0015 | 9.4892 | 0.5081 | 4 | 22 | positive regulation of collagen biosynthetic process |
GO:0072262 | 0.0016 | 85.0374 | 0.0693 | 2 | 3 | metanephric glomerular mesangial cell proliferation involved in metanephros development |
GO:0044253 | 0.0018 | 8.9892 | 0.5312 | 4 | 23 | positive regulation of multicellular organismal metabolic process |
GO:0060421 | 0.0022 | 6.1101 | 0.9239 | 5 | 40 | positive regulation of heart growth |
GO:0001867 | 0.0023 | 14.2038 | 0.2772 | 3 | 12 | complement activation, lectin pathway |
GO:0010712 | 0.0024 | 5.94 | 0.947 | 5 | 41 | regulation of collagen metabolic process |
GO:0006775 | 0.0027 | 5.7791 | 0.9701 | 5 | 42 | fat-soluble vitamin metabolic process |
GO:0035924 | 0.0027 | 5.7791 | 0.9701 | 5 | 42 | cellular response to vascular endothelial growth factor stimulus |
GO:0034341 | 0.0028 | 3.0326 | 3.5108 | 10 | 152 | response to interferon-gamma |
GO:0000320 | 0.0031 | 42.516 | 0.0924 | 2 | 4 | re-entry into mitotic cell cycle |
GO:0051216 | 0.0031 | 2.8058 | 4.1575 | 11 | 180 | cartilage development |
GO:0071345 | 0.0032 | 1.745 | 19.956 | 33 | 864 | cellular response to cytokine stimulus |
GO:0060045 | 0.0032 | 7.424 | 0.6236 | 4 | 27 | positive regulation of cardiac muscle cell proliferation |
GO:0042742 | 0.0037 | 2.6016 | 4.8735 | 12 | 211 | defense response to bacterium |
GO:0090288 | 0.0041 | 3.0707 | 3.1181 | 9 | 135 | negative regulation of cellular response to growth factor stimulus |
GO:0048856 | 0.0042 | 1.3619 | 104.9474 | 128 | 4814 | anatomical structure development |
GO:0060044 | 0.0045 | 10.6508 | 0.3465 | 3 | 15 | negative regulation of cardiac muscle cell proliferation |
GO:2000726 | 0.0045 | 10.6508 | 0.3465 | 3 | 15 | negative regulation of cardiac muscle cell differentiation |
GO:0070374 | 0.0047 | 2.6473 | 4.3885 | 11 | 190 | positive regulation of ERK1 and ERK2 cascade |
GO:0001525 | 0.0048 | 1.993 | 10.5323 | 20 | 456 | angiogenesis |
GO:0060414 | 0.0051 | 28.3422 | 0.1155 | 2 | 5 | aorta smooth muscle tissue morphogenesis |
GO:0060437 | 0.0051 | 28.3422 | 0.1155 | 2 | 5 | lung growth |
GO:0030512 | 0.0051 | 4.0772 | 1.5937 | 6 | 69 | negative regulation of transforming growth factor beta receptor signaling pathway |
GO:0032200 | 0.0053 | 2.758 | 3.8341 | 10 | 166 | telomere organization |
GO:0048247 | 0.0053 | 4.8576 | 1.1318 | 5 | 49 | lymphocyte chemotaxis |
GO:0014898 | 0.0054 | 6.3226 | 0.716 | 4 | 31 | cardiac muscle hypertrophy in response to stress |
GO:0071559 | 0.0054 | 2.4755 | 5.1045 | 12 | 221 | response to transforming growth factor beta |
GO:0045019 | 0.0055 | 9.8309 | 0.3696 | 3 | 16 | negative regulation of nitric oxide biosynthetic process |
GO:0051093 | 0.0058 | 1.685 | 19.956 | 32 | 864 | negative regulation of developmental process |
GO:0010466 | 0.0059 | 2.3472 | 5.8205 | 13 | 252 | negative regulation of peptidase activity |
GO:0065004 | 0.0064 | 2.4169 | 5.22 | 12 | 226 | protein-DNA complex assembly |
GO:0035195 | 0.0066 | 3.0762 | 2.7609 | 8 | 122 | gene silencing by miRNA |
GO:0015721 | 0.0068 | 5.8858 | 0.7622 | 4 | 33 | bile acid and bile salt transport |
GO:0001957 | 0.0075 | 21.2553 | 0.1386 | 2 | 6 | intramembranous ossification |
GO:0070278 | 0.0075 | 21.2553 | 0.1386 | 2 | 6 | extracellular matrix constituent secretion |
GO:0072284 | 0.0075 | 21.2553 | 0.1386 | 2 | 6 | metanephric S-shaped body morphogenesis |
GO:1900747 | 0.0075 | 21.2553 | 0.1386 | 2 | 6 | negative regulation of vascular endothelial growth factor signaling pathway |
GO:0044243 | 0.0077 | 3.7213 | 1.7323 | 6 | 75 | multicellular organismal catabolic process |
GO:0070098 | 0.0077 | 3.7213 | 1.7323 | 6 | 75 | chemokine-mediated signaling pathway |
GO:0071371 | 0.0077 | 8.519 | 0.4158 | 3 | 18 | cellular response to gonadotropin stimulus |
GO:1901342 | 0.0079 | 2.1817 | 6.7213 | 14 | 291 | regulation of vasculature development |
GO:0002548 | 0.008 | 4.3605 | 1.2473 | 5 | 54 | monocyte chemotaxis |
GO:0060795 | 0.0083 | 5.5054 | 0.8084 | 4 | 35 | cell fate commitment involved in formation of primary germ layer |
GO:0030099 | 0.009 | 1.9825 | 8.9617 | 17 | 388 | myeloid cell differentiation |
GO:0055021 | 0.0093 | 4.189 | 1.2934 | 5 | 56 | regulation of cardiac muscle tissue growth |
GO:0048705 | 0.0095 | 2.3904 | 4.8273 | 11 | 209 | skeletal system morphogenesis |
GO:0051241 | 0.0097 | 1.5647 | 24.8064 | 37 | 1074 | negative regulation of multicellular organismal process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 19.2388 | 0.7568 | 10 | 32 | DNA replication-dependent nucleosome assembly |
GO:0044259 | 0 | 6.6899 | 2.9799 | 17 | 126 | multicellular organismal macromolecule metabolic process |
GO:0000183 | 0 | 15.1105 | 0.8987 | 10 | 38 | chromatin silencing at rDNA |
GO:0038111 | 0 | 15.1105 | 0.8987 | 10 | 38 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 14.5885 | 0.9224 | 10 | 39 | response to interleukin-7 |
GO:0051290 | 0 | 12.4392 | 1.0406 | 10 | 44 | protein heterotetramerization |
GO:0010712 | 0 | 11.8649 | 0.9697 | 9 | 41 | regulation of collagen metabolic process |
GO:0051241 | 0 | 2.1674 | 25.4002 | 50 | 1074 | negative regulation of multicellular organismal process |
GO:0016441 | 0 | 3.768 | 5.5578 | 19 | 235 | posttranscriptional gene silencing |
GO:0032967 | 0 | 15.7104 | 0.5203 | 6 | 22 | positive regulation of collagen biosynthetic process |
GO:0045652 | 0 | 6.4939 | 1.7738 | 10 | 75 | regulation of megakaryocyte differentiation |
GO:0031214 | 0 | 4.7949 | 3.0272 | 13 | 128 | biomineral tissue development |
GO:0044253 | 0 | 14.7853 | 0.544 | 6 | 23 | positive regulation of multicellular organismal metabolic process |
GO:0031047 | 0 | 3.4004 | 6.1017 | 19 | 258 | gene silencing by RNA |
GO:0045815 | 0 | 6.0282 | 1.892 | 10 | 80 | positive regulation of gene expression, epigenetic |
GO:0009611 | 0 | 2.3773 | 15.0415 | 33 | 636 | response to wounding |
GO:0040017 | 0 | 2.5943 | 11.2574 | 27 | 476 | positive regulation of locomotion |
GO:0051272 | 0 | 2.5922 | 10.8317 | 26 | 458 | positive regulation of cellular component movement |
GO:0003301 | 1e-04 | 10.9242 | 0.6859 | 6 | 29 | physiological cardiac muscle hypertrophy |
GO:0043932 | 1e-04 | 124.8141 | 0.0946 | 3 | 4 | ossification involved in bone remodeling |
GO:0034249 | 1e-04 | 2.8533 | 7.9464 | 21 | 336 | negative regulation of cellular amide metabolic process |
GO:0022610 | 1e-04 | 1.8469 | 31.7857 | 54 | 1344 | biological adhesion |
GO:2000026 | 1e-04 | 1.8605 | 31.0793 | 53 | 1363 | regulation of multicellular organismal development |
GO:0051674 | 1e-04 | 1.8074 | 33.6777 | 56 | 1424 | localization of cell |
GO:0045595 | 1e-04 | 1.7382 | 39.5193 | 63 | 1671 | regulation of cell differentiation |
GO:0061051 | 1e-04 | 20.8478 | 0.2838 | 4 | 12 | positive regulation of cell growth involved in cardiac muscle cell development |
GO:0061448 | 2e-04 | 3.1035 | 5.5578 | 16 | 235 | connective tissue development |
GO:1902036 | 2e-04 | 4.5308 | 2.436 | 10 | 103 | regulation of hematopoietic stem cell differentiation |
GO:0043270 | 2e-04 | 3.0751 | 5.6051 | 16 | 237 | positive regulation of ion transport |
GO:0060964 | 2e-04 | 4.3883 | 2.5069 | 10 | 106 | regulation of gene silencing by miRNA |
GO:0035932 | 2e-04 | 41.5995 | 0.1419 | 3 | 6 | aldosterone secretion |
GO:0070278 | 2e-04 | 41.5995 | 0.1419 | 3 | 6 | extracellular matrix constituent secretion |
GO:2000855 | 2e-04 | 41.5995 | 0.1419 | 3 | 6 | regulation of mineralocorticoid secretion |
GO:0050878 | 3e-04 | 2.3093 | 11.5649 | 25 | 489 | regulation of body fluid levels |
GO:2000145 | 3e-04 | 1.9886 | 18.8255 | 35 | 796 | regulation of cell motility |
GO:0030198 | 4e-04 | 3.2916 | 4.2535 | 13 | 186 | extracellular matrix organization |
GO:0007596 | 4e-04 | 2.5842 | 7.8518 | 19 | 332 | blood coagulation |
GO:0030335 | 4e-04 | 2.66 | 7.2321 | 18 | 310 | positive regulation of cell migration |
GO:0097530 | 4e-04 | 3.9718 | 2.7434 | 10 | 116 | granulocyte migration |
GO:0035988 | 4e-04 | 13.895 | 0.3784 | 4 | 16 | chondrocyte proliferation |
GO:0007199 | 6e-04 | Inf | 0.0473 | 2 | 2 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger |
GO:0042704 | 6e-04 | Inf | 0.0473 | 2 | 2 | uterine wall breakdown |
GO:0061766 | 6e-04 | Inf | 0.0473 | 2 | 2 | positive regulation of lung blood pressure |
GO:1905180 | 6e-04 | Inf | 0.0473 | 2 | 2 | positive regulation of cardiac muscle tissue regeneration |
GO:1905237 | 6e-04 | Inf | 0.0473 | 2 | 2 | response to cyclosporin A |
GO:0055001 | 6e-04 | 3.3099 | 3.9023 | 12 | 165 | muscle cell development |
GO:0090280 | 6e-04 | 12.8254 | 0.4021 | 4 | 17 | positive regulation of calcium ion import |
GO:1900116 | 6e-04 | 12.8254 | 0.4021 | 4 | 17 | extracellular negative regulation of signal transduction |
GO:0050848 | 6e-04 | 4.6631 | 1.892 | 8 | 80 | regulation of calcium-mediated signaling |
GO:0006954 | 6e-04 | 2.0208 | 15.7983 | 30 | 668 | inflammatory response |
GO:0071560 | 7e-04 | 2.9168 | 5.1321 | 14 | 217 | cellular response to transforming growth factor beta stimulus |
GO:0072132 | 7e-04 | 6.2747 | 1.0879 | 6 | 46 | mesenchyme morphogenesis |
GO:0010612 | 7e-04 | 11.9085 | 0.4257 | 4 | 18 | regulation of cardiac muscle adaptation |
GO:1903055 | 7e-04 | 11.9085 | 0.4257 | 4 | 18 | positive regulation of extracellular matrix organization |
GO:0045814 | 7e-04 | 3.6912 | 2.9326 | 10 | 124 | negative regulation of gene expression, epigenetic |
GO:0006958 | 7e-04 | 8.0304 | 0.7332 | 5 | 31 | complement activation, classical pathway |
GO:0061061 | 8e-04 | 2.038 | 14.5921 | 28 | 617 | muscle structure development |
GO:0030593 | 8e-04 | 4.4166 | 1.9866 | 8 | 84 | neutrophil chemotaxis |
GO:0010518 | 9e-04 | 5.9751 | 1.1352 | 6 | 48 | positive regulation of phospholipase activity |
GO:0010862 | 9e-04 | 5.9751 | 1.1352 | 6 | 48 | positive regulation of pathway-restricted SMAD protein phosphorylation |
GO:0001558 | 9e-04 | 2.3182 | 9.1526 | 20 | 387 | regulation of cell growth |
GO:0038063 | 0.001 | 20.7958 | 0.2129 | 3 | 9 | collagen-activated tyrosine kinase receptor signaling pathway |
GO:0051601 | 0.001 | 20.7958 | 0.2129 | 3 | 9 | exocyst localization |
GO:0051341 | 0.001 | 4.2481 | 2.0576 | 8 | 87 | regulation of oxidoreductase activity |
GO:0060968 | 0.001 | 3.5053 | 3.0745 | 10 | 130 | regulation of gene silencing |
GO:0032501 | 0.0011 | 1.4279 | 120.804 | 148 | 5596 | multicellular organismal process |
GO:0010469 | 0.0011 | 2.0779 | 12.7474 | 25 | 539 | regulation of receptor activity |
GO:0055013 | 0.0011 | 4.8066 | 1.6082 | 7 | 68 | cardiac muscle cell development |
GO:0032890 | 0.0011 | 5.7028 | 1.1825 | 6 | 50 | regulation of organic acid transport |
GO:0060419 | 0.0011 | 4.1947 | 2.0812 | 8 | 88 | heart growth |
GO:1905209 | 0.0011 | 7.1983 | 0.8041 | 5 | 34 | positive regulation of cardiocyte differentiation |
GO:0030501 | 0.0013 | 6.9579 | 0.8278 | 5 | 35 | positive regulation of bone mineralization |
GO:1900274 | 0.0013 | 6.9579 | 0.8278 | 5 | 35 | regulation of phospholipase C activity |
GO:0003181 | 0.0013 | 9.8052 | 0.4967 | 4 | 21 | atrioventricular valve morphogenesis |
GO:0035904 | 0.0014 | 5.4542 | 1.2298 | 6 | 52 | aorta development |
GO:2000379 | 0.0014 | 4.0423 | 2.1522 | 8 | 91 | positive regulation of reactive oxygen species metabolic process |
GO:0051146 | 0.0014 | 2.5788 | 6.1727 | 15 | 261 | striated muscle cell differentiation |
GO:0014742 | 0.0015 | 6.733 | 0.8514 | 5 | 36 | positive regulation of muscle hypertrophy |
GO:0003272 | 0.0016 | 9.2598 | 0.5203 | 4 | 22 | endocardial cushion formation |
GO:0014916 | 0.0016 | 83.4278 | 0.0706 | 2 | 3 | regulation of lung blood pressure |
GO:0003274 | 0.0016 | 82.9922 | 0.071 | 2 | 3 | endocardial cushion fusion |
GO:0019747 | 0.0016 | 82.9922 | 0.071 | 2 | 3 | regulation of isoprenoid metabolic process |
GO:0038183 | 0.0016 | 82.9922 | 0.071 | 2 | 3 | bile acid signaling pathway |
GO:0044691 | 0.0016 | 82.9922 | 0.071 | 2 | 3 | tooth eruption |
GO:0002548 | 0.0017 | 5.2263 | 1.2771 | 6 | 54 | monocyte chemotaxis |
GO:0046209 | 0.0017 | 4.4411 | 1.7265 | 7 | 73 | nitric oxide metabolic process |
GO:0048762 | 0.0017 | 2.8897 | 4.4226 | 12 | 187 | mesenchymal cell differentiation |
GO:0046717 | 0.0017 | 3.5316 | 2.7434 | 9 | 116 | acid secretion |
GO:0048771 | 0.0017 | 3.0461 | 3.855 | 11 | 163 | tissue remodeling |
GO:0002244 | 0.0018 | 2.8731 | 4.4462 | 12 | 188 | hematopoietic progenitor cell differentiation |
GO:0090092 | 0.0019 | 2.7147 | 5.0848 | 13 | 215 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
GO:1903244 | 0.0019 | 15.5949 | 0.2602 | 3 | 11 | positive regulation of cardiac muscle hypertrophy in response to stress |
GO:0002062 | 0.0019 | 4.3403 | 1.7619 | 7 | 75 | chondrocyte differentiation |
GO:0007184 | 0.0019 | 8.7719 | 0.544 | 4 | 23 | SMAD protein import into nucleus |
GO:0061041 | 0.0019 | 3.2088 | 3.3347 | 10 | 141 | regulation of wound healing |
GO:0007167 | 0.0019 | 1.7343 | 23.2244 | 38 | 982 | enzyme linked receptor protein signaling pathway |
GO:0006959 | 0.002 | 2.8297 | 4.5088 | 12 | 192 | humoral immune response |
GO:0032200 | 0.002 | 2.9865 | 3.9259 | 11 | 166 | telomere organization |
GO:0048869 | 0.002 | 1.3943 | 95.8539 | 121 | 4053 | cellular developmental process |
GO:0003197 | 0.0021 | 6.1378 | 0.9224 | 5 | 39 | endocardial cushion development |
GO:0035195 | 0.0021 | 3.4132 | 2.8288 | 9 | 122 | gene silencing by miRNA |
GO:0007202 | 0.0022 | 8.3328 | 0.5676 | 4 | 24 | activation of phospholipase C activity |
GO:0002921 | 0.0025 | 13.8613 | 0.2838 | 3 | 12 | negative regulation of humoral immune response |
GO:0042416 | 0.0025 | 13.8613 | 0.2838 | 3 | 12 | dopamine biosynthetic process |
GO:0060541 | 0.0026 | 2.7318 | 4.6591 | 12 | 197 | respiratory system development |
GO:0010718 | 0.0026 | 5.8256 | 0.9649 | 5 | 41 | positive regulation of epithelial to mesenchymal transition |
GO:1903426 | 0.0026 | 4.0694 | 1.8684 | 7 | 79 | regulation of reactive oxygen species biosynthetic process |
GO:0010611 | 0.0026 | 4.7317 | 1.3954 | 6 | 59 | regulation of cardiac muscle hypertrophy |
GO:0097435 | 0.0029 | 1.9785 | 12.2415 | 23 | 523 | supramolecular fiber organization |
GO:0030323 | 0.003 | 2.821 | 4.1388 | 11 | 175 | respiratory tube development |
GO:0032835 | 0.0031 | 4.5591 | 1.4427 | 6 | 61 | glomerulus development |
GO:0035815 | 0.0031 | 12.4743 | 0.3075 | 3 | 13 | positive regulation of renal sodium excretion |
GO:2001044 | 0.0031 | 12.4743 | 0.3075 | 3 | 13 | regulation of integrin-mediated signaling pathway |
GO:0031497 | 0.0032 | 2.9793 | 3.5712 | 10 | 151 | chromatin assembly |
GO:0032355 | 0.0032 | 3.2001 | 3.0036 | 9 | 127 | response to estradiol |
GO:0000320 | 0.0032 | 41.4935 | 0.0946 | 2 | 4 | re-entry into mitotic cell cycle |
GO:0002018 | 0.0032 | 41.4935 | 0.0946 | 2 | 4 | renin-angiotensin regulation of aldosterone production |
GO:0002034 | 0.0032 | 41.4935 | 0.0946 | 2 | 4 | regulation of blood vessel diameter by renin-angiotensin |
GO:0002035 | 0.0032 | 41.4935 | 0.0946 | 2 | 4 | brain renin-angiotensin system |
GO:0035582 | 0.0032 | 41.4935 | 0.0946 | 2 | 4 | sequestering of BMP in extracellular matrix |
GO:0051387 | 0.0032 | 41.4935 | 0.0946 | 2 | 4 | negative regulation of neurotrophin TRK receptor signaling pathway |
GO:0051835 | 0.0032 | 41.4935 | 0.0946 | 2 | 4 | positive regulation of synapse structural plasticity |
GO:0050886 | 0.0033 | 3.9059 | 1.9393 | 7 | 82 | endocrine process |
GO:0002698 | 0.0033 | 3.492 | 2.4596 | 8 | 104 | negative regulation of immune effector process |
GO:0015718 | 0.0037 | 2.9167 | 3.6421 | 10 | 154 | monocarboxylic acid transport |
GO:0030199 | 0.0037 | 5.3492 | 1.0406 | 5 | 44 | collagen fibril organization |
GO:0061035 | 0.0037 | 4.3986 | 1.49 | 6 | 63 | regulation of cartilage development |
GO:0001568 | 0.0038 | 1.8557 | 14.734 | 26 | 623 | blood vessel development |
GO:0051094 | 0.0039 | 1.6002 | 29.0896 | 44 | 1230 | positive regulation of developmental process |
GO:0001675 | 0.0039 | 11.3396 | 0.3311 | 3 | 14 | acrosome assembly |
GO:0014744 | 0.0039 | 11.3396 | 0.3311 | 3 | 14 | positive regulation of muscle adaptation |
GO:0034111 | 0.0039 | 11.3396 | 0.3311 | 3 | 14 | negative regulation of homotypic cell-cell adhesion |
GO:2001275 | 0.0039 | 11.3396 | 0.3311 | 3 | 14 | positive regulation of glucose import in response to insulin stimulus |
GO:0072358 | 0.004 | 1.8243 | 15.5618 | 27 | 658 | cardiovascular system development |
GO:0010922 | 0.004 | 6.9423 | 0.6622 | 4 | 28 | positive regulation of phosphatase activity |
GO:0032570 | 0.004 | 5.2151 | 1.0643 | 5 | 45 | response to progesterone |
GO:1903706 | 0.0041 | 2.0237 | 10.3824 | 20 | 439 | regulation of hemopoiesis |
GO:0010828 | 0.0045 | 5.0876 | 1.0879 | 5 | 46 | positive regulation of glucose transport |
GO:0001503 | 0.0045 | 2.8257 | 3.7496 | 10 | 162 | ossification |
GO:0042742 | 0.0045 | 2.5374 | 4.9902 | 12 | 211 | defense response to bacterium |
GO:0034142 | 0.0046 | 6.6641 | 0.6859 | 4 | 29 | toll-like receptor 4 signaling pathway |
GO:0051093 | 0.0046 | 1.6993 | 20.4337 | 33 | 864 | negative regulation of developmental process |
GO:0001501 | 0.0046 | 2.2586 | 6.9835 | 15 | 303 | skeletal system development |
GO:0031960 | 0.0046 | 10.5543 | 0.3496 | 3 | 15 | response to corticosteroid |
GO:0010817 | 0.0048 | 1.9576 | 11.2574 | 21 | 476 | regulation of hormone levels |
GO:0060349 | 0.0048 | 3.6152 | 2.0812 | 7 | 88 | bone morphogenesis |
GO:0051957 | 0.0048 | 10.394 | 0.3548 | 3 | 15 | positive regulation of amino acid transport |
GO:0060044 | 0.0048 | 10.394 | 0.3548 | 3 | 15 | negative regulation of cardiac muscle cell proliferation |
GO:1901201 | 0.0048 | 10.394 | 0.3548 | 3 | 15 | regulation of extracellular matrix assembly |
GO:0071715 | 0.0049 | 4.9662 | 1.1116 | 5 | 47 | icosanoid transport |
GO:0034728 | 0.005 | 2.7802 | 3.8077 | 10 | 161 | nucleosome organization |
GO:0061572 | 0.0051 | 2.9717 | 3.2164 | 9 | 136 | actin filament bundle organization |
GO:0022617 | 0.0051 | 3.5709 | 2.1049 | 7 | 89 | extracellular matrix disassembly |
GO:0001992 | 0.0053 | 27.6606 | 0.1183 | 2 | 5 | regulation of systemic arterial blood pressure by vasopressin |
GO:0003289 | 0.0053 | 27.6606 | 0.1183 | 2 | 5 | atrial septum primum morphogenesis |
GO:0010936 | 0.0053 | 27.6606 | 0.1183 | 2 | 5 | negative regulation of macrophage cytokine production |
GO:0060414 | 0.0053 | 27.6606 | 0.1183 | 2 | 5 | aorta smooth muscle tissue morphogenesis |
GO:0060437 | 0.0053 | 27.6606 | 0.1183 | 2 | 5 | lung growth |
GO:0060591 | 0.0053 | 27.6606 | 0.1183 | 2 | 5 | chondroblast differentiation |
GO:1903401 | 0.0053 | 27.6606 | 0.1183 | 2 | 5 | L-lysine transmembrane transport |
GO:1905007 | 0.0053 | 27.6606 | 0.1183 | 2 | 5 | positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation |
GO:0003044 | 0.0054 | 4.8504 | 1.1352 | 5 | 48 | regulation of systemic arterial blood pressure mediated by a chemical signal |
GO:0045937 | 0.0054 | 1.6116 | 25.4948 | 39 | 1078 | positive regulation of phosphate metabolic process |
GO:0030512 | 0.0058 | 3.9781 | 1.6319 | 6 | 69 | negative regulation of transforming growth factor beta receptor signaling pathway |
GO:0014897 | 0.0058 | 3.4854 | 2.1522 | 7 | 91 | striated muscle hypertrophy |
GO:0050900 | 0.0058 | 2.0353 | 9.2708 | 18 | 392 | leukocyte migration |
GO:0035930 | 0.0058 | 9.5938 | 0.3784 | 3 | 16 | corticosteroid hormone secretion |
GO:0045019 | 0.0058 | 9.5938 | 0.3784 | 3 | 16 | negative regulation of nitric oxide biosynthetic process |
GO:0061298 | 0.0058 | 9.5938 | 0.3784 | 3 | 16 | retina vasculature development in camera-type eye |
GO:1905314 | 0.0058 | 9.5938 | 0.3784 | 3 | 16 | semi-lunar valve development |
GO:0003299 | 0.0058 | 6.1697 | 0.7332 | 4 | 31 | muscle hypertrophy in response to stress |
GO:0010171 | 0.0059 | 4.7398 | 1.1589 | 5 | 49 | body morphogenesis |
GO:0071773 | 0.0059 | 2.7078 | 3.9023 | 10 | 165 | cellular response to BMP stimulus |
GO:0032102 | 0.006 | 2.2602 | 6.5038 | 14 | 275 | negative regulation of response to external stimulus |
GO:0050678 | 0.006 | 2.189 | 7.1896 | 15 | 304 | regulation of epithelial cell proliferation |
GO:0001525 | 0.0062 | 1.9427 | 10.7844 | 20 | 456 | angiogenesis |
GO:0030500 | 0.0063 | 6.0167 | 0.7486 | 4 | 32 | regulation of bone mineralization |
GO:0009725 | 0.0064 | 1.6729 | 20.0789 | 32 | 849 | response to hormone |
GO:0006584 | 0.0064 | 4.6342 | 1.1825 | 5 | 50 | catecholamine metabolic process |
GO:0035272 | 0.0064 | 4.6342 | 1.1825 | 5 | 50 | exocrine system development |
GO:0060348 | 0.0064 | 3.4105 | 2.1946 | 7 | 94 | bone development |
GO:0018958 | 0.0065 | 3.404 | 2.1995 | 7 | 93 | phenol-containing compound metabolic process |
GO:0060317 | 0.0066 | 5.949 | 0.7568 | 4 | 32 | cardiac epithelial to mesenchymal transition |
GO:0072359 | 0.0066 | 2.1665 | 7.265 | 15 | 317 | circulatory system development |
GO:0009967 | 0.0067 | 1.5062 | 35.0731 | 50 | 1483 | positive regulation of signal transduction |
GO:0030155 | 0.0071 | 1.7576 | 15.4908 | 26 | 655 | regulation of cell adhesion |
GO:0031589 | 0.0072 | 2.1437 | 7.3315 | 15 | 310 | cell-substrate adhesion |
GO:0051384 | 0.0073 | 2.7941 | 3.4056 | 9 | 144 | response to glucocorticoid |
GO:0010634 | 0.0073 | 3.0173 | 2.8144 | 8 | 119 | positive regulation of epithelial cell migration |
GO:0060537 | 0.0074 | 2.0279 | 8.7742 | 17 | 371 | muscle tissue development |
GO:0006810 | 0.0074 | 1.3116 | 115.5544 | 138 | 4886 | transport |
GO:0070848 | 0.0077 | 1.7461 | 15.5854 | 26 | 659 | response to growth factor |
GO:0006935 | 0.0078 | 1.81 | 13.2914 | 23 | 562 | chemotaxis |
GO:0006874 | 0.0078 | 1.9705 | 9.5546 | 18 | 404 | cellular calcium ion homeostasis |
GO:0001957 | 0.0079 | 20.7441 | 0.1419 | 2 | 6 | intramembranous ossification |
GO:0071692 | 0.0079 | 20.7441 | 0.1419 | 2 | 6 | protein localization to extracellular region |
GO:2000489 | 0.0079 | 20.7441 | 0.1419 | 2 | 6 | regulation of hepatic stellate cell activation |
GO:2001023 | 0.0079 | 20.7441 | 0.1419 | 2 | 6 | regulation of response to drug |
GO:0032303 | 0.0082 | 8.3136 | 0.4257 | 3 | 18 | regulation of icosanoid secretion |
GO:0032332 | 0.0082 | 8.3136 | 0.4257 | 3 | 18 | positive regulation of chondrocyte differentiation |
GO:0032928 | 0.0082 | 8.3136 | 0.4257 | 3 | 18 | regulation of superoxide anion generation |
GO:0090330 | 0.0082 | 8.3136 | 0.4257 | 3 | 18 | regulation of platelet aggregation |
GO:2000831 | 0.0082 | 8.3136 | 0.4257 | 3 | 18 | regulation of steroid hormone secretion |
GO:0048738 | 0.0085 | 2.431 | 4.7537 | 11 | 201 | cardiac muscle tissue development |
GO:0090257 | 0.0085 | 2.3242 | 5.4159 | 12 | 229 | regulation of muscle system process |
GO:0110053 | 0.0085 | 2.3242 | 5.4159 | 12 | 229 | regulation of actin filament organization |
GO:0044243 | 0.0086 | 3.6308 | 1.7738 | 6 | 75 | multicellular organismal catabolic process |
GO:0048856 | 0.0086 | 1.3318 | 96.6805 | 117 | 4374 | anatomical structure development |
GO:0031032 | 0.0089 | 2.5421 | 4.1388 | 10 | 175 | actomyosin structure organization |
GO:0045823 | 0.009 | 5.3723 | 0.8278 | 4 | 35 | positive regulation of heart contraction |
GO:0006936 | 0.0092 | 2.0262 | 8.2539 | 16 | 349 | muscle contraction |
GO:0001822 | 0.0092 | 2.2138 | 6.149 | 13 | 260 | kidney development |
GO:0002576 | 0.0093 | 2.8863 | 2.9326 | 8 | 124 | platelet degranulation |
GO:0008015 | 0.0093 | 1.833 | 11.967 | 21 | 506 | blood circulation |
GO:0045216 | 0.0094 | 2.2921 | 5.4868 | 12 | 232 | cell-cell junction organization |
GO:0001649 | 0.0094 | 2.3927 | 4.8246 | 11 | 204 | osteoblast differentiation |
GO:0048863 | 0.0095 | 2.2047 | 6.1727 | 13 | 261 | stem cell differentiation |
GO:0032233 | 0.0095 | 4.1695 | 1.3008 | 5 | 55 | positive regulation of actin filament bundle assembly |
GO:0034308 | 0.0095 | 4.1695 | 1.3008 | 5 | 55 | primary alcohol metabolic process |
GO:0051057 | 0.0095 | 4.1695 | 1.3008 | 5 | 55 | positive regulation of small GTPase mediated signal transduction |
GO:0001991 | 0.0096 | 7.7935 | 0.4494 | 3 | 19 | regulation of systemic arterial blood pressure by circulatory renin-angiotensin |
GO:2000725 | 0.01 | 5.2041 | 0.8514 | 4 | 36 | regulation of cardiac muscle cell differentiation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0008544 | 0 | 4.1916 | 11.0566 | 40 | 410 | epidermis development |
GO:0051290 | 0 | 15.5624 | 1.1866 | 13 | 44 | protein heterotetramerization |
GO:0038111 | 0 | 17.0931 | 1.0248 | 12 | 38 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 16.459 | 1.0517 | 12 | 39 | response to interleukin-7 |
GO:0070268 | 0 | 7.3995 | 2.9394 | 18 | 109 | cornification |
GO:0030216 | 0 | 4.4874 | 6.8767 | 27 | 255 | keratinocyte differentiation |
GO:0006335 | 0 | 16.7599 | 0.863 | 10 | 32 | DNA replication-dependent nucleosome assembly |
GO:0030855 | 0 | 2.8201 | 17.005 | 43 | 637 | epithelial cell differentiation |
GO:0000183 | 0 | 13.1635 | 1.0248 | 10 | 38 | chromatin silencing at rDNA |
GO:0045815 | 0 | 6.5183 | 2.1574 | 12 | 80 | positive regulation of gene expression, epigenetic |
GO:0048869 | 0 | 1.6209 | 109.2983 | 152 | 4053 | cellular developmental process |
GO:0031581 | 0 | 36.4862 | 0.2697 | 5 | 10 | hemidesmosome assembly |
GO:0031497 | 0 | 4.4003 | 4.0721 | 16 | 151 | chromatin assembly |
GO:0034097 | 0 | 2.1809 | 24.0835 | 48 | 918 | response to cytokine |
GO:0045652 | 0 | 6.3353 | 2.0225 | 11 | 75 | regulation of megakaryocyte differentiation |
GO:0035194 | 0 | 3.4854 | 6.3103 | 20 | 234 | posttranscriptional gene silencing by RNA |
GO:0034728 | 0 | 4.0942 | 4.3417 | 16 | 161 | nucleosome organization |
GO:0060964 | 0 | 4.7076 | 2.8585 | 12 | 106 | regulation of gene silencing by miRNA |
GO:0002385 | 0 | 11.5383 | 0.6742 | 6 | 25 | mucosal immune response |
GO:0060968 | 0 | 4.1009 | 3.5057 | 13 | 130 | regulation of gene silencing |
GO:0008285 | 1e-04 | 2.1044 | 18.3647 | 36 | 681 | negative regulation of cell proliferation |
GO:1902036 | 1e-04 | 4.3993 | 2.7776 | 11 | 103 | regulation of hematopoietic stem cell differentiation |
GO:0002294 | 1e-04 | 6.2371 | 1.4832 | 8 | 55 | CD4-positive, alpha-beta T cell differentiation involved in immune response |
GO:0002287 | 1e-04 | 6.1067 | 1.5102 | 8 | 56 | alpha-beta T cell activation involved in immune response |
GO:0034329 | 1e-04 | 3.1834 | 5.4474 | 16 | 202 | cell junction assembly |
GO:0065004 | 1e-04 | 3.0128 | 6.0946 | 17 | 226 | protein-DNA complex assembly |
GO:0017148 | 2e-04 | 2.5936 | 8.6835 | 21 | 322 | negative regulation of translation |
GO:0002292 | 2e-04 | 5.5289 | 1.645 | 8 | 61 | T cell differentiation involved in immune response |
GO:0034248 | 4e-04 | 2.1175 | 14.5893 | 29 | 541 | regulation of cellular amide metabolic process |
GO:0030099 | 4e-04 | 2.3441 | 10.4633 | 23 | 388 | myeloid cell differentiation |
GO:0044092 | 4e-04 | 1.7549 | 30.5 | 50 | 1131 | negative regulation of molecular function |
GO:0048513 | 5e-04 | 1.5364 | 62.6813 | 88 | 2399 | animal organ development |
GO:0001667 | 5e-04 | 2.4059 | 9.3037 | 21 | 345 | ameboidal-type cell migration |
GO:0050878 | 5e-04 | 2.2452 | 11.3751 | 24 | 426 | regulation of body fluid levels |
GO:0045814 | 5e-04 | 3.577 | 3.3439 | 11 | 124 | negative regulation of gene expression, epigenetic |
GO:0090132 | 6e-04 | 2.6408 | 6.8767 | 17 | 255 | epithelium migration |
GO:0051674 | 6e-04 | 1.6465 | 38.4014 | 59 | 1424 | localization of cell |
GO:0002526 | 7e-04 | 3.2451 | 3.9912 | 12 | 148 | acute inflammatory response |
GO:0022610 | 7e-04 | 1.6519 | 36.244 | 56 | 1344 | biological adhesion |
GO:0048627 | 7e-04 | Inf | 0.0539 | 2 | 2 | myoblast development |
GO:1904639 | 7e-04 | Inf | 0.0539 | 2 | 2 | cellular response to resveratrol |
GO:1904826 | 7e-04 | Inf | 0.0539 | 2 | 2 | regulation of hydrogen sulfide biosynthetic process |
GO:0046637 | 7e-04 | 5.2219 | 1.5102 | 7 | 56 | regulation of alpha-beta T cell differentiation |
GO:0043371 | 7e-04 | 12.1287 | 0.4315 | 4 | 16 | negative regulation of CD4-positive, alpha-beta T cell differentiation |
GO:0045019 | 7e-04 | 12.1287 | 0.4315 | 4 | 16 | negative regulation of nitric oxide biosynthetic process |
GO:0045104 | 8e-04 | 6.2573 | 1.1057 | 6 | 41 | intermediate filament cytoskeleton organization |
GO:0051248 | 9e-04 | 1.6587 | 34.0866 | 53 | 1264 | negative regulation of protein metabolic process |
GO:0010951 | 9e-04 | 2.6251 | 6.4991 | 16 | 241 | negative regulation of endopeptidase activity |
GO:1901343 | 0.001 | 3.5615 | 3.0473 | 10 | 113 | negative regulation of vasculature development |
GO:0032653 | 0.001 | 5.9184 | 1.1596 | 6 | 43 | regulation of interleukin-10 production |
GO:0031340 | 0.001 | 21.7913 | 0.2157 | 3 | 8 | positive regulation of vesicle fusion |
GO:0048608 | 0.0011 | 2.1562 | 11.2993 | 23 | 419 | reproductive structure development |
GO:0008584 | 0.0011 | 3.2574 | 3.6406 | 11 | 135 | male gonad development |
GO:2000145 | 0.0011 | 1.8221 | 20.9368 | 36 | 781 | regulation of cell motility |
GO:0048646 | 0.0012 | 1.7133 | 27.2639 | 44 | 1011 | anatomical structure formation involved in morphogenesis |
GO:0040017 | 0.0012 | 2.0605 | 12.8364 | 25 | 476 | positive regulation of locomotion |
GO:0034260 | 0.0012 | 5.6141 | 1.2135 | 6 | 45 | negative regulation of GTPase activity |
GO:0022603 | 0.0013 | 1.7173 | 26.5627 | 43 | 985 | regulation of anatomical structure morphogenesis |
GO:0071103 | 0.0013 | 2.4426 | 7.389 | 17 | 274 | DNA conformation change |
GO:1905331 | 0.0015 | 9.7011 | 0.5124 | 4 | 19 | negative regulation of morphogenesis of an epithelium |
GO:0006952 | 0.0016 | 1.5751 | 39.2104 | 58 | 1454 | defense response |
GO:0071310 | 0.0017 | 1.4572 | 64.2899 | 87 | 2384 | cellular response to organic substance |
GO:1903038 | 0.0017 | 3.544 | 2.7507 | 9 | 102 | negative regulation of leukocyte cell-cell adhesion |
GO:0007165 | 0.0018 | 1.3429 | 150.5312 | 180 | 5582 | signal transduction |
GO:0061436 | 0.0018 | 9.0943 | 0.5393 | 4 | 20 | establishment of skin barrier |
GO:0002244 | 0.0018 | 2.7317 | 5.0698 | 13 | 188 | hematopoietic progenitor cell differentiation |
GO:0016525 | 0.0019 | 3.506 | 2.7776 | 9 | 103 | negative regulation of angiogenesis |
GO:2000026 | 0.0019 | 1.5835 | 37.0007 | 55 | 1412 | regulation of multicellular organismal development |
GO:1903706 | 0.0019 | 2.0499 | 11.8386 | 23 | 439 | regulation of hemopoiesis |
GO:0052547 | 0.002 | 2.0845 | 11.1375 | 22 | 413 | regulation of peptidase activity |
GO:0045625 | 0.002 | 15.5632 | 0.2697 | 3 | 10 | regulation of T-helper 1 cell differentiation |
GO:0071474 | 0.002 | 15.5632 | 0.2697 | 3 | 10 | cellular hyperosmotic response |
GO:0045581 | 0.002 | 6.2812 | 0.9169 | 5 | 34 | negative regulation of T cell differentiation |
GO:0016480 | 0.0021 | 72.4897 | 0.0809 | 2 | 3 | negative regulation of transcription from RNA polymerase III promoter |
GO:0045624 | 0.0022 | 8.5588 | 0.5663 | 4 | 21 | positive regulation of T-helper cell differentiation |
GO:0051497 | 0.0022 | 8.5588 | 0.5663 | 4 | 21 | negative regulation of stress fiber assembly |
GO:0002376 | 0.0022 | 1.4233 | 71.9756 | 95 | 2669 | immune system process |
GO:0071356 | 0.0023 | 2.3684 | 7.1463 | 16 | 265 | cellular response to tumor necrosis factor |
GO:0098609 | 0.0026 | 1.7382 | 21.2232 | 35 | 787 | cell-cell adhesion |
GO:0019731 | 0.0026 | 5.8752 | 0.9708 | 5 | 36 | antibacterial humoral response |
GO:0060433 | 0.0027 | 13.617 | 0.2966 | 3 | 11 | bronchus development |
GO:0019221 | 0.0028 | 1.8745 | 15.1618 | 27 | 578 | cytokine-mediated signaling pathway |
GO:0042127 | 0.0029 | 1.7018 | 22.9688 | 37 | 889 | regulation of cell proliferation |
GO:2000378 | 0.0029 | 4.6562 | 1.4293 | 6 | 53 | negative regulation of reactive oxygen species metabolic process |
GO:0031579 | 0.0031 | 7.6569 | 0.6202 | 4 | 23 | membrane raft organization |
GO:0042347 | 0.0031 | 7.6569 | 0.6202 | 4 | 23 | negative regulation of NF-kappaB import into nucleus |
GO:0051272 | 0.0033 | 1.958 | 12.351 | 23 | 458 | positive regulation of cellular component movement |
GO:0009888 | 0.0034 | 1.548 | 36.3573 | 53 | 1446 | tissue development |
GO:0045582 | 0.0035 | 3.8727 | 1.9686 | 7 | 73 | positive regulation of T cell differentiation |
GO:0010608 | 0.0037 | 1.7935 | 16.9894 | 29 | 630 | posttranscriptional regulation of gene expression |
GO:0030198 | 0.0037 | 2.1349 | 8.8722 | 18 | 329 | extracellular matrix organization |
GO:0046661 | 0.0038 | 2.7437 | 4.2608 | 11 | 158 | male sex differentiation |
GO:0001659 | 0.0038 | 5.3558 | 1.0517 | 5 | 39 | temperature homeostasis |
GO:0042088 | 0.0038 | 5.3558 | 1.0517 | 5 | 39 | T-helper 1 type immune response |
GO:0007596 | 0.0041 | 2.1141 | 8.9531 | 18 | 332 | blood coagulation |
GO:0051346 | 0.0042 | 2.0621 | 9.6821 | 19 | 363 | negative regulation of hydrolase activity |
GO:1902904 | 0.0042 | 3.0775 | 3.1282 | 9 | 116 | negative regulation of supramolecular fiber organization |
GO:0001806 | 0.0042 | 36.2426 | 0.1079 | 2 | 4 | type IV hypersensitivity |
GO:0021615 | 0.0042 | 36.2426 | 0.1079 | 2 | 4 | glossopharyngeal nerve morphogenesis |
GO:0035582 | 0.0042 | 36.2426 | 0.1079 | 2 | 4 | sequestering of BMP in extracellular matrix |
GO:0038113 | 0.0042 | 36.2426 | 0.1079 | 2 | 4 | interleukin-9-mediated signaling pathway |
GO:0045110 | 0.0042 | 36.2426 | 0.1079 | 2 | 4 | intermediate filament bundle assembly |
GO:0045629 | 0.0042 | 36.2426 | 0.1079 | 2 | 4 | negative regulation of T-helper 2 cell differentiation |
GO:0060480 | 0.0042 | 36.2426 | 0.1079 | 2 | 4 | lung goblet cell differentiation |
GO:1903553 | 0.0042 | 36.2426 | 0.1079 | 2 | 4 | positive regulation of extracellular exosome assembly |
GO:1904637 | 0.0042 | 36.2426 | 0.1079 | 2 | 4 | cellular response to ionomycin |
GO:2001181 | 0.0042 | 36.2426 | 0.1079 | 2 | 4 | positive regulation of interleukin-10 secretion |
GO:0061037 | 0.0042 | 6.9268 | 0.6742 | 4 | 25 | negative regulation of cartilage development |
GO:0032501 | 0.0045 | 1.2946 | 187.6652 | 215 | 6959 | multicellular organismal process |
GO:0090343 | 0.0046 | 10.8922 | 0.3506 | 3 | 13 | positive regulation of cell aging |
GO:0097284 | 0.0046 | 10.8922 | 0.3506 | 3 | 13 | hepatocyte apoptotic process |
GO:0045604 | 0.0046 | 4.2071 | 1.5641 | 6 | 58 | regulation of epidermal cell differentiation |
GO:0009617 | 0.0047 | 1.8707 | 13.4567 | 24 | 499 | response to bacterium |
GO:0001657 | 0.0047 | 3.285 | 2.6158 | 8 | 97 | ureteric bud development |
GO:0030036 | 0.0048 | 1.7948 | 15.7758 | 27 | 585 | actin cytoskeleton organization |
GO:0072163 | 0.005 | 3.2483 | 2.6428 | 8 | 98 | mesonephric epithelium development |
GO:0030858 | 0.005 | 4.1275 | 1.5911 | 6 | 59 | positive regulation of epithelial cell differentiation |
GO:0010595 | 0.005 | 3.5988 | 2.1034 | 7 | 78 | positive regulation of endothelial cell migration |
GO:0007162 | 0.0051 | 2.3069 | 6.3912 | 14 | 237 | negative regulation of cell adhesion |
GO:0008360 | 0.0052 | 2.7739 | 3.8294 | 10 | 142 | regulation of cell shape |
GO:0032200 | 0.0054 | 2.6008 | 4.4766 | 11 | 166 | telomere organization |
GO:0048534 | 0.0055 | 1.6384 | 23.057 | 36 | 855 | hematopoietic or lymphoid organ development |
GO:0050727 | 0.0056 | 2.0938 | 8.5217 | 17 | 316 | regulation of inflammatory response |
GO:1901700 | 0.0056 | 1.4797 | 40.6666 | 57 | 1508 | response to oxygen-containing compound |
GO:0040037 | 0.0057 | 9.9014 | 0.3775 | 3 | 14 | negative regulation of fibroblast growth factor receptor signaling pathway |
GO:0002285 | 0.0057 | 2.7321 | 3.8833 | 10 | 144 | lymphocyte activation involved in immune response |
GO:0032612 | 0.0058 | 3.4998 | 2.1574 | 7 | 80 | interleukin-1 production |
GO:0060548 | 0.0061 | 1.6052 | 24.8368 | 38 | 921 | negative regulation of cell death |
GO:0035239 | 0.0062 | 2.022 | 9.3307 | 18 | 346 | tube morphogenesis |
GO:1902743 | 0.0064 | 4.6677 | 1.1866 | 5 | 44 | regulation of lamellipodium organization |
GO:1903036 | 0.0064 | 3.9056 | 1.672 | 6 | 62 | positive regulation of response to wounding |
GO:0046636 | 0.0064 | 6.0598 | 0.7551 | 4 | 28 | negative regulation of alpha-beta T cell activation |
GO:0030335 | 0.0065 | 1.9002 | 11.569 | 21 | 429 | positive regulation of cell migration |
GO:0008219 | 0.0065 | 1.5409 | 30.7801 | 45 | 1176 | cell death |
GO:0009636 | 0.0066 | 2.316 | 5.9058 | 13 | 219 | response to toxic substance |
GO:0002580 | 0.0069 | 24.1602 | 0.1348 | 2 | 5 | regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II |
GO:0061302 | 0.0069 | 24.1602 | 0.1348 | 2 | 5 | smooth muscle cell-matrix adhesion |
GO:0071104 | 0.0069 | 24.1602 | 0.1348 | 2 | 5 | response to interleukin-9 |
GO:1900028 | 0.0069 | 24.1602 | 0.1348 | 2 | 5 | negative regulation of ruffle assembly |
GO:1901509 | 0.0069 | 24.1602 | 0.1348 | 2 | 5 | regulation of endothelial tube morphogenesis |
GO:1901668 | 0.0069 | 24.1602 | 0.1348 | 2 | 5 | regulation of superoxide dismutase activity |
GO:1905098 | 0.0069 | 24.1602 | 0.1348 | 2 | 5 | negative regulation of guanyl-nucleotide exchange factor activity |
GO:0050891 | 0.0069 | 3.8369 | 1.6989 | 6 | 63 | multicellular organismal water homeostasis |
GO:0031268 | 0.007 | 9.0757 | 0.4045 | 3 | 15 | pseudopodium organization |
GO:0097709 | 0.007 | 9.0757 | 0.4045 | 3 | 15 | connective tissue replacement |
GO:1901317 | 0.007 | 9.0757 | 0.4045 | 3 | 15 | regulation of flagellated sperm motility |
GO:0048585 | 0.0071 | 1.4704 | 39.3992 | 55 | 1461 | negative regulation of response to stimulus |
GO:0001773 | 0.0073 | 5.817 | 0.7821 | 4 | 29 | myeloid dendritic cell activation |
GO:0003401 | 0.0073 | 5.817 | 0.7821 | 4 | 29 | axis elongation |
GO:0032689 | 0.0073 | 5.817 | 0.7821 | 4 | 29 | negative regulation of interferon-gamma production |
GO:0010632 | 0.0074 | 2.7931 | 3.4189 | 9 | 128 | regulation of epithelial cell migration |
GO:0043207 | 0.0074 | 1.6377 | 21.0884 | 33 | 782 | response to external biotic stimulus |
GO:0042308 | 0.0075 | 3.7705 | 1.7259 | 6 | 64 | negative regulation of protein import into nucleus |
GO:0010033 | 0.0077 | 1.8162 | 13.3014 | 23 | 529 | response to organic substance |
GO:0042058 | 0.008 | 3.2744 | 2.2922 | 7 | 85 | regulation of epidermal growth factor receptor signaling pathway |
GO:0071347 | 0.008 | 3.2744 | 2.2922 | 7 | 85 | cellular response to interleukin-1 |
GO:0003382 | 0.0082 | 5.5929 | 0.809 | 4 | 30 | epithelial cell morphogenesis |
GO:0090322 | 0.0082 | 5.5929 | 0.809 | 4 | 30 | regulation of superoxide metabolic process |
GO:2000516 | 0.0082 | 5.5929 | 0.809 | 4 | 30 | positive regulation of CD4-positive, alpha-beta T cell activation |
GO:0009653 | 0.0083 | 1.617 | 22.0988 | 34 | 880 | anatomical structure morphogenesis |
GO:0032695 | 0.0084 | 8.377 | 0.4315 | 3 | 16 | negative regulation of interleukin-12 production |
GO:0007266 | 0.0094 | 2.3975 | 4.8271 | 11 | 179 | Rho protein signal transduction |
GO:0110053 | 0.0094 | 2.2074 | 6.1755 | 13 | 229 | regulation of actin filament organization |
GO:0006959 | 0.0095 | 2.2904 | 5.5013 | 12 | 204 | humoral immune response |
GO:0097435 | 0.0096 | 1.8273 | 11.9984 | 21 | 451 | supramolecular fiber organization |
GO:0050896 | 0.0096 | 1.281 | 174.8965 | 198 | 6749 | response to stimulus |
GO:0045861 | 0.0097 | 1.9663 | 9.034 | 17 | 335 | negative regulation of proteolysis |
GO:0051271 | 0.0098 | 2.0634 | 7.6048 | 15 | 282 | negative regulation of cellular component movement |
GO:0010633 | 0.0099 | 3.5263 | 1.8338 | 6 | 68 | negative regulation of epithelial cell migration |
GO:2000738 | 0.01 | 7.7782 | 0.4584 | 3 | 17 | positive regulation of stem cell differentiation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 49.9652 | 6.5575 | 124 | 261 | detection of chemical stimulus involved in sensory perception of smell |
GO:0050906 | 0 | 33.2995 | 8.7684 | 130 | 349 | detection of stimulus involved in sensory perception |
GO:0009593 | 0 | 34.6369 | 8.3915 | 128 | 334 | detection of chemical stimulus |
GO:0007606 | 0 | 32.4741 | 8.8187 | 129 | 351 | sensory perception of chemical stimulus |
GO:0007186 | 0 | 8.7967 | 28.2187 | 149 | 1133 | G-protein coupled receptor signaling pathway |
GO:0050877 | 0 | 8.9089 | 25.9284 | 141 | 1048 | nervous system process |
GO:0023052 | 0 | 2.2288 | 152.5302 | 231 | 6071 | signaling |
GO:0032501 | 0 | 2.2339 | 165.8638 | 242 | 6776 | multicellular organismal process |
GO:0007154 | 0 | 2.2099 | 148.8905 | 225 | 6018 | cell communication |
GO:0051716 | 0 | 1.9096 | 172.077 | 236 | 6849 | cellular response to stimulus |
GO:0050896 | 0 | 2.1876 | 24.9685 | 46 | 1361 | response to stimulus |
GO:0031424 | 1e-04 | 3.5583 | 4.5978 | 15 | 183 | keratinization |
GO:0009913 | 3e-04 | 2.6641 | 7.6378 | 19 | 304 | epidermal cell differentiation |
GO:0002548 | 4e-04 | 5.8622 | 1.3567 | 7 | 54 | monocyte chemotaxis |
GO:0019226 | 4e-04 | 5.0056 | 1.7838 | 8 | 71 | transmission of nerve impulse |
GO:0065007 | 5e-04 | 1.4709 | 285.0111 | 315 | 11344 | biological regulation |
GO:0033141 | 5e-04 | 29.3091 | 0.1759 | 3 | 7 | positive regulation of peptidyl-serine phosphorylation of STAT protein |
GO:0050704 | 6e-04 | 6.5484 | 1.0552 | 6 | 42 | regulation of interleukin-1 secretion |
GO:0070269 | 8e-04 | 23.4458 | 0.201 | 3 | 8 | pyroptosis |
GO:0098664 | 9e-04 | 11.1859 | 0.4522 | 4 | 18 | G-protein coupled serotonin receptor signaling pathway |
GO:0042742 | 0.0011 | 3.2584 | 3.6288 | 11 | 146 | defense response to bacterium |
GO:0050794 | 0.0011 | 1.3949 | 254.1835 | 284 | 10117 | regulation of cellular process |
GO:0045087 | 0.0012 | 1.8277 | 20.3005 | 35 | 808 | innate immune response |
GO:0050832 | 0.0015 | 6.7604 | 0.8542 | 5 | 34 | defense response to fungus |
GO:0018149 | 0.0015 | 5.3551 | 1.2562 | 6 | 50 | peptide cross-linking |
GO:0031640 | 0.0017 | 5.2357 | 1.2813 | 6 | 51 | killing of cells of other organism |
GO:1903015 | 0.0019 | 77.9803 | 0.0754 | 2 | 3 | regulation of exo-alpha-sialidase activity |
GO:0019730 | 0.0022 | 3.7492 | 2.3114 | 8 | 92 | antimicrobial humoral response |
GO:0050713 | 0.0022 | 14.6509 | 0.2764 | 3 | 11 | negative regulation of interleukin-1 beta secretion |
GO:0043588 | 0.0024 | 2.1794 | 9.1955 | 19 | 366 | skin development |
GO:0097530 | 0.0026 | 3.3146 | 2.9144 | 9 | 116 | granulocyte migration |
GO:0007338 | 0.0027 | 3.0582 | 3.4923 | 10 | 139 | single fertilization |
GO:0070098 | 0.0027 | 4.0465 | 1.8843 | 7 | 75 | chemokine-mediated signaling pathway |
GO:0060158 | 0.0029 | 13.0222 | 0.3015 | 3 | 12 | phospholipase C-activating dopamine receptor signaling pathway |
GO:0006954 | 0.0031 | 1.819 | 16.7831 | 29 | 668 | inflammatory response |
GO:0072540 | 0.0037 | 11.7192 | 0.3266 | 3 | 13 | T-helper 17 cell lineage commitment |
GO:0032651 | 0.0039 | 4.3606 | 1.5075 | 6 | 60 | regulation of interleukin-1 beta production |
GO:0032612 | 0.0039 | 3.7681 | 2.01 | 7 | 80 | interleukin-1 production |
GO:0002323 | 0.0047 | 10.6532 | 0.3517 | 3 | 14 | natural killer cell activation involved in immune response |
GO:0044130 | 0.0047 | 10.6532 | 0.3517 | 3 | 14 | negative regulation of growth of symbiont in host |
GO:0097340 | 0.0047 | 10.6532 | 0.3517 | 3 | 14 | inhibition of cysteine-type endopeptidase activity |
GO:0043207 | 0.0047 | 1.7112 | 19.6473 | 32 | 782 | response to external biotic stimulus |
GO:0030593 | 0.0052 | 3.5715 | 2.1104 | 7 | 84 | neutrophil chemotaxis |
GO:0002250 | 0.0054 | 2.1007 | 8.492 | 17 | 338 | adaptive immune response |
GO:2000316 | 0.0057 | 9.7648 | 0.3769 | 3 | 15 | regulation of T-helper 17 type immune response |
GO:0050829 | 0.0057 | 3.9898 | 1.6331 | 6 | 65 | defense response to Gram-negative bacterium |
GO:0042089 | 0.0059 | 3.1461 | 2.7134 | 8 | 108 | cytokine biosynthetic process |
GO:0002309 | 0.006 | 25.9902 | 0.1256 | 2 | 5 | T cell proliferation involved in immune response |
GO:0032747 | 0.006 | 25.9902 | 0.1256 | 2 | 5 | positive regulation of interleukin-23 production |
GO:2000516 | 0.0064 | 6.0186 | 0.7537 | 4 | 30 | positive regulation of CD4-positive, alpha-beta T cell activation |
GO:0006959 | 0.0067 | 3.0695 | 2.7746 | 8 | 112 | humoral immune response |
GO:0044144 | 0.0069 | 9.0131 | 0.402 | 3 | 16 | modulation of growth of symbiont involved in interaction with host |
GO:0050908 | 0.0069 | 9.0131 | 0.402 | 3 | 16 | detection of light stimulus involved in visual perception |
GO:0050663 | 0.0081 | 2.4504 | 4.7234 | 11 | 188 | cytokine secretion |
GO:0032604 | 0.0082 | 8.3688 | 0.4271 | 3 | 17 | granulocyte macrophage colony-stimulating factor production |
GO:0032693 | 0.0082 | 8.3688 | 0.4271 | 3 | 17 | negative regulation of interleukin-10 production |
GO:0043373 | 0.0082 | 8.3688 | 0.4271 | 3 | 17 | CD4-positive, alpha-beta T cell lineage commitment |
GO:0051238 | 0.0082 | 8.3688 | 0.4271 | 3 | 17 | sequestering of metal ion |
GO:0001781 | 0.0088 | 19.4914 | 0.1507 | 2 | 6 | neutrophil apoptotic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 29.8975 | 6.83 | 100 | 261 | detection of chemical stimulus involved in sensory perception of smell |
GO:0051606 | 0 | 14.4764 | 12.4851 | 109 | 481 | detection of stimulus |
GO:0007600 | 0 | 8.8472 | 20.3069 | 118 | 776 | sensory perception |
GO:0007186 | 0 | 6.6945 | 30.1202 | 134 | 1151 | G-protein coupled receptor signaling pathway |
GO:0003008 | 0 | 4.1273 | 48.5429 | 142 | 1855 | system process |
GO:0042221 | 0 | 2.0948 | 107.3963 | 174 | 4104 | response to chemical |
GO:0009913 | 0 | 4.6524 | 7.9553 | 32 | 304 | epidermal cell differentiation |
GO:0031424 | 0 | 10.0277 | 1.89 | 15 | 74 | keratinization |
GO:0043588 | 0 | 3.9135 | 9.5777 | 33 | 366 | skin development |
GO:0050896 | 0 | 3.1497 | 18.5853 | 47 | 880 | response to stimulus |
GO:0023052 | 0 | 1.7734 | 158.8701 | 217 | 6071 | signaling |
GO:0007154 | 0 | 1.7648 | 159.3411 | 217 | 6089 | cell communication |
GO:0018149 | 0 | 10.7479 | 1.3084 | 11 | 50 | peptide cross-linking |
GO:0061844 | 0 | 8.7515 | 1.2561 | 9 | 48 | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO:0051716 | 0 | 1.5596 | 179.2293 | 225 | 6849 | cellular response to stimulus |
GO:0070268 | 0 | 5.1665 | 2.8524 | 13 | 109 | cornification |
GO:0002250 | 0 | 2.8152 | 8.845 | 23 | 338 | adaptive immune response |
GO:0045087 | 0 | 2.0946 | 21.1443 | 41 | 808 | innate immune response |
GO:0050829 | 0 | 6.0883 | 1.701 | 9 | 65 | defense response to Gram-negative bacterium |
GO:0031640 | 0 | 8.5828 | 0.9882 | 7 | 38 | killing of cells of other organism |
GO:0050776 | 1e-04 | 3.2669 | 5.3174 | 16 | 209 | regulation of immune response |
GO:0050704 | 1e-04 | 7.5504 | 1.0991 | 7 | 42 | regulation of interleukin-1 secretion |
GO:0050789 | 1e-04 | 1.5092 | 281.418 | 317 | 10754 | regulation of biological process |
GO:0050713 | 1e-04 | 21.457 | 0.2879 | 4 | 11 | negative regulation of interleukin-1 beta secretion |
GO:0070098 | 1e-04 | 5.1625 | 1.9627 | 9 | 75 | chemokine-mediated signaling pathway |
GO:0006954 | 2e-04 | 2.082 | 17.4807 | 34 | 668 | inflammatory response |
GO:0010951 | 2e-04 | 2.9001 | 6.3067 | 17 | 241 | negative regulation of endopeptidase activity |
GO:0019228 | 3e-04 | 7.7951 | 0.9159 | 6 | 35 | neuronal action potential |
GO:0007338 | 3e-04 | 3.5892 | 3.6374 | 12 | 139 | single fertilization |
GO:0048007 | 6e-04 | 28.1011 | 0.1832 | 3 | 7 | antigen processing and presentation, exogenous lipid antigen via MHC class Ib |
GO:0043207 | 7e-04 | 1.8693 | 20.4639 | 36 | 782 | response to external biotic stimulus |
GO:0050830 | 8e-04 | 4.5093 | 1.9627 | 8 | 75 | defense response to Gram-positive bacterium |
GO:0032651 | 9e-04 | 4.9804 | 1.5701 | 7 | 60 | regulation of interleukin-1 beta production |
GO:0035821 | 0.001 | 3.2822 | 3.6113 | 11 | 138 | modification of morphology or physiology of other organism |
GO:0042742 | 0.0012 | 3.7522 | 2.6052 | 9 | 102 | defense response to bacterium |
GO:0006953 | 0.0012 | 5.6475 | 1.2038 | 6 | 46 | acute-phase response |
GO:0002376 | 0.0012 | 1.46 | 69.8442 | 94 | 2669 | immune system process |
GO:0045670 | 0.0013 | 4.7127 | 1.6486 | 7 | 63 | regulation of osteoclast differentiation |
GO:0044110 | 0.0013 | 10.0082 | 0.4972 | 4 | 19 | growth involved in symbiotic interaction |
GO:0060046 | 0.0016 | 9.3821 | 0.5234 | 4 | 20 | regulation of acrosome reaction |
GO:0050832 | 0.0018 | 6.4805 | 0.8897 | 5 | 34 | defense response to fungus |
GO:0002475 | 0.0019 | 16.0547 | 0.2617 | 3 | 10 | antigen processing and presentation via MHC class Ib |
GO:0009595 | 0.0019 | 8.8297 | 0.5495 | 4 | 21 | detection of biotic stimulus |
GO:0051714 | 0.002 | 74.7736 | 0.0785 | 2 | 3 | positive regulation of cytolysis in other organism |
GO:0051346 | 0.0026 | 2.0722 | 10.6768 | 21 | 408 | negative regulation of hydrolase activity |
GO:0060326 | 0.0027 | 2.4048 | 6.5945 | 15 | 252 | cell chemotaxis |
GO:0002548 | 0.0028 | 4.7039 | 1.4131 | 6 | 54 | monocyte chemotaxis |
GO:0032700 | 0.0033 | 12.4854 | 0.314 | 3 | 12 | negative regulation of interleukin-17 production |
GO:0050710 | 0.0036 | 4.4263 | 1.4916 | 6 | 57 | negative regulation of cytokine secretion |
GO:0032692 | 0.0038 | 7.146 | 0.6542 | 4 | 25 | negative regulation of interleukin-1 production |
GO:0032497 | 0.004 | 37.3844 | 0.1047 | 2 | 4 | detection of lipopolysaccharide |
GO:0046634 | 0.004 | 3.7668 | 2.015 | 7 | 77 | regulation of alpha-beta T cell activation |
GO:0051709 | 0.0042 | 11.2362 | 0.3402 | 3 | 13 | regulation of killing of cells of other organism |
GO:0072540 | 0.0042 | 11.2362 | 0.3402 | 3 | 13 | T-helper 17 cell lineage commitment |
GO:0098543 | 0.0042 | 11.2362 | 0.3402 | 3 | 13 | detection of other organism |
GO:0051349 | 0.0043 | 4.2588 | 1.544 | 6 | 59 | positive regulation of lyase activity |
GO:0019835 | 0.0049 | 6.5655 | 0.7022 | 4 | 27 | cytolysis |
GO:0019730 | 0.0052 | 4.9088 | 1.1304 | 5 | 44 | antimicrobial humoral response |
GO:0002323 | 0.0052 | 10.2141 | 0.3664 | 3 | 14 | natural killer cell activation involved in immune response |
GO:0044130 | 0.0052 | 10.2141 | 0.3664 | 3 | 14 | negative regulation of growth of symbiont in host |
GO:0097340 | 0.0052 | 10.2141 | 0.3664 | 3 | 14 | inhibition of cysteine-type endopeptidase activity |
GO:0071621 | 0.0056 | 3.1746 | 2.6954 | 8 | 103 | granulocyte chemotaxis |
GO:0031349 | 0.0058 | 1.9194 | 11.4619 | 21 | 438 | positive regulation of defense response |
GO:0050778 | 0.0063 | 1.7196 | 17.6639 | 29 | 675 | positive regulation of immune response |
GO:0042268 | 0.0064 | 9.3623 | 0.3925 | 3 | 15 | regulation of cytolysis |
GO:2000316 | 0.0064 | 9.3623 | 0.3925 | 3 | 15 | regulation of T-helper 17 type immune response |
GO:0002309 | 0.0065 | 24.9214 | 0.1308 | 2 | 5 | T cell proliferation involved in immune response |
GO:0002361 | 0.0065 | 24.9214 | 0.1308 | 2 | 5 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation |
GO:0032747 | 0.0065 | 24.9214 | 0.1308 | 2 | 5 | positive regulation of interleukin-23 production |
GO:0050482 | 0.0065 | 6.0011 | 0.7589 | 4 | 29 | arachidonic acid secretion |
GO:0045861 | 0.0073 | 2.0305 | 8.7665 | 17 | 335 | negative regulation of proteolysis |
GO:2000516 | 0.0074 | 5.77 | 0.7851 | 4 | 30 | positive regulation of CD4-positive, alpha-beta T cell activation |
GO:0032695 | 0.0077 | 8.6416 | 0.4187 | 3 | 16 | negative regulation of interleukin-12 production |
GO:0044144 | 0.0077 | 8.6416 | 0.4187 | 3 | 16 | modulation of growth of symbiont involved in interaction with host |
GO:0002366 | 0.0078 | 1.7056 | 17.1667 | 28 | 656 | leukocyte activation involved in immune response |
GO:0050907 | 0.0079 | 5.5571 | 0.7937 | 4 | 39 | detection of chemical stimulus involved in sensory perception |
GO:0007157 | 0.0081 | 4.3667 | 1.2561 | 5 | 48 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules |
GO:0006952 | 0.0088 | 2.4186 | 4.7843 | 11 | 198 | defense response |
GO:0048247 | 0.0089 | 4.2672 | 1.2823 | 5 | 49 | lymphocyte chemotaxis |
GO:0086010 | 0.0089 | 4.2672 | 1.2823 | 5 | 49 | membrane depolarization during action potential |
GO:0043373 | 0.0092 | 8.0238 | 0.4449 | 3 | 17 | CD4-positive, alpha-beta T cell lineage commitment |
GO:0001781 | 0.0096 | 18.6899 | 0.157 | 2 | 6 | neutrophil apoptotic process |
GO:0021707 | 0.0096 | 18.6899 | 0.157 | 2 | 6 | cerebellar granule cell differentiation |
GO:0045084 | 0.0096 | 18.6899 | 0.157 | 2 | 6 | positive regulation of interleukin-12 biosynthetic process |
GO:0070663 | 0.0098 | 2.2801 | 5.5216 | 12 | 211 | regulation of leukocyte proliferation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0008967 | 0.001 | Inf | 0.0635 | 2 | 2 | phosphoglycolate phosphatase activity |
GO:0016167 | 0.003 | 61.2699 | 0.0952 | 2 | 3 | glial cell-derived neurotrophic factor receptor activity |
GO:0016520 | 0.0058 | 30.633 | 0.1269 | 2 | 4 | growth hormone-releasing hormone receptor activity |
GO:0030197 | 0.0058 | 30.633 | 0.1269 | 2 | 4 | extracellular matrix constituent, lubricant activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:1903231 | 1e-04 | 4.7492 | 2.3711 | 10 | 81 | mRNA binding involved in posttranscriptional gene silencing |
GO:0003723 | 3e-04 | 1.6135 | 48.7685 | 73 | 1666 | RNA binding |
GO:0043023 | 8e-04 | 25.0222 | 0.2049 | 3 | 7 | ribosomal large subunit binding |
GO:0047017 | 9e-04 | Inf | 0.0585 | 2 | 2 | prostaglandin-F synthase activity |
GO:0019003 | 0.0016 | 4.5156 | 1.7271 | 7 | 59 | GDP binding |
GO:0004984 | 0.0018 | 2.3589 | 7.6402 | 17 | 261 | olfactory receptor activity |
GO:0002162 | 0.0018 | 16.6793 | 0.2635 | 3 | 9 | dystroglycan binding |
GO:0016462 | 0.0027 | 1.6804 | 24.4428 | 39 | 835 | pyrophosphatase activity |
GO:0016817 | 0.003 | 1.6715 | 24.5599 | 39 | 839 | hydrolase activity, acting on acid anhydrides |
GO:0016614 | 0.0055 | 2.7549 | 3.864 | 10 | 132 | oxidoreductase activity, acting on CH-OH group of donors |
GO:0003924 | 0.0073 | 2.085 | 8.05 | 16 | 275 | GTPase activity |
GO:0004024 | 0.0081 | 22.1965 | 0.1464 | 2 | 5 | alcohol dehydrogenase activity, zinc-dependent |
GO:0004659 | 0.0087 | 8.3365 | 0.4391 | 3 | 15 | prenyltransferase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 14.8599 | 5.4138 | 55 | 261 | olfactory receptor activity |
GO:0004930 | 0 | 5.8368 | 14.0635 | 64 | 678 | G-protein coupled receptor activity |
GO:0099600 | 0 | 3.8428 | 23.2732 | 72 | 1122 | transmembrane receptor activity |
GO:0038023 | 0 | 3.6882 | 24.5177 | 73 | 1182 | signaling receptor activity |
GO:0060089 | 0 | 3.1968 | 30.0145 | 78 | 1447 | molecular transducer activity |
GO:0005549 | 0 | 9.898 | 1.2238 | 10 | 59 | odorant binding |
GO:0070330 | 0 | 19.2072 | 0.4356 | 6 | 21 | aromatase activity |
GO:0030414 | 0 | 4.6142 | 3.6092 | 15 | 174 | peptidase inhibitor activity |
GO:0019825 | 0 | 9.6205 | 0.8712 | 7 | 42 | oxygen binding |
GO:0061135 | 1e-04 | 3.9493 | 3.5885 | 13 | 173 | endopeptidase regulator activity |
GO:0030883 | 1e-04 | 71.4403 | 0.1037 | 3 | 5 | endogenous lipid antigen binding |
GO:0030884 | 1e-04 | 71.4403 | 0.1037 | 3 | 5 | exogenous lipid antigen binding |
GO:0004867 | 1e-04 | 5.1692 | 1.9291 | 9 | 93 | serine-type endopeptidase inhibitor activity |
GO:0008131 | 2e-04 | 47.6239 | 0.1245 | 3 | 6 | primary amine oxidase activity |
GO:0020037 | 2e-04 | 4.3132 | 2.5306 | 10 | 122 | heme binding |
GO:0033038 | 3e-04 | 15.9132 | 0.3319 | 4 | 16 | bitter taste receptor activity |
GO:0048020 | 3e-04 | 9.5688 | 0.6223 | 5 | 30 | CCR chemokine receptor binding |
GO:0003823 | 4e-04 | 6.8481 | 0.9956 | 6 | 48 | antigen binding |
GO:0030881 | 7e-04 | 23.8075 | 0.1867 | 3 | 9 | beta-2-microglobulin binding |
GO:0071723 | 0.001 | 20.4051 | 0.2074 | 3 | 10 | lipopeptide binding |
GO:0016705 | 0.001 | 3.5206 | 3.0492 | 10 | 147 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen |
GO:0004833 | 0.0013 | 94.9762 | 0.0622 | 2 | 3 | tryptophan 2,3-dioxygenase activity |
GO:0005506 | 0.0013 | 3.3955 | 3.1529 | 10 | 152 | iron ion binding |
GO:0030246 | 0.0019 | 2.7112 | 5.0819 | 13 | 245 | carbohydrate binding |
GO:0016701 | 0.0019 | 8.6745 | 0.5393 | 4 | 26 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen |
GO:0034875 | 0.0025 | 47.4851 | 0.083 | 2 | 4 | caffeine oxidase activity |
GO:0042056 | 0.0025 | 7.9506 | 0.5808 | 4 | 28 | chemoattractant activity |
GO:0008395 | 0.0037 | 7.0659 | 0.643 | 4 | 31 | steroid hydroxylase activity |
GO:0005537 | 0.0041 | 10.9832 | 0.3319 | 3 | 16 | mannose binding |
GO:0008392 | 0.0041 | 10.9832 | 0.3319 | 3 | 16 | arachidonic acid epoxygenase activity |
GO:0030545 | 0.0054 | 2.0507 | 9.2097 | 18 | 444 | receptor regulator activity |
GO:0001591 | 0.0084 | 18.9905 | 0.1452 | 2 | 7 | dopamine neurotransmitter receptor activity, coupled via Gi/Go |
GO:0004190 | 0.0089 | 7.9299 | 0.4356 | 3 | 21 | aspartic-type endopeptidase activity |
GO:0016638 | 0.0089 | 7.9299 | 0.4356 | 3 | 21 | oxidoreductase activity, acting on the CH-NH2 group of donors |
GO:0051213 | 0.0094 | 3.5422 | 1.8046 | 6 | 87 | dioxygenase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005509 | 0 | 2.5768 | 16.6523 | 39 | 670 | calcium ion binding |
GO:1903231 | 0 | 6.3096 | 2.0132 | 11 | 81 | mRNA binding involved in posttranscriptional gene silencing |
GO:0005125 | 1e-04 | 3.3381 | 4.8714 | 15 | 196 | cytokine activity |
GO:0001228 | 2e-04 | 2.4443 | 10.066 | 23 | 405 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding |
GO:0030246 | 0.0012 | 2.6187 | 6.0893 | 15 | 245 | carbohydrate binding |
GO:0050786 | 0.0016 | 16.9328 | 0.2485 | 3 | 10 | RAGE receptor binding |
GO:0035662 | 0.0018 | 78.8536 | 0.0746 | 2 | 3 | Toll-like receptor 4 binding |
GO:0045569 | 0.0036 | 39.4243 | 0.0994 | 2 | 4 | TRAIL binding |
GO:0030545 | 0.0038 | 1.9996 | 11.0353 | 21 | 444 | receptor regulator activity |
GO:0004888 | 0.0042 | 1.6183 | 26.7183 | 41 | 1075 | transmembrane signaling receptor activity |
GO:0002020 | 0.0049 | 2.9867 | 3.2062 | 9 | 129 | protease binding |
GO:0050544 | 0.0059 | 26.2812 | 0.1243 | 2 | 5 | arachidonic acid binding |
GO:0004872 | 0.006 | 1.5145 | 34.8457 | 50 | 1402 | receptor activity |
GO:0005160 | 0.0072 | 4.5017 | 1.2179 | 5 | 49 | transforming growth factor beta receptor binding |
GO:0030020 | 0.0087 | 19.7097 | 0.1491 | 2 | 6 | extracellular matrix structural constituent conferring tensile strength |
GO:0042289 | 0.0087 | 19.7097 | 0.1491 | 2 | 6 | MHC class II protein binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004872 | 0 | 3.4252 | 34.374 | 94 | 1385 | receptor activity |
GO:0004984 | 0 | 7.1942 | 6.551 | 38 | 261 | olfactory receptor activity |
GO:0004871 | 0 | 2.8643 | 37.5241 | 89 | 1495 | signal transducer activity |
GO:0004930 | 0 | 4.1422 | 13.6216 | 48 | 552 | G-protein coupled receptor activity |
GO:0005549 | 0 | 10.1864 | 1.4809 | 12 | 59 | odorant binding |
GO:0031726 | 0 | 156.8889 | 0.1255 | 4 | 5 | CCR1 chemokine receptor binding |
GO:0004867 | 0 | 5.8979 | 2.3343 | 12 | 93 | serine-type endopeptidase inhibitor activity |
GO:0008009 | 0 | 9.3015 | 1.0542 | 8 | 42 | chemokine activity |
GO:0061135 | 0 | 3.7898 | 4.3423 | 15 | 173 | endopeptidase regulator activity |
GO:0030414 | 0 | 3.7657 | 4.3674 | 15 | 174 | peptidase inhibitor activity |
GO:0005126 | 0 | 3.2188 | 6.0741 | 18 | 242 | cytokine receptor binding |
GO:0038187 | 0 | 16.3717 | 0.4267 | 5 | 17 | pattern recognition receptor activity |
GO:0001588 | 1e-04 | 117.3768 | 0.1004 | 3 | 4 | dopamine neurotransmitter receptor activity, coupled via Gs |
GO:0030246 | 2e-04 | 2.9783 | 6.1494 | 17 | 245 | carbohydrate binding |
GO:0030280 | 2e-04 | 17.4233 | 0.3263 | 4 | 13 | structural constituent of epidermis |
GO:0042056 | 6e-04 | 8.5358 | 0.7028 | 5 | 28 | chemoattractant activity |
GO:0031729 | 6e-04 | Inf | 0.0502 | 2 | 2 | CCR4 chemokine receptor binding |
GO:0102294 | 6e-04 | Inf | 0.0502 | 2 | 2 | cholesterol dehydrogenase activity |
GO:0008528 | 0.0013 | 3.4072 | 3.1626 | 10 | 126 | G-protein coupled peptide receptor activity |
GO:0004769 | 0.0019 | 78.059 | 0.0753 | 2 | 3 | steroid delta-isomerase activity |
GO:0018685 | 0.0019 | 78.059 | 0.0753 | 2 | 3 | alkane 1-monooxygenase activity |
GO:0098772 | 0.0023 | 1.5292 | 43.2719 | 62 | 1724 | molecular function regulator |
GO:0008745 | 0.0036 | 39.027 | 0.1004 | 2 | 4 | N-acetylmuramoyl-L-alanine amidase activity |
GO:0050051 | 0.0036 | 39.027 | 0.1004 | 2 | 4 | leukotriene-B4 20-monooxygenase activity |
GO:0004950 | 0.0038 | 7.1219 | 0.6526 | 4 | 26 | chemokine receptor activity |
GO:0019825 | 0.0039 | 5.3014 | 1.0542 | 5 | 42 | oxygen binding |
GO:0016229 | 0.0043 | 6.8118 | 0.6777 | 4 | 27 | steroid dehydrogenase activity |
GO:0001875 | 0.006 | 26.0164 | 0.1255 | 2 | 5 | lipopolysaccharide receptor activity |
GO:0003854 | 0.006 | 26.0164 | 0.1255 | 2 | 5 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity |
GO:0016019 | 0.006 | 26.0164 | 0.1255 | 2 | 5 | peptidoglycan receptor activity |
GO:0050544 | 0.006 | 26.0164 | 0.1255 | 2 | 5 | arachidonic acid binding |
GO:0101020 | 0.006 | 26.0164 | 0.1255 | 2 | 5 | estrogen 16-alpha-hydroxylase activity |
GO:0008392 | 0.0069 | 9.0222 | 0.4016 | 3 | 16 | arachidonic acid epoxygenase activity |
GO:0004497 | 0.007 | 3.356 | 2.2339 | 7 | 89 | monooxygenase activity |
GO:0048018 | 0.0085 | 1.9526 | 9.6362 | 18 | 388 | receptor ligand activity |
GO:0004888 | 0.0086 | 1.9939 | 8.9228 | 17 | 397 | transmembrane signaling receptor activity |
GO:0004111 | 0.0088 | 19.5111 | 0.1506 | 2 | 6 | creatine kinase activity |
GO:0031730 | 0.0088 | 19.5111 | 0.1506 | 2 | 6 | CCR5 chemokine receptor binding |
GO:0030674 | 0.0092 | 2.5272 | 4.1666 | 10 | 166 | protein binding, bridging |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0003723 | 0 | 2.0132 | 44.1677 | 79 | 1666 | RNA binding |
GO:0046982 | 0 | 2.5502 | 12.7519 | 30 | 481 | protein heterodimerization activity |
GO:0042393 | 1e-04 | 3.3892 | 5.1432 | 16 | 194 | histone binding |
GO:0004689 | 2e-04 | 55.458 | 0.1326 | 3 | 5 | phosphorylase kinase activity |
GO:0004704 | 2e-04 | 55.458 | 0.1326 | 3 | 5 | NF-kappaB-inducing kinase activity |
GO:1903231 | 3e-04 | 4.6664 | 2.1474 | 9 | 81 | mRNA binding involved in posttranscriptional gene silencing |
GO:0036374 | 3e-04 | 36.9697 | 0.1591 | 3 | 6 | glutathione hydrolase activity |
GO:0005049 | 9e-04 | 22.179 | 0.2121 | 3 | 8 | nuclear export signal receptor activity |
GO:0097159 | 0.0011 | 1.3634 | 154.958 | 186 | 5845 | organic cyclic compound binding |
GO:0031720 | 0.0021 | 73.7767 | 0.0795 | 2 | 3 | haptoglobin binding |
GO:1901363 | 0.0035 | 1.3156 | 152.7575 | 180 | 5762 | heterocyclic compound binding |
GO:0140104 | 0.0054 | 10.1222 | 0.3696 | 3 | 14 | molecular carrier activity |
GO:0015248 | 0.0077 | 5.6927 | 0.7953 | 4 | 30 | sterol transporter activity |
GO:0015197 | 0.0089 | 2.9155 | 2.9162 | 8 | 110 | peptide transporter activity |
GO:0015095 | 0.0095 | 7.9166 | 0.4507 | 3 | 17 | magnesium ion transmembrane transporter activity |
GO:0004111 | 0.0098 | 18.4407 | 0.1591 | 2 | 6 | creatine kinase activity |
GO:0004468 | 0.0098 | 18.4407 | 0.1591 | 2 | 6 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor |
GO:0005375 | 0.0098 | 18.4407 | 0.1591 | 2 | 6 | copper ion transmembrane transporter activity |
GO:0016530 | 0.0098 | 18.4407 | 0.1591 | 2 | 6 | metallochaperone activity |
GO:0017176 | 0.0098 | 18.4407 | 0.1591 | 2 | 6 | phosphatidylinositol N-acetylglucosaminyltransferase activity |
GO:0019237 | 0.0098 | 18.4407 | 0.1591 | 2 | 6 | centromeric DNA binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0003723 | 0 | 1.9196 | 51.2222 | 88 | 1666 | RNA binding |
GO:1901363 | 0 | 1.5744 | 177.1563 | 230 | 5762 | heterocyclic compound binding |
GO:0042393 | 0 | 3.9504 | 5.9647 | 21 | 194 | histone binding |
GO:0097159 | 0 | 1.5643 | 179.7082 | 232 | 5845 | organic cyclic compound binding |
GO:0046982 | 0 | 2.6704 | 14.7886 | 36 | 481 | protein heterodimerization activity |
GO:0003677 | 0 | 1.7836 | 47.4833 | 77 | 1589 | DNA binding |
GO:1903231 | 8e-04 | 3.9944 | 2.4904 | 9 | 81 | mRNA binding involved in posttranscriptional gene silencing |
GO:0035925 | 0.0052 | 10.5656 | 0.3689 | 3 | 12 | mRNA 3'-UTR AU-rich region binding |
GO:0003690 | 0.0054 | 1.6168 | 24.6272 | 38 | 801 | double-stranded DNA binding |
GO:0001159 | 0.006 | 1.9137 | 11.4989 | 21 | 374 | core promoter proximal region DNA binding |
GO:0000976 | 0.0071 | 1.6428 | 20.9993 | 33 | 683 | transcription regulatory region sequence-specific DNA binding |
GO:0008173 | 0.0072 | 3.8167 | 1.7218 | 6 | 56 | RNA methyltransferase activity |
GO:0001228 | 0.0073 | 1.8481 | 12.452 | 22 | 405 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding |
GO:0001012 | 0.0074 | 1.6798 | 18.6626 | 30 | 607 | RNA polymerase II regulatory region DNA binding |
GO:0003700 | 0.0075 | 1.4775 | 36.8948 | 52 | 1200 | DNA binding transcription factor activity |
GO:0000978 | 0.0077 | 1.9014 | 11.0069 | 20 | 358 | RNA polymerase II core promoter proximal region sequence-specific DNA binding |
GO:0050145 | 0.0089 | 21.0969 | 0.1537 | 2 | 5 | nucleoside phosphate kinase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0019864 | 1e-04 | 28.0887 | 0.2513 | 4 | 9 | IgG binding |
GO:0005179 | 1e-04 | 4.2637 | 3.1273 | 12 | 112 | hormone activity |
GO:0046920 | 0.0011 | 21.0199 | 0.2234 | 3 | 8 | alpha-(1->3)-fucosyltransferase activity |
GO:0050786 | 0.0022 | 15.0123 | 0.2792 | 3 | 10 | RAGE receptor binding |
GO:0017060 | 0.0023 | 69.9294 | 0.0838 | 2 | 3 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity |
GO:0031720 | 0.0023 | 69.9294 | 0.0838 | 2 | 3 | haptoglobin binding |
GO:0031735 | 0.0023 | 69.9294 | 0.0838 | 2 | 3 | CCR10 chemokine receptor binding |
GO:0050220 | 0.0023 | 69.9294 | 0.0838 | 2 | 3 | prostaglandin-E synthase activity |
GO:0004864 | 0.0027 | 5.8556 | 0.9773 | 5 | 35 | protein phosphatase inhibitor activity |
GO:0004601 | 0.0067 | 4.6205 | 1.2007 | 5 | 43 | peroxidase activity |
GO:0004568 | 0.0074 | 23.3068 | 0.1396 | 2 | 5 | chitinase activity |
GO:0070290 | 0.0074 | 23.3068 | 0.1396 | 2 | 5 | N-acylphosphatidylethanolamine-specific phospholipase D activity |
GO:0015491 | 0.0093 | 5.3945 | 0.8377 | 4 | 30 | cation:cation antiporter activity |
GO:0004872 | 0.0096 | 1.4477 | 39.1476 | 54 | 1402 | receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0003735 | 0 | 4.7714 | 6.1902 | 25 | 154 | structural constituent of ribosome |
GO:0003723 | 0.0013 | 1.4996 | 52.9852 | 75 | 1348 | RNA binding |
GO:0005488 | 0.0013 | 1.4756 | 564.4778 | 590 | 14043 | binding |
GO:0046964 | 0.0016 | Inf | 0.0804 | 2 | 2 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity |
GO:0032794 | 0.0019 | 9.6037 | 0.5627 | 4 | 14 | GTPase activating protein binding |
GO:0003743 | 0.0025 | 4.213 | 1.8892 | 7 | 47 | translation initiation factor activity |
GO:0008327 | 0.0032 | 8.002 | 0.6431 | 4 | 16 | methyl-CpG binding |
GO:0055106 | 0.0041 | 7.386 | 0.6833 | 4 | 17 | ubiquitin-protein transferase regulator activity |
GO:0043130 | 0.0048 | 3.3219 | 2.653 | 8 | 66 | ubiquitin binding |
GO:0003676 | 0.005 | 1.3448 | 85.4317 | 108 | 2260 | nucleic acid binding |
GO:0015605 | 0.005 | 6.858 | 0.7235 | 4 | 18 | organophosphate ester transmembrane transporter activity |
GO:0003729 | 0.0065 | 1.9389 | 10.853 | 20 | 270 | mRNA binding |
GO:0019843 | 0.0076 | 3.3682 | 2.2912 | 7 | 57 | rRNA binding |
GO:0003697 | 0.0079 | 2.6202 | 4.1 | 10 | 102 | single-stranded DNA binding |
GO:0031492 | 0.0079 | 3.7958 | 1.7686 | 6 | 44 | nucleosomal DNA binding |
GO:0015216 | 0.0084 | 8.9908 | 0.4422 | 3 | 11 | purine nucleotide transmembrane transporter activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0031492 | 0 | 12.9828 | 0.9991 | 10 | 44 | nucleosomal DNA binding |
GO:0042393 | 0 | 3.7169 | 4.405 | 15 | 194 | histone binding |
GO:0016638 | 1e-04 | 13.6207 | 0.4768 | 5 | 21 | oxidoreductase activity, acting on the CH-NH2 group of donors |
GO:0020037 | 1e-04 | 4.3653 | 2.7702 | 11 | 122 | heme binding |
GO:0008131 | 2e-04 | 43.3842 | 0.1362 | 3 | 6 | primary amine oxidase activity |
GO:0008459 | 5e-04 | Inf | 0.0454 | 2 | 2 | chondroitin 6-sulfotransferase activity |
GO:0048020 | 5e-04 | 8.7123 | 0.6812 | 5 | 30 | CCR chemokine receptor binding |
GO:0008201 | 9e-04 | 3.3115 | 3.5649 | 11 | 157 | heparin binding |
GO:0004497 | 9e-04 | 4.3228 | 2.0209 | 8 | 89 | monooxygenase activity |
GO:0004190 | 0.0012 | 10.2269 | 0.4768 | 4 | 21 | aspartic-type endopeptidase activity |
GO:0004867 | 0.0012 | 4.1183 | 2.1117 | 8 | 93 | serine-type endopeptidase inhibitor activity |
GO:0004833 | 0.0015 | 86.5435 | 0.0681 | 2 | 3 | tryptophan 2,3-dioxygenase activity |
GO:0048407 | 0.0017 | 16.264 | 0.2498 | 3 | 11 | platelet-derived growth factor binding |
GO:0061135 | 0.002 | 2.9814 | 3.9282 | 11 | 173 | endopeptidase regulator activity |
GO:0030414 | 0.0021 | 2.9629 | 3.9509 | 11 | 174 | peptidase inhibitor activity |
GO:0003682 | 0.0024 | 2.0518 | 11.3078 | 22 | 498 | chromatin binding |
GO:0005518 | 0.0033 | 4.5094 | 1.4532 | 6 | 64 | collagen binding |
GO:0050839 | 0.0045 | 2.0063 | 10.4676 | 20 | 461 | cell adhesion molecule binding |
GO:0030023 | 0.0049 | 28.8442 | 0.1135 | 2 | 5 | extracellular matrix constituent conferring elasticity |
GO:0005537 | 0.0052 | 10.0054 | 0.3633 | 3 | 16 | mannose binding |
GO:0008392 | 0.0052 | 10.0054 | 0.3633 | 3 | 16 | arachidonic acid epoxygenase activity |
GO:0005201 | 0.0053 | 4.0434 | 1.6039 | 6 | 71 | extracellular matrix structural constituent |
GO:0016705 | 0.0064 | 2.852 | 3.3378 | 9 | 147 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen |
GO:0048018 | 0.007 | 1.995 | 9.4458 | 18 | 416 | receptor ligand activity |
GO:0004111 | 0.0073 | 21.6318 | 0.1362 | 2 | 6 | creatine kinase activity |
GO:0008508 | 0.0073 | 21.6318 | 0.1362 | 2 | 6 | bile acid:sodium symporter activity |
GO:0005506 | 0.008 | 2.7514 | 3.4514 | 9 | 152 | iron ion binding |
GO:0050431 | 0.0086 | 8.1279 | 0.4314 | 3 | 19 | transforming growth factor beta binding |
GO:0022804 | 0.0086 | 2.0411 | 8.197 | 16 | 361 | active transmembrane transporter activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0031492 | 0 | 12.7296 | 1.018 | 10 | 44 | nucleosomal DNA binding |
GO:0044877 | 0 | 2.225 | 22.1874 | 45 | 959 | macromolecular complex binding |
GO:0005518 | 0 | 7.0537 | 1.4807 | 9 | 64 | collagen binding |
GO:0005178 | 0 | 4.8024 | 2.545 | 11 | 110 | integrin binding |
GO:0030545 | 1e-04 | 2.5088 | 10.2724 | 24 | 444 | receptor regulator activity |
GO:0008201 | 3e-04 | 3.5763 | 3.6323 | 12 | 157 | heparin binding |
GO:0016641 | 4e-04 | 14.2145 | 0.3702 | 4 | 16 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor |
GO:1903231 | 6e-04 | 4.7058 | 1.874 | 8 | 81 | mRNA binding involved in posttranscriptional gene silencing |
GO:0050431 | 8e-04 | 11.3694 | 0.4396 | 4 | 19 | transforming growth factor beta binding |
GO:0050840 | 0.0011 | 5.7046 | 1.1799 | 6 | 51 | extracellular matrix binding |
GO:0004190 | 0.0012 | 10.0306 | 0.4859 | 4 | 21 | aspartic-type endopeptidase activity |
GO:0036122 | 0.0013 | 18.2326 | 0.2314 | 3 | 10 | BMP binding |
GO:0034714 | 0.0016 | 84.8907 | 0.0694 | 2 | 3 | type III transforming growth factor beta receptor binding |
GO:0038181 | 0.0016 | 84.8907 | 0.0694 | 2 | 3 | bile acid receptor activity |
GO:0048407 | 0.0018 | 15.9525 | 0.2545 | 3 | 11 | platelet-derived growth factor binding |
GO:0042393 | 0.0019 | 2.8426 | 4.4884 | 12 | 194 | histone binding |
GO:0046982 | 0.0019 | 2.0872 | 11.1284 | 22 | 481 | protein heterodimerization activity |
GO:0004620 | 0.002 | 3.8128 | 2.2673 | 8 | 98 | phospholipase activity |
GO:0005102 | 0.0025 | 1.6286 | 30.0534 | 46 | 1329 | receptor binding |
GO:0044323 | 0.0031 | 42.4427 | 0.0925 | 2 | 4 | retinoic acid-responsive element binding |
GO:0051431 | 0.0031 | 42.4427 | 0.0925 | 2 | 4 | corticotropin-releasing hormone receptor 2 binding |
GO:0001968 | 0.0032 | 7.4111 | 0.6247 | 4 | 27 | fibronectin binding |
GO:0008083 | 0.0034 | 2.9435 | 3.6092 | 10 | 156 | growth factor activity |
GO:0042056 | 0.0037 | 7.1019 | 0.6478 | 4 | 28 | chemoattractant activity |
GO:0015020 | 0.0048 | 6.5548 | 0.6941 | 4 | 30 | glucuronosyltransferase activity |
GO:0048020 | 0.0048 | 6.5548 | 0.6941 | 4 | 30 | CCR chemokine receptor binding |
GO:0030023 | 0.0051 | 28.2933 | 0.1157 | 2 | 5 | extracellular matrix constituent conferring elasticity |
GO:0004866 | 0.0056 | 2.7354 | 3.8637 | 10 | 167 | endopeptidase inhibitor activity |
GO:0008172 | 0.0075 | 21.2187 | 0.1388 | 2 | 6 | S-methyltransferase activity |
GO:0005507 | 0.0081 | 4.3529 | 1.2493 | 5 | 54 | copper ion binding |
GO:0061134 | 0.0096 | 2.3862 | 4.8354 | 11 | 209 | peptidase regulator activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0031492 | 0 | 10.9788 | 1.1719 | 10 | 44 | nucleosomal DNA binding |
GO:0098641 | 0 | 18.5152 | 0.4794 | 6 | 18 | cadherin binding involved in cell-cell adhesion |
GO:0019834 | 1e-04 | 110.3944 | 0.1065 | 3 | 4 | phospholipase A2 inhibitor activity |
GO:0008201 | 3e-04 | 3.3703 | 4.1815 | 13 | 157 | heparin binding |
GO:0098631 | 5e-04 | 6.9344 | 1.0121 | 6 | 38 | cell adhesion mediator activity |
GO:0004252 | 7e-04 | 3.0689 | 4.5544 | 13 | 171 | serine-type endopeptidase activity |
GO:0008459 | 7e-04 | Inf | 0.0533 | 2 | 2 | chondroitin 6-sulfotransferase activity |
GO:0070851 | 7e-04 | 3.4401 | 3.4624 | 11 | 130 | growth factor receptor binding |
GO:0005198 | 0.0012 | 1.8809 | 18.0045 | 32 | 676 | structural molecule activity |
GO:0061134 | 0.0015 | 2.6779 | 5.5665 | 14 | 209 | peptidase regulator activity |
GO:0044877 | 0.0015 | 2.7898 | 4.9713 | 13 | 193 | macromolecular complex binding |
GO:0004866 | 0.0017 | 2.8814 | 4.4479 | 12 | 167 | endopeptidase inhibitor activity |
GO:0042015 | 0.0021 | 73.4259 | 0.0799 | 2 | 3 | interleukin-20 binding |
GO:0098772 | 0.0025 | 1.508 | 45.9169 | 65 | 1724 | molecular function regulator |
GO:0032403 | 0.0025 | 1.7568 | 20.4016 | 34 | 766 | protein complex binding |
GO:0017134 | 0.0029 | 7.7562 | 0.6126 | 4 | 23 | fibroblast growth factor binding |
GO:0017171 | 0.0032 | 2.5469 | 5.4067 | 13 | 203 | serine hydrolase activity |
GO:0045296 | 0.0038 | 2.2408 | 7.5203 | 16 | 286 | cadherin binding |
GO:0003682 | 0.0039 | 1.9002 | 13.2637 | 24 | 498 | chromatin binding |
GO:0031267 | 0.0059 | 1.8324 | 13.7165 | 24 | 515 | small GTPase binding |
GO:0042393 | 0.0059 | 2.4497 | 5.167 | 12 | 194 | histone binding |
GO:0005544 | 0.0061 | 4.7283 | 1.1719 | 5 | 44 | calcium-dependent phospholipid binding |
GO:0004904 | 0.0067 | 24.4722 | 0.1332 | 2 | 5 | interferon receptor activity |
GO:0017049 | 0.0081 | 8.4855 | 0.4261 | 3 | 16 | GTP-Rho binding |
GO:0055102 | 0.0081 | 8.4855 | 0.4261 | 3 | 16 | lipase inhibitor activity |
GO:0004857 | 0.009 | 1.9412 | 9.6902 | 18 | 366 | enzyme inhibitor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 52.845 | 6.3108 | 124 | 261 | olfactory receptor activity |
GO:0004930 | 0 | 17.1332 | 16.0155 | 144 | 667 | G-protein coupled receptor activity |
GO:0099600 | 0 | 9.8988 | 27.1291 | 154 | 1122 | transmembrane receptor activity |
GO:0038023 | 0 | 9.5029 | 28.5798 | 156 | 1182 | signaling receptor activity |
GO:0060089 | 0 | 8.0328 | 34.9873 | 163 | 1447 | molecular transducer activity |
GO:0005549 | 0 | 27.3207 | 1.4266 | 23 | 59 | odorant binding |
GO:0005125 | 3e-04 | 3.182 | 4.7391 | 14 | 196 | cytokine activity |
GO:0004993 | 8e-04 | 11.6388 | 0.4352 | 4 | 18 | G-protein coupled serotonin receptor activity |
GO:0050786 | 0.0015 | 17.4213 | 0.2418 | 3 | 10 | RAGE receptor binding |
GO:0089720 | 0.0015 | 17.4213 | 0.2418 | 3 | 10 | caspase binding |
GO:0004982 | 0.0017 | 81.1224 | 0.0725 | 2 | 3 | N-formyl peptide receptor activity |
GO:0005124 | 0.0017 | 81.1224 | 0.0725 | 2 | 3 | scavenger receptor binding |
GO:0005132 | 0.0017 | 81.1224 | 0.0725 | 2 | 3 | type I interferon receptor binding |
GO:0004952 | 0.002 | 15.2426 | 0.266 | 3 | 11 | dopamine neurotransmitter receptor activity |
GO:0035240 | 0.0026 | 13.5482 | 0.2902 | 3 | 12 | dopamine binding |
GO:1903231 | 0.0034 | 3.8686 | 1.9585 | 7 | 81 | mRNA binding involved in posttranscriptional gene silencing |
GO:0050700 | 0.0042 | 11.0835 | 0.3385 | 3 | 14 | CARD domain binding |
GO:0008188 | 0.0044 | 5.0967 | 1.0881 | 5 | 45 | neuropeptide receptor activity |
GO:0008201 | 0.0049 | 2.7909 | 3.7961 | 10 | 157 | heparin binding |
GO:0097153 | 0.0051 | 10.1592 | 0.3627 | 3 | 15 | cysteine-type endopeptidase activity involved in apoptotic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 5.9653 | 6.3909 | 32 | 261 | olfactory receptor activity |
GO:0004930 | 0 | 2.9797 | 16.2203 | 43 | 667 | G-protein coupled receptor activity |
GO:0099600 | 0 | 2.2713 | 27.4733 | 56 | 1122 | transmembrane receptor activity |
GO:0060089 | 0 | 2.0438 | 35.4313 | 65 | 1447 | molecular transducer activity |
GO:0038023 | 3e-04 | 1.8488 | 26.1686 | 45 | 1090 | signaling receptor activity |
GO:0008392 | 5e-04 | 13.4042 | 0.3918 | 4 | 16 | arachidonic acid epoxygenase activity |
GO:0019825 | 5e-04 | 6.726 | 1.0284 | 6 | 42 | oxygen binding |
GO:0004993 | 8e-04 | 11.4879 | 0.4407 | 4 | 18 | G-protein coupled serotonin receptor activity |
GO:0089720 | 0.0015 | 17.1959 | 0.2449 | 3 | 10 | caspase binding |
GO:0004370 | 0.0018 | 80.0756 | 0.0735 | 2 | 3 | glycerol kinase activity |
GO:0008431 | 0.0018 | 80.0756 | 0.0735 | 2 | 3 | vitamin E binding |
GO:0004952 | 0.0021 | 15.0455 | 0.2693 | 3 | 11 | dopamine neurotransmitter receptor activity |
GO:0004129 | 0.0026 | 8.0385 | 0.5877 | 4 | 24 | cytochrome-c oxidase activity |
GO:0035240 | 0.0027 | 13.3729 | 0.2938 | 3 | 12 | dopamine binding |
GO:0016675 | 0.003 | 7.6552 | 0.6122 | 4 | 25 | oxidoreductase activity, acting on a heme group of donors |
GO:0020037 | 0.0031 | 3.2232 | 2.9873 | 9 | 122 | heme binding |
GO:0061676 | 0.0035 | 40.0353 | 0.0979 | 2 | 4 | importin-alpha family protein binding |
GO:0030594 | 0.0035 | 3.8455 | 1.9698 | 7 | 81 | neurotransmitter receptor activity |
GO:0016614 | 0.0052 | 2.9593 | 3.2322 | 9 | 132 | oxidoreductase activity, acting on CH-OH group of donors |
GO:0004024 | 0.0057 | 26.6885 | 0.1224 | 2 | 5 | alcohol dehydrogenase activity, zinc-dependent |
GO:0044388 | 0.0057 | 26.6885 | 0.1224 | 2 | 5 | small protein activating enzyme binding |
GO:0008395 | 0.0066 | 5.9518 | 0.7591 | 4 | 31 | steroid hydroxylase activity |
GO:0001618 | 0.0073 | 3.7767 | 1.714 | 6 | 70 | virus receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 31.1968 | 6.6151 | 100 | 261 | olfactory receptor activity |
GO:0004930 | 0 | 14.0068 | 13.7582 | 115 | 552 | G-protein coupled receptor activity |
GO:0099600 | 0 | 7.5071 | 28.4373 | 137 | 1122 | transmembrane receptor activity |
GO:0038023 | 0 | 7.3705 | 27.3122 | 131 | 1090 | signaling receptor activity |
GO:0060089 | 0 | 6.1285 | 36.6745 | 146 | 1447 | molecular transducer activity |
GO:0005549 | 0 | 22.3365 | 1.4954 | 21 | 59 | odorant binding |
GO:0061135 | 0 | 4.0366 | 4.3847 | 16 | 173 | endopeptidase regulator activity |
GO:0030414 | 0 | 4.0108 | 4.4101 | 16 | 174 | peptidase inhibitor activity |
GO:0030492 | 2e-04 | 58.0976 | 0.1267 | 3 | 5 | hemoglobin binding |
GO:0030883 | 2e-04 | 58.0976 | 0.1267 | 3 | 5 | endogenous lipid antigen binding |
GO:0030884 | 2e-04 | 58.0976 | 0.1267 | 3 | 5 | exogenous lipid antigen binding |
GO:0030280 | 2e-04 | 17.2486 | 0.3295 | 4 | 13 | structural constituent of epidermis |
GO:0042834 | 2e-04 | 17.2486 | 0.3295 | 4 | 13 | peptidoglycan binding |
GO:0038187 | 7e-04 | 11.9383 | 0.4309 | 4 | 17 | pattern recognition receptor activity |
GO:1903231 | 0.001 | 4.2778 | 2.053 | 8 | 81 | mRNA binding involved in posttranscriptional gene silencing |
GO:0030881 | 0.0012 | 19.361 | 0.2281 | 3 | 9 | beta-2-microglobulin binding |
GO:0003823 | 0.0013 | 5.5598 | 1.2166 | 6 | 48 | antigen binding |
GO:0008528 | 0.0014 | 3.3726 | 3.1935 | 10 | 126 | G-protein coupled peptide receptor activity |
GO:0071723 | 0.0017 | 16.5941 | 0.2535 | 3 | 10 | lipopeptide binding |
GO:0089720 | 0.0017 | 16.5941 | 0.2535 | 3 | 10 | caspase binding |
GO:0004869 | 0.0024 | 4.863 | 1.3686 | 6 | 54 | cysteine-type endopeptidase inhibitor activity |
GO:0005248 | 0.0025 | 8.1652 | 0.5829 | 4 | 23 | voltage-gated sodium channel activity |
GO:0004867 | 0.0025 | 3.6711 | 2.3571 | 8 | 93 | serine-type endopeptidase inhibitor activity |
GO:0008745 | 0.0037 | 38.6375 | 0.1014 | 2 | 4 | N-acetylmuramoyl-L-alanine amidase activity |
GO:0030246 | 0.004 | 2.3773 | 6.2096 | 14 | 245 | carbohydrate binding |
GO:0008009 | 0.004 | 5.2481 | 1.0645 | 5 | 42 | chemokine activity |
GO:0008066 | 0.0045 | 6.7435 | 0.6843 | 4 | 27 | glutamate receptor activity |
GO:0050700 | 0.0048 | 10.5572 | 0.3548 | 3 | 14 | CARD domain binding |
GO:0016019 | 0.0061 | 25.7567 | 0.1267 | 2 | 5 | peptidoglycan receptor activity |
GO:0005537 | 0.0071 | 8.9319 | 0.4055 | 3 | 16 | mannose binding |
GO:0033038 | 0.0071 | 8.9319 | 0.4055 | 3 | 16 | bitter taste receptor activity |
GO:0030594 | 0.0088 | 3.2043 | 2.3318 | 7 | 92 | neurotransmitter receptor activity |
GO:0004993 | 0.0099 | 7.74 | 0.4562 | 3 | 18 | G-protein coupled serotonin receptor activity |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0045595 | 0 | 1.9965 | 63.0784 | 111 | 1601 | regulation of cell differentiation |
GO:1902679 | 0 | 2.1701 | 44.0091 | 85 | 1117 | negative regulation of RNA biosynthetic process |
GO:0035295 | 0 | 2.6379 | 21.5909 | 51 | 548 | tube development |
GO:0048568 | 0 | 3.2661 | 12.4537 | 36 | 319 | embryonic organ development |
GO:0048523 | 0 | 1.6221 | 169.171 | 231 | 4324 | negative regulation of cellular process |
GO:0051290 | 0 | 9.606 | 1.6942 | 12 | 43 | protein heterotetramerization |
GO:2000026 | 0 | 1.9567 | 51.9048 | 91 | 1345 | regulation of multicellular organismal development |
GO:0007399 | 0 | 1.8622 | 63.8563 | 106 | 1664 | nervous system development |
GO:0006335 | 0 | 11.7857 | 1.2214 | 10 | 31 | DNA replication-dependent nucleosome assembly |
GO:0009890 | 0 | 1.82 | 64.1816 | 105 | 1629 | negative regulation of biosynthetic process |
GO:0045934 | 0 | 1.8885 | 52.7164 | 90 | 1338 | negative regulation of nucleobase-containing compound metabolic process |
GO:0007389 | 0 | 2.6838 | 16.0749 | 39 | 408 | pattern specification process |
GO:0000122 | 0 | 2.1901 | 29.6283 | 59 | 752 | negative regulation of transcription from RNA polymerase II promoter |
GO:0048598 | 0 | 2.4282 | 20.8493 | 46 | 532 | embryonic morphogenesis |
GO:0000183 | 0 | 9.163 | 1.4578 | 10 | 37 | chromatin silencing at rDNA |
GO:0038111 | 0 | 9.163 | 1.4578 | 10 | 37 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 8.8351 | 1.4972 | 10 | 38 | response to interleukin-7 |
GO:0009887 | 0 | 2.1985 | 24.3362 | 49 | 638 | animal organ morphogenesis |
GO:0030099 | 0 | 2.5767 | 14.4596 | 34 | 367 | myeloid cell differentiation |
GO:0048869 | 0 | 1.5042 | 140.8665 | 187 | 3644 | cellular developmental process |
GO:0010646 | 0 | 1.52 | 123.7535 | 168 | 3141 | regulation of cell communication |
GO:0023051 | 0 | 1.5163 | 125.6052 | 170 | 3188 | regulation of signaling |
GO:0050767 | 0 | 2.0277 | 26.1218 | 49 | 663 | regulation of neurogenesis |
GO:0003151 | 0 | 4.9535 | 2.8368 | 12 | 72 | outflow tract morphogenesis |
GO:0060562 | 0 | 2.8713 | 8.7911 | 23 | 225 | epithelial tube morphogenesis |
GO:0035148 | 0 | 3.5357 | 5.3808 | 17 | 137 | tube formation |
GO:0045944 | 0 | 1.7779 | 41.2906 | 68 | 1048 | positive regulation of transcription from RNA polymerase II promoter |
GO:0001501 | 0 | 2.184 | 18.2813 | 37 | 464 | skeletal system development |
GO:1902036 | 0 | 3.946 | 4.0187 | 14 | 102 | regulation of hematopoietic stem cell differentiation |
GO:0045815 | 1e-04 | 4.5014 | 3.0732 | 12 | 78 | positive regulation of gene expression, epigenetic |
GO:0007420 | 1e-04 | 2.0581 | 21.435 | 41 | 550 | brain development |
GO:0071895 | 1e-04 | Inf | 0.1182 | 3 | 3 | odontoblast differentiation |
GO:0048557 | 1e-04 | 11.354 | 0.7486 | 6 | 19 | embryonic digestive tract morphogenesis |
GO:0042475 | 1e-04 | 4.3048 | 3.1914 | 12 | 81 | odontogenesis of dentin-containing tooth |
GO:0050772 | 1e-04 | 4.6901 | 2.7186 | 11 | 69 | positive regulation of axonogenesis |
GO:0048863 | 1e-04 | 2.9107 | 7.1464 | 19 | 183 | stem cell differentiation |
GO:0031128 | 1e-04 | 7.8356 | 1.1426 | 7 | 29 | developmental induction |
GO:0045666 | 1e-04 | 2.3785 | 12.2532 | 27 | 311 | positive regulation of neuron differentiation |
GO:0022603 | 1e-04 | 1.7553 | 36.6414 | 60 | 930 | regulation of anatomical structure morphogenesis |
GO:0045652 | 1e-04 | 4.4586 | 2.8368 | 11 | 72 | regulation of megakaryocyte differentiation |
GO:0043009 | 1e-04 | 2.0139 | 20.7538 | 39 | 529 | chordate embryonic development |
GO:0061138 | 1e-04 | 2.9639 | 6.6585 | 18 | 169 | morphogenesis of a branching epithelium |
GO:0032502 | 1e-04 | 1.6555 | 50.6249 | 76 | 1476 | developmental process |
GO:0048534 | 2e-04 | 1.7783 | 32.4651 | 54 | 824 | hematopoietic or lymphoid organ development |
GO:0001569 | 2e-04 | 7.1816 | 1.2214 | 7 | 31 | branching involved in blood vessel morphogenesis |
GO:0120036 | 2e-04 | 1.6118 | 51.2192 | 77 | 1300 | plasma membrane bounded cell projection organization |
GO:0051093 | 2e-04 | 1.7566 | 32.8197 | 54 | 833 | negative regulation of developmental process |
GO:0048666 | 2e-04 | 1.7012 | 37.6658 | 60 | 956 | neuron development |
GO:2000649 | 2e-04 | 5.6332 | 1.6942 | 8 | 43 | regulation of sodium ion transmembrane transporter activity |
GO:0021953 | 3e-04 | 2.8714 | 6.4615 | 17 | 164 | central nervous system neuron differentiation |
GO:0009893 | 3e-04 | 2.7306 | 7.1743 | 18 | 192 | positive regulation of metabolic process |
GO:0120039 | 3e-04 | 1.8839 | 22.6152 | 40 | 574 | plasma membrane bounded cell projection morphogenesis |
GO:0048699 | 3e-04 | 1.8405 | 24.9159 | 43 | 658 | generation of neurons |
GO:0099622 | 4e-04 | 6.154 | 1.379 | 7 | 35 | cardiac muscle cell membrane repolarization |
GO:0051962 | 4e-04 | 2.012 | 17.4933 | 33 | 444 | positive regulation of nervous system development |
GO:0001656 | 4e-04 | 3.7746 | 3.2701 | 11 | 83 | metanephros development |
GO:0007167 | 4e-04 | 1.6743 | 36.8778 | 58 | 936 | enzyme linked receptor protein signaling pathway |
GO:0010628 | 5e-04 | 1.5112 | 63.7873 | 90 | 1643 | positive regulation of gene expression |
GO:0010605 | 5e-04 | 1.4126 | 100.9806 | 132 | 2563 | negative regulation of macromolecule metabolic process |
GO:0010529 | 5e-04 | 9.4461 | 0.7092 | 5 | 18 | negative regulation of transposition |
GO:0045892 | 5e-04 | 2.1976 | 12.1612 | 25 | 325 | negative regulation of transcription, DNA-templated |
GO:0080090 | 6e-04 | 1.3195 | 223.0399 | 262 | 5661 | regulation of primary metabolic process |
GO:0032713 | 6e-04 | 36.7463 | 0.197 | 3 | 5 | negative regulation of interleukin-4 production |
GO:0070383 | 6e-04 | 36.7463 | 0.197 | 3 | 5 | DNA cytosine deamination |
GO:0040007 | 6e-04 | 1.6613 | 35.1443 | 55 | 892 | growth |
GO:0002521 | 7e-04 | 1.9624 | 17.3357 | 32 | 440 | leukocyte differentiation |
GO:0045165 | 7e-04 | 2.3419 | 9.6134 | 21 | 244 | cell fate commitment |
GO:0009855 | 7e-04 | 3.0919 | 4.6097 | 13 | 117 | determination of bilateral symmetry |
GO:0032990 | 7e-04 | 1.81 | 23.4426 | 40 | 595 | cell part morphogenesis |
GO:0048729 | 7e-04 | 1.8697 | 20.4344 | 36 | 523 | tissue morphogenesis |
GO:0034654 | 8e-04 | 1.336 | 157.4005 | 192 | 3995 | nucleobase-containing compound biosynthetic process |
GO:0048583 | 8e-04 | 1.3581 | 131.5288 | 164 | 3393 | regulation of response to stimulus |
GO:2000112 | 8e-04 | 1.3358 | 154.7608 | 189 | 3928 | regulation of cellular macromolecule biosynthetic process |
GO:0042471 | 9e-04 | 3.3722 | 3.6055 | 11 | 92 | ear morphogenesis |
GO:0030278 | 9e-04 | 2.6258 | 6.5797 | 16 | 167 | regulation of ossification |
GO:0007605 | 0.001 | 2.8398 | 5.3583 | 14 | 136 | sensory perception of sound |
GO:0060968 | 0.001 | 2.9766 | 4.7673 | 13 | 121 | regulation of gene silencing |
GO:0031623 | 0.001 | 3.5754 | 3.1126 | 10 | 79 | receptor internalization |
GO:0042330 | 0.0011 | 1.8251 | 20.8817 | 36 | 530 | taxis |
GO:0045814 | 0.0011 | 2.9221 | 4.8461 | 13 | 123 | negative regulation of gene expression, epigenetic |
GO:0060307 | 0.0011 | 7.6734 | 0.8274 | 5 | 21 | regulation of ventricular cardiac muscle cell membrane repolarization |
GO:0072358 | 0.0011 | 1.747 | 24.8216 | 41 | 630 | cardiovascular system development |
GO:0010975 | 0.0012 | 1.9561 | 15.7204 | 29 | 399 | regulation of neuron projection development |
GO:0051716 | 0.0012 | 1.2885 | 258.066 | 295 | 6550 | cellular response to stimulus |
GO:0065008 | 0.0012 | 1.3429 | 128.9148 | 160 | 3272 | regulation of biological quality |
GO:0010720 | 0.0013 | 1.8772 | 18.0449 | 32 | 458 | positive regulation of cell development |
GO:0051173 | 0.0013 | 1.3658 | 107.8755 | 137 | 2738 | positive regulation of nitrogen compound metabolic process |
GO:0071772 | 0.0013 | 2.6336 | 6.1463 | 15 | 156 | response to BMP |
GO:0050995 | 0.0014 | 7.2216 | 0.8668 | 5 | 22 | negative regulation of lipid catabolic process |
GO:0048762 | 0.0014 | 2.9923 | 4.3738 | 12 | 112 | mesenchymal cell differentiation |
GO:1903508 | 0.0015 | 1.4933 | 53.2286 | 75 | 1351 | positive regulation of nucleic acid-templated transcription |
GO:0010769 | 0.0015 | 2.2368 | 9.5347 | 20 | 242 | regulation of cell morphogenesis involved in differentiation |
GO:0003195 | 0.0015 | Inf | 0.0788 | 2 | 2 | tricuspid valve formation |
GO:0009946 | 0.0015 | Inf | 0.0788 | 2 | 2 | proximal/distal axis specification |
GO:0021941 | 0.0015 | Inf | 0.0788 | 2 | 2 | negative regulation of cerebellar granule cell precursor proliferation |
GO:0035332 | 0.0015 | Inf | 0.0788 | 2 | 2 | positive regulation of hippo signaling |
GO:0060375 | 0.0015 | Inf | 0.0788 | 2 | 2 | regulation of mast cell differentiation |
GO:0060876 | 0.0015 | Inf | 0.0788 | 2 | 2 | semicircular canal formation |
GO:0051254 | 0.0016 | 1.4766 | 55.9865 | 78 | 1421 | positive regulation of RNA metabolic process |
GO:0006928 | 0.0018 | 1.4525 | 61.3997 | 84 | 1583 | movement of cell or subcellular component |
GO:0060964 | 0.0018 | 3.085 | 3.9005 | 11 | 99 | regulation of gene silencing by miRNA |
GO:0009952 | 0.0019 | 2.3664 | 7.6829 | 17 | 195 | anterior/posterior pattern specification |
GO:0021798 | 0.0019 | 18.3707 | 0.2758 | 3 | 7 | forebrain dorsal/ventral pattern formation |
GO:0044829 | 0.0019 | 18.3707 | 0.2758 | 3 | 7 | positive regulation by host of viral genome replication |
GO:0045869 | 0.0019 | 18.3707 | 0.2758 | 3 | 7 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate |
GO:0060054 | 0.0019 | 18.3707 | 0.2758 | 3 | 7 | positive regulation of epithelial cell proliferation involved in wound healing |
GO:0060075 | 0.0019 | 18.3707 | 0.2758 | 3 | 7 | regulation of resting membrane potential |
GO:0031346 | 0.002 | 2.0166 | 12.6078 | 24 | 320 | positive regulation of cell projection organization |
GO:0009953 | 0.0021 | 3.2174 | 3.4125 | 10 | 87 | dorsal/ventral pattern formation |
GO:0007275 | 0.0022 | 1.3861 | 90.062 | 115 | 2621 | multicellular organism development |
GO:0003205 | 0.0023 | 2.5641 | 5.8705 | 14 | 149 | cardiac chamber development |
GO:0006837 | 0.0023 | 8.9174 | 0.591 | 4 | 15 | serotonin transport |
GO:0032793 | 0.0023 | 8.9174 | 0.591 | 4 | 15 | positive regulation of CREB transcription factor activity |
GO:0032879 | 0.0024 | 1.3576 | 95.8981 | 122 | 2434 | regulation of localization |
GO:0060541 | 0.0024 | 2.3717 | 7.2101 | 16 | 183 | respiratory system development |
GO:0016055 | 0.0025 | 1.811 | 18.0449 | 31 | 458 | Wnt signaling pathway |
GO:0090287 | 0.0025 | 2.1812 | 9.2589 | 19 | 235 | regulation of cellular response to growth factor stimulus |
GO:0097485 | 0.0025 | 2.2304 | 8.5891 | 18 | 218 | neuron projection guidance |
GO:0045665 | 0.0026 | 2.3574 | 7.2495 | 16 | 184 | negative regulation of neuron differentiation |
GO:0042481 | 0.0026 | 6.1371 | 0.985 | 5 | 25 | regulation of odontogenesis |
GO:0060441 | 0.0026 | 6.1371 | 0.985 | 5 | 25 | epithelial tube branching involved in lung morphogenesis |
GO:0060429 | 0.0028 | 1.4951 | 45.1169 | 64 | 1150 | epithelium development |
GO:0009972 | 0.0029 | 14.6956 | 0.3152 | 3 | 8 | cytidine deamination |
GO:0030917 | 0.0029 | 14.6956 | 0.3152 | 3 | 8 | midbrain-hindbrain boundary development |
GO:0046087 | 0.0029 | 14.6956 | 0.3152 | 3 | 8 | cytidine metabolic process |
GO:1903706 | 0.003 | 1.8244 | 16.7447 | 29 | 425 | regulation of hemopoiesis |
GO:0042127 | 0.003 | 1.6483 | 26.1935 | 41 | 682 | regulation of cell proliferation |
GO:0001558 | 0.0031 | 1.8856 | 14.5384 | 26 | 369 | regulation of cell growth |
GO:0035107 | 0.0032 | 2.5689 | 5.4371 | 13 | 138 | appendage morphogenesis |
GO:0042063 | 0.0033 | 2.1214 | 9.4953 | 19 | 241 | gliogenesis |
GO:0072001 | 0.0033 | 2.0753 | 10.2044 | 20 | 259 | renal system development |
GO:0000902 | 0.0033 | 1.5531 | 34.5139 | 51 | 876 | cell morphogenesis |
GO:0001568 | 0.0035 | 1.7032 | 21.5955 | 35 | 552 | blood vessel development |
GO:0048844 | 0.0035 | 3.5158 | 2.5216 | 8 | 64 | artery morphogenesis |
GO:0031325 | 0.0036 | 1.3187 | 111.7367 | 138 | 2836 | positive regulation of cellular metabolic process |
GO:0035904 | 0.0037 | 3.912 | 2.0094 | 7 | 51 | aorta development |
GO:0010765 | 0.0037 | 5.5784 | 1.0638 | 5 | 27 | positive regulation of sodium ion transport |
GO:0030851 | 0.0037 | 5.5784 | 1.0638 | 5 | 27 | granulocyte differentiation |
GO:0061351 | 0.0038 | 2.6208 | 4.9249 | 12 | 125 | neural precursor cell proliferation |
GO:0060411 | 0.0039 | 3.4539 | 2.561 | 8 | 65 | cardiac septum morphogenesis |
GO:0001754 | 0.0039 | 4.4668 | 1.5366 | 6 | 39 | eye photoreceptor cell differentiation |
GO:0001570 | 0.0043 | 3.3941 | 2.6004 | 8 | 66 | vasculogenesis |
GO:0014033 | 0.0043 | 3.3941 | 2.6004 | 8 | 66 | neural crest cell differentiation |
GO:0060174 | 0.0043 | 12.2455 | 0.3546 | 3 | 9 | limb bud formation |
GO:0051241 | 0.0043 | 1.5017 | 39.1588 | 56 | 999 | negative regulation of multicellular organismal process |
GO:0090596 | 0.0043 | 2.5784 | 4.9939 | 12 | 129 | sensory organ morphogenesis |
GO:0030316 | 0.0045 | 3.0781 | 3.1914 | 9 | 81 | osteoclast differentiation |
GO:0030538 | 0.0045 | 48.9183 | 0.1182 | 2 | 3 | embryonic genitalia morphogenesis |
GO:0042631 | 0.0045 | 48.9183 | 0.1182 | 2 | 3 | cellular response to water deprivation |
GO:0045402 | 0.0045 | 48.9183 | 0.1182 | 2 | 3 | regulation of interleukin-4 biosynthetic process |
GO:0060948 | 0.0045 | 48.9183 | 0.1182 | 2 | 3 | cardiac vascular smooth muscle cell development |
GO:0071896 | 0.0045 | 48.9183 | 0.1182 | 2 | 3 | protein localization to adherens junction |
GO:0089700 | 0.0045 | 48.9183 | 0.1182 | 2 | 3 | protein kinase D signaling |
GO:1905180 | 0.0045 | 48.9183 | 0.1182 | 2 | 3 | positive regulation of cardiac muscle tissue regeneration |
GO:0061061 | 0.0045 | 1.647 | 23.5608 | 37 | 598 | muscle structure development |
GO:0007166 | 0.0047 | 1.4046 | 60.2004 | 80 | 1586 | cell surface receptor signaling pathway |
GO:0030509 | 0.0048 | 2.4315 | 5.7129 | 13 | 145 | BMP signaling pathway |
GO:0060173 | 0.0049 | 2.3368 | 6.3827 | 14 | 162 | limb development |
GO:0071805 | 0.005 | 2.1861 | 7.7617 | 16 | 197 | potassium ion transmembrane transport |
GO:0010092 | 0.0051 | 5.1129 | 1.1426 | 5 | 29 | specification of animal organ identity |
GO:0016477 | 0.0051 | 1.4419 | 48.0672 | 66 | 1220 | cell migration |
GO:0001823 | 0.0052 | 2.7999 | 3.8611 | 10 | 98 | mesonephros development |
GO:0007626 | 0.0054 | 2.2332 | 7.1313 | 15 | 181 | locomotory behavior |
GO:0030901 | 0.0057 | 2.9544 | 3.3095 | 9 | 84 | midbrain development |
GO:0007413 | 0.0058 | 6.5377 | 0.7486 | 4 | 19 | axonal fasciculation |
GO:0042474 | 0.0058 | 6.5377 | 0.7486 | 4 | 19 | middle ear morphogenesis |
GO:0090312 | 0.0058 | 6.5377 | 0.7486 | 4 | 19 | positive regulation of protein deacetylation |
GO:0010721 | 0.0059 | 1.9586 | 10.756 | 20 | 273 | negative regulation of cell development |
GO:0001840 | 0.0059 | 10.4954 | 0.394 | 3 | 10 | neural plate development |
GO:0043568 | 0.0059 | 10.4954 | 0.394 | 3 | 10 | positive regulation of insulin-like growth factor receptor signaling pathway |
GO:0045176 | 0.0059 | 10.4954 | 0.394 | 3 | 10 | apical protein localization |
GO:0046133 | 0.0059 | 10.4954 | 0.394 | 3 | 10 | pyrimidine ribonucleoside catabolic process |
GO:0060453 | 0.0059 | 10.4954 | 0.394 | 3 | 10 | regulation of gastric acid secretion |
GO:0055123 | 0.0059 | 2.4668 | 5.2007 | 12 | 132 | digestive system development |
GO:0001841 | 0.006 | 2.7373 | 3.9399 | 10 | 100 | neural tube formation |
GO:0048646 | 0.0063 | 1.5305 | 31.4656 | 46 | 818 | anatomical structure formation involved in morphogenesis |
GO:0046661 | 0.0064 | 2.3419 | 5.9099 | 13 | 150 | male sex differentiation |
GO:0060976 | 0.0064 | 3.9828 | 1.6942 | 6 | 43 | coronary vasculature development |
GO:0008284 | 0.0065 | 1.5203 | 32.3469 | 47 | 821 | positive regulation of cell proliferation |
GO:0072359 | 0.0066 | 1.902 | 11.6102 | 21 | 303 | circulatory system development |
GO:0060828 | 0.0066 | 2.0156 | 9.4165 | 18 | 239 | regulation of canonical Wnt signaling pathway |
GO:0043903 | 0.0066 | 2.1151 | 7.9981 | 16 | 203 | regulation of symbiosis, encompassing mutualism through parasitism |
GO:0001843 | 0.0067 | 2.8773 | 3.3883 | 9 | 86 | neural tube closure |
GO:0060021 | 0.0067 | 2.8773 | 3.3883 | 9 | 86 | palate development |
GO:0060993 | 0.0067 | 2.8773 | 3.3883 | 9 | 86 | kidney morphogenesis |
GO:0009968 | 0.0067 | 1.4417 | 44.3243 | 61 | 1125 | negative regulation of signal transduction |
GO:0001838 | 0.0067 | 6.1933 | 0.7802 | 4 | 20 | embryonic epithelial tube formation |
GO:0031497 | 0.0068 | 2.3248 | 5.9493 | 13 | 151 | chromatin assembly |
GO:0060317 | 0.0068 | 4.719 | 1.2214 | 5 | 31 | cardiac epithelial to mesenchymal transition |
GO:0031290 | 0.007 | 6.1287 | 0.788 | 4 | 20 | retinal ganglion cell axon guidance |
GO:0043586 | 0.007 | 6.1287 | 0.788 | 4 | 20 | tongue development |
GO:0009967 | 0.0071 | 1.3943 | 54.9249 | 73 | 1400 | positive regulation of signal transduction |
GO:0001892 | 0.0072 | 2.8402 | 3.4277 | 9 | 87 | embryonic placenta development |
GO:0007409 | 0.0072 | 1.8258 | 13.2143 | 23 | 340 | axonogenesis |
GO:0050905 | 0.0077 | 2.804 | 3.4671 | 9 | 88 | neuromuscular process |
GO:0060306 | 0.0078 | 4.5439 | 1.2608 | 5 | 32 | regulation of membrane repolarization |
GO:0021536 | 0.0078 | 3.0272 | 2.8762 | 8 | 73 | diencephalon development |
GO:0048771 | 0.0079 | 2.2749 | 6.0675 | 13 | 154 | tissue remodeling |
GO:0043269 | 0.008 | 1.603 | 22.8122 | 35 | 579 | regulation of ion transport |
GO:0048608 | 0.0082 | 1.7573 | 14.8943 | 25 | 380 | reproductive structure development |
GO:0061371 | 0.0082 | 3.3084 | 2.3246 | 7 | 59 | determination of heart left/right asymmetry |
GO:0034505 | 0.0084 | 5.7678 | 0.8274 | 4 | 21 | tooth mineralization |
GO:0060716 | 0.0084 | 5.7678 | 0.8274 | 4 | 21 | labyrinthine layer blood vessel development |
GO:2000678 | 0.0084 | 5.7678 | 0.8274 | 4 | 21 | negative regulation of transcription regulatory region DNA binding |
GO:0050673 | 0.0085 | 1.7989 | 13.3958 | 23 | 340 | epithelial cell proliferation |
GO:0060415 | 0.0085 | 2.9811 | 2.9156 | 8 | 74 | muscle tissue morphogenesis |
GO:0061333 | 0.0085 | 2.9811 | 2.9156 | 8 | 74 | renal tubule morphogenesis |
GO:0043010 | 0.0086 | 1.8828 | 11.15 | 20 | 283 | camera-type eye development |
GO:0097084 | 0.0088 | 24.5361 | 0.1571 | 2 | 4 | vascular smooth muscle cell development |
GO:0006104 | 0.0088 | 24.4575 | 0.1576 | 2 | 4 | succinyl-CoA metabolic process |
GO:0008078 | 0.0088 | 24.4575 | 0.1576 | 2 | 4 | mesodermal cell migration |
GO:0014063 | 0.0088 | 24.4575 | 0.1576 | 2 | 4 | negative regulation of serotonin secretion |
GO:0038033 | 0.0088 | 24.4575 | 0.1576 | 2 | 4 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway |
GO:0060018 | 0.0088 | 24.4575 | 0.1576 | 2 | 4 | astrocyte fate commitment |
GO:0060319 | 0.0088 | 24.4575 | 0.1576 | 2 | 4 | primitive erythrocyte differentiation |
GO:0060510 | 0.0088 | 24.4575 | 0.1576 | 2 | 4 | Type II pneumocyte differentiation |
GO:0072086 | 0.0088 | 24.4575 | 0.1576 | 2 | 4 | specification of loop of Henle identity |
GO:0099550 | 0.0088 | 24.4575 | 0.1576 | 2 | 4 | trans-synaptic signaling, modulating synaptic transmission |
GO:1901727 | 0.0088 | 24.4575 | 0.1576 | 2 | 4 | positive regulation of histone deacetylase activity |
GO:1902746 | 0.0088 | 24.4575 | 0.1576 | 2 | 4 | regulation of lens fiber cell differentiation |
GO:0035725 | 0.0089 | 2.3297 | 5.4765 | 12 | 139 | sodium ion transmembrane transport |
GO:1902742 | 0.0089 | 4.3813 | 1.3002 | 5 | 33 | apoptotic process involved in development |
GO:0071495 | 0.0089 | 1.4112 | 46.6883 | 63 | 1185 | cellular response to endogenous stimulus |
GO:0055010 | 0.0089 | 3.6834 | 1.8124 | 6 | 46 | ventricular cardiac muscle tissue morphogenesis |
GO:0032535 | 0.0092 | 1.8379 | 11.9774 | 21 | 304 | regulation of cellular component size |
GO:0048638 | 0.0096 | 1.8612 | 11.2682 | 20 | 286 | regulation of developmental growth |
GO:0051145 | 0.0098 | 3.1854 | 2.4034 | 7 | 61 | smooth muscle cell differentiation |
GO:0001508 | 0.0098 | 2.3984 | 4.8855 | 11 | 124 | action potential |
GO:1905208 | 0.0099 | 5.447 | 0.8668 | 4 | 22 | negative regulation of cardiocyte differentiation |
GO:0048839 | 0.0099 | 2.1328 | 6.9343 | 14 | 176 | inner ear development |
GO:0045599 | 0.0099 | 3.5933 | 1.8518 | 6 | 47 | negative regulation of fat cell differentiation |
GO:0086002 | 0.0099 | 3.5933 | 1.8518 | 6 | 47 | cardiac muscle cell action potential involved in contraction |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 10.1464 | 8.5564 | 62 | 301 | detection of chemical stimulus involved in sensory perception of smell |
GO:0007606 | 0 | 8.2926 | 11.1432 | 68 | 392 | sensory perception of chemical stimulus |
GO:0009593 | 0 | 8.4591 | 10.6031 | 66 | 373 | detection of chemical stimulus |
GO:0050906 | 0 | 8.2795 | 10.9727 | 67 | 386 | detection of stimulus involved in sensory perception |
GO:0007186 | 0 | 3.6598 | 32.5769 | 95 | 1146 | G-protein coupled receptor signaling pathway |
GO:0050877 | 0 | 3.5002 | 31.7809 | 90 | 1118 | nervous system process |
GO:0010838 | 0 | 43.1992 | 0.2558 | 5 | 9 | positive regulation of keratinocyte proliferation |
GO:0015721 | 0 | 12.1384 | 0.7675 | 7 | 27 | bile acid and bile salt transport |
GO:0018149 | 0 | 7.2812 | 1.4782 | 9 | 52 | peptide cross-linking |
GO:1901750 | 0 | 34.4806 | 0.2274 | 4 | 8 | leukotriene D4 biosynthetic process |
GO:0006751 | 1e-04 | 27.5827 | 0.2558 | 4 | 9 | glutathione catabolic process |
GO:0007195 | 1e-04 | 27.5827 | 0.2558 | 4 | 9 | adenylate cyclase-inhibiting dopamine receptor signaling pathway |
GO:0031424 | 2e-04 | 3.0128 | 5.7422 | 16 | 202 | keratinization |
GO:0050896 | 2e-04 | 1.8318 | 32.1675 | 52 | 1269 | response to stimulus |
GO:0051967 | 3e-04 | 17.2358 | 0.3411 | 4 | 12 | negative regulation of synaptic transmission, glutamatergic |
GO:0003008 | 4e-04 | 2.032 | 16.8862 | 32 | 692 | system process |
GO:0019730 | 5e-04 | 4.2804 | 2.331 | 9 | 82 | antimicrobial humoral response |
GO:0009913 | 7e-04 | 2.396 | 8.8975 | 20 | 313 | epidermal cell differentiation |
GO:0006776 | 0.0011 | 20.64 | 0.2274 | 3 | 8 | vitamin A metabolic process |
GO:0043588 | 0.0012 | 2.1765 | 10.7168 | 22 | 377 | skin development |
GO:0006953 | 0.0014 | 5.4569 | 1.2508 | 6 | 44 | acute-phase response |
GO:0010876 | 0.0016 | 2.211 | 9.5798 | 20 | 337 | lipid localization |
GO:0042574 | 0.0017 | 17.1989 | 0.2558 | 3 | 9 | retinal metabolic process |
GO:0042742 | 0.0018 | 2.6239 | 5.6853 | 14 | 200 | defense response to bacterium |
GO:0031348 | 0.0022 | 2.8014 | 4.5767 | 12 | 161 | negative regulation of defense response |
GO:0014809 | 0.0024 | 68.6621 | 0.0853 | 2 | 3 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion |
GO:0060662 | 0.0024 | 68.6621 | 0.0853 | 2 | 3 | salivary gland cavitation |
GO:1900039 | 0.0024 | 68.6621 | 0.0853 | 2 | 3 | positive regulation of cellular response to hypoxia |
GO:1903015 | 0.0024 | 68.6621 | 0.0853 | 2 | 3 | regulation of exo-alpha-sialidase activity |
GO:1904879 | 0.0024 | 68.6621 | 0.0853 | 2 | 3 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel |
GO:0022617 | 0.0026 | 3.6455 | 2.3878 | 8 | 84 | extracellular matrix disassembly |
GO:0014819 | 0.0032 | 12.8974 | 0.3127 | 3 | 11 | regulation of skeletal muscle contraction |
GO:1905065 | 0.0032 | 12.8974 | 0.3127 | 3 | 11 | positive regulation of vascular smooth muscle cell differentiation |
GO:0051716 | 0.004 | 1.2987 | 186.1942 | 214 | 6550 | cellular response to stimulus |
GO:0051481 | 0.0041 | 11.4636 | 0.3411 | 3 | 12 | negative regulation of cytosolic calcium ion concentration |
GO:0060158 | 0.0041 | 11.4636 | 0.3411 | 3 | 12 | phospholipase C-activating dopamine receptor signaling pathway |
GO:0048149 | 0.0053 | 10.3166 | 0.3695 | 3 | 13 | behavioral response to ethanol |
GO:1901019 | 0.0054 | 3.5588 | 2.132 | 7 | 75 | regulation of calcium ion transmembrane transporter activity |
GO:0010959 | 0.0061 | 2.0262 | 9.3239 | 18 | 328 | regulation of metal ion transport |
GO:0007015 | 0.0063 | 2.0196 | 9.3523 | 18 | 329 | actin filament organization |
GO:0009636 | 0.0064 | 2.3293 | 5.8843 | 13 | 207 | response to toxic substance |
GO:0007154 | 0.0068 | 1.2793 | 165.5565 | 191 | 5824 | cell communication |
GO:0006814 | 0.0072 | 2.2934 | 5.9696 | 13 | 210 | sodium ion transport |
GO:0008206 | 0.0072 | 4.5371 | 1.2223 | 5 | 43 | bile acid metabolic process |
GO:0006269 | 0.0076 | 22.8844 | 0.1421 | 2 | 5 | DNA replication, synthesis of RNA primer |
GO:1901386 | 0.008 | 8.596 | 0.4264 | 3 | 15 | negative regulation of voltage-gated calcium channel activity |
GO:0007586 | 0.0081 | 2.5864 | 4.0934 | 10 | 144 | digestion |
GO:0030808 | 0.0081 | 2.5864 | 4.0934 | 10 | 144 | regulation of nucleotide biosynthetic process |
GO:0006691 | 0.0087 | 5.5092 | 0.8244 | 4 | 29 | leukotriene metabolic process |
GO:0010951 | 0.0093 | 2.2136 | 6.1686 | 13 | 217 | negative regulation of endopeptidase activity |
GO:0052652 | 0.0093 | 2.5293 | 4.1787 | 10 | 147 | cyclic purine nucleotide metabolic process |
GO:0007194 | 0.0098 | 5.297 | 0.8528 | 4 | 30 | negative regulation of adenylate cyclase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 97.5649 | 1.098 | 24 | 31 | DNA replication-dependent nucleosome assembly |
GO:0000183 | 0 | 52.514 | 1.3106 | 24 | 37 | chromatin silencing at rDNA |
GO:0051290 | 0 | 35.9163 | 1.5231 | 24 | 43 | protein heterotetramerization |
GO:0045653 | 0 | 130.3631 | 0.6022 | 14 | 17 | negative regulation of megakaryocyte differentiation |
GO:0045815 | 0 | 12.6077 | 2.7628 | 24 | 78 | positive regulation of gene expression, epigenetic |
GO:0060964 | 0 | 9.589 | 3.5067 | 25 | 99 | regulation of gene silencing by miRNA |
GO:0006323 | 0 | 6.1397 | 6.8362 | 34 | 193 | DNA packaging |
GO:1902036 | 0 | 9.2135 | 3.6129 | 25 | 102 | regulation of hematopoietic stem cell differentiation |
GO:0060968 | 0 | 7.3806 | 4.2859 | 25 | 121 | regulation of gene silencing |
GO:0045814 | 0 | 7.229 | 4.3568 | 25 | 123 | negative regulation of gene expression, epigenetic |
GO:0002244 | 0 | 5.2876 | 6.5529 | 29 | 185 | hematopoietic progenitor cell differentiation |
GO:0071824 | 0 | 4.3989 | 9.0323 | 34 | 255 | protein-DNA complex subunit organization |
GO:0048863 | 0 | 4.6415 | 8.0977 | 32 | 230 | stem cell differentiation |
GO:0034080 | 0 | 13.9442 | 1.4877 | 14 | 42 | CENP-A containing nucleosome assembly |
GO:1904837 | 0 | 13.9442 | 1.4877 | 14 | 42 | beta-catenin-TCF complex assembly |
GO:1903707 | 0 | 6.1222 | 4.5693 | 23 | 129 | negative regulation of hemopoiesis |
GO:0016233 | 0 | 10.8397 | 1.771 | 14 | 50 | telomere capping |
GO:0032200 | 0 | 4.9786 | 5.6674 | 24 | 160 | telomere organization |
GO:0034724 | 0 | 10.0039 | 1.8773 | 14 | 53 | DNA replication-independent nucleosome organization |
GO:0006333 | 0 | 5.6367 | 4.2261 | 20 | 122 | chromatin assembly or disassembly |
GO:0030099 | 0 | 3.2008 | 12.9995 | 37 | 367 | myeloid cell differentiation |
GO:0045892 | 0 | 2.1294 | 38.1484 | 73 | 1077 | negative regulation of transcription, DNA-templated |
GO:2000026 | 0 | 1.8858 | 62.6951 | 105 | 1770 | regulation of multicellular organismal development |
GO:0006303 | 0 | 7.0861 | 2.444 | 14 | 69 | double-strand break repair via nonhomologous end joining |
GO:0048534 | 0 | 2.2319 | 29.1869 | 59 | 824 | hematopoietic or lymphoid organ development |
GO:1902679 | 0 | 2.0419 | 39.5652 | 73 | 1117 | negative regulation of RNA biosynthetic process |
GO:0043044 | 0 | 6.2831 | 2.692 | 14 | 76 | ATP-dependent chromatin remodeling |
GO:0038111 | 0 | 10.2535 | 1.3106 | 10 | 37 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 9.8867 | 1.346 | 10 | 38 | response to interleukin-7 |
GO:0001655 | 0 | 3.1018 | 10.3783 | 29 | 293 | urogenital system development |
GO:0048869 | 0 | 1.7913 | 67.292 | 106 | 2030 | cellular developmental process |
GO:0045934 | 0 | 1.8846 | 47.3932 | 81 | 1338 | negative regulation of nucleobase-containing compound metabolic process |
GO:0001501 | 0 | 2.5348 | 16.4353 | 38 | 464 | skeletal system development |
GO:0045596 | 0 | 2.3065 | 21.8193 | 46 | 616 | negative regulation of cell differentiation |
GO:0035194 | 0 | 2.9105 | 10.2012 | 27 | 288 | posttranscriptional gene silencing by RNA |
GO:0048731 | 0 | 1.5883 | 103.5316 | 144 | 3154 | system development |
GO:0048598 | 0 | 2.2201 | 19.5169 | 40 | 551 | embryonic morphogenesis |
GO:0045652 | 0 | 6.3064 | 1.9008 | 10 | 55 | regulation of megakaryocyte differentiation |
GO:0051259 | 0 | 2.281 | 17.5688 | 37 | 496 | protein oligomerization |
GO:0007389 | 0 | 2.3987 | 14.4517 | 32 | 408 | pattern specification process |
GO:0017148 | 0 | 2.4612 | 13.212 | 30 | 373 | negative regulation of translation |
GO:0035914 | 0 | 5.5284 | 2.1253 | 10 | 60 | skeletal muscle cell differentiation |
GO:0043009 | 0 | 2.1443 | 19.0919 | 38 | 539 | chordate embryonic development |
GO:0001822 | 0 | 3.3418 | 5.6151 | 17 | 160 | kidney development |
GO:0021879 | 1e-04 | 5.6459 | 1.8773 | 9 | 53 | forebrain neuron differentiation |
GO:1903506 | 1e-04 | 1.4466 | 120.3249 | 157 | 3397 | regulation of nucleic acid-templated transcription |
GO:0048568 | 1e-04 | 2.2402 | 14.3809 | 30 | 406 | embryonic organ development |
GO:0034622 | 1e-04 | 1.7663 | 34.6063 | 57 | 977 | cellular macromolecular complex assembly |
GO:0051248 | 2e-04 | 1.6587 | 44.6658 | 69 | 1261 | negative regulation of protein metabolic process |
GO:0060537 | 2e-04 | 2.2771 | 12.7161 | 27 | 359 | muscle tissue development |
GO:0009952 | 2e-04 | 2.829 | 6.9071 | 18 | 195 | anterior/posterior pattern specification |
GO:0051252 | 2e-04 | 1.4109 | 126.8424 | 162 | 3581 | regulation of RNA metabolic process |
GO:0009890 | 3e-04 | 1.5668 | 57.7007 | 84 | 1629 | negative regulation of biosynthetic process |
GO:0001764 | 3e-04 | 3.2611 | 4.711 | 14 | 133 | neuron migration |
GO:0061326 | 3e-04 | 3.8981 | 3.1525 | 11 | 89 | renal tubule development |
GO:0060065 | 3e-04 | 10.5604 | 0.6376 | 5 | 18 | uterus development |
GO:0002251 | 4e-04 | 7.4975 | 0.9918 | 6 | 28 | organ or tissue specific immune response |
GO:0048704 | 4e-04 | 4.0803 | 2.7499 | 10 | 78 | embryonic skeletal system morphogenesis |
GO:0032534 | 4e-04 | 41.0656 | 0.1771 | 3 | 5 | regulation of microvillus assembly |
GO:1900086 | 4e-04 | 41.0656 | 0.1771 | 3 | 5 | positive regulation of peptidyl-tyrosine autophosphorylation |
GO:1903244 | 4e-04 | 15.6674 | 0.3896 | 4 | 11 | positive regulation of cardiac muscle hypertrophy in response to stress |
GO:0002227 | 4e-04 | 9.8054 | 0.673 | 5 | 19 | innate immune response in mucosa |
GO:0009954 | 5e-04 | 7.171 | 1.0272 | 6 | 29 | proximal/distal pattern formation |
GO:0007275 | 5e-04 | 2.1481 | 13.5523 | 27 | 464 | multicellular organism development |
GO:0002682 | 5e-04 | 1.5949 | 45.5159 | 68 | 1285 | regulation of immune system process |
GO:0014855 | 6e-04 | 4.2063 | 2.4086 | 9 | 68 | striated muscle cell proliferation |
GO:0061061 | 7e-04 | 1.8532 | 21.1817 | 37 | 598 | muscle structure development |
GO:0060249 | 8e-04 | 2.14 | 12.4328 | 25 | 351 | anatomical structure homeostasis |
GO:0034654 | 9e-04 | 1.3506 | 141.5067 | 174 | 3995 | nucleobase-containing compound biosynthetic process |
GO:0048665 | 9e-04 | 6.107 | 1.1689 | 6 | 33 | neuron fate specification |
GO:0072009 | 0.001 | 3.3384 | 3.6129 | 11 | 102 | nephron epithelium development |
GO:0010460 | 0.0011 | 7.6244 | 0.8147 | 5 | 23 | positive regulation of heart rate |
GO:0060343 | 0.0011 | 7.6244 | 0.8147 | 5 | 23 | trabecula formation |
GO:0048468 | 0.0011 | 1.5351 | 48.5918 | 70 | 1400 | cell development |
GO:0014744 | 0.0012 | 10.965 | 0.4959 | 4 | 14 | positive regulation of muscle adaptation |
GO:0060192 | 0.0012 | 10.965 | 0.4959 | 4 | 14 | negative regulation of lipase activity |
GO:0007283 | 0.0012 | 1.9285 | 16.4707 | 30 | 465 | spermatogenesis |
GO:0035544 | 0.0013 | Inf | 0.0708 | 2 | 2 | negative regulation of SNARE complex assembly |
GO:1900155 | 0.0013 | Inf | 0.0708 | 2 | 2 | negative regulation of bone trabecula formation |
GO:0072028 | 0.0013 | 3.7584 | 2.6566 | 9 | 75 | nephron morphogenesis |
GO:0048593 | 0.0013 | 3.1969 | 3.7546 | 11 | 106 | camera-type eye morphogenesis |
GO:0032502 | 0.0014 | 1.5732 | 44.3257 | 64 | 1523 | developmental process |
GO:0071415 | 0.0014 | 20.5301 | 0.2479 | 3 | 7 | cellular response to purine-containing compound |
GO:0006352 | 0.0015 | 2.3451 | 8.1822 | 18 | 231 | DNA-templated transcription, initiation |
GO:0045595 | 0.0015 | 1.6235 | 33.2984 | 51 | 985 | regulation of cell differentiation |
GO:0007276 | 0.0016 | 1.7799 | 21.3588 | 36 | 603 | gamete generation |
GO:0048646 | 0.0017 | 1.859 | 17.6237 | 31 | 512 | anatomical structure formation involved in morphogenesis |
GO:0072593 | 0.0017 | 2.3121 | 8.2885 | 18 | 234 | reactive oxygen species metabolic process |
GO:0044703 | 0.0018 | 1.6296 | 31.0996 | 48 | 878 | multi-organism reproductive process |
GO:0034248 | 0.002 | 1.7692 | 20.8629 | 35 | 589 | regulation of cellular amide metabolic process |
GO:0006590 | 0.002 | 9.1363 | 0.5667 | 4 | 16 | thyroid hormone generation |
GO:0055012 | 0.002 | 9.1363 | 0.5667 | 4 | 16 | ventricular cardiac muscle cell differentiation |
GO:0072148 | 0.002 | 9.1363 | 0.5667 | 4 | 16 | epithelial cell fate commitment |
GO:0071229 | 0.0022 | 2.4714 | 6.482 | 15 | 183 | cellular response to acid chemical |
GO:0048518 | 0.0023 | 1.2958 | 182.347 | 214 | 5148 | positive regulation of biological process |
GO:0001568 | 0.0023 | 1.7495 | 21.0755 | 35 | 595 | blood vessel development |
GO:0051962 | 0.0024 | 1.8774 | 15.7269 | 28 | 444 | positive regulation of nervous system development |
GO:0006935 | 0.0024 | 1.796 | 18.7731 | 32 | 530 | chemotaxis |
GO:0010604 | 0.0025 | 1.3526 | 100.8434 | 127 | 2847 | positive regulation of macromolecule metabolic process |
GO:0071711 | 0.0026 | 8.4329 | 0.6022 | 4 | 17 | basement membrane organization |
GO:0032526 | 0.0026 | 3.0978 | 3.5067 | 10 | 99 | response to retinoic acid |
GO:2000112 | 0.0027 | 1.3116 | 139.1335 | 168 | 3928 | regulation of cellular macromolecule biosynthetic process |
GO:0003206 | 0.0029 | 2.8631 | 4.1443 | 11 | 117 | cardiac chamber morphogenesis |
GO:0043062 | 0.003 | 2.0464 | 10.8388 | 21 | 306 | extracellular structure organization |
GO:0033002 | 0.003 | 2.8459 | 4.1645 | 11 | 119 | muscle cell proliferation |
GO:0018958 | 0.0031 | 3.2617 | 3.0108 | 9 | 85 | phenol-containing compound metabolic process |
GO:0046085 | 0.0032 | 13.6849 | 0.3188 | 3 | 9 | adenosine metabolic process |
GO:0048664 | 0.0032 | 13.6849 | 0.3188 | 3 | 9 | neuron fate determination |
GO:0072172 | 0.0032 | 13.6849 | 0.3188 | 3 | 9 | mesonephric tubule formation |
GO:0001525 | 0.0032 | 1.8574 | 15.3018 | 27 | 432 | angiogenesis |
GO:0010612 | 0.0032 | 7.83 | 0.6376 | 4 | 18 | regulation of cardiac muscle adaptation |
GO:0098869 | 0.0034 | 3.2191 | 3.0462 | 9 | 86 | cellular oxidant detoxification |
GO:0072078 | 0.0035 | 3.4942 | 2.5149 | 8 | 71 | nephron tubule morphogenesis |
GO:0002019 | 0.0037 | 54.6582 | 0.1063 | 2 | 3 | regulation of renal output by angiotensin |
GO:0007412 | 0.0037 | 54.6582 | 0.1063 | 2 | 3 | axon target recognition |
GO:0019448 | 0.0037 | 54.6582 | 0.1063 | 2 | 3 | L-cysteine catabolic process |
GO:0043418 | 0.0037 | 54.6582 | 0.1063 | 2 | 3 | homocysteine catabolic process |
GO:0055014 | 0.0037 | 54.6582 | 0.1063 | 2 | 3 | atrial cardiac muscle cell development |
GO:0070370 | 0.0037 | 54.6582 | 0.1063 | 2 | 3 | cellular heat acclimation |
GO:0070434 | 0.0037 | 54.6582 | 0.1063 | 2 | 3 | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway |
GO:0090361 | 0.0037 | 54.6582 | 0.1063 | 2 | 3 | regulation of platelet-derived growth factor production |
GO:0035107 | 0.0037 | 2.6289 | 4.8881 | 12 | 138 | appendage morphogenesis |
GO:0010002 | 0.0039 | 7.3075 | 0.673 | 4 | 19 | cardioblast differentiation |
GO:0048660 | 0.0043 | 2.7086 | 4.3568 | 11 | 123 | regulation of smooth muscle cell proliferation |
GO:0061844 | 0.0043 | 4.336 | 1.5585 | 6 | 44 | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO:0014841 | 0.0044 | 11.7291 | 0.3542 | 3 | 10 | skeletal muscle satellite cell proliferation |
GO:0002052 | 0.0048 | 6.8504 | 0.7084 | 4 | 20 | positive regulation of neuroblast proliferation |
GO:0021854 | 0.0048 | 6.8504 | 0.7084 | 4 | 20 | hypothalamus development |
GO:0008217 | 0.0048 | 2.4256 | 5.7028 | 13 | 161 | regulation of blood pressure |
GO:0090257 | 0.0048 | 2.1915 | 7.7218 | 16 | 218 | regulation of muscle system process |
GO:0006928 | 0.0049 | 1.3919 | 63.7931 | 84 | 1801 | movement of cell or subcellular component |
GO:0060173 | 0.0051 | 2.4091 | 5.7382 | 13 | 162 | limb development |
GO:0048738 | 0.0051 | 2.2417 | 7.0842 | 15 | 200 | cardiac muscle tissue development |
GO:0090596 | 0.0053 | 2.1102 | 8.501 | 17 | 240 | sensory organ morphogenesis |
GO:0009994 | 0.0054 | 4.1187 | 1.6294 | 6 | 46 | oocyte differentiation |
GO:0009605 | 0.0054 | 1.3739 | 68.5041 | 89 | 1934 | response to external stimulus |
GO:0035295 | 0.0056 | 2.2188 | 7.1496 | 15 | 206 | tube development |
GO:0072091 | 0.0056 | 3.5626 | 2.1607 | 7 | 61 | regulation of stem cell proliferation |
GO:0001657 | 0.0056 | 2.9495 | 3.2941 | 9 | 93 | ureteric bud development |
GO:0045823 | 0.0058 | 10.3442 | 0.3867 | 3 | 11 | positive regulation of heart contraction |
GO:0048523 | 0.0058 | 1.2953 | 125.9591 | 151 | 3726 | negative regulation of cellular process |
GO:0072358 | 0.0058 | 1.6426 | 22.3152 | 35 | 630 | cardiovascular system development |
GO:0034103 | 0.0058 | 3.189 | 2.7274 | 8 | 77 | regulation of tissue remodeling |
GO:0010608 | 0.0058 | 1.6182 | 23.9446 | 37 | 676 | posttranscriptional regulation of gene expression |
GO:0051451 | 0.0059 | 10.2623 | 0.3896 | 3 | 11 | myoblast migration |
GO:0030182 | 0.006 | 1.552 | 29.7291 | 44 | 860 | neuron differentiation |
GO:0072163 | 0.0061 | 2.9146 | 3.3296 | 9 | 94 | mesonephric epithelium development |
GO:0098754 | 0.0061 | 2.9146 | 3.3296 | 9 | 94 | detoxification |
GO:0080090 | 0.0062 | 1.253 | 200.518 | 229 | 5661 | regulation of primary metabolic process |
GO:0040019 | 0.0065 | 4.7289 | 1.2043 | 5 | 34 | positive regulation of embryonic development |
GO:0060043 | 0.0067 | 3.922 | 1.7002 | 6 | 48 | regulation of cardiac muscle cell proliferation |
GO:0043010 | 0.0067 | 2.8615 | 3.3828 | 9 | 97 | camera-type eye development |
GO:0032098 | 0.0069 | 6.0884 | 0.7793 | 4 | 22 | regulation of appetite |
GO:0010720 | 0.0069 | 1.7422 | 16.2228 | 27 | 458 | positive regulation of cell development |
GO:0035239 | 0.0069 | 1.8906 | 11.6535 | 21 | 329 | tube morphogenesis |
GO:0022008 | 0.007 | 1.4577 | 41.032 | 57 | 1175 | neurogenesis |
GO:0003257 | 0.0072 | 27.3273 | 0.1417 | 2 | 4 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation |
GO:0018916 | 0.0072 | 27.3273 | 0.1417 | 2 | 4 | nitrobenzene metabolic process |
GO:0021615 | 0.0072 | 27.3273 | 0.1417 | 2 | 4 | glossopharyngeal nerve morphogenesis |
GO:0046398 | 0.0072 | 27.3273 | 0.1417 | 2 | 4 | UDP-glucuronate metabolic process |
GO:0048295 | 0.0072 | 27.3273 | 0.1417 | 2 | 4 | positive regulation of isotype switching to IgE isotypes |
GO:0060040 | 0.0072 | 27.3273 | 0.1417 | 2 | 4 | retinal bipolar neuron differentiation |
GO:0061055 | 0.0072 | 27.3273 | 0.1417 | 2 | 4 | myotome development |
GO:0061343 | 0.0072 | 27.3273 | 0.1417 | 2 | 4 | cell adhesion involved in heart morphogenesis |
GO:0090063 | 0.0072 | 27.3273 | 0.1417 | 2 | 4 | positive regulation of microtubule nucleation |
GO:0090191 | 0.0072 | 27.3273 | 0.1417 | 2 | 4 | negative regulation of branching involved in ureteric bud morphogenesis |
GO:0097070 | 0.0072 | 27.3273 | 0.1417 | 2 | 4 | ductus arteriosus closure |
GO:0006334 | 0.0074 | 2.8147 | 3.4288 | 9 | 101 | nucleosome assembly |
GO:0019731 | 0.0074 | 4.571 | 1.2397 | 5 | 35 | antibacterial humoral response |
GO:0071542 | 0.0074 | 4.571 | 1.2397 | 5 | 35 | dopaminergic neuron differentiation |
GO:0045666 | 0.0076 | 1.9044 | 11.0159 | 20 | 311 | positive regulation of neuron differentiation |
GO:0006534 | 0.0077 | 9.1214 | 0.4251 | 3 | 12 | cysteine metabolic process |
GO:0009886 | 0.0077 | 9.1214 | 0.4251 | 3 | 12 | post-embryonic animal morphogenesis |
GO:0060272 | 0.0077 | 9.1214 | 0.4251 | 3 | 12 | embryonic skeletal joint morphogenesis |
GO:0061548 | 0.0077 | 9.1214 | 0.4251 | 3 | 12 | ganglion development |
GO:2000846 | 0.0077 | 9.1214 | 0.4251 | 3 | 12 | regulation of corticosteroid hormone secretion |
GO:0016202 | 0.0077 | 2.4849 | 4.711 | 11 | 133 | regulation of striated muscle tissue development |
GO:0060538 | 0.0079 | 2.3638 | 5.384 | 12 | 152 | skeletal muscle organ development |
GO:0032504 | 0.0079 | 1.5552 | 26.8845 | 40 | 759 | multicellular organism reproduction |
GO:0007218 | 0.0079 | 2.7829 | 3.4713 | 9 | 98 | neuropeptide signaling pathway |
GO:0030878 | 0.0081 | 5.7676 | 0.8147 | 4 | 23 | thyroid gland development |
GO:0060041 | 0.0081 | 2.4646 | 4.7464 | 11 | 134 | retina development in camera-type eye |
GO:0097237 | 0.0084 | 2.7517 | 3.5067 | 9 | 99 | cellular response to toxic substance |
GO:0061564 | 0.0086 | 1.7281 | 15.7269 | 26 | 444 | axon development |
GO:0009566 | 0.0087 | 2.3302 | 5.4548 | 12 | 154 | fertilization |
GO:0040011 | 0.0087 | 1.382 | 55.4692 | 73 | 1566 | locomotion |
GO:0001656 | 0.0091 | 2.9327 | 2.9399 | 8 | 83 | metanephros development |
GO:0035136 | 0.0094 | 4.2847 | 1.3106 | 5 | 37 | forelimb morphogenesis |
GO:0050482 | 0.0094 | 5.4788 | 0.8501 | 4 | 24 | arachidonic acid secretion |
GO:0030326 | 0.0097 | 2.526 | 4.2151 | 10 | 119 | embryonic limb morphogenesis |
GO:0050768 | 0.0097 | 2.0191 | 8.3239 | 16 | 235 | negative regulation of neurogenesis |
GO:0021781 | 0.0097 | 8.2087 | 0.4605 | 3 | 13 | glial cell fate commitment |
GO:1905205 | 0.0097 | 8.2087 | 0.4605 | 3 | 13 | positive regulation of connective tissue replacement |
GO:0045453 | 0.0098 | 3.58 | 1.8419 | 6 | 52 | bone resorption |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 97.5649 | 1.098 | 24 | 31 | DNA replication-dependent nucleosome assembly |
GO:0000183 | 0 | 52.514 | 1.3106 | 24 | 37 | chromatin silencing at rDNA |
GO:0051290 | 0 | 39.5688 | 1.5231 | 25 | 43 | protein heterotetramerization |
GO:0045653 | 0 | 130.3631 | 0.6022 | 14 | 17 | negative regulation of megakaryocyte differentiation |
GO:0045815 | 0 | 12.6077 | 2.7628 | 24 | 78 | positive regulation of gene expression, epigenetic |
GO:1902036 | 0 | 9.2135 | 3.6129 | 25 | 102 | regulation of hematopoietic stem cell differentiation |
GO:0060964 | 0 | 9.0648 | 3.5067 | 24 | 99 | regulation of gene silencing by miRNA |
GO:0031497 | 0 | 6.7766 | 5.3486 | 29 | 151 | chromatin assembly |
GO:0045814 | 0 | 7.6106 | 4.3568 | 26 | 123 | negative regulation of gene expression, epigenetic |
GO:0002244 | 0 | 5.5161 | 6.5529 | 30 | 185 | hematopoietic progenitor cell differentiation |
GO:0060968 | 0 | 6.9986 | 4.2859 | 24 | 121 | regulation of gene silencing |
GO:0048863 | 0 | 4.5235 | 8.8198 | 34 | 249 | stem cell differentiation |
GO:0034080 | 0 | 13.9442 | 1.4877 | 14 | 42 | CENP-A containing nucleosome assembly |
GO:1904837 | 0 | 13.9442 | 1.4877 | 14 | 42 | beta-catenin-TCF complex assembly |
GO:0032200 | 0 | 5.2347 | 5.6674 | 25 | 160 | telomere organization |
GO:1903707 | 0 | 5.79 | 4.5693 | 22 | 129 | negative regulation of hemopoiesis |
GO:0016233 | 0 | 10.8397 | 1.771 | 14 | 50 | telomere capping |
GO:0065004 | 0 | 4.219 | 7.9343 | 29 | 224 | protein-DNA complex assembly |
GO:0002520 | 0 | 2.4287 | 30.5329 | 66 | 862 | immune system development |
GO:0034724 | 0 | 10.0039 | 1.8773 | 14 | 53 | DNA replication-independent nucleosome organization |
GO:0030099 | 0 | 3.3039 | 12.9995 | 38 | 367 | myeloid cell differentiation |
GO:0071103 | 0 | 3.5421 | 9.5637 | 30 | 270 | DNA conformation change |
GO:0043044 | 0 | 6.8555 | 2.692 | 15 | 76 | ATP-dependent chromatin remodeling |
GO:0006303 | 0 | 7.0861 | 2.444 | 14 | 69 | double-strand break repair via nonhomologous end joining |
GO:0048869 | 0 | 1.641 | 132.8509 | 186 | 3807 | cellular developmental process |
GO:2000026 | 0 | 1.8661 | 56.825 | 95 | 1628 | regulation of multicellular organismal development |
GO:0038111 | 0 | 10.2535 | 1.3106 | 10 | 37 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 9.8867 | 1.346 | 10 | 38 | response to interleukin-7 |
GO:0045892 | 0 | 1.9526 | 38.1484 | 68 | 1077 | negative regulation of transcription, DNA-templated |
GO:0048598 | 0 | 2.3497 | 19.5169 | 42 | 551 | embryonic morphogenesis |
GO:0045596 | 0 | 2.2478 | 21.8193 | 45 | 616 | negative regulation of cell differentiation |
GO:0035194 | 0 | 2.9105 | 10.2012 | 27 | 288 | posttranscriptional gene silencing by RNA |
GO:1902679 | 0 | 1.8728 | 39.5652 | 68 | 1117 | negative regulation of RNA biosynthetic process |
GO:0061061 | 0 | 2.2036 | 21.1817 | 43 | 598 | muscle structure development |
GO:0001501 | 0 | 2.3806 | 16.4353 | 36 | 464 | skeletal system development |
GO:0022008 | 0 | 1.7461 | 49.9435 | 80 | 1410 | neurogenesis |
GO:0045652 | 0 | 6.3064 | 1.9008 | 10 | 55 | regulation of megakaryocyte differentiation |
GO:0009952 | 0 | 3.1916 | 6.9071 | 20 | 195 | anterior/posterior pattern specification |
GO:0034728 | 0 | 4.2347 | 3.7412 | 14 | 108 | nucleosome organization |
GO:1903506 | 0 | 1.501 | 120.3249 | 161 | 3397 | regulation of nucleic acid-templated transcription |
GO:0060065 | 0 | 13.7546 | 0.6376 | 6 | 18 | uterus development |
GO:0051259 | 0 | 2.2101 | 17.5688 | 36 | 496 | protein oligomerization |
GO:0007218 | 0 | 4.2412 | 3.4713 | 13 | 98 | neuropeptide signaling pathway |
GO:0045934 | 0 | 1.7141 | 47.3932 | 75 | 1338 | negative regulation of nucleobase-containing compound metabolic process |
GO:0048568 | 1e-04 | 2.3256 | 14.3809 | 31 | 406 | embryonic organ development |
GO:0009954 | 1e-04 | 8.7631 | 1.0272 | 7 | 29 | proximal/distal pattern formation |
GO:0007389 | 1e-04 | 2.313 | 14.4517 | 31 | 408 | pattern specification process |
GO:0017148 | 1e-04 | 2.3676 | 13.212 | 29 | 373 | negative regulation of translation |
GO:0043010 | 1e-04 | 2.5927 | 10.0241 | 24 | 283 | camera-type eye development |
GO:0048513 | 1e-04 | 1.7073 | 43.9811 | 69 | 1336 | animal organ development |
GO:0051252 | 1e-04 | 1.4368 | 126.8424 | 164 | 3581 | regulation of RNA metabolic process |
GO:0001655 | 1e-04 | 2.4946 | 10.3783 | 24 | 293 | urogenital system development |
GO:0014855 | 1e-04 | 4.7633 | 2.4086 | 10 | 68 | striated muscle cell proliferation |
GO:0060043 | 3e-04 | 5.5118 | 1.7002 | 8 | 48 | regulation of cardiac muscle cell proliferation |
GO:0010604 | 3e-04 | 1.4407 | 100.8434 | 133 | 2847 | positive regulation of macromolecule metabolic process |
GO:0021872 | 3e-04 | 4.6844 | 2.1961 | 9 | 62 | forebrain generation of neurons |
GO:0002682 | 3e-04 | 1.6231 | 45.5159 | 69 | 1285 | regulation of immune system process |
GO:0060249 | 3e-04 | 2.2368 | 12.4328 | 26 | 351 | anatomical structure homeostasis |
GO:0048771 | 4e-04 | 2.9928 | 5.4548 | 15 | 154 | tissue remodeling |
GO:0035107 | 4e-04 | 3.1286 | 4.8881 | 14 | 138 | appendage morphogenesis |
GO:0061743 | 4e-04 | 41.0656 | 0.1771 | 3 | 5 | motor learning |
GO:1900086 | 4e-04 | 41.0656 | 0.1771 | 3 | 5 | positive regulation of peptidyl-tyrosine autophosphorylation |
GO:0001822 | 4e-04 | 2.4965 | 8.6073 | 20 | 243 | kidney development |
GO:1903244 | 4e-04 | 15.6674 | 0.3896 | 4 | 11 | positive regulation of cardiac muscle hypertrophy in response to stress |
GO:0043009 | 4e-04 | 1.9514 | 19.0919 | 35 | 539 | chordate embryonic development |
GO:0008284 | 4e-04 | 1.7568 | 29.0806 | 48 | 821 | positive regulation of cell proliferation |
GO:0051248 | 5e-04 | 1.601 | 44.6658 | 67 | 1261 | negative regulation of protein metabolic process |
GO:0045595 | 5e-04 | 1.6946 | 33.3642 | 53 | 985 | regulation of cell differentiation |
GO:0010935 | 6e-04 | 13.708 | 0.4251 | 4 | 12 | regulation of macrophage cytokine production |
GO:0021889 | 6e-04 | 13.708 | 0.4251 | 4 | 12 | olfactory bulb interneuron differentiation |
GO:0006935 | 6e-04 | 1.9236 | 18.7731 | 34 | 530 | chemotaxis |
GO:0060173 | 6e-04 | 2.8284 | 5.7382 | 15 | 162 | limb development |
GO:0000003 | 7e-04 | 1.5852 | 45.0554 | 67 | 1272 | reproduction |
GO:0021953 | 7e-04 | 2.7901 | 5.809 | 15 | 164 | central nervous system neuron differentiation |
GO:0055024 | 8e-04 | 3.6795 | 3.0108 | 10 | 85 | regulation of cardiac muscle tissue development |
GO:0032098 | 9e-04 | 8.0734 | 0.7793 | 5 | 22 | regulation of appetite |
GO:0034654 | 9e-04 | 1.3506 | 141.5067 | 174 | 3995 | nucleobase-containing compound biosynthetic process |
GO:1901861 | 9e-04 | 2.9722 | 4.7464 | 13 | 134 | regulation of muscle tissue development |
GO:0048732 | 0.001 | 2.038 | 14.0621 | 27 | 397 | gland development |
GO:0007423 | 0.001 | 1.9108 | 17.7459 | 32 | 501 | sensory organ development |
GO:0050896 | 0.001 | 1.3131 | 276.9564 | 313 | 7819 | response to stimulus |
GO:0048519 | 0.001 | 1.3295 | 169.2413 | 203 | 4778 | negative regulation of biological process |
GO:0007631 | 0.001 | 3.3019 | 3.6484 | 11 | 103 | feeding behavior |
GO:0045823 | 0.0011 | 5.8885 | 1.2043 | 6 | 34 | positive regulation of heart contraction |
GO:0035295 | 0.0011 | 1.8539 | 19.4107 | 34 | 548 | tube development |
GO:0070887 | 0.0011 | 1.3926 | 96.9117 | 125 | 2736 | cellular response to chemical stimulus |
GO:0030182 | 0.0011 | 1.872 | 18.6827 | 33 | 547 | neuron differentiation |
GO:0014744 | 0.0012 | 10.965 | 0.4959 | 4 | 14 | positive regulation of muscle adaptation |
GO:0051962 | 0.0012 | 1.953 | 15.7269 | 29 | 444 | positive regulation of nervous system development |
GO:0048518 | 0.0012 | 1.3295 | 166.2532 | 199 | 4783 | positive regulation of biological process |
GO:0048592 | 0.0012 | 2.8763 | 4.8881 | 13 | 138 | eye morphogenesis |
GO:0048634 | 0.0012 | 2.8763 | 4.8881 | 13 | 138 | regulation of muscle organ development |
GO:0035544 | 0.0013 | Inf | 0.0708 | 2 | 2 | negative regulation of SNARE complex assembly |
GO:1900155 | 0.0013 | Inf | 0.0708 | 2 | 2 | negative regulation of bone trabecula formation |
GO:0007275 | 0.0014 | 1.4351 | 80.058 | 105 | 2581 | multicellular organism development |
GO:0006352 | 0.0015 | 2.3451 | 8.1822 | 18 | 231 | DNA-templated transcription, initiation |
GO:0009653 | 0.0016 | 1.5616 | 40.8697 | 60 | 1213 | anatomical structure morphogenesis |
GO:0010720 | 0.0019 | 1.8875 | 16.2228 | 29 | 458 | positive regulation of cell development |
GO:0042554 | 0.0019 | 6.5339 | 0.9209 | 5 | 26 | superoxide anion generation |
GO:2000112 | 0.002 | 1.3233 | 139.1335 | 169 | 3928 | regulation of cellular macromolecule biosynthetic process |
GO:0055012 | 0.002 | 9.1363 | 0.5667 | 4 | 16 | ventricular cardiac muscle cell differentiation |
GO:0008584 | 0.0021 | 2.8329 | 4.5693 | 12 | 129 | male gonad development |
GO:0006776 | 0.0022 | 16.423 | 0.2834 | 3 | 8 | vitamin A metabolic process |
GO:0046006 | 0.0023 | 4.9947 | 1.3814 | 6 | 39 | regulation of activated T cell proliferation |
GO:0001568 | 0.0023 | 1.7495 | 21.0755 | 35 | 595 | blood vessel development |
GO:0060420 | 0.0024 | 3.7321 | 2.3732 | 8 | 67 | regulation of heart growth |
GO:0002042 | 0.0026 | 4.8474 | 1.4168 | 6 | 40 | cell migration involved in sprouting angiogenesis |
GO:0001764 | 0.0027 | 2.7385 | 4.711 | 12 | 133 | neuron migration |
GO:1905039 | 0.0028 | 3.0631 | 3.5421 | 10 | 100 | carboxylic acid transmembrane transport |
GO:0009887 | 0.0029 | 1.6148 | 29.3452 | 45 | 840 | animal organ morphogenesis |
GO:0046850 | 0.003 | 4.7086 | 1.4523 | 6 | 41 | regulation of bone remodeling |
GO:0018958 | 0.0031 | 3.2617 | 3.0108 | 9 | 85 | phenol-containing compound metabolic process |
GO:0048856 | 0.0032 | 2.6837 | 4.7978 | 12 | 169 | anatomical structure development |
GO:0009128 | 0.0032 | 13.6849 | 0.3188 | 3 | 9 | purine nucleoside monophosphate catabolic process |
GO:0044848 | 0.0032 | 13.6849 | 0.3188 | 3 | 9 | biological phase |
GO:0046085 | 0.0032 | 13.6849 | 0.3188 | 3 | 9 | adenosine metabolic process |
GO:0010612 | 0.0032 | 7.83 | 0.6376 | 4 | 18 | regulation of cardiac muscle adaptation |
GO:0021988 | 0.0032 | 5.716 | 1.0272 | 5 | 29 | olfactory lobe development |
GO:0050878 | 0.0033 | 1.8277 | 16.1165 | 28 | 455 | regulation of body fluid levels |
GO:0002019 | 0.0037 | 54.6582 | 0.1063 | 2 | 3 | regulation of renal output by angiotensin |
GO:0007412 | 0.0037 | 54.6582 | 0.1063 | 2 | 3 | axon target recognition |
GO:0055005 | 0.0037 | 54.6582 | 0.1063 | 2 | 3 | ventricular cardiac myofibril assembly |
GO:0055014 | 0.0037 | 54.6582 | 0.1063 | 2 | 3 | atrial cardiac muscle cell development |
GO:0060978 | 0.0037 | 54.6582 | 0.1063 | 2 | 3 | angiogenesis involved in coronary vascular morphogenesis |
GO:0070370 | 0.0037 | 54.6582 | 0.1063 | 2 | 3 | cellular heat acclimation |
GO:0070434 | 0.0037 | 54.6582 | 0.1063 | 2 | 3 | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway |
GO:0035115 | 0.0037 | 5.487 | 1.0626 | 5 | 30 | embryonic forelimb morphogenesis |
GO:0007420 | 0.0038 | 1.6781 | 22.5277 | 36 | 636 | brain development |
GO:0055017 | 0.0039 | 3.1372 | 3.117 | 9 | 88 | cardiac muscle tissue growth |
GO:0001759 | 0.0039 | 7.3075 | 0.673 | 4 | 19 | organ induction |
GO:0030326 | 0.004 | 3.1214 | 3.1299 | 9 | 89 | embryonic limb morphogenesis |
GO:0035270 | 0.004 | 2.7332 | 4.3214 | 11 | 122 | endocrine system development |
GO:0035265 | 0.0041 | 2.4762 | 5.5965 | 13 | 158 | organ growth |
GO:0048738 | 0.0042 | 3.1019 | 3.1466 | 9 | 90 | cardiac muscle tissue development |
GO:0071542 | 0.0043 | 5.2943 | 1.0944 | 5 | 31 | dopaminergic neuron differentiation |
GO:0003209 | 0.0043 | 5.2756 | 1.098 | 5 | 31 | cardiac atrium morphogenesis |
GO:0016486 | 0.0043 | 5.2756 | 1.098 | 5 | 31 | peptide hormone processing |
GO:0120039 | 0.0044 | 1.7031 | 20.3316 | 33 | 574 | plasma membrane bounded cell projection morphogenesis |
GO:0003407 | 0.0047 | 3.7001 | 2.0898 | 7 | 59 | neural retina development |
GO:0002052 | 0.0048 | 6.8504 | 0.7084 | 4 | 20 | positive regulation of neuroblast proliferation |
GO:0021854 | 0.0048 | 6.8504 | 0.7084 | 4 | 20 | hypothalamus development |
GO:0008217 | 0.0048 | 2.4256 | 5.7028 | 13 | 161 | regulation of blood pressure |
GO:0044703 | 0.0051 | 1.5516 | 31.0996 | 46 | 878 | multi-organism reproductive process |
GO:0009890 | 0.0051 | 1.408 | 57.7007 | 77 | 1629 | negative regulation of biosynthetic process |
GO:0001525 | 0.0054 | 1.801 | 15.1434 | 26 | 429 | angiogenesis |
GO:0032526 | 0.0055 | 4.9421 | 1.159 | 5 | 33 | response to retinoic acid |
GO:0045785 | 0.0056 | 1.8675 | 12.9286 | 23 | 365 | positive regulation of cell adhesion |
GO:0060537 | 0.0056 | 2.152 | 7.8495 | 16 | 225 | muscle tissue development |
GO:0048665 | 0.0057 | 4.8981 | 1.1689 | 5 | 33 | neuron fate specification |
GO:0061082 | 0.0058 | 6.447 | 0.7438 | 4 | 21 | myeloid leukocyte cytokine production |
GO:0072358 | 0.0058 | 1.6426 | 22.3152 | 35 | 630 | cardiovascular system development |
GO:0050886 | 0.0058 | 3.189 | 2.7274 | 8 | 77 | endocrine process |
GO:0060042 | 0.006 | 4.018 | 1.6648 | 6 | 47 | retina morphogenesis in camera-type eye |
GO:0009953 | 0.0061 | 2.9146 | 3.3296 | 9 | 94 | dorsal/ventral pattern formation |
GO:0048704 | 0.0061 | 3.1588 | 2.7499 | 8 | 78 | embryonic skeletal system morphogenesis |
GO:0045137 | 0.0061 | 2.1937 | 7.2259 | 15 | 204 | development of primary sexual characteristics |
GO:0031175 | 0.0062 | 1.547 | 29.789 | 44 | 841 | neuron projection development |
GO:0045664 | 0.0062 | 1.6874 | 19.2336 | 31 | 543 | regulation of neuron differentiation |
GO:0001708 | 0.0065 | 3.9509 | 1.6884 | 6 | 48 | cell fate specification |
GO:0048870 | 0.0066 | 1.4291 | 47.7829 | 65 | 1349 | cell motility |
GO:0071398 | 0.0067 | 3.922 | 1.7002 | 6 | 48 | cellular response to fatty acid |
GO:0042060 | 0.007 | 1.703 | 17.8167 | 29 | 503 | wound healing |
GO:0046661 | 0.0071 | 2.3984 | 5.3131 | 12 | 150 | male sex differentiation |
GO:0002317 | 0.0072 | 27.3273 | 0.1417 | 2 | 4 | plasma cell differentiation |
GO:0018916 | 0.0072 | 27.3273 | 0.1417 | 2 | 4 | nitrobenzene metabolic process |
GO:0042636 | 0.0072 | 27.3273 | 0.1417 | 2 | 4 | negative regulation of hair cycle |
GO:0061343 | 0.0072 | 27.3273 | 0.1417 | 2 | 4 | cell adhesion involved in heart morphogenesis |
GO:0090063 | 0.0072 | 27.3273 | 0.1417 | 2 | 4 | positive regulation of microtubule nucleation |
GO:0097176 | 0.0072 | 27.3273 | 0.1417 | 2 | 4 | epoxide metabolic process |
GO:1904340 | 0.0072 | 27.3273 | 0.1417 | 2 | 4 | positive regulation of dopaminergic neuron differentiation |
GO:0071345 | 0.0072 | 1.5394 | 29.2223 | 43 | 825 | cellular response to cytokine stimulus |
GO:0048644 | 0.0073 | 3.0556 | 2.8337 | 8 | 80 | muscle organ morphogenesis |
GO:0010464 | 0.0074 | 4.571 | 1.2397 | 5 | 35 | regulation of mesenchymal cell proliferation |
GO:0032990 | 0.0074 | 1.6371 | 21.0755 | 33 | 595 | cell part morphogenesis |
GO:1903039 | 0.0076 | 2.1364 | 7.403 | 15 | 209 | positive regulation of leukocyte cell-cell adhesion |
GO:0060272 | 0.0077 | 9.1214 | 0.4251 | 3 | 12 | embryonic skeletal joint morphogenesis |
GO:2000846 | 0.0077 | 9.1214 | 0.4251 | 3 | 12 | regulation of corticosteroid hormone secretion |
GO:0010033 | 0.0077 | 1.3029 | 99.5329 | 122 | 2810 | response to organic substance |
GO:0030316 | 0.0079 | 3.0135 | 2.8691 | 8 | 81 | osteoclast differentiation |
GO:0003341 | 0.0079 | 3.316 | 2.3024 | 7 | 65 | cilium movement |
GO:0060343 | 0.0081 | 5.7676 | 0.8147 | 4 | 23 | trabecula formation |
GO:0010803 | 0.0081 | 3.7433 | 1.771 | 6 | 50 | regulation of tumor necrosis factor-mediated signaling pathway |
GO:0014742 | 0.0083 | 4.4232 | 1.2752 | 5 | 36 | positive regulation of muscle hypertrophy |
GO:0032094 | 0.0083 | 4.4232 | 1.2752 | 5 | 36 | response to food |
GO:0045944 | 0.0085 | 1.4656 | 37.1211 | 52 | 1048 | positive regulation of transcription from RNA polymerase II promoter |
GO:0042445 | 0.0086 | 2.4431 | 4.7831 | 11 | 136 | hormone metabolic process |
GO:0071300 | 0.0086 | 3.2596 | 2.3378 | 7 | 66 | cellular response to retinoic acid |
GO:0007276 | 0.009 | 1.6132 | 21.3588 | 33 | 603 | gamete generation |
GO:0072593 | 0.0093 | 2.0285 | 8.2885 | 16 | 234 | reactive oxygen species metabolic process |
GO:0000904 | 0.0094 | 1.5954 | 22.2444 | 34 | 628 | cell morphogenesis involved in differentiation |
GO:0050482 | 0.0094 | 5.4788 | 0.8501 | 4 | 24 | arachidonic acid secretion |
GO:0030097 | 0.0097 | 2.0185 | 8.3221 | 16 | 248 | hemopoiesis |
GO:0002087 | 0.0097 | 8.2087 | 0.4605 | 3 | 13 | regulation of respiratory gaseous exchange by neurological system process |
GO:0021978 | 0.0097 | 8.2087 | 0.4605 | 3 | 13 | telencephalon regionalization |
GO:0060547 | 0.0097 | 8.2087 | 0.4605 | 3 | 13 | negative regulation of necrotic cell death |
GO:1905205 | 0.0097 | 8.2087 | 0.4605 | 3 | 13 | positive regulation of connective tissue replacement |
GO:0007409 | 0.0098 | 1.7497 | 14.3316 | 24 | 406 | axonogenesis |
GO:0045453 | 0.0098 | 3.58 | 1.8419 | 6 | 52 | bone resorption |
GO:0010648 | 0.0098 | 1.4205 | 43.4615 | 59 | 1227 | negative regulation of cell communication |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0070098 | 1e-04 | 5.2292 | 2.1843 | 10 | 74 | chemokine-mediated signaling pathway |
GO:0006955 | 1e-04 | 1.6828 | 49.914 | 77 | 1691 | immune response |
GO:1902746 | 1e-04 | 99.2757 | 0.1181 | 3 | 4 | regulation of lens fiber cell differentiation |
GO:0048247 | 1e-04 | 6.2075 | 1.5054 | 8 | 51 | lymphocyte chemotaxis |
GO:0046641 | 1e-04 | 12.7735 | 0.5313 | 5 | 18 | positive regulation of alpha-beta T cell proliferation |
GO:0007165 | 1e-04 | 1.4285 | 157.5347 | 195 | 5337 | signal transduction |
GO:0001895 | 3e-04 | 5.4452 | 1.6825 | 8 | 57 | retina homeostasis |
GO:0008347 | 3e-04 | 6.1347 | 1.3283 | 7 | 45 | glial cell migration |
GO:0031295 | 5e-04 | 4.8492 | 1.8596 | 8 | 63 | T cell costimulation |
GO:0018003 | 9e-04 | Inf | 0.059 | 2 | 2 | peptidyl-lysine N6-acetylation |
GO:0002252 | 0.001 | 1.6998 | 29.3994 | 47 | 996 | immune effector process |
GO:0002548 | 0.0012 | 4.754 | 1.653 | 7 | 56 | monocyte chemotaxis |
GO:0051249 | 0.0016 | 2.1202 | 10.9805 | 22 | 372 | regulation of lymphocyte activation |
GO:0045321 | 0.0016 | 1.6438 | 30.9638 | 48 | 1049 | leukocyte activation |
GO:0030593 | 0.0024 | 3.7001 | 2.3614 | 8 | 80 | neutrophil chemotaxis |
GO:0014031 | 0.0025 | 4.1578 | 1.8596 | 7 | 63 | mesenchymal cell development |
GO:0048864 | 0.0025 | 4.1578 | 1.8596 | 7 | 63 | stem cell development |
GO:0042631 | 0.0026 | 66.0393 | 0.0886 | 2 | 3 | cellular response to water deprivation |
GO:0090292 | 0.0026 | 66.0393 | 0.0886 | 2 | 3 | nuclear matrix anchoring at nuclear membrane |
GO:0050865 | 0.0027 | 1.9315 | 13.6371 | 25 | 462 | regulation of cell activation |
GO:0008037 | 0.0028 | 3.0612 | 3.5126 | 10 | 119 | cell recognition |
GO:0071248 | 0.0029 | 2.8478 | 4.1324 | 11 | 140 | cellular response to metal ion |
GO:0006687 | 0.0032 | 3.9456 | 1.9482 | 7 | 66 | glycosphingolipid metabolic process |
GO:0014033 | 0.0032 | 3.9456 | 1.9482 | 7 | 66 | neural crest cell differentiation |
GO:0070374 | 0.0034 | 2.5282 | 5.4607 | 13 | 185 | positive regulation of ERK1 and ERK2 cascade |
GO:0097286 | 0.0035 | 12.4037 | 0.3247 | 3 | 11 | iron ion import |
GO:0043567 | 0.0036 | 7.3616 | 0.6494 | 4 | 22 | regulation of insulin-like growth factor receptor signaling pathway |
GO:0007264 | 0.0037 | 1.8827 | 13.9618 | 25 | 473 | small GTPase mediated signal transduction |
GO:0048731 | 0.0038 | 1.3201 | 126.866 | 153 | 4298 | system development |
GO:0001755 | 0.0039 | 5.3502 | 1.0626 | 5 | 36 | neural crest cell migration |
GO:0090066 | 0.0046 | 1.9031 | 12.6925 | 23 | 430 | regulation of anatomical structure size |
GO:0045060 | 0.0046 | 11.0248 | 0.3542 | 3 | 12 | negative thymic T cell selection |
GO:0051481 | 0.0046 | 11.0248 | 0.3542 | 3 | 12 | negative regulation of cytosolic calcium ion concentration |
GO:0022407 | 0.005 | 1.9507 | 11.3052 | 21 | 383 | regulation of cell-cell adhesion |
GO:0001994 | 0.005 | 33.0175 | 0.1181 | 2 | 4 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure |
GO:0008588 | 0.005 | 33.0175 | 0.1181 | 2 | 4 | release of cytoplasmic sequestered NF-kappaB |
GO:0098707 | 0.005 | 33.0175 | 0.1181 | 2 | 4 | ferrous iron import across plasma membrane |
GO:1903237 | 0.005 | 33.0175 | 0.1181 | 2 | 4 | negative regulation of leukocyte tethering or rolling |
GO:0048583 | 0.005 | 1.3239 | 107.0893 | 131 | 3628 | regulation of response to stimulus |
GO:0097530 | 0.0056 | 2.939 | 3.2764 | 9 | 111 | granulocyte migration |
GO:2000403 | 0.0058 | 6.3087 | 0.7379 | 4 | 25 | positive regulation of lymphocyte migration |
GO:0010771 | 0.0061 | 3.4727 | 2.1843 | 7 | 74 | negative regulation of cell morphogenesis involved in differentiation |
GO:0046634 | 0.0066 | 3.4214 | 2.2138 | 7 | 75 | regulation of alpha-beta T cell activation |
GO:0048589 | 0.007 | 1.7408 | 16.2346 | 27 | 550 | developmental growth |
GO:0006684 | 0.0073 | 9.0191 | 0.4132 | 3 | 14 | sphingomyelin metabolic process |
GO:0034433 | 0.0073 | 9.0191 | 0.4132 | 3 | 14 | steroid esterification |
GO:0034435 | 0.0073 | 9.0191 | 0.4132 | 3 | 14 | cholesterol esterification |
GO:0050965 | 0.0073 | 9.0191 | 0.4132 | 3 | 14 | detection of temperature stimulus involved in sensory perception of pain |
GO:1903509 | 0.0074 | 2.8007 | 3.424 | 9 | 116 | liposaccharide metabolic process |
GO:0050900 | 0.0077 | 1.902 | 11.01 | 20 | 373 | leukocyte migration |
GO:0010648 | 0.0081 | 1.4789 | 36.2179 | 51 | 1227 | negative regulation of cell communication |
GO:0006528 | 0.0082 | 22.0102 | 0.1476 | 2 | 5 | asparagine metabolic process |
GO:0043087 | 0.0083 | 1.8255 | 12.604 | 22 | 427 | regulation of GTPase activity |
GO:0072678 | 0.0084 | 4.3626 | 1.2693 | 5 | 43 | T cell migration |
GO:0050896 | 0.0084 | 1.3442 | 97.0698 | 117 | 3625 | response to stimulus |
GO:0023057 | 0.0086 | 1.4735 | 36.336 | 51 | 1231 | negative regulation of signaling |
GO:1902532 | 0.0086 | 1.7706 | 14.1684 | 24 | 480 | negative regulation of intracellular signal transduction |
GO:0006898 | 0.0086 | 2.0993 | 7.4974 | 15 | 254 | receptor-mediated endocytosis |
GO:0048870 | 0.0088 | 1.4514 | 39.819 | 55 | 1349 | cell motility |
GO:0006968 | 0.0092 | 4.2505 | 1.2988 | 5 | 44 | cellular defense response |
GO:0046580 | 0.0092 | 4.2505 | 1.2988 | 5 | 44 | negative regulation of Ras protein signal transduction |
GO:1903039 | 0.0093 | 2.215 | 6.1691 | 13 | 209 | positive regulation of leukocyte cell-cell adhesion |
GO:0042692 | 0.0093 | 1.8641 | 11.2166 | 20 | 380 | muscle cell differentiation |
GO:0048869 | 0.0096 | 1.286 | 114.7639 | 137 | 3888 | cellular developmental process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0045653 | 0 | 104.0848 | 0.744 | 14 | 17 | negative regulation of megakaryocyte differentiation |
GO:0034724 | 0 | 12.5318 | 2.3194 | 19 | 53 | DNA replication-independent nucleosome organization |
GO:0034080 | 0 | 15.2126 | 1.838 | 17 | 42 | CENP-A containing nucleosome assembly |
GO:1904837 | 0 | 13.7454 | 1.838 | 16 | 42 | beta-catenin-TCF complex assembly |
GO:0006335 | 0 | 18.3507 | 1.3566 | 14 | 31 | DNA replication-dependent nucleosome assembly |
GO:0051290 | 0 | 11.9463 | 1.8818 | 15 | 43 | protein heterotetramerization |
GO:0000183 | 0 | 13.5581 | 1.6192 | 14 | 37 | chromatin silencing at rDNA |
GO:0065004 | 0 | 3.9163 | 9.8029 | 33 | 224 | protein-DNA complex assembly |
GO:0016233 | 0 | 9.5526 | 2.1881 | 15 | 50 | telomere capping |
GO:0006303 | 0 | 7.3005 | 3.0196 | 17 | 69 | double-strand break repair via nonhomologous end joining |
GO:0043044 | 0 | 6.4313 | 3.326 | 17 | 76 | ATP-dependent chromatin remodeling |
GO:0006352 | 0 | 3.3653 | 10.1092 | 30 | 231 | DNA-templated transcription, initiation |
GO:0031497 | 0 | 4.0284 | 6.6082 | 23 | 151 | chromatin assembly |
GO:0071103 | 0 | 3.0333 | 11.816 | 32 | 270 | DNA conformation change |
GO:1902036 | 0 | 4.4562 | 4.4638 | 17 | 102 | regulation of hematopoietic stem cell differentiation |
GO:0060968 | 0 | 3.8949 | 5.2953 | 18 | 121 | regulation of gene silencing |
GO:0060964 | 0 | 4.2893 | 4.3325 | 16 | 99 | regulation of gene silencing by miRNA |
GO:0045815 | 0 | 4.859 | 3.4135 | 14 | 78 | positive regulation of gene expression, epigenetic |
GO:0097659 | 0 | 1.4648 | 155.2268 | 203 | 3547 | nucleic acid-templated transcription |
GO:2001141 | 0 | 1.4596 | 148.9249 | 195 | 3403 | regulation of RNA biosynthetic process |
GO:0044237 | 0 | 1.4282 | 430.5825 | 482 | 9839 | cellular metabolic process |
GO:0034654 | 0 | 1.4336 | 174.8325 | 223 | 3995 | nucleobase-containing compound biosynthetic process |
GO:0045814 | 0 | 3.5683 | 5.3828 | 17 | 123 | negative regulation of gene expression, epigenetic |
GO:0006396 | 0 | 2.1343 | 20.7816 | 41 | 484 | RNA processing |
GO:0019219 | 0 | 1.4138 | 172.2068 | 218 | 3935 | regulation of nucleobase-containing compound metabolic process |
GO:0010467 | 0 | 1.4543 | 145.8744 | 188 | 3595 | gene expression |
GO:0043604 | 0 | 1.7861 | 39.1677 | 65 | 895 | amide biosynthetic process |
GO:0006807 | 0 | 1.3804 | 405.025 | 454 | 9255 | nitrogen compound metabolic process |
GO:0016070 | 0 | 1.4567 | 129.9168 | 170 | 3137 | RNA metabolic process |
GO:0071840 | 0 | 1.3661 | 254.9623 | 304 | 5826 | cellular component organization or biogenesis |
GO:0002244 | 1e-04 | 2.855 | 8.0961 | 21 | 185 | hematopoietic progenitor cell differentiation |
GO:0032200 | 1e-04 | 3.0001 | 7.0021 | 19 | 160 | telomere organization |
GO:0006139 | 1e-04 | 1.7243 | 44.524 | 70 | 1133 | nucleobase-containing compound metabolic process |
GO:0006325 | 1e-04 | 1.8211 | 31.1591 | 53 | 712 | chromatin organization |
GO:0022613 | 1e-04 | 2.0638 | 19.2556 | 37 | 440 | ribonucleoprotein complex biogenesis |
GO:1903707 | 2e-04 | 3.1442 | 5.6454 | 16 | 129 | negative regulation of hemopoiesis |
GO:0006412 | 2e-04 | 1.7454 | 34.879 | 57 | 797 | translation |
GO:0006518 | 2e-04 | 1.6706 | 41.5309 | 65 | 949 | peptide metabolic process |
GO:0009889 | 3e-04 | 1.3432 | 186.561 | 227 | 4263 | regulation of biosynthetic process |
GO:0006355 | 3e-04 | 1.4394 | 97.9377 | 130 | 2299 | regulation of transcription, DNA-templated |
GO:0090063 | 3e-04 | 65.8365 | 0.1751 | 3 | 4 | positive regulation of microtubule nucleation |
GO:1901576 | 4e-04 | 1.3109 | 262.2269 | 305 | 5992 | organic substance biosynthetic process |
GO:0051259 | 6e-04 | 1.8609 | 21.7064 | 38 | 496 | protein oligomerization |
GO:0071681 | 8e-04 | 32.9161 | 0.2188 | 3 | 5 | cellular response to indole-3-methanol |
GO:1901673 | 8e-04 | 8.4587 | 0.7877 | 5 | 18 | regulation of mitotic spindle assembly |
GO:0042886 | 0.001 | 1.4177 | 82.7118 | 110 | 1890 | amide transport |
GO:0090224 | 0.001 | 5.1409 | 1.6192 | 7 | 37 | regulation of spindle organization |
GO:0044403 | 0.001 | 1.6405 | 34.1788 | 53 | 781 | symbiosis, encompassing mutualism through parasitism |
GO:0045637 | 0.0011 | 2.2444 | 10.0217 | 21 | 229 | regulation of myeloid cell differentiation |
GO:0006364 | 0.0012 | 2.1942 | 10.7219 | 22 | 245 | rRNA processing |
GO:0046907 | 0.0018 | 1.4356 | 65.6862 | 89 | 1524 | intracellular transport |
GO:0036112 | 0.0019 | Inf | 0.0875 | 2 | 2 | medium-chain fatty-acyl-CoA metabolic process |
GO:0042998 | 0.0019 | Inf | 0.0875 | 2 | 2 | positive regulation of Golgi to plasma membrane protein transport |
GO:1902766 | 0.0019 | Inf | 0.0875 | 2 | 2 | skeletal muscle satellite cell migration |
GO:1905366 | 0.0019 | Inf | 0.0875 | 2 | 2 | negative regulation of intralumenal vesicle formation |
GO:0034613 | 0.002 | 1.409 | 72.9089 | 97 | 1666 | cellular protein localization |
GO:0016236 | 0.002 | 2.0539 | 11.9035 | 23 | 272 | macroautophagy |
GO:0000377 | 0.002 | 1.9871 | 13.3477 | 25 | 305 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile |
GO:0010608 | 0.002 | 1.6385 | 29.5837 | 46 | 676 | posttranscriptional regulation of gene expression |
GO:0000245 | 0.002 | 3.9188 | 2.3194 | 8 | 53 | spliceosomal complex assembly |
GO:0006893 | 0.0024 | 4.2824 | 1.8818 | 7 | 43 | Golgi to plasma membrane transport |
GO:1903265 | 0.0026 | 16.4558 | 0.3063 | 3 | 7 | positive regulation of tumor necrosis factor-mediated signaling pathway |
GO:0008380 | 0.0028 | 1.8122 | 17.4614 | 30 | 399 | RNA splicing |
GO:0016071 | 0.0029 | 1.5721 | 33.4348 | 50 | 764 | mRNA metabolic process |
GO:0016197 | 0.003 | 2.0539 | 10.8532 | 21 | 248 | endosomal transport |
GO:0065003 | 0.003 | 1.8923 | 14.5284 | 26 | 349 | macromolecular complex assembly |
GO:0060249 | 0.0033 | 1.8547 | 15.3608 | 27 | 351 | anatomical structure homeostasis |
GO:0007033 | 0.0033 | 2.4578 | 6.1268 | 14 | 140 | vacuole organization |
GO:0022904 | 0.0034 | 2.8242 | 4.245 | 11 | 97 | respiratory electron transport chain |
GO:0007005 | 0.0034 | 1.6801 | 23.1505 | 37 | 529 | mitochondrion organization |
GO:0046034 | 0.0035 | 2.0267 | 10.9845 | 21 | 251 | ATP metabolic process |
GO:0019058 | 0.0036 | 1.9502 | 12.4724 | 23 | 285 | viral life cycle |
GO:0007041 | 0.0036 | 2.9818 | 3.6761 | 10 | 84 | lysosomal transport |
GO:0007032 | 0.0037 | 3.2009 | 3.1072 | 9 | 71 | endosome organization |
GO:0006296 | 0.0038 | 4.552 | 1.5317 | 6 | 35 | nucleotide-excision repair, DNA incision, 5'-to lesion |
GO:0061919 | 0.004 | 1.7314 | 19.4307 | 32 | 444 | process utilizing autophagic mechanism |
GO:0006605 | 0.0041 | 1.8011 | 16.3673 | 28 | 374 | protein targeting |
GO:0006281 | 0.0043 | 1.6795 | 21.8814 | 35 | 500 | DNA repair |
GO:0015980 | 0.0044 | 1.9829 | 11.2033 | 21 | 256 | energy derivation by oxidation of organic compounds |
GO:0033554 | 0.0044 | 1.3563 | 78.5105 | 101 | 1794 | cellular response to stress |
GO:0097193 | 0.0046 | 1.9378 | 11.991 | 22 | 274 | intrinsic apoptotic signaling pathway |
GO:0006457 | 0.0048 | 2.0879 | 9.1464 | 18 | 209 | protein folding |
GO:1902115 | 0.0048 | 2.3451 | 6.3894 | 14 | 146 | regulation of organelle assembly |
GO:0009126 | 0.0052 | 1.8843 | 12.8663 | 23 | 294 | purine nucleoside monophosphate metabolic process |
GO:0050684 | 0.0054 | 2.639 | 4.5076 | 11 | 103 | regulation of mRNA processing |
GO:0030260 | 0.0055 | 2.5 | 5.164 | 12 | 118 | entry into host cell |
GO:0051828 | 0.0055 | 2.5 | 5.164 | 12 | 118 | entry into other organism involved in symbiotic interaction |
GO:0070370 | 0.0056 | 43.8265 | 0.1313 | 2 | 3 | cellular heat acclimation |
GO:0070434 | 0.0056 | 43.8265 | 0.1313 | 2 | 3 | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway |
GO:0071603 | 0.0056 | 43.8265 | 0.1313 | 2 | 3 | endothelial cell-cell adhesion |
GO:1903542 | 0.0056 | 43.8265 | 0.1313 | 2 | 3 | negative regulation of exosomal secretion |
GO:0072594 | 0.0056 | 1.5823 | 27.133 | 41 | 620 | establishment of protein localization to organelle |
GO:0006094 | 0.0058 | 2.961 | 3.326 | 9 | 76 | gluconeogenesis |
GO:0070972 | 0.0059 | 2.4765 | 5.2078 | 12 | 119 | protein localization to endoplasmic reticulum |
GO:0071704 | 0.0059 | 1.3109 | 159.7298 | 184 | 4064 | organic substance metabolic process |
GO:0030073 | 0.006 | 2.0908 | 8.6213 | 17 | 197 | insulin secretion |
GO:0140053 | 0.0063 | 2.3541 | 5.908 | 13 | 135 | mitochondrial gene expression |
GO:0034660 | 0.0063 | 1.609 | 24.0696 | 37 | 550 | ncRNA metabolic process |
GO:0048863 | 0.0067 | 1.9358 | 10.8969 | 20 | 249 | stem cell differentiation |
GO:0033036 | 0.0068 | 1.2788 | 120.0415 | 145 | 2743 | macromolecule localization |
GO:0009199 | 0.007 | 1.8626 | 12.4286 | 22 | 284 | ribonucleoside triphosphate metabolic process |
GO:1901796 | 0.007 | 2.1679 | 7.3522 | 15 | 168 | regulation of signal transduction by p53 class mediator |
GO:0045892 | 0.0075 | 1.4199 | 47.1326 | 64 | 1077 | negative regulation of transcription, DNA-templated |
GO:0009144 | 0.0075 | 1.8482 | 12.5162 | 22 | 286 | purine nucleoside triphosphate metabolic process |
GO:0051223 | 0.0077 | 1.5104 | 31.8156 | 46 | 727 | regulation of protein transport |
GO:0051123 | 0.0078 | 4.5784 | 1.2691 | 5 | 29 | RNA polymerase II transcriptional preinitiation complex assembly |
GO:0070911 | 0.0078 | 4.5784 | 1.2691 | 5 | 29 | global genome nucleotide-excision repair |
GO:0034645 | 0.0079 | 1.2441 | 171.8148 | 199 | 4065 | cellular macromolecule biosynthetic process |
GO:0040015 | 0.0079 | 9.4014 | 0.4376 | 3 | 10 | negative regulation of multicellular organism growth |
GO:0009161 | 0.008 | 1.8094 | 13.3477 | 23 | 305 | ribonucleoside monophosphate metabolic process |
GO:0021697 | 0.0083 | 5.8553 | 0.8315 | 4 | 19 | cerebellar cortex formation |
GO:0090140 | 0.0083 | 5.8553 | 0.8315 | 4 | 19 | regulation of mitochondrial fission |
GO:0022607 | 0.0083 | 1.4636 | 37.9589 | 53 | 931 | cellular component assembly |
GO:0006369 | 0.0086 | 2.9861 | 2.9321 | 8 | 67 | termination of RNA polymerase II transcription |
GO:0000045 | 0.0088 | 2.7545 | 3.5448 | 9 | 81 | autophagosome assembly |
GO:0002790 | 0.0091 | 1.6006 | 22.1878 | 34 | 507 | peptide secretion |
GO:0006461 | 0.0094 | 1.4727 | 34.743 | 49 | 815 | protein complex assembly |
GO:0072665 | 0.0094 | 3.6652 | 1.838 | 6 | 42 | protein localization to vacuole |
GO:0072659 | 0.0096 | 1.9795 | 9.0589 | 17 | 207 | protein localization to plasma membrane |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0003008 | 0 | 1.766 | 49.4777 | 79 | 1810 | system process |
GO:0014897 | 0 | 5.1914 | 2.4055 | 11 | 88 | striated muscle hypertrophy |
GO:1901750 | 0 | 35.91 | 0.2187 | 4 | 8 | leukotriene D4 biosynthetic process |
GO:0006751 | 1e-04 | 28.7261 | 0.246 | 4 | 9 | glutathione catabolic process |
GO:0015721 | 1e-04 | 10.2973 | 0.7381 | 6 | 27 | bile acid and bile salt transport |
GO:0010596 | 1e-04 | 6.4276 | 1.4488 | 8 | 53 | negative regulation of endothelial cell migration |
GO:0044259 | 1e-04 | 4.1159 | 3.2256 | 12 | 118 | multicellular organismal macromolecule metabolic process |
GO:0006691 | 1e-04 | 9.4006 | 0.7927 | 6 | 29 | leukotriene metabolic process |
GO:0010632 | 2e-04 | 3.1799 | 5.1118 | 15 | 187 | regulation of epithelial cell migration |
GO:0007186 | 2e-04 | 1.7874 | 31.3267 | 52 | 1146 | G-protein coupled receptor signaling pathway |
GO:0006936 | 2e-04 | 2.5421 | 8.8568 | 21 | 324 | muscle contraction |
GO:0030198 | 3e-04 | 2.5707 | 8.3374 | 20 | 305 | extracellular matrix organization |
GO:0030574 | 3e-04 | 5.2555 | 1.7222 | 8 | 63 | collagen catabolic process |
GO:0034308 | 4e-04 | 5.8725 | 1.3668 | 7 | 50 | primary alcohol metabolic process |
GO:0043535 | 6e-04 | 4.66 | 1.9135 | 8 | 70 | regulation of blood vessel endothelial cell migration |
GO:1900747 | 7e-04 | 26.8688 | 0.1914 | 3 | 7 | negative regulation of vascular endothelial growth factor signaling pathway |
GO:0001667 | 7e-04 | 2.383 | 8.9388 | 20 | 327 | ameboidal-type cell migration |
GO:0002644 | 7e-04 | Inf | 0.0547 | 2 | 2 | negative regulation of tolerance induction |
GO:0061766 | 7e-04 | Inf | 0.0547 | 2 | 2 | positive regulation of lung blood pressure |
GO:1902340 | 7e-04 | Inf | 0.0547 | 2 | 2 | negative regulation of chromosome condensation |
GO:1902547 | 8e-04 | 11.9637 | 0.4374 | 4 | 16 | regulation of cellular response to vascular endothelial growth factor stimulus |
GO:0001525 | 8e-04 | 2.1583 | 11.809 | 24 | 432 | angiogenesis |
GO:0006776 | 0.001 | 21.4936 | 0.2187 | 3 | 8 | vitamin A metabolic process |
GO:0046456 | 0.001 | 5.8382 | 1.1754 | 6 | 43 | icosanoid biosynthetic process |
GO:0072358 | 0.0012 | 1.9075 | 17.2215 | 31 | 630 | cardiovascular system development |
GO:0014898 | 0.0012 | 7.1891 | 0.8201 | 5 | 30 | cardiac muscle hypertrophy in response to stress |
GO:0003301 | 0.0014 | 6.9121 | 0.8474 | 5 | 31 | physiological cardiac muscle hypertrophy |
GO:0055001 | 0.0015 | 2.9397 | 4.3737 | 12 | 160 | muscle cell development |
GO:0042574 | 0.0015 | 17.9102 | 0.246 | 3 | 9 | retinal metabolic process |
GO:0045603 | 0.0015 | 9.569 | 0.5194 | 4 | 19 | positive regulation of endothelial cell differentiation |
GO:0035023 | 0.0016 | 3.3189 | 3.253 | 10 | 119 | regulation of Rho protein signal transduction |
GO:0046942 | 0.0017 | 2.3724 | 7.5993 | 17 | 278 | carboxylic acid transport |
GO:0009888 | 0.0017 | 1.517 | 48.7123 | 69 | 1782 | tissue development |
GO:0014888 | 0.0021 | 5.0216 | 1.3395 | 6 | 49 | striated muscle adaptation |
GO:0055013 | 0.0021 | 4.2754 | 1.8042 | 7 | 66 | cardiac muscle cell development |
GO:0006068 | 0.0021 | 15.3506 | 0.2734 | 3 | 10 | ethanol catabolic process |
GO:0001501 | 0.0022 | 1.997 | 12.6838 | 24 | 464 | skeletal system development |
GO:0019344 | 0.0022 | 71.4953 | 0.082 | 2 | 3 | cysteine biosynthetic process |
GO:0019448 | 0.0022 | 71.4953 | 0.082 | 2 | 3 | L-cysteine catabolic process |
GO:0031509 | 0.0022 | 71.4953 | 0.082 | 2 | 3 | telomeric heterochromatin assembly |
GO:0035879 | 0.0022 | 71.4953 | 0.082 | 2 | 3 | plasma membrane lactate transport |
GO:0038129 | 0.0022 | 71.4953 | 0.082 | 2 | 3 | ERBB3 signaling pathway |
GO:0060278 | 0.0022 | 71.4953 | 0.082 | 2 | 3 | regulation of ovulation |
GO:1905180 | 0.0022 | 71.4953 | 0.082 | 2 | 3 | positive regulation of cardiac muscle tissue regeneration |
GO:1905209 | 0.0025 | 5.9889 | 0.9568 | 5 | 35 | positive regulation of cardiocyte differentiation |
GO:0090132 | 0.0028 | 2.4006 | 6.6152 | 15 | 242 | epithelium migration |
GO:0001867 | 0.0028 | 13.4309 | 0.3007 | 3 | 11 | complement activation, lectin pathway |
GO:1904018 | 0.0029 | 2.8433 | 4.1277 | 11 | 151 | positive regulation of vasculature development |
GO:0006820 | 0.0034 | 1.8707 | 14.6246 | 26 | 535 | anion transport |
GO:1903670 | 0.0034 | 4.497 | 1.4761 | 6 | 54 | regulation of sprouting angiogenesis |
GO:0001568 | 0.0038 | 1.8104 | 16.2648 | 28 | 595 | blood vessel development |
GO:0031508 | 0.0043 | 35.7453 | 0.1093 | 2 | 4 | pericentric heterochromatin assembly |
GO:0030819 | 0.0044 | 3.7074 | 2.0502 | 7 | 75 | positive regulation of cAMP biosynthetic process |
GO:0010614 | 0.0044 | 6.8323 | 0.6834 | 4 | 25 | negative regulation of cardiac muscle hypertrophy |
GO:0051241 | 0.0047 | 1.5959 | 27.7279 | 42 | 1019 | negative regulation of multicellular organismal process |
GO:0061051 | 0.0047 | 10.7433 | 0.3554 | 3 | 13 | positive regulation of cell growth involved in cardiac muscle cell development |
GO:0006814 | 0.0052 | 2.3905 | 5.7405 | 13 | 210 | sodium ion transport |
GO:0007517 | 0.0059 | 1.9926 | 10.0049 | 19 | 366 | muscle organ development |
GO:0070207 | 0.0059 | 6.2374 | 0.7381 | 4 | 27 | protein homotrimerization |
GO:0006942 | 0.0062 | 3.4523 | 2.1869 | 7 | 80 | regulation of striated muscle contraction |
GO:0007586 | 0.0062 | 2.6952 | 3.9363 | 10 | 144 | digestion |
GO:0008015 | 0.0063 | 1.8484 | 13.0391 | 23 | 477 | blood circulation |
GO:0030336 | 0.0066 | 2.2351 | 6.5879 | 14 | 241 | negative regulation of cell migration |
GO:0010862 | 0.0067 | 4.6041 | 1.2028 | 5 | 44 | positive regulation of pathway-restricted SMAD protein phosphorylation |
GO:0000320 | 0.0071 | 23.8286 | 0.1367 | 2 | 5 | re-entry into mitotic cell cycle |
GO:0060426 | 0.0071 | 23.8286 | 0.1367 | 2 | 5 | lung vasculature development |
GO:1903589 | 0.0071 | 23.8286 | 0.1367 | 2 | 5 | positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis |
GO:0019730 | 0.0071 | 3.3598 | 2.2415 | 7 | 82 | antimicrobial humoral response |
GO:0052652 | 0.0072 | 2.6356 | 4.0184 | 10 | 147 | cyclic purine nucleotide metabolic process |
GO:0035988 | 0.0072 | 8.9515 | 0.41 | 3 | 15 | chondrocyte proliferation |
GO:0051271 | 0.0073 | 2.1415 | 7.3533 | 15 | 269 | negative regulation of cellular component movement |
GO:0046661 | 0.0082 | 2.5786 | 4.1004 | 10 | 150 | male sex differentiation |
GO:0016049 | 0.0085 | 1.8215 | 12.6291 | 22 | 462 | cell growth |
GO:0051155 | 0.0085 | 3.6559 | 1.7768 | 6 | 65 | positive regulation of striated muscle cell differentiation |
GO:0015850 | 0.0087 | 2.4256 | 4.7786 | 11 | 177 | organic hydroxy compound transport |
GO:0090051 | 0.0087 | 8.2624 | 0.4374 | 3 | 16 | negative regulation of cell migration involved in sprouting angiogenesis |
GO:0090280 | 0.0087 | 8.2624 | 0.4374 | 3 | 16 | positive regulation of calcium ion import |
GO:0008584 | 0.009 | 2.7047 | 3.5263 | 9 | 129 | male gonad development |
GO:0048738 | 0.009 | 2.308 | 5.4671 | 12 | 200 | cardiac muscle tissue development |
GO:0030856 | 0.0094 | 2.6821 | 3.5536 | 9 | 130 | regulation of epithelial cell differentiation |
GO:0006812 | 0.0095 | 1.5307 | 28.0738 | 41 | 1027 | cation transport |
GO:0001936 | 0.0095 | 2.8819 | 2.9523 | 8 | 108 | regulation of endothelial cell proliferation |
GO:0048762 | 0.0099 | 2.3794 | 4.8658 | 11 | 178 | mesenchymal cell differentiation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007155 | 0 | 1.8926 | 34.658 | 60 | 1259 | cell adhesion |
GO:2000145 | 0 | 2.1626 | 20.5636 | 41 | 747 | regulation of cell motility |
GO:2000026 | 3e-04 | 1.6262 | 48.725 | 73 | 1770 | regulation of multicellular organismal development |
GO:0030574 | 3e-04 | 5.217 | 1.7343 | 8 | 63 | collagen catabolic process |
GO:0044259 | 4e-04 | 3.7009 | 3.2483 | 11 | 118 | multicellular organismal macromolecule metabolic process |
GO:0001501 | 5e-04 | 2.1678 | 12.7731 | 26 | 464 | skeletal system development |
GO:0006959 | 6e-04 | 2.9736 | 5.0652 | 14 | 184 | humoral immune response |
GO:0001869 | 8e-04 | Inf | 0.0551 | 2 | 2 | negative regulation of complement activation, lectin pathway |
GO:0061766 | 8e-04 | Inf | 0.0551 | 2 | 2 | positive regulation of lung blood pressure |
GO:1902340 | 8e-04 | Inf | 0.0551 | 2 | 2 | negative regulation of chromosome condensation |
GO:0010827 | 9e-04 | 4.4115 | 2.0096 | 8 | 73 | regulation of glucose transport |
GO:0046326 | 0.001 | 5.9571 | 1.1562 | 6 | 42 | positive regulation of glucose import |
GO:1902548 | 0.001 | 21.338 | 0.2202 | 3 | 8 | negative regulation of cellular response to vascular endothelial growth factor stimulus |
GO:0030336 | 0.0011 | 2.5707 | 6.6343 | 16 | 241 | negative regulation of cell migration |
GO:0032501 | 0.0011 | 1.384 | 149.3494 | 179 | 5664 | multicellular organismal process |
GO:0032879 | 0.0011 | 1.4722 | 67.0037 | 91 | 2434 | regulation of localization |
GO:0001822 | 0.0012 | 2.5477 | 6.6894 | 16 | 243 | kidney development |
GO:0051241 | 0.0012 | 1.7025 | 28.1063 | 45 | 1021 | negative regulation of multicellular organismal process |
GO:0051674 | 0.0012 | 1.6096 | 37.1356 | 56 | 1349 | localization of cell |
GO:0051271 | 0.0013 | 2.4402 | 7.4051 | 17 | 269 | negative regulation of cellular component movement |
GO:0003301 | 0.0015 | 6.8618 | 0.8534 | 5 | 31 | physiological cardiac muscle hypertrophy |
GO:0030198 | 0.0016 | 2.7668 | 5.0153 | 13 | 186 | extracellular matrix organization |
GO:0008645 | 0.0018 | 3.2643 | 3.3034 | 10 | 120 | hexose transport |
GO:0007165 | 0.0019 | 1.3454 | 146.1792 | 175 | 5334 | signal transduction |
GO:0010632 | 0.0021 | 2.6906 | 5.1478 | 13 | 187 | regulation of epithelial cell migration |
GO:0040013 | 0.0021 | 2.3274 | 7.7354 | 17 | 281 | negative regulation of locomotion |
GO:0009888 | 0.0021 | 1.504 | 49.0553 | 69 | 1782 | tissue development |
GO:0022617 | 0.0022 | 3.7702 | 2.3124 | 8 | 84 | extracellular matrix disassembly |
GO:0031509 | 0.0022 | 70.9789 | 0.0826 | 2 | 3 | telomeric heterochromatin assembly |
GO:0035879 | 0.0022 | 70.9789 | 0.0826 | 2 | 3 | plasma membrane lactate transport |
GO:0038183 | 0.0022 | 70.9789 | 0.0826 | 2 | 3 | bile acid signaling pathway |
GO:0048014 | 0.0022 | 70.9789 | 0.0826 | 2 | 3 | Tie signaling pathway |
GO:0050915 | 0.0022 | 70.9789 | 0.0826 | 2 | 3 | sensory perception of sour taste |
GO:0061368 | 0.0022 | 70.9789 | 0.0826 | 2 | 3 | behavioral response to formalin induced pain |
GO:1905180 | 0.0022 | 70.9789 | 0.0826 | 2 | 3 | positive regulation of cardiac muscle tissue regeneration |
GO:0043542 | 0.0024 | 2.7668 | 4.6247 | 12 | 168 | endothelial cell migration |
GO:0051056 | 0.0029 | 2.2493 | 7.9832 | 17 | 290 | regulation of small GTPase mediated signal transduction |
GO:0046415 | 0.0029 | 13.3336 | 0.3028 | 3 | 11 | urate metabolic process |
GO:1901678 | 0.0029 | 13.3336 | 0.3028 | 3 | 11 | iron coordination entity transport |
GO:0043535 | 0.0031 | 3.9737 | 1.927 | 7 | 70 | regulation of blood vessel endothelial cell migration |
GO:0001655 | 0.0032 | 2.2244 | 8.0658 | 17 | 293 | urogenital system development |
GO:0030199 | 0.0033 | 5.573 | 1.0185 | 5 | 37 | collagen fibril organization |
GO:0045765 | 0.0036 | 2.3306 | 6.7995 | 15 | 247 | regulation of angiogenesis |
GO:0002576 | 0.0042 | 3.0714 | 3.1382 | 9 | 114 | platelet degranulation |
GO:0051924 | 0.0043 | 2.4483 | 5.6158 | 13 | 204 | regulation of calcium ion transport |
GO:0010958 | 0.0044 | 35.4871 | 0.1101 | 2 | 4 | regulation of amino acid import |
GO:0015842 | 0.0044 | 35.4871 | 0.1101 | 2 | 4 | aminergic neurotransmitter loading into synaptic vesicle |
GO:0031508 | 0.0044 | 35.4871 | 0.1101 | 2 | 4 | pericentric heterochromatin assembly |
GO:0042904 | 0.0044 | 35.4871 | 0.1101 | 2 | 4 | 9-cis-retinoic acid biosynthetic process |
GO:0070173 | 0.0044 | 35.4871 | 0.1101 | 2 | 4 | regulation of enamel mineralization |
GO:0061051 | 0.0048 | 10.6655 | 0.3579 | 3 | 13 | positive regulation of cell growth involved in cardiac muscle cell development |
GO:0001938 | 0.0049 | 3.6267 | 2.0921 | 7 | 76 | positive regulation of endothelial cell proliferation |
GO:0050777 | 0.005 | 2.9855 | 3.2208 | 9 | 117 | negative regulation of immune response |
GO:0001578 | 0.0052 | 3.5746 | 2.1197 | 7 | 77 | microtubule bundle formation |
GO:0090287 | 0.0057 | 2.2796 | 6.4691 | 14 | 235 | regulation of cellular response to growth factor stimulus |
GO:0007342 | 0.006 | 9.6953 | 0.3854 | 3 | 14 | fusion of sperm to egg plasma membrane involved in single fertilization |
GO:0034433 | 0.006 | 9.6953 | 0.3854 | 3 | 14 | steroid esterification |
GO:0034435 | 0.006 | 9.6953 | 0.3854 | 3 | 14 | cholesterol esterification |
GO:0015721 | 0.006 | 6.1921 | 0.7433 | 4 | 27 | bile acid and bile salt transport |
GO:0043114 | 0.006 | 6.1921 | 0.7433 | 4 | 27 | regulation of vascular permeability |
GO:0032502 | 0.0067 | 1.2869 | 155.0115 | 180 | 5631 | developmental process |
GO:1903427 | 0.0069 | 5.9337 | 0.7708 | 4 | 28 | negative regulation of reactive oxygen species biosynthetic process |
GO:0023051 | 0.0069 | 1.3359 | 87.76 | 109 | 3188 | regulation of signaling |
GO:0010862 | 0.0069 | 4.5706 | 1.2112 | 5 | 44 | positive regulation of pathway-restricted SMAD protein phosphorylation |
GO:0000320 | 0.0072 | 23.6565 | 0.1376 | 2 | 5 | re-entry into mitotic cell cycle |
GO:0051122 | 0.0072 | 23.6565 | 0.1376 | 2 | 5 | hepoxilin biosynthetic process |
GO:1903789 | 0.0072 | 23.6565 | 0.1376 | 2 | 5 | regulation of amino acid transmembrane transport |
GO:0009612 | 0.0073 | 2.3807 | 5.3129 | 12 | 193 | response to mechanical stimulus |
GO:0090132 | 0.0073 | 2.2086 | 6.6618 | 14 | 242 | epithelium migration |
GO:0006837 | 0.0074 | 8.8867 | 0.4129 | 3 | 15 | serotonin transport |
GO:1900746 | 0.0074 | 8.8867 | 0.4129 | 3 | 15 | regulation of vascular endothelial growth factor signaling pathway |
GO:0008643 | 0.0075 | 2.6162 | 4.0467 | 10 | 147 | carbohydrate transport |
GO:0009593 | 0.0077 | 1.9376 | 10.268 | 19 | 373 | detection of chemical stimulus |
GO:0014068 | 0.0082 | 3.6921 | 1.7618 | 6 | 64 | positive regulation of phosphatidylinositol 3-kinase signaling |
GO:0044273 | 0.0084 | 4.3471 | 1.2663 | 5 | 46 | sulfur compound catabolic process |
GO:0046426 | 0.0084 | 4.3471 | 1.2663 | 5 | 46 | negative regulation of JAK-STAT cascade |
GO:0048514 | 0.0084 | 1.7735 | 14.1495 | 24 | 514 | blood vessel morphogenesis |
GO:0046661 | 0.0086 | 2.5597 | 4.1292 | 10 | 150 | male sex differentiation |
GO:0070286 | 0.0088 | 5.4766 | 0.8258 | 4 | 30 | axonemal dynein complex assembly |
GO:0007597 | 0.0089 | 8.2026 | 0.4405 | 3 | 16 | blood coagulation, intrinsic pathway |
GO:0090280 | 0.0089 | 8.2026 | 0.4405 | 3 | 16 | positive regulation of calcium ion import |
GO:0008584 | 0.0094 | 2.6848 | 3.5511 | 9 | 129 | male gonad development |
GO:0055013 | 0.0095 | 3.5686 | 1.8169 | 6 | 66 | cardiac muscle cell development |
GO:0097696 | 0.0098 | 2.5055 | 4.2118 | 10 | 153 | STAT cascade |
GO:1903825 | 0.0099 | 2.8608 | 2.973 | 8 | 108 | organic acid transmembrane transport |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0045653 | 0 | 146.9951 | 0.5378 | 14 | 17 | negative regulation of megakaryocyte differentiation |
GO:0000183 | 0 | 21.4944 | 1.1705 | 15 | 37 | chromatin silencing at rDNA |
GO:0006335 | 0 | 25.9162 | 0.9807 | 14 | 31 | DNA replication-dependent nucleosome assembly |
GO:0051290 | 0 | 16.8817 | 1.3603 | 15 | 43 | protein heterotetramerization |
GO:0034080 | 0 | 15.7234 | 1.3287 | 14 | 42 | CENP-A containing nucleosome assembly |
GO:1904837 | 0 | 15.7234 | 1.3287 | 14 | 42 | beta-catenin-TCF complex assembly |
GO:0016233 | 0 | 12.2228 | 1.5818 | 14 | 50 | telomere capping |
GO:0034724 | 0 | 11.2803 | 1.6767 | 14 | 53 | DNA replication-independent nucleosome organization |
GO:0008544 | 0 | 3.4717 | 10.7065 | 33 | 346 | epidermis development |
GO:0045815 | 0 | 7.4856 | 2.4675 | 15 | 78 | positive regulation of gene expression, epigenetic |
GO:0006303 | 0 | 7.9903 | 2.1828 | 14 | 69 | double-strand break repair via nonhomologous end joining |
GO:0070268 | 0 | 6.0889 | 3.3217 | 17 | 105 | cornification |
GO:0043044 | 0 | 7.0849 | 2.4043 | 14 | 76 | ATP-dependent chromatin remodeling |
GO:0045682 | 0 | 6.9003 | 2.2777 | 13 | 72 | regulation of epidermis development |
GO:0030216 | 0 | 3.6581 | 7.3435 | 24 | 234 | keratinocyte differentiation |
GO:0045814 | 0 | 4.6973 | 3.8911 | 16 | 123 | negative regulation of gene expression, epigenetic |
GO:0002244 | 0 | 3.825 | 5.8525 | 20 | 185 | hematopoietic progenitor cell differentiation |
GO:0060964 | 0 | 5.1599 | 3.1319 | 14 | 99 | regulation of gene silencing by miRNA |
GO:1903707 | 0 | 4.4461 | 4.0809 | 16 | 129 | negative regulation of hemopoiesis |
GO:1902036 | 0 | 4.983 | 3.2268 | 14 | 102 | regulation of hematopoietic stem cell differentiation |
GO:0048869 | 0 | 1.536 | 122.9969 | 165 | 3888 | cellular developmental process |
GO:0048731 | 0 | 1.5047 | 135.9673 | 178 | 4298 | system development |
GO:0060968 | 0 | 4.093 | 3.8278 | 14 | 121 | regulation of gene silencing |
GO:0032200 | 0 | 3.4817 | 5.0616 | 16 | 160 | telomere organization |
GO:0007155 | 1e-04 | 1.7348 | 39.8285 | 64 | 1259 | cell adhesion |
GO:0008284 | 1e-04 | 1.9009 | 25.9723 | 46 | 821 | positive regulation of cell proliferation |
GO:0045637 | 1e-04 | 2.8405 | 7.2444 | 19 | 229 | regulation of myeloid cell differentiation |
GO:0042634 | 1e-04 | 9.284 | 0.8225 | 6 | 26 | regulation of hair cycle |
GO:0034329 | 1e-04 | 3.0093 | 6.1372 | 17 | 194 | cell junction assembly |
GO:0061572 | 2e-04 | 3.5899 | 3.986 | 13 | 126 | actin filament bundle organization |
GO:0030856 | 2e-04 | 3.4662 | 4.1126 | 13 | 130 | regulation of epithelial cell differentiation |
GO:0048534 | 3e-04 | 1.8454 | 26.0672 | 45 | 824 | hematopoietic or lymphoid organ development |
GO:0031581 | 3e-04 | 17.6266 | 0.348 | 4 | 11 | hemidesmosome assembly |
GO:0031497 | 3e-04 | 3.1903 | 4.7769 | 14 | 151 | chromatin assembly |
GO:1903035 | 4e-04 | 4.5075 | 2.2461 | 9 | 71 | negative regulation of response to wounding |
GO:0008219 | 5e-04 | 1.5213 | 62.4475 | 88 | 1974 | cell death |
GO:0030855 | 5e-04 | 1.9854 | 17.1451 | 32 | 552 | epithelial cell differentiation |
GO:0008542 | 6e-04 | 5.5589 | 1.4552 | 7 | 46 | visual learning |
GO:0030038 | 8e-04 | 4.0483 | 2.4675 | 9 | 78 | contractile actin filament bundle assembly |
GO:0006952 | 8e-04 | 1.5893 | 42.992 | 64 | 1359 | defense response |
GO:0032231 | 9e-04 | 3.9902 | 2.4992 | 9 | 79 | regulation of actin filament bundle assembly |
GO:0007266 | 9e-04 | 2.8536 | 5.283 | 14 | 167 | Rho protein signal transduction |
GO:0035194 | 9e-04 | 2.3387 | 9.1109 | 20 | 288 | posttranscriptional gene silencing by RNA |
GO:0097325 | 0.001 | Inf | 0.0633 | 2 | 2 | melanocyte proliferation |
GO:0051895 | 0.001 | 11.214 | 0.4745 | 4 | 15 | negative regulation of focal adhesion assembly |
GO:0032102 | 0.0012 | 2.3956 | 8.0037 | 18 | 253 | negative regulation of response to external stimulus |
GO:0002682 | 0.0015 | 1.5685 | 40.651 | 60 | 1285 | regulation of immune system process |
GO:0030195 | 0.0015 | 5.4561 | 1.2654 | 6 | 40 | negative regulation of blood coagulation |
GO:0010951 | 0.0015 | 2.4849 | 6.8648 | 16 | 217 | negative regulation of endopeptidase activity |
GO:0031032 | 0.0016 | 3.6227 | 2.7209 | 9 | 87 | actomyosin structure organization |
GO:0010631 | 0.0016 | 2.3921 | 7.5608 | 17 | 239 | epithelial cell migration |
GO:0051094 | 0.0016 | 1.5909 | 36.665 | 55 | 1159 | positive regulation of developmental process |
GO:0071711 | 0.0017 | 9.4875 | 0.5378 | 4 | 17 | basement membrane organization |
GO:2000738 | 0.0017 | 9.4875 | 0.5378 | 4 | 17 | positive regulation of stem cell differentiation |
GO:0051346 | 0.0018 | 2.0671 | 11.7682 | 23 | 372 | negative regulation of hydrolase activity |
GO:0042303 | 0.0018 | 3.2682 | 3.3217 | 10 | 105 | molting cycle |
GO:0017148 | 0.0018 | 2.0611 | 11.7999 | 23 | 373 | negative regulation of translation |
GO:0050891 | 0.0018 | 4.4215 | 1.7716 | 7 | 56 | multicellular organismal water homeostasis |
GO:0060249 | 0.0019 | 2.0958 | 11.1039 | 22 | 351 | anatomical structure homeostasis |
GO:0051716 | 0.0019 | 1.3091 | 207.2093 | 239 | 6550 | cellular response to stimulus |
GO:0008354 | 0.0023 | 15.3929 | 0.2847 | 3 | 9 | germ cell migration |
GO:0019755 | 0.0023 | 15.3929 | 0.2847 | 3 | 9 | one-carbon compound transport |
GO:0090331 | 0.0023 | 15.3929 | 0.2847 | 3 | 9 | negative regulation of platelet aggregation |
GO:0090130 | 0.0024 | 2.2975 | 7.8455 | 17 | 248 | tissue migration |
GO:0042445 | 0.0025 | 2.6269 | 5.283 | 13 | 167 | hormone metabolic process |
GO:0050727 | 0.0026 | 2.1676 | 9.2691 | 19 | 293 | regulation of inflammatory response |
GO:1905331 | 0.0026 | 8.2214 | 0.6011 | 4 | 19 | negative regulation of morphogenesis of an epithelium |
GO:0110020 | 0.0027 | 3.6441 | 2.4043 | 8 | 76 | regulation of actomyosin structure organization |
GO:0009653 | 0.0027 | 1.4009 | 74.1208 | 97 | 2343 | anatomical structure morphogenesis |
GO:0051239 | 0.0029 | 1.6568 | 26.2195 | 41 | 881 | regulation of multicellular organismal process |
GO:0002581 | 0.0029 | 61.4664 | 0.0949 | 2 | 3 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II |
GO:0010710 | 0.0029 | 61.4664 | 0.0949 | 2 | 3 | regulation of collagen catabolic process |
GO:0051799 | 0.0029 | 61.4664 | 0.0949 | 2 | 3 | negative regulation of hair follicle development |
GO:0071918 | 0.0029 | 61.4664 | 0.0949 | 2 | 3 | urea transmembrane transport |
GO:0061041 | 0.0031 | 2.8235 | 4.1758 | 11 | 132 | regulation of wound healing |
GO:0045606 | 0.0032 | 7.7071 | 0.6327 | 4 | 20 | positive regulation of epidermal cell differentiation |
GO:0048518 | 0.0034 | 1.3339 | 121.1218 | 147 | 3989 | positive regulation of biological process |
GO:0051497 | 0.0039 | 7.2532 | 0.6643 | 4 | 21 | negative regulation of stress fiber assembly |
GO:0030029 | 0.004 | 1.7148 | 20.2148 | 33 | 639 | actin filament-based process |
GO:0045616 | 0.004 | 5.3215 | 1.0756 | 5 | 34 | regulation of keratinocyte differentiation |
GO:0045216 | 0.0042 | 2.29 | 6.9281 | 15 | 219 | cell-cell junction organization |
GO:0015791 | 0.0043 | 11.5431 | 0.348 | 3 | 11 | polyol transport |
GO:0051917 | 0.0043 | 11.5431 | 0.348 | 3 | 11 | regulation of fibrinolysis |
GO:1901678 | 0.0043 | 11.5431 | 0.348 | 3 | 11 | iron coordination entity transport |
GO:0051259 | 0.0045 | 1.8064 | 15.691 | 27 | 496 | protein oligomerization |
GO:0030198 | 0.0045 | 2.096 | 9.0468 | 18 | 288 | extracellular matrix organization |
GO:1905517 | 0.0046 | 5.1438 | 1.1072 | 5 | 35 | macrophage migration |
GO:0090109 | 0.0047 | 4.2133 | 1.5818 | 6 | 50 | regulation of cell-substrate junction assembly |
GO:0007188 | 0.0052 | 2.6264 | 4.4605 | 11 | 141 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway |
GO:0034110 | 0.0054 | 6.4889 | 0.7276 | 4 | 23 | regulation of homotypic cell-cell adhesion |
GO:0051798 | 0.0056 | 10.2599 | 0.3796 | 3 | 12 | positive regulation of hair follicle development |
GO:0010046 | 0.0057 | 30.7312 | 0.1265 | 2 | 4 | response to mycotoxin |
GO:0016554 | 0.0057 | 30.7312 | 0.1265 | 2 | 4 | cytidine to uridine editing |
GO:0051884 | 0.0057 | 30.7312 | 0.1265 | 2 | 4 | regulation of timing of anagen |
GO:0070294 | 0.0057 | 30.7312 | 0.1265 | 2 | 4 | renal sodium ion absorption |
GO:1905867 | 0.0057 | 30.7312 | 0.1265 | 2 | 4 | epididymis development |
GO:0043588 | 0.0058 | 2.918 | 3.3022 | 9 | 109 | skin development |
GO:0007045 | 0.006 | 3.4914 | 2.1828 | 7 | 69 | cell-substrate adherens junction assembly |
GO:0097435 | 0.0063 | 1.7356 | 16.8931 | 28 | 534 | supramolecular fiber organization |
GO:1903391 | 0.0063 | 3.9436 | 1.6767 | 6 | 53 | regulation of adherens junction organization |
GO:0042044 | 0.0064 | 6.164 | 0.7592 | 4 | 24 | fluid transport |
GO:0048863 | 0.0067 | 2.1672 | 7.2877 | 15 | 232 | stem cell differentiation |
GO:0006352 | 0.0068 | 2.1611 | 7.3077 | 15 | 231 | DNA-templated transcription, initiation |
GO:0008595 | 0.0071 | 9.2333 | 0.4113 | 3 | 13 | anterior/posterior axis specification, embryo |
GO:0034248 | 0.0072 | 1.6844 | 18.633 | 30 | 589 | regulation of cellular amide metabolic process |
GO:0060706 | 0.0074 | 5.8701 | 0.7909 | 4 | 25 | cell differentiation involved in embryonic placenta development |
GO:0045596 | 0.0075 | 1.6638 | 19.4872 | 31 | 616 | negative regulation of cell differentiation |
GO:0010595 | 0.0076 | 3.3296 | 2.2777 | 7 | 72 | positive regulation of endothelial cell migration |
GO:2000026 | 0.008 | 1.4071 | 50.9383 | 68 | 1640 | regulation of multicellular organismal development |
GO:0030335 | 0.008 | 1.833 | 12.5591 | 22 | 397 | positive regulation of cell migration |
GO:0030799 | 0.0082 | 2.4549 | 4.7453 | 11 | 150 | regulation of cyclic nucleotide metabolic process |
GO:0010812 | 0.0083 | 3.7062 | 1.7716 | 6 | 56 | negative regulation of cell-substrate adhesion |
GO:0042554 | 0.0085 | 5.6029 | 0.8225 | 4 | 26 | superoxide anion generation |
GO:0065009 | 0.0086 | 1.306 | 96.4235 | 118 | 3048 | regulation of molecular function |
GO:0051272 | 0.0087 | 1.7927 | 13.4132 | 23 | 424 | positive regulation of cellular component movement |
GO:0009415 | 0.0088 | 8.3933 | 0.4429 | 3 | 14 | response to water |
GO:0060326 | 0.0089 | 2.0922 | 7.5291 | 15 | 238 | cell chemotaxis |
GO:0016485 | 0.009 | 2.1543 | 6.8332 | 14 | 216 | protein processing |
GO:0045766 | 0.0092 | 2.5403 | 4.1758 | 10 | 132 | positive regulation of angiogenesis |
GO:0022409 | 0.0092 | 2.0828 | 7.5608 | 15 | 239 | positive regulation of cell-cell adhesion |
GO:0009952 | 0.0092 | 2.2186 | 6.1688 | 13 | 195 | anterior/posterior pattern specification |
GO:0010641 | 0.0094 | 20.4861 | 0.1582 | 2 | 5 | positive regulation of platelet-derived growth factor receptor signaling pathway |
GO:0032914 | 0.0094 | 20.4861 | 0.1582 | 2 | 5 | positive regulation of transforming growth factor beta1 production |
GO:1901668 | 0.0094 | 20.4861 | 0.1582 | 2 | 5 | regulation of superoxide dismutase activity |
GO:2001286 | 0.0094 | 20.4861 | 0.1582 | 2 | 5 | regulation of caveolin-mediated endocytosis |
GO:1900046 | 0.0095 | 3.1821 | 2.3726 | 7 | 75 | regulation of hemostasis |
GO:0050730 | 0.0097 | 2.1329 | 6.8964 | 14 | 218 | regulation of peptidyl-tyrosine phosphorylation |
GO:0010837 | 0.0097 | 5.3589 | 0.8541 | 4 | 27 | regulation of keratinocyte proliferation |
GO:0019229 | 0.0098 | 3.5632 | 1.8348 | 6 | 58 | regulation of vasoconstriction |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 41.4405 | 7.919 | 131 | 301 | detection of chemical stimulus involved in sensory perception of smell |
GO:0007606 | 0 | 28.4937 | 10.3131 | 135 | 392 | sensory perception of chemical stimulus |
GO:0050906 | 0 | 28.749 | 10.1553 | 134 | 386 | detection of stimulus involved in sensory perception |
GO:0009593 | 0 | 29.4211 | 9.8133 | 132 | 373 | detection of chemical stimulus |
GO:0050877 | 0 | 8.1757 | 29.4135 | 147 | 1118 | nervous system process |
GO:0007186 | 0 | 8.0918 | 29.228 | 145 | 1126 | G-protein coupled receptor signaling pathway |
GO:0031424 | 0 | 9.6167 | 2.5004 | 19 | 97 | keratinization |
GO:0009913 | 0 | 4.4868 | 8.2347 | 32 | 313 | epidermal cell differentiation |
GO:0032501 | 0 | 1.8766 | 160.1573 | 218 | 6483 | multicellular organismal process |
GO:0007154 | 0 | 1.7702 | 153.2238 | 209 | 5824 | cell communication |
GO:0023052 | 0 | 1.7609 | 152.7766 | 208 | 5807 | signaling |
GO:0043588 | 0 | 3.5053 | 9.9185 | 31 | 377 | skin development |
GO:0016441 | 0 | 3.6674 | 7.6033 | 25 | 289 | posttranscriptional gene silencing |
GO:0031047 | 0 | 3.3803 | 8.1821 | 25 | 311 | gene silencing by RNA |
GO:0098664 | 0 | 16.082 | 0.5262 | 6 | 20 | G-protein coupled serotonin receptor signaling pathway |
GO:0035278 | 0 | 7.5456 | 1.4207 | 9 | 54 | miRNA mediated inhibition of translation |
GO:0045974 | 0 | 7.5456 | 1.4207 | 9 | 54 | regulation of translation, ncRNA-mediated |
GO:0034249 | 0 | 2.7783 | 10.1816 | 26 | 387 | negative regulation of cellular amide metabolic process |
GO:0070268 | 1e-04 | 4.4228 | 2.7624 | 11 | 105 | cornification |
GO:0051716 | 1e-04 | 1.4484 | 172.3242 | 209 | 6550 | cellular response to stimulus |
GO:0015671 | 2e-04 | 18.6773 | 0.3157 | 4 | 12 | oxygen transport |
GO:0050896 | 2e-04 | 1.9008 | 28.2343 | 47 | 1269 | response to stimulus |
GO:0035195 | 3e-04 | 2.9242 | 5.8872 | 16 | 228 | gene silencing by miRNA |
GO:0018149 | 4e-04 | 5.8397 | 1.3681 | 7 | 52 | peptide cross-linking |
GO:0048007 | 6e-04 | 27.9545 | 0.1842 | 3 | 7 | antigen processing and presentation, exogenous lipid antigen via MHC class Ib |
GO:0070269 | 6e-04 | 27.9545 | 0.1842 | 3 | 7 | pyroptosis |
GO:0060046 | 9e-04 | 11.49 | 0.4473 | 4 | 17 | regulation of acrosome reaction |
GO:0048245 | 9e-04 | 22.3622 | 0.2105 | 3 | 8 | eosinophil chemotaxis |
GO:0033141 | 0.0013 | 18.6339 | 0.2368 | 3 | 9 | positive regulation of peptidyl-serine phosphorylation of STAT protein |
GO:0050704 | 0.0016 | 6.6781 | 0.8682 | 5 | 33 | regulation of interleukin-1 secretion |
GO:0002475 | 0.0019 | 15.9709 | 0.2631 | 3 | 10 | antigen processing and presentation via MHC class Ib |
GO:0050713 | 0.0019 | 15.9709 | 0.2631 | 3 | 10 | negative regulation of interleukin-1 beta secretion |
GO:1903015 | 0.002 | 74.3775 | 0.0789 | 2 | 3 | regulation of exo-alpha-sialidase activity |
GO:0097340 | 0.0025 | 13.9736 | 0.2894 | 3 | 11 | inhibition of cysteine-type endopeptidase activity |
GO:0060467 | 0.0066 | 24.7892 | 0.1315 | 2 | 5 | negative regulation of fertilization |
GO:0006704 | 0.0093 | 7.9817 | 0.4473 | 3 | 17 | glucocorticoid biosynthetic process |
GO:0002430 | 0.0097 | 18.5907 | 0.1579 | 2 | 6 | complement receptor mediated signaling pathway |
GO:0019236 | 0.0097 | 18.5907 | 0.1579 | 2 | 6 | response to pheromone |
GO:0032651 | 0.0099 | 4.1506 | 1.3155 | 5 | 50 | regulation of interleukin-1 beta production |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 30.9731 | 7.8997 | 114 | 301 | detection of chemical stimulus involved in sensory perception of smell |
GO:0007606 | 0 | 22.3991 | 10.288 | 119 | 392 | sensory perception of chemical stimulus |
GO:0009593 | 0 | 22.9809 | 9.7893 | 116 | 373 | detection of chemical stimulus |
GO:0050906 | 0 | 21.8554 | 10.1305 | 116 | 386 | detection of stimulus involved in sensory perception |
GO:0050877 | 0 | 6.9421 | 29.3418 | 133 | 1118 | nervous system process |
GO:0007186 | 0 | 6.6391 | 29.3003 | 129 | 1126 | G-protein coupled receptor signaling pathway |
GO:0009913 | 0 | 5.3692 | 8.2146 | 37 | 313 | epidermal cell differentiation |
GO:0043588 | 0 | 4.1985 | 9.8943 | 36 | 377 | skin development |
GO:0032501 | 0 | 1.9467 | 158.4715 | 219 | 6483 | multicellular organismal process |
GO:0031424 | 0 | 8.4808 | 2.4628 | 17 | 97 | keratinization |
GO:0018149 | 0 | 11.437 | 1.3647 | 12 | 52 | peptide cross-linking |
GO:0070268 | 0 | 6.901 | 2.7557 | 16 | 105 | cornification |
GO:0007154 | 0 | 1.6416 | 152.8501 | 201 | 5824 | cell communication |
GO:0023052 | 0 | 1.633 | 152.4039 | 200 | 5807 | signaling |
GO:0050701 | 0 | 9.4408 | 1.0498 | 8 | 40 | interleukin-1 secretion |
GO:0035278 | 1e-04 | 6.5614 | 1.4172 | 8 | 54 | miRNA mediated inhibition of translation |
GO:0045974 | 1e-04 | 6.5614 | 1.4172 | 8 | 54 | regulation of translation, ncRNA-mediated |
GO:0050713 | 1e-04 | 24.9695 | 0.2624 | 4 | 10 | negative regulation of interleukin-1 beta secretion |
GO:0032611 | 1e-04 | 5.9162 | 1.5484 | 8 | 59 | interleukin-1 beta production |
GO:0035194 | 2e-04 | 2.6996 | 7.5585 | 19 | 288 | posttranscriptional gene silencing by RNA |
GO:0050896 | 2e-04 | 1.8805 | 29.0772 | 48 | 1269 | response to stimulus |
GO:0051709 | 3e-04 | 16.6431 | 0.3412 | 4 | 13 | regulation of killing of cells of other organism |
GO:0019730 | 3e-04 | 4.6547 | 2.1521 | 9 | 82 | antimicrobial humoral response |
GO:0007338 | 3e-04 | 3.7852 | 3.1756 | 11 | 121 | single fertilization |
GO:0070269 | 6e-04 | 28.0252 | 0.1837 | 3 | 7 | pyroptosis |
GO:0010951 | 6e-04 | 2.822 | 5.6951 | 15 | 217 | negative regulation of endopeptidase activity |
GO:0042742 | 6e-04 | 4.147 | 2.3838 | 9 | 92 | defense response to bacterium |
GO:0045087 | 8e-04 | 1.8815 | 19.7886 | 35 | 754 | innate immune response |
GO:0048245 | 9e-04 | 22.4187 | 0.21 | 3 | 8 | eosinophil chemotaxis |
GO:0098664 | 0.0016 | 9.3574 | 0.5249 | 4 | 20 | G-protein coupled serotonin receptor signaling pathway |
GO:2000344 | 0.0019 | 16.0113 | 0.2624 | 3 | 10 | positive regulation of acrosome reaction |
GO:0050706 | 0.0019 | 8.8907 | 0.5461 | 4 | 21 | regulation of interleukin-1 beta secretion |
GO:0031640 | 0.002 | 6.3067 | 0.9103 | 5 | 35 | killing of cells of other organism |
GO:0002774 | 0.002 | 74.5651 | 0.0787 | 2 | 3 | Fc receptor mediated inhibitory signaling pathway |
GO:0051714 | 0.002 | 74.5651 | 0.0787 | 2 | 3 | positive regulation of cytolysis in other organism |
GO:0017148 | 0.0021 | 2.1588 | 9.7893 | 20 | 373 | negative regulation of translation |
GO:0035821 | 0.0025 | 3.0924 | 3.4643 | 10 | 132 | modification of morphology or physiology of other organism |
GO:0001820 | 0.0025 | 14.0089 | 0.2887 | 3 | 11 | serotonin secretion |
GO:0097340 | 0.0025 | 14.0089 | 0.2887 | 3 | 11 | inhibition of cysteine-type endopeptidase activity |
GO:0050710 | 0.0026 | 4.7921 | 1.391 | 6 | 53 | negative regulation of cytokine secretion |
GO:0097028 | 0.0027 | 5.8567 | 0.9711 | 5 | 37 | dendritic cell differentiation |
GO:0032692 | 0.0028 | 7.8784 | 0.6036 | 4 | 23 | negative regulation of interleukin-1 production |
GO:0070098 | 0.0032 | 3.9265 | 1.9421 | 7 | 74 | chemokine-mediated signaling pathway |
GO:0060429 | 0.0033 | 1.5995 | 30.444 | 46 | 1160 | epithelium development |
GO:0002922 | 0.0033 | 12.4516 | 0.3149 | 3 | 12 | positive regulation of humoral immune response |
GO:0051716 | 0.0039 | 1.3181 | 164.5845 | 191 | 6370 | cellular response to stimulus |
GO:0009253 | 0.004 | 37.2801 | 0.105 | 2 | 4 | peptidoglycan catabolic process |
GO:0035962 | 0.004 | 37.2801 | 0.105 | 2 | 4 | response to interleukin-13 |
GO:0050830 | 0.004 | 3.7575 | 2.0209 | 7 | 77 | defense response to Gram-positive bacterium |
GO:0031343 | 0.0052 | 4.93 | 1.1285 | 5 | 43 | positive regulation of cell killing |
GO:0042268 | 0.0053 | 10.1863 | 0.3674 | 3 | 14 | regulation of cytolysis |
GO:0006953 | 0.0057 | 4.8032 | 1.1548 | 5 | 44 | acute-phase response |
GO:0050829 | 0.0061 | 3.9488 | 1.6534 | 6 | 63 | defense response to Gram-negative bacterium |
GO:0098581 | 0.0065 | 9.3368 | 0.3937 | 3 | 15 | detection of external biotic stimulus |
GO:0071347 | 0.0065 | 3.4143 | 2.2046 | 7 | 84 | cellular response to interleukin-1 |
GO:0006824 | 0.0065 | 24.8518 | 0.1312 | 2 | 5 | cobalt ion transport |
GO:0032747 | 0.0065 | 24.8518 | 0.1312 | 2 | 5 | positive regulation of interleukin-23 production |
GO:0060467 | 0.0065 | 24.8518 | 0.1312 | 2 | 5 | negative regulation of fertilization |
GO:0071222 | 0.0066 | 2.6723 | 3.963 | 10 | 151 | cellular response to lipopolysaccharide |
GO:0002577 | 0.0078 | 8.618 | 0.4199 | 3 | 16 | regulation of antigen processing and presentation |
GO:0071216 | 0.008 | 2.4541 | 4.7241 | 11 | 180 | cellular response to biotic stimulus |
GO:0050832 | 0.0084 | 5.5411 | 0.8136 | 4 | 31 | defense response to fungus |
GO:0016458 | 0.0084 | 1.9175 | 10.3667 | 19 | 395 | gene silencing |
GO:0032604 | 0.0093 | 8.0019 | 0.4462 | 3 | 17 | granulocyte macrophage colony-stimulating factor production |
GO:0044117 | 0.0093 | 8.0019 | 0.4462 | 3 | 17 | growth of symbiont in host |
GO:0006959 | 0.0093 | 3.1695 | 2.3576 | 7 | 92 | humoral immune response |
GO:0002765 | 0.0096 | 18.6376 | 0.1575 | 2 | 6 | immune response-inhibiting signal transduction |
GO:0002885 | 0.0096 | 18.6376 | 0.1575 | 2 | 6 | positive regulation of hypersensitivity |
GO:0019236 | 0.0096 | 18.6376 | 0.1575 | 2 | 6 | response to pheromone |
GO:0051346 | 0.0096 | 1.9274 | 9.7631 | 18 | 372 | negative regulation of hydrolase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042393 | 0 | 3.528 | 6.9897 | 22 | 188 | histone binding |
GO:0004937 | 1e-04 | Inf | 0.1115 | 3 | 3 | alpha1-adrenergic receptor activity |
GO:0046982 | 4e-04 | 2.0132 | 17.4744 | 33 | 470 | protein heterodimerization activity |
GO:0004300 | 0.0025 | 15.6135 | 0.2974 | 3 | 8 | enoyl-CoA hydratase activity |
GO:0044183 | 0.0029 | 5.9281 | 1.0038 | 5 | 27 | protein binding involved in protein folding |
GO:0004165 | 0.004 | 51.9689 | 0.1115 | 2 | 3 | dodecenoyl-CoA delta-isomerase activity |
GO:0004948 | 0.004 | 51.9689 | 0.1115 | 2 | 3 | calcitonin receptor activity |
GO:0035614 | 0.004 | 51.9689 | 0.1115 | 2 | 3 | snRNA stem-loop binding |
GO:0035663 | 0.004 | 51.9689 | 0.1115 | 2 | 3 | Toll-like receptor 2 binding |
GO:0097643 | 0.004 | 51.9689 | 0.1115 | 2 | 3 | amylin receptor activity |
GO:0004935 | 0.005 | 11.151 | 0.3718 | 3 | 10 | adrenergic receptor activity |
GO:0019904 | 0.0063 | 1.6097 | 24.0551 | 37 | 647 | protein domain specific binding |
GO:0086080 | 0.0067 | 9.7565 | 0.409 | 3 | 11 | protein binding involved in heterotypic cell-cell adhesion |
GO:0070717 | 0.0068 | 6.1287 | 0.7808 | 4 | 21 | poly-purine tract binding |
GO:0061575 | 0.0079 | 25.9827 | 0.1487 | 2 | 4 | cyclin-dependent protein serine/threonine kinase activator activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042393 | 0 | 6.5645 | 6.0136 | 32 | 188 | histone binding |
GO:0019904 | 0 | 2.1412 | 20.6957 | 41 | 647 | protein domain specific binding |
GO:0046982 | 3e-04 | 2.1314 | 15.034 | 30 | 470 | protein heterodimerization activity |
GO:0052659 | 0.0024 | 15.2167 | 0.2879 | 3 | 9 | inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity |
GO:0031492 | 0.0026 | 4.8243 | 1.4074 | 6 | 44 | nucleosomal DNA binding |
GO:0045322 | 0.003 | 60.7646 | 0.096 | 2 | 3 | unmethylated CpG binding |
GO:0060002 | 0.003 | 60.7646 | 0.096 | 2 | 3 | plus-end directed microfilament motor activity |
GO:0004930 | 0.0033 | 1.6959 | 22.3271 | 36 | 698 | G-protein coupled receptor activity |
GO:0051787 | 0.0058 | 10.1425 | 0.3838 | 3 | 12 | misfolded protein binding |
GO:0001640 | 0.0059 | 30.3803 | 0.1279 | 2 | 4 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity |
GO:0034485 | 0.0059 | 30.3803 | 0.1279 | 2 | 4 | phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity |
GO:0008757 | 0.0073 | 2.4989 | 4.6701 | 11 | 146 | S-adenosylmethionine-dependent methyltransferase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 10.4381 | 8.3547 | 62 | 301 | olfactory receptor activity |
GO:0004930 | 0 | 4.8907 | 19.374 | 75 | 698 | G-protein coupled receptor activity |
GO:0038023 | 0 | 3.3881 | 32.3362 | 89 | 1165 | signaling receptor activity |
GO:0099600 | 0 | 3.4374 | 30.6986 | 86 | 1106 | transmembrane receptor activity |
GO:0060089 | 0 | 2.9805 | 38.9145 | 95 | 1402 | molecular transducer activity |
GO:0005549 | 0 | 8.8573 | 1.9707 | 14 | 71 | odorant binding |
GO:0015125 | 0 | 25.3004 | 0.3331 | 5 | 12 | bile acid transmembrane transporter activity |
GO:0030246 | 3e-04 | 2.8554 | 6.4117 | 17 | 231 | carbohydrate binding |
GO:0004867 | 3e-04 | 4.7132 | 2.1372 | 9 | 77 | serine-type endopeptidase inhibitor activity |
GO:0004252 | 4e-04 | 3.2985 | 4.2745 | 13 | 154 | serine-type endopeptidase activity |
GO:0001591 | 4e-04 | 35.2651 | 0.1665 | 3 | 6 | dopamine neurotransmitter receptor activity, coupled via Gi/Go |
GO:0036374 | 4e-04 | 35.2651 | 0.1665 | 3 | 6 | glutathione hydrolase activity |
GO:0017171 | 6e-04 | 2.9652 | 5.0794 | 14 | 183 | serine hydrolase activity |
GO:0030414 | 0.0011 | 3.0595 | 4.219 | 12 | 152 | peptidase inhibitor activity |
GO:0035240 | 0.003 | 13.2201 | 0.3053 | 3 | 11 | dopamine binding |
GO:0061135 | 0.0035 | 2.7778 | 4.219 | 11 | 152 | endopeptidase regulator activity |
GO:0033265 | 0.0044 | 35.1856 | 0.111 | 2 | 4 | choline binding |
GO:0004028 | 0.0073 | 23.4555 | 0.1388 | 2 | 5 | 3-chloroallyl aldehyde dehydrogenase activity |
GO:0008048 | 0.0073 | 23.4555 | 0.1388 | 2 | 5 | calcium sensitive guanylate cyclase activator activity |
GO:0015349 | 0.0073 | 23.4555 | 0.1388 | 2 | 5 | thyroid hormone transmembrane transporter activity |
GO:0030883 | 0.0073 | 23.4555 | 0.1388 | 2 | 5 | endogenous lipid antigen binding |
GO:0030884 | 0.0073 | 23.4555 | 0.1388 | 2 | 5 | exogenous lipid antigen binding |
GO:0015081 | 0.008 | 2.5936 | 4.0802 | 10 | 147 | sodium ion transmembrane transporter activity |
GO:0008395 | 0.0091 | 5.4298 | 0.8327 | 4 | 30 | steroid hydroxylase activity |
GO:0015238 | 0.0091 | 8.1327 | 0.4441 | 3 | 16 | drug transmembrane transporter activity |
GO:0022804 | 0.0098 | 1.965 | 9.0486 | 17 | 326 | active transmembrane transporter activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042288 | 2e-04 | 11.8193 | 0.5627 | 5 | 19 | MHC class I protein binding |
GO:0050544 | 2e-04 | 49.4641 | 0.1481 | 3 | 5 | arachidonic acid binding |
GO:0045028 | 4e-04 | 14.6812 | 0.385 | 4 | 13 | G-protein coupled purinergic nucleotide receptor activity |
GO:0042289 | 5e-04 | 32.9739 | 0.1777 | 3 | 6 | MHC class II protein binding |
GO:0030246 | 5e-04 | 2.6642 | 6.8412 | 17 | 231 | carbohydrate binding |
GO:0004911 | 9e-04 | Inf | 0.0592 | 2 | 2 | interleukin-2 receptor activity |
GO:0019976 | 9e-04 | Inf | 0.0592 | 2 | 2 | interleukin-2 binding |
GO:0031720 | 9e-04 | Inf | 0.0592 | 2 | 2 | haptoglobin binding |
GO:0032394 | 9e-04 | Inf | 0.0592 | 2 | 2 | MHC class Ib receptor activity |
GO:0032396 | 9e-04 | Inf | 0.0592 | 2 | 2 | inhibitory MHC class I receptor activity |
GO:0097199 | 9e-04 | Inf | 0.0592 | 2 | 2 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway |
GO:0099600 | 0.0018 | 1.6184 | 32.7546 | 50 | 1106 | transmembrane receptor activity |
GO:0016502 | 0.0021 | 8.8052 | 0.5627 | 4 | 19 | nucleotide receptor activity |
GO:0005102 | 0.0023 | 1.5389 | 40.6915 | 59 | 1374 | receptor binding |
GO:0035662 | 0.0026 | 65.813 | 0.0888 | 2 | 3 | Toll-like receptor 4 binding |
GO:0036041 | 0.0027 | 14.1279 | 0.2962 | 3 | 10 | long-chain fatty acid binding |
GO:0038023 | 0.0032 | 1.5621 | 34.5019 | 51 | 1165 | signaling receptor activity |
GO:0005344 | 0.0036 | 12.3611 | 0.3258 | 3 | 11 | oxygen carrier activity |
GO:0005031 | 0.0036 | 7.3362 | 0.6515 | 4 | 22 | tumor necrosis factor-activated receptor activity |
GO:0043325 | 0.0036 | 7.3362 | 0.6515 | 4 | 22 | phosphatidylinositol-3,4-bisphosphate binding |
GO:0060089 | 0.0037 | 1.5038 | 41.5208 | 59 | 1402 | molecular transducer activity |
GO:0035586 | 0.0043 | 6.9497 | 0.6812 | 4 | 23 | purinergic receptor activity |
GO:0004871 | 0.0047 | 2.1365 | 8.388 | 17 | 296 | signal transducer activity |
GO:0042802 | 0.005 | 1.4666 | 44.6896 | 62 | 1509 | identical protein binding |
GO:0030492 | 0.005 | 32.9043 | 0.1185 | 2 | 4 | hemoglobin binding |
GO:0035877 | 0.005 | 32.9043 | 0.1185 | 2 | 4 | death effector domain binding |
GO:0060090 | 0.0057 | 2.4652 | 5.1531 | 12 | 174 | molecular adaptor activity |
GO:0001228 | 0.0058 | 1.9219 | 11.4612 | 21 | 387 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding |
GO:0005070 | 0.0061 | 3.9705 | 1.6585 | 6 | 56 | SH3/SH2 adaptor activity |
GO:0004435 | 0.0068 | 6.0008 | 0.77 | 4 | 26 | phosphatidylinositol phospholipase C activity |
GO:1903231 | 0.008 | 2.5944 | 4.0869 | 10 | 138 | mRNA binding involved in posttranscriptional gene silencing |
GO:0001665 | 0.0082 | 21.9348 | 0.1481 | 2 | 5 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity |
GO:0005085 | 0.0088 | 1.9909 | 8.9438 | 17 | 302 | guanyl-nucleotide exchange factor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004715 | 1e-04 | 6.5765 | 1.4369 | 8 | 48 | non-membrane spanning protein tyrosine kinase activity |
GO:0005125 | 2e-04 | 3.05 | 5.6878 | 16 | 190 | cytokine activity |
GO:0030545 | 2e-04 | 2.2602 | 12.7826 | 27 | 427 | receptor regulator activity |
GO:0005070 | 2e-04 | 5.4775 | 1.6764 | 8 | 56 | SH3/SH2 adaptor activity |
GO:0050544 | 3e-04 | 48.9149 | 0.1497 | 3 | 5 | arachidonic acid binding |
GO:0001784 | 3e-04 | 7.5623 | 0.9579 | 6 | 32 | phosphotyrosine residue binding |
GO:0043325 | 4e-04 | 9.6231 | 0.6586 | 5 | 22 | phosphatidylinositol-3,4-bisphosphate binding |
GO:0005102 | 5e-04 | 1.7107 | 33.1759 | 53 | 1135 | receptor binding |
GO:0034987 | 5e-04 | 32.6078 | 0.1796 | 3 | 6 | immunoglobulin receptor binding |
GO:0042289 | 5e-04 | 32.6078 | 0.1796 | 3 | 6 | MHC class II protein binding |
GO:0004911 | 9e-04 | Inf | 0.0599 | 2 | 2 | interleukin-2 receptor activity |
GO:0019976 | 9e-04 | Inf | 0.0599 | 2 | 2 | interleukin-2 binding |
GO:0032396 | 9e-04 | Inf | 0.0599 | 2 | 2 | inhibitory MHC class I receptor activity |
GO:0097199 | 9e-04 | Inf | 0.0599 | 2 | 2 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway |
GO:0060089 | 0.0012 | 1.5758 | 41.9701 | 62 | 1402 | molecular transducer activity |
GO:0051219 | 0.0014 | 4.1038 | 2.1554 | 8 | 72 | phosphoprotein binding |
GO:0016502 | 0.0021 | 8.7073 | 0.5688 | 4 | 19 | nucleotide receptor activity |
GO:0038023 | 0.0024 | 1.5784 | 34.8753 | 52 | 1165 | signaling receptor activity |
GO:0003726 | 0.0026 | 65.0839 | 0.0898 | 2 | 3 | double-stranded RNA adenosine deaminase activity |
GO:0005094 | 0.0026 | 65.0839 | 0.0898 | 2 | 3 | Rho GDP-dissociation inhibitor activity |
GO:0035662 | 0.0026 | 65.0839 | 0.0898 | 2 | 3 | Toll-like receptor 4 binding |
GO:0005509 | 0.0027 | 1.7818 | 18.9195 | 32 | 632 | calcium ion binding |
GO:0036041 | 0.0027 | 13.9711 | 0.2994 | 3 | 10 | long-chain fatty acid binding |
GO:0046934 | 0.0032 | 3.9552 | 1.9458 | 7 | 65 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity |
GO:0035586 | 0.0045 | 6.8723 | 0.6885 | 4 | 23 | purinergic receptor activity |
GO:0005126 | 0.0045 | 2.2705 | 6.9751 | 15 | 233 | cytokine receptor binding |
GO:0030492 | 0.0052 | 32.5398 | 0.1197 | 2 | 4 | hemoglobin binding |
GO:0035877 | 0.0052 | 32.5398 | 0.1197 | 2 | 4 | death effector domain binding |
GO:0004871 | 0.0052 | 2.1143 | 8.47 | 17 | 296 | signal transducer activity |
GO:0099600 | 0.006 | 1.524 | 33.1091 | 48 | 1106 | transmembrane receptor activity |
GO:0045028 | 0.0061 | 9.7778 | 0.3892 | 3 | 13 | G-protein coupled purinergic nucleotide receptor activity |
GO:0001205 | 0.0081 | 5.6757 | 0.8083 | 4 | 27 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding |
GO:0008422 | 0.0084 | 21.6918 | 0.1497 | 2 | 5 | beta-glucosidase activity |
GO:0023026 | 0.0093 | 8.1471 | 0.449 | 3 | 15 | MHC class II protein complex binding |
GO:0046625 | 0.0093 | 8.1471 | 0.449 | 3 | 15 | sphingolipid binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004872 | 0 | 2.9263 | 39.3469 | 95 | 1361 | receptor activity |
GO:0004871 | 0 | 2.2855 | 42.2957 | 84 | 1463 | signal transducer activity |
GO:0004930 | 0 | 2.2687 | 20.1794 | 42 | 698 | G-protein coupled receptor activity |
GO:0003823 | 0 | 8.0282 | 1.2142 | 8 | 42 | antigen binding |
GO:0004896 | 0 | 5.2351 | 2.3996 | 11 | 83 | cytokine receptor activity |
GO:0001637 | 1e-04 | 10.7368 | 0.7228 | 6 | 25 | G-protein coupled chemoattractant receptor activity |
GO:0004888 | 1e-04 | 2.7039 | 8.3826 | 21 | 308 | transmembrane signaling receptor activity |
GO:0030246 | 1e-04 | 2.915 | 6.6783 | 18 | 231 | carbohydrate binding |
GO:0005070 | 2e-04 | 5.6813 | 1.619 | 8 | 56 | SH3/SH2 adaptor activity |
GO:0061134 | 3e-04 | 3.0679 | 5.2906 | 15 | 183 | peptidase regulator activity |
GO:0016493 | 3e-04 | 16.9362 | 0.3469 | 4 | 12 | C-C chemokine receptor activity |
GO:0034987 | 4e-04 | 33.808 | 0.1735 | 3 | 6 | immunoglobulin receptor binding |
GO:0042289 | 4e-04 | 33.808 | 0.1735 | 3 | 6 | MHC class II protein binding |
GO:0032396 | 8e-04 | Inf | 0.0578 | 2 | 2 | inhibitory MHC class I receptor activity |
GO:0102294 | 8e-04 | Inf | 0.0578 | 2 | 2 | cholesterol dehydrogenase activity |
GO:0004866 | 0.0011 | 3.0629 | 4.2209 | 12 | 146 | endopeptidase inhibitor activity |
GO:0004252 | 0.0017 | 2.8888 | 4.4522 | 12 | 154 | serine-type endopeptidase activity |
GO:0004769 | 0.0025 | 67.4744 | 0.0867 | 2 | 3 | steroid delta-isomerase activity |
GO:0019959 | 0.0025 | 67.4744 | 0.0867 | 2 | 3 | interleukin-8 binding |
GO:0036041 | 0.0025 | 14.4853 | 0.2891 | 3 | 10 | long-chain fatty acid binding |
GO:0004984 | 0.003 | 2.1837 | 8.702 | 18 | 301 | olfactory receptor activity |
GO:0008329 | 0.0033 | 12.729 | 0.3167 | 3 | 11 | signaling pattern recognition receptor activity |
GO:0019956 | 0.0039 | 7.1259 | 0.6649 | 4 | 23 | chemokine binding |
GO:0043027 | 0.0039 | 7.1259 | 0.6649 | 4 | 23 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process |
GO:1901567 | 0.0039 | 7.1259 | 0.6649 | 4 | 23 | fatty acid derivative binding |
GO:0042287 | 0.0045 | 6.8135 | 0.6895 | 4 | 24 | MHC protein binding |
GO:0001875 | 0.0048 | 33.735 | 0.1156 | 2 | 4 | lipopolysaccharide receptor activity |
GO:0033293 | 0.0049 | 4.155 | 1.5901 | 6 | 55 | monocarboxylic acid binding |
GO:0045028 | 0.0055 | 10.1377 | 0.3758 | 3 | 13 | G-protein coupled purinergic nucleotide receptor activity |
GO:0017171 | 0.007 | 2.3943 | 5.2906 | 12 | 183 | serine hydrolase activity |
GO:0003854 | 0.0079 | 22.4885 | 0.1446 | 2 | 5 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity |
GO:0031433 | 0.0079 | 22.4885 | 0.1446 | 2 | 5 | telethonin binding |
GO:0050544 | 0.0079 | 22.4885 | 0.1446 | 2 | 5 | arachidonic acid binding |
GO:0101020 | 0.0079 | 22.4885 | 0.1446 | 2 | 5 | estrogen 16-alpha-hydroxylase activity |
GO:0005102 | 0.0079 | 1.471 | 37.9117 | 53 | 1338 | receptor binding |
GO:0042803 | 0.0089 | 1.6151 | 21.3647 | 33 | 739 | protein homodimerization activity |
GO:0016709 | 0.0092 | 5.4135 | 0.8384 | 4 | 29 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen |
GO:0005125 | 0.0093 | 2.299 | 5.4929 | 12 | 190 | cytokine activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 3.7012 | 16.3897 | 52 | 470 | protein heterodimerization activity |
GO:0042393 | 0 | 4.8316 | 6.5559 | 27 | 188 | histone binding |
GO:0043565 | 0 | 3.6403 | 9.3377 | 30 | 275 | sequence-specific DNA binding |
GO:0031492 | 0 | 8.2738 | 1.5344 | 10 | 44 | nucleosomal DNA binding |
GO:0000981 | 0 | 2.065 | 25.1774 | 48 | 722 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
GO:0001077 | 0 | 2.8085 | 8.9272 | 23 | 256 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding |
GO:0003682 | 8e-04 | 1.9614 | 16.7733 | 31 | 481 | chromatin binding |
GO:0004957 | 8e-04 | 27.8244 | 0.2092 | 3 | 6 | prostaglandin E receptor activity |
GO:0140110 | 0.0012 | 1.5155 | 51.9938 | 74 | 1491 | transcription regulator activity |
GO:0004666 | 0.0012 | Inf | 0.0697 | 2 | 2 | prostaglandin-endoperoxide synthase activity |
GO:0031711 | 0.0012 | Inf | 0.0697 | 2 | 2 | bradykinin receptor binding |
GO:0000977 | 0.0012 | 1.8239 | 20.2954 | 35 | 582 | RNA polymerase II regulatory region sequence-specific DNA binding |
GO:0009055 | 0.0017 | 3.2983 | 3.3128 | 10 | 95 | electron transfer activity |
GO:0004601 | 0.0019 | 5.2361 | 1.3251 | 6 | 38 | peroxidase activity |
GO:0003677 | 0.0024 | 1.5375 | 40.7372 | 59 | 1252 | DNA binding |
GO:0005184 | 0.003 | 5.8101 | 1.0113 | 5 | 29 | neuropeptide hormone activity |
GO:0017077 | 0.0036 | 55.5535 | 0.1046 | 2 | 3 | oxidative phosphorylation uncoupler activity |
GO:0070573 | 0.0036 | 55.5535 | 0.1046 | 2 | 3 | metallodipeptidase activity |
GO:0000975 | 0.0039 | 1.6012 | 28.2113 | 43 | 809 | regulatory region DNA binding |
GO:0019904 | 0.0039 | 1.6754 | 22.5621 | 36 | 647 | protein domain specific binding |
GO:0004954 | 0.0042 | 11.9216 | 0.3487 | 3 | 10 | prostanoid receptor activity |
GO:1990837 | 0.0044 | 1.6381 | 24.3405 | 38 | 698 | sequence-specific double-stranded DNA binding |
GO:0050839 | 0.0063 | 1.7752 | 15.3436 | 26 | 440 | cell adhesion molecule binding |
GO:0004364 | 0.0065 | 6.1885 | 0.7672 | 4 | 22 | glutathione transferase activity |
GO:0008198 | 0.0065 | 6.1885 | 0.7672 | 4 | 22 | ferrous iron binding |
GO:0016702 | 0.0065 | 6.1885 | 0.7672 | 4 | 22 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen |
GO:0001159 | 0.0068 | 1.8634 | 12.3795 | 22 | 355 | core promoter proximal region DNA binding |
GO:0030023 | 0.007 | 27.7749 | 0.1395 | 2 | 4 | extracellular matrix constituent conferring elasticity |
GO:0038085 | 0.007 | 27.7749 | 0.1395 | 2 | 4 | vascular endothelial growth factor binding |
GO:0045503 | 0.0076 | 5.8624 | 0.8021 | 4 | 23 | dynein light chain binding |
GO:0008514 | 0.0096 | 2.2095 | 6.2072 | 13 | 178 | organic anion transmembrane transporter activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0030676 | 0.003 | 12.4922 | 0.3015 | 3 | 14 | Rac guanyl-nucleotide exchange factor activity |
GO:0048273 | 0.0044 | 30.4611 | 0.1077 | 2 | 5 | mitogen-activated protein kinase p38 binding |
GO:0102567 | 0.0054 | 9.8134 | 0.3662 | 3 | 17 | phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) |
GO:0102568 | 0.0054 | 9.8134 | 0.3662 | 3 | 17 | phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) |
GO:0098772 | 0.0055 | 1.5292 | 34.8062 | 50 | 1616 | molecular function regulator |
GO:0017048 | 0.0059 | 2.8899 | 3.2954 | 9 | 153 | Rho GTPase binding |
GO:0003950 | 0.0074 | 8.5856 | 0.4092 | 3 | 19 | NAD+ ADP-ribosyltransferase activity |
GO:0008970 | 0.009 | 18.2743 | 0.1508 | 2 | 7 | phosphatidylcholine 1-acylhydrolase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 3.4774 | 16.2391 | 49 | 470 | protein heterodimerization activity |
GO:0042393 | 0 | 4.4455 | 6.4956 | 25 | 188 | histone binding |
GO:0031492 | 0 | 8.3548 | 1.5203 | 10 | 44 | nucleosomal DNA binding |
GO:0043565 | 0 | 1.9799 | 33.6184 | 61 | 973 | sequence-specific DNA binding |
GO:0000981 | 0 | 2.036 | 24.946 | 47 | 722 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
GO:0001077 | 1e-04 | 2.6963 | 8.8451 | 22 | 256 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding |
GO:0003682 | 7e-04 | 1.9814 | 16.6192 | 31 | 481 | chromatin binding |
GO:0004957 | 8e-04 | 28.0933 | 0.2073 | 3 | 6 | prostaglandin E receptor activity |
GO:0016702 | 8e-04 | 8.286 | 0.7601 | 5 | 22 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen |
GO:0019904 | 0.0011 | 1.805 | 21.6952 | 37 | 632 | protein domain specific binding |
GO:0031711 | 0.0012 | Inf | 0.0691 | 2 | 2 | bradykinin receptor binding |
GO:0071837 | 0.0014 | 10.2294 | 0.5183 | 4 | 15 | HMG box domain binding |
GO:0005104 | 0.0014 | 7.0417 | 0.8638 | 5 | 25 | fibroblast growth factor receptor binding |
GO:0048018 | 0.0016 | 1.9849 | 13.8551 | 26 | 401 | receptor ligand activity |
GO:0001664 | 0.0018 | 2.3077 | 8.297 | 18 | 241 | G-protein coupled receptor binding |
GO:1901612 | 0.002 | 16.8537 | 0.2764 | 3 | 8 | cardiolipin binding |
GO:0005342 | 0.0022 | 2.8115 | 4.5953 | 12 | 133 | organic acid transmembrane transporter activity |
GO:0005184 | 0.0029 | 5.8665 | 1.002 | 5 | 29 | neuropeptide hormone activity |
GO:0045296 | 0.0029 | 2.0952 | 10.089 | 20 | 292 | cadherin binding |
GO:0017077 | 0.0035 | 56.0894 | 0.1037 | 2 | 3 | oxidative phosphorylation uncoupler activity |
GO:0070573 | 0.0035 | 56.0894 | 0.1037 | 2 | 3 | metallodipeptidase activity |
GO:0008514 | 0.0036 | 2.4223 | 6.1501 | 14 | 178 | organic anion transmembrane transporter activity |
GO:0004954 | 0.0041 | 12.0368 | 0.3455 | 3 | 10 | prostanoid receptor activity |
GO:0042923 | 0.0044 | 7.0304 | 0.691 | 4 | 20 | neuropeptide binding |
GO:0140110 | 0.0049 | 1.4327 | 51.516 | 70 | 1491 | transcription regulator activity |
GO:0009055 | 0.0055 | 2.9569 | 3.2824 | 9 | 95 | electron transfer activity |
GO:0008198 | 0.0063 | 6.2484 | 0.7601 | 4 | 22 | ferrous iron binding |
GO:0038085 | 0.0068 | 28.0428 | 0.1382 | 2 | 4 | vascular endothelial growth factor binding |
GO:0090722 | 0.0068 | 28.0428 | 0.1382 | 2 | 4 | receptor-receptor interaction |
GO:0045503 | 0.0074 | 5.9191 | 0.7947 | 4 | 23 | dynein light chain binding |
GO:0004896 | 0.0079 | 3.0104 | 2.8678 | 8 | 83 | cytokine receptor activity |
GO:0016918 | 0.0091 | 8.4241 | 0.4492 | 3 | 13 | retinal binding |
GO:0008028 | 0.0095 | 4.264 | 1.3129 | 5 | 38 | monocarboxylic acid transmembrane transporter activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042393 | 0 | 7.8745 | 4.9169 | 31 | 188 | histone binding |
GO:0046982 | 0 | 3.9585 | 12.2923 | 42 | 470 | protein heterodimerization activity |
GO:0031492 | 0 | 14.3561 | 1.1508 | 12 | 44 | nucleosomal DNA binding |
GO:0003677 | 0 | 1.7735 | 60.5462 | 95 | 2315 | DNA binding |
GO:0003714 | 1e-04 | 3.2751 | 5.3092 | 16 | 203 | transcription corepressor activity |
GO:0003682 | 4e-04 | 2.2045 | 12.58 | 26 | 481 | chromatin binding |
GO:1903231 | 0.0034 | 2.957 | 3.6092 | 10 | 138 | mRNA binding involved in posttranscriptional gene silencing |
GO:0019904 | 0.0034 | 1.8045 | 16.9215 | 29 | 647 | protein domain specific binding |
GO:0030160 | 0.004 | 37.4138 | 0.1046 | 2 | 4 | GKAP/Homer scaffold activity |
GO:0045296 | 0.0044 | 2.2059 | 7.6369 | 16 | 292 | cadherin binding |
GO:0004046 | 0.0065 | 24.9409 | 0.1308 | 2 | 5 | aminoacylase activity |
GO:0070883 | 0.0065 | 24.9409 | 0.1308 | 2 | 5 | pre-miRNA binding |
GO:0001099 | 0.0096 | 4.1762 | 1.3077 | 5 | 50 | basal RNA polymerase II transcription machinery binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0008009 | 0 | 7.991 | 1.2196 | 8 | 42 | chemokine activity |
GO:0048020 | 3e-04 | 7.8064 | 0.9292 | 6 | 32 | CCR chemokine receptor binding |
GO:0004873 | 8e-04 | Inf | 0.0581 | 2 | 2 | asialoglycoprotein receptor activity |
GO:1905576 | 8e-04 | Inf | 0.0581 | 2 | 2 | ganglioside GT1b binding |
GO:0004937 | 0.0025 | 67.1663 | 0.0871 | 2 | 3 | alpha1-adrenergic receptor activity |
GO:0070644 | 0.0025 | 67.1663 | 0.0871 | 2 | 3 | vitamin D response element binding |
GO:0098772 | 0.0027 | 1.496 | 46.9262 | 66 | 1616 | molecular function regulator |
GO:0004872 | 0.0031 | 1.528 | 39.5213 | 57 | 1361 | receptor activity |
GO:0043027 | 0.004 | 7.0932 | 0.6679 | 4 | 23 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process |
GO:0044183 | 0.0072 | 5.858 | 0.784 | 4 | 27 | protein binding involved in protein folding |
GO:0003847 | 0.0079 | 22.3858 | 0.1452 | 2 | 5 | 1-alkyl-2-acetylglycerophosphocholine esterase activity |
GO:0016416 | 0.0079 | 22.3858 | 0.1452 | 2 | 5 | O-palmitoyltransferase activity |
GO:0030955 | 0.0085 | 8.4083 | 0.4356 | 3 | 15 | potassium ion binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042393 | 0 | 3.8747 | 8.3636 | 28 | 188 | histone binding |
GO:0003723 | 0 | 1.7206 | 74.4271 | 116 | 1673 | RNA binding |
GO:1901363 | 0 | 1.4017 | 248.6388 | 302 | 5589 | heterocyclic compound binding |
GO:0097159 | 0 | 1.3878 | 252.0199 | 304 | 5665 | organic cyclic compound binding |
GO:0005515 | 6e-04 | 1.3303 | 445.6565 | 484 | 10313 | protein binding |
GO:0001042 | 8e-04 | 32.3531 | 0.2224 | 3 | 5 | RNA polymerase I core binding |
GO:0046982 | 0.0011 | 1.8244 | 20.909 | 36 | 470 | protein heterodimerization activity |
GO:0055131 | 0.0016 | 21.5673 | 0.2669 | 3 | 6 | C3HC4-type RING finger domain binding |
GO:0003677 | 0.0024 | 1.3419 | 102.9878 | 130 | 2315 | DNA binding |
GO:0043021 | 0.0031 | 2.7144 | 4.8046 | 12 | 108 | ribonucleoprotein complex binding |
GO:0003857 | 0.0042 | 12.9386 | 0.3559 | 3 | 8 | 3-hydroxyacyl-CoA dehydrogenase activity |
GO:0008169 | 0.0058 | 43.078 | 0.1335 | 2 | 3 | C-methyltransferase activity |
GO:0016508 | 0.0058 | 43.078 | 0.1335 | 2 | 3 | long-chain-enoyl-CoA hydratase activity |
GO:0001104 | 0.0071 | 2.6758 | 4.0483 | 10 | 91 | RNA polymerase II transcription cofactor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:1990837 | 0 | 2.3342 | 22.5955 | 48 | 698 | sequence-specific double-stranded DNA binding |
GO:0001067 | 0 | 2.1742 | 26.1888 | 52 | 809 | regulatory region nucleic acid binding |
GO:0003700 | 0 | 1.9732 | 37.3247 | 67 | 1153 | DNA binding transcription factor activity |
GO:0000977 | 0 | 3.1575 | 7.6589 | 22 | 243 | RNA polymerase II regulatory region sequence-specific DNA binding |
GO:0038023 | 0 | 1.8795 | 37.7131 | 65 | 1165 | signaling receptor activity |
GO:0005070 | 0 | 6.6091 | 1.8128 | 10 | 56 | SH3/SH2 adaptor activity |
GO:0001077 | 0 | 2.8927 | 8.2872 | 22 | 256 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding |
GO:0030545 | 1e-04 | 2.2498 | 13.8228 | 29 | 427 | receptor regulator activity |
GO:0005126 | 2e-04 | 2.7185 | 7.5426 | 19 | 233 | cytokine receptor binding |
GO:0005102 | 2e-04 | 1.7265 | 36.0855 | 58 | 1141 | receptor binding |
GO:0001228 | 3e-04 | 3.4558 | 4.1236 | 13 | 131 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding |
GO:0016502 | 3e-04 | 10.7721 | 0.6151 | 5 | 19 | nucleotide receptor activity |
GO:0000978 | 3e-04 | 2.3412 | 10.974 | 24 | 339 | RNA polymerase II core promoter proximal region sequence-specific DNA binding |
GO:0099600 | 3e-04 | 1.7036 | 35.8032 | 57 | 1106 | transmembrane receptor activity |
GO:0003823 | 4e-04 | 6.0482 | 1.3596 | 7 | 42 | antigen binding |
GO:0030246 | 5e-04 | 2.5824 | 7.4779 | 18 | 231 | carbohydrate binding |
GO:0044212 | 5e-04 | 2.0905 | 14.2612 | 28 | 452 | transcription regulatory region DNA binding |
GO:0001159 | 6e-04 | 2.2256 | 11.492 | 24 | 355 | core promoter proximal region DNA binding |
GO:0045028 | 6e-04 | 13.383 | 0.4208 | 4 | 13 | G-protein coupled purinergic nucleotide receptor activity |
GO:0019864 | 6e-04 | 30.0637 | 0.1942 | 3 | 6 | IgG binding |
GO:0042289 | 6e-04 | 30.0637 | 0.1942 | 3 | 6 | MHC class II protein binding |
GO:0035586 | 7e-04 | 8.3761 | 0.7446 | 5 | 23 | purinergic receptor activity |
GO:0004872 | 0.001 | 2.9613 | 4.7381 | 13 | 155 | receptor activity |
GO:0004911 | 0.001 | Inf | 0.0647 | 2 | 2 | interleukin-2 receptor activity |
GO:0019976 | 0.001 | Inf | 0.0647 | 2 | 2 | interleukin-2 binding |
GO:0046934 | 0.0011 | 4.2467 | 2.1042 | 8 | 65 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity |
GO:0005125 | 0.0013 | 2.6099 | 6.1506 | 15 | 190 | cytokine activity |
GO:0004897 | 0.0031 | 60.0159 | 0.0971 | 2 | 3 | ciliary neurotrophic factor receptor activity |
GO:0033829 | 0.0031 | 60.0159 | 0.0971 | 2 | 3 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity |
GO:0032403 | 0.0031 | 1.6784 | 23.8256 | 38 | 736 | protein complex binding |
GO:0004896 | 0.0035 | 3.4828 | 2.5058 | 8 | 78 | cytokine receptor activity |
GO:0004715 | 0.0043 | 4.3095 | 1.5538 | 6 | 48 | non-membrane spanning protein tyrosine kinase activity |
GO:0005085 | 0.0046 | 2.0462 | 9.7763 | 19 | 302 | guanyl-nucleotide exchange factor activity |
GO:0015106 | 0.005 | 6.6875 | 0.7122 | 4 | 22 | bicarbonate transmembrane transporter activity |
GO:0043325 | 0.005 | 6.6875 | 0.7122 | 4 | 22 | phosphatidylinositol-3,4-bisphosphate binding |
GO:0019956 | 0.0059 | 6.3351 | 0.7446 | 4 | 23 | chemokine binding |
GO:0016493 | 0.006 | 10.0173 | 0.3885 | 3 | 12 | C-C chemokine receptor activity |
GO:0001851 | 0.006 | 30.006 | 0.1295 | 2 | 4 | complement component C3b binding |
GO:0030492 | 0.006 | 30.006 | 0.1295 | 2 | 4 | hemoglobin binding |
GO:0001191 | 0.0065 | 4.7072 | 1.1978 | 5 | 37 | transcriptional repressor activity, RNA polymerase II transcription factor binding |
GO:0061134 | 0.0067 | 2.3198 | 5.924 | 13 | 183 | peptidase regulator activity |
GO:0043425 | 0.0069 | 6.018 | 0.7769 | 4 | 24 | bHLH transcription factor binding |
GO:0001637 | 0.008 | 5.731 | 0.8093 | 4 | 25 | G-protein coupled chemoattractant receptor activity |
GO:0001968 | 0.008 | 5.731 | 0.8093 | 4 | 25 | fibronectin binding |
GO:0008191 | 0.0094 | 8.1949 | 0.4532 | 3 | 14 | metalloendopeptidase inhibitor activity |
GO:0030676 | 0.0094 | 8.1949 | 0.4532 | 3 | 14 | Rac guanyl-nucleotide exchange factor activity |
GO:0004875 | 0.0098 | 20.0027 | 0.1619 | 2 | 5 | complement receptor activity |
GO:0015057 | 0.0098 | 20.0027 | 0.1619 | 2 | 5 | thrombin-activated receptor activity |
GO:0046935 | 0.0098 | 20.0027 | 0.1619 | 2 | 5 | 1-phosphatidylinositol-3-kinase regulator activity |
GO:0050544 | 0.0098 | 20.0027 | 0.1619 | 2 | 5 | arachidonic acid binding |
GO:0005044 | 0.01 | 4.1831 | 1.3272 | 5 | 41 | scavenger receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004930 | 1e-04 | 2.1392 | 18.6581 | 37 | 698 | G-protein coupled receptor activity |
GO:0038023 | 3e-04 | 1.7598 | 31.1413 | 51 | 1165 | signaling receptor activity |
GO:0008201 | 4e-04 | 3.5126 | 3.7156 | 12 | 139 | heparin binding |
GO:0008508 | 4e-04 | 36.6667 | 0.1604 | 3 | 6 | bile acid:sodium symporter activity |
GO:0036374 | 4e-04 | 36.6667 | 0.1604 | 3 | 6 | glutathione hydrolase activity |
GO:0099600 | 6e-04 | 1.7367 | 29.5642 | 48 | 1106 | transmembrane receptor activity |
GO:0005518 | 9e-04 | 5.0657 | 1.5504 | 7 | 58 | collagen binding |
GO:0004252 | 9e-04 | 3.1384 | 4.1165 | 12 | 154 | serine-type endopeptidase activity |
GO:0060089 | 9e-04 | 1.629 | 37.4765 | 57 | 1402 | molecular transducer activity |
GO:0017171 | 0.0013 | 2.8417 | 4.8917 | 13 | 183 | serine hydrolase activity |
GO:0046943 | 0.0019 | 3.2193 | 3.3413 | 10 | 125 | carboxylic acid transmembrane transporter activity |
GO:0042978 | 0.0021 | 73.1663 | 0.0802 | 2 | 3 | ornithine decarboxylase activator activity |
GO:0005201 | 0.0026 | 4.0976 | 1.8712 | 7 | 70 | extracellular matrix structural constituent |
GO:0030545 | 0.0026 | 2.0323 | 11.414 | 22 | 427 | receptor regulator activity |
GO:0046332 | 0.0028 | 4.0333 | 1.8979 | 7 | 71 | SMAD binding |
GO:0000979 | 0.004 | 4.3315 | 1.5237 | 6 | 57 | RNA polymerase II core promoter sequence-specific DNA binding |
GO:0051431 | 0.0041 | 36.5807 | 0.1069 | 2 | 4 | corticotropin-releasing hormone receptor 2 binding |
GO:0042056 | 0.0047 | 6.6744 | 0.695 | 4 | 26 | chemoattractant activity |
GO:0005539 | 0.0062 | 4.6925 | 1.1788 | 5 | 45 | glycosaminoglycan binding |
GO:0052689 | 0.0064 | 2.8652 | 3.3413 | 9 | 125 | carboxylic ester hydrolase activity |
GO:0004028 | 0.0068 | 24.3855 | 0.1337 | 2 | 5 | 3-chloroallyl aldehyde dehydrogenase activity |
GO:0008083 | 0.0074 | 2.6212 | 4.0363 | 10 | 151 | growth factor activity |
GO:0008509 | 0.0085 | 2.1005 | 7.4846 | 15 | 280 | anion transmembrane transporter activity |
GO:0020037 | 0.0093 | 2.892 | 2.9404 | 8 | 110 | heme binding |
GO:0015125 | 0.0098 | 18.4175 | 0.1593 | 2 | 6 | bile acid transmembrane transporter activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050431 | 1e-04 | 14.0218 | 0.4858 | 5 | 18 | transforming growth factor beta binding |
GO:0030545 | 3e-04 | 2.3206 | 11.5235 | 25 | 427 | receptor regulator activity |
GO:0005201 | 4e-04 | 5.0739 | 1.7731 | 8 | 66 | extracellular matrix structural constituent |
GO:0008083 | 8e-04 | 3.1746 | 4.0751 | 12 | 151 | growth factor activity |
GO:0005518 | 9e-04 | 5.0154 | 1.5653 | 7 | 58 | collagen binding |
GO:0005102 | 0.0012 | 1.6135 | 37.0804 | 56 | 1374 | receptor binding |
GO:0050840 | 0.0016 | 5.3381 | 1.2684 | 6 | 47 | extracellular matrix binding |
GO:0015222 | 0.0021 | 72.4487 | 0.081 | 2 | 3 | serotonin transmembrane transporter activity |
GO:0038181 | 0.0021 | 72.4487 | 0.081 | 2 | 3 | bile acid receptor activity |
GO:0050473 | 0.0021 | 72.4487 | 0.081 | 2 | 3 | arachidonate 15-lipoxygenase activity |
GO:0099600 | 0.0022 | 1.6339 | 29.8478 | 46 | 1106 | transmembrane receptor activity |
GO:0004620 | 0.0028 | 3.6106 | 2.4019 | 8 | 89 | phospholipase activity |
GO:0060089 | 0.003 | 1.5431 | 37.836 | 55 | 1402 | molecular transducer activity |
GO:0008028 | 0.0034 | 5.5165 | 1.0255 | 5 | 38 | monocarboxylic acid transmembrane transporter activity |
GO:0005025 | 0.0042 | 36.222 | 0.1079 | 2 | 4 | transforming growth factor beta receptor activity, type I |
GO:0030023 | 0.0042 | 36.222 | 0.1079 | 2 | 4 | extracellular matrix constituent conferring elasticity |
GO:0051431 | 0.0042 | 36.222 | 0.1079 | 2 | 4 | corticotropin-releasing hormone receptor 2 binding |
GO:0008201 | 0.0045 | 2.8386 | 3.7512 | 10 | 139 | heparin binding |
GO:0022848 | 0.0046 | 10.8868 | 0.3508 | 3 | 13 | acetylcholine-gated cation-selective channel activity |
GO:0004930 | 0.0046 | 1.7294 | 18.8371 | 31 | 698 | G-protein coupled receptor activity |
GO:0008191 | 0.0057 | 9.8965 | 0.3778 | 3 | 14 | metalloendopeptidase inhibitor activity |
GO:0005539 | 0.0066 | 4.6213 | 1.1962 | 5 | 45 | glycosaminoglycan binding |
GO:0003847 | 0.0069 | 24.1464 | 0.1349 | 2 | 5 | 1-alkyl-2-acetylglycerophosphocholine esterase activity |
GO:0004028 | 0.0069 | 24.1464 | 0.1349 | 2 | 5 | 3-chloroallyl aldehyde dehydrogenase activity |
GO:0008131 | 0.0069 | 24.1464 | 0.1349 | 2 | 5 | primary amine oxidase activity |
GO:0004745 | 0.007 | 9.0712 | 0.4048 | 3 | 15 | retinol dehydrogenase activity |
GO:0030414 | 0.0083 | 2.5765 | 4.1021 | 10 | 152 | peptidase inhibitor activity |
GO:0038023 | 0.0083 | 1.5146 | 31.2161 | 45 | 1162 | signaling receptor activity |
GO:0099529 | 0.0084 | 8.3728 | 0.4318 | 3 | 16 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential |
GO:0005179 | 0.0094 | 2.8918 | 2.9416 | 8 | 109 | hormone activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005178 | 2e-04 | 3.876 | 3.4338 | 12 | 108 | integrin binding |
GO:0098772 | 5e-04 | 1.568 | 51.3805 | 75 | 1616 | molecular function regulator |
GO:0071253 | 6e-04 | 30.6308 | 0.1908 | 3 | 6 | connexin binding |
GO:0042015 | 0.001 | Inf | 0.0636 | 2 | 2 | interleukin-20 binding |
GO:0008970 | 0.001 | 22.9716 | 0.2226 | 3 | 7 | phosphatidylcholine 1-acylhydrolase activity |
GO:0032395 | 0.001 | 22.9716 | 0.2226 | 3 | 7 | MHC class II receptor activity |
GO:0004252 | 0.0013 | 2.8562 | 4.8964 | 13 | 154 | serine-type endopeptidase activity |
GO:0043236 | 0.0017 | 6.6771 | 0.8903 | 5 | 28 | laminin binding |
GO:0048018 | 0.0023 | 1.9863 | 12.7497 | 24 | 401 | receptor ligand activity |
GO:0017080 | 0.0027 | 5.9055 | 0.9856 | 5 | 31 | sodium channel regulator activity |
GO:0042393 | 0.0028 | 2.4922 | 5.9774 | 14 | 188 | histone binding |
GO:0015265 | 0.003 | 61.1457 | 0.0954 | 2 | 3 | urea channel activity |
GO:0072341 | 0.0034 | 3.9168 | 1.9713 | 7 | 62 | modified amino acid binding |
GO:0005372 | 0.0044 | 11.4828 | 0.3497 | 3 | 11 | water transmembrane transporter activity |
GO:0046982 | 0.0045 | 1.8265 | 14.9436 | 26 | 470 | protein heterodimerization activity |
GO:0004896 | 0.0048 | 3.285 | 2.639 | 8 | 83 | cytokine receptor activity |
GO:0019904 | 0.0052 | 1.682 | 20.5713 | 33 | 647 | protein domain specific binding |
GO:0017171 | 0.0058 | 2.3644 | 5.8185 | 13 | 183 | serine hydrolase activity |
GO:0015254 | 0.0058 | 30.5709 | 0.1272 | 2 | 4 | glycerol channel activity |
GO:0050294 | 0.0058 | 30.5709 | 0.1272 | 2 | 4 | steroid sulfotransferase activity |
GO:0004866 | 0.007 | 2.5148 | 4.6421 | 11 | 146 | endopeptidase inhibitor activity |
GO:0004435 | 0.0087 | 5.5735 | 0.8267 | 4 | 26 | phosphatidylinositol phospholipase C activity |
GO:0019955 | 0.0087 | 2.9434 | 2.9137 | 8 | 92 | cytokine binding |
GO:0005044 | 0.0093 | 4.2623 | 1.3036 | 5 | 41 | scavenger receptor activity |
GO:0047035 | 0.0095 | 20.3792 | 0.159 | 2 | 5 | testosterone dehydrogenase (NAD+) activity |
GO:0016298 | 0.0099 | 2.6655 | 3.5928 | 9 | 113 | lipase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 45.2811 | 7.4671 | 131 | 301 | olfactory receptor activity |
GO:0004930 | 0 | 15.2895 | 17.1555 | 141 | 695 | G-protein coupled receptor activity |
GO:0099600 | 0 | 9.5526 | 27.4373 | 151 | 1106 | transmembrane receptor activity |
GO:0038023 | 0 | 9.4932 | 26.2219 | 145 | 1076 | signaling receptor activity |
GO:0060089 | 0 | 7.57 | 34.7804 | 156 | 1402 | molecular transducer activity |
GO:0005549 | 0 | 17.4002 | 1.7613 | 21 | 71 | odorant binding |
GO:1903231 | 0 | 8.7569 | 3.4235 | 24 | 138 | mRNA binding involved in posttranscriptional gene silencing |
GO:0004993 | 0 | 17.0967 | 0.4962 | 6 | 20 | G-protein coupled serotonin receptor activity |
GO:0005344 | 1e-04 | 22.6871 | 0.2729 | 4 | 11 | oxygen carrier activity |
GO:0019863 | 1e-04 | 59.418 | 0.124 | 3 | 5 | IgE binding |
GO:0030883 | 1e-04 | 59.418 | 0.124 | 3 | 5 | endogenous lipid antigen binding |
GO:0030884 | 1e-04 | 59.418 | 0.124 | 3 | 5 | exogenous lipid antigen binding |
GO:0019825 | 3e-04 | 7.7125 | 0.9179 | 6 | 37 | oxygen binding |
GO:0030594 | 4e-04 | 4.5039 | 2.2079 | 9 | 89 | neurotransmitter receptor activity |
GO:0030881 | 5e-04 | 29.7051 | 0.1737 | 3 | 7 | beta-2-microglobulin binding |
GO:0004507 | 6e-04 | Inf | 0.0496 | 2 | 2 | steroid 11-beta-monooxygenase activity |
GO:0004982 | 6e-04 | Inf | 0.0496 | 2 | 2 | N-formyl peptide receptor activity |
GO:0031720 | 6e-04 | Inf | 0.0496 | 2 | 2 | haptoglobin binding |
GO:0047783 | 6e-04 | Inf | 0.0496 | 2 | 2 | corticosterone 18-monooxygenase activity |
GO:0071723 | 0.0016 | 16.971 | 0.2481 | 3 | 10 | lipopeptide binding |
GO:0089720 | 0.0016 | 16.971 | 0.2481 | 3 | 10 | caspase binding |
GO:0020037 | 0.0017 | 3.5625 | 2.7288 | 9 | 110 | heme binding |
GO:0016503 | 0.0018 | 79.0234 | 0.0744 | 2 | 3 | pheromone receptor activity |
GO:0050700 | 0.0028 | 13.1979 | 0.2977 | 3 | 12 | CARD domain binding |
GO:0005506 | 0.003 | 3.0075 | 3.5475 | 10 | 143 | iron ion binding |
GO:0003823 | 0.0037 | 5.3686 | 1.0419 | 5 | 42 | antigen binding |
GO:0008009 | 0.0037 | 5.3686 | 1.0419 | 5 | 42 | chemokine activity |
GO:0097153 | 0.0045 | 10.7969 | 0.3473 | 3 | 14 | cysteine-type endopeptidase activity involved in apoptotic process |
GO:0004875 | 0.0058 | 26.3377 | 0.124 | 2 | 5 | complement receptor activity |
GO:0005132 | 0.0058 | 26.3377 | 0.124 | 2 | 5 | type I interferon receptor binding |
GO:0048020 | 0.0077 | 5.6639 | 0.7938 | 4 | 32 | CCR chemokine receptor binding |
GO:0070330 | 0.008 | 8.4816 | 0.4217 | 3 | 17 | aromatase activity |
GO:0001591 | 0.0086 | 19.7519 | 0.1488 | 2 | 6 | dopamine neurotransmitter receptor activity, coupled via Gi/Go |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 5.7357 | 8.2196 | 39 | 301 | olfactory receptor activity |
GO:0042393 | 0 | 6.0233 | 5.1338 | 26 | 188 | histone binding |
GO:0005549 | 0 | 7.4257 | 1.9388 | 12 | 71 | odorant binding |
GO:0004930 | 0 | 2.4887 | 19.0608 | 43 | 698 | G-protein coupled receptor activity |
GO:0046982 | 0 | 2.8317 | 12.8346 | 33 | 470 | protein heterodimerization activity |
GO:0099600 | 0 | 1.9055 | 30.2023 | 53 | 1106 | transmembrane receptor activity |
GO:0038023 | 0 | 1.8783 | 31.8135 | 55 | 1165 | signaling receptor activity |
GO:0060089 | 2e-04 | 1.7239 | 38.2854 | 61 | 1402 | molecular transducer activity |
GO:0008479 | 4e-04 | 35.8652 | 0.1638 | 3 | 6 | queuine tRNA-ribosyltransferase activity |
GO:0047196 | 7e-04 | Inf | 0.0546 | 2 | 2 | long-chain-alcohol O-fatty-acyltransferase activity |
GO:0102966 | 7e-04 | Inf | 0.0546 | 2 | 2 | arachidoyl-CoA:1-dodecanol O-acyltransferase activity |
GO:0103095 | 7e-04 | Inf | 0.0546 | 2 | 2 | wax ester synthase activity |
GO:0019904 | 9e-04 | 1.9227 | 17.6681 | 32 | 647 | protein domain specific binding |
GO:0003677 | 0.001 | 1.4912 | 63.2173 | 87 | 2315 | DNA binding |
GO:0004129 | 0.0032 | 7.5605 | 0.6281 | 4 | 23 | cytochrome-c oxidase activity |
GO:0016675 | 0.0032 | 7.5605 | 0.6281 | 4 | 23 | oxidoreductase activity, acting on a heme group of donors |
GO:1901363 | 0.0058 | 1.295 | 152.6227 | 178 | 5589 | heterocyclic compound binding |
GO:0031492 | 0.0067 | 4.609 | 1.2015 | 5 | 44 | nucleosomal DNA binding |
GO:0005132 | 0.007 | 23.8538 | 0.1365 | 2 | 5 | type I interferon receptor binding |
GO:0097159 | 0.0079 | 1.2798 | 154.6981 | 179 | 5665 | organic cyclic compound binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 32.8193 | 7.5829 | 114 | 301 | olfactory receptor activity |
GO:0004930 | 0 | 11.5821 | 17.4229 | 122 | 695 | G-protein coupled receptor activity |
GO:0038023 | 0 | 7.2913 | 29.349 | 136 | 1165 | signaling receptor activity |
GO:0099600 | 0 | 7.3905 | 27.8627 | 132 | 1106 | transmembrane receptor activity |
GO:0060089 | 0 | 6.2622 | 35.3196 | 142 | 1402 | molecular transducer activity |
GO:0005549 | 0 | 23.8699 | 1.7887 | 26 | 71 | odorant binding |
GO:1903231 | 0 | 6.4412 | 3.4765 | 19 | 138 | mRNA binding involved in posttranscriptional gene silencing |
GO:0030414 | 0 | 4.0336 | 3.8292 | 14 | 152 | peptidase inhibitor activity |
GO:0061135 | 0 | 4.0336 | 3.8292 | 14 | 152 | endopeptidase regulator activity |
GO:0004869 | 2e-04 | 6.5479 | 1.2344 | 7 | 49 | cysteine-type endopeptidase inhibitor activity |
GO:0038187 | 4e-04 | 14.2052 | 0.3779 | 4 | 15 | pattern recognition receptor activity |
GO:0032396 | 6e-04 | Inf | 0.0504 | 2 | 2 | inhibitory MHC class I receptor activity |
GO:0004993 | 0.0014 | 9.7629 | 0.5038 | 4 | 20 | G-protein coupled serotonin receptor activity |
GO:0089720 | 0.0017 | 16.7033 | 0.2519 | 3 | 10 | caspase binding |
GO:0008745 | 0.0019 | 77.7801 | 0.0756 | 2 | 3 | N-acetylmuramoyl-L-alanine amidase activity |
GO:0016503 | 0.0019 | 77.7801 | 0.0756 | 2 | 3 | pheromone receptor activity |
GO:0042834 | 0.0023 | 14.6144 | 0.2771 | 3 | 11 | peptidoglycan binding |
GO:0050700 | 0.0029 | 12.9897 | 0.3023 | 3 | 12 | CARD domain binding |
GO:0016019 | 0.0037 | 38.8875 | 0.1008 | 2 | 4 | peptidoglycan receptor activity |
GO:0016715 | 0.0037 | 38.8875 | 0.1008 | 2 | 4 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen |
GO:0030492 | 0.0037 | 38.8875 | 0.1008 | 2 | 4 | hemoglobin binding |
GO:0097153 | 0.0047 | 10.6266 | 0.3527 | 3 | 14 | cysteine-type endopeptidase activity involved in apoptotic process |
GO:0019863 | 0.006 | 25.9233 | 0.126 | 2 | 5 | IgE binding |
GO:0048020 | 0.0082 | 5.5744 | 0.8062 | 4 | 32 | CCR chemokine receptor binding |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0044571 | 4e-04 | 8137.5 | 4e-04 | 1 | 3 | [2Fe-2S] cluster assembly |
GO:0097428 | 7e-04 | 3254.4 | 7e-04 | 1 | 6 | protein maturation by iron-sulfur cluster transfer |
GO:0031163 | 0.0021 | 1016.3125 | 0.0021 | 1 | 17 | metallo-sulfur cluster assembly |
GO:0035722 | 0.0069 | 294.9455 | 0.0069 | 1 | 56 | interleukin-12-mediated signaling pathway |
GO:0070671 | 0.007 | 289.6607 | 0.007 | 1 | 57 | response to interleukin-12 |
GO:0032204 | 0.0093 | 216.0267 | 0.0093 | 1 | 76 | regulation of telomere maintenance |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0008344 | 0.0094 | 213.1711 | 0.0095 | 1 | 77 | adult locomotory behavior |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0035021 | 2e-04 | Inf | 2e-04 | 1 | 4 | negative regulation of Rac protein signal transduction |
GO:0007019 | 0.0018 | Inf | 0.0018 | 1 | 30 | microtubule depolymerization |
GO:0031122 | 0.0025 | Inf | 0.0025 | 1 | 41 | cytoplasmic microtubule organization |
GO:0051058 | 0.0031 | Inf | 0.0031 | 1 | 50 | negative regulation of small GTPase mediated signal transduction |
GO:0031110 | 0.0037 | Inf | 0.0037 | 1 | 60 | regulation of microtubule polymerization or depolymerization |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 91.8268 | 1.0576 | 24 | 32 | DNA replication-dependent nucleosome assembly |
GO:0000183 | 0 | 52.4525 | 1.2559 | 24 | 38 | chromatin silencing at rDNA |
GO:0051290 | 0 | 40.3252 | 1.4541 | 25 | 44 | protein heterotetramerization |
GO:0006323 | 0 | 7.5927 | 6.4115 | 38 | 194 | DNA packaging |
GO:0045653 | 0 | 105.1135 | 0.5949 | 14 | 18 | negative regulation of megakaryocyte differentiation |
GO:0045815 | 0 | 13.0781 | 2.6439 | 24 | 80 | positive regulation of gene expression, epigenetic |
GO:0048863 | 0 | 5.9784 | 7.9973 | 39 | 244 | stem cell differentiation |
GO:1902036 | 0 | 9.7859 | 3.404 | 25 | 103 | regulation of hematopoietic stem cell differentiation |
GO:0045814 | 0 | 8.5216 | 4.098 | 27 | 124 | negative regulation of gene expression, epigenetic |
GO:0060964 | 0 | 9.4217 | 3.5032 | 25 | 106 | regulation of gene silencing by miRNA |
GO:1903707 | 0 | 17.7267 | 1.6039 | 18 | 49 | negative regulation of hemopoiesis |
GO:0071824 | 0 | 5.3866 | 8.4935 | 38 | 257 | protein-DNA complex subunit organization |
GO:0007389 | 0 | 5.0919 | 9.3965 | 40 | 289 | pattern specification process |
GO:1902679 | 0 | 2.7151 | 38.3365 | 89 | 1160 | negative regulation of RNA biosynthetic process |
GO:0006333 | 0 | 8.0594 | 3.9401 | 25 | 122 | chromatin assembly or disassembly |
GO:0034654 | 0 | 1.9736 | 137.5157 | 214 | 4161 | nucleobase-containing compound biosynthetic process |
GO:0032502 | 0 | 2.0463 | 122.4848 | 191 | 4071 | developmental process |
GO:0060968 | 0 | 7.257 | 4.2963 | 25 | 130 | regulation of gene silencing |
GO:0045944 | 0 | 2.5824 | 36.0892 | 81 | 1092 | positive regulation of transcription from RNA polymerase II promoter |
GO:1904837 | 0 | 15.539 | 1.4541 | 15 | 44 | beta-catenin-TCF complex assembly |
GO:0045934 | 0 | 2.3902 | 45.9708 | 95 | 1391 | negative regulation of nucleobase-containing compound metabolic process |
GO:0010628 | 0 | 2.2459 | 54.3858 | 105 | 1714 | positive regulation of gene expression |
GO:0034080 | 0 | 14.9933 | 1.388 | 14 | 42 | CENP-A containing nucleosome assembly |
GO:1903508 | 0 | 2.3061 | 46.3012 | 93 | 1401 | positive regulation of nucleic acid-templated transcription |
GO:0051254 | 0 | 2.2674 | 48.6477 | 96 | 1472 | positive regulation of RNA metabolic process |
GO:2000026 | 0 | 2.2137 | 52.1104 | 100 | 1610 | regulation of multicellular organismal development |
GO:0009893 | 0 | 3.9695 | 10.5097 | 36 | 347 | positive regulation of metabolic process |
GO:0009890 | 0 | 2.1808 | 53.7703 | 102 | 1627 | negative regulation of biosynthetic process |
GO:0001501 | 0 | 3.2589 | 16.0286 | 46 | 485 | skeletal system development |
GO:0048534 | 0 | 2.6007 | 28.2566 | 65 | 855 | hematopoietic or lymphoid organ development |
GO:0032200 | 0 | 5.1293 | 5.4861 | 24 | 166 | telomere organization |
GO:0034724 | 0 | 10.4873 | 1.7846 | 14 | 54 | DNA replication-independent nucleosome organization |
GO:0031328 | 0 | 2.0446 | 58.6284 | 105 | 1774 | positive regulation of cellular biosynthetic process |
GO:0016233 | 0 | 10.2309 | 1.8177 | 14 | 55 | telomere capping |
GO:0009952 | 0 | 5.394 | 4.8021 | 22 | 147 | anterior/posterior pattern specification |
GO:0034645 | 0 | 1.6838 | 164.8139 | 227 | 4987 | cellular macromolecule biosynthetic process |
GO:0045892 | 0 | 3.5477 | 10.5054 | 33 | 337 | negative regulation of transcription, DNA-templated |
GO:0010557 | 0 | 2.0283 | 54.1007 | 97 | 1637 | positive regulation of macromolecule biosynthetic process |
GO:0035194 | 0 | 3.9651 | 7.7334 | 27 | 234 | posttranscriptional gene silencing by RNA |
GO:0007423 | 0 | 2.7919 | 17.1192 | 43 | 518 | sensory organ development |
GO:1901576 | 0 | 1.618 | 204.7698 | 266 | 6196 | organic substance biosynthetic process |
GO:0035107 | 0 | 4.7469 | 4.8582 | 20 | 147 | appendage morphogenesis |
GO:0000122 | 0 | 2.3415 | 25.9432 | 55 | 785 | negative regulation of transcription from RNA polymerase II promoter |
GO:0006303 | 0 | 6.8677 | 2.4787 | 14 | 75 | double-strand break repair via nonhomologous end joining |
GO:0006355 | 0 | 1.8314 | 70.9276 | 113 | 2389 | regulation of transcription, DNA-templated |
GO:2001141 | 0 | 1.8173 | 70.6806 | 112 | 2380 | regulation of RNA biosynthetic process |
GO:0060173 | 0 | 4.2219 | 5.6513 | 21 | 171 | limb development |
GO:0043044 | 0 | 6.5445 | 2.5778 | 14 | 78 | ATP-dependent chromatin remodeling |
GO:0038111 | 0 | 10.6284 | 1.2559 | 10 | 38 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 10.2612 | 1.2889 | 10 | 39 | response to interleukin-7 |
GO:0097659 | 0 | 1.8004 | 68.4592 | 108 | 2289 | nucleic acid-templated transcription |
GO:0021515 | 0 | 7.9928 | 1.7185 | 11 | 52 | cell differentiation in spinal cord |
GO:0002227 | 0 | 18.8512 | 0.5949 | 7 | 18 | innate immune response in mucosa |
GO:0021517 | 0 | 8.7494 | 1.4541 | 10 | 44 | ventral spinal cord development |
GO:0043010 | 0 | 3.0978 | 9.6155 | 27 | 292 | camera-type eye development |
GO:0002682 | 0 | 1.8899 | 45.4089 | 78 | 1374 | regulation of immune system process |
GO:0021953 | 0 | 5.9638 | 2.5769 | 13 | 79 | central nervous system neuron differentiation |
GO:0051259 | 0 | 2.4902 | 17.1192 | 39 | 518 | protein oligomerization |
GO:0002251 | 0 | 12.4902 | 0.8923 | 8 | 27 | organ or tissue specific immune response |
GO:0090304 | 0 | 1.5313 | 165.6071 | 216 | 5011 | nucleic acid metabolic process |
GO:0009889 | 0 | 1.7007 | 80.115 | 119 | 2710 | regulation of biosynthetic process |
GO:0045596 | 0 | 3.1562 | 8.7353 | 25 | 271 | negative regulation of cell differentiation |
GO:0017148 | 0 | 2.8846 | 10.6417 | 28 | 322 | negative regulation of translation |
GO:0060322 | 0 | 2.1942 | 23.2993 | 47 | 705 | head development |
GO:0009953 | 0 | 5.9024 | 2.3979 | 12 | 73 | dorsal/ventral pattern formation |
GO:0009954 | 0 | 10.3153 | 1.0245 | 8 | 31 | proximal/distal pattern formation |
GO:0019219 | 0 | 1.6588 | 80.6969 | 118 | 2712 | regulation of nucleobase-containing compound metabolic process |
GO:0045652 | 0 | 6.4947 | 1.8368 | 10 | 57 | regulation of megakaryocyte differentiation |
GO:0006725 | 0 | 1.4605 | 193.7646 | 241 | 5863 | cellular aromatic compound metabolic process |
GO:0006352 | 0 | 3.0644 | 7.8656 | 22 | 238 | DNA-templated transcription, initiation |
GO:0003207 | 0 | 21.0855 | 0.3966 | 5 | 12 | cardiac chamber formation |
GO:0060272 | 0 | 21.0855 | 0.3966 | 5 | 12 | embryonic skeletal joint morphogenesis |
GO:0008284 | 0 | 1.961 | 28.0584 | 51 | 849 | positive regulation of cell proliferation |
GO:0051173 | 0 | 1.5413 | 94.982 | 132 | 2874 | positive regulation of nitrogen compound metabolic process |
GO:1901360 | 0 | 1.4345 | 200.6057 | 246 | 6070 | organic cyclic compound metabolic process |
GO:0048665 | 0 | 12.7831 | 0.6554 | 6 | 20 | neuron fate specification |
GO:0035270 | 0 | 4.3336 | 3.3837 | 13 | 103 | endocrine system development |
GO:0048545 | 0 | 2.4693 | 12.6907 | 29 | 384 | response to steroid hormone |
GO:0002125 | 0 | Inf | 0.0991 | 3 | 3 | maternal aggressive behavior |
GO:0003357 | 0 | 39.2959 | 0.2313 | 4 | 7 | noradrenergic neuron differentiation |
GO:0021520 | 0 | 18.4486 | 0.4296 | 5 | 13 | spinal cord motor neuron cell fate specification |
GO:0021978 | 0 | 18.4486 | 0.4296 | 5 | 13 | telencephalon regionalization |
GO:0048935 | 0 | 18.4486 | 0.4296 | 5 | 13 | peripheral nervous system neuron development |
GO:0031016 | 0 | 4.9573 | 2.5448 | 11 | 77 | pancreas development |
GO:0046483 | 1e-04 | 1.4195 | 192.5088 | 236 | 5825 | heterocycle metabolic process |
GO:0048731 | 1e-04 | 1.6427 | 62.5422 | 92 | 2252 | system development |
GO:0072210 | 1e-04 | 6.9731 | 1.388 | 8 | 42 | metanephric nephron development |
GO:0048562 | 1e-04 | 3.3964 | 5.1734 | 16 | 162 | embryonic organ morphogenesis |
GO:0048704 | 1e-04 | 4.7155 | 2.654 | 11 | 81 | embryonic skeletal system morphogenesis |
GO:0061458 | 1e-04 | 2.3123 | 13.9466 | 30 | 422 | reproductive system development |
GO:0006334 | 1e-04 | 4.2498 | 3.1637 | 12 | 100 | nucleosome assembly |
GO:0030900 | 1e-04 | 2.4152 | 12.0297 | 27 | 364 | forebrain development |
GO:0048048 | 1e-04 | 7.6723 | 1.1237 | 7 | 34 | embryonic eye morphogenesis |
GO:0060537 | 1e-04 | 2.3649 | 12.2611 | 27 | 371 | muscle tissue development |
GO:0060249 | 1e-04 | 2.351 | 12.3272 | 27 | 373 | anatomical structure homeostasis |
GO:0007218 | 1e-04 | 4.0121 | 3.3379 | 12 | 101 | neuropeptide signaling pathway |
GO:0045823 | 1e-04 | 7.3978 | 1.1567 | 7 | 35 | positive regulation of heart contraction |
GO:0030154 | 1e-04 | 1.726 | 41.2052 | 65 | 1477 | cell differentiation |
GO:0051248 | 1e-04 | 1.6975 | 41.7736 | 66 | 1264 | negative regulation of protein metabolic process |
GO:0002317 | 1e-04 | 88.2617 | 0.1322 | 3 | 4 | plasma cell differentiation |
GO:0031394 | 1e-04 | 88.2617 | 0.1322 | 3 | 4 | positive regulation of prostaglandin biosynthetic process |
GO:0072193 | 1e-04 | 88.2617 | 0.1322 | 3 | 4 | ureter smooth muscle cell differentiation |
GO:0048645 | 1e-04 | 5.2341 | 1.9829 | 9 | 60 | animal organ formation |
GO:0060349 | 1e-04 | 4.2461 | 2.9083 | 11 | 88 | bone morphogenesis |
GO:0019731 | 2e-04 | 7.1423 | 1.1898 | 7 | 36 | antibacterial humoral response |
GO:0061844 | 2e-04 | 5.9249 | 1.5863 | 8 | 48 | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO:0043009 | 2e-04 | 2.3019 | 12.5668 | 27 | 387 | chordate embryonic development |
GO:0043651 | 2e-04 | 12.296 | 0.5618 | 5 | 17 | linoleic acid metabolic process |
GO:2000738 | 2e-04 | 12.296 | 0.5618 | 5 | 17 | positive regulation of stem cell differentiation |
GO:0071542 | 2e-04 | 6.9038 | 1.2228 | 7 | 37 | dopaminergic neuron differentiation |
GO:0007517 | 2e-04 | 2.8415 | 6.8545 | 18 | 210 | muscle organ development |
GO:0008217 | 2e-04 | 3.0622 | 5.6844 | 16 | 172 | regulation of blood pressure |
GO:0046887 | 2e-04 | 8.5267 | 0.8839 | 6 | 27 | positive regulation of hormone secretion |
GO:0042756 | 2e-04 | 19.6442 | 0.3305 | 4 | 10 | drinking behavior |
GO:0072009 | 2e-04 | 3.7573 | 3.5362 | 12 | 107 | nephron epithelium development |
GO:0061326 | 2e-04 | 3.986 | 3.0735 | 11 | 93 | renal tubule development |
GO:0072359 | 2e-04 | 1.7564 | 32.2225 | 53 | 975 | circulatory system development |
GO:0034641 | 2e-04 | 1.3654 | 211.4126 | 251 | 6397 | cellular nitrogen compound metabolic process |
GO:0060562 | 3e-04 | 2.4134 | 10.2121 | 23 | 309 | epithelial tube morphogenesis |
GO:0034248 | 3e-04 | 2.027 | 17.8794 | 34 | 541 | regulation of cellular amide metabolic process |
GO:0001655 | 3e-04 | 2.3879 | 10.3112 | 23 | 312 | urogenital system development |
GO:0090084 | 3e-04 | 16.8368 | 0.3635 | 4 | 11 | negative regulation of inclusion body assembly |
GO:0010040 | 3e-04 | 44.128 | 0.1652 | 3 | 5 | response to iron(II) ion |
GO:0032892 | 4e-04 | 7.3858 | 0.9915 | 6 | 30 | positive regulation of organic acid transport |
GO:0048699 | 4e-04 | 1.9413 | 19.7581 | 36 | 622 | generation of neurons |
GO:0060065 | 4e-04 | 9.8349 | 0.661 | 5 | 20 | uterus development |
GO:0060216 | 4e-04 | 9.8349 | 0.661 | 5 | 20 | definitive hemopoiesis |
GO:0051954 | 5e-04 | 7.0899 | 1.0245 | 6 | 31 | positive regulation of amine transport |
GO:0060021 | 5e-04 | 3.9779 | 2.7945 | 10 | 85 | palate development |
GO:1903793 | 5e-04 | 5.7509 | 1.4211 | 7 | 43 | positive regulation of anion transport |
GO:0070887 | 5e-04 | 1.4315 | 95.7421 | 126 | 2897 | cellular response to chemical stimulus |
GO:0021854 | 5e-04 | 9.2196 | 0.694 | 5 | 21 | hypothalamus development |
GO:0048485 | 5e-04 | 9.2196 | 0.694 | 5 | 21 | sympathetic nervous system development |
GO:0050767 | 5e-04 | 1.8412 | 23.068 | 40 | 698 | regulation of neurogenesis |
GO:0035115 | 6e-04 | 6.8168 | 1.0576 | 6 | 32 | embryonic forelimb morphogenesis |
GO:0034622 | 6e-04 | 1.6882 | 33.3792 | 53 | 1010 | cellular macromolecular complex assembly |
GO:0001947 | 6e-04 | 4.7369 | 1.9168 | 8 | 58 | heart looping |
GO:0007530 | 6e-04 | 8.6767 | 0.7271 | 5 | 22 | sex determination |
GO:0035050 | 7e-04 | 4.1674 | 2.4126 | 9 | 73 | embryonic heart tube development |
GO:0003278 | 7e-04 | 29.4168 | 0.1983 | 3 | 6 | apoptotic process involved in heart morphogenesis |
GO:0034112 | 7e-04 | 29.4168 | 0.1983 | 3 | 6 | positive regulation of homotypic cell-cell adhesion |
GO:0038001 | 7e-04 | 29.4168 | 0.1983 | 3 | 6 | paracrine signaling |
GO:0060022 | 7e-04 | 29.4168 | 0.1983 | 3 | 6 | hard palate development |
GO:0072284 | 7e-04 | 29.4168 | 0.1983 | 3 | 6 | metanephric S-shaped body morphogenesis |
GO:2001279 | 7e-04 | 29.4168 | 0.1983 | 3 | 6 | regulation of unsaturated fatty acid biosynthetic process |
GO:0048609 | 7e-04 | 1.7979 | 24.1818 | 41 | 738 | multicellular organismal reproductive process |
GO:0030326 | 7e-04 | 6.429 | 1.107 | 6 | 34 | embryonic limb morphogenesis |
GO:0010720 | 7e-04 | 1.993 | 15.9625 | 30 | 483 | positive regulation of cell development |
GO:0098801 | 8e-04 | 6.3291 | 1.1237 | 6 | 34 | regulation of renal system process |
GO:0009887 | 8e-04 | 1.8983 | 18.9949 | 34 | 613 | animal organ morphogenesis |
GO:0090092 | 8e-04 | 2.5614 | 7.1055 | 17 | 215 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
GO:0014032 | 9e-04 | 4.4679 | 2.016 | 8 | 61 | neural crest cell development |
GO:0048592 | 9e-04 | 3.3365 | 3.5956 | 11 | 110 | eye morphogenesis |
GO:0060255 | 0.001 | 1.42 | 98.4576 | 126 | 3282 | regulation of macromolecule metabolic process |
GO:0071345 | 0.001 | 1.7057 | 28.5541 | 46 | 864 | cellular response to cytokine stimulus |
GO:0051384 | 0.001 | 2.9506 | 4.759 | 13 | 144 | response to glucocorticoid |
GO:0051047 | 0.0011 | 2.1197 | 12.0051 | 24 | 365 | positive regulation of secretion |
GO:2000177 | 0.0011 | 3.8642 | 2.5778 | 9 | 78 | regulation of neural precursor cell proliferation |
GO:0048565 | 0.0011 | 3.0847 | 4.215 | 12 | 128 | digestive tract development |
GO:0021545 | 0.0011 | 4.9275 | 1.6194 | 7 | 49 | cranial nerve development |
GO:0051962 | 0.0011 | 1.9629 | 15.632 | 29 | 473 | positive regulation of nervous system development |
GO:0002930 | 0.0011 | Inf | 0.0661 | 2 | 2 | trabecular meshwork development |
GO:0014036 | 0.0011 | Inf | 0.0661 | 2 | 2 | neural crest cell fate specification |
GO:0060465 | 0.0011 | Inf | 0.0661 | 2 | 2 | pharynx development |
GO:0060516 | 0.0011 | Inf | 0.0661 | 2 | 2 | primary prostatic bud elongation |
GO:0061032 | 0.0011 | Inf | 0.0661 | 2 | 2 | visceral serous pericardium development |
GO:2000824 | 0.0011 | Inf | 0.0661 | 2 | 2 | negative regulation of androgen receptor activity |
GO:2001111 | 0.0011 | Inf | 0.0661 | 2 | 2 | positive regulation of lens epithelial cell proliferation |
GO:0035282 | 0.0012 | 3.4884 | 3.1396 | 10 | 95 | segmentation |
GO:0071773 | 0.0012 | 2.7585 | 5.453 | 14 | 165 | cellular response to BMP stimulus |
GO:0072091 | 0.0012 | 4.2278 | 2.1151 | 8 | 64 | regulation of stem cell proliferation |
GO:0060548 | 0.0012 | 1.6683 | 30.4379 | 48 | 921 | negative regulation of cell death |
GO:0045666 | 0.0014 | 2.1506 | 10.84 | 22 | 328 | positive regulation of neuron differentiation |
GO:0007283 | 0.0014 | 1.9272 | 15.8964 | 29 | 481 | spermatogenesis |
GO:0007618 | 0.0014 | 5.5365 | 1.2559 | 6 | 38 | mating |
GO:0048598 | 0.0014 | 2.349 | 8.1433 | 18 | 260 | embryonic morphogenesis |
GO:0010605 | 0.0015 | 1.5589 | 42.3747 | 62 | 1348 | negative regulation of macromolecule metabolic process |
GO:0002089 | 0.0015 | 9.854 | 0.5269 | 4 | 16 | lens morphogenesis in camera-type eye |
GO:0009719 | 0.0015 | 1.5166 | 48.2842 | 69 | 1461 | response to endogenous stimulus |
GO:0051241 | 0.0016 | 1.7823 | 21.3353 | 36 | 682 | negative regulation of multicellular organismal process |
GO:0072148 | 0.0016 | 9.8184 | 0.5288 | 4 | 16 | epithelial cell fate commitment |
GO:0007275 | 0.0016 | 2.0605 | 12.453 | 24 | 492 | multicellular organism development |
GO:1903251 | 0.0018 | 17.6479 | 0.2644 | 3 | 8 | multi-ciliated epithelial cell differentiation |
GO:0021879 | 0.0019 | 4.4019 | 1.7846 | 7 | 54 | forebrain neuron differentiation |
GO:0003205 | 0.0019 | 2.7201 | 5.1226 | 13 | 155 | cardiac chamber development |
GO:0048522 | 0.0019 | 1.3449 | 125.5379 | 154 | 3977 | positive regulation of cellular process |
GO:0051955 | 0.002 | 6.4108 | 0.9254 | 5 | 28 | regulation of amino acid transport |
GO:0043066 | 0.0022 | 1.6573 | 27.3313 | 43 | 827 | negative regulation of apoptotic process |
GO:0021915 | 0.0023 | 2.6634 | 5.2217 | 13 | 158 | neural tube development |
GO:0007281 | 0.0023 | 2.302 | 7.8325 | 17 | 237 | germ cell development |
GO:0035116 | 0.0024 | 6.1433 | 0.9584 | 5 | 29 | embryonic hindlimb morphogenesis |
GO:0001838 | 0.0024 | 2.9391 | 4.0319 | 11 | 122 | embryonic epithelial tube formation |
GO:0060429 | 0.0024 | 1.6303 | 29.1012 | 45 | 915 | epithelium development |
GO:0019953 | 0.0024 | 1.6911 | 24.2726 | 39 | 741 | sexual reproduction |
GO:0032095 | 0.0025 | 8.4147 | 0.5949 | 4 | 18 | regulation of response to food |
GO:0003208 | 0.0025 | 3.6974 | 2.3795 | 8 | 72 | cardiac ventricle morphogenesis |
GO:0007498 | 0.0025 | 2.9127 | 4.065 | 11 | 123 | mesoderm development |
GO:0003149 | 0.0026 | 14.7056 | 0.2974 | 3 | 9 | membranous septum morphogenesis |
GO:0014049 | 0.0026 | 14.7056 | 0.2974 | 3 | 9 | positive regulation of glutamate secretion |
GO:0042538 | 0.0026 | 14.7056 | 0.2974 | 3 | 9 | hyperosmotic salinity response |
GO:0043084 | 0.0026 | 14.7056 | 0.2974 | 3 | 9 | penile erection |
GO:0048664 | 0.0026 | 14.7056 | 0.2974 | 3 | 9 | neuron fate determination |
GO:0060180 | 0.0026 | 14.7056 | 0.2974 | 3 | 9 | female mating behavior |
GO:0061004 | 0.0026 | 14.7056 | 0.2974 | 3 | 9 | pattern specification involved in kidney development |
GO:0007548 | 0.0026 | 2.217 | 8.5927 | 18 | 260 | sex differentiation |
GO:0006950 | 0.0027 | 1.3295 | 119.5372 | 147 | 3617 | response to stress |
GO:0009799 | 0.0027 | 2.8867 | 4.098 | 11 | 124 | specification of symmetry |
GO:0072078 | 0.0028 | 3.6403 | 2.4126 | 8 | 73 | nephron tubule morphogenesis |
GO:0019098 | 0.0028 | 5.8972 | 0.9915 | 5 | 30 | reproductive behavior |
GO:0051240 | 0.0028 | 1.6354 | 27.7139 | 43 | 882 | positive regulation of multicellular organismal process |
GO:0048738 | 0.0028 | 2.3985 | 6.6428 | 15 | 201 | cardiac muscle tissue development |
GO:0051094 | 0.0029 | 1.6978 | 22.9361 | 37 | 719 | positive regulation of developmental process |
GO:0009266 | 0.003 | 2.3115 | 7.3368 | 16 | 222 | response to temperature stimulus |
GO:0035148 | 0.003 | 2.6977 | 4.759 | 12 | 144 | tube formation |
GO:0048646 | 0.0031 | 1.6461 | 26.1988 | 41 | 815 | anatomical structure formation involved in morphogenesis |
GO:0042743 | 0.0031 | 4.6606 | 1.4541 | 6 | 44 | hydrogen peroxide metabolic process |
GO:0001759 | 0.0031 | 7.8532 | 0.6279 | 4 | 19 | organ induction |
GO:0002320 | 0.0031 | 7.8532 | 0.6279 | 4 | 19 | lymphoid progenitor cell differentiation |
GO:0060438 | 0.0031 | 7.8532 | 0.6279 | 4 | 19 | trachea development |
GO:0007417 | 0.0032 | 1.6872 | 23.0516 | 37 | 721 | central nervous system development |
GO:0003407 | 0.0032 | 3.9774 | 1.9499 | 7 | 59 | neural retina development |
GO:0001546 | 0.0032 | 58.7313 | 0.0991 | 2 | 3 | preantral ovarian follicle growth |
GO:0007412 | 0.0032 | 58.7313 | 0.0991 | 2 | 3 | axon target recognition |
GO:0032227 | 0.0032 | 58.7313 | 0.0991 | 2 | 3 | negative regulation of synaptic transmission, dopaminergic |
GO:0055014 | 0.0032 | 58.7313 | 0.0991 | 2 | 3 | atrial cardiac muscle cell development |
GO:0060278 | 0.0032 | 58.7313 | 0.0991 | 2 | 3 | regulation of ovulation |
GO:0070370 | 0.0032 | 58.7313 | 0.0991 | 2 | 3 | cellular heat acclimation |
GO:0070434 | 0.0032 | 58.7313 | 0.0991 | 2 | 3 | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway |
GO:0072190 | 0.0032 | 58.7313 | 0.0991 | 2 | 3 | ureter urothelium development |
GO:0072197 | 0.0032 | 58.7313 | 0.0991 | 2 | 3 | ureter morphogenesis |
GO:0072199 | 0.0032 | 58.7313 | 0.0991 | 2 | 3 | regulation of mesenchymal cell proliferation involved in ureter development |
GO:0001944 | 0.0032 | 1.7114 | 21.4817 | 35 | 650 | vasculature development |
GO:1903530 | 0.0032 | 1.7114 | 21.4817 | 35 | 650 | regulation of secretion by cell |
GO:1901532 | 0.0032 | 13.1563 | 0.3171 | 3 | 10 | regulation of hematopoietic progenitor cell differentiation |
GO:0009914 | 0.0032 | 2.0717 | 10.179 | 20 | 308 | hormone transport |
GO:0032355 | 0.0033 | 2.8115 | 4.1972 | 11 | 127 | response to estradiol |
GO:0050830 | 0.0033 | 3.5312 | 2.4787 | 8 | 75 | defense response to Gram-positive bacterium |
GO:0010721 | 0.0033 | 2.1136 | 9.485 | 19 | 287 | negative regulation of cell development |
GO:0050878 | 0.0034 | 1.8456 | 15.3716 | 27 | 468 | regulation of body fluid levels |
GO:0051961 | 0.0034 | 2.1537 | 8.824 | 18 | 267 | negative regulation of nervous system development |
GO:0060174 | 0.0036 | 12.604 | 0.3305 | 3 | 10 | limb bud formation |
GO:0060502 | 0.0036 | 12.604 | 0.3305 | 3 | 10 | epithelial cell proliferation involved in lung morphogenesis |
GO:2001214 | 0.0036 | 12.604 | 0.3305 | 3 | 10 | positive regulation of vasculogenesis |
GO:0042423 | 0.0037 | 7.3619 | 0.661 | 4 | 20 | catecholamine biosynthetic process |
GO:0033002 | 0.0038 | 2.4043 | 6.1801 | 14 | 187 | muscle cell proliferation |
GO:0048762 | 0.0038 | 2.4043 | 6.1801 | 14 | 187 | mesenchymal cell differentiation |
GO:0060415 | 0.0038 | 3.4284 | 2.5448 | 8 | 77 | muscle tissue morphogenesis |
GO:0072028 | 0.0038 | 3.4284 | 2.5448 | 8 | 77 | nephron morphogenesis |
GO:0032330 | 0.0039 | 4.427 | 1.5202 | 6 | 46 | regulation of chondrocyte differentiation |
GO:0070848 | 0.004 | 1.6857 | 21.7791 | 35 | 659 | response to growth factor |
GO:0003338 | 0.0043 | 5.2643 | 1.0906 | 5 | 33 | metanephros morphogenesis |
GO:0006693 | 0.0043 | 5.2643 | 1.0906 | 5 | 33 | prostaglandin metabolic process |
GO:0045907 | 0.0043 | 5.2643 | 1.0906 | 5 | 33 | positive regulation of vasoconstriction |
GO:0098751 | 0.0043 | 5.2643 | 1.0906 | 5 | 33 | bone cell development |
GO:0009743 | 0.0043 | 2.2865 | 6.9402 | 15 | 210 | response to carbohydrate |
GO:1903556 | 0.0043 | 4.3187 | 1.5533 | 6 | 47 | negative regulation of tumor necrosis factor superfamily cytokine production |
GO:2000677 | 0.0043 | 4.3187 | 1.5533 | 6 | 47 | regulation of transcription regulatory region DNA binding |
GO:1903426 | 0.0045 | 3.3314 | 2.6108 | 8 | 79 | regulation of reactive oxygen species biosynthetic process |
GO:0007368 | 0.0045 | 2.8476 | 3.7676 | 10 | 114 | determination of left/right symmetry |
GO:0002052 | 0.0045 | 6.9284 | 0.694 | 4 | 21 | positive regulation of neuroblast proliferation |
GO:0035809 | 0.0045 | 6.9284 | 0.694 | 4 | 21 | regulation of urine volume |
GO:0042733 | 0.0046 | 3.6923 | 2.0821 | 7 | 63 | embryonic digit morphogenesis |
GO:0010463 | 0.0048 | 4.2156 | 1.5863 | 6 | 48 | mesenchymal cell proliferation |
GO:0045933 | 0.0048 | 4.2156 | 1.5863 | 6 | 48 | positive regulation of muscle contraction |
GO:0048484 | 0.0049 | 11.0278 | 0.3635 | 3 | 11 | enteric nervous system development |
GO:0060433 | 0.0049 | 11.0278 | 0.3635 | 3 | 11 | bronchus development |
GO:0045165 | 0.0049 | 2.5213 | 5.0565 | 12 | 158 | cell fate commitment |
GO:0045665 | 0.005 | 2.3228 | 6.3784 | 14 | 193 | negative regulation of neuron differentiation |
GO:0001708 | 0.0054 | 4.1027 | 1.6219 | 6 | 50 | cell fate specification |
GO:0021513 | 0.0054 | 6.5431 | 0.7271 | 4 | 22 | spinal cord dorsal/ventral patterning |
GO:1904888 | 0.0055 | 3.5645 | 2.1482 | 7 | 65 | cranial skeletal system development |
GO:2000826 | 0.0055 | 4.9128 | 1.1567 | 5 | 35 | regulation of heart morphogenesis |
GO:0042127 | 0.0055 | 1.6613 | 21.461 | 34 | 681 | regulation of cell proliferation |
GO:0060485 | 0.0058 | 4.8437 | 1.1687 | 5 | 36 | mesenchyme development |
GO:0120039 | 0.0059 | 1.6802 | 19.9284 | 32 | 603 | plasma membrane bounded cell projection morphogenesis |
GO:0009712 | 0.0059 | 4.0235 | 1.6524 | 6 | 50 | catechol-containing compound metabolic process |
GO:0097756 | 0.0061 | 3.1529 | 2.743 | 8 | 83 | negative regulation of blood vessel diameter |
GO:0030856 | 0.0061 | 2.5662 | 4.5607 | 11 | 138 | regulation of epithelial cell differentiation |
GO:0040011 | 0.0062 | 1.4061 | 54.6626 | 73 | 1654 | locomotion |
GO:0001705 | 0.0063 | 29.3638 | 0.1322 | 2 | 4 | ectoderm formation |
GO:0003219 | 0.0063 | 29.3638 | 0.1322 | 2 | 4 | cardiac right ventricle formation |
GO:0003415 | 0.0063 | 29.3638 | 0.1322 | 2 | 4 | chondrocyte hypertrophy |
GO:0007621 | 0.0063 | 29.3638 | 0.1322 | 2 | 4 | negative regulation of female receptivity |
GO:0018916 | 0.0063 | 29.3638 | 0.1322 | 2 | 4 | nitrobenzene metabolic process |
GO:0021764 | 0.0063 | 29.3638 | 0.1322 | 2 | 4 | amygdala development |
GO:0021797 | 0.0063 | 29.3638 | 0.1322 | 2 | 4 | forebrain anterior/posterior pattern specification |
GO:0032849 | 0.0063 | 29.3638 | 0.1322 | 2 | 4 | positive regulation of cellular pH reduction |
GO:0034287 | 0.0063 | 29.3638 | 0.1322 | 2 | 4 | detection of monosaccharide stimulus |
GO:0051594 | 0.0063 | 29.3638 | 0.1322 | 2 | 4 | detection of glucose |
GO:0051673 | 0.0063 | 29.3638 | 0.1322 | 2 | 4 | membrane disruption in other organism |
GO:0060018 | 0.0063 | 29.3638 | 0.1322 | 2 | 4 | astrocyte fate commitment |
GO:0060235 | 0.0063 | 29.3638 | 0.1322 | 2 | 4 | lens induction in camera-type eye |
GO:0061047 | 0.0063 | 29.3638 | 0.1322 | 2 | 4 | positive regulation of branching involved in lung morphogenesis |
GO:0061056 | 0.0063 | 29.3638 | 0.1322 | 2 | 4 | sclerotome development |
GO:0061325 | 0.0063 | 29.3638 | 0.1322 | 2 | 4 | cell proliferation involved in outflow tract morphogenesis |
GO:0070384 | 0.0063 | 29.3638 | 0.1322 | 2 | 4 | Harderian gland development |
GO:0072086 | 0.0063 | 29.3638 | 0.1322 | 2 | 4 | specification of loop of Henle identity |
GO:0072125 | 0.0063 | 29.3638 | 0.1322 | 2 | 4 | negative regulation of glomerular mesangial cell proliferation |
GO:0072278 | 0.0063 | 29.3638 | 0.1322 | 2 | 4 | metanephric comma-shaped body morphogenesis |
GO:0090063 | 0.0063 | 29.3638 | 0.1322 | 2 | 4 | positive regulation of microtubule nucleation |
GO:0097476 | 0.0063 | 29.3638 | 0.1322 | 2 | 4 | spinal cord motor neuron migration |
GO:0010608 | 0.0063 | 1.6576 | 20.8207 | 33 | 630 | posttranscriptional regulation of gene expression |
GO:0003084 | 0.0063 | 9.8019 | 0.3966 | 3 | 12 | positive regulation of systemic arterial blood pressure |
GO:0003184 | 0.0063 | 9.8019 | 0.3966 | 3 | 12 | pulmonary valve morphogenesis |
GO:0032099 | 0.0063 | 9.8019 | 0.3966 | 3 | 12 | negative regulation of appetite |
GO:0043576 | 0.0063 | 6.1983 | 0.7601 | 4 | 23 | regulation of respiratory gaseous exchange |
GO:0046457 | 0.0063 | 6.1983 | 0.7601 | 4 | 23 | prostanoid biosynthetic process |
GO:0045637 | 0.0064 | 2.4275 | 5.2339 | 12 | 165 | regulation of myeloid cell differentiation |
GO:0045995 | 0.0065 | 2.6913 | 3.9658 | 10 | 120 | regulation of embryonic development |
GO:0009948 | 0.0065 | 3.9338 | 1.6855 | 6 | 51 | anterior/posterior axis specification |
GO:0007631 | 0.0065 | 3.1085 | 2.7765 | 8 | 85 | feeding behavior |
GO:0001764 | 0.0068 | 2.5261 | 4.6268 | 11 | 140 | neuron migration |
GO:0048729 | 0.007 | 1.7036 | 17.7953 | 29 | 544 | tissue morphogenesis |
GO:0045778 | 0.007 | 3.0706 | 2.8091 | 8 | 85 | positive regulation of ossification |
GO:0032526 | 0.0071 | 2.832 | 3.404 | 9 | 103 | response to retinoic acid |
GO:0010469 | 0.0071 | 1.7015 | 17.8133 | 29 | 539 | regulation of receptor activity |
GO:0035176 | 0.0071 | 3.8481 | 1.7185 | 6 | 52 | social behavior |
GO:0060038 | 0.0071 | 3.8481 | 1.7185 | 6 | 52 | cardiac muscle cell proliferation |
GO:0048839 | 0.0072 | 2.2953 | 5.9818 | 13 | 181 | inner ear development |
GO:0051091 | 0.0073 | 2.0855 | 8.0639 | 16 | 244 | positive regulation of DNA binding transcription factor activity |
GO:0002068 | 0.0074 | 5.888 | 0.7932 | 4 | 24 | glandular epithelial cell development |
GO:0030878 | 0.0074 | 5.888 | 0.7932 | 4 | 24 | thyroid gland development |
GO:0032104 | 0.0074 | 5.888 | 0.7932 | 4 | 24 | regulation of response to extracellular stimulus |
GO:0042026 | 0.0074 | 5.888 | 0.7932 | 4 | 24 | protein refolding |
GO:0048103 | 0.0074 | 5.888 | 0.7932 | 4 | 24 | somatic stem cell division |
GO:0070193 | 0.0074 | 5.888 | 0.7932 | 4 | 24 | synaptonemal complex organization |
GO:0048514 | 0.0074 | 1.6947 | 17.8794 | 29 | 541 | blood vessel morphogenesis |
GO:0030902 | 0.0075 | 2.4872 | 4.6929 | 11 | 142 | hindbrain development |
GO:0048523 | 0.0076 | 1.3657 | 68.8715 | 88 | 2324 | negative regulation of cellular process |
GO:0021954 | 0.0076 | 3.3337 | 2.2804 | 7 | 69 | central nervous system neuron development |
GO:0060688 | 0.0078 | 3.766 | 1.7516 | 6 | 53 | regulation of morphogenesis of a branching structure |
GO:0061005 | 0.0078 | 3.766 | 1.7516 | 6 | 53 | cell differentiation involved in kidney development |
GO:0014003 | 0.0079 | 4.4653 | 1.2559 | 5 | 38 | oligodendrocyte development |
GO:0031113 | 0.0079 | 4.4653 | 1.2559 | 5 | 38 | regulation of microtubule polymerization |
GO:0048568 | 0.008 | 2.5973 | 4.0886 | 10 | 131 | embryonic organ development |
GO:0001967 | 0.008 | 8.8211 | 0.4296 | 3 | 13 | suckling behavior |
GO:0002087 | 0.008 | 8.8211 | 0.4296 | 3 | 13 | regulation of respiratory gaseous exchange by neurological system process |
GO:0007320 | 0.008 | 8.8211 | 0.4296 | 3 | 13 | insemination |
GO:0035815 | 0.008 | 8.8211 | 0.4296 | 3 | 13 | positive regulation of renal sodium excretion |
GO:0072044 | 0.008 | 8.8211 | 0.4296 | 3 | 13 | collecting duct development |
GO:1902106 | 0.008 | 2.9925 | 2.8752 | 8 | 87 | negative regulation of leukocyte differentiation |
GO:0010648 | 0.0082 | 1.4395 | 42.2032 | 58 | 1277 | negative regulation of cell communication |
GO:0051048 | 0.0083 | 2.1752 | 6.775 | 14 | 205 | negative regulation of secretion |
GO:0060538 | 0.0084 | 2.3398 | 5.42 | 12 | 164 | skeletal muscle organ development |
GO:0002065 | 0.0085 | 2.7439 | 3.5032 | 9 | 106 | columnar/cuboidal epithelial cell differentiation |
GO:0043279 | 0.0085 | 2.7439 | 3.5032 | 9 | 106 | response to alkaloid |
GO:0030316 | 0.0086 | 2.9549 | 2.9083 | 8 | 88 | osteoclast differentiation |
GO:0030901 | 0.0086 | 2.9549 | 2.9083 | 8 | 88 | midbrain development |
GO:0060419 | 0.0086 | 2.9549 | 2.9083 | 8 | 88 | heart growth |
GO:0003148 | 0.0086 | 5.6073 | 0.8262 | 4 | 25 | outflow tract septum morphogenesis |
GO:0003309 | 0.0086 | 5.6073 | 0.8262 | 4 | 25 | type B pancreatic cell differentiation |
GO:0031112 | 0.0086 | 5.6073 | 0.8262 | 4 | 25 | positive regulation of microtubule polymerization or depolymerization |
GO:0042481 | 0.0086 | 5.6073 | 0.8262 | 4 | 25 | regulation of odontogenesis |
GO:0044062 | 0.0086 | 5.6073 | 0.8262 | 4 | 25 | regulation of excretion |
GO:0060037 | 0.0086 | 5.6073 | 0.8262 | 4 | 25 | pharyngeal system development |
GO:0060351 | 0.0086 | 5.6073 | 0.8262 | 4 | 25 | cartilage development involved in endochondral bone morphogenesis |
GO:0023057 | 0.0088 | 1.4344 | 42.3354 | 58 | 1281 | negative regulation of signaling |
GO:0003170 | 0.0088 | 4.3337 | 1.2889 | 5 | 39 | heart valve development |
GO:0003197 | 0.0088 | 4.3337 | 1.2889 | 5 | 39 | endocardial cushion development |
GO:0090184 | 0.0088 | 4.3337 | 1.2889 | 5 | 39 | positive regulation of kidney development |
GO:0008406 | 0.0094 | 2.1411 | 6.8741 | 14 | 208 | gonad development |
GO:0048468 | 0.0096 | 1.4913 | 32.296 | 46 | 1038 | cell development |
GO:0032990 | 0.0097 | 1.6155 | 20.6554 | 32 | 625 | cell part morphogenesis |
GO:0090277 | 0.0098 | 2.8825 | 2.9744 | 8 | 90 | positive regulation of peptide hormone secretion |
GO:0014014 | 0.0098 | 4.2096 | 1.3219 | 5 | 40 | negative regulation of gliogenesis |
GO:0061217 | 0.0099 | 5.3521 | 0.8593 | 4 | 26 | regulation of mesonephros development |
GO:0072207 | 0.0099 | 5.3521 | 0.8593 | 4 | 26 | metanephric epithelium development |
GO:0002791 | 0.0099 | 1.746 | 14.3431 | 24 | 434 | regulation of peptide secretion |
GO:0032108 | 0.01 | 8.0187 | 0.4627 | 3 | 14 | negative regulation of response to nutrient levels |
GO:0042711 | 0.01 | 8.0187 | 0.4627 | 3 | 14 | maternal behavior |
GO:0060712 | 0.01 | 8.0187 | 0.4627 | 3 | 14 | spongiotrophoblast layer development |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 195.9429 | 0.5288 | 24 | 32 | DNA replication-dependent nucleosome assembly |
GO:0000183 | 0 | 111.9254 | 0.6279 | 24 | 38 | chromatin silencing at rDNA |
GO:0051290 | 0 | 86.2327 | 0.7271 | 25 | 44 | protein heterotetramerization |
GO:0045815 | 0 | 29.7224 | 1.3219 | 25 | 80 | positive regulation of gene expression, epigenetic |
GO:0045653 | 0 | 219.6902 | 0.2974 | 14 | 18 | negative regulation of megakaryocyte differentiation |
GO:0060964 | 0 | 20.149 | 1.7516 | 25 | 106 | regulation of gene silencing by miRNA |
GO:0045814 | 0 | 17.3726 | 2.049 | 26 | 124 | negative regulation of gene expression, epigenetic |
GO:1902036 | 0 | 19.7543 | 1.702 | 24 | 103 | regulation of hematopoietic stem cell differentiation |
GO:0031497 | 0 | 14.2936 | 2.4952 | 27 | 151 | chromatin assembly |
GO:0060968 | 0 | 15.5201 | 2.1482 | 25 | 130 | regulation of gene silencing |
GO:0048863 | 0 | 9.9092 | 3.8041 | 30 | 236 | stem cell differentiation |
GO:0002244 | 0 | 11.5048 | 2.9862 | 27 | 182 | hematopoietic progenitor cell differentiation |
GO:0065004 | 0 | 9.2782 | 3.7345 | 28 | 226 | protein-DNA complex assembly |
GO:0035194 | 0 | 8.9133 | 3.8667 | 28 | 234 | posttranscriptional gene silencing by RNA |
GO:1902679 | 0 | 3.979 | 19.1683 | 61 | 1160 | negative regulation of RNA biosynthetic process |
GO:0032200 | 0 | 10.9466 | 2.743 | 24 | 166 | telomere organization |
GO:0045934 | 0 | 3.6033 | 22.9854 | 66 | 1391 | negative regulation of nucleobase-containing compound metabolic process |
GO:0034080 | 0 | 31.3373 | 0.694 | 14 | 42 | CENP-A containing nucleosome assembly |
GO:1904837 | 0 | 29.2444 | 0.7271 | 14 | 44 | beta-catenin-TCF complex assembly |
GO:0030099 | 0 | 5.9371 | 6.4115 | 32 | 388 | myeloid cell differentiation |
GO:0071103 | 0 | 7.1202 | 4.5277 | 27 | 274 | DNA conformation change |
GO:0034724 | 0 | 21.9196 | 0.8923 | 14 | 54 | DNA replication-independent nucleosome organization |
GO:0016233 | 0 | 21.3836 | 0.9088 | 14 | 55 | telomere capping |
GO:0045892 | 0 | 6.4809 | 5.1548 | 28 | 337 | negative regulation of transcription, DNA-templated |
GO:0009890 | 0 | 3.1359 | 26.8851 | 68 | 1627 | negative regulation of biosynthetic process |
GO:1903707 | 0 | 10.9708 | 2.133 | 19 | 130 | negative regulation of hemopoiesis |
GO:0017148 | 0 | 6.2106 | 5.3208 | 28 | 322 | negative regulation of translation |
GO:0034654 | 0 | 2.4223 | 68.7578 | 121 | 4161 | nucleobase-containing compound biosynthetic process |
GO:0048534 | 0 | 3.7698 | 14.1283 | 45 | 855 | hematopoietic or lymphoid organ development |
GO:0006303 | 0 | 14.3546 | 1.2393 | 14 | 75 | double-strand break repair via nonhomologous end joining |
GO:0043044 | 0 | 13.6792 | 1.2889 | 14 | 78 | ATP-dependent chromatin remodeling |
GO:0097659 | 0 | 2.7338 | 34.7681 | 74 | 2289 | nucleic acid-templated transcription |
GO:0032502 | 0 | 2.2608 | 92.8443 | 144 | 5735 | developmental process |
GO:0051259 | 0 | 4.3129 | 8.5596 | 32 | 518 | protein oligomerization |
GO:0038111 | 0 | 22.0381 | 0.6279 | 10 | 38 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 21.2768 | 0.6444 | 10 | 39 | response to interleukin-7 |
GO:0034728 | 0 | 9.9174 | 1.6817 | 14 | 107 | nucleosome organization |
GO:0045596 | 0 | 4.9886 | 5.5022 | 24 | 345 | negative regulation of cell differentiation |
GO:0009893 | 0 | 2.213 | 53.225 | 94 | 3221 | positive regulation of metabolic process |
GO:0034248 | 0 | 3.8072 | 8.9397 | 30 | 541 | regulation of cellular amide metabolic process |
GO:0034645 | 0 | 2.0519 | 82.407 | 127 | 4987 | cellular macromolecule biosynthetic process |
GO:0006352 | 0 | 5.48 | 3.9328 | 19 | 238 | DNA-templated transcription, initiation |
GO:0045652 | 0 | 13.8593 | 0.8939 | 10 | 57 | regulation of megakaryocyte differentiation |
GO:0010608 | 0 | 3.3511 | 10.4103 | 31 | 630 | posttranscriptional regulation of gene expression |
GO:0010628 | 0 | 2.3291 | 25.8174 | 52 | 1714 | positive regulation of gene expression |
GO:0051248 | 0 | 2.4376 | 20.8868 | 45 | 1264 | negative regulation of protein metabolic process |
GO:0048665 | 0 | 16.4251 | 0.5453 | 7 | 33 | neuron fate specification |
GO:0007389 | 0 | 3.5948 | 6.7612 | 22 | 412 | pattern specification process |
GO:0016070 | 0 | 2.0115 | 46.0162 | 76 | 3042 | RNA metabolic process |
GO:0043043 | 0 | 2.7588 | 12.8725 | 32 | 779 | peptide biosynthetic process |
GO:0000122 | 0 | 2.7357 | 12.9716 | 32 | 785 | negative regulation of transcription from RNA polymerase II promoter |
GO:1901576 | 0 | 1.757 | 102.3849 | 139 | 6196 | organic substance biosynthetic process |
GO:0045944 | 0 | 2.4085 | 18.0446 | 39 | 1092 | positive regulation of transcription from RNA polymerase II promoter |
GO:1901360 | 0 | 1.7363 | 100.3028 | 136 | 6070 | organic cyclic compound metabolic process |
GO:0001501 | 0 | 3.1465 | 8.0143 | 23 | 485 | skeletal system development |
GO:0006725 | 0 | 1.7281 | 96.8823 | 132 | 5863 | cellular aromatic compound metabolic process |
GO:0046483 | 0 | 1.7198 | 96.2544 | 131 | 5825 | heterocycle metabolic process |
GO:2001141 | 0 | 2.0455 | 32.7429 | 57 | 2380 | regulation of RNA biosynthetic process |
GO:0006355 | 0 | 2.0287 | 32.9419 | 57 | 2389 | regulation of transcription, DNA-templated |
GO:0043009 | 0 | 2.828 | 9.2536 | 24 | 560 | chordate embryonic development |
GO:0048484 | 0 | 34.5078 | 0.1818 | 4 | 11 | enteric nervous system development |
GO:0090084 | 0 | 34.5078 | 0.1818 | 4 | 11 | negative regulation of inclusion body assembly |
GO:0034641 | 0 | 1.6662 | 105.7063 | 139 | 6397 | cellular nitrogen compound metabolic process |
GO:0007530 | 0 | 17.8175 | 0.3635 | 5 | 22 | sex determination |
GO:0061458 | 0 | 3.1185 | 6.9733 | 20 | 422 | reproductive system development |
GO:0009953 | 0 | 6.4095 | 1.5698 | 9 | 95 | dorsal/ventral pattern formation |
GO:2000738 | 0 | 30.4163 | 0.1969 | 4 | 12 | positive regulation of stem cell differentiation |
GO:0002376 | 0 | 1.8151 | 44.1035 | 70 | 2669 | immune system process |
GO:0051254 | 0 | 2.053 | 24.3239 | 45 | 1472 | positive regulation of RNA metabolic process |
GO:0060249 | 1e-04 | 3.1624 | 6.1636 | 18 | 373 | anatomical structure homeostasis |
GO:1903508 | 1e-04 | 2.0528 | 23.1506 | 43 | 1401 | positive regulation of nucleic acid-templated transcription |
GO:0048565 | 1e-04 | 5.1126 | 2.1482 | 10 | 130 | digestive tract development |
GO:0003278 | 1e-04 | 60.1767 | 0.0991 | 3 | 6 | apoptotic process involved in heart morphogenesis |
GO:0009889 | 1e-04 | 1.8613 | 37.7115 | 60 | 2749 | regulation of biosynthetic process |
GO:0070271 | 1e-04 | 1.9931 | 23.1671 | 42 | 1402 | protein complex biogenesis |
GO:0003357 | 1e-04 | 45.1297 | 0.1157 | 3 | 7 | noradrenergic neuron differentiation |
GO:0060537 | 2e-04 | 2.9835 | 6.1305 | 17 | 371 | muscle tissue development |
GO:0007517 | 2e-04 | 2.9579 | 6.1801 | 17 | 374 | muscle organ development |
GO:0019219 | 2e-04 | 1.8133 | 36.9785 | 58 | 2712 | regulation of nucleobase-containing compound metabolic process |
GO:0010605 | 2e-04 | 2.0345 | 20.11 | 37 | 1348 | negative regulation of macromolecule metabolic process |
GO:0048731 | 2e-04 | 1.6881 | 53.3221 | 77 | 3641 | system development |
GO:0019953 | 2e-04 | 2.2637 | 12.8725 | 27 | 779 | sexual reproduction |
GO:0045823 | 3e-04 | 10.0884 | 0.5784 | 5 | 35 | positive regulation of heart contraction |
GO:1903706 | 3e-04 | 3.2308 | 4.6549 | 14 | 303 | regulation of hemopoiesis |
GO:0014036 | 3e-04 | Inf | 0.033 | 2 | 2 | neural crest cell fate specification |
GO:0061032 | 3e-04 | Inf | 0.033 | 2 | 2 | visceral serous pericardium development |
GO:0048664 | 3e-04 | 30.0827 | 0.1487 | 3 | 9 | neuron fate determination |
GO:0031328 | 4e-04 | 1.7975 | 29.3142 | 48 | 1774 | positive regulation of cellular biosynthetic process |
GO:0007548 | 4e-04 | 3.2407 | 4.2963 | 13 | 260 | sex differentiation |
GO:0042127 | 4e-04 | 2.1517 | 14.0776 | 28 | 889 | regulation of cell proliferation |
GO:0007631 | 4e-04 | 4.8766 | 1.7846 | 8 | 108 | feeding behavior |
GO:0071345 | 5e-04 | 2.1088 | 14.277 | 28 | 864 | cellular response to cytokine stimulus |
GO:0001764 | 5e-04 | 4.1959 | 2.3134 | 9 | 140 | neuron migration |
GO:0009952 | 6e-04 | 3.5312 | 3.3379 | 11 | 202 | anterior/posterior pattern specification |
GO:0060485 | 6e-04 | 3.2906 | 3.8997 | 12 | 236 | mesenchyme development |
GO:0051241 | 6e-04 | 2.324 | 10.174 | 22 | 682 | negative regulation of multicellular organismal process |
GO:0042026 | 6e-04 | 12.0679 | 0.3966 | 4 | 24 | protein refolding |
GO:0007281 | 6e-04 | 3.2757 | 3.9163 | 12 | 237 | germ cell development |
GO:0030154 | 7e-04 | 1.8093 | 27.895 | 45 | 2009 | cell differentiation |
GO:0001546 | 8e-04 | 119.9176 | 0.0496 | 2 | 3 | preantral ovarian follicle growth |
GO:0055014 | 8e-04 | 119.9176 | 0.0496 | 2 | 3 | atrial cardiac muscle cell development |
GO:0070370 | 8e-04 | 119.9176 | 0.0496 | 2 | 3 | cellular heat acclimation |
GO:0070434 | 8e-04 | 119.9176 | 0.0496 | 2 | 3 | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway |
GO:0072190 | 8e-04 | 119.9176 | 0.0496 | 2 | 3 | ureter urothelium development |
GO:0072197 | 8e-04 | 119.9176 | 0.0496 | 2 | 3 | ureter morphogenesis |
GO:0061217 | 8e-04 | 10.9695 | 0.4296 | 4 | 26 | regulation of mesonephros development |
GO:0010557 | 8e-04 | 1.7698 | 27.0504 | 44 | 1637 | positive regulation of macromolecule biosynthetic process |
GO:0031018 | 8e-04 | 7.5616 | 0.7436 | 5 | 45 | endocrine pancreas development |
GO:0003207 | 9e-04 | 20.0514 | 0.1983 | 3 | 12 | cardiac chamber formation |
GO:0048704 | 9e-04 | 4.9471 | 1.5368 | 7 | 93 | embryonic skeletal system morphogenesis |
GO:0035883 | 9e-04 | 10.4919 | 0.4462 | 4 | 27 | enteroendocrine cell differentiation |
GO:0048609 | 0.001 | 2.1014 | 12.7158 | 25 | 775 | multicellular organismal reproductive process |
GO:0010721 | 0.001 | 2.9164 | 4.7425 | 13 | 287 | negative regulation of cell development |
GO:0048562 | 0.0011 | 3.4709 | 3.0755 | 10 | 190 | embryonic organ morphogenesis |
GO:0021781 | 0.0011 | 18.0451 | 0.2148 | 3 | 13 | glial cell fate commitment |
GO:0048870 | 0.0012 | 1.7905 | 23.5307 | 39 | 1424 | cell motility |
GO:0065007 | 0.0012 | 1.5588 | 187.4523 | 210 | 11344 | biological regulation |
GO:0048523 | 0.0012 | 1.6061 | 47.5567 | 67 | 3346 | negative regulation of cellular process |
GO:0035019 | 0.0013 | 5.4286 | 1.2063 | 6 | 73 | somatic stem cell population maintenance |
GO:0035050 | 0.0013 | 5.4286 | 1.2063 | 6 | 73 | embryonic heart tube development |
GO:0050878 | 0.0013 | 2.3659 | 8.0804 | 18 | 489 | regulation of body fluid levels |
GO:0045665 | 0.0014 | 3.3392 | 3.1892 | 10 | 193 | negative regulation of neuron differentiation |
GO:0007218 | 0.0014 | 4.5238 | 1.669 | 7 | 101 | neuropeptide signaling pathway |
GO:0002317 | 0.0016 | 59.9551 | 0.0661 | 2 | 4 | plasma cell differentiation |
GO:0003219 | 0.0016 | 59.9551 | 0.0661 | 2 | 4 | cardiac right ventricle formation |
GO:0021764 | 0.0016 | 59.9551 | 0.0661 | 2 | 4 | amygdala development |
GO:0034287 | 0.0016 | 59.9551 | 0.0661 | 2 | 4 | detection of monosaccharide stimulus |
GO:0051594 | 0.0016 | 59.9551 | 0.0661 | 2 | 4 | detection of glucose |
GO:0061325 | 0.0016 | 59.9551 | 0.0661 | 2 | 4 | cell proliferation involved in outflow tract morphogenesis |
GO:0072125 | 0.0016 | 59.9551 | 0.0661 | 2 | 4 | negative regulation of glomerular mesangial cell proliferation |
GO:0072193 | 0.0016 | 59.9551 | 0.0661 | 2 | 4 | ureter smooth muscle cell differentiation |
GO:0090063 | 0.0016 | 59.9551 | 0.0661 | 2 | 4 | positive regulation of microtubule nucleation |
GO:0090191 | 0.0016 | 59.9551 | 0.0661 | 2 | 4 | negative regulation of branching involved in ureteric bud morphogenesis |
GO:1901896 | 0.0016 | 59.9551 | 0.0661 | 2 | 4 | positive regulation of calcium-transporting ATPase activity |
GO:0071822 | 0.0016 | 1.7136 | 27.1495 | 43 | 1643 | protein complex subunit organization |
GO:0009954 | 0.0016 | 8.9353 | 0.5123 | 4 | 31 | proximal/distal pattern formation |
GO:0051961 | 0.0017 | 2.8849 | 4.412 | 12 | 267 | negative regulation of nervous system development |
GO:0060579 | 0.0018 | 15.0357 | 0.2479 | 3 | 15 | ventral spinal cord interneuron fate commitment |
GO:1901317 | 0.0018 | 15.0357 | 0.2479 | 3 | 15 | regulation of flagellated sperm motility |
GO:0021522 | 0.0018 | 8.6156 | 0.5288 | 4 | 32 | spinal cord motor neuron differentiation |
GO:0002065 | 0.0019 | 4.294 | 1.7516 | 7 | 106 | columnar/cuboidal epithelial cell differentiation |
GO:0046546 | 0.0019 | 3.8032 | 2.2473 | 8 | 136 | development of primary male sexual characteristics |
GO:0065003 | 0.0019 | 1.6767 | 29.0498 | 45 | 1758 | macromolecular complex assembly |
GO:0021879 | 0.0019 | 6.1692 | 0.8923 | 5 | 54 | forebrain neuron differentiation |
GO:0045682 | 0.002 | 4.9806 | 1.3054 | 6 | 79 | regulation of epidermis development |
GO:0003338 | 0.002 | 8.318 | 0.5453 | 4 | 33 | metanephros morphogenesis |
GO:0009611 | 0.0021 | 2.1197 | 10.5095 | 21 | 636 | response to wounding |
GO:0072148 | 0.0021 | 13.8783 | 0.2644 | 3 | 16 | epithelial cell fate commitment |
GO:0008285 | 0.0022 | 2.0748 | 11.2531 | 22 | 681 | negative regulation of cell proliferation |
GO:0010812 | 0.0023 | 5.9265 | 0.9254 | 5 | 56 | negative regulation of cell-substrate adhesion |
GO:0003156 | 0.0023 | 8.0403 | 0.5618 | 4 | 34 | regulation of animal organ formation |
GO:0032268 | 0.0024 | 1.561 | 42.0875 | 60 | 2547 | regulation of cellular protein metabolic process |
GO:0048598 | 0.0024 | 2.7614 | 4.6002 | 12 | 292 | embryonic morphogenesis |
GO:0006281 | 0.0025 | 2.2245 | 8.5596 | 18 | 518 | DNA repair |
GO:0042475 | 0.0025 | 4.7207 | 1.3715 | 6 | 83 | odontogenesis of dentin-containing tooth |
GO:2000826 | 0.0026 | 7.7804 | 0.5784 | 4 | 35 | regulation of heart morphogenesis |
GO:0048880 | 0.0026 | 39.9675 | 0.0826 | 2 | 5 | sensory system development |
GO:0051891 | 0.0026 | 39.9675 | 0.0826 | 2 | 5 | positive regulation of cardioblast differentiation |
GO:0061743 | 0.0026 | 39.9675 | 0.0826 | 2 | 5 | motor learning |
GO:1900028 | 0.0026 | 39.9675 | 0.0826 | 2 | 5 | negative regulation of ruffle assembly |
GO:2000195 | 0.0026 | 39.9675 | 0.0826 | 2 | 5 | negative regulation of female gonad development |
GO:2000609 | 0.0026 | 39.9675 | 0.0826 | 2 | 5 | regulation of thyroid hormone generation |
GO:2000851 | 0.0026 | 39.9675 | 0.0826 | 2 | 5 | positive regulation of glucocorticoid secretion |
GO:0001947 | 0.0027 | 5.7022 | 0.9584 | 5 | 58 | heart looping |
GO:0007283 | 0.0028 | 2.2602 | 7.9482 | 17 | 481 | spermatogenesis |
GO:0060255 | 0.0028 | 1.5804 | 44.9063 | 62 | 3282 | regulation of macromolecule metabolic process |
GO:1905939 | 0.003 | 12.0263 | 0.2974 | 3 | 18 | regulation of gonad development |
GO:0035107 | 0.0031 | 3.4998 | 2.4291 | 8 | 147 | appendage morphogenesis |
GO:0071542 | 0.0031 | 7.3079 | 0.6114 | 4 | 37 | dopaminergic neuron differentiation |
GO:0014032 | 0.0033 | 5.3957 | 1.008 | 5 | 61 | neural crest cell development |
GO:0003323 | 0.0036 | 11.274 | 0.314 | 3 | 19 | type B pancreatic cell development |
GO:0022605 | 0.0039 | 29.9738 | 0.0991 | 2 | 6 | oogenesis stage |
GO:0061046 | 0.0039 | 29.9738 | 0.0991 | 2 | 6 | regulation of branching involved in lung morphogenesis |
GO:0072049 | 0.0039 | 29.9738 | 0.0991 | 2 | 6 | comma-shaped body morphogenesis |
GO:0072284 | 0.0039 | 29.9738 | 0.0991 | 2 | 6 | metanephric S-shaped body morphogenesis |
GO:1901533 | 0.0039 | 29.9738 | 0.0991 | 2 | 6 | negative regulation of hematopoietic progenitor cell differentiation |
GO:1903236 | 0.0039 | 29.9738 | 0.0991 | 2 | 6 | regulation of leukocyte tethering or rolling |
GO:2000138 | 0.0039 | 29.9738 | 0.0991 | 2 | 6 | positive regulation of cell proliferation involved in heart morphogenesis |
GO:2001236 | 0.004 | 3.3537 | 2.5282 | 8 | 153 | regulation of extrinsic apoptotic signaling pathway |
GO:0008406 | 0.0041 | 3.0597 | 3.108 | 9 | 190 | gonad development |
GO:0032691 | 0.0041 | 10.6101 | 0.3305 | 3 | 20 | negative regulation of interleukin-1 beta production |
GO:0060065 | 0.0041 | 10.6101 | 0.3305 | 3 | 20 | uterus development |
GO:0060231 | 0.0041 | 10.6101 | 0.3305 | 3 | 20 | mesenchymal to epithelial transition |
GO:0001704 | 0.0043 | 3.6608 | 2.0325 | 7 | 123 | formation of primary germ layer |
GO:0035239 | 0.0045 | 2.4317 | 5.6268 | 13 | 343 | tube morphogenesis |
GO:0098727 | 0.0046 | 3.2628 | 2.5943 | 8 | 157 | maintenance of cell number |
GO:0045595 | 0.0047 | 1.8377 | 15.0768 | 26 | 1020 | regulation of cell differentiation |
GO:0048485 | 0.0048 | 10.0201 | 0.347 | 3 | 21 | sympathetic nervous system development |
GO:0007586 | 0.0048 | 3.2409 | 2.6108 | 8 | 158 | digestion |
GO:0070887 | 0.0049 | 1.4827 | 47.8711 | 65 | 2897 | cellular response to chemical stimulus |
GO:0051705 | 0.005 | 4.8717 | 1.1071 | 5 | 67 | multi-organism behavior |
GO:0072210 | 0.005 | 6.3444 | 0.694 | 4 | 42 | metanephric nephron development |
GO:0001667 | 0.005 | 2.398 | 5.7009 | 13 | 345 | ameboidal-type cell migration |
GO:0030326 | 0.0052 | 3.5378 | 2.0986 | 7 | 127 | embryonic limb morphogenesis |
GO:0032355 | 0.0052 | 3.5378 | 2.0986 | 7 | 127 | response to estradiol |
GO:0051239 | 0.0053 | 1.6588 | 24.1331 | 37 | 1713 | regulation of multicellular organismal process |
GO:0003253 | 0.0054 | 23.9775 | 0.1157 | 2 | 7 | cardiac neural crest cell migration involved in outflow tract morphogenesis |
GO:0061626 | 0.0054 | 23.9775 | 0.1157 | 2 | 7 | pharyngeal arch artery morphogenesis |
GO:1904995 | 0.0054 | 23.9775 | 0.1157 | 2 | 7 | negative regulation of leukocyte adhesion to vascular endothelial cell |
GO:2000020 | 0.0054 | 23.9775 | 0.1157 | 2 | 7 | positive regulation of male gonad development |
GO:0044060 | 0.0054 | 6.1813 | 0.7105 | 4 | 43 | regulation of endocrine process |
GO:0044238 | 0.0055 | 1.4087 | 167.7387 | 188 | 10151 | primary metabolic process |
GO:0021954 | 0.0056 | 4.7189 | 1.1402 | 5 | 69 | central nervous system neuron development |
GO:0007275 | 0.0058 | 2.2981 | 6.5311 | 14 | 519 | multicellular organism development |
GO:0032652 | 0.006 | 4.646 | 1.1567 | 5 | 70 | regulation of interleukin-1 production |
GO:0043576 | 0.0062 | 9.0169 | 0.3801 | 3 | 23 | regulation of respiratory gaseous exchange |
GO:0045686 | 0.0062 | 9.0169 | 0.3801 | 3 | 23 | negative regulation of glial cell differentiation |
GO:0071773 | 0.0062 | 3.095 | 2.7265 | 8 | 165 | cellular response to BMP stimulus |
GO:0048738 | 0.0063 | 2.8518 | 3.3214 | 9 | 201 | cardiac muscle tissue development |
GO:0032757 | 0.0064 | 5.8791 | 0.7436 | 4 | 45 | positive regulation of interleukin-8 production |
GO:0048522 | 0.0066 | 1.3892 | 79.7796 | 99 | 4828 | positive regulation of cellular process |
GO:0046545 | 0.0069 | 3.7818 | 1.6855 | 6 | 102 | development of primary female sexual characteristics |
GO:0021511 | 0.007 | 8.587 | 0.3966 | 3 | 24 | spinal cord patterning |
GO:0048103 | 0.007 | 8.587 | 0.3966 | 3 | 24 | somatic stem cell division |
GO:0070193 | 0.007 | 8.587 | 0.3966 | 3 | 24 | synaptonemal complex organization |
GO:0007217 | 0.0071 | 19.98 | 0.1322 | 2 | 8 | tachykinin receptor signaling pathway |
GO:0060539 | 0.0071 | 19.98 | 0.1322 | 2 | 8 | diaphragm development |
GO:0072282 | 0.0071 | 19.98 | 0.1322 | 2 | 8 | metanephric nephron tubule morphogenesis |
GO:1903265 | 0.0071 | 19.98 | 0.1322 | 2 | 8 | positive regulation of tumor necrosis factor-mediated signaling pathway |
GO:1905456 | 0.0071 | 19.98 | 0.1322 | 2 | 8 | regulation of lymphoid progenitor cell differentiation |
GO:0060429 | 0.0072 | 1.7116 | 17.9445 | 29 | 1114 | epithelium development |
GO:0009887 | 0.0074 | 1.9155 | 10.9969 | 20 | 698 | animal organ morphogenesis |
GO:0060986 | 0.0074 | 5.6049 | 0.7766 | 4 | 47 | endocrine hormone secretion |
GO:0060173 | 0.0076 | 2.9799 | 2.8257 | 8 | 171 | limb development |
GO:0003148 | 0.0078 | 8.1962 | 0.4131 | 3 | 25 | outflow tract septum morphogenesis |
GO:0007420 | 0.0079 | 1.9011 | 11.0548 | 20 | 669 | brain development |
GO:0006950 | 0.0079 | 1.4561 | 47.26 | 63 | 2981 | response to stress |
GO:0072088 | 0.008 | 4.3128 | 1.2393 | 5 | 75 | nephron epithelium morphogenesis |
GO:0055010 | 0.008 | 5.4772 | 0.7932 | 4 | 48 | ventricular cardiac muscle tissue morphogenesis |
GO:0021536 | 0.0085 | 4.2518 | 1.2559 | 5 | 76 | diencephalon development |
GO:0001708 | 0.0085 | 5.3718 | 0.8064 | 4 | 50 | cell fate specification |
GO:0021545 | 0.0086 | 5.3551 | 0.8097 | 4 | 49 | cranial nerve development |
GO:0072207 | 0.0088 | 7.8393 | 0.4296 | 3 | 26 | metanephric epithelium development |
GO:0061333 | 0.0089 | 4.1924 | 1.2724 | 5 | 77 | renal tubule morphogenesis |
GO:0003149 | 0.0091 | 17.1247 | 0.1487 | 2 | 9 | membranous septum morphogenesis |
GO:0048865 | 0.0091 | 17.1247 | 0.1487 | 2 | 9 | stem cell fate commitment |
GO:0060923 | 0.0091 | 17.1247 | 0.1487 | 2 | 9 | cardiac muscle cell fate commitment |
GO:0061004 | 0.0091 | 17.1247 | 0.1487 | 2 | 9 | pattern specification involved in kidney development |
GO:0070424 | 0.0091 | 17.1247 | 0.1487 | 2 | 9 | regulation of nucleotide-binding oligomerization domain containing signaling pathway |
GO:0072217 | 0.0091 | 17.1247 | 0.1487 | 2 | 9 | negative regulation of metanephros development |
GO:1903624 | 0.0091 | 17.1247 | 0.1487 | 2 | 9 | regulation of DNA catabolic process |
GO:2000833 | 0.0091 | 17.1247 | 0.1487 | 2 | 9 | positive regulation of steroid hormone secretion |
GO:0007596 | 0.0094 | 2.2894 | 5.4861 | 12 | 332 | blood coagulation |
GO:0007492 | 0.0099 | 4.0786 | 1.3054 | 5 | 79 | endoderm development |
GO:1905207 | 0.0099 | 5.1266 | 0.8427 | 4 | 51 | regulation of cardiocyte differentiation |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0044571 | 6e-04 | 4068.5 | 6e-04 | 1 | 3 | [2Fe-2S] cluster assembly |
GO:0097428 | 0.0011 | 1627.1 | 0.0011 | 1 | 6 | protein maturation by iron-sulfur cluster transfer |
GO:0031163 | 0.0031 | 508.125 | 0.0031 | 1 | 17 | metallo-sulfur cluster assembly |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006114 | 5e-04 | 5424.6667 | 5e-04 | 1 | 4 | glycerol biosynthetic process |
GO:0045721 | 0.0016 | 1355.4167 | 0.0016 | 1 | 13 | negative regulation of gluconeogenesis |
GO:0019400 | 0.0023 | 903.2778 | 0.0023 | 1 | 19 | alditol metabolic process |
GO:0045912 | 0.0049 | 416.359 | 0.0049 | 1 | 40 | negative regulation of carbohydrate metabolic process |
GO:0046173 | 0.006 | 338.1042 | 0.006 | 1 | 49 | polyol biosynthetic process |
GO:0034637 | 0.0091 | 221.9726 | 0.0091 | 1 | 74 | cellular carbohydrate biosynthetic process |
GO:0043255 | 0.0099 | 202.4625 | 0.01 | 1 | 81 | regulation of carbohydrate biosynthetic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050865 | 0 | 4.8583 | 5.2195 | 22 | 494 | regulation of cell activation |
GO:0045055 | 0 | 3.548 | 7.6919 | 24 | 728 | regulated exocytosis |
GO:0002275 | 0 | 4.0404 | 5.5787 | 20 | 528 | myeloid cell activation involved in immune response |
GO:0002444 | 0 | 3.9997 | 5.6315 | 20 | 533 | myeloid leukocyte mediated immunity |
GO:0007155 | 0 | 2.7992 | 14.1264 | 34 | 1337 | cell adhesion |
GO:0032940 | 0 | 2.7289 | 14.4732 | 34 | 1385 | secretion by cell |
GO:0006954 | 0 | 3.5102 | 7.0579 | 22 | 668 | inflammatory response |
GO:0043312 | 0 | 4.0027 | 5.0187 | 18 | 475 | neutrophil degranulation |
GO:0001501 | 0 | 3.9145 | 5.1244 | 18 | 485 | skeletal system development |
GO:0042119 | 0 | 3.9058 | 5.135 | 18 | 486 | neutrophil activation |
GO:0002263 | 0 | 3.372 | 6.9628 | 21 | 659 | cell activation involved in immune response |
GO:0045321 | 0 | 4.0419 | 4.4254 | 16 | 477 | leukocyte activation |
GO:0048704 | 0 | 14.1305 | 0.4967 | 6 | 48 | embryonic skeletal system morphogenesis |
GO:0002757 | 0 | 3.7987 | 4.9553 | 17 | 469 | immune response-activating signal transduction |
GO:0050776 | 0 | 3.0351 | 8.4958 | 23 | 820 | regulation of immune response |
GO:0032943 | 0 | 5.0007 | 2.6414 | 12 | 250 | mononuclear cell proliferation |
GO:0002768 | 0 | 4.1339 | 3.7191 | 14 | 352 | immune response-regulating cell surface receptor signaling pathway |
GO:0045576 | 0 | 11.8451 | 0.5811 | 6 | 55 | mast cell activation |
GO:0002695 | 0 | 6.3429 | 1.5637 | 9 | 148 | negative regulation of leukocyte activation |
GO:0006911 | 0 | 15.0402 | 0.3909 | 5 | 37 | phagocytosis, engulfment |
GO:0007154 | 1e-04 | 1.9388 | 47.1513 | 70 | 4812 | cell communication |
GO:0048870 | 1e-04 | 3.1701 | 6.2869 | 18 | 628 | cell motility |
GO:0009952 | 1e-04 | 5.1167 | 2.1343 | 10 | 202 | anterior/posterior pattern specification |
GO:0006955 | 1e-04 | 5.4934 | 1.802 | 9 | 208 | immune response |
GO:0072172 | 1e-04 | 47.6361 | 0.0951 | 3 | 9 | mesonephric tubule formation |
GO:0007389 | 1e-04 | 3.5406 | 4.3049 | 14 | 412 | pattern specification process |
GO:0044663 | 1e-04 | Inf | 0.0211 | 2 | 2 | establishment or maintenance of cell type involved in phenotypic switching |
GO:0072078 | 1e-04 | 8.6531 | 0.7713 | 6 | 73 | nephron tubule morphogenesis |
GO:0015844 | 1e-04 | 8.5253 | 0.7819 | 6 | 74 | monoamine transport |
GO:0046649 | 1e-04 | 5.8285 | 1.4982 | 8 | 152 | lymphocyte activation |
GO:0048585 | 1e-04 | 2.2565 | 15.4366 | 31 | 1461 | negative regulation of response to stimulus |
GO:0048568 | 2e-04 | 3.4094 | 4.4588 | 14 | 422 | embryonic organ development |
GO:0072028 | 2e-04 | 8.1636 | 0.8136 | 6 | 77 | nephron morphogenesis |
GO:0035107 | 2e-04 | 5.6038 | 1.5532 | 8 | 147 | appendage morphogenesis |
GO:0009967 | 2e-04 | 2.219 | 15.669 | 31 | 1483 | positive regulation of signal transduction |
GO:0030595 | 2e-04 | 4.8313 | 2.0181 | 9 | 191 | leukocyte chemotaxis |
GO:0002684 | 3e-04 | 2.9886 | 5.8423 | 16 | 589 | positive regulation of immune system process |
GO:0002250 | 3e-04 | 3.6306 | 3.5712 | 12 | 338 | adaptive immune response |
GO:0010324 | 3e-04 | 9.8118 | 0.5706 | 5 | 54 | membrane invagination |
GO:0072376 | 3e-04 | 7.4277 | 0.8875 | 6 | 84 | protein activation cascade |
GO:0009954 | 3e-04 | 14.1799 | 0.3275 | 4 | 31 | proximal/distal pattern formation |
GO:0048935 | 3e-04 | 28.5746 | 0.1374 | 3 | 13 | peripheral nervous system neuron development |
GO:1902532 | 3e-04 | 3.0323 | 5.3568 | 15 | 507 | negative regulation of intracellular signal transduction |
GO:0002351 | 3e-04 | 189.4824 | 0.0317 | 2 | 3 | serotonin production involved in inflammatory response |
GO:0002554 | 3e-04 | 189.4824 | 0.0317 | 2 | 3 | serotonin secretion by platelet |
GO:0045658 | 3e-04 | 189.4824 | 0.0317 | 2 | 3 | regulation of neutrophil differentiation |
GO:0006935 | 3e-04 | 3.0096 | 5.4003 | 15 | 522 | chemotaxis |
GO:0023052 | 4e-04 | 1.7959 | 46.9483 | 67 | 4790 | signaling |
GO:0030097 | 4e-04 | 2.5376 | 8.6005 | 20 | 814 | hemopoiesis |
GO:0006957 | 4e-04 | 25.9753 | 0.1479 | 3 | 14 | complement activation, alternative pathway |
GO:0050863 | 4e-04 | 3.6876 | 3.212 | 11 | 304 | regulation of T cell activation |
GO:0002252 | 4e-04 | 3.6842 | 3.232 | 11 | 342 | immune effector process |
GO:0050852 | 4e-04 | 4.8314 | 1.7856 | 8 | 169 | T cell receptor signaling pathway |
GO:2000249 | 4e-04 | 12.7595 | 0.3592 | 4 | 34 | regulation of actin cytoskeleton reorganization |
GO:0061326 | 5e-04 | 6.6556 | 0.9826 | 6 | 93 | renal tubule development |
GO:0060173 | 5e-04 | 4.7715 | 1.8067 | 8 | 171 | limb development |
GO:0050900 | 5e-04 | 4.7243 | 1.8249 | 8 | 181 | leukocyte migration |
GO:0002520 | 5e-04 | 2.4181 | 9.4775 | 21 | 897 | immune system development |
GO:0042098 | 5e-04 | 4.6561 | 1.849 | 8 | 175 | T cell proliferation |
GO:0060537 | 6e-04 | 3.29 | 3.9199 | 12 | 371 | muscle tissue development |
GO:0035137 | 6e-04 | 11.5974 | 0.3909 | 4 | 37 | hindlimb morphogenesis |
GO:0007159 | 6e-04 | 5.2528 | 1.4377 | 7 | 140 | leukocyte cell-cell adhesion |
GO:0030168 | 6e-04 | 6.2226 | 1.0459 | 6 | 101 | platelet activation |
GO:0072107 | 7e-04 | 94.7353 | 0.0423 | 2 | 4 | positive regulation of ureteric bud formation |
GO:0072268 | 7e-04 | 94.7353 | 0.0423 | 2 | 4 | pattern specification involved in metanephros development |
GO:2001274 | 7e-04 | 94.7353 | 0.0423 | 2 | 4 | negative regulation of glucose import in response to insulin stimulus |
GO:0023014 | 7e-04 | 2.3694 | 9.6571 | 21 | 914 | signal transduction by protein phosphorylation |
GO:0019220 | 7e-04 | 2.0041 | 17.761 | 32 | 1681 | regulation of phosphate metabolic process |
GO:0050922 | 8e-04 | 10.629 | 0.4226 | 4 | 40 | negative regulation of chemotaxis |
GO:0010818 | 8e-04 | 19.0438 | 0.1902 | 3 | 18 | T cell chemotaxis |
GO:0033622 | 8e-04 | 19.0438 | 0.1902 | 3 | 18 | integrin activation |
GO:1905276 | 8e-04 | 19.0438 | 0.1902 | 3 | 18 | regulation of epithelial tube formation |
GO:0022407 | 9e-04 | 3.1331 | 4.1068 | 12 | 393 | regulation of cell-cell adhesion |
GO:0032675 | 9e-04 | 5.7857 | 1.12 | 6 | 106 | regulation of interleukin-6 production |
GO:0007422 | 9e-04 | 7.2768 | 0.7502 | 5 | 71 | peripheral nervous system development |
GO:0007599 | 9e-04 | 3.3074 | 3.5607 | 11 | 337 | hemostasis |
GO:0050817 | 9e-04 | 3.3074 | 3.5607 | 11 | 337 | coagulation |
GO:0051241 | 9e-04 | 2.2113 | 11.3476 | 23 | 1074 | negative regulation of multicellular organismal process |
GO:0051897 | 0.001 | 4.8385 | 1.5532 | 7 | 147 | positive regulation of protein kinase B signaling |
GO:0072210 | 0.001 | 10.0683 | 0.4438 | 4 | 42 | metanephric nephron development |
GO:2000401 | 0.001 | 10.0683 | 0.4438 | 4 | 42 | regulation of lymphocyte migration |
GO:0042474 | 0.001 | 17.8524 | 0.2007 | 3 | 19 | middle ear morphogenesis |
GO:0010562 | 0.001 | 2.2023 | 11.3899 | 23 | 1078 | positive regulation of phosphorus metabolic process |
GO:0060414 | 0.0011 | 63.1529 | 0.0528 | 2 | 5 | aorta smooth muscle tissue morphogenesis |
GO:0072081 | 0.0011 | 63.1529 | 0.0528 | 2 | 5 | specification of nephron tubule identity |
GO:0031347 | 0.0011 | 2.4921 | 7.3538 | 17 | 696 | regulation of defense response |
GO:0002761 | 0.0012 | 5.5084 | 1.1728 | 6 | 111 | regulation of myeloid leukocyte differentiation |
GO:0072087 | 0.0012 | 16.8013 | 0.2113 | 3 | 20 | renal vesicle development |
GO:2000406 | 0.0012 | 16.8013 | 0.2113 | 3 | 20 | positive regulation of T cell migration |
GO:0042327 | 0.0012 | 2.2541 | 10.1114 | 21 | 957 | positive regulation of phosphorylation |
GO:0045944 | 0.0012 | 2.1715 | 11.5378 | 23 | 1092 | positive regulation of transcription from RNA polymerase II promoter |
GO:0048598 | 0.0013 | 2.7312 | 5.5019 | 14 | 535 | embryonic morphogenesis |
GO:0048701 | 0.0013 | 9.3298 | 0.4755 | 4 | 45 | embryonic cranial skeleton morphogenesis |
GO:0008344 | 0.0013 | 6.6679 | 0.8136 | 5 | 77 | adult locomotory behavior |
GO:2000106 | 0.0013 | 6.6679 | 0.8136 | 5 | 77 | regulation of leukocyte apoptotic process |
GO:0050855 | 0.0013 | 15.8669 | 0.2219 | 3 | 21 | regulation of B cell receptor signaling pathway |
GO:0048662 | 0.0015 | 8.8948 | 0.4966 | 4 | 47 | negative regulation of smooth muscle cell proliferation |
GO:0006915 | 0.0016 | 1.8764 | 19.4621 | 33 | 1842 | apoptotic process |
GO:0010463 | 0.0016 | 8.6921 | 0.5072 | 4 | 48 | mesenchymal cell proliferation |
GO:0043067 | 0.0017 | 1.97 | 15.5845 | 28 | 1475 | regulation of programmed cell death |
GO:0090189 | 0.0018 | 14.2784 | 0.243 | 3 | 23 | regulation of branching involved in ureteric bud morphogenesis |
GO:0051251 | 0.0018 | 3.5022 | 2.7365 | 9 | 259 | positive regulation of lymphocyte activation |
GO:0001708 | 0.0019 | 6.1527 | 0.877 | 5 | 83 | cell fate specification |
GO:0048644 | 0.0019 | 6.1527 | 0.877 | 5 | 83 | muscle organ morphogenesis |
GO:0051173 | 0.0019 | 1.7142 | 30.366 | 46 | 2874 | positive regulation of nitrogen compound metabolic process |
GO:0010648 | 0.002 | 2.0179 | 13.4925 | 25 | 1277 | negative regulation of cell communication |
GO:0090103 | 0.002 | 13.5976 | 0.2536 | 3 | 24 | cochlea morphogenesis |
GO:2000482 | 0.002 | 13.5976 | 0.2536 | 3 | 24 | regulation of interleukin-8 secretion |
GO:0070372 | 0.0021 | 3.4188 | 2.7999 | 9 | 265 | regulation of ERK1 and ERK2 cascade |
GO:0023057 | 0.0021 | 2.0109 | 13.5347 | 25 | 1281 | negative regulation of signaling |
GO:0097529 | 0.0021 | 4.1756 | 1.7856 | 7 | 169 | myeloid leukocyte migration |
GO:0032226 | 0.0023 | 37.8871 | 0.074 | 2 | 7 | positive regulation of synaptic transmission, dopaminergic |
GO:0045656 | 0.0023 | 37.8871 | 0.074 | 2 | 7 | negative regulation of monocyte differentiation |
GO:1900165 | 0.0023 | 37.8871 | 0.074 | 2 | 7 | negative regulation of interleukin-6 secretion |
GO:1900239 | 0.0023 | 37.8871 | 0.074 | 2 | 7 | regulation of phenotypic switching |
GO:0009887 | 0.0023 | 2.21 | 9.2698 | 19 | 899 | animal organ morphogenesis |
GO:0090183 | 0.0024 | 7.8027 | 0.56 | 4 | 53 | regulation of kidney development |
GO:0007264 | 0.0025 | 2.6335 | 5.2617 | 13 | 498 | small GTPase mediated signal transduction |
GO:0065009 | 0.0025 | 1.6576 | 34.2648 | 50 | 3243 | regulation of molecular function |
GO:0045730 | 0.0025 | 12.4137 | 0.2747 | 3 | 26 | respiratory burst |
GO:0045822 | 0.0025 | 12.4137 | 0.2747 | 3 | 26 | negative regulation of heart contraction |
GO:0015696 | 0.0025 | 5.7111 | 0.9404 | 5 | 89 | ammonium transport |
GO:2000242 | 0.0025 | 7.6462 | 0.5706 | 4 | 54 | negative regulation of reproductive process |
GO:0070527 | 0.0027 | 7.4958 | 0.5811 | 4 | 55 | platelet aggregation |
GO:0002675 | 0.0028 | 11.8957 | 0.2853 | 3 | 27 | positive regulation of acute inflammatory response |
GO:0050670 | 0.0028 | 4.5696 | 1.3989 | 6 | 135 | regulation of lymphocyte proliferation |
GO:0030854 | 0.003 | 31.5706 | 0.0845 | 2 | 8 | positive regulation of granulocyte differentiation |
GO:0048743 | 0.003 | 31.5706 | 0.0845 | 2 | 8 | positive regulation of skeletal muscle fiber development |
GO:0051584 | 0.003 | 31.5706 | 0.0845 | 2 | 8 | regulation of dopamine uptake involved in synaptic transmission |
GO:0072161 | 0.003 | 31.5706 | 0.0845 | 2 | 8 | mesenchymal cell differentiation involved in kidney development |
GO:1905522 | 0.003 | 31.5706 | 0.0845 | 2 | 8 | negative regulation of macrophage migration |
GO:2000270 | 0.003 | 31.5706 | 0.0845 | 2 | 8 | negative regulation of fibroblast apoptotic process |
GO:0051271 | 0.0031 | 3.2025 | 2.9795 | 9 | 282 | negative regulation of cellular component movement |
GO:0030326 | 0.0031 | 5.416 | 0.9882 | 5 | 95 | embryonic limb morphogenesis |
GO:0002682 | 0.0032 | 3.4836 | 2.4464 | 8 | 269 | regulation of immune system process |
GO:0042326 | 0.0033 | 2.6519 | 4.8074 | 12 | 455 | negative regulation of phosphorylation |
GO:0001932 | 0.0033 | 1.9906 | 12.5139 | 23 | 1211 | regulation of protein phosphorylation |
GO:0032502 | 0.0033 | 1.5403 | 62.2535 | 80 | 5892 | developmental process |
GO:1903508 | 0.0033 | 1.908 | 14.8026 | 26 | 1401 | positive regulation of nucleic acid-templated transcription |
GO:0035282 | 0.0033 | 5.3283 | 1.0037 | 5 | 95 | segmentation |
GO:0070663 | 0.0035 | 4.3638 | 1.4614 | 6 | 141 | regulation of leukocyte proliferation |
GO:0010563 | 0.0036 | 2.4197 | 6.1598 | 14 | 583 | negative regulation of phosphorus metabolic process |
GO:0002673 | 0.0037 | 6.8159 | 0.6343 | 4 | 61 | regulation of acute inflammatory response |
GO:0045087 | 0.0038 | 2.205 | 8.25 | 17 | 794 | innate immune response |
GO:0002696 | 0.0038 | 10.5998 | 0.3154 | 3 | 31 | positive regulation of leukocyte activation |
GO:0010557 | 0.0038 | 1.8286 | 17.2961 | 29 | 1637 | positive regulation of macromolecule biosynthetic process |
GO:0002883 | 0.0038 | 27.0588 | 0.0951 | 2 | 9 | regulation of hypersensitivity |
GO:0045988 | 0.0038 | 27.0588 | 0.0951 | 2 | 9 | negative regulation of striated muscle contraction |
GO:0072048 | 0.0038 | 27.0588 | 0.0951 | 2 | 9 | renal system pattern specification |
GO:2000035 | 0.0038 | 27.0588 | 0.0951 | 2 | 9 | regulation of stem cell division |
GO:0008284 | 0.0038 | 2.1486 | 8.9703 | 18 | 849 | positive regulation of cell proliferation |
GO:0043207 | 0.0038 | 2.1996 | 8.2624 | 17 | 782 | response to external biotic stimulus |
GO:0042060 | 0.0042 | 2.4655 | 5.5999 | 13 | 530 | wound healing |
GO:0050869 | 0.0042 | 10.1938 | 0.3275 | 3 | 31 | negative regulation of B cell activation |
GO:0032879 | 0.0042 | 1.667 | 27.3336 | 41 | 2587 | regulation of localization |
GO:0035148 | 0.0043 | 4.1826 | 1.5215 | 6 | 144 | tube formation |
GO:0048844 | 0.0044 | 6.4762 | 0.6656 | 4 | 63 | artery morphogenesis |
GO:2000145 | 0.0046 | 2.1581 | 8.4103 | 17 | 796 | regulation of cell motility |
GO:0035115 | 0.0046 | 9.8417 | 0.3381 | 3 | 32 | embryonic forelimb morphogenesis |
GO:0070232 | 0.0046 | 9.8417 | 0.3381 | 3 | 32 | regulation of T cell apoptotic process |
GO:0002920 | 0.0047 | 6.3679 | 0.6762 | 4 | 64 | regulation of humoral immune response |
GO:0042116 | 0.0047 | 6.3679 | 0.6762 | 4 | 64 | macrophage activation |
GO:0042447 | 0.0047 | 23.675 | 0.1057 | 2 | 10 | hormone catabolic process |
GO:0019724 | 0.0047 | 4.8909 | 1.0883 | 5 | 103 | B cell mediated immunity |
GO:0030183 | 0.0049 | 4.8412 | 1.0988 | 5 | 104 | B cell differentiation |
GO:0002253 | 0.0049 | 6.2569 | 0.6863 | 4 | 70 | activation of immune response |
GO:0050678 | 0.0051 | 2.9595 | 3.212 | 9 | 304 | regulation of epithelial cell proliferation |
GO:0050672 | 0.0052 | 6.1617 | 0.6973 | 4 | 66 | negative regulation of lymphocyte proliferation |
GO:0030336 | 0.0053 | 3.1846 | 2.652 | 8 | 251 | negative regulation of cell migration |
GO:0009966 | 0.0053 | 1.8748 | 14.6375 | 25 | 1536 | regulation of signal transduction |
GO:0002707 | 0.0055 | 9.2056 | 0.3592 | 3 | 34 | negative regulation of lymphocyte mediated immunity |
GO:0003156 | 0.0055 | 9.2056 | 0.3592 | 3 | 34 | regulation of animal organ formation |
GO:0031295 | 0.0055 | 6.0635 | 0.7079 | 4 | 67 | T cell costimulation |
GO:0030098 | 0.0056 | 3.4756 | 2.1269 | 7 | 206 | lymphocyte differentiation |
GO:0001820 | 0.0057 | 21.0431 | 0.1162 | 2 | 11 | serotonin secretion |
GO:0002863 | 0.0057 | 21.0431 | 0.1162 | 2 | 11 | positive regulation of inflammatory response to antigenic stimulus |
GO:0061081 | 0.0057 | 21.0431 | 0.1162 | 2 | 11 | positive regulation of myeloid leukocyte cytokine production involved in immune response |
GO:0090009 | 0.0057 | 21.0431 | 0.1162 | 2 | 11 | primitive streak formation |
GO:2000047 | 0.0057 | 21.0431 | 0.1162 | 2 | 11 | regulation of cell-cell adhesion mediated by cadherin |
GO:0033077 | 0.0058 | 5.9684 | 0.7185 | 4 | 68 | T cell differentiation in thymus |
GO:0048663 | 0.0058 | 5.9684 | 0.7185 | 4 | 68 | neuron fate commitment |
GO:0031401 | 0.0059 | 1.9129 | 12.3514 | 22 | 1169 | positive regulation of protein modification process |
GO:0051048 | 0.0062 | 3.4087 | 2.166 | 7 | 205 | negative regulation of secretion |
GO:0032680 | 0.0062 | 4.5629 | 1.1622 | 5 | 110 | regulation of tumor necrosis factor production |
GO:0048729 | 0.0062 | 2.2626 | 6.5613 | 14 | 621 | tissue morphogenesis |
GO:0031328 | 0.0063 | 1.7399 | 18.7437 | 30 | 1774 | positive regulation of cellular biosynthetic process |
GO:0043583 | 0.0063 | 3.3914 | 2.1765 | 7 | 206 | ear development |
GO:0051254 | 0.0064 | 1.8056 | 15.5528 | 26 | 1472 | positive regulation of RNA metabolic process |
GO:0045124 | 0.0064 | 8.6466 | 0.3804 | 3 | 36 | regulation of bone resorption |
GO:0043410 | 0.0064 | 2.4261 | 5.2301 | 12 | 495 | positive regulation of MAPK cascade |
GO:0070664 | 0.0064 | 5.7868 | 0.7396 | 4 | 70 | negative regulation of leukocyte proliferation |
GO:0001568 | 0.0064 | 2.2549 | 6.5825 | 14 | 623 | blood vessel development |
GO:0006897 | 0.0064 | 2.2549 | 6.5825 | 14 | 623 | endocytosis |
GO:0002700 | 0.0065 | 4.5195 | 1.1728 | 5 | 111 | regulation of production of molecular mediator of immune response |
GO:0043009 | 0.0066 | 2.3258 | 5.9168 | 13 | 560 | chordate embryonic development |
GO:0008219 | 0.0068 | 1.6782 | 22.1458 | 34 | 2096 | cell death |
GO:0009617 | 0.0068 | 2.4055 | 5.2723 | 12 | 499 | response to bacterium |
GO:0003376 | 0.0068 | 18.9376 | 0.1268 | 2 | 12 | sphingosine-1-phosphate signaling pathway |
GO:0021889 | 0.0068 | 18.9376 | 0.1268 | 2 | 12 | olfactory bulb interneuron differentiation |
GO:0033605 | 0.0068 | 18.9376 | 0.1268 | 2 | 12 | positive regulation of catecholamine secretion |
GO:0038166 | 0.0068 | 18.9376 | 0.1268 | 2 | 12 | angiotensin-activated signaling pathway |
GO:0045060 | 0.0068 | 18.9376 | 0.1268 | 2 | 12 | negative thymic T cell selection |
GO:0051934 | 0.0068 | 18.9376 | 0.1268 | 2 | 12 | catecholamine uptake involved in synaptic transmission |
GO:0090494 | 0.0068 | 18.9376 | 0.1268 | 2 | 12 | dopamine uptake |
GO:0070887 | 0.007 | 1.7349 | 18.9698 | 30 | 1894 | cellular response to chemical stimulus |
GO:0006937 | 0.0071 | 3.7442 | 1.6905 | 6 | 160 | regulation of muscle contraction |
GO:0002703 | 0.0073 | 3.7199 | 1.7011 | 6 | 161 | regulation of leukocyte mediated immunity |
GO:0010628 | 0.0073 | 1.7178 | 18.955 | 30 | 1794 | positive regulation of gene expression |
GO:1903039 | 0.0074 | 3.2909 | 2.2399 | 7 | 212 | positive regulation of leukocyte cell-cell adhesion |
GO:0002639 | 0.0075 | 8.1515 | 0.4015 | 3 | 38 | positive regulation of immunoglobulin production |
GO:0033628 | 0.0075 | 8.1515 | 0.4015 | 3 | 38 | regulation of cell adhesion mediated by integrin |
GO:0050709 | 0.0078 | 4.3146 | 1.2256 | 5 | 116 | negative regulation of protein secretion |
GO:0051952 | 0.0078 | 5.4548 | 0.7819 | 4 | 74 | regulation of amine transport |
GO:0007167 | 0.0079 | 1.9529 | 10.3756 | 19 | 982 | enzyme linked receptor protein signaling pathway |
GO:0032103 | 0.0079 | 2.9616 | 2.8422 | 8 | 269 | positive regulation of response to external stimulus |
GO:0072507 | 0.008 | 2.4557 | 4.7229 | 11 | 447 | divalent inorganic cation homeostasis |
GO:0003337 | 0.008 | 17.215 | 0.1374 | 2 | 13 | mesenchymal to epithelial transition involved in metanephros morphogenesis |
GO:0010766 | 0.008 | 17.215 | 0.1374 | 2 | 13 | negative regulation of sodium ion transport |
GO:0021520 | 0.008 | 17.215 | 0.1374 | 2 | 13 | spinal cord motor neuron cell fate specification |
GO:0035723 | 0.008 | 17.215 | 0.1374 | 2 | 13 | interleukin-15-mediated signaling pathway |
GO:0072189 | 0.008 | 17.215 | 0.1374 | 2 | 13 | ureter development |
GO:0071706 | 0.008 | 4.2758 | 1.2362 | 5 | 117 | tumor necrosis factor superfamily cytokine production |
GO:0051240 | 0.0083 | 1.7639 | 15.8803 | 26 | 1503 | positive regulation of multicellular organismal process |
GO:0016192 | 0.0083 | 1.8841 | 11.9792 | 21 | 1187 | vesicle-mediated transport |
GO:0050851 | 0.0083 | 7.8006 | 0.4174 | 3 | 41 | antigen receptor-mediated signaling pathway |
GO:0033135 | 0.0083 | 4.2377 | 1.2468 | 5 | 118 | regulation of peptidyl-serine phosphorylation |
GO:0051716 | 0.009 | 1.5873 | 36.3246 | 49 | 3952 | cellular response to stimulus |
GO:0002699 | 0.0092 | 3.5355 | 1.7856 | 6 | 169 | positive regulation of immune effector process |
GO:0045744 | 0.0092 | 7.5065 | 0.4332 | 3 | 41 | negative regulation of G-protein coupled receptor protein signaling pathway |
GO:0002822 | 0.0092 | 4.1273 | 1.2785 | 5 | 121 | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
GO:0048853 | 0.0093 | 15.7794 | 0.1479 | 2 | 14 | forebrain morphogenesis |
GO:0051580 | 0.0093 | 15.7794 | 0.1479 | 2 | 14 | regulation of neurotransmitter uptake |
GO:0070672 | 0.0093 | 15.7794 | 0.1479 | 2 | 14 | response to interleukin-15 |
GO:0099068 | 0.0093 | 15.7794 | 0.1479 | 2 | 14 | postsynapse assembly |
GO:0030036 | 0.0093 | 2.2206 | 6.181 | 13 | 585 | actin cytoskeleton organization |
GO:0001838 | 0.0095 | 4.0918 | 1.289 | 5 | 122 | embryonic epithelial tube formation |
GO:1901701 | 0.0097 | 1.9086 | 10.5975 | 19 | 1003 | cellular response to oxygen-containing compound |
GO:0046849 | 0.0098 | 5.0895 | 0.8347 | 4 | 79 | bone remodeling |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 51.0292 | 6.8942 | 129 | 261 | detection of chemical stimulus involved in sensory perception of smell |
GO:0009593 | 0 | 34.8625 | 8.8224 | 133 | 334 | detection of chemical stimulus |
GO:0050906 | 0 | 33.4346 | 9.2186 | 135 | 349 | detection of stimulus involved in sensory perception |
GO:0007606 | 0 | 32.6113 | 9.2715 | 134 | 351 | sensory perception of chemical stimulus |
GO:0007186 | 0 | 8.6887 | 29.6819 | 155 | 1133 | G-protein coupled receptor signaling pathway |
GO:0050877 | 0 | 8.7288 | 27.2863 | 146 | 1048 | nervous system process |
GO:0032501 | 0 | 2.1974 | 173.8623 | 252 | 6776 | multicellular organismal process |
GO:0023052 | 0 | 2.1492 | 160.3618 | 239 | 6071 | signaling |
GO:0007154 | 0 | 2.1312 | 156.6878 | 233 | 6018 | cell communication |
GO:0051716 | 0 | 1.8721 | 180.9122 | 246 | 6849 | cellular response to stimulus |
GO:0050896 | 0 | 2.2584 | 26.5561 | 50 | 1361 | response to stimulus |
GO:0031424 | 0 | 3.8888 | 4.8338 | 17 | 183 | keratinization |
GO:0048007 | 0 | 49.5962 | 0.1849 | 4 | 7 | antigen processing and presentation, exogenous lipid antigen via MHC class Ib |
GO:0009913 | 1e-04 | 2.8241 | 8.03 | 21 | 304 | epidermal cell differentiation |
GO:0002475 | 1e-04 | 24.7934 | 0.2641 | 4 | 10 | antigen processing and presentation via MHC class Ib |
GO:0002548 | 5e-04 | 5.5638 | 1.4264 | 7 | 54 | monocyte chemotaxis |
GO:0019226 | 6e-04 | 4.7502 | 1.8754 | 8 | 71 | transmission of nerve impulse |
GO:0033141 | 6e-04 | 27.8308 | 0.1849 | 3 | 7 | positive regulation of peptidyl-serine phosphorylation of STAT protein |
GO:0002250 | 7e-04 | 2.3824 | 8.9281 | 20 | 338 | adaptive immune response |
GO:0043588 | 8e-04 | 2.3074 | 9.6677 | 21 | 366 | skin development |
GO:0050704 | 8e-04 | 6.2158 | 1.1094 | 6 | 42 | regulation of interleukin-1 secretion |
GO:0070269 | 9e-04 | 22.2632 | 0.2113 | 3 | 8 | pyroptosis |
GO:0098664 | 0.0011 | 10.6204 | 0.4755 | 4 | 18 | G-protein coupled serotonin receptor signaling pathway |
GO:0032342 | 0.0014 | 18.5515 | 0.2377 | 3 | 9 | aldosterone biosynthetic process |
GO:0034651 | 0.0014 | 18.5515 | 0.2377 | 3 | 9 | cortisol biosynthetic process |
GO:0045087 | 0.0016 | 1.7844 | 21.3428 | 36 | 808 | innate immune response |
GO:0042742 | 0.0016 | 3.0886 | 3.8179 | 11 | 146 | defense response to bacterium |
GO:0050832 | 0.0019 | 6.4178 | 0.8981 | 5 | 34 | defense response to fungus |
GO:0018149 | 0.0019 | 5.0831 | 1.3207 | 6 | 50 | peptide cross-linking |
GO:1903015 | 0.0021 | 74.0561 | 0.0792 | 2 | 3 | regulation of exo-alpha-sialidase activity |
GO:0031640 | 0.0022 | 4.9698 | 1.3471 | 6 | 51 | killing of cells of other organism |
GO:0050713 | 0.0026 | 13.9119 | 0.2906 | 3 | 11 | negative regulation of interleukin-1 beta secretion |
GO:0050794 | 0.0027 | 1.3409 | 267.2345 | 295 | 10117 | regulation of cellular process |
GO:0019730 | 0.003 | 3.5579 | 2.4301 | 8 | 92 | antimicrobial humoral response |
GO:0008212 | 0.0034 | 12.3653 | 0.317 | 3 | 12 | mineralocorticoid metabolic process |
GO:0060158 | 0.0034 | 12.3653 | 0.317 | 3 | 12 | phospholipase C-activating dopamine receptor signaling pathway |
GO:0070098 | 0.0036 | 3.8405 | 1.9811 | 7 | 75 | chemokine-mediated signaling pathway |
GO:0097530 | 0.0036 | 3.1451 | 3.0641 | 9 | 116 | granulocyte migration |
GO:0007338 | 0.0038 | 2.9014 | 3.6716 | 10 | 139 | single fertilization |
GO:0072540 | 0.0043 | 11.1281 | 0.3434 | 3 | 13 | T-helper 17 cell lineage commitment |
GO:0032651 | 0.0049 | 4.1392 | 1.5849 | 6 | 60 | regulation of interleukin-1 beta production |
GO:0032612 | 0.0052 | 3.5763 | 2.1132 | 7 | 80 | interleukin-1 production |
GO:0002323 | 0.0054 | 10.1158 | 0.3698 | 3 | 14 | natural killer cell activation involved in immune response |
GO:0044130 | 0.0054 | 10.1158 | 0.3698 | 3 | 14 | negative regulation of growth of symbiont in host |
GO:0097340 | 0.0054 | 10.1158 | 0.3698 | 3 | 14 | inhibition of cysteine-type endopeptidase activity |
GO:0050789 | 0.0054 | 1.9096 | 13.9557 | 24 | 637 | regulation of biological process |
GO:0006954 | 0.0062 | 1.7214 | 17.6448 | 29 | 668 | inflammatory response |
GO:2000316 | 0.0066 | 9.2722 | 0.3962 | 3 | 15 | regulation of T-helper 17 type immune response |
GO:0002309 | 0.0066 | 24.6822 | 0.1321 | 2 | 5 | T cell proliferation involved in immune response |
GO:0032747 | 0.0066 | 24.6822 | 0.1321 | 2 | 5 | positive regulation of interleukin-23 production |
GO:0030593 | 0.0068 | 3.3896 | 2.2188 | 7 | 84 | neutrophil chemotaxis |
GO:0050829 | 0.0073 | 3.7872 | 1.7169 | 6 | 65 | defense response to Gram-negative bacterium |
GO:2000516 | 0.0076 | 5.7143 | 0.7924 | 4 | 30 | positive regulation of CD4-positive, alpha-beta T cell activation |
GO:0042089 | 0.0079 | 2.9856 | 2.8528 | 8 | 108 | cytokine biosynthetic process |
GO:0032695 | 0.0079 | 8.5585 | 0.4226 | 3 | 16 | negative regulation of interleukin-12 production |
GO:0044144 | 0.0079 | 8.5585 | 0.4226 | 3 | 16 | modulation of growth of symbiont involved in interaction with host |
GO:0050908 | 0.0079 | 8.5585 | 0.4226 | 3 | 16 | detection of light stimulus involved in visual perception |
GO:0006959 | 0.009 | 2.9099 | 2.9199 | 8 | 112 | humoral immune response |
GO:0032604 | 0.0094 | 7.9466 | 0.449 | 3 | 17 | granulocyte macrophage colony-stimulating factor production |
GO:0032693 | 0.0094 | 7.9466 | 0.449 | 3 | 17 | negative regulation of interleukin-10 production |
GO:0043373 | 0.0094 | 7.9466 | 0.449 | 3 | 17 | CD4-positive, alpha-beta T cell lineage commitment |
GO:0051238 | 0.0094 | 7.9466 | 0.449 | 3 | 17 | sequestering of metal ion |
GO:0043207 | 0.0096 | 1.6187 | 20.6561 | 32 | 782 | response to external biotic stimulus |
GO:0001781 | 0.0097 | 18.5105 | 0.1585 | 2 | 6 | neutrophil apoptotic process |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 30.1539 | 4.0563 | 68 | 261 | detection of chemical stimulus involved in sensory perception of smell |
GO:0009593 | 0 | 23.3814 | 5.1909 | 71 | 334 | detection of chemical stimulus |
GO:0050906 | 0 | 21.5894 | 5.424 | 70 | 349 | detection of stimulus involved in sensory perception |
GO:0007606 | 0 | 21.433 | 5.4551 | 70 | 351 | sensory perception of chemical stimulus |
GO:0007186 | 0 | 7.3699 | 17.8883 | 87 | 1151 | G-protein coupled receptor signaling pathway |
GO:0050877 | 0 | 6.2913 | 17.3909 | 77 | 1119 | nervous system process |
GO:0018149 | 0 | 14.3807 | 0.7771 | 9 | 50 | peptide cross-linking |
GO:0023052 | 0 | 1.9135 | 94.3524 | 134 | 6071 | signaling |
GO:0007154 | 0 | 1.9044 | 94.6322 | 134 | 6089 | cell communication |
GO:0009913 | 0 | 4.4846 | 4.7246 | 19 | 304 | epidermal cell differentiation |
GO:0050896 | 0 | 2.9391 | 16.3089 | 37 | 1361 | response to stimulus |
GO:0043588 | 0 | 3.89 | 5.6882 | 20 | 366 | skin development |
GO:0031424 | 0 | 9.3051 | 1.1212 | 9 | 74 | keratinization |
GO:0006959 | 0 | 4.8823 | 3.1705 | 14 | 204 | humoral immune response |
GO:0032501 | 0 | 1.7606 | 99.3499 | 132 | 6776 | multicellular organismal process |
GO:0051716 | 0 | 1.7206 | 106.4437 | 140 | 6849 | cellular response to stimulus |
GO:0002250 | 1e-04 | 3.2925 | 5.253 | 16 | 338 | adaptive immune response |
GO:0061844 | 1e-04 | 9.2447 | 0.746 | 6 | 48 | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO:0045087 | 2e-04 | 2.332 | 12.5575 | 27 | 808 | innate immune response |
GO:0070268 | 3e-04 | 5.1485 | 1.694 | 8 | 109 | cornification |
GO:0050776 | 3e-04 | 3.7798 | 3.1342 | 11 | 209 | regulation of immune response |
GO:0031640 | 4e-04 | 8.7794 | 0.6479 | 5 | 42 | killing of cells of other organism |
GO:0002376 | 6e-04 | 1.6708 | 41.4803 | 62 | 2669 | immune system process |
GO:2000514 | 9e-04 | 7.4939 | 0.746 | 5 | 48 | regulation of CD4-positive, alpha-beta T cell activation |
GO:0050707 | 0.0011 | 3.7768 | 2.5488 | 9 | 164 | regulation of cytokine secretion |
GO:0050830 | 0.0011 | 5.6177 | 1.1656 | 6 | 75 | defense response to Gram-positive bacterium |
GO:0035821 | 0.0014 | 3.9927 | 2.1447 | 8 | 138 | modification of morphology or physiology of other organism |
GO:0006954 | 0.0018 | 2.1516 | 10.3817 | 21 | 668 | inflammatory response |
GO:0050832 | 0.0018 | 8.5655 | 0.5284 | 4 | 34 | defense response to fungus |
GO:0019228 | 0.002 | 8.2886 | 0.544 | 4 | 35 | neuronal action potential |
GO:0009617 | 0.0021 | 2.323 | 7.7552 | 17 | 499 | response to bacterium |
GO:0002309 | 0.0023 | 42.5578 | 0.0777 | 2 | 5 | T cell proliferation involved in immune response |
GO:0002361 | 0.0023 | 42.5578 | 0.0777 | 2 | 5 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation |
GO:0032747 | 0.0023 | 42.5578 | 0.0777 | 2 | 5 | positive regulation of interleukin-23 production |
GO:0045670 | 0.0029 | 5.5506 | 0.9791 | 5 | 63 | regulation of osteoclast differentiation |
GO:0050706 | 0.0031 | 7.3395 | 0.6061 | 4 | 39 | regulation of interleukin-1 beta secretion |
GO:0050829 | 0.0034 | 5.3649 | 1.0102 | 5 | 65 | defense response to Gram-negative bacterium |
GO:0001781 | 0.0035 | 31.9163 | 0.0932 | 2 | 6 | neutrophil apoptotic process |
GO:0060046 | 0.0035 | 11.3005 | 0.3108 | 3 | 20 | regulation of acrosome reaction |
GO:0032611 | 0.0044 | 5.0284 | 1.0724 | 5 | 69 | interleukin-1 beta production |
GO:0072538 | 0.0052 | 9.6036 | 0.3575 | 3 | 23 | T-helper 17 type immune response |
GO:0006953 | 0.0056 | 6.1136 | 0.7149 | 4 | 46 | acute-phase response |
GO:0007338 | 0.0061 | 3.4263 | 2.1603 | 7 | 139 | single fertilization |
GO:0060326 | 0.0062 | 2.6841 | 3.9165 | 10 | 252 | cell chemotaxis |
GO:0006952 | 0.0063 | 4.5817 | 1.1663 | 5 | 84 | defense response |
GO:0098542 | 0.0066 | 2.3136 | 5.9012 | 13 | 385 | defense response to other organism |
GO:0050701 | 0.007 | 5.705 | 0.7615 | 4 | 49 | interleukin-1 secretion |
GO:0071354 | 0.0074 | 8.3494 | 0.4041 | 3 | 26 | cellular response to interleukin-6 |
GO:0065007 | 0.0078 | 1.4379 | 176.3027 | 194 | 11344 | biological regulation |
GO:0051715 | 0.0081 | 18.2345 | 0.1399 | 2 | 9 | cytolysis in other organism |
GO:0042129 | 0.0091 | 3.1605 | 2.3312 | 7 | 150 | regulation of T cell proliferation |
GO:0046636 | 0.0091 | 7.6805 | 0.4352 | 3 | 28 | negative regulation of alpha-beta T cell activation |
GO:0050778 | 0.0093 | 1.9024 | 10.4905 | 19 | 675 | positive regulation of immune response |
GO:0045919 | 0.01 | 15.9542 | 0.1554 | 2 | 10 | positive regulation of cytolysis |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042162 | 0.0044 | 464.5143 | 0.0044 | 1 | 36 | telomeric DNA binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004869 | 0.0066 | 306.4151 | 0.0066 | 1 | 54 | cysteine-type endopeptidase inhibitor activity |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 17.5476 | 1.858 | 24 | 261 | olfactory receptor activity |
GO:0004930 | 0 | 7.2362 | 4.8265 | 27 | 678 | G-protein coupled receptor activity |
GO:0038023 | 0 | 4.5503 | 8.4144 | 30 | 1182 | signaling receptor activity |
GO:0099600 | 0 | 4.6008 | 7.9872 | 29 | 1122 | transmembrane receptor activity |
GO:0060089 | 0 | 3.6341 | 10.3008 | 30 | 1447 | molecular transducer activity |
GO:0005549 | 0 | 16.5962 | 0.42 | 6 | 59 | odorant binding |
GO:0070330 | 0 | 33.9538 | 0.1495 | 4 | 21 | aromatase activity |
GO:0019825 | 2e-04 | 15.1701 | 0.299 | 4 | 42 | oxygen binding |
GO:0034875 | 3e-04 | 141.9035 | 0.0285 | 2 | 4 | caffeine oxidase activity |
GO:0004190 | 4e-04 | 23.8363 | 0.1495 | 3 | 21 | aspartic-type endopeptidase activity |
GO:0016705 | 6e-04 | 6.2043 | 1.0465 | 6 | 147 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen |
GO:0001591 | 0.001 | 56.7509 | 0.0498 | 2 | 7 | dopamine neurotransmitter receptor activity, coupled via Gi/Go |
GO:0008395 | 0.0014 | 15.3138 | 0.2207 | 3 | 31 | steroid hydroxylase activity |
GO:0016725 | 0.0018 | 40.5313 | 0.0641 | 2 | 9 | oxidoreductase activity, acting on CH or CH2 groups |
GO:0020037 | 0.0018 | 6.1839 | 0.8685 | 5 | 122 | heme binding |
GO:0035240 | 0.0032 | 28.3667 | 0.0854 | 2 | 12 | dopamine binding |
GO:0005506 | 0.0046 | 4.9127 | 1.082 | 5 | 152 | iron ion binding |
GO:0008392 | 0.0056 | 20.2569 | 0.1139 | 2 | 16 | arachidonic acid epoxygenase activity |
GO:0033038 | 0.0056 | 20.2569 | 0.1139 | 2 | 16 | bitter taste receptor activity |
GO:0005133 | 0.0071 | Inf | 0.0071 | 1 | 1 | interferon-gamma receptor binding |
GO:0036458 | 0.0071 | Inf | 0.0071 | 1 | 1 | hepatocyte growth factor binding |
GO:0038164 | 0.0071 | Inf | 0.0071 | 1 | 1 | thrombopoietin receptor activity |
GO:1902122 | 0.0071 | Inf | 0.0071 | 1 | 1 | chenodeoxycholic acid binding |
GO:0030414 | 0.0081 | 4.2673 | 1.2387 | 5 | 174 | peptidase inhibitor activity |
GO:0019865 | 0.0097 | 14.9215 | 0.1495 | 2 | 21 | immunoglobulin binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0001228 | 0 | 4.1491 | 3.4547 | 13 | 405 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding |
GO:0035662 | 2e-04 | 235.8394 | 0.0256 | 2 | 3 | Toll-like receptor 4 binding |
GO:0005125 | 3e-04 | 5.1869 | 1.6719 | 8 | 196 | cytokine activity |
GO:0050544 | 7e-04 | 78.6034 | 0.0427 | 2 | 5 | arachidonic acid binding |
GO:0003705 | 0.0014 | 6.5152 | 0.8274 | 5 | 97 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding |
GO:0030545 | 0.0015 | 3.1205 | 3.7874 | 11 | 444 | receptor regulator activity |
GO:0050786 | 0.0031 | 29.4672 | 0.0853 | 2 | 10 | RAGE receptor binding |
GO:0004872 | 0.0038 | 2.0133 | 11.9594 | 22 | 1402 | receptor activity |
GO:0036041 | 0.0038 | 26.1914 | 0.0938 | 2 | 11 | long-chain fatty acid binding |
GO:0004871 | 0.0039 | 1.9779 | 12.7527 | 23 | 1495 | signal transducer activity |
GO:0004888 | 0.0046 | 2.125 | 9.17 | 18 | 1075 | transmembrane signaling receptor activity |
GO:0005126 | 0.0048 | 3.5927 | 2.0643 | 7 | 242 | cytokine receptor binding |
GO:0003692 | 0.0085 | Inf | 0.0085 | 1 | 1 | left-handed Z-DNA binding |
GO:0004876 | 0.0085 | Inf | 0.0085 | 1 | 1 | complement component C3a receptor activity |
GO:0016430 | 0.0085 | Inf | 0.0085 | 1 | 1 | tRNA (adenine-N6-)-methyltransferase activity |
GO:0031851 | 0.0085 | Inf | 0.0085 | 1 | 1 | kappa-type opioid receptor binding |
GO:0031854 | 0.0085 | Inf | 0.0085 | 1 | 1 | orexigenic neuropeptide QRFP receptor binding |
GO:0033798 | 0.0085 | Inf | 0.0085 | 1 | 1 | thyroxine 5-deiodinase activity |
GO:0050337 | 0.0085 | Inf | 0.0085 | 1 | 1 | thiosulfate-thiol sulfurtransferase activity |
GO:0102008 | 0.0085 | Inf | 0.0085 | 1 | 1 | cytosolic dipeptidase activity |
GO:0103046 | 0.0085 | Inf | 0.0085 | 1 | 1 | alanylglutamate dipeptidase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004872 | 0 | 3.4553 | 11.3571 | 32 | 1402 | receptor activity |
GO:0004871 | 0 | 2.8226 | 12.1105 | 29 | 1495 | signal transducer activity |
GO:0001875 | 6e-04 | 82.8718 | 0.0405 | 2 | 5 | lipopolysaccharide receptor activity |
GO:0004111 | 0.001 | 62.15 | 0.0486 | 2 | 6 | creatine kinase activity |
GO:0004930 | 0.0012 | 2.7694 | 5.4922 | 14 | 678 | G-protein coupled receptor activity |
GO:0004984 | 0.0013 | 4.0571 | 2.1143 | 8 | 261 | olfactory receptor activity |
GO:0005549 | 0.0013 | 9.1523 | 0.4779 | 4 | 59 | odorant binding |
GO:0004888 | 0.0032 | 3.2157 | 2.9997 | 9 | 397 | transmembrane signaling receptor activity |
GO:0030246 | 0.0038 | 3.7471 | 1.9847 | 7 | 245 | carbohydrate binding |
GO:0008329 | 0.004 | 25.2344 | 0.0958 | 2 | 12 | signaling pattern recognition receptor activity |
GO:1903231 | 0.0042 | 6.5284 | 0.6562 | 4 | 81 | mRNA binding involved in posttranscriptional gene silencing |
GO:0001604 | 0.0081 | Inf | 0.0081 | 1 | 1 | urotensin II receptor activity |
GO:0102116 | 0.0081 | Inf | 0.0081 | 1 | 1 | laurate hydroxylase activity |
GO:0103002 | 0.0081 | Inf | 0.0081 | 1 | 1 | 16-hydroxypalmitate dehydrogenase activity |
GO:0042379 | 0.0082 | 7.8077 | 0.4131 | 3 | 51 | chemokine receptor binding |
GO:0046625 | 0.0082 | 16.5621 | 0.1377 | 2 | 17 | sphingolipid binding |
GO:0005198 | 0.0088 | 2.3342 | 5.476 | 12 | 676 | structural molecule activity |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042162 | 0.0066 | 232.2429 | 0.0066 | 1 | 36 | telomeric DNA binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0000121 | 1e-04 | Inf | 1e-04 | 1 | 1 | glycerol-1-phosphatase activity |
GO:0043136 | 1e-04 | Inf | 1e-04 | 1 | 1 | glycerol-3-phosphatase activity |
GO:0008967 | 2e-04 | 16292 | 2e-04 | 1 | 2 | phosphoglycolate phosphatase activity |
GO:0098519 | 6e-04 | 4072.25 | 6e-04 | 1 | 5 | nucleotide phosphatase activity, acting on free nucleotides |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004872 | 2e-04 | 2.275 | 14.2824 | 29 | 1402 | receptor activity |
GO:0005070 | 3e-04 | 9.6016 | 0.5807 | 5 | 57 | SH3/SH2 adaptor activity |
GO:0048018 | 0.0012 | 3.033 | 4.2379 | 12 | 416 | receptor ligand activity |
GO:0004888 | 0.0014 | 2.1873 | 10.9512 | 22 | 1075 | transmembrane signaling receptor activity |
GO:0004871 | 0.0018 | 1.9834 | 14.9457 | 27 | 1484 | signal transducer activity |
GO:0001228 | 0.003 | 2.8342 | 4.1258 | 11 | 405 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding |
GO:0019864 | 0.0035 | 28.0871 | 0.0917 | 2 | 9 | IgG binding |
GO:0046934 | 0.0043 | 6.5039 | 0.6622 | 4 | 65 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity |
GO:0098772 | 0.0046 | 1.8026 | 17.5627 | 29 | 1724 | molecular function regulator |
GO:0019901 | 0.0047 | 2.4342 | 5.6743 | 13 | 557 | protein kinase binding |
GO:0004952 | 0.0053 | 21.8428 | 0.1121 | 2 | 11 | dopamine neurotransmitter receptor activity |
GO:0005068 | 0.0053 | 21.8428 | 0.1121 | 2 | 11 | transmembrane receptor protein tyrosine kinase adaptor activity |
GO:0043565 | 0.0067 | 1.9893 | 10.2177 | 19 | 1003 | sequence-specific DNA binding |
GO:0017124 | 0.0085 | 4.2139 | 1.253 | 5 | 123 | SH3 domain binding |
GO:0016303 | 0.0089 | 7.5932 | 0.4279 | 3 | 42 | 1-phosphatidylinositol-3-kinase activity |
GO:1903231 | 0.0094 | 5.1473 | 0.8252 | 4 | 81 | mRNA binding involved in posttranscriptional gene silencing |
GO:0051020 | 0.0095 | 2.2144 | 6.204 | 13 | 609 | GTPase binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005518 | 1e-04 | 11.7731 | 0.4752 | 5 | 64 | collagen binding |
GO:0004190 | 5e-04 | 22.8192 | 0.1559 | 3 | 21 | aspartic-type endopeptidase activity |
GO:0034713 | 0.0019 | 38.8163 | 0.0668 | 2 | 9 | type I transforming growth factor beta receptor binding |
GO:0048407 | 0.0029 | 30.1867 | 0.0817 | 2 | 11 | platelet-derived growth factor binding |
GO:1903231 | 0.0031 | 7.1471 | 0.6015 | 4 | 81 | mRNA binding involved in posttranscriptional gene silencing |
GO:0050840 | 0.0064 | 8.5413 | 0.3787 | 3 | 51 | extracellular matrix binding |
GO:0003868 | 0.0074 | Inf | 0.0074 | 1 | 1 | 4-hydroxyphenylpyruvate dioxygenase activity |
GO:0019807 | 0.0074 | Inf | 0.0074 | 1 | 1 | aspartoacylase activity |
GO:0030629 | 0.0074 | Inf | 0.0074 | 1 | 1 | U6 snRNA 3'-end binding |
GO:0036458 | 0.0074 | Inf | 0.0074 | 1 | 1 | hepatocyte growth factor binding |
GO:0052907 | 0.0074 | Inf | 0.0074 | 1 | 1 | 23S rRNA (adenine(1618)-N(6))-methyltransferase activity |
GO:0070524 | 0.0074 | Inf | 0.0074 | 1 | 1 | 11-beta-hydroxysteroid dehydrogenase (NADP+) activity |
GO:0120048 | 0.0074 | Inf | 0.0074 | 1 | 1 | U6 snRNA (adenine-(43)-N(6))-methyltransferase activity |
GO:0004866 | 0.0082 | 4.2603 | 1.2401 | 5 | 167 | endopeptidase inhibitor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0031492 | 0 | 51.6592 | 0.2754 | 10 | 44 | nucleosomal DNA binding |
GO:0042393 | 0 | 9.4571 | 1.2144 | 10 | 194 | histone binding |
GO:0044877 | 0 | 3.9622 | 6.0029 | 20 | 959 | macromolecular complex binding |
GO:0046982 | 0 | 5.3573 | 3.0109 | 14 | 481 | protein heterodimerization activity |
GO:0045296 | 0 | 5.8781 | 1.9029 | 10 | 304 | cadherin binding |
GO:0003682 | 3e-04 | 3.8984 | 3.1173 | 11 | 498 | chromatin binding |
GO:0004190 | 3e-04 | 27.2306 | 0.1315 | 3 | 21 | aspartic-type endopeptidase activity |
GO:1903231 | 0.0017 | 8.5428 | 0.507 | 4 | 81 | mRNA binding involved in posttranscriptional gene silencing |
GO:0048407 | 0.0021 | 35.9644 | 0.0689 | 2 | 11 | platelet-derived growth factor binding |
GO:0048019 | 0.0029 | 29.4218 | 0.0814 | 2 | 13 | receptor antagonist activity |
GO:0008201 | 0.0031 | 5.4398 | 0.9828 | 5 | 157 | heparin binding |
GO:0008191 | 0.0039 | 24.8923 | 0.0939 | 2 | 15 | metalloendopeptidase inhibitor activity |
GO:0048038 | 0.0044 | 23.1129 | 0.1002 | 2 | 16 | quinone binding |
GO:0061135 | 0.0046 | 4.9169 | 1.0829 | 5 | 173 | endopeptidase regulator activity |
GO:0030414 | 0.0047 | 4.8875 | 1.0892 | 5 | 174 | peptidase inhibitor activity |
GO:0005178 | 0.005 | 6.1945 | 0.6886 | 4 | 110 | integrin binding |
GO:0050431 | 0.0062 | 19.0306 | 0.1189 | 2 | 19 | transforming growth factor beta binding |
GO:0003868 | 0.0063 | Inf | 0.0063 | 1 | 1 | 4-hydroxyphenylpyruvate dioxygenase activity |
GO:0008112 | 0.0063 | Inf | 0.0063 | 1 | 1 | nicotinamide N-methyltransferase activity |
GO:0030760 | 0.0063 | Inf | 0.0063 | 1 | 1 | pyridine N-methyltransferase activity |
GO:0050683 | 0.0063 | Inf | 0.0063 | 1 | 1 | AF-1 domain binding |
GO:0061627 | 0.0063 | Inf | 0.0063 | 1 | 1 | S-methylmethionine-homocysteine S-methyltransferase activity |
GO:0070524 | 0.0063 | Inf | 0.0063 | 1 | 1 | 11-beta-hydroxysteroid dehydrogenase (NADP+) activity |
GO:1902118 | 0.0063 | Inf | 0.0063 | 1 | 1 | calcidiol binding |
GO:0005518 | 0.0075 | 8.0139 | 0.4006 | 3 | 64 | collagen binding |
GO:0070330 | 0.0075 | 17.0253 | 0.1315 | 2 | 21 | aromatase activity |
GO:0002020 | 0.0088 | 5.2467 | 0.8075 | 4 | 129 | protease binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 54.1973 | 6.6151 | 129 | 261 | olfactory receptor activity |
GO:0004930 | 0 | 17.137 | 16.7938 | 150 | 667 | G-protein coupled receptor activity |
GO:0099600 | 0 | 9.8083 | 28.4373 | 160 | 1122 | transmembrane receptor activity |
GO:0038023 | 0 | 10.0436 | 26.3619 | 153 | 1055 | signaling receptor activity |
GO:0005549 | 0 | 27.9345 | 1.4954 | 24 | 59 | odorant binding |
GO:0030883 | 0 | 155.3154 | 0.1267 | 4 | 5 | endogenous lipid antigen binding |
GO:0030884 | 0 | 155.3154 | 0.1267 | 4 | 5 | exogenous lipid antigen binding |
GO:0030881 | 0 | 31.0553 | 0.2281 | 4 | 9 | beta-2-microglobulin binding |
GO:0071723 | 1e-04 | 25.8778 | 0.2535 | 4 | 10 | lipopeptide binding |
GO:0003823 | 2e-04 | 6.6615 | 1.2166 | 7 | 48 | antigen binding |
GO:0005125 | 5e-04 | 3.0268 | 4.9677 | 14 | 196 | cytokine activity |
GO:0004507 | 6e-04 | Inf | 0.0507 | 2 | 2 | steroid 11-beta-monooxygenase activity |
GO:0047783 | 6e-04 | Inf | 0.0507 | 2 | 2 | corticosterone 18-monooxygenase activity |
GO:0004993 | 9e-04 | 11.0849 | 0.4562 | 4 | 18 | G-protein coupled serotonin receptor activity |
GO:0050786 | 0.0017 | 16.5941 | 0.2535 | 3 | 10 | RAGE receptor binding |
GO:0089720 | 0.0017 | 16.5941 | 0.2535 | 3 | 10 | caspase binding |
GO:0004982 | 0.0019 | 77.2798 | 0.076 | 2 | 3 | N-formyl peptide receptor activity |
GO:0005124 | 0.0019 | 77.2798 | 0.076 | 2 | 3 | scavenger receptor binding |
GO:0005132 | 0.0019 | 77.2798 | 0.076 | 2 | 3 | type I interferon receptor binding |
GO:0004952 | 0.0023 | 14.5189 | 0.2788 | 3 | 11 | dopamine neurotransmitter receptor activity |
GO:0035240 | 0.003 | 12.9049 | 0.3041 | 3 | 12 | dopamine binding |
GO:1903231 | 0.0044 | 3.6831 | 2.053 | 7 | 81 | mRNA binding involved in posttranscriptional gene silencing |
GO:0050700 | 0.0048 | 10.5572 | 0.3548 | 3 | 14 | CARD domain binding |
GO:0001653 | 0.0051 | 2.9761 | 3.2188 | 9 | 127 | peptide receptor activity |
GO:0008188 | 0.0054 | 4.8536 | 1.1405 | 5 | 45 | neuropeptide receptor activity |
GO:0097153 | 0.0059 | 9.6768 | 0.3802 | 3 | 15 | cysteine-type endopeptidase activity involved in apoptotic process |
GO:0008201 | 0.0068 | 2.6561 | 3.9792 | 10 | 157 | heparin binding |
GO:0004497 | 0.0074 | 3.3221 | 2.2557 | 7 | 89 | monooxygenase activity |
GO:0004872 | 0.0088 | 2.9054 | 2.8987 | 8 | 174 | receptor activity |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 32.6844 | 3.8281 | 68 | 261 | olfactory receptor activity |
GO:0004930 | 0 | 15.9272 | 7.8862 | 76 | 552 | G-protein coupled receptor activity |
GO:0099600 | 0 | 8.6289 | 16.4565 | 89 | 1122 | transmembrane receptor activity |
GO:0038023 | 0 | 8.2772 | 17.3365 | 90 | 1182 | signaling receptor activity |
GO:0060089 | 0 | 6.9165 | 21.2233 | 93 | 1447 | molecular transducer activity |
GO:0005549 | 0 | 29.1976 | 0.8654 | 17 | 59 | odorant binding |
GO:0030280 | 0 | 30.3489 | 0.1907 | 4 | 13 | structural constituent of epidermis |
GO:1903231 | 2e-04 | 6.5164 | 1.188 | 7 | 81 | mRNA binding involved in posttranscriptional gene silencing |
GO:0008528 | 5e-04 | 4.6777 | 1.8481 | 8 | 126 | G-protein coupled peptide receptor activity |
GO:0042834 | 8e-04 | 20.3975 | 0.1907 | 3 | 13 | peptidoglycan binding |
GO:0030492 | 0.0021 | 45.1561 | 0.0733 | 2 | 5 | hemoglobin binding |
GO:0003823 | 0.0053 | 6.1942 | 0.704 | 4 | 48 | antigen binding |
GO:0015143 | 0.0089 | 16.9283 | 0.1467 | 2 | 10 | urate transmembrane transporter activity |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0043066 | 5e-04 | 56.6935 | 0.2017 | 3 | 786 | negative regulation of apoptotic process |
GO:0045967 | 5e-04 | 5193 | 5e-04 | 1 | 2 | negative regulation of growth rate |
GO:0060548 | 7e-04 | 50.8479 | 0.2236 | 3 | 871 | negative regulation of cell death |
GO:1902746 | 0.001 | 1730.7778 | 0.001 | 1 | 4 | regulation of lens fiber cell differentiation |
GO:0060770 | 0.0013 | 1298 | 0.0013 | 1 | 5 | negative regulation of epithelial cell proliferation involved in prostate gland development |
GO:0006685 | 0.0015 | 1038.3333 | 0.0015 | 1 | 6 | sphingomyelin catabolic process |
GO:0031584 | 0.0015 | 1038.3333 | 0.0015 | 1 | 6 | activation of phospholipase D activity |
GO:0048102 | 0.0018 | 865.2222 | 0.0018 | 1 | 7 | autophagic cell death |
GO:0002315 | 0.0023 | 648.8333 | 0.0023 | 1 | 9 | marginal zone B cell differentiation |
GO:0061314 | 0.0023 | 648.8333 | 0.0023 | 1 | 9 | Notch signaling involved in heart development |
GO:0043067 | 0.0026 | 30.7229 | 0.3565 | 3 | 1389 | regulation of programmed cell death |
GO:0003184 | 0.0028 | 519 | 0.0028 | 1 | 11 | pulmonary valve morphogenesis |
GO:0071236 | 0.0033 | 432.4444 | 0.0033 | 1 | 13 | cellular response to antibiotic |
GO:0071285 | 0.0033 | 432.4444 | 0.0033 | 1 | 13 | cellular response to lithium ion |
GO:0071850 | 0.0033 | 432.4444 | 0.0033 | 1 | 13 | mitotic cell cycle arrest |
GO:1905314 | 0.0038 | 370.619 | 0.0039 | 1 | 15 | semi-lunar valve development |
GO:0046475 | 0.0041 | 345.8889 | 0.0041 | 1 | 16 | glycerophospholipid catabolic process |
GO:0060413 | 0.0041 | 345.8889 | 0.0041 | 1 | 16 | atrial septum morphogenesis |
GO:1904706 | 0.0041 | 345.8889 | 0.0041 | 1 | 16 | negative regulation of vascular smooth muscle cell proliferation |
GO:0007096 | 0.0044 | 324.25 | 0.0044 | 1 | 17 | regulation of exit from mitosis |
GO:0002335 | 0.0051 | 273 | 0.0051 | 1 | 20 | mature B cell differentiation |
GO:0007264 | 0.0053 | 32.0786 | 0.1214 | 2 | 473 | small GTPase mediated signal transduction |
GO:0031116 | 0.0056 | 246.9683 | 0.0056 | 1 | 22 | positive regulation of microtubule polymerization |
GO:0045736 | 0.0059 | 235.7273 | 0.0059 | 1 | 23 | negative regulation of cyclin-dependent protein serine/threonine kinase activity |
GO:0046466 | 0.0059 | 235.7273 | 0.0059 | 1 | 23 | membrane lipid catabolic process |
GO:0006471 | 0.0069 | 199.4103 | 0.0069 | 1 | 27 | protein ADP-ribosylation |
GO:0045737 | 0.0082 | 167.1935 | 0.0082 | 1 | 32 | positive regulation of cyclin-dependent protein serine/threonine kinase activity |
GO:0044271 | 0.0087 | Inf | 1.221 | 4 | 4757 | cellular nitrogen compound biosynthetic process |
GO:0003230 | 0.0087 | 157.0404 | 0.0087 | 1 | 34 | cardiac atrium development |
GO:0040008 | 0.0087 | 24.5829 | 0.1568 | 2 | 611 | regulation of growth |
GO:0001709 | 0.01 | 136.3333 | 0.01 | 1 | 39 | cell fate determination |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 9.7738 | 9.0006 | 63 | 301 | detection of chemical stimulus involved in sensory perception of smell |
GO:0007606 | 0 | 7.9611 | 11.7218 | 69 | 392 | sensory perception of chemical stimulus |
GO:0009593 | 0 | 8.1282 | 11.1536 | 67 | 373 | detection of chemical stimulus |
GO:0050906 | 0 | 7.9517 | 11.5424 | 68 | 386 | detection of stimulus involved in sensory perception |
GO:0007186 | 0 | 3.6253 | 34.2682 | 99 | 1146 | G-protein coupled receptor signaling pathway |
GO:0050877 | 0 | 3.4779 | 33.431 | 94 | 1118 | nervous system process |
GO:0018149 | 0 | 7.8718 | 1.5549 | 10 | 52 | peptide cross-linking |
GO:0010838 | 0 | 40.9816 | 0.2691 | 5 | 9 | positive regulation of keratinocyte proliferation |
GO:0015721 | 0 | 11.5126 | 0.8074 | 7 | 27 | bile acid and bile salt transport |
GO:0031424 | 0 | 3.261 | 6.0403 | 18 | 202 | keratinization |
GO:1901750 | 1e-04 | 32.7143 | 0.2392 | 4 | 8 | leukotriene D4 biosynthetic process |
GO:0006751 | 1e-04 | 26.1697 | 0.2691 | 4 | 9 | glutathione catabolic process |
GO:0007195 | 1e-04 | 26.1697 | 0.2691 | 4 | 9 | adenylate cyclase-inhibiting dopamine receptor signaling pathway |
GO:0042574 | 1e-04 | 26.1697 | 0.2691 | 4 | 9 | retinal metabolic process |
GO:0009913 | 2e-04 | 2.5246 | 9.3595 | 22 | 313 | epidermal cell differentiation |
GO:0050896 | 2e-04 | 1.821 | 33.5722 | 54 | 1269 | response to stimulus |
GO:0051967 | 3e-04 | 16.3528 | 0.3588 | 4 | 12 | negative regulation of synaptic transmission, glutamatergic |
GO:0043588 | 4e-04 | 2.2712 | 11.2732 | 24 | 377 | skin development |
GO:0003008 | 5e-04 | 1.9846 | 17.7951 | 33 | 692 | system process |
GO:0019730 | 7e-04 | 4.0588 | 2.452 | 9 | 82 | antimicrobial humoral response |
GO:0010951 | 8e-04 | 2.6387 | 6.4888 | 16 | 217 | negative regulation of endopeptidase activity |
GO:0006583 | 9e-04 | Inf | 0.0598 | 2 | 2 | melanin biosynthetic process from tyrosine |
GO:0006776 | 0.0013 | 19.5849 | 0.2392 | 3 | 8 | vitamin A metabolic process |
GO:0016102 | 0.0013 | 19.5849 | 0.2392 | 3 | 8 | diterpenoid biosynthetic process |
GO:0002548 | 0.0013 | 4.69 | 1.6745 | 7 | 56 | monocyte chemotaxis |
GO:0051716 | 0.0018 | 1.3211 | 195.8611 | 227 | 6550 | cellular response to stimulus |
GO:0006953 | 0.0019 | 5.1762 | 1.3157 | 6 | 44 | acute-phase response |
GO:0014809 | 0.0026 | 65.1595 | 0.0897 | 2 | 3 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion |
GO:0060662 | 0.0026 | 65.1595 | 0.0897 | 2 | 3 | salivary gland cavitation |
GO:1900039 | 0.0026 | 65.1595 | 0.0897 | 2 | 3 | positive regulation of cellular response to hypoxia |
GO:1903015 | 0.0026 | 65.1595 | 0.0897 | 2 | 3 | regulation of exo-alpha-sialidase activity |
GO:1904879 | 0.0026 | 65.1595 | 0.0897 | 2 | 3 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel |
GO:0042742 | 0.0028 | 2.4865 | 5.9805 | 14 | 200 | defense response to bacterium |
GO:0010876 | 0.0029 | 2.0938 | 10.0771 | 20 | 337 | lipid localization |
GO:0072676 | 0.0031 | 3.551 | 2.452 | 8 | 82 | lymphocyte migration |
GO:0031348 | 0.0033 | 2.6554 | 4.8143 | 12 | 161 | negative regulation of defense response |
GO:0022617 | 0.0036 | 3.4571 | 2.5118 | 8 | 84 | extracellular matrix disassembly |
GO:0014819 | 0.0037 | 12.2381 | 0.3289 | 3 | 11 | regulation of skeletal muscle contraction |
GO:1905065 | 0.0037 | 12.2381 | 0.3289 | 3 | 11 | positive regulation of vascular smooth muscle cell differentiation |
GO:0006954 | 0.0038 | 1.7548 | 18.5694 | 31 | 621 | inflammatory response |
GO:0007586 | 0.004 | 2.7239 | 4.306 | 11 | 144 | digestion |
GO:0051346 | 0.0041 | 1.9854 | 11.1237 | 21 | 372 | negative regulation of hydrolase activity |
GO:0007154 | 0.0042 | 1.2924 | 174.152 | 202 | 5824 | cell communication |
GO:0051481 | 0.0048 | 10.8776 | 0.3588 | 3 | 12 | negative regulation of cytosolic calcium ion concentration |
GO:0060158 | 0.0048 | 10.8776 | 0.3588 | 3 | 12 | phospholipase C-activating dopamine receptor signaling pathway |
GO:0042904 | 0.0051 | 32.5776 | 0.1196 | 2 | 4 | 9-cis-retinoic acid biosynthetic process |
GO:0009072 | 0.0052 | 6.5359 | 0.7177 | 4 | 24 | aromatic amino acid family metabolic process |
GO:0048149 | 0.0061 | 9.7892 | 0.3887 | 3 | 13 | behavioral response to ethanol |
GO:0023052 | 0.0063 | 1.2754 | 173.6436 | 200 | 5807 | signaling |
GO:1901019 | 0.007 | 3.3753 | 2.2427 | 7 | 75 | regulation of calcium ion transmembrane transporter activity |
GO:0006032 | 0.0084 | 21.717 | 0.1495 | 2 | 5 | chitin catabolic process |
GO:0006269 | 0.0084 | 21.717 | 0.1495 | 2 | 5 | DNA replication, synthesis of RNA primer |
GO:0051924 | 0.0085 | 2.2428 | 6.1001 | 13 | 204 | regulation of calcium ion transport |
GO:0008206 | 0.0088 | 4.3041 | 1.2858 | 5 | 43 | bile acid metabolic process |
GO:1901386 | 0.0092 | 8.1566 | 0.4485 | 3 | 15 | negative regulation of voltage-gated calcium channel activity |
GO:0009636 | 0.0095 | 2.2076 | 6.1898 | 13 | 207 | response to toxic substance |
GO:0052547 | 0.0098 | 1.8541 | 11.2732 | 20 | 377 | regulation of peptidase activity |
GO:0030001 | 0.0099 | 1.5686 | 23.9818 | 36 | 802 | metal ion transport |
GO:0030593 | 0.0099 | 3.1431 | 2.3922 | 7 | 80 | neutrophil chemotaxis |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042119 | 0 | 3.8849 | 7.8416 | 27 | 446 | neutrophil activation |
GO:0002275 | 0 | 3.7077 | 8.5098 | 28 | 484 | myeloid cell activation involved in immune response |
GO:0002252 | 0 | 2.998 | 14.0285 | 37 | 832 | immune effector process |
GO:0002695 | 0 | 6.6485 | 2.4088 | 14 | 137 | negative regulation of leukocyte activation |
GO:0002444 | 0 | 3.5131 | 8.5977 | 27 | 489 | myeloid leukocyte mediated immunity |
GO:0043312 | 0 | 3.6396 | 7.6658 | 25 | 436 | neutrophil degranulation |
GO:0050900 | 0 | 4.6346 | 4.0874 | 17 | 242 | leukocyte migration |
GO:0045055 | 0 | 2.9434 | 11.7273 | 31 | 667 | regulated exocytosis |
GO:0007159 | 0 | 6.5675 | 2.072 | 12 | 123 | leukocyte cell-cell adhesion |
GO:0002699 | 0 | 5.4421 | 2.8835 | 14 | 164 | positive regulation of immune effector process |
GO:0002520 | 0 | 2.5646 | 15.1558 | 35 | 862 | immune system development |
GO:0050868 | 0 | 7.3029 | 1.5648 | 10 | 89 | negative regulation of T cell activation |
GO:0050776 | 0 | 8.2435 | 1.2559 | 9 | 78 | regulation of immune response |
GO:1903039 | 0 | 4.5126 | 3.6747 | 15 | 209 | positive regulation of leukocyte cell-cell adhesion |
GO:0022408 | 0 | 5.4325 | 2.4615 | 12 | 140 | negative regulation of cell-cell adhesion |
GO:0045785 | 0 | 3.4155 | 6.4175 | 20 | 365 | positive regulation of cell adhesion |
GO:0050867 | 0 | 3.6165 | 5.134 | 17 | 292 | positive regulation of cell activation |
GO:0032940 | 0 | 2.135 | 22.9095 | 44 | 1303 | secretion by cell |
GO:0006955 | 0 | 2.8474 | 9.2953 | 24 | 610 | immune response |
GO:0002253 | 0 | 2.8996 | 8.6504 | 23 | 492 | activation of immune response |
GO:0048870 | 0 | 2.1106 | 23.7183 | 45 | 1349 | cell motility |
GO:0050865 | 0 | 4.6118 | 2.857 | 12 | 170 | regulation of cell activation |
GO:0051251 | 0 | 3.6833 | 4.4307 | 15 | 252 | positive regulation of lymphocyte activation |
GO:0002764 | 0 | 2.8944 | 7.8747 | 21 | 451 | immune response-regulating signaling pathway |
GO:0002429 | 1e-04 | 3.3656 | 5.1516 | 16 | 293 | immune response-activating cell surface receptor signaling pathway |
GO:0002675 | 1e-04 | 12.9165 | 0.4747 | 5 | 27 | positive regulation of acute inflammatory response |
GO:0032944 | 1e-04 | 7.3031 | 1.0844 | 7 | 63 | regulation of mononuclear cell proliferation |
GO:0043085 | 1e-04 | 2.0031 | 23.0502 | 42 | 1311 | positive regulation of catalytic activity |
GO:0050672 | 1e-04 | 7.2717 | 1.0901 | 7 | 62 | negative regulation of lymphocyte proliferation |
GO:0043207 | 1e-04 | 2.344 | 12.958 | 28 | 737 | response to external biotic stimulus |
GO:0097530 | 1e-04 | 5.0637 | 1.9516 | 9 | 111 | granulocyte migration |
GO:0070664 | 2e-04 | 6.7769 | 1.1604 | 7 | 66 | negative regulation of leukocyte proliferation |
GO:0007599 | 2e-04 | 3.1028 | 5.556 | 16 | 316 | hemostasis |
GO:0050817 | 2e-04 | 3.0923 | 5.5735 | 16 | 317 | coagulation |
GO:0030097 | 2e-04 | 2.4309 | 10.6634 | 24 | 623 | hemopoiesis |
GO:0030168 | 2e-04 | 5.4947 | 1.6047 | 8 | 93 | platelet activation |
GO:0023052 | 2e-04 | 1.5549 | 102.0995 | 131 | 5807 | signaling |
GO:0032101 | 2e-04 | 2.359 | 11.4284 | 25 | 650 | regulation of response to external stimulus |
GO:0007229 | 2e-04 | 5.4515 | 1.6176 | 8 | 92 | integrin-mediated signaling pathway |
GO:0050777 | 2e-04 | 4.7805 | 2.0571 | 9 | 117 | negative regulation of immune response |
GO:0045576 | 2e-04 | 7.7676 | 0.8791 | 6 | 50 | mast cell activation |
GO:0042113 | 2e-04 | 3.6644 | 3.534 | 12 | 201 | B cell activation |
GO:0033622 | 2e-04 | 16.1862 | 0.3165 | 4 | 18 | integrin activation |
GO:0007154 | 2e-04 | 1.5475 | 102.3984 | 131 | 5824 | cell communication |
GO:0022407 | 3e-04 | 3.394 | 4.1224 | 13 | 243 | regulation of cell-cell adhesion |
GO:0008284 | 3e-04 | 2.1698 | 14.4349 | 29 | 821 | positive regulation of cell proliferation |
GO:0070527 | 3e-04 | 7.4289 | 0.9143 | 6 | 52 | platelet aggregation |
GO:0070488 | 3e-04 | Inf | 0.0352 | 2 | 2 | neutrophil aggregation |
GO:0002456 | 3e-04 | 5.9646 | 1.3011 | 7 | 74 | T cell mediated immunity |
GO:0002682 | 3e-04 | 2.6938 | 7.1987 | 18 | 462 | regulation of immune system process |
GO:0006919 | 3e-04 | 5.8765 | 1.3187 | 7 | 75 | activation of cysteine-type endopeptidase activity involved in apoptotic process |
GO:0030098 | 4e-04 | 4.0208 | 2.6876 | 10 | 156 | lymphocyte differentiation |
GO:0001816 | 4e-04 | 3.4317 | 3.7583 | 12 | 223 | cytokine production |
GO:0070661 | 5e-04 | 3.618 | 3.2691 | 11 | 190 | leukocyte proliferation |
GO:0010942 | 5e-04 | 2.2983 | 10.7251 | 23 | 610 | positive regulation of cell death |
GO:1902106 | 5e-04 | 5.4722 | 1.4066 | 7 | 80 | negative regulation of leukocyte differentiation |
GO:1903708 | 5e-04 | 3.8283 | 2.8131 | 10 | 160 | positive regulation of hemopoiesis |
GO:0032649 | 6e-04 | 5.3979 | 1.4242 | 7 | 81 | regulation of interferon-gamma production |
GO:0032496 | 6e-04 | 2.9659 | 5.0461 | 14 | 287 | response to lipopolysaccharide |
GO:0072676 | 6e-04 | 5.3256 | 1.4417 | 7 | 82 | lymphocyte migration |
GO:0042733 | 6e-04 | 6.325 | 1.0549 | 6 | 60 | embryonic digit morphogenesis |
GO:0002460 | 6e-04 | 6.2828 | 1.0595 | 6 | 62 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
GO:0045321 | 7e-04 | 3.0381 | 4.5806 | 13 | 298 | leukocyte activation |
GO:0031347 | 8e-04 | 2.9971 | 4.6326 | 13 | 272 | regulation of defense response |
GO:0043303 | 8e-04 | 7.6726 | 0.7384 | 5 | 42 | mast cell degranulation |
GO:0002274 | 8e-04 | 5.987 | 1.1038 | 6 | 68 | myeloid leukocyte activation |
GO:0050732 | 9e-04 | 7.4702 | 0.756 | 5 | 43 | negative regulation of peptidyl-tyrosine phosphorylation |
GO:0002774 | 9e-04 | 112.5662 | 0.0527 | 2 | 3 | Fc receptor mediated inhibitory signaling pathway |
GO:0045658 | 9e-04 | 112.5662 | 0.0527 | 2 | 3 | regulation of neutrophil differentiation |
GO:0043065 | 9e-04 | 2.2747 | 9.846 | 21 | 560 | positive regulation of apoptotic process |
GO:0090023 | 0.001 | 10.2949 | 0.4571 | 4 | 26 | positive regulation of neutrophil chemotaxis |
GO:0046651 | 0.001 | 3.4943 | 3.0618 | 10 | 178 | lymphocyte proliferation |
GO:0045060 | 0.0011 | 18.8204 | 0.211 | 3 | 12 | negative thymic T cell selection |
GO:0050862 | 0.0011 | 18.8204 | 0.211 | 3 | 12 | positive regulation of T cell receptor signaling pathway |
GO:0051798 | 0.0011 | 18.8204 | 0.211 | 3 | 12 | positive regulation of hair follicle development |
GO:0060326 | 0.0011 | 3.0569 | 4.1845 | 12 | 238 | cell chemotaxis |
GO:0098609 | 0.0012 | 2.7415 | 5.4394 | 14 | 337 | cell-cell adhesion |
GO:0016339 | 0.0012 | 9.8467 | 0.4747 | 4 | 27 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules |
GO:0030851 | 0.0012 | 9.8467 | 0.4747 | 4 | 27 | granulocyte differentiation |
GO:0050854 | 0.0012 | 6.9222 | 0.8088 | 5 | 46 | regulation of antigen receptor-mediated signaling pathway |
GO:0042033 | 0.0013 | 16.9373 | 0.2286 | 3 | 13 | chemokine biosynthetic process |
GO:0002763 | 0.0014 | 6.7569 | 0.8264 | 5 | 47 | positive regulation of myeloid leukocyte differentiation |
GO:0042102 | 0.0015 | 4.4837 | 1.6879 | 7 | 96 | positive regulation of T cell proliferation |
GO:0050778 | 0.0016 | 3.9394 | 2.1787 | 8 | 131 | positive regulation of immune response |
GO:2000404 | 0.0016 | 9.0578 | 0.5099 | 4 | 29 | regulation of T cell migration |
GO:0002440 | 0.0016 | 3.552 | 2.7076 | 9 | 154 | production of molecular mediator of immune response |
GO:0042267 | 0.0016 | 6.449 | 0.8615 | 5 | 49 | natural killer cell mediated cytotoxicity |
GO:0045682 | 0.0017 | 5.171 | 1.2659 | 6 | 72 | regulation of epidermis development |
GO:0048856 | 0.0017 | 1.4526 | 92.4117 | 116 | 5256 | anatomical structure development |
GO:2000242 | 0.0018 | 6.3052 | 0.8791 | 5 | 50 | negative regulation of reproductive process |
GO:0016554 | 0.0018 | 56.2794 | 0.0703 | 2 | 4 | cytidine to uridine editing |
GO:0046874 | 0.0018 | 56.2794 | 0.0703 | 2 | 4 | quinolinate metabolic process |
GO:2001188 | 0.0018 | 56.2794 | 0.0703 | 2 | 4 | regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell |
GO:2001205 | 0.0018 | 56.2794 | 0.0703 | 2 | 4 | negative regulation of osteoclast development |
GO:2001274 | 0.0018 | 56.2794 | 0.0703 | 2 | 4 | negative regulation of glucose import in response to insulin stimulus |
GO:0043547 | 0.0018 | 2.5122 | 6.3296 | 15 | 360 | positive regulation of GTPase activity |
GO:0010952 | 0.0019 | 3.4557 | 2.778 | 9 | 158 | positive regulation of peptidase activity |
GO:0071219 | 0.0019 | 3.4557 | 2.778 | 9 | 158 | cellular response to molecule of bacterial origin |
GO:0032946 | 0.0021 | 3.7441 | 2.2857 | 8 | 130 | positive regulation of mononuclear cell proliferation |
GO:0001819 | 0.0021 | 2.4682 | 6.4351 | 15 | 366 | positive regulation of cytokine production |
GO:2001244 | 0.0021 | 6.0361 | 0.9143 | 5 | 52 | positive regulation of intrinsic apoptotic signaling pathway |
GO:1902622 | 0.0023 | 8.0857 | 0.5626 | 4 | 32 | regulation of neutrophil migration |
GO:0002920 | 0.0023 | 5.91 | 0.9319 | 5 | 53 | regulation of humoral immune response |
GO:0006954 | 0.0025 | 2.2295 | 8.5535 | 18 | 503 | inflammatory response |
GO:0045859 | 0.0025 | 1.9829 | 12.8525 | 24 | 731 | regulation of protein kinase activity |
GO:0002577 | 0.0025 | 13.0261 | 0.2813 | 3 | 16 | regulation of antigen processing and presentation |
GO:0010829 | 0.0025 | 13.0261 | 0.2813 | 3 | 16 | negative regulation of glucose transport |
GO:0045064 | 0.0025 | 13.0261 | 0.2813 | 3 | 16 | T-helper 2 cell differentiation |
GO:0051446 | 0.0025 | 13.0261 | 0.2813 | 3 | 16 | positive regulation of meiotic cell cycle |
GO:0002690 | 0.0027 | 4.673 | 1.389 | 6 | 79 | positive regulation of leukocyte chemotaxis |
GO:0042107 | 0.0027 | 4.0282 | 1.8637 | 7 | 106 | cytokine metabolic process |
GO:0016192 | 0.0028 | 1.6391 | 29.6083 | 45 | 1684 | vesicle-mediated transport |
GO:0002286 | 0.0028 | 4.6095 | 1.4066 | 6 | 80 | T cell activation involved in immune response |
GO:0045088 | 0.0028 | 2.3915 | 6.6285 | 15 | 377 | regulation of innate immune response |
GO:0002686 | 0.0029 | 7.5457 | 0.5978 | 4 | 34 | negative regulation of leukocyte migration |
GO:0050859 | 0.003 | 37.5172 | 0.0879 | 2 | 5 | negative regulation of B cell receptor signaling pathway |
GO:0060157 | 0.003 | 37.5172 | 0.0879 | 2 | 5 | urinary bladder development |
GO:0070245 | 0.003 | 37.5172 | 0.0879 | 2 | 5 | positive regulation of thymocyte apoptotic process |
GO:1902262 | 0.003 | 37.5172 | 0.0879 | 2 | 5 | apoptotic process involved in blood vessel morphogenesis |
GO:0030888 | 0.003 | 5.5613 | 0.9846 | 5 | 56 | regulation of B cell proliferation |
GO:0042249 | 0.003 | 12.0949 | 0.2989 | 3 | 17 | establishment of planar polarity of embryonic epithelium |
GO:0045944 | 0.0031 | 1.7929 | 18.4261 | 31 | 1048 | positive regulation of transcription from RNA polymerase II promoter |
GO:0006909 | 0.0032 | 2.9669 | 3.5692 | 10 | 203 | phagocytosis |
GO:0045670 | 0.0032 | 5.454 | 1.0022 | 5 | 57 | regulation of osteoclast differentiation |
GO:0032635 | 0.0033 | 3.8707 | 1.934 | 7 | 110 | interleukin-6 production |
GO:0002449 | 0.0033 | 5.409 | 1.0083 | 5 | 59 | lymphocyte mediated immunity |
GO:0042060 | 0.0035 | 2.1492 | 8.8438 | 18 | 503 | wound healing |
GO:0033628 | 0.0035 | 7.0731 | 0.633 | 4 | 36 | regulation of cell adhesion mediated by integrin |
GO:1902042 | 0.0035 | 7.0731 | 0.633 | 4 | 36 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors |
GO:0001501 | 0.0036 | 2.1995 | 8.1581 | 17 | 464 | skeletal system development |
GO:0010818 | 0.0036 | 11.2878 | 0.3165 | 3 | 18 | T cell chemotaxis |
GO:0002822 | 0.0036 | 3.7965 | 1.9692 | 7 | 112 | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
GO:0002718 | 0.0037 | 5.2513 | 1.0373 | 5 | 59 | regulation of cytokine production involved in immune response |
GO:0046631 | 0.0038 | 3.7604 | 1.9868 | 7 | 113 | alpha-beta T cell activation |
GO:0045619 | 0.004 | 3.3556 | 2.5318 | 8 | 144 | regulation of lymphocyte differentiation |
GO:0002706 | 0.004 | 3.7251 | 2.0044 | 7 | 114 | regulation of lymphocyte mediated immunity |
GO:0051336 | 0.0042 | 1.771 | 18.0098 | 30 | 1034 | regulation of hydrolase activity |
GO:0060429 | 0.0042 | 1.7232 | 20.3953 | 33 | 1160 | epithelium development |
GO:0002366 | 0.0042 | 3.6891 | 2.0201 | 7 | 124 | leukocyte activation involved in immune response |
GO:0002704 | 0.0043 | 6.6562 | 0.6681 | 4 | 38 | negative regulation of leukocyte mediated immunity |
GO:0002740 | 0.0044 | 28.136 | 0.1055 | 2 | 6 | negative regulation of cytokine secretion involved in immune response |
GO:0002765 | 0.0044 | 28.136 | 0.1055 | 2 | 6 | immune response-inhibiting signal transduction |
GO:0003402 | 0.0044 | 28.136 | 0.1055 | 2 | 6 | planar cell polarity pathway involved in axis elongation |
GO:0030335 | 0.0046 | 2.2632 | 6.9801 | 15 | 397 | positive regulation of cell migration |
GO:2001056 | 0.0046 | 3.6227 | 2.0571 | 7 | 117 | positive regulation of cysteine-type endopeptidase activity |
GO:0006952 | 0.0047 | 3.2533 | 2.6069 | 8 | 166 | defense response |
GO:0051249 | 0.0048 | 9.9747 | 0.3488 | 3 | 21 | regulation of lymphocyte activation |
GO:0002438 | 0.0049 | 9.9585 | 0.3516 | 3 | 20 | acute inflammatory response to antigenic stimulus |
GO:1904385 | 0.0049 | 9.9585 | 0.3516 | 3 | 20 | cellular response to angiotensin |
GO:0031295 | 0.005 | 4.8878 | 1.1077 | 5 | 63 | T cell costimulation |
GO:2001233 | 0.005 | 2.3151 | 6.3647 | 14 | 362 | regulation of apoptotic signaling pathway |
GO:0040017 | 0.005 | 2.1773 | 7.7361 | 16 | 440 | positive regulation of locomotion |
GO:0071675 | 0.0052 | 6.2856 | 0.7033 | 4 | 40 | regulation of mononuclear cell migration |
GO:0043367 | 0.0053 | 4.8047 | 1.1253 | 5 | 64 | CD4-positive, alpha-beta T cell differentiation |
GO:0045087 | 0.0053 | 2.2959 | 6.4209 | 14 | 377 | innate immune response |
GO:0016064 | 0.0054 | 4.0101 | 1.6 | 6 | 91 | immunoglobulin mediated immune response |
GO:0007155 | 0.0055 | 2.2902 | 6.451 | 14 | 419 | cell adhesion |
GO:0048565 | 0.0055 | 3.4947 | 2.1274 | 7 | 121 | digestive tract development |
GO:0071887 | 0.0056 | 3.9632 | 1.6176 | 6 | 92 | leukocyte apoptotic process |
GO:0002544 | 0.0057 | 9.4047 | 0.3692 | 3 | 21 | chronic inflammatory response |
GO:0002861 | 0.0057 | 9.4047 | 0.3692 | 3 | 21 | regulation of inflammatory response to antigenic stimulus |
GO:0001756 | 0.006 | 4.6465 | 1.1604 | 5 | 66 | somitogenesis |
GO:0033077 | 0.006 | 4.6465 | 1.1604 | 5 | 66 | T cell differentiation in thymus |
GO:0002606 | 0.0061 | 22.5074 | 0.1231 | 2 | 7 | positive regulation of dendritic cell antigen processing and presentation |
GO:0002883 | 0.0061 | 22.5074 | 0.1231 | 2 | 7 | regulation of hypersensitivity |
GO:0045656 | 0.0061 | 22.5074 | 0.1231 | 2 | 7 | negative regulation of monocyte differentiation |
GO:0060028 | 0.0061 | 22.5074 | 0.1231 | 2 | 7 | convergent extension involved in axis elongation |
GO:0060907 | 0.0061 | 22.5074 | 0.1231 | 2 | 7 | positive regulation of macrophage cytokine production |
GO:2000343 | 0.0061 | 22.5074 | 0.1231 | 2 | 7 | positive regulation of chemokine (C-X-C motif) ligand 2 production |
GO:0009617 | 0.0062 | 2.5447 | 4.5476 | 11 | 264 | response to bacterium |
GO:0048869 | 0.0062 | 1.4087 | 68.3593 | 87 | 3888 | cellular developmental process |
GO:0043122 | 0.0062 | 2.6848 | 3.9208 | 10 | 223 | regulation of I-kappaB kinase/NF-kappaB signaling |
GO:0045446 | 0.0063 | 3.8726 | 1.6527 | 6 | 94 | endothelial cell differentiation |
GO:0045123 | 0.0063 | 8.9965 | 0.3832 | 3 | 22 | cellular extravasation |
GO:0051093 | 0.0065 | 1.802 | 14.6459 | 25 | 833 | negative regulation of developmental process |
GO:0050863 | 0.0068 | 2.82 | 3.3609 | 9 | 198 | regulation of T cell activation |
GO:0043067 | 0.0071 | 1.6118 | 24.4216 | 37 | 1389 | regulation of programmed cell death |
GO:0046677 | 0.0073 | 5.6556 | 0.7736 | 4 | 44 | response to antibiotic |
GO:0071622 | 0.0073 | 5.6556 | 0.7736 | 4 | 44 | regulation of granulocyte chemotaxis |
GO:0006882 | 0.0073 | 8.4631 | 0.4044 | 3 | 23 | cellular zinc ion homeostasis |
GO:0042832 | 0.0073 | 8.4631 | 0.4044 | 3 | 23 | defense response to protozoan |
GO:0045637 | 0.0074 | 2.6102 | 4.0263 | 10 | 229 | regulation of myeloid cell differentiation |
GO:0019221 | 0.0075 | 1.9445 | 10.268 | 19 | 584 | cytokine-mediated signaling pathway |
GO:0035306 | 0.0079 | 5.5173 | 0.7912 | 4 | 45 | positive regulation of dephosphorylation |
GO:0045058 | 0.0079 | 5.5173 | 0.7912 | 4 | 45 | T cell selection |
GO:0032071 | 0.008 | 18.7549 | 0.1407 | 2 | 8 | regulation of endodeoxyribonuclease activity |
GO:0045617 | 0.008 | 18.7549 | 0.1407 | 2 | 8 | negative regulation of keratinocyte differentiation |
GO:0051133 | 0.008 | 18.7549 | 0.1407 | 2 | 8 | regulation of NK T cell activation |
GO:0071316 | 0.008 | 18.7549 | 0.1407 | 2 | 8 | cellular response to nicotine |
GO:0071550 | 0.008 | 18.7549 | 0.1407 | 2 | 8 | death-inducing signaling complex assembly |
GO:0072610 | 0.008 | 18.7549 | 0.1407 | 2 | 8 | interleukin-12 secretion |
GO:2000035 | 0.008 | 18.7549 | 0.1407 | 2 | 8 | regulation of stem cell division |
GO:2000304 | 0.008 | 18.7549 | 0.1407 | 2 | 8 | positive regulation of ceramide biosynthetic process |
GO:2001198 | 0.008 | 18.7549 | 0.1407 | 2 | 8 | regulation of dendritic cell differentiation |
GO:0051272 | 0.0082 | 2.11 | 7.4548 | 15 | 424 | positive regulation of cellular component movement |
GO:0002691 | 0.0083 | 8.0596 | 0.422 | 3 | 24 | regulation of cellular extravasation |
GO:0045662 | 0.0083 | 8.0596 | 0.422 | 3 | 24 | negative regulation of myoblast differentiation |
GO:0060142 | 0.0083 | 8.0596 | 0.422 | 3 | 24 | regulation of syncytium formation by plasma membrane fusion |
GO:0042110 | 0.0083 | 4.2712 | 1.2515 | 5 | 76 | T cell activation |
GO:0031663 | 0.0085 | 5.3855 | 0.8088 | 4 | 46 | lipopolysaccharide-mediated signaling pathway |
GO:0065009 | 0.0087 | 1.4209 | 53.5903 | 70 | 3048 | regulation of molecular function |
GO:0045582 | 0.0087 | 4.2288 | 1.2659 | 5 | 72 | positive regulation of T cell differentiation |
GO:0009967 | 0.0089 | 1.5847 | 24.7908 | 37 | 1410 | positive regulation of signal transduction |
GO:0098657 | 0.009 | 1.8751 | 11.1998 | 20 | 637 | import into cell |
GO:0042742 | 0.009 | 2.6884 | 3.5164 | 9 | 200 | defense response to bacterium |
GO:0050729 | 0.0091 | 4.1774 | 1.2796 | 5 | 74 | positive regulation of inflammatory response |
GO:0043407 | 0.0092 | 4.1663 | 1.2835 | 5 | 73 | negative regulation of MAP kinase activity |
GO:0032069 | 0.0093 | 7.6927 | 0.4396 | 3 | 25 | regulation of nuclease activity |
GO:0060706 | 0.0093 | 7.6927 | 0.4396 | 3 | 25 | cell differentiation involved in embryonic placenta development |
GO:0033674 | 0.0098 | 1.9674 | 9.0548 | 17 | 515 | positive regulation of kinase activity |
GO:0009615 | 0.0098 | 2.3746 | 4.8527 | 11 | 276 | response to virus |
GO:0051239 | 0.0099 | 1.4343 | 46.6806 | 62 | 2655 | regulation of multicellular organismal process |
GO:0042127 | 0.0099 | 1.8605 | 11.3182 | 20 | 682 | regulation of cell proliferation |
GO:0070228 | 0.0099 | 5.1401 | 0.8439 | 4 | 48 | regulation of lymphocyte apoptotic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:1903039 | 0 | 8.795 | 2.4274 | 18 | 209 | positive regulation of leukocyte cell-cell adhesion |
GO:0051251 | 0 | 7.636 | 2.9268 | 19 | 252 | positive regulation of lymphocyte activation |
GO:0050867 | 0 | 6.9104 | 3.3914 | 20 | 292 | positive regulation of cell activation |
GO:0002263 | 0 | 4.6438 | 7.1081 | 28 | 612 | cell activation involved in immune response |
GO:0002250 | 0 | 6.8916 | 3.2166 | 19 | 281 | adaptive immune response |
GO:0045087 | 0 | 6.0123 | 3.8735 | 20 | 350 | innate immune response |
GO:0022407 | 0 | 5.4534 | 4.4483 | 21 | 383 | regulation of cell-cell adhesion |
GO:0002694 | 0 | 6.044 | 3.2214 | 17 | 291 | regulation of leukocyte activation |
GO:0050778 | 0 | 4.0949 | 7.0345 | 25 | 612 | positive regulation of immune response |
GO:0045785 | 0 | 5.1039 | 4.2393 | 19 | 365 | positive regulation of cell adhesion |
GO:0002275 | 0 | 4.2352 | 5.6214 | 21 | 484 | myeloid cell activation involved in immune response |
GO:0045321 | 0 | 4.0075 | 6.31 | 22 | 621 | leukocyte activation |
GO:0032946 | 0 | 8.3106 | 1.5099 | 11 | 130 | positive regulation of mononuclear cell proliferation |
GO:0050776 | 0 | 8.7163 | 1.3078 | 10 | 129 | regulation of immune response |
GO:0043312 | 0 | 4.2149 | 5.0639 | 19 | 436 | neutrophil degranulation |
GO:0045058 | 0 | 16.2666 | 0.5227 | 7 | 45 | T cell selection |
GO:0002444 | 0 | 3.9556 | 5.6795 | 20 | 489 | myeloid leukocyte mediated immunity |
GO:0042119 | 0 | 4.1135 | 5.1801 | 19 | 446 | neutrophil activation |
GO:0006911 | 0 | 18.8265 | 0.3949 | 6 | 34 | phagocytosis, engulfment |
GO:0050670 | 0 | 6.0051 | 2.23 | 12 | 192 | regulation of lymphocyte proliferation |
GO:0042102 | 0 | 10.2978 | 0.8919 | 8 | 78 | positive regulation of T cell proliferation |
GO:0002443 | 0 | 7.0783 | 1.5831 | 10 | 151 | leukocyte mediated immunity |
GO:0070663 | 0 | 5.6552 | 2.3577 | 12 | 203 | regulation of leukocyte proliferation |
GO:0050900 | 0 | 5.9757 | 2.0455 | 11 | 182 | leukocyte migration |
GO:0045060 | 0 | 43.4887 | 0.1394 | 4 | 12 | negative thymic T cell selection |
GO:0002757 | 0 | 3.7717 | 4.9826 | 17 | 429 | immune response-activating signal transduction |
GO:0048870 | 0 | 2.4779 | 15.6679 | 34 | 1349 | cell motility |
GO:0050851 | 0 | 5.5345 | 2.1951 | 11 | 189 | antigen receptor-mediated signaling pathway |
GO:0045582 | 0 | 9.493 | 0.8362 | 7 | 72 | positive regulation of T cell differentiation |
GO:0002768 | 0 | 4.095 | 3.7515 | 14 | 323 | immune response-regulating cell surface receptor signaling pathway |
GO:0010324 | 0 | 11.7013 | 0.5923 | 6 | 51 | membrane invagination |
GO:0045055 | 0 | 2.9982 | 7.7469 | 21 | 667 | regulated exocytosis |
GO:0032940 | 0 | 2.3879 | 15.1337 | 32 | 1303 | secretion by cell |
GO:0032649 | 0 | 8.3336 | 0.9408 | 7 | 81 | regulation of interferon-gamma production |
GO:0050863 | 1e-04 | 5.8349 | 1.6945 | 9 | 154 | regulation of T cell activation |
GO:0098657 | 1e-04 | 2.9769 | 7.3984 | 20 | 637 | import into cell |
GO:0080134 | 1e-04 | 2.3667 | 14.7272 | 31 | 1268 | regulation of response to stress |
GO:0006959 | 1e-04 | 5.1183 | 2.1371 | 10 | 184 | humoral immune response |
GO:0032753 | 1e-04 | 23.1834 | 0.2207 | 4 | 19 | positive regulation of interleukin-4 production |
GO:0016192 | 1e-04 | 2.146 | 19.5588 | 37 | 1684 | vesicle-mediated transport |
GO:0051716 | 1e-04 | 1.7529 | 76.0748 | 101 | 6550 | cellular response to stimulus |
GO:0002695 | 1e-04 | 5.9063 | 1.4825 | 8 | 129 | negative regulation of leukocyte activation |
GO:0052547 | 1e-04 | 3.4734 | 4.3787 | 14 | 377 | regulation of peptidase activity |
GO:0006950 | 1e-04 | 2.0837 | 22.4733 | 40 | 2145 | response to stress |
GO:0050727 | 2e-04 | 3.8212 | 3.403 | 12 | 293 | regulation of inflammatory response |
GO:0002285 | 2e-04 | 5.4328 | 1.6028 | 8 | 138 | lymphocyte activation involved in immune response |
GO:0050864 | 2e-04 | 6.2828 | 1.2195 | 7 | 105 | regulation of B cell activation |
GO:0023052 | 2e-04 | 1.7135 | 67.4453 | 91 | 5807 | signaling |
GO:0007154 | 3e-04 | 1.7055 | 67.6427 | 91 | 5824 | cell communication |
GO:0046634 | 3e-04 | 14.7746 | 0.319 | 4 | 28 | regulation of alpha-beta T cell activation |
GO:0045619 | 3e-04 | 5.1911 | 1.6725 | 8 | 144 | regulation of lymphocyte differentiation |
GO:0031349 | 3e-04 | 3.2102 | 4.7155 | 14 | 406 | positive regulation of defense response |
GO:0001787 | 3e-04 | 28.8277 | 0.1394 | 3 | 12 | natural killer cell proliferation |
GO:0018149 | 3e-04 | 9.2819 | 0.604 | 5 | 52 | peptide cross-linking |
GO:0042269 | 4e-04 | 13.3655 | 0.3484 | 4 | 30 | regulation of natural killer cell mediated cytotoxicity |
GO:0002774 | 4e-04 | 172.0894 | 0.0348 | 2 | 3 | Fc receptor mediated inhibitory signaling pathway |
GO:0042110 | 4e-04 | 5.5477 | 1.3683 | 7 | 130 | T cell activation |
GO:0002710 | 5e-04 | 23.5832 | 0.1626 | 3 | 14 | negative regulation of T cell mediated immunity |
GO:0031348 | 6e-04 | 4.6092 | 1.8699 | 8 | 161 | negative regulation of defense response |
GO:0002718 | 6e-04 | 8.075 | 0.6853 | 5 | 59 | regulation of cytokine production involved in immune response |
GO:0032715 | 6e-04 | 11.5804 | 0.3949 | 4 | 34 | negative regulation of interleukin-6 production |
GO:0006909 | 7e-04 | 4.5268 | 1.9019 | 8 | 169 | phagocytosis |
GO:1902107 | 7e-04 | 5.167 | 1.4634 | 7 | 126 | positive regulation of leukocyte differentiation |
GO:0031341 | 8e-04 | 7.6485 | 0.7201 | 5 | 62 | regulation of cell killing |
GO:0030097 | 8e-04 | 2.3835 | 9.0941 | 20 | 783 | hemopoiesis |
GO:0008588 | 8e-04 | 86.0391 | 0.0465 | 2 | 4 | release of cytoplasmic sequestered NF-kappaB |
GO:2001187 | 8e-04 | 86.0391 | 0.0465 | 2 | 4 | positive regulation of CD8-positive, alpha-beta T cell activation |
GO:0031295 | 8e-04 | 7.5162 | 0.7317 | 5 | 63 | T cell costimulation |
GO:0002706 | 9e-04 | 10.4637 | 0.4313 | 4 | 38 | regulation of lymphocyte mediated immunity |
GO:0051240 | 9e-04 | 2.0077 | 16.4577 | 30 | 1417 | positive regulation of multicellular organismal process |
GO:0002704 | 0.001 | 10.2154 | 0.4414 | 4 | 38 | negative regulation of leukocyte mediated immunity |
GO:0033077 | 0.001 | 7.1451 | 0.7666 | 5 | 66 | T cell differentiation in thymus |
GO:0046641 | 0.0011 | 17.2899 | 0.2091 | 3 | 18 | positive regulation of alpha-beta T cell proliferation |
GO:0030216 | 0.0012 | 3.4328 | 3.1127 | 10 | 268 | keratinocyte differentiation |
GO:0002702 | 0.0012 | 6.8089 | 0.8014 | 5 | 69 | positive regulation of production of molecular mediator of immune response |
GO:0046645 | 0.0013 | 57.3557 | 0.0581 | 2 | 5 | positive regulation of gamma-delta T cell activation |
GO:0061737 | 0.0013 | 57.3557 | 0.0581 | 2 | 5 | leukotriene signaling pathway |
GO:0007155 | 0.0013 | 2.2856 | 9.5163 | 20 | 894 | cell adhesion |
GO:0051346 | 0.0014 | 2.9671 | 4.3206 | 12 | 372 | negative regulation of hydrolase activity |
GO:0002438 | 0.0015 | 15.2538 | 0.2323 | 3 | 20 | acute inflammatory response to antigenic stimulus |
GO:0045088 | 0.0015 | 2.9254 | 4.3787 | 12 | 377 | regulation of innate immune response |
GO:0006968 | 0.0017 | 8.6797 | 0.511 | 4 | 44 | cellular defense response |
GO:0070098 | 0.0017 | 6.3134 | 0.8595 | 5 | 74 | chemokine-mediated signaling pathway |
GO:0071674 | 0.0018 | 6.2228 | 0.8711 | 5 | 75 | mononuclear cell migration |
GO:0046903 | 0.0018 | 5.026 | 1.2833 | 6 | 123 | secretion |
GO:0097530 | 0.0019 | 4.9953 | 1.2892 | 6 | 111 | granulocyte migration |
GO:0030098 | 0.0019 | 4.2786 | 1.7479 | 7 | 156 | lymphocyte differentiation |
GO:0002708 | 0.0019 | 6.1348 | 0.8827 | 5 | 76 | positive regulation of lymphocyte mediated immunity |
GO:0002666 | 0.002 | 43.014 | 0.0697 | 2 | 6 | positive regulation of T cell tolerance induction |
GO:0002765 | 0.002 | 43.014 | 0.0697 | 2 | 6 | immune response-inhibiting signal transduction |
GO:0002933 | 0.002 | 43.014 | 0.0697 | 2 | 6 | lipid hydroxylation |
GO:2000271 | 0.002 | 43.014 | 0.0697 | 2 | 6 | positive regulation of fibroblast apoptotic process |
GO:2000510 | 0.002 | 43.014 | 0.0697 | 2 | 6 | positive regulation of dendritic cell chemotaxis |
GO:0002822 | 0.002 | 4.9478 | 1.3008 | 6 | 112 | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
GO:0001909 | 0.002 | 6.0492 | 0.8943 | 5 | 77 | leukocyte mediated cytotoxicity |
GO:0002507 | 0.002 | 13.6464 | 0.2555 | 3 | 22 | tolerance induction |
GO:0042347 | 0.002 | 13.6464 | 0.2555 | 3 | 22 | negative regulation of NF-kappaB import into nucleus |
GO:0072538 | 0.002 | 13.6464 | 0.2555 | 3 | 22 | T-helper 17 type immune response |
GO:2000514 | 0.0021 | 8.0725 | 0.5459 | 4 | 47 | regulation of CD4-positive, alpha-beta T cell activation |
GO:0001816 | 0.0022 | 2.564 | 5.8326 | 14 | 513 | cytokine production |
GO:0051607 | 0.0022 | 3.7026 | 2.2997 | 8 | 198 | defense response to virus |
GO:0030593 | 0.0024 | 5.8061 | 0.9292 | 5 | 80 | neutrophil chemotaxis |
GO:0009617 | 0.0025 | 4.067 | 1.8345 | 7 | 163 | response to bacterium |
GO:0050921 | 0.0027 | 4.6392 | 1.3821 | 6 | 119 | positive regulation of chemotaxis |
GO:0002291 | 0.0027 | 34.4089 | 0.0813 | 2 | 7 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell |
GO:0002883 | 0.0027 | 34.4089 | 0.0813 | 2 | 7 | regulation of hypersensitivity |
GO:0032661 | 0.0027 | 34.4089 | 0.0813 | 2 | 7 | regulation of interleukin-18 production |
GO:1902715 | 0.0027 | 34.4089 | 0.0813 | 2 | 7 | positive regulation of interferon-gamma secretion |
GO:0002228 | 0.0029 | 7.3836 | 0.5923 | 4 | 51 | natural killer cell mediated immunity |
GO:0036336 | 0.0029 | 11.7832 | 0.2904 | 3 | 25 | dendritic cell migration |
GO:0050790 | 0.003 | 1.7309 | 24.251 | 38 | 2088 | regulation of catalytic activity |
GO:0051051 | 0.003 | 2.5654 | 5.3891 | 13 | 464 | negative regulation of transport |
GO:0008284 | 0.0033 | 2.1352 | 9.5355 | 19 | 821 | positive regulation of cell proliferation |
GO:0006869 | 0.0033 | 2.9642 | 3.5773 | 10 | 308 | lipid transport |
GO:0043547 | 0.0033 | 2.7911 | 4.1812 | 11 | 360 | positive regulation of GTPase activity |
GO:0001782 | 0.0033 | 11.2702 | 0.302 | 3 | 26 | B cell homeostasis |
GO:0043372 | 0.0033 | 11.2702 | 0.302 | 3 | 26 | positive regulation of CD4-positive, alpha-beta T cell differentiation |
GO:0071276 | 0.0033 | 11.2702 | 0.302 | 3 | 26 | cellular response to cadmium ion |
GO:0046632 | 0.0034 | 5.308 | 1.0105 | 5 | 87 | alpha-beta T cell differentiation |
GO:0002520 | 0.0035 | 2.1197 | 9.608 | 19 | 840 | immune system development |
GO:0006954 | 0.0036 | 2.9279 | 3.6251 | 10 | 328 | inflammatory response |
GO:0033004 | 0.0036 | 28.6723 | 0.0929 | 2 | 8 | negative regulation of mast cell activation |
GO:0072610 | 0.0036 | 28.6723 | 0.0929 | 2 | 8 | interleukin-12 secretion |
GO:2001198 | 0.0036 | 28.6723 | 0.0929 | 2 | 8 | regulation of dendritic cell differentiation |
GO:0042330 | 0.0036 | 2.4186 | 6.1557 | 14 | 530 | taxis |
GO:0050868 | 0.0038 | 5.1809 | 1.0337 | 5 | 89 | negative regulation of T cell activation |
GO:0043207 | 0.0039 | 2.5979 | 4.9069 | 12 | 436 | response to external biotic stimulus |
GO:0010951 | 0.0039 | 3.3618 | 2.5203 | 8 | 217 | negative regulation of endopeptidase activity |
GO:0001773 | 0.0041 | 10.3672 | 0.3252 | 3 | 28 | myeloid dendritic cell activation |
GO:0035556 | 0.0044 | 1.6402 | 29.0594 | 43 | 2502 | intracellular signal transduction |
GO:0002699 | 0.0045 | 4.9542 | 1.0777 | 5 | 95 | positive regulation of immune effector process |
GO:0019724 | 0.0046 | 4.9442 | 1.0801 | 5 | 93 | B cell mediated immunity |
GO:0042035 | 0.0046 | 4.9442 | 1.0801 | 5 | 93 | regulation of cytokine biosynthetic process |
GO:0006527 | 0.0046 | 24.5746 | 0.1045 | 2 | 9 | arginine catabolic process |
GO:0034447 | 0.0046 | 24.5746 | 0.1045 | 2 | 9 | very-low-density lipoprotein particle clearance |
GO:0051234 | 0.005 | 1.5097 | 54.4022 | 71 | 4684 | establishment of localization |
GO:0030595 | 0.0051 | 3.5416 | 2.0906 | 7 | 180 | leukocyte chemotaxis |
GO:0032680 | 0.0055 | 4.728 | 1.1266 | 5 | 97 | regulation of tumor necrosis factor production |
GO:0050706 | 0.0055 | 9.2546 | 0.36 | 3 | 31 | regulation of interleukin-1 beta secretion |
GO:0007585 | 0.0055 | 6.0843 | 0.7085 | 4 | 61 | respiratory gaseous exchange |
GO:0051704 | 0.0057 | 1.6532 | 25.215 | 38 | 2171 | multi-organism process |
GO:0042308 | 0.0062 | 5.8772 | 0.7317 | 4 | 63 | negative regulation of protein import into nucleus |
GO:0043281 | 0.0066 | 3.3645 | 2.1951 | 7 | 189 | regulation of cysteine-type endopeptidase activity involved in apoptotic process |
GO:0001771 | 0.0069 | 19.1111 | 0.1278 | 2 | 11 | immunological synapse formation |
GO:0001867 | 0.0069 | 19.1111 | 0.1278 | 2 | 11 | complement activation, lectin pathway |
GO:0002863 | 0.0069 | 19.1111 | 0.1278 | 2 | 11 | positive regulation of inflammatory response to antigenic stimulus |
GO:0044546 | 0.0069 | 19.1111 | 0.1278 | 2 | 11 | NLRP3 inflammasome complex assembly |
GO:1901223 | 0.0069 | 19.1111 | 0.1278 | 2 | 11 | negative regulation of NIK/NF-kappaB signaling |
GO:0002820 | 0.0071 | 8.3574 | 0.3949 | 3 | 34 | negative regulation of adaptive immune response |
GO:0071706 | 0.0073 | 4.3916 | 1.2079 | 5 | 104 | tumor necrosis factor superfamily cytokine production |
GO:0050707 | 0.0074 | 3.7111 | 1.7073 | 6 | 147 | regulation of cytokine secretion |
GO:0070268 | 0.0076 | 4.3474 | 1.2195 | 5 | 105 | cornification |
GO:0019731 | 0.0077 | 8.0957 | 0.4065 | 3 | 35 | antibacterial humoral response |
GO:0007166 | 0.0078 | 1.6429 | 24.0635 | 36 | 2199 | cell surface receptor signaling pathway |
GO:0042107 | 0.0079 | 4.3041 | 1.2311 | 5 | 106 | cytokine metabolic process |
GO:0002674 | 0.0082 | 17.1989 | 0.1394 | 2 | 12 | negative regulation of acute inflammatory response |
GO:0045086 | 0.0082 | 17.1989 | 0.1394 | 2 | 12 | positive regulation of interleukin-2 biosynthetic process |
GO:0045579 | 0.0082 | 17.1989 | 0.1394 | 2 | 12 | positive regulation of B cell differentiation |
GO:0050711 | 0.0082 | 17.1989 | 0.1394 | 2 | 12 | negative regulation of interleukin-1 secretion |
GO:0050862 | 0.0082 | 17.1989 | 0.1394 | 2 | 12 | positive regulation of T cell receptor signaling pathway |
GO:0071222 | 0.0084 | 3.6078 | 1.7538 | 6 | 151 | cellular response to lipopolysaccharide |
GO:0002237 | 0.0087 | 2.7078 | 3.496 | 9 | 301 | response to molecule of bacterial origin |
GO:0045861 | 0.0094 | 2.6705 | 3.5424 | 9 | 305 | negative regulation of proteolysis |
GO:0006955 | 0.0096 | 4.0948 | 1.2931 | 5 | 158 | immune response |
GO:0002726 | 0.0096 | 15.6343 | 0.151 | 2 | 13 | positive regulation of T cell cytokine production |
GO:0032688 | 0.0096 | 15.6343 | 0.151 | 2 | 13 | negative regulation of interferon-beta production |
GO:0032740 | 0.0096 | 15.6343 | 0.151 | 2 | 13 | positive regulation of interleukin-17 production |
GO:0072540 | 0.0096 | 15.6343 | 0.151 | 2 | 13 | T-helper 17 cell lineage commitment |
GO:0032309 | 0.0096 | 7.4003 | 0.4414 | 3 | 38 | icosanoid secretion |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 199.3265 | 0.5709 | 24 | 31 | DNA replication-dependent nucleosome assembly |
GO:0000183 | 0 | 107.2875 | 0.6814 | 24 | 37 | chromatin silencing at rDNA |
GO:0051290 | 0 | 73.3784 | 0.7919 | 24 | 43 | protein heterotetramerization |
GO:0045815 | 0 | 25.7592 | 1.4365 | 24 | 78 | positive regulation of gene expression, epigenetic |
GO:0045653 | 0 | 261.4359 | 0.3131 | 14 | 17 | negative regulation of megakaryocyte differentiation |
GO:0060964 | 0 | 18.5211 | 1.8232 | 24 | 99 | regulation of gene silencing by miRNA |
GO:0031497 | 0 | 13.3368 | 2.7809 | 28 | 151 | chromatin assembly |
GO:1902036 | 0 | 17.8052 | 1.8785 | 24 | 102 | regulation of hematopoietic stem cell differentiation |
GO:0045814 | 0 | 14.7988 | 2.2652 | 25 | 123 | negative regulation of gene expression, epigenetic |
GO:0060968 | 0 | 14.2997 | 2.2284 | 24 | 121 | regulation of gene silencing |
GO:0048863 | 0 | 8.0369 | 4.5857 | 30 | 249 | stem cell differentiation |
GO:0002244 | 0 | 9.4843 | 3.407 | 26 | 185 | hematopoietic progenitor cell differentiation |
GO:0065004 | 0 | 8.3293 | 4.1253 | 28 | 224 | protein-DNA complex assembly |
GO:0032200 | 0 | 10.1729 | 2.9466 | 24 | 160 | telomere organization |
GO:0034080 | 0 | 27.9652 | 0.7735 | 14 | 42 | CENP-A containing nucleosome assembly |
GO:1904837 | 0 | 27.9652 | 0.7735 | 14 | 42 | beta-catenin-TCF complex assembly |
GO:0071103 | 0 | 6.7255 | 4.9724 | 28 | 270 | DNA conformation change |
GO:0016233 | 0 | 21.7393 | 0.9208 | 14 | 50 | telomere capping |
GO:0034724 | 0 | 20.0631 | 0.9761 | 14 | 53 | DNA replication-independent nucleosome organization |
GO:1903707 | 0 | 9.7881 | 2.3757 | 19 | 129 | negative regulation of hemopoiesis |
GO:0006303 | 0 | 14.2117 | 1.2707 | 14 | 69 | double-strand break repair via nonhomologous end joining |
GO:0030099 | 0 | 4.9747 | 6.7588 | 29 | 367 | myeloid cell differentiation |
GO:0043044 | 0 | 12.6013 | 1.3996 | 14 | 76 | ATP-dependent chromatin remodeling |
GO:0035194 | 0 | 5.4545 | 5.3039 | 25 | 288 | posttranscriptional gene silencing by RNA |
GO:0051259 | 0 | 4.0116 | 9.1345 | 32 | 496 | protein oligomerization |
GO:0038111 | 0 | 20.4172 | 0.6814 | 10 | 37 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 19.6867 | 0.6998 | 10 | 38 | response to interleukin-7 |
GO:0017148 | 0 | 4.4873 | 6.8693 | 27 | 373 | negative regulation of translation |
GO:0045652 | 0 | 12.8847 | 0.9645 | 10 | 55 | regulation of megakaryocyte differentiation |
GO:0034728 | 0 | 7.9805 | 1.8984 | 13 | 108 | nucleosome organization |
GO:0048534 | 0 | 2.9072 | 15.1751 | 39 | 824 | hematopoietic or lymphoid organ development |
GO:0034248 | 0 | 2.958 | 10.8472 | 29 | 589 | regulation of cellular amide metabolic process |
GO:0010608 | 0 | 2.7508 | 12.4494 | 31 | 676 | posttranscriptional regulation of gene expression |
GO:0045596 | 0 | 2.8168 | 11.3445 | 29 | 616 | negative regulation of cell differentiation |
GO:0048869 | 0 | 2.0611 | 34.01 | 60 | 1999 | cellular developmental process |
GO:0051239 | 0 | 1.8756 | 48.8953 | 79 | 2655 | regulation of multicellular organismal process |
GO:0051248 | 0 | 2.2122 | 23.223 | 46 | 1261 | negative regulation of protein metabolic process |
GO:0045892 | 0 | 2.2269 | 19.8344 | 40 | 1077 | negative regulation of transcription, DNA-templated |
GO:0006352 | 0 | 3.8503 | 4.2542 | 15 | 231 | DNA-templated transcription, initiation |
GO:1902679 | 0 | 2.1382 | 20.571 | 40 | 1117 | negative regulation of RNA biosynthetic process |
GO:0045934 | 1e-04 | 2.014 | 24.641 | 45 | 1338 | negative regulation of nucleobase-containing compound metabolic process |
GO:0070271 | 1e-04 | 2.0106 | 24.6779 | 45 | 1340 | protein complex biogenesis |
GO:0048731 | 1e-04 | 1.6522 | 72.0277 | 101 | 4005 | system development |
GO:0009611 | 1e-04 | 2.4343 | 11.0866 | 25 | 602 | response to wounding |
GO:0014855 | 2e-04 | 6.2443 | 1.2523 | 7 | 68 | striated muscle cell proliferation |
GO:0065003 | 3e-04 | 1.8033 | 31.0868 | 51 | 1688 | macromolecular complex assembly |
GO:0060249 | 3e-04 | 2.8207 | 6.4641 | 17 | 351 | anatomical structure homeostasis |
GO:0050878 | 3e-04 | 2.5592 | 8.3794 | 20 | 455 | regulation of body fluid levels |
GO:0021879 | 4e-04 | 6.9281 | 0.9761 | 6 | 53 | forebrain neuron differentiation |
GO:0071822 | 6e-04 | 1.7685 | 28.9505 | 47 | 1572 | protein complex subunit organization |
GO:0001764 | 8e-04 | 3.9614 | 2.4494 | 9 | 133 | neuron migration |
GO:0045595 | 8e-04 | 1.9692 | 16.9782 | 31 | 985 | regulation of cell differentiation |
GO:0002019 | 0.001 | 107.3404 | 0.0552 | 2 | 3 | regulation of renal output by angiotensin |
GO:0007412 | 0.001 | 107.3404 | 0.0552 | 2 | 3 | axon target recognition |
GO:0055014 | 0.001 | 107.3404 | 0.0552 | 2 | 3 | atrial cardiac muscle cell development |
GO:0070370 | 0.001 | 107.3404 | 0.0552 | 2 | 3 | cellular heat acclimation |
GO:0070434 | 0.001 | 107.3404 | 0.0552 | 2 | 3 | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway |
GO:0043043 | 0.0013 | 1.9773 | 15.1198 | 28 | 821 | peptide biosynthetic process |
GO:0071345 | 0.0014 | 1.9668 | 15.1935 | 28 | 825 | cellular response to cytokine stimulus |
GO:0061061 | 0.0017 | 2.1217 | 11.013 | 22 | 598 | muscle structure development |
GO:0010823 | 0.0017 | 6.44 | 0.8656 | 5 | 47 | negative regulation of mitochondrion organization |
GO:0060043 | 0.0018 | 6.2898 | 0.884 | 5 | 48 | regulation of cardiac muscle cell proliferation |
GO:0055003 | 0.0019 | 14.6793 | 0.2578 | 3 | 14 | cardiac myofibril assembly |
GO:0060192 | 0.0019 | 14.6793 | 0.2578 | 3 | 14 | negative regulation of lipase activity |
GO:0061343 | 0.002 | 53.6667 | 0.0737 | 2 | 4 | cell adhesion involved in heart morphogenesis |
GO:0090063 | 0.002 | 53.6667 | 0.0737 | 2 | 4 | positive regulation of microtubule nucleation |
GO:0006935 | 0.002 | 2.1718 | 9.7607 | 20 | 530 | chemotaxis |
GO:0007411 | 0.0023 | 2.9341 | 3.9779 | 11 | 216 | axon guidance |
GO:1903506 | 0.0026 | 1.4712 | 62.5603 | 83 | 3397 | regulation of nucleic acid-templated transcription |
GO:0034654 | 0.0026 | 1.4459 | 73.5732 | 95 | 3995 | nucleobase-containing compound biosynthetic process |
GO:0048856 | 0.0027 | 2.1453 | 10.1246 | 20 | 684 | anatomical structure development |
GO:0006590 | 0.0029 | 12.4193 | 0.2947 | 3 | 16 | thyroid hormone generation |
GO:0048598 | 0.0031 | 2.083 | 10.1474 | 20 | 551 | embryonic morphogenesis |
GO:0048519 | 0.0031 | 1.4151 | 87.9932 | 110 | 4778 | negative regulation of biological process |
GO:0010936 | 0.0033 | 35.7754 | 0.0921 | 2 | 5 | negative regulation of macrophage cytokine production |
GO:0033864 | 0.0033 | 35.7754 | 0.0921 | 2 | 5 | positive regulation of NAD(P)H oxidase activity |
GO:0051891 | 0.0033 | 35.7754 | 0.0921 | 2 | 5 | positive regulation of cardioblast differentiation |
GO:0045823 | 0.0034 | 7.1929 | 0.6262 | 4 | 34 | positive regulation of heart contraction |
GO:0051252 | 0.0035 | 1.4448 | 65.9489 | 86 | 3581 | regulation of RNA metabolic process |
GO:0009890 | 0.0037 | 1.6098 | 30.0002 | 45 | 1629 | negative regulation of biosynthetic process |
GO:0061564 | 0.0037 | 2.1926 | 8.1768 | 17 | 444 | axon development |
GO:0001708 | 0.0038 | 4.3337 | 1.4917 | 6 | 81 | cell fate specification |
GO:0034599 | 0.0038 | 2.5947 | 4.8803 | 12 | 265 | cellular response to oxidative stress |
GO:0060065 | 0.0041 | 10.762 | 0.3315 | 3 | 18 | uterus development |
GO:1904994 | 0.0041 | 10.762 | 0.3315 | 3 | 18 | regulation of leukocyte adhesion to vascular endothelial cell |
GO:0000302 | 0.0043 | 2.8401 | 3.7201 | 10 | 202 | response to reactive oxygen species |
GO:0030182 | 0.0047 | 1.7062 | 20.5557 | 33 | 1131 | neuron differentiation |
GO:0018958 | 0.0048 | 4.1132 | 1.5654 | 6 | 85 | phenol-containing compound metabolic process |
GO:0003278 | 0.0048 | 26.8298 | 0.1105 | 2 | 6 | apoptotic process involved in heart morphogenesis |
GO:0072049 | 0.0048 | 26.8298 | 0.1105 | 2 | 6 | comma-shaped body morphogenesis |
GO:0007596 | 0.0052 | 2.388 | 5.7275 | 13 | 311 | blood coagulation |
GO:0072091 | 0.0052 | 4.8255 | 1.1234 | 5 | 61 | regulation of stem cell proliferation |
GO:2000379 | 0.0054 | 4.0111 | 1.6022 | 6 | 87 | positive regulation of reactive oxygen species metabolic process |
GO:0001822 | 0.0055 | 2.588 | 4.4752 | 11 | 243 | kidney development |
GO:0048468 | 0.0056 | 1.5696 | 30.7146 | 45 | 1698 | cell development |
GO:0001709 | 0.0056 | 6.1634 | 0.7182 | 4 | 39 | cell fate determination |
GO:0007595 | 0.0056 | 6.1634 | 0.7182 | 4 | 39 | lactation |
GO:0002052 | 0.0056 | 9.4946 | 0.3683 | 3 | 20 | positive regulation of neuroblast proliferation |
GO:1903706 | 0.0057 | 2.4598 | 5.1328 | 12 | 296 | regulation of hemopoiesis |
GO:0055017 | 0.0057 | 3.9619 | 1.6206 | 6 | 88 | cardiac muscle tissue growth |
GO:0032268 | 0.0058 | 1.4749 | 45.4883 | 62 | 2470 | regulation of cellular protein metabolic process |
GO:0043010 | 0.0064 | 2.4195 | 5.2118 | 12 | 283 | camera-type eye development |
GO:0021796 | 0.0067 | 21.4625 | 0.1289 | 2 | 7 | cerebral cortex regionalization |
GO:0032429 | 0.0067 | 21.4625 | 0.1289 | 2 | 7 | regulation of phospholipase A2 activity |
GO:0046439 | 0.0067 | 21.4625 | 0.1289 | 2 | 7 | L-cysteine metabolic process |
GO:1903265 | 0.0067 | 21.4625 | 0.1289 | 2 | 7 | positive regulation of tumor necrosis factor-mediated signaling pathway |
GO:0022008 | 0.0067 | 1.5974 | 25.967 | 39 | 1410 | neurogenesis |
GO:0048518 | 0.0069 | 1.3635 | 94.8072 | 115 | 5148 | positive regulation of biological process |
GO:0002376 | 0.0071 | 1.4584 | 45.9119 | 62 | 2493 | immune system process |
GO:0003081 | 0.0073 | 8.4941 | 0.4052 | 3 | 22 | regulation of systemic arterial blood pressure by renin-angiotensin |
GO:0060420 | 0.0078 | 4.3568 | 1.2339 | 5 | 67 | regulation of heart growth |
GO:0010604 | 0.008 | 1.4264 | 52.4313 | 69 | 2847 | positive regulation of macromolecule metabolic process |
GO:0001655 | 0.0083 | 2.3318 | 5.396 | 12 | 293 | urogenital system development |
GO:0048663 | 0.0083 | 4.2874 | 1.2523 | 5 | 68 | neuron fate commitment |
GO:0060343 | 0.0083 | 8.0688 | 0.4236 | 3 | 23 | trabecula formation |
GO:0048568 | 0.0085 | 2.1024 | 7.477 | 15 | 406 | embryonic organ development |
GO:0006928 | 0.0086 | 1.5121 | 33.1678 | 47 | 1801 | movement of cell or subcellular component |
GO:0072050 | 0.0088 | 17.8842 | 0.1473 | 2 | 8 | S-shaped body morphogenesis |
GO:0003006 | 0.0089 | 1.8771 | 11.1787 | 20 | 607 | developmental process involved in reproduction |
GO:0042026 | 0.0094 | 7.6841 | 0.442 | 3 | 24 | protein refolding |
GO:0050482 | 0.0094 | 7.6841 | 0.442 | 3 | 24 | arachidonic acid secretion |
GO:0040008 | 0.0095 | 1.8639 | 11.2524 | 20 | 611 | regulation of growth |
GO:0055001 | 0.0097 | 2.857 | 2.9466 | 8 | 160 | muscle cell development |
GO:0032526 | 0.0099 | 3.4908 | 1.8232 | 6 | 99 | response to retinoic acid |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 80.6796 | 1.3089 | 24 | 31 | DNA replication-dependent nucleosome assembly |
GO:0051290 | 0 | 36.0791 | 1.8156 | 26 | 43 | protein heterotetramerization |
GO:0000183 | 0 | 43.4254 | 1.5622 | 24 | 37 | chromatin silencing at rDNA |
GO:0045653 | 0 | 108.1377 | 0.7178 | 14 | 17 | negative regulation of megakaryocyte differentiation |
GO:0031497 | 0 | 6.8966 | 6.3756 | 34 | 151 | chromatin assembly |
GO:0045815 | 0 | 10.4255 | 3.2934 | 24 | 78 | positive regulation of gene expression, epigenetic |
GO:1902036 | 0 | 8.0384 | 4.3067 | 26 | 102 | regulation of hematopoietic stem cell differentiation |
GO:0060964 | 0 | 7.4958 | 4.1801 | 24 | 99 | regulation of gene silencing by miRNA |
GO:0045814 | 0 | 6.2892 | 5.1934 | 26 | 123 | negative regulation of gene expression, epigenetic |
GO:0002244 | 0 | 4.9357 | 7.8112 | 32 | 185 | hematopoietic progenitor cell differentiation |
GO:0065004 | 0 | 4.3805 | 9.4579 | 35 | 224 | protein-DNA complex assembly |
GO:0048863 | 0 | 4.1353 | 10.5135 | 37 | 249 | stem cell differentiation |
GO:0060968 | 0 | 5.7871 | 5.109 | 24 | 121 | regulation of gene silencing |
GO:0034080 | 0 | 11.5668 | 1.7734 | 14 | 42 | CENP-A containing nucleosome assembly |
GO:1904837 | 0 | 11.5668 | 1.7734 | 14 | 42 | beta-catenin-TCF complex assembly |
GO:0032200 | 0 | 4.5413 | 6.7556 | 26 | 160 | telomere organization |
GO:0071103 | 0 | 3.5121 | 11.4002 | 35 | 270 | DNA conformation change |
GO:0016233 | 0 | 8.9915 | 2.1111 | 14 | 50 | telomere capping |
GO:1903707 | 0 | 4.7907 | 5.4467 | 22 | 129 | negative regulation of hemopoiesis |
GO:0034724 | 0 | 8.2982 | 2.2378 | 14 | 53 | DNA replication-independent nucleosome organization |
GO:0048534 | 0 | 2.1988 | 34.7916 | 69 | 824 | hematopoietic or lymphoid organ development |
GO:0030099 | 0 | 2.8897 | 15.4958 | 40 | 367 | myeloid cell differentiation |
GO:0048598 | 0 | 2.4809 | 23.2648 | 52 | 551 | embryonic morphogenesis |
GO:0048869 | 0 | 1.5991 | 158.6352 | 218 | 3807 | cellular developmental process |
GO:0034728 | 0 | 5.0546 | 4.4783 | 19 | 108 | nucleosome organization |
GO:2000026 | 0 | 1.8197 | 68.0003 | 111 | 1628 | regulation of multicellular organismal development |
GO:0043044 | 0 | 5.6848 | 3.2089 | 15 | 76 | ATP-dependent chromatin remodeling |
GO:0006303 | 0 | 5.8779 | 2.9134 | 14 | 69 | double-strand break repair via nonhomologous end joining |
GO:0038111 | 0 | 8.5157 | 1.5622 | 10 | 37 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 8.211 | 1.6045 | 10 | 38 | response to interleukin-7 |
GO:0045892 | 0 | 1.8456 | 45.4739 | 77 | 1077 | negative regulation of transcription, DNA-templated |
GO:0045596 | 0 | 2.0864 | 26.0092 | 50 | 616 | negative regulation of cell differentiation |
GO:0032501 | 0 | 1.4459 | 233.9271 | 285 | 5896 | multicellular organismal process |
GO:0009887 | 0 | 1.8621 | 39.605 | 68 | 938 | animal organ morphogenesis |
GO:0048568 | 0 | 2.3505 | 17.1425 | 37 | 406 | embryonic organ development |
GO:0007389 | 0 | 2.3375 | 17.2269 | 37 | 408 | pattern specification process |
GO:1902679 | 0 | 1.7695 | 47.1629 | 77 | 1117 | negative regulation of RNA biosynthetic process |
GO:0045652 | 0 | 5.8764 | 2.2753 | 11 | 55 | regulation of megakaryocyte differentiation |
GO:0048731 | 0 | 1.511 | 122.0266 | 164 | 3095 | system development |
GO:0007218 | 0 | 4.1718 | 4.1378 | 15 | 98 | neuropeptide signaling pathway |
GO:0001501 | 0 | 2.2138 | 19.5914 | 40 | 464 | skeletal system development |
GO:0009954 | 0 | 8.7355 | 1.2245 | 8 | 29 | proximal/distal pattern formation |
GO:0043010 | 0 | 2.557 | 11.9491 | 28 | 283 | camera-type eye development |
GO:0009952 | 0 | 2.9498 | 8.2334 | 22 | 195 | anterior/posterior pattern specification |
GO:0021872 | 0 | 4.9588 | 2.6178 | 11 | 62 | forebrain generation of neurons |
GO:0045934 | 1e-04 | 1.6421 | 56.4941 | 86 | 1338 | negative regulation of nucleobase-containing compound metabolic process |
GO:0045823 | 1e-04 | 7.0533 | 1.4356 | 8 | 34 | positive regulation of heart contraction |
GO:0060065 | 1e-04 | 11.4371 | 0.76 | 6 | 18 | uterus development |
GO:0035194 | 1e-04 | 2.4042 | 12.1602 | 27 | 288 | posttranscriptional gene silencing by RNA |
GO:0048704 | 1e-04 | 3.8868 | 3.8001 | 13 | 90 | embryonic skeletal system morphogenesis |
GO:0001655 | 1e-04 | 2.3582 | 12.3713 | 27 | 293 | urogenital system development |
GO:0001708 | 1e-04 | 3.9997 | 3.42 | 12 | 81 | cell fate specification |
GO:0051259 | 1e-04 | 1.9948 | 20.9425 | 39 | 496 | protein oligomerization |
GO:0014706 | 2e-04 | 2.2158 | 14.5669 | 30 | 345 | striated muscle tissue development |
GO:0048870 | 2e-04 | 1.5804 | 56.9585 | 84 | 1349 | cell motility |
GO:0021953 | 2e-04 | 2.8472 | 6.9245 | 18 | 164 | central nervous system neuron differentiation |
GO:0001101 | 2e-04 | 2.2797 | 12.7513 | 27 | 302 | response to acid chemical |
GO:0009893 | 2e-04 | 1.4004 | 129.3706 | 166 | 3064 | positive regulation of metabolic process |
GO:0002042 | 2e-04 | 5.7285 | 1.6889 | 8 | 40 | cell migration involved in sprouting angiogenesis |
GO:0035107 | 2e-04 | 3.0242 | 5.8267 | 16 | 138 | appendage morphogenesis |
GO:1903506 | 2e-04 | 1.3817 | 143.4308 | 181 | 3397 | regulation of nucleic acid-templated transcription |
GO:0061061 | 2e-04 | 1.8591 | 25.2492 | 44 | 598 | muscle structure development |
GO:0001822 | 3e-04 | 2.4212 | 10.2601 | 23 | 243 | kidney development |
GO:0018916 | 3e-04 | 68.3588 | 0.1689 | 3 | 4 | nitrobenzene metabolic process |
GO:0045595 | 4e-04 | 1.6531 | 40.0107 | 62 | 985 | regulation of cell differentiation |
GO:0006590 | 4e-04 | 10.3822 | 0.6756 | 5 | 16 | thyroid hormone generation |
GO:0043009 | 4e-04 | 1.8713 | 22.7581 | 40 | 539 | chordate embryonic development |
GO:0022414 | 5e-04 | 1.5481 | 53.6652 | 78 | 1271 | reproductive process |
GO:0060173 | 5e-04 | 2.7035 | 6.8401 | 17 | 162 | limb development |
GO:0014855 | 5e-04 | 3.9559 | 2.8711 | 10 | 68 | striated muscle cell proliferation |
GO:0071711 | 5e-04 | 9.5163 | 0.7178 | 5 | 17 | basement membrane organization |
GO:0006935 | 5e-04 | 1.8523 | 22.3781 | 39 | 530 | chemotaxis |
GO:0071542 | 6e-04 | 5.7212 | 1.4778 | 7 | 35 | dopaminergic neuron differentiation |
GO:0043062 | 6e-04 | 2.1519 | 12.9202 | 26 | 306 | extracellular structure organization |
GO:0050767 | 6e-04 | 1.7431 | 27.9937 | 46 | 663 | regulation of neurogenesis |
GO:0061743 | 7e-04 | 34.1771 | 0.2111 | 3 | 5 | motor learning |
GO:1900086 | 7e-04 | 34.1771 | 0.2111 | 3 | 5 | positive regulation of peptidyl-tyrosine autophosphorylation |
GO:0060042 | 7e-04 | 4.6981 | 1.9845 | 8 | 47 | retina morphogenesis in camera-type eye |
GO:0048592 | 7e-04 | 2.8075 | 5.8267 | 15 | 138 | eye morphogenesis |
GO:0051252 | 7e-04 | 1.3384 | 151.1998 | 186 | 3581 | regulation of RNA metabolic process |
GO:0003407 | 8e-04 | 4.1259 | 2.4911 | 9 | 59 | neural retina development |
GO:0008284 | 8e-04 | 1.6504 | 34.6649 | 54 | 821 | positive regulation of cell proliferation |
GO:0048771 | 8e-04 | 2.6706 | 6.5023 | 16 | 154 | tissue remodeling |
GO:0060043 | 8e-04 | 4.5803 | 2.0267 | 8 | 48 | regulation of cardiac muscle cell proliferation |
GO:1903244 | 8e-04 | 13.0354 | 0.4645 | 4 | 11 | positive regulation of cardiac muscle hypertrophy in response to stress |
GO:0018958 | 9e-04 | 3.4123 | 3.5889 | 11 | 85 | phenol-containing compound metabolic process |
GO:0002227 | 9e-04 | 8.1558 | 0.8022 | 5 | 19 | innate immune response in mucosa |
GO:2000178 | 9e-04 | 8.1558 | 0.8022 | 5 | 19 | negative regulation of neural precursor cell proliferation |
GO:0002251 | 9e-04 | 6.2342 | 1.1822 | 6 | 28 | organ or tissue specific immune response |
GO:0060249 | 0.001 | 2.0094 | 14.8202 | 28 | 351 | anatomical structure homeostasis |
GO:1905039 | 0.001 | 3.1321 | 4.2223 | 12 | 100 | carboxylic acid transmembrane transport |
GO:0021988 | 0.0011 | 5.9628 | 1.2245 | 6 | 29 | olfactory lobe development |
GO:0009888 | 0.0012 | 1.4287 | 75.241 | 101 | 1782 | tissue development |
GO:0017148 | 0.0012 | 1.9544 | 15.7491 | 29 | 373 | negative regulation of translation |
GO:0010935 | 0.0012 | 11.4052 | 0.5067 | 4 | 12 | regulation of macrophage cytokine production |
GO:0021889 | 0.0012 | 11.4052 | 0.5067 | 4 | 12 | olfactory bulb interneuron differentiation |
GO:0009605 | 0.0013 | 1.4087 | 81.6589 | 108 | 1934 | response to external stimulus |
GO:0007631 | 0.0013 | 3.0283 | 4.3489 | 12 | 103 | feeding behavior |
GO:0007423 | 0.0013 | 1.7999 | 21.1536 | 36 | 501 | sensory organ development |
GO:0001764 | 0.0015 | 2.705 | 5.6156 | 14 | 133 | neuron migration |
GO:0046850 | 0.0015 | 4.7097 | 1.7311 | 7 | 41 | regulation of bone remodeling |
GO:0051248 | 0.0015 | 1.4904 | 53.2429 | 75 | 1261 | negative regulation of protein metabolic process |
GO:0048732 | 0.0015 | 1.8951 | 16.7624 | 30 | 397 | gland development |
GO:0010628 | 0.0016 | 1.4383 | 67.178 | 91 | 1643 | positive regulation of gene expression |
GO:0003341 | 0.0016 | 3.6823 | 2.7445 | 9 | 65 | cilium movement |
GO:0002682 | 0.0016 | 1.4816 | 54.2563 | 76 | 1285 | regulation of immune system process |
GO:0060547 | 0.0017 | 10.1373 | 0.5489 | 4 | 13 | negative regulation of necrotic cell death |
GO:0035544 | 0.0018 | Inf | 0.0844 | 2 | 2 | negative regulation of SNARE complex assembly |
GO:1900155 | 0.0018 | Inf | 0.0844 | 2 | 2 | negative regulation of bone trabecula formation |
GO:0032098 | 0.0019 | 6.7152 | 0.9289 | 5 | 22 | regulation of appetite |
GO:0006352 | 0.0019 | 2.1862 | 9.7535 | 20 | 231 | DNA-templated transcription, initiation |
GO:0098754 | 0.002 | 3.0404 | 3.9689 | 11 | 94 | detoxification |
GO:0045665 | 0.0021 | 2.3439 | 7.769 | 17 | 184 | negative regulation of neuron differentiation |
GO:0048663 | 0.0021 | 3.4944 | 2.8711 | 9 | 68 | neuron fate commitment |
GO:0014744 | 0.0022 | 9.1229 | 0.5911 | 4 | 14 | positive regulation of muscle adaptation |
GO:0060192 | 0.0022 | 9.1229 | 0.5911 | 4 | 14 | negative regulation of lipase activity |
GO:0071415 | 0.0023 | 17.0863 | 0.2956 | 3 | 7 | cellular response to purine-containing compound |
GO:0022008 | 0.0023 | 1.6173 | 30.639 | 47 | 747 | neurogenesis |
GO:0120039 | 0.0024 | 1.6948 | 24.2359 | 39 | 574 | plasma membrane bounded cell projection morphogenesis |
GO:0001525 | 0.0025 | 1.8104 | 18.062 | 31 | 429 | angiogenesis |
GO:0001568 | 0.0025 | 1.676 | 25.1226 | 40 | 595 | blood vessel development |
GO:0007420 | 0.0028 | 1.6451 | 26.8537 | 42 | 636 | brain development |
GO:0009950 | 0.003 | 8.293 | 0.6333 | 4 | 15 | dorsal/ventral axis specification |
GO:0097237 | 0.003 | 2.8667 | 4.1801 | 11 | 99 | cellular response to toxic substance |
GO:0043154 | 0.003 | 3.0558 | 3.5889 | 10 | 85 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process |
GO:0055024 | 0.003 | 3.0558 | 3.5889 | 10 | 85 | regulation of cardiac muscle tissue development |
GO:0019953 | 0.0032 | 1.5871 | 31.1182 | 47 | 737 | sexual reproduction |
GO:0098869 | 0.0033 | 3.0154 | 3.6312 | 10 | 86 | cellular oxidant detoxification |
GO:0035295 | 0.0034 | 1.6808 | 23.1381 | 37 | 548 | tube development |
GO:0008217 | 0.0034 | 2.3616 | 6.7979 | 15 | 161 | regulation of blood pressure |
GO:0006950 | 0.0036 | 1.2871 | 144.0642 | 173 | 3412 | response to stress |
GO:0006776 | 0.0036 | 13.6681 | 0.3378 | 3 | 8 | vitamin A metabolic process |
GO:0009653 | 0.0038 | 1.4624 | 48.3387 | 67 | 1213 | anatomical structure morphogenesis |
GO:0000904 | 0.0038 | 1.6232 | 26.5159 | 41 | 628 | cell morphogenesis involved in differentiation |
GO:0055012 | 0.0038 | 7.6014 | 0.6756 | 4 | 16 | ventricular cardiac muscle cell differentiation |
GO:0048585 | 0.0038 | 1.417 | 58.6897 | 79 | 1390 | negative regulation of response to stimulus |
GO:0010648 | 0.004 | 1.4408 | 51.8074 | 71 | 1227 | negative regulation of cell communication |
GO:0072358 | 0.004 | 1.6175 | 26.6004 | 41 | 630 | cardiovascular system development |
GO:0030326 | 0.0041 | 2.9179 | 3.7365 | 10 | 89 | embryonic limb morphogenesis |
GO:0042554 | 0.0042 | 5.4346 | 1.0978 | 5 | 26 | superoxide anion generation |
GO:0010470 | 0.0042 | 4.4216 | 1.5622 | 6 | 37 | regulation of gastrulation |
GO:0023057 | 0.0043 | 1.4354 | 51.9763 | 71 | 1231 | negative regulation of signaling |
GO:0051962 | 0.0043 | 1.7374 | 18.7469 | 31 | 444 | positive regulation of nervous system development |
GO:0032990 | 0.0044 | 1.6284 | 25.1226 | 39 | 595 | cell part morphogenesis |
GO:1901861 | 0.0044 | 2.4661 | 5.6579 | 13 | 134 | regulation of muscle tissue development |
GO:0042060 | 0.0048 | 1.6796 | 21.2381 | 34 | 503 | wound healing |
GO:0042445 | 0.0048 | 2.4403 | 5.71 | 13 | 136 | hormone metabolic process |
GO:0042633 | 0.0048 | 2.6826 | 4.4334 | 11 | 105 | hair cycle |
GO:0007292 | 0.0048 | 2.5487 | 5.0667 | 12 | 120 | female gamete generation |
GO:0010951 | 0.005 | 2.0814 | 9.1623 | 18 | 217 | negative regulation of endopeptidase activity |
GO:0043542 | 0.0051 | 2.2525 | 7.0934 | 15 | 168 | endothelial cell migration |
GO:0002019 | 0.0052 | 45.503 | 0.1267 | 2 | 3 | regulation of renal output by angiotensin |
GO:0007412 | 0.0052 | 45.503 | 0.1267 | 2 | 3 | axon target recognition |
GO:0019448 | 0.0052 | 45.503 | 0.1267 | 2 | 3 | L-cysteine catabolic process |
GO:0032227 | 0.0052 | 45.503 | 0.1267 | 2 | 3 | negative regulation of synaptic transmission, dopaminergic |
GO:0043418 | 0.0052 | 45.503 | 0.1267 | 2 | 3 | homocysteine catabolic process |
GO:0055005 | 0.0052 | 45.503 | 0.1267 | 2 | 3 | ventricular cardiac myofibril assembly |
GO:0055014 | 0.0052 | 45.503 | 0.1267 | 2 | 3 | atrial cardiac muscle cell development |
GO:0060978 | 0.0052 | 45.503 | 0.1267 | 2 | 3 | angiogenesis involved in coronary vascular morphogenesis |
GO:0070370 | 0.0052 | 45.503 | 0.1267 | 2 | 3 | cellular heat acclimation |
GO:0070434 | 0.0052 | 45.503 | 0.1267 | 2 | 3 | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway |
GO:0070458 | 0.0052 | 45.503 | 0.1267 | 2 | 3 | cellular detoxification of nitrogen compound |
GO:1904395 | 0.0052 | 45.503 | 0.1267 | 2 | 3 | positive regulation of skeletal muscle acetylcholine-gated channel clustering |
GO:0009128 | 0.0052 | 11.3893 | 0.38 | 3 | 9 | purine nucleoside monophosphate catabolic process |
GO:0042178 | 0.0052 | 11.3893 | 0.38 | 3 | 9 | xenobiotic catabolic process |
GO:0044848 | 0.0052 | 11.3893 | 0.38 | 3 | 9 | biological phase |
GO:0046085 | 0.0052 | 11.3893 | 0.38 | 3 | 9 | adenosine metabolic process |
GO:0035270 | 0.0055 | 2.502 | 5.1512 | 12 | 122 | endocrine system development |
GO:0046006 | 0.0055 | 4.1531 | 1.6467 | 6 | 39 | regulation of activated T cell proliferation |
GO:0070887 | 0.0055 | 1.3 | 110.1801 | 135 | 2637 | cellular response to chemical stimulus |
GO:0048634 | 0.0056 | 2.3865 | 5.8267 | 13 | 138 | regulation of muscle organ development |
GO:0021884 | 0.0058 | 4.9614 | 1.1822 | 5 | 28 | forebrain neuron development |
GO:0032355 | 0.0058 | 2.4793 | 5.1934 | 12 | 123 | response to estradiol |
GO:0031175 | 0.0058 | 1.5034 | 35.5094 | 51 | 841 | neuron projection development |
GO:0051961 | 0.0059 | 1.9597 | 10.7668 | 20 | 255 | negative regulation of nervous system development |
GO:0045453 | 0.0059 | 3.5558 | 2.1956 | 7 | 52 | bone resorption |
GO:0010612 | 0.006 | 6.5146 | 0.76 | 4 | 18 | regulation of cardiac muscle adaptation |
GO:0032095 | 0.006 | 6.5146 | 0.76 | 4 | 18 | regulation of response to food |
GO:0050878 | 0.0061 | 1.691 | 19.2114 | 31 | 455 | regulation of body fluid levels |
GO:0034654 | 0.0061 | 1.2521 | 168.6801 | 197 | 3995 | nucleobase-containing compound biosynthetic process |
GO:0071345 | 0.0064 | 1.5016 | 34.8338 | 50 | 825 | cellular response to cytokine stimulus |
GO:0071300 | 0.0064 | 3.155 | 2.7867 | 8 | 66 | cellular response to retinoic acid |
GO:0045666 | 0.0067 | 1.841 | 13.1313 | 23 | 311 | positive regulation of neuron differentiation |
GO:0010720 | 0.0067 | 1.6788 | 19.338 | 31 | 458 | positive regulation of cell development |
GO:0044057 | 0.007 | 1.6457 | 20.9847 | 33 | 497 | regulation of system process |
GO:0060420 | 0.007 | 3.1013 | 2.8289 | 8 | 67 | regulation of heart growth |
GO:0042743 | 0.0071 | 3.9152 | 1.7311 | 6 | 41 | hydrogen peroxide metabolic process |
GO:0035265 | 0.0071 | 2.2316 | 6.6712 | 14 | 158 | organ growth |
GO:0035082 | 0.0073 | 3.404 | 2.28 | 7 | 54 | axoneme assembly |
GO:1903670 | 0.0073 | 3.404 | 2.28 | 7 | 54 | regulation of sprouting angiogenesis |
GO:0007409 | 0.0073 | 1.7159 | 17.0936 | 28 | 406 | axonogenesis |
GO:0001759 | 0.0074 | 6.0799 | 0.8022 | 4 | 19 | organ induction |
GO:1901889 | 0.0074 | 6.0799 | 0.8022 | 4 | 19 | negative regulation of cell junction assembly |
GO:1902532 | 0.0074 | 1.652 | 20.2669 | 32 | 480 | negative regulation of intracellular signal transduction |
GO:0072593 | 0.0074 | 2.0913 | 8.096 | 16 | 193 | reactive oxygen species metabolic process |
GO:0035115 | 0.0078 | 4.5639 | 1.2667 | 5 | 30 | embryonic forelimb morphogenesis |
GO:0090322 | 0.0078 | 4.5639 | 1.2667 | 5 | 30 | regulation of superoxide metabolic process |
GO:0030182 | 0.0079 | 1.5844 | 24.4209 | 37 | 603 | neuron differentiation |
GO:0007586 | 0.008 | 2.2763 | 6.0801 | 13 | 144 | digestion |
GO:0051270 | 0.0081 | 1.4853 | 34.4538 | 49 | 816 | regulation of cellular component movement |
GO:0008584 | 0.0084 | 2.3512 | 5.4467 | 12 | 129 | male gonad development |
GO:0002052 | 0.0089 | 5.6995 | 0.8445 | 4 | 20 | positive regulation of neuroblast proliferation |
GO:0021854 | 0.0089 | 5.6995 | 0.8445 | 4 | 20 | hypothalamus development |
GO:0003209 | 0.009 | 4.388 | 1.3089 | 5 | 31 | cardiac atrium morphogenesis |
GO:0016486 | 0.009 | 4.388 | 1.3089 | 5 | 31 | peptide hormone processing |
GO:2000392 | 0.0096 | 8.5408 | 0.4645 | 3 | 11 | regulation of lamellipodium morphogenesis |
GO:0048878 | 0.0096 | 1.429 | 41.6317 | 57 | 986 | chemical homeostasis |
GO:0045944 | 0.0097 | 1.4154 | 44.2495 | 60 | 1048 | positive regulation of transcription from RNA polymerase II promoter |
GO:0061844 | 0.01 | 3.6054 | 1.8578 | 6 | 44 | antimicrobial humoral immune response mediated by antimicrobial peptide |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0051336 | 0.0012 | 41.2614 | 0.2718 | 3 | 1059 | regulation of hydrolase activity |
GO:0070389 | 0.0018 | 865.2222 | 0.0018 | 1 | 7 | chaperone cofactor-dependent protein refolding |
GO:0051988 | 0.0031 | 471.7879 | 0.0031 | 1 | 12 | regulation of attachment of spindle microtubules to kinetochore |
GO:0032467 | 0.0084 | 161.9583 | 0.0085 | 1 | 33 | positive regulation of cytokinesis |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:1902598 | 1e-04 | Inf | 1e-04 | 1 | 1 | creatine transmembrane transport |
GO:0006600 | 6e-04 | Inf | 6e-04 | 1 | 9 | creatine metabolic process |
GO:0072337 | 0.001 | Inf | 0.001 | 1 | 15 | modified amino acid transport |
GO:1905039 | 0.0064 | Inf | 0.0064 | 1 | 100 | carboxylic acid transmembrane transport |
GO:0006865 | 0.0083 | Inf | 0.0083 | 1 | 129 | amino acid transport |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0014897 | 0 | 5.5333 | 2.2644 | 11 | 88 | striated muscle hypertrophy |
GO:0003012 | 0 | 2.6578 | 10.6014 | 26 | 412 | muscle system process |
GO:1901750 | 0 | 38.2343 | 0.2059 | 4 | 8 | leukotriene D4 biosynthetic process |
GO:0006751 | 0 | 30.5854 | 0.2316 | 4 | 9 | glutathione catabolic process |
GO:0032501 | 1e-04 | 1.8183 | 38.387 | 61 | 1686 | multicellular organismal process |
GO:1901342 | 1e-04 | 2.8548 | 7.1791 | 19 | 279 | regulation of vasculature development |
GO:0030198 | 1e-04 | 2.744 | 7.8481 | 20 | 305 | extracellular matrix organization |
GO:0007186 | 2e-04 | 1.8309 | 29.4883 | 50 | 1146 | G-protein coupled receptor signaling pathway |
GO:0044259 | 2e-04 | 3.974 | 3.0363 | 11 | 118 | multicellular organismal macromolecule metabolic process |
GO:0034308 | 3e-04 | 6.2555 | 1.2866 | 7 | 50 | primary alcohol metabolic process |
GO:0010632 | 4e-04 | 3.1387 | 4.8118 | 14 | 187 | regulation of epithelial cell migration |
GO:0010596 | 4e-04 | 5.8463 | 1.3638 | 7 | 53 | negative regulation of endothelial cell migration |
GO:0043535 | 4e-04 | 4.9646 | 1.8012 | 8 | 70 | regulation of blood vessel endothelial cell migration |
GO:0072358 | 4e-04 | 2.0399 | 16.2109 | 31 | 630 | cardiovascular system development |
GO:1900747 | 5e-04 | 28.6036 | 0.1801 | 3 | 7 | negative regulation of vascular endothelial growth factor signaling pathway |
GO:0015721 | 6e-04 | 8.7012 | 0.6948 | 5 | 27 | bile acid and bile salt transport |
GO:1902547 | 6e-04 | 12.738 | 0.4117 | 4 | 16 | regulation of cellular response to vascular endothelial growth factor stimulus |
GO:0002644 | 7e-04 | Inf | 0.0515 | 2 | 2 | negative regulation of tolerance induction |
GO:0061766 | 7e-04 | Inf | 0.0515 | 2 | 2 | positive regulation of lung blood pressure |
GO:1902340 | 7e-04 | Inf | 0.0515 | 2 | 2 | negative regulation of chromosome condensation |
GO:0046456 | 8e-04 | 6.218 | 1.1065 | 6 | 43 | icosanoid biosynthetic process |
GO:0006691 | 8e-04 | 7.9751 | 0.7462 | 5 | 29 | leukotriene metabolic process |
GO:0001667 | 8e-04 | 2.4021 | 8.4142 | 19 | 327 | ameboidal-type cell migration |
GO:0006776 | 9e-04 | 22.8814 | 0.2059 | 3 | 8 | vitamin A metabolic process |
GO:0055001 | 9e-04 | 3.1338 | 4.117 | 12 | 160 | muscle cell development |
GO:0014898 | 9e-04 | 7.6556 | 0.7719 | 5 | 30 | cardiac muscle hypertrophy in response to stress |
GO:0035023 | 0.001 | 3.5369 | 3.0621 | 10 | 119 | regulation of Rho protein signal transduction |
GO:0003301 | 0.0011 | 7.3606 | 0.7977 | 5 | 31 | physiological cardiac muscle hypertrophy |
GO:0030574 | 0.0011 | 4.7992 | 1.6211 | 7 | 63 | collagen catabolic process |
GO:0045603 | 0.0012 | 10.1884 | 0.4889 | 4 | 19 | positive regulation of endothelial cell differentiation |
GO:0042574 | 0.0013 | 19.0666 | 0.2316 | 3 | 9 | retinal metabolic process |
GO:0055013 | 0.0015 | 4.5542 | 1.6983 | 7 | 66 | cardiac muscle cell development |
GO:0014888 | 0.0015 | 5.3482 | 1.2608 | 6 | 49 | striated muscle adaptation |
GO:0001568 | 0.0016 | 1.9351 | 15.3103 | 28 | 595 | blood vessel development |
GO:0006068 | 0.0018 | 16.3417 | 0.2573 | 3 | 10 | ethanol catabolic process |
GO:1905209 | 0.0019 | 6.3775 | 0.9006 | 5 | 35 | positive regulation of cardiocyte differentiation |
GO:0031509 | 0.0019 | 76.1003 | 0.0772 | 2 | 3 | telomeric heterochromatin assembly |
GO:0035879 | 0.0019 | 76.1003 | 0.0772 | 2 | 3 | plasma membrane lactate transport |
GO:0038129 | 0.0019 | 76.1003 | 0.0772 | 2 | 3 | ERBB3 signaling pathway |
GO:0060278 | 0.0019 | 76.1003 | 0.0772 | 2 | 3 | regulation of ovulation |
GO:1905180 | 0.0019 | 76.1003 | 0.0772 | 2 | 3 | positive regulation of cardiac muscle tissue regeneration |
GO:0001501 | 0.0021 | 2.034 | 11.9394 | 23 | 464 | skeletal system development |
GO:0001867 | 0.0024 | 14.2981 | 0.283 | 3 | 11 | complement activation, lectin pathway |
GO:1903670 | 0.0025 | 4.7896 | 1.3895 | 6 | 54 | regulation of sprouting angiogenesis |
GO:0007275 | 0.0028 | 1.3556 | 118.2576 | 144 | 4668 | multicellular organism development |
GO:0007517 | 0.0031 | 2.1266 | 9.4177 | 19 | 366 | muscle organ development |
GO:0030819 | 0.0031 | 3.9491 | 1.9299 | 7 | 75 | positive regulation of cAMP biosynthetic process |
GO:0010614 | 0.0036 | 7.2746 | 0.6433 | 4 | 25 | negative regulation of cardiac muscle hypertrophy |
GO:0031508 | 0.0038 | 38.0476 | 0.1029 | 2 | 4 | pericentric heterochromatin assembly |
GO:0061051 | 0.004 | 11.4369 | 0.3345 | 3 | 13 | positive regulation of cell growth involved in cardiac muscle cell development |
GO:0090132 | 0.0041 | 2.3728 | 6.227 | 14 | 242 | epithelium migration |
GO:0051241 | 0.0047 | 1.6166 | 26.093 | 40 | 1019 | negative regulation of multicellular organismal process |
GO:0052652 | 0.0048 | 2.8088 | 3.7825 | 10 | 147 | cyclic purine nucleotide metabolic process |
GO:0010862 | 0.0052 | 4.9029 | 1.1322 | 5 | 44 | positive regulation of pathway-restricted SMAD protein phosphorylation |
GO:0046661 | 0.0055 | 2.7481 | 3.8597 | 10 | 150 | male sex differentiation |
GO:0060537 | 0.0056 | 2.0456 | 9.2376 | 18 | 359 | muscle tissue development |
GO:0048738 | 0.0057 | 2.4605 | 5.1463 | 12 | 200 | cardiac muscle tissue development |
GO:0046942 | 0.0057 | 2.2045 | 7.1534 | 15 | 278 | carboxylic acid transport |
GO:0008584 | 0.0061 | 2.882 | 3.3194 | 9 | 129 | male gonad development |
GO:0000320 | 0.0063 | 25.3634 | 0.1287 | 2 | 5 | re-entry into mitotic cell cycle |
GO:0060426 | 0.0063 | 25.3634 | 0.1287 | 2 | 5 | lung vasculature development |
GO:1903589 | 0.0063 | 25.3634 | 0.1287 | 2 | 5 | positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis |
GO:0051155 | 0.0064 | 3.8938 | 1.6725 | 6 | 65 | positive regulation of striated muscle cell differentiation |
GO:0048762 | 0.0064 | 2.5361 | 4.5802 | 11 | 178 | mesenchymal cell differentiation |
GO:0030856 | 0.0065 | 2.8579 | 3.3451 | 9 | 130 | regulation of epithelial cell differentiation |
GO:0043491 | 0.0065 | 2.3216 | 5.8925 | 13 | 229 | protein kinase B signaling |
GO:0006941 | 0.0066 | 2.671 | 3.9627 | 10 | 154 | striated muscle contraction |
GO:0001936 | 0.0067 | 3.0703 | 2.779 | 8 | 108 | regulation of endothelial cell proliferation |
GO:0045766 | 0.0071 | 2.8111 | 3.3966 | 9 | 132 | positive regulation of angiogenesis |
GO:0009187 | 0.0073 | 2.4908 | 4.6574 | 11 | 181 | cyclic nucleotide metabolic process |
GO:0090051 | 0.0074 | 8.7959 | 0.4117 | 3 | 16 | negative regulation of cell migration involved in sprouting angiogenesis |
GO:0006959 | 0.0082 | 2.4472 | 4.7346 | 11 | 184 | humoral immune response |
GO:0006814 | 0.0083 | 2.3347 | 5.4036 | 12 | 210 | sodium ion transport |
GO:0016049 | 0.0086 | 1.8474 | 11.888 | 21 | 462 | cell growth |
GO:0030513 | 0.0088 | 5.4534 | 0.8234 | 4 | 32 | positive regulation of BMP signaling pathway |
GO:0045019 | 0.0088 | 8.1671 | 0.4374 | 3 | 17 | negative regulation of nitric oxide biosynthetic process |
GO:0060044 | 0.0088 | 8.1671 | 0.4374 | 3 | 17 | negative regulation of cardiac muscle cell proliferation |
GO:0003097 | 0.0093 | 19.0213 | 0.1544 | 2 | 6 | renal water transport |
GO:0015727 | 0.0093 | 19.0213 | 0.1544 | 2 | 6 | lactate transport |
GO:0030579 | 0.0093 | 19.0213 | 0.1544 | 2 | 6 | ubiquitin-dependent SMAD protein catabolic process |
GO:0030948 | 0.0093 | 19.0213 | 0.1544 | 2 | 6 | negative regulation of vascular endothelial growth factor receptor signaling pathway |
GO:0090230 | 0.0093 | 19.0213 | 0.1544 | 2 | 6 | regulation of centromere complex assembly |
GO:0022603 | 0.0095 | 1.5764 | 23.9303 | 36 | 930 | regulation of anatomical structure morphogenesis |
GO:0006812 | 0.0095 | 1.5479 | 26.4263 | 39 | 1027 | cation transport |
GO:0050679 | 0.0096 | 2.5124 | 4.1942 | 10 | 163 | positive regulation of epithelial cell proliferation |
GO:0009888 | 0.0096 | 1.473 | 35.797 | 50 | 1423 | tissue development |
GO:0030336 | 0.0098 | 2.1977 | 6.2013 | 13 | 241 | negative regulation of cell migration |
GO:0006027 | 0.0098 | 4.1549 | 1.3123 | 5 | 51 | glycosaminoglycan catabolic process |
GO:0001525 | 0.0099 | 2.0627 | 7.6107 | 15 | 300 | angiogenesis |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0030198 | 1e-04 | 4.14 | 3.151 | 12 | 221 | extracellular matrix organization |
GO:2000145 | 1e-04 | 2.5087 | 10.881 | 25 | 747 | regulation of cell motility |
GO:0007155 | 2e-04 | 2.1048 | 18.3389 | 35 | 1259 | cell adhesion |
GO:0061766 | 2e-04 | Inf | 0.0291 | 2 | 2 | positive regulation of lung blood pressure |
GO:1902340 | 2e-04 | Inf | 0.0291 | 2 | 2 | negative regulation of chromosome condensation |
GO:0001867 | 5e-04 | 25.6959 | 0.1602 | 3 | 11 | complement activation, lectin pathway |
GO:0031509 | 6e-04 | 136.4978 | 0.0437 | 2 | 3 | telomeric heterochromatin assembly |
GO:0035879 | 6e-04 | 136.4978 | 0.0437 | 2 | 3 | plasma membrane lactate transport |
GO:0048014 | 6e-04 | 136.4978 | 0.0437 | 2 | 3 | Tie signaling pathway |
GO:1905180 | 6e-04 | 136.4978 | 0.0437 | 2 | 3 | positive regulation of cardiac muscle tissue regeneration |
GO:0061051 | 8e-04 | 20.554 | 0.1894 | 3 | 13 | positive regulation of cell growth involved in cardiac muscle cell development |
GO:0003301 | 0.001 | 10.1844 | 0.4516 | 4 | 31 | physiological cardiac muscle hypertrophy |
GO:0031508 | 0.0012 | 68.2444 | 0.0583 | 2 | 4 | pericentric heterochromatin assembly |
GO:0022617 | 0.0014 | 5.3181 | 1.2236 | 6 | 84 | extracellular matrix disassembly |
GO:0042246 | 0.0014 | 6.629 | 0.8303 | 5 | 57 | tissue regeneration |
GO:0032963 | 0.0015 | 4.4926 | 1.6751 | 7 | 115 | collagen metabolic process |
GO:0090280 | 0.0015 | 15.8077 | 0.2331 | 3 | 16 | positive regulation of calcium ion import |
GO:0010632 | 0.0017 | 3.5205 | 2.7239 | 9 | 187 | regulation of epithelial cell migration |
GO:0000320 | 0.0021 | 45.4933 | 0.0728 | 2 | 5 | re-entry into mitotic cell cycle |
GO:0030336 | 0.0029 | 3.0175 | 3.5105 | 10 | 241 | negative regulation of cell migration |
GO:0015727 | 0.003 | 34.1178 | 0.0874 | 2 | 6 | lactate transport |
GO:0019800 | 0.003 | 34.1178 | 0.0874 | 2 | 6 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan |
GO:0034638 | 0.003 | 34.1178 | 0.0874 | 2 | 6 | phosphatidylcholine catabolic process |
GO:0090230 | 0.003 | 34.1178 | 0.0874 | 2 | 6 | regulation of centromere complex assembly |
GO:0061041 | 0.0032 | 3.8772 | 1.9227 | 7 | 132 | regulation of wound healing |
GO:0045765 | 0.0034 | 2.94 | 3.5979 | 10 | 247 | regulation of angiogenesis |
GO:0043535 | 0.0035 | 5.2987 | 1.0196 | 5 | 70 | regulation of blood vessel endothelial cell migration |
GO:0060421 | 0.0038 | 6.8686 | 0.6409 | 4 | 44 | positive regulation of heart growth |
GO:0044236 | 0.0039 | 3.7269 | 1.9956 | 7 | 137 | multicellular organism metabolic process |
GO:0031666 | 0.0042 | 27.2924 | 0.102 | 2 | 7 | positive regulation of lipopolysaccharide-mediated signaling pathway |
GO:1900747 | 0.0042 | 27.2924 | 0.102 | 2 | 7 | negative regulation of vascular endothelial growth factor signaling pathway |
GO:1903510 | 0.0043 | 4.1843 | 1.5295 | 6 | 105 | mucopolysaccharide metabolic process |
GO:0008015 | 0.0043 | 2.2812 | 6.9481 | 15 | 477 | blood circulation |
GO:0071526 | 0.0044 | 10.2703 | 0.335 | 3 | 23 | semaphorin-plexin signaling pathway |
GO:0044273 | 0.0044 | 6.5407 | 0.67 | 4 | 46 | sulfur compound catabolic process |
GO:0022412 | 0.0051 | 2.6183 | 4.4281 | 11 | 304 | cellular process involved in reproduction in multicellular organism |
GO:2000026 | 0.0054 | 1.633 | 25.7822 | 39 | 1770 | regulation of multicellular organismal development |
GO:0051058 | 0.0056 | 6.1034 | 0.7137 | 4 | 49 | negative regulation of small GTPase mediated signal transduction |
GO:0030210 | 0.0056 | 22.7422 | 0.1165 | 2 | 8 | heparin biosynthetic process |
GO:0061052 | 0.0056 | 22.7422 | 0.1165 | 2 | 8 | negative regulation of cell growth involved in cardiac muscle cell development |
GO:0006959 | 0.0056 | 3.1509 | 2.6802 | 8 | 184 | humoral immune response |
GO:0051271 | 0.0062 | 2.6863 | 3.9183 | 10 | 269 | negative regulation of cellular component movement |
GO:0032501 | 0.0063 | 1.4165 | 93.2582 | 112 | 6548 | multicellular organismal process |
GO:0006027 | 0.0064 | 5.843 | 0.7429 | 4 | 51 | glycosaminoglycan catabolic process |
GO:0043491 | 0.0065 | 2.8406 | 3.3357 | 9 | 229 | protein kinase B signaling |
GO:0014842 | 0.0071 | 19.4921 | 0.1311 | 2 | 9 | regulation of skeletal muscle satellite cell proliferation |
GO:0032490 | 0.0071 | 19.4921 | 0.1311 | 2 | 9 | detection of molecule of bacterial origin |
GO:0043116 | 0.0071 | 19.4921 | 0.1311 | 2 | 9 | negative regulation of vascular permeability |
GO:0009611 | 0.0071 | 2.0442 | 8.7689 | 17 | 602 | response to wounding |
GO:0050777 | 0.0073 | 3.729 | 1.7042 | 6 | 117 | negative regulation of immune response |
GO:0010596 | 0.0073 | 5.6037 | 0.772 | 4 | 53 | negative regulation of endothelial cell migration |
GO:0055025 | 0.0073 | 5.6037 | 0.772 | 4 | 53 | positive regulation of cardiac muscle tissue development |
GO:0051674 | 0.0074 | 1.6847 | 19.6498 | 31 | 1349 | localization of cell |
GO:0050918 | 0.0078 | 5.4913 | 0.7866 | 4 | 54 | positive chemotaxis |
GO:0016049 | 0.0079 | 2.1874 | 6.7296 | 14 | 462 | cell growth |
GO:0035023 | 0.0079 | 3.6625 | 1.7334 | 6 | 119 | regulation of Rho protein signal transduction |
GO:0006936 | 0.0081 | 2.4477 | 4.7195 | 11 | 324 | muscle contraction |
GO:0007292 | 0.0082 | 3.6302 | 1.7479 | 6 | 120 | female gamete generation |
GO:0040013 | 0.0083 | 2.5653 | 4.0931 | 10 | 281 | negative regulation of locomotion |
GO:0030166 | 0.0084 | 5.3833 | 0.8011 | 4 | 55 | proteoglycan biosynthetic process |
GO:2000378 | 0.0084 | 5.3833 | 0.8011 | 4 | 55 | negative regulation of reactive oxygen species metabolic process |
GO:0090132 | 0.0092 | 2.6798 | 3.525 | 9 | 242 | epithelium migration |
GO:0070286 | 0.0093 | 7.6042 | 0.437 | 3 | 30 | axonemal dynein complex assembly |
GO:0072359 | 0.0095 | 1.7899 | 13.5903 | 23 | 933 | circulatory system development |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0008544 | 0 | 5.9365 | 3.7027 | 19 | 346 | epidermis development |
GO:0070268 | 0 | 11.0643 | 1.1656 | 11 | 105 | cornification |
GO:0030216 | 0 | 6.1304 | 2.9751 | 16 | 268 | keratinocyte differentiation |
GO:0048869 | 0 | 2.1143 | 43.1612 | 71 | 3888 | cellular developmental process |
GO:0030855 | 0 | 3.5082 | 6.7325 | 21 | 626 | epithelial cell differentiation |
GO:0031581 | 2e-04 | 33.9772 | 0.1221 | 3 | 11 | hemidesmosome assembly |
GO:0009653 | 2e-04 | 1.9453 | 26.0099 | 44 | 2343 | anatomical structure morphogenesis |
GO:1904590 | 7e-04 | 7.8782 | 0.6994 | 5 | 63 | negative regulation of protein import |
GO:0042636 | 7e-04 | 90.1111 | 0.0444 | 2 | 4 | negative regulation of hair cycle |
GO:0051094 | 0.001 | 2.1267 | 12.8662 | 25 | 1159 | positive regulation of developmental process |
GO:0045603 | 0.0011 | 16.9798 | 0.2109 | 3 | 19 | positive regulation of endothelial cell differentiation |
GO:0046823 | 0.0012 | 6.8159 | 0.7993 | 5 | 72 | negative regulation of nucleocytoplasmic transport |
GO:0045682 | 0.0013 | 16.314 | 0.2176 | 3 | 20 | regulation of epidermis development |
GO:0010631 | 0.0014 | 3.6222 | 2.6532 | 9 | 239 | epithelial cell migration |
GO:1900181 | 0.0015 | 6.5225 | 0.8326 | 5 | 75 | negative regulation of protein localization to nucleus |
GO:0034329 | 0.0015 | 3.9687 | 2.1536 | 8 | 194 | cell junction assembly |
GO:0008542 | 0.0017 | 8.661 | 0.5107 | 4 | 46 | visual learning |
GO:0008219 | 0.0017 | 1.8268 | 21.9136 | 36 | 1974 | cell death |
GO:0090130 | 0.0018 | 3.4837 | 2.7531 | 9 | 248 | tissue migration |
GO:0031032 | 0.0023 | 4.1236 | 1.8095 | 7 | 163 | actomyosin structure organization |
GO:0032287 | 0.0025 | 36.0374 | 0.0777 | 2 | 7 | peripheral nervous system myelin maintenance |
GO:0045604 | 0.0026 | 7.5754 | 0.5773 | 4 | 52 | regulation of epidermal cell differentiation |
GO:0043124 | 0.0028 | 7.4204 | 0.5884 | 4 | 53 | negative regulation of I-kappaB kinase/NF-kappaB signaling |
GO:0090317 | 0.003 | 5.4963 | 0.9769 | 5 | 88 | negative regulation of intracellular protein transport |
GO:0045600 | 0.0032 | 7.1284 | 0.6106 | 4 | 55 | positive regulation of fat cell differentiation |
GO:0015886 | 0.0033 | 30.0292 | 0.0888 | 2 | 8 | heme transport |
GO:0090594 | 0.0033 | 30.0292 | 0.0888 | 2 | 8 | inflammatory response to wounding |
GO:1904685 | 0.0033 | 30.0292 | 0.0888 | 2 | 8 | positive regulation of metalloendopeptidase activity |
GO:0050891 | 0.0034 | 6.9909 | 0.6217 | 4 | 56 | multicellular organismal water homeostasis |
GO:0007015 | 0.0038 | 2.9025 | 3.6523 | 10 | 329 | actin filament organization |
GO:0051240 | 0.0038 | 1.8654 | 15.7303 | 27 | 1417 | positive regulation of multicellular organismal process |
GO:0003382 | 0.004 | 10.4423 | 0.3219 | 3 | 29 | epithelial cell morphogenesis |
GO:0010838 | 0.0042 | 25.7377 | 0.0999 | 2 | 9 | positive regulation of keratinocyte proliferation |
GO:0090331 | 0.0042 | 25.7377 | 0.0999 | 2 | 9 | negative regulation of platelet aggregation |
GO:0007275 | 0.0047 | 1.5263 | 53.4852 | 70 | 4818 | multicellular organism development |
GO:0010469 | 0.0048 | 2.423 | 5.6949 | 13 | 513 | regulation of receptor activity |
GO:0009628 | 0.0051 | 1.941 | 12.189 | 22 | 1098 | response to abiotic stimulus |
GO:0033623 | 0.0052 | 22.519 | 0.111 | 2 | 10 | regulation of integrin activation |
GO:0042552 | 0.0056 | 4.6987 | 1.1323 | 5 | 102 | myelination |
GO:0007272 | 0.0063 | 4.5568 | 1.1656 | 5 | 105 | ensheathment of neurons |
GO:0035414 | 0.0063 | 20.0156 | 0.1221 | 2 | 11 | negative regulation of catenin import into nucleus |
GO:1904753 | 0.0063 | 20.0156 | 0.1221 | 2 | 11 | negative regulation of vascular associated smooth muscle cell migration |
GO:2000147 | 0.0064 | 2.5416 | 4.5737 | 11 | 412 | positive regulation of cell motility |
GO:0007155 | 0.0064 | 1.8489 | 13.9763 | 24 | 1259 | cell adhesion |
GO:0014911 | 0.0068 | 8.4811 | 0.3885 | 3 | 35 | positive regulation of smooth muscle cell migration |
GO:0048771 | 0.0075 | 3.7052 | 1.7096 | 6 | 154 | tissue remodeling |
GO:0016540 | 0.0075 | 18.0129 | 0.1332 | 2 | 12 | protein autoprocessing |
GO:0051798 | 0.0075 | 18.0129 | 0.1332 | 2 | 12 | positive regulation of hair follicle development |
GO:0060707 | 0.0075 | 18.0129 | 0.1332 | 2 | 12 | trophoblast giant cell differentiation |
GO:0030858 | 0.0076 | 8.1161 | 0.4041 | 3 | 37 | positive regulation of epithelial cell differentiation |
GO:0022612 | 0.0079 | 4.2972 | 1.2322 | 5 | 111 | gland morphogenesis |
GO:0071453 | 0.008 | 3.24 | 2.2757 | 7 | 205 | cellular response to oxygen levels |
GO:0010595 | 0.0084 | 5.3404 | 0.7993 | 4 | 72 | positive regulation of endothelial cell migration |
GO:0016477 | 0.0086 | 1.8208 | 13.5434 | 23 | 1220 | cell migration |
GO:0042306 | 0.0097 | 3.4908 | 1.8095 | 6 | 163 | regulation of protein import into nucleus |
GO:0008284 | 0.0099 | 1.9798 | 9.114 | 17 | 821 | positive regulation of cell proliferation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 37.1336 | 3.9981 | 74 | 301 | detection of chemical stimulus involved in sensory perception of smell |
GO:0007606 | 0 | 27.6509 | 5.2069 | 76 | 392 | sensory perception of chemical stimulus |
GO:0050906 | 0 | 27.5248 | 5.1272 | 75 | 386 | detection of stimulus involved in sensory perception |
GO:0009593 | 0 | 28.0577 | 4.9545 | 74 | 373 | detection of chemical stimulus |
GO:0050877 | 0 | 8.7018 | 14.8502 | 80 | 1118 | nervous system process |
GO:0007186 | 0 | 8.6397 | 14.7587 | 79 | 1126 | G-protein coupled receptor signaling pathway |
GO:0032501 | 0 | 2.3576 | 83.0289 | 124 | 6483 | multicellular organismal process |
GO:0007154 | 0 | 1.9178 | 77.3593 | 110 | 5824 | cell communication |
GO:0023052 | 0 | 1.8893 | 77.1335 | 109 | 5807 | signaling |
GO:0016441 | 0 | 3.9836 | 3.8387 | 14 | 289 | posttranscriptional gene silencing |
GO:0050704 | 1e-04 | 13.5688 | 0.4383 | 5 | 33 | regulation of interleukin-1 secretion |
GO:0031047 | 1e-04 | 3.6831 | 4.131 | 14 | 311 | gene silencing by RNA |
GO:0035278 | 1e-04 | 9.533 | 0.7173 | 6 | 54 | miRNA mediated inhibition of translation |
GO:0045974 | 1e-04 | 9.533 | 0.7173 | 6 | 54 | regulation of translation, ncRNA-mediated |
GO:0070269 | 1e-04 | 56.5184 | 0.093 | 3 | 7 | pyroptosis |
GO:0050713 | 3e-04 | 32.2899 | 0.1328 | 3 | 10 | negative regulation of interleukin-1 beta secretion |
GO:0097340 | 4e-04 | 28.2518 | 0.1461 | 3 | 11 | inhibition of cysteine-type endopeptidase activity |
GO:0031424 | 4e-04 | 4.0146 | 2.6831 | 10 | 202 | keratinization |
GO:0032651 | 5e-04 | 8.4334 | 0.6641 | 5 | 50 | regulation of interleukin-1 beta production |
GO:0034249 | 7e-04 | 2.9179 | 5.1405 | 14 | 387 | negative regulation of cellular amide metabolic process |
GO:0051716 | 0.0012 | 1.5431 | 87.0027 | 109 | 6550 | cellular response to stimulus |
GO:0098664 | 0.0022 | 13.2872 | 0.2657 | 3 | 20 | G-protein coupled serotonin receptor signaling pathway |
GO:0019236 | 0.0025 | 37.4951 | 0.0797 | 2 | 6 | response to pheromone |
GO:0032692 | 0.0034 | 11.2919 | 0.3055 | 3 | 23 | negative regulation of interleukin-1 production |
GO:0048245 | 0.0047 | 24.9935 | 0.1063 | 2 | 8 | eosinophil chemotaxis |
GO:0050794 | 0.0055 | 1.4838 | 129.1625 | 147 | 9724 | regulation of cellular process |
GO:0033141 | 0.0059 | 21.4216 | 0.1195 | 2 | 9 | positive regulation of peptidyl-serine phosphorylation of STAT protein |
GO:0065007 | 0.0061 | 1.5242 | 144.4245 | 161 | 10873 | biological regulation |
GO:2000010 | 0.0089 | 16.6591 | 0.1461 | 2 | 11 | positive regulation of protein localization to cell surface |
GO:0009913 | 0.0092 | 2.5253 | 4.1575 | 10 | 313 | epidermal cell differentiation |
GO:0035195 | 0.0098 | 2.8467 | 2.9509 | 8 | 228 | gene silencing by miRNA |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 32.7229 | 9.2131 | 130 | 301 | detection of chemical stimulus involved in sensory perception of smell |
GO:0007606 | 0 | 23.4686 | 11.9985 | 137 | 392 | sensory perception of chemical stimulus |
GO:0009593 | 0 | 24.3033 | 11.4169 | 134 | 373 | detection of chemical stimulus |
GO:0050906 | 0 | 23.0294 | 11.8148 | 134 | 386 | detection of stimulus involved in sensory perception |
GO:0050877 | 0 | 6.9204 | 34.2201 | 153 | 1118 | nervous system process |
GO:0007186 | 0 | 6.7375 | 34.1475 | 150 | 1126 | G-protein coupled receptor signaling pathway |
GO:0009913 | 0 | 5.6052 | 9.5804 | 44 | 313 | epidermal cell differentiation |
GO:0043588 | 0 | 4.3823 | 11.5393 | 43 | 377 | skin development |
GO:0070268 | 0 | 8.7522 | 3.2139 | 22 | 105 | cornification |
GO:0032501 | 0 | 1.961 | 184.1809 | 255 | 6483 | multicellular organismal process |
GO:0018149 | 0 | 13.2239 | 1.5916 | 15 | 52 | peptide cross-linking |
GO:0031424 | 0 | 7.7922 | 2.8513 | 18 | 97 | keratinization |
GO:0007154 | 0 | 1.6681 | 178.2628 | 236 | 5824 | cell communication |
GO:0023052 | 0 | 1.6617 | 177.7425 | 235 | 5807 | signaling |
GO:0050701 | 0 | 8.0357 | 1.2243 | 8 | 40 | interleukin-1 secretion |
GO:0006953 | 0 | 7.141 | 1.3468 | 8 | 44 | acute-phase response |
GO:0050896 | 1e-04 | 1.9128 | 33.5722 | 56 | 1269 | response to stimulus |
GO:0050713 | 2e-04 | 21.284 | 0.3061 | 4 | 10 | negative regulation of interleukin-1 beta secretion |
GO:0035278 | 2e-04 | 5.5849 | 1.6528 | 8 | 54 | miRNA mediated inhibition of translation |
GO:0045974 | 2e-04 | 5.5849 | 1.6528 | 8 | 54 | regulation of translation, ncRNA-mediated |
GO:0035194 | 2e-04 | 2.5596 | 8.8152 | 21 | 288 | posttranscriptional gene silencing by RNA |
GO:0098664 | 3e-04 | 10.6582 | 0.6122 | 5 | 20 | G-protein coupled serotonin receptor signaling pathway |
GO:0032611 | 4e-04 | 5.0357 | 1.8059 | 8 | 59 | interleukin-1 beta production |
GO:0070098 | 4e-04 | 4.4503 | 2.265 | 9 | 74 | chemokine-mediated signaling pathway |
GO:0042742 | 4e-04 | 3.9833 | 2.7762 | 10 | 92 | defense response to bacterium |
GO:0051709 | 5e-04 | 14.1865 | 0.3979 | 4 | 13 | regulation of killing of cells of other organism |
GO:0050830 | 6e-04 | 4.2531 | 2.3568 | 9 | 77 | defense response to Gram-positive bacterium |
GO:0060429 | 8e-04 | 1.6515 | 35.5056 | 55 | 1160 | epithelium development |
GO:0051716 | 8e-04 | 1.3536 | 192.291 | 226 | 6370 | cellular response to stimulus |
GO:0019730 | 9e-04 | 3.9605 | 2.5099 | 9 | 82 | antimicrobial humoral response |
GO:0070269 | 9e-04 | 23.8972 | 0.2143 | 3 | 7 | pyroptosis |
GO:0010951 | 0.0011 | 2.5739 | 6.642 | 16 | 217 | negative regulation of endopeptidase activity |
GO:0050710 | 0.0011 | 4.8764 | 1.6222 | 7 | 53 | negative regulation of cytokine secretion |
GO:0007338 | 0.0012 | 3.2182 | 3.7036 | 11 | 121 | single fertilization |
GO:0048245 | 0.0014 | 19.1165 | 0.2449 | 3 | 8 | eosinophil chemotaxis |
GO:0032604 | 0.0015 | 9.8188 | 0.5203 | 4 | 17 | granulocyte macrophage colony-stimulating factor production |
GO:0051926 | 0.0015 | 4.5769 | 1.7141 | 7 | 56 | negative regulation of calcium ion transport |
GO:0045087 | 0.0018 | 1.7398 | 23.0787 | 38 | 754 | innate immune response |
GO:0001542 | 0.0021 | 15.9293 | 0.2755 | 3 | 9 | ovulation from ovarian follicle |
GO:0009620 | 0.0024 | 4.9218 | 1.3774 | 6 | 45 | response to fungus |
GO:0017148 | 0.0026 | 2.0327 | 11.4169 | 22 | 373 | negative regulation of translation |
GO:0002774 | 0.0027 | 63.6042 | 0.0918 | 2 | 3 | Fc receptor mediated inhibitory signaling pathway |
GO:0042109 | 0.0027 | 63.6042 | 0.0918 | 2 | 3 | lymphotoxin A biosynthetic process |
GO:0051714 | 0.0027 | 63.6042 | 0.0918 | 2 | 3 | positive regulation of cytolysis in other organism |
GO:2000344 | 0.0029 | 13.6528 | 0.3061 | 3 | 10 | positive regulation of acrosome reaction |
GO:0050829 | 0.003 | 4.0029 | 1.9283 | 7 | 63 | defense response to Gram-negative bacterium |
GO:0050706 | 0.0033 | 7.5675 | 0.6378 | 4 | 21 | regulation of interleukin-1 beta secretion |
GO:0031640 | 0.0039 | 5.3661 | 1.0632 | 5 | 35 | killing of cells of other organism |
GO:0001820 | 0.0039 | 11.9454 | 0.3367 | 3 | 11 | serotonin secretion |
GO:0097340 | 0.0039 | 11.9454 | 0.3367 | 3 | 11 | inhibition of cysteine-type endopeptidase activity |
GO:0032692 | 0.0048 | 6.7155 | 0.704 | 4 | 23 | negative regulation of interleukin-1 production |
GO:0002922 | 0.0051 | 10.6174 | 0.3673 | 3 | 12 | positive regulation of humoral immune response |
GO:0045414 | 0.0051 | 10.6174 | 0.3673 | 3 | 12 | regulation of interleukin-8 biosynthetic process |
GO:0097028 | 0.0051 | 4.9904 | 1.1325 | 5 | 37 | dendritic cell differentiation |
GO:0051346 | 0.0054 | 1.936 | 11.3863 | 21 | 372 | negative regulation of hydrolase activity |
GO:0009253 | 0.0054 | 31.8 | 0.1224 | 2 | 4 | peptidoglycan catabolic process |
GO:0035962 | 0.0054 | 31.8 | 0.1224 | 2 | 4 | response to interleukin-13 |
GO:0045423 | 0.0054 | 31.8 | 0.1224 | 2 | 4 | regulation of granulocyte macrophage colony-stimulating factor biosynthetic process |
GO:0071222 | 0.0068 | 2.5236 | 4.6219 | 11 | 151 | cellular response to lipopolysaccharide |
GO:0035821 | 0.0074 | 2.6301 | 4.0403 | 10 | 132 | modification of morphology or physiology of other organism |
GO:0050707 | 0.0076 | 3.0152 | 2.8446 | 8 | 94 | regulation of cytokine secretion |
GO:0043207 | 0.0079 | 1.6181 | 21.9814 | 34 | 722 | response to external biotic stimulus |
GO:0002710 | 0.0081 | 8.6858 | 0.4285 | 3 | 14 | negative regulation of T cell mediated immunity |
GO:0042268 | 0.0081 | 8.6858 | 0.4285 | 3 | 14 | regulation of cytolysis |
GO:0002250 | 0.0085 | 1.9555 | 9.6416 | 18 | 315 | adaptive immune response |
GO:0006824 | 0.0088 | 21.1986 | 0.153 | 2 | 5 | cobalt ion transport |
GO:0032747 | 0.0088 | 21.1986 | 0.153 | 2 | 5 | positive regulation of interleukin-23 production |
GO:0060467 | 0.0088 | 21.1986 | 0.153 | 2 | 5 | negative regulation of fertilization |
GO:0006952 | 0.0088 | 2.3207 | 5.4523 | 12 | 188 | defense response |
GO:0006954 | 0.0094 | 1.6484 | 19.0078 | 30 | 621 | inflammatory response |
GO:0071216 | 0.0095 | 2.2948 | 5.5095 | 12 | 180 | cellular response to biotic stimulus |
GO:0031343 | 0.0097 | 4.2008 | 1.3162 | 5 | 43 | positive regulation of cell killing |
GO:0098581 | 0.0099 | 7.9615 | 0.4591 | 3 | 15 | detection of external biotic stimulus |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050290 | 3e-04 | Inf | 3e-04 | 1 | 1 | sphingomyelin phosphodiesterase D activity |
GO:0038049 | 5e-04 | 5198.3333 | 5e-04 | 1 | 2 | transcription factor activity, ligand-activated RNA polymerase II transcription factor binding |
GO:0004767 | 0.0015 | 1039.4 | 0.0015 | 1 | 6 | sphingomyelin phosphodiesterase activity |
GO:0005072 | 0.0026 | 577.2963 | 0.0026 | 1 | 10 | transforming growth factor beta receptor, cytoplasmic mediator activity |
GO:0004861 | 0.0031 | 472.2727 | 0.0031 | 1 | 12 | cyclin-dependent protein serine/threonine kinase inhibitor activity |
GO:0005086 | 0.0046 | 305.4706 | 0.0046 | 1 | 18 | ARF guanyl-nucleotide exchange factor activity |
GO:0004693 | 0.0067 | 207.6133 | 0.0067 | 1 | 26 | cyclin-dependent protein serine/threonine kinase activity |
GO:0030332 | 0.0074 | 185.3333 | 0.0074 | 1 | 29 | cyclin binding |
GO:0005154 | 0.0079 | 172.9556 | 0.0079 | 1 | 31 | epidermal growth factor receptor binding |
GO:0030544 | 0.0095 | 144.0741 | 0.0095 | 1 | 37 | Hsp70 protein binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004530 | 4e-04 | 7798 | 4e-04 | 1 | 2 | deoxyribonuclease I activity |
GO:0004525 | 8e-04 | 2599 | 8e-04 | 1 | 4 | ribonuclease III activity |
GO:0070883 | 0.001 | 1949.125 | 0.001 | 1 | 5 | pre-miRNA binding |
GO:0035197 | 0.0017 | 974.3125 | 0.0017 | 1 | 9 | siRNA binding |
GO:0001671 | 0.004 | 389.425 | 0.004 | 1 | 21 | ATPase activator activity |
GO:0016893 | 0.0063 | 243.2031 | 0.0063 | 1 | 33 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters |
GO:0004520 | 0.0067 | 228.8676 | 0.0067 | 1 | 35 | endodeoxyribonuclease activity |
GO:0004869 | 0.0094 | 161.9688 | 0.0094 | 1 | 49 | cysteine-type endopeptidase inhibitor activity |
GO:0030234 | 0.0098 | 32.3546 | 0.175 | 2 | 910 | enzyme regulator activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005109 | 0.0022 | Inf | 0.0022 | 1 | 35 | frizzled binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 10.04 | 8.7985 | 63 | 301 | olfactory receptor activity |
GO:0004930 | 0 | 4.6695 | 20.4031 | 76 | 698 | G-protein coupled receptor activity |
GO:0038023 | 0 | 3.2182 | 34.0538 | 90 | 1165 | signaling receptor activity |
GO:0099600 | 0 | 3.2682 | 32.3292 | 87 | 1106 | transmembrane receptor activity |
GO:0060089 | 0 | 2.8255 | 40.9815 | 96 | 1402 | molecular transducer activity |
GO:0005549 | 0 | 8.3837 | 2.0754 | 14 | 71 | odorant binding |
GO:0004867 | 0 | 5.6472 | 2.2508 | 11 | 77 | serine-type endopeptidase inhibitor activity |
GO:0015125 | 0 | 23.9737 | 0.3508 | 5 | 12 | bile acid transmembrane transporter activity |
GO:0030414 | 1e-04 | 3.4442 | 4.4431 | 14 | 152 | peptidase inhibitor activity |
GO:0030246 | 2e-04 | 2.8808 | 6.7523 | 18 | 231 | carbohydrate binding |
GO:0004252 | 2e-04 | 3.3946 | 4.5015 | 14 | 154 | serine-type endopeptidase activity |
GO:0017171 | 3e-04 | 3.0321 | 5.3492 | 15 | 183 | serine hydrolase activity |
GO:0001591 | 5e-04 | 33.4238 | 0.1754 | 3 | 6 | dopamine neurotransmitter receptor activity, coupled via Gi/Go |
GO:0036374 | 5e-04 | 33.4238 | 0.1754 | 3 | 6 | glutathione hydrolase activity |
GO:0061135 | 5e-04 | 3.1678 | 4.4431 | 13 | 152 | endopeptidase regulator activity |
GO:0048020 | 0.0022 | 6.2072 | 0.9354 | 5 | 32 | CCR chemokine receptor binding |
GO:0035240 | 0.0034 | 12.5298 | 0.3215 | 3 | 11 | dopamine binding |
GO:0001758 | 0.0049 | 33.3524 | 0.1169 | 2 | 4 | retinal dehydrogenase activity |
GO:0033265 | 0.0049 | 33.3524 | 0.1169 | 2 | 4 | choline binding |
GO:0042056 | 0.0065 | 6.0829 | 0.76 | 4 | 26 | chemoattractant activity |
GO:0008009 | 0.0073 | 4.5266 | 1.2277 | 5 | 42 | chemokine activity |
GO:0022804 | 0.0076 | 1.9795 | 9.5292 | 18 | 326 | active transmembrane transporter activity |
GO:0008201 | 0.0077 | 2.6098 | 4.0631 | 10 | 139 | heparin binding |
GO:0004028 | 0.008 | 22.2335 | 0.1462 | 2 | 5 | 3-chloroallyl aldehyde dehydrogenase activity |
GO:0004568 | 0.008 | 22.2335 | 0.1462 | 2 | 5 | chitinase activity |
GO:0008048 | 0.008 | 22.2335 | 0.1462 | 2 | 5 | calcium sensitive guanylate cyclase activator activity |
GO:0015349 | 0.008 | 22.2335 | 0.1462 | 2 | 5 | thyroid hormone transmembrane transporter activity |
GO:0030883 | 0.008 | 22.2335 | 0.1462 | 2 | 5 | endogenous lipid antigen binding |
GO:0030884 | 0.008 | 22.2335 | 0.1462 | 2 | 5 | exogenous lipid antigen binding |
GO:0004497 | 0.0083 | 3.2635 | 2.3092 | 7 | 79 | monooxygenase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042288 | 1e-04 | 12.6141 | 0.5286 | 5 | 19 | MHC class I protein binding |
GO:0050544 | 2e-04 | 52.7749 | 0.1391 | 3 | 5 | arachidonic acid binding |
GO:0004871 | 3e-04 | 1.6814 | 40.4636 | 63 | 1461 | signal transducer activity |
GO:0042289 | 4e-04 | 35.181 | 0.1669 | 3 | 6 | MHC class II protein binding |
GO:0004911 | 8e-04 | Inf | 0.0556 | 2 | 2 | interleukin-2 receptor activity |
GO:0019976 | 8e-04 | Inf | 0.0556 | 2 | 2 | interleukin-2 binding |
GO:0031720 | 8e-04 | Inf | 0.0556 | 2 | 2 | haptoglobin binding |
GO:0032394 | 8e-04 | Inf | 0.0556 | 2 | 2 | MHC class Ib receptor activity |
GO:0032396 | 8e-04 | Inf | 0.0556 | 2 | 2 | inhibitory MHC class I receptor activity |
GO:0097199 | 8e-04 | Inf | 0.0556 | 2 | 2 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway |
GO:0004872 | 0.0019 | 1.5735 | 37.8637 | 56 | 1361 | receptor activity |
GO:0036041 | 0.0022 | 15.0736 | 0.2782 | 3 | 10 | long-chain fatty acid binding |
GO:0035662 | 0.0023 | 70.2083 | 0.0835 | 2 | 3 | Toll-like receptor 4 binding |
GO:0005102 | 0.0024 | 1.5566 | 38.2254 | 56 | 1374 | receptor binding |
GO:0005031 | 0.0029 | 7.8284 | 0.6121 | 4 | 22 | tumor necrosis factor-activated receptor activity |
GO:0043325 | 0.0029 | 7.8284 | 0.6121 | 4 | 22 | phosphatidylinositol-3,4-bisphosphate binding |
GO:0005344 | 0.003 | 13.1885 | 0.306 | 3 | 11 | oxygen carrier activity |
GO:0030492 | 0.0045 | 35.1019 | 0.1113 | 2 | 4 | hemoglobin binding |
GO:0035877 | 0.0045 | 35.1019 | 0.1113 | 2 | 4 | death effector domain binding |
GO:0004888 | 0.0048 | 1.576 | 29.413 | 44 | 1062 | transmembrane signaling receptor activity |
GO:0005085 | 0.0048 | 2.1286 | 8.4018 | 17 | 302 | guanyl-nucleotide exchange factor activity |
GO:0030674 | 0.0049 | 2.6388 | 4.4235 | 11 | 159 | protein binding, bridging |
GO:0045028 | 0.005 | 10.5494 | 0.3617 | 3 | 13 | G-protein coupled purinergic nucleotide receptor activity |
GO:1903231 | 0.0052 | 2.7709 | 3.8392 | 10 | 138 | mRNA binding involved in posttranscriptional gene silencing |
GO:0030246 | 0.0054 | 2.2963 | 6.4265 | 14 | 231 | carbohydrate binding |
GO:0004435 | 0.0054 | 6.4034 | 0.7233 | 4 | 26 | phosphatidylinositol phospholipase C activity |
GO:0042802 | 0.007 | 1.458 | 41.9812 | 58 | 1509 | identical protein binding |
GO:0001665 | 0.0073 | 23.3997 | 0.1391 | 2 | 5 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity |
GO:0046934 | 0.0093 | 3.5895 | 1.8083 | 6 | 65 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050544 | 0 | 87.7844 | 0.0849 | 3 | 5 | arachidonic acid binding |
GO:0032396 | 3e-04 | Inf | 0.034 | 2 | 2 | inhibitory MHC class I receptor activity |
GO:0097199 | 3e-04 | Inf | 0.034 | 2 | 2 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway |
GO:0036041 | 5e-04 | 25.0731 | 0.1699 | 3 | 10 | long-chain fatty acid binding |
GO:0035662 | 9e-04 | 116.6084 | 0.051 | 2 | 3 | Toll-like receptor 4 binding |
GO:0001205 | 0.0011 | 10.2029 | 0.4587 | 4 | 27 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding |
GO:0030492 | 0.0017 | 58.3004 | 0.0679 | 2 | 4 | hemoglobin binding |
GO:0035877 | 0.0017 | 58.3004 | 0.0679 | 2 | 4 | death effector domain binding |
GO:0001784 | 0.002 | 8.3782 | 0.5436 | 4 | 32 | phosphotyrosine residue binding |
GO:0004465 | 0.0041 | 29.1464 | 0.1019 | 2 | 6 | lipoprotein lipase activity |
GO:0042289 | 0.0041 | 29.1464 | 0.1019 | 2 | 6 | MHC class II protein binding |
GO:0005125 | 0.0053 | 2.9434 | 3.2276 | 9 | 190 | cytokine activity |
GO:0042609 | 0.0057 | 23.3156 | 0.1189 | 2 | 7 | CD4 receptor binding |
GO:1901567 | 0.0067 | 8.7681 | 0.3907 | 3 | 23 | fatty acid derivative binding |
GO:0005102 | 0.0069 | 1.6388 | 22.7437 | 35 | 1358 | receptor binding |
GO:0004715 | 0.0088 | 5.326 | 0.8154 | 4 | 48 | non-membrane spanning protein tyrosine kinase activity |
GO:0050786 | 0.0096 | 16.6518 | 0.1529 | 2 | 9 | RAGE receptor binding |
GO:0097200 | 0.0096 | 16.6518 | 0.1529 | 2 | 9 | cysteine-type endopeptidase activity involved in execution phase of apoptosis |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004872 | 0 | 2.6181 | 15.0059 | 34 | 1361 | receptor activity |
GO:0005070 | 0 | 11.1166 | 0.6174 | 6 | 56 | SH3/SH2 adaptor activity |
GO:0032396 | 1e-04 | Inf | 0.0221 | 2 | 2 | inhibitory MHC class I receptor activity |
GO:0061134 | 2e-04 | 4.8405 | 2.0177 | 9 | 183 | peptidase regulator activity |
GO:0042288 | 0.0011 | 17.0991 | 0.2095 | 3 | 19 | MHC class I protein binding |
GO:0004866 | 0.0012 | 4.6664 | 1.6097 | 7 | 146 | endopeptidase inhibitor activity |
GO:0004465 | 0.0018 | 45.3647 | 0.0662 | 2 | 6 | lipoprotein lipase activity |
GO:0034987 | 0.0018 | 45.3647 | 0.0662 | 2 | 6 | immunoglobulin receptor binding |
GO:0001637 | 0.0025 | 12.4309 | 0.2756 | 3 | 25 | G-protein coupled chemoattractant receptor activity |
GO:0004871 | 0.0027 | 1.8961 | 16.1305 | 28 | 1463 | signal transducer activity |
GO:0060090 | 0.0032 | 3.8769 | 1.9185 | 7 | 174 | molecular adaptor activity |
GO:0004888 | 0.0032 | 2.0249 | 11.7313 | 22 | 1064 | transmembrane signaling receptor activity |
GO:0042169 | 0.0039 | 10.5157 | 0.3197 | 3 | 29 | SH2 domain binding |
GO:0016813 | 0.0051 | 22.6765 | 0.1103 | 2 | 10 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines |
GO:0048020 | 0.0052 | 9.426 | 0.3528 | 3 | 32 | CCR chemokine receptor binding |
GO:0005096 | 0.0066 | 3.0611 | 2.7564 | 8 | 250 | GTPase activator activity |
GO:0001846 | 0.0074 | 18.1388 | 0.1323 | 2 | 12 | opsonin binding |
GO:0016493 | 0.0074 | 18.1388 | 0.1323 | 2 | 12 | C-C chemokine receptor activity |
GO:0060589 | 0.0078 | 2.7562 | 3.44 | 9 | 312 | nucleoside-triphosphatase regulator activity |
GO:0016298 | 0.0083 | 4.2471 | 1.2459 | 5 | 113 | lipase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042393 | 0 | 9.1897 | 3.3503 | 25 | 188 | histone binding |
GO:0046982 | 0 | 5.4574 | 8.3756 | 38 | 470 | protein heterodimerization activity |
GO:0031492 | 0 | 16.7779 | 0.7841 | 10 | 44 | nucleosomal DNA binding |
GO:0003677 | 1e-04 | 2.0614 | 22.6618 | 42 | 1342 | DNA binding |
GO:0019904 | 2e-04 | 2.3772 | 11.3451 | 25 | 641 | protein domain specific binding |
GO:0031711 | 3e-04 | Inf | 0.0356 | 2 | 2 | bradykinin receptor binding |
GO:0017077 | 9e-04 | 111.0217 | 0.0535 | 2 | 3 | oxidative phosphorylation uncoupler activity |
GO:0070573 | 9e-04 | 111.0217 | 0.0535 | 2 | 3 | metallodipeptidase activity |
GO:0003682 | 0.001 | 2.3596 | 8.5717 | 19 | 481 | chromatin binding |
GO:0043565 | 0.0012 | 1.9159 | 17.3394 | 31 | 973 | sequence-specific DNA binding |
GO:0045296 | 0.0023 | 2.645 | 5.2036 | 13 | 292 | cadherin binding |
GO:0055131 | 0.0045 | 27.75 | 0.1069 | 2 | 6 | C3HC4-type RING finger domain binding |
GO:0008198 | 0.0067 | 8.7864 | 0.3921 | 3 | 22 | ferrous iron binding |
GO:0045503 | 0.0076 | 8.3465 | 0.4099 | 3 | 23 | dynein light chain binding |
GO:1901612 | 0.0083 | 18.4976 | 0.1426 | 2 | 8 | cardiolipin binding |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 3.5628 | 19.4327 | 59 | 470 | protein heterodimerization activity |
GO:0042393 | 0 | 3.6592 | 7.7731 | 25 | 188 | histone binding |
GO:0043565 | 0 | 1.9271 | 40.2298 | 71 | 973 | sequence-specific DNA binding |
GO:0031492 | 0 | 6.9111 | 1.8192 | 10 | 44 | nucleosomal DNA binding |
GO:0000981 | 0 | 1.9542 | 29.8519 | 54 | 722 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
GO:0001077 | 1e-04 | 2.5702 | 10.5846 | 25 | 256 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding |
GO:0016702 | 2e-04 | 8.767 | 0.9096 | 6 | 22 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen |
GO:0004957 | 0.0013 | 23.2897 | 0.2481 | 3 | 6 | prostaglandin E receptor activity |
GO:0004666 | 0.0017 | Inf | 0.0827 | 2 | 2 | prostaglandin-endoperoxide synthase activity |
GO:0031711 | 0.0017 | Inf | 0.0827 | 2 | 2 | bradykinin receptor binding |
GO:0019904 | 0.0027 | 1.6595 | 25.9937 | 41 | 632 | protein domain specific binding |
GO:0071837 | 0.0027 | 8.4777 | 0.6202 | 4 | 15 | HMG box domain binding |
GO:0003682 | 0.0031 | 1.7461 | 19.8875 | 33 | 481 | chromatin binding |
GO:0005104 | 0.0032 | 5.834 | 1.0337 | 5 | 25 | fibroblast growth factor receptor binding |
GO:1901612 | 0.0034 | 13.972 | 0.3308 | 3 | 8 | cardiolipin binding |
GO:0004601 | 0.0044 | 4.3788 | 1.5712 | 6 | 38 | peroxidase activity |
GO:0048018 | 0.0049 | 1.7741 | 16.5798 | 28 | 401 | receptor ligand activity |
GO:0017077 | 0.005 | 46.5132 | 0.124 | 2 | 3 | oxidative phosphorylation uncoupler activity |
GO:0070573 | 0.005 | 46.5132 | 0.124 | 2 | 3 | metallodipeptidase activity |
GO:0045296 | 0.005 | 1.9206 | 12.0731 | 22 | 292 | cadherin binding |
GO:0004857 | 0.0051 | 1.8324 | 14.3471 | 25 | 347 | enzyme inhibitor activity |
GO:0001664 | 0.0053 | 2.0207 | 9.9348 | 19 | 241 | G-protein coupled receptor binding |
GO:0043236 | 0.0053 | 5.072 | 1.1577 | 5 | 28 | laminin binding |
GO:0046943 | 0.0056 | 2.49 | 5.1683 | 12 | 125 | carboxylic acid transmembrane transporter activity |
GO:0009055 | 0.0058 | 2.755 | 3.9279 | 10 | 95 | electron transfer activity |
GO:0005184 | 0.0062 | 4.8604 | 1.199 | 5 | 29 | neuropeptide hormone activity |
GO:0005044 | 0.0064 | 4.0027 | 1.6952 | 6 | 41 | scavenger receptor activity |
GO:0004954 | 0.0068 | 9.9786 | 0.4135 | 3 | 10 | prostanoid receptor activity |
GO:0043295 | 0.0068 | 9.9786 | 0.4135 | 3 | 10 | glutathione binding |
GO:0004896 | 0.0072 | 2.8457 | 3.4317 | 9 | 83 | cytokine receptor activity |
GO:0042923 | 0.0083 | 5.8264 | 0.8269 | 4 | 20 | neuropeptide binding |
GO:0140110 | 0.0089 | 1.3591 | 61.6471 | 80 | 1491 | transcription regulator activity |
GO:0038085 | 0.0097 | 23.2551 | 0.1654 | 2 | 4 | vascular endothelial growth factor binding |
GO:0090722 | 0.0097 | 23.2551 | 0.1654 | 2 | 4 | receptor-receptor interaction |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0060589 | 0.0023 | 49.3097 | 0.08 | 2 | 312 | nucleoside-triphosphatase regulator activity |
GO:0098772 | 0.0041 | 26.0068 | 0.4144 | 3 | 1616 | molecular function regulator |
GO:0001671 | 0.0054 | 259.6 | 0.0054 | 1 | 21 | ATPase activator activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005093 | 1e-04 | Inf | 1e-04 | 1 | 2 | Rab GDP-dissociation inhibitor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005309 | 1e-04 | Inf | 1e-04 | 1 | 1 | creatine:sodium symporter activity |
GO:0072349 | 7e-04 | Inf | 7e-04 | 1 | 11 | modified amino acid transmembrane transporter activity |
GO:0051184 | 0.0011 | Inf | 0.0011 | 1 | 17 | cofactor transporter activity |
GO:0005328 | 0.0012 | Inf | 0.0012 | 1 | 19 | neurotransmitter:sodium symporter activity |
GO:0015171 | 0.0046 | Inf | 0.0046 | 1 | 72 | amino acid transmembrane transporter activity |
GO:0015294 | 0.0065 | Inf | 0.0065 | 1 | 102 | solute:cation symporter activity |
GO:0022853 | 0.0078 | Inf | 0.0078 | 1 | 122 | active ion transmembrane transporter activity |
GO:0005342 | 0.0085 | Inf | 0.0085 | 1 | 133 | organic acid transmembrane transporter activity |
GO:0015081 | 0.0094 | Inf | 0.0094 | 1 | 147 | sodium ion transmembrane transporter activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:1990837 | 0 | 2.3233 | 24.1615 | 51 | 698 | sequence-specific double-stranded DNA binding |
GO:0001067 | 0 | 2.1983 | 28.0038 | 56 | 809 | regulatory region nucleic acid binding |
GO:0003700 | 0 | 1.9557 | 39.9115 | 71 | 1153 | DNA binding transcription factor activity |
GO:0000977 | 0 | 3.2424 | 8.2003 | 24 | 243 | RNA polymerase II regulatory region sequence-specific DNA binding |
GO:0001077 | 0 | 2.9727 | 8.8615 | 24 | 256 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding |
GO:0005070 | 0 | 6.1583 | 1.9385 | 10 | 56 | SH3/SH2 adaptor activity |
GO:0038023 | 0 | 1.7688 | 40.3269 | 66 | 1165 | signaling receptor activity |
GO:0005126 | 1e-04 | 2.8339 | 8.0654 | 21 | 233 | cytokine receptor binding |
GO:0030545 | 2e-04 | 2.1726 | 14.7808 | 30 | 427 | receptor regulator activity |
GO:0005102 | 2e-04 | 1.6979 | 38.5358 | 61 | 1141 | receptor binding |
GO:0001159 | 3e-04 | 2.2649 | 12.2885 | 26 | 355 | core promoter proximal region DNA binding |
GO:0000978 | 3e-04 | 2.2797 | 11.7346 | 25 | 339 | RNA polymerase II core promoter proximal region sequence-specific DNA binding |
GO:0016502 | 4e-04 | 10.0441 | 0.6577 | 5 | 19 | nucleotide receptor activity |
GO:0001228 | 5e-04 | 3.2219 | 4.4054 | 13 | 131 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding |
GO:0003823 | 5e-04 | 5.6379 | 1.4538 | 7 | 42 | antigen binding |
GO:0019904 | 6e-04 | 1.8503 | 22.3962 | 39 | 647 | protein domain specific binding |
GO:0019864 | 8e-04 | 28.0391 | 0.2077 | 3 | 6 | IgG binding |
GO:0042289 | 8e-04 | 28.0391 | 0.2077 | 3 | 6 | MHC class II protein binding |
GO:0045028 | 8e-04 | 12.4801 | 0.45 | 4 | 13 | G-protein coupled purinergic nucleotide receptor activity |
GO:0044212 | 8e-04 | 2.0945 | 13.1983 | 26 | 393 | transcription regulatory region DNA binding |
GO:0005125 | 0.001 | 2.6123 | 6.5769 | 16 | 190 | cytokine activity |
GO:0046982 | 0.001 | 1.9545 | 16.2692 | 30 | 470 | protein heterodimerization activity |
GO:0099600 | 0.001 | 1.6089 | 38.2846 | 58 | 1106 | transmembrane receptor activity |
GO:0035586 | 0.001 | 7.81 | 0.7962 | 5 | 23 | purinergic receptor activity |
GO:0030246 | 0.0012 | 2.4036 | 7.9962 | 18 | 231 | carbohydrate binding |
GO:0004911 | 0.0012 | Inf | 0.0692 | 2 | 2 | interleukin-2 receptor activity |
GO:0019976 | 0.0012 | Inf | 0.0692 | 2 | 2 | interleukin-2 binding |
GO:0036461 | 0.0012 | Inf | 0.0692 | 2 | 2 | BLOC-2 complex binding |
GO:0004715 | 0.0012 | 4.8109 | 1.6615 | 7 | 48 | non-membrane spanning protein tyrosine kinase activity |
GO:0001968 | 0.0015 | 7.028 | 0.8654 | 5 | 25 | fibronectin binding |
GO:0046934 | 0.0017 | 3.9581 | 2.25 | 8 | 65 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity |
GO:0004872 | 0.0019 | 2.7362 | 5.1042 | 13 | 155 | receptor activity |
GO:0035326 | 0.0024 | 3.1384 | 3.4615 | 10 | 100 | enhancer binding |
GO:0004897 | 0.0035 | 55.9814 | 0.1038 | 2 | 3 | ciliary neurotrophic factor receptor activity |
GO:0033829 | 0.0035 | 55.9814 | 0.1038 | 2 | 3 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity |
GO:0035651 | 0.0035 | 55.9814 | 0.1038 | 2 | 3 | AP-3 adaptor complex binding |
GO:0005085 | 0.0043 | 2.0155 | 10.4538 | 20 | 302 | guanyl-nucleotide exchange factor activity |
GO:0032403 | 0.0047 | 1.6224 | 25.2182 | 39 | 731 | protein complex binding |
GO:0004896 | 0.0053 | 3.2444 | 2.6809 | 8 | 78 | cytokine receptor activity |
GO:0042393 | 0.0059 | 2.277 | 6.5077 | 14 | 188 | histone binding |
GO:0015106 | 0.0063 | 6.2363 | 0.7615 | 4 | 22 | bicarbonate transmembrane transporter activity |
GO:0043325 | 0.0063 | 6.2363 | 0.7615 | 4 | 22 | phosphatidylinositol-3,4-bisphosphate binding |
GO:0001851 | 0.0069 | 27.9888 | 0.1385 | 2 | 4 | complement component C3b binding |
GO:0030492 | 0.0069 | 27.9888 | 0.1385 | 2 | 4 | hemoglobin binding |
GO:0035650 | 0.0069 | 27.9888 | 0.1385 | 2 | 4 | AP-1 adaptor complex binding |
GO:0016493 | 0.0072 | 9.3426 | 0.4154 | 3 | 12 | C-C chemokine receptor activity |
GO:0019956 | 0.0074 | 5.9077 | 0.7962 | 4 | 23 | chemokine binding |
GO:0001191 | 0.0085 | 4.389 | 1.2808 | 5 | 37 | transcriptional repressor activity, RNA polymerase II transcription factor binding |
GO:0043425 | 0.0087 | 5.6119 | 0.8308 | 4 | 24 | bHLH transcription factor binding |
GO:0043565 | 0.0095 | 1.976 | 9.024 | 17 | 275 | sequence-specific DNA binding |
GO:0004871 | 0.0097 | 1.9287 | 9.7854 | 18 | 298 | signal transducer activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004930 | 0 | 2.2284 | 17.4947 | 36 | 698 | G-protein coupled receptor activity |
GO:0038023 | 1e-04 | 1.8534 | 29.1997 | 50 | 1165 | signaling receptor activity |
GO:0008201 | 2e-04 | 3.7601 | 3.4839 | 12 | 139 | heparin binding |
GO:0099600 | 3e-04 | 1.8256 | 27.7209 | 47 | 1106 | transmembrane receptor activity |
GO:0036374 | 3e-04 | 39.1907 | 0.1504 | 3 | 6 | glutathione hydrolase activity |
GO:0060089 | 3e-04 | 1.7217 | 35.1399 | 56 | 1402 | molecular transducer activity |
GO:0005518 | 6e-04 | 5.418 | 1.4537 | 7 | 58 | collagen binding |
GO:0004252 | 0.0017 | 3.0498 | 3.8599 | 11 | 154 | serine-type endopeptidase activity |
GO:0005201 | 0.0018 | 4.3825 | 1.7545 | 7 | 70 | extracellular matrix structural constituent |
GO:0042978 | 0.0018 | 78.1902 | 0.0752 | 2 | 3 | ornithine decarboxylase activator activity |
GO:0046332 | 0.002 | 4.3138 | 1.7796 | 7 | 71 | SMAD binding |
GO:0017171 | 0.0023 | 2.7844 | 4.5867 | 12 | 183 | serine hydrolase activity |
GO:0030545 | 0.0026 | 2.0694 | 10.7024 | 21 | 427 | receptor regulator activity |
GO:0000979 | 0.0029 | 4.6319 | 1.4287 | 6 | 57 | RNA polymerase II core promoter sequence-specific DNA binding |
GO:0051431 | 0.0036 | 39.0925 | 0.1003 | 2 | 4 | corticotropin-releasing hormone receptor 2 binding |
GO:0042056 | 0.0038 | 7.1351 | 0.6517 | 4 | 26 | chemoattractant activity |
GO:0046943 | 0.0042 | 3.0655 | 3.133 | 9 | 125 | carboxylic acid transmembrane transporter activity |
GO:0005539 | 0.0047 | 5.0274 | 1.1031 | 5 | 45 | glycosaminoglycan binding |
GO:0008083 | 0.0048 | 2.8049 | 3.7847 | 10 | 151 | growth factor activity |
GO:0004028 | 0.006 | 26.06 | 0.1253 | 2 | 5 | 3-chloroallyl aldehyde dehydrogenase activity |
GO:0015125 | 0.0087 | 19.6395 | 0.1497 | 2 | 6 | bile acid transmembrane transporter activity |
GO:0008508 | 0.0088 | 19.5437 | 0.1504 | 2 | 6 | bile acid:sodium symporter activity |
GO:0050431 | 0.0096 | 7.832 | 0.4512 | 3 | 18 | transforming growth factor beta binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005518 | 0 | 9.831 | 0.8217 | 7 | 58 | collagen binding |
GO:0005201 | 5e-04 | 6.6781 | 0.9917 | 6 | 70 | extracellular matrix structural constituent |
GO:0008083 | 0.0014 | 4.0017 | 2.1392 | 8 | 151 | growth factor activity |
GO:0004028 | 0.0019 | 46.8067 | 0.0708 | 2 | 5 | 3-chloroallyl aldehyde dehydrogenase activity |
GO:0008028 | 0.002 | 8.3193 | 0.5383 | 4 | 38 | monocarboxylic acid transmembrane transporter activity |
GO:0005539 | 0.0034 | 7.0643 | 0.6229 | 4 | 45 | glycosaminoglycan binding |
GO:0008201 | 0.0037 | 3.7783 | 1.9692 | 7 | 139 | heparin binding |
GO:0017171 | 0.0046 | 3.2631 | 2.5925 | 8 | 183 | serine hydrolase activity |
GO:0004930 | 0.005 | 2.0363 | 9.8883 | 19 | 698 | G-protein coupled receptor activity |
GO:0004252 | 0.0064 | 3.3894 | 2.1817 | 7 | 154 | serine-type endopeptidase activity |
GO:0043236 | 0.0071 | 8.4517 | 0.3967 | 3 | 28 | laminin binding |
GO:0098772 | 0.0072 | 1.6423 | 22.8933 | 35 | 1616 | molecular function regulator |
GO:0004623 | 0.0078 | 8.1261 | 0.4108 | 3 | 29 | phospholipase A2 activity |
GO:0004620 | 0.0099 | 5.1058 | 0.84 | 4 | 60 | phospholipase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005200 | 1e-04 | 7.3503 | 1.0535 | 7 | 95 | structural constituent of cytoskeleton |
GO:0097110 | 2e-04 | 9.9515 | 0.5656 | 5 | 51 | scaffold protein binding |
GO:0070851 | 5e-04 | 5.379 | 1.4084 | 7 | 127 | growth factor receptor binding |
GO:0050294 | 7e-04 | 90.2047 | 0.0444 | 2 | 4 | steroid sulfotransferase activity |
GO:0032395 | 0.0025 | 36.0749 | 0.0776 | 2 | 7 | MHC class II receptor activity |
GO:0003810 | 0.0033 | 30.0604 | 0.0887 | 2 | 8 | protein-glutamine gamma-glutamyltransferase activity |
GO:0015232 | 0.0033 | 30.0604 | 0.0887 | 2 | 8 | heme transporter activity |
GO:0016493 | 0.0075 | 18.0316 | 0.1331 | 2 | 12 | C-C chemokine receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 40.8917 | 3.7625 | 74 | 301 | olfactory receptor activity |
GO:0004930 | 0 | 15.8816 | 8.6001 | 77 | 695 | G-protein coupled receptor activity |
GO:0099600 | 0 | 10.6501 | 13.825 | 84 | 1106 | transmembrane receptor activity |
GO:0038023 | 0 | 10.2494 | 14.5625 | 85 | 1165 | signaling receptor activity |
GO:0060089 | 0 | 8.6314 | 17.525 | 87 | 1402 | molecular transducer activity |
GO:1903231 | 0 | 9.5319 | 1.725 | 14 | 138 | mRNA binding involved in posttranscriptional gene silencing |
GO:0005549 | 0 | 13.5968 | 0.8875 | 10 | 71 | odorant binding |
GO:0089720 | 2e-04 | 34.3705 | 0.125 | 3 | 10 | caspase binding |
GO:0050700 | 4e-04 | 26.7292 | 0.15 | 3 | 12 | CARD domain binding |
GO:0016503 | 5e-04 | 159.6269 | 0.0375 | 2 | 3 | pheromone receptor activity |
GO:0097153 | 6e-04 | 21.8665 | 0.175 | 3 | 14 | cysteine-type endopeptidase activity involved in apoptotic process |
GO:0005132 | 0.0015 | 53.2021 | 0.0625 | 2 | 5 | type I interferon receptor binding |
GO:0004993 | 0.0019 | 14.1434 | 0.25 | 3 | 20 | G-protein coupled serotonin receptor activity |
GO:0004869 | 0.0032 | 7.1483 | 0.6125 | 4 | 49 | cysteine-type endopeptidase inhibitor activity |
GO:0005344 | 0.0079 | 17.7271 | 0.1375 | 2 | 11 | oxygen carrier activity |
GO:0061134 | 0.0082 | 3.2218 | 2.2875 | 7 | 183 | peptidase regulator activity |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 34.5918 | 8.8563 | 130 | 301 | olfactory receptor activity |
GO:0004930 | 0 | 12.0355 | 20.3639 | 143 | 695 | G-protein coupled receptor activity |
GO:0099600 | 0 | 7.6908 | 32.5419 | 156 | 1106 | transmembrane receptor activity |
GO:0038023 | 0 | 7.4452 | 33.5002 | 156 | 1150 | signaling receptor activity |
GO:0060089 | 0 | 6.5063 | 41.2512 | 168 | 1402 | molecular transducer activity |
GO:0005549 | 0 | 25.7547 | 2.089 | 30 | 71 | odorant binding |
GO:1903231 | 0 | 6.1567 | 4.0604 | 21 | 138 | mRNA binding involved in posttranscriptional gene silencing |
GO:0030414 | 0 | 3.6999 | 4.4723 | 15 | 152 | peptidase inhibitor activity |
GO:0061135 | 0 | 3.6999 | 4.4723 | 15 | 152 | endopeptidase regulator activity |
GO:0004993 | 2e-04 | 11.1057 | 0.5885 | 5 | 20 | G-protein coupled serotonin receptor activity |
GO:0019863 | 2e-04 | 49.7993 | 0.1471 | 3 | 5 | IgE binding |
GO:0004869 | 5e-04 | 5.5675 | 1.4417 | 7 | 49 | cysteine-type endopeptidase inhibitor activity |
GO:0032396 | 9e-04 | Inf | 0.0588 | 2 | 2 | inhibitory MHC class I receptor activity |
GO:0003823 | 0.0013 | 5.5574 | 1.2358 | 6 | 42 | antigen binding |
GO:0008745 | 0.0025 | 66.2582 | 0.0883 | 2 | 3 | N-acetylmuramoyl-L-alanine amidase activity |
GO:0016503 | 0.0025 | 66.2582 | 0.0883 | 2 | 3 | pheromone receptor activity |
GO:0089720 | 0.0026 | 14.2237 | 0.2942 | 3 | 10 | caspase binding |
GO:0008329 | 0.0035 | 12.4981 | 0.3223 | 3 | 11 | signaling pattern recognition receptor activity |
GO:0042834 | 0.0035 | 12.4449 | 0.3237 | 3 | 11 | peptidoglycan binding |
GO:0050700 | 0.0046 | 11.0614 | 0.3531 | 3 | 12 | CARD domain binding |
GO:0016019 | 0.005 | 33.1269 | 0.1177 | 2 | 4 | peptidoglycan receptor activity |
GO:0016715 | 0.005 | 33.1269 | 0.1177 | 2 | 4 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen |
GO:0030492 | 0.005 | 33.1269 | 0.1177 | 2 | 4 | hemoglobin binding |
GO:0030280 | 0.0058 | 9.9546 | 0.3825 | 3 | 13 | structural constituent of epidermis |
GO:0097153 | 0.0072 | 9.049 | 0.4119 | 3 | 14 | cysteine-type endopeptidase activity involved in apoptotic process |
GO:0004867 | 0.0075 | 3.3343 | 2.2656 | 7 | 77 | serine-type endopeptidase inhibitor activity |
GO:0008009 | 0.0075 | 4.4958 | 1.2358 | 5 | 42 | chemokine activity |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
No LOLA Enrichment Analysis was conducted